Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.741725985535937,-2.9325431921825267,0.0,0.0,0.0,71/87,19.18%,RPS24;RPL18A;RPS9;RPL19;RPS12;RPS29;RPL26;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPS6;RPL35A;RPL21;RPS3;RPS17;RPL39;RPL37A;RPS7;RPL4;RPS15A;RPLP0;RPS25;RPL6;RPS21;RPL11;RPL28;RPL8;RPLP2;RPL32;RPS28;RPL30;RPL13A;RPS4X;RPS20;SRP14;RPS13;RPL18;RPS2;RPL14;RPL22;RPS26;RPS10;RPL23;RPL17;RPL29;RPS5;RPS14;UBA52;ZFAND2B;SRP9;RPL12;RPL9;RPL37;RPS11;SEC61A1;RPL7A;RPL7;RPL31
prerank,cytoplasmic translation (GO:0002181),-0.733079266624641,-2.912674025498225,0.0,0.0,0.0,62/91,13.48%,RPS24;RPL18A;RPS9;RPL19;RPS12;RPS29;RPL26;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPS6;RPL35A;RPL21;RPS3;RPS17;RPL39;RPL37A;RPS7;RPL4;RPS15A;RPLP0;RPS25;RPL6;RPS21;RPL11;RPL28;RPL8;RPL32;RPS28;RPL30;RPL13A;RPS4X;RPS20;RPS13;RPL18;RPS2;RPL14;RPL22;RPS26;RPS10;RPL23;RPL17;RPL29;EIF4A1;GSPT2;RPS5;RPL22L1;RPS14;UBA52
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.7178319845776506,-2.858615221183768,0.0,0.0,0.0,73/91,19.18%,RPS24;RPL18A;RPS9;RPL19;RPS12;RPS29;RPL26;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPS6;RPL35A;RPL21;RPS3;RPS17;RPL39;RPL37A;RPS7;ARL6IP1;RPL4;RPS15A;RPLP0;RPS25;RPL6;RPS21;RPL11;RPL28;RPL8;RPLP2;RPL32;RPS28;RPL30;RPL13A;RPS4X;RPS20;SRP14;RPS13;RPL18;RPS2;RPL14;RPL22;RPS26;RPS10;TRAM1;RPL23;RPL17;RPL29;RPS5;RPS14;UBA52;SSR2;SRP9;RPL12;RPL9;RPL37;RPS11;SEC61A1;RPL7A;RPL7;RPL31
prerank,protein targeting to ER (GO:0045047),-0.6941167307634817,-2.792609571846477,0.0,0.0,0.0,74/99,19.65%,RPS24;RPL18A;RPS9;RPL19;RPS12;RPS29;RPL26;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPS6;RPL35A;RPL21;RPS3;RPS17;RPL39;RPL37A;RPS7;RPL4;RPS15A;RPLP0;RPS25;RPL6;RPS21;RPL11;RPL28;RPL8;RPLP2;RPL32;RPS28;RPL30;RPL13A;RPS4X;RPS20;SRP14;RPS13;RPL18;RPS2;RPL14;RPL22;SPCS2;RPS26;RPS10;SPCS1;RPL23;RPL17;RPL29;RPS5;RPS14;UBA52;ZFAND2B;SRP9;RPL12;RPL9;RPL37;RPS11;SEC61A1;RPL7A;RPL7;RPL31;SEC61G
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6594038820758431,-2.6987892338904023,0.0,0.0,0.0,74/110,19.55%,RPS24;RPL18A;RPS9;RPL19;RPS12;RPS29;RPL26;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;PPP2R1A;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPS6;RPL35A;RPL21;RPS3;RPS17;RPL39;RPL37A;RPS7;RPL4;RPS15A;RPLP0;RPS25;RPL6;RPS21;RPL11;RPL28;RPL8;RPLP2;RPL32;RPS28;RPL30;RPL13A;RPS4X;RPS20;RPS13;RPL18;RPS2;RPL14;RPL22;RPS26;PNRC2;RPS10;RPL23;RPL17;RPL29;GSPT2;RPS5;RPS14;UBA52;DCP1A;RPL12;RPL9;RPL37;RPS11;PABPC1;RNPS1;RPL7A;RPL7;RPL31;UPF1
prerank,peptide biosynthetic process (GO:0043043),-0.6144059482757106,-2.6072462540867205,0.0,0.0,0.0,95/153,23.12%,RPS24;DMD;RPL18A;RPS9;RPL19;RPS12;RPS29;RPL26;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPS6;RPL35A;RPL21;RPS3;RPS17;RPL39;RPL37A;RPS7;RPL4;EEF1A1;RPS15A;RPLP0;RPS25;RPL6;RPS21;RPL11;RPL28;RPL8;RPLP2;RPL32;RPS28;RPL30;RPL13A;RPS4X;RPS20;RPS13;RPL18;RPS2;RPL14;RPL22;RPS26;MRPS18A;ASMT;RPS10;IGHMBP2;RPL23;RPL17;GGT5;RPL29;GSPT2;PABPC4;RPS5;RPS14;COPS5;MRPL28;SRBD1;HBS1L;RPL12;RPL9;GGT7;RPL37;RPS11;MRPL35;RPL7A;RPL7;MRPS5;RPL31;MRPL34;HARS1;GGT1;RPL3;YARS2;MRPL23;MRPL9;MRPL52;FARSB;PCSK5;MRPS12;RPL23A;MRPL11;GSPT1
prerank,translation (GO:0006412),-0.5638605457821001,-2.518969625435653,0.0,0.0,0.0,107/208,23.12%,RPS24;RPL18A;RPS9;RPL19;RPS12;RPS29;RPL26;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPS6;RPL35A;RPL21;EEF1G;RPS3;RPS17;RPL39;RPL37A;RPS7;RPL4;EEF1A1;RPS15A;RPLP0;RPS25;RPL6;RPS21;RPL11;RPL28;RPL8;RPLP2;RPL32;RPS28;RPL30;RPL13A;RPS4X;RPS20;GTPBP1;RPS13;RPL18;EEF2;RPS2;LARS2;RPL14;RPL22;RPS26;KARS1;MRPS18A;ASMT;RPS10;CARS1;IGHMBP2;RPL23;RPL17;EEF1E1;RPL29;GSPT2;PABPC4;RPS5;RPL22L1;FASTKD2;RPS14;UBA52;IARS1;COPS5;MRPL57;MRPL28;SRBD1;RARS2;HBS1L;RPL12;RPL9;RPL37;RPS11;MRPL35;MRPL47;RPL7A;RPL7;MRPS5;RPL31;MRPL34;HARS1;RPL3;YARS2;MRPL23;MRPL9;MRPL52;MRPS2;FARSB;MRPS12;TUFM;RPL23A;MRPL11;N6AMT1;GSPT1
prerank,chemical synaptic transmission (GO:0007268),-0.5030338952313776,-2.3074293857702006,0.0,0.00012897004490020642,0.001,114/284,21.68%,GRM7;NRXN1;NLGN1;DLG2;GRID2;SLC12A7;KCND2;RIMS1;SYT1;CACNA1E;GRIA4;GRM3;GRIK2;CACNB2;CHRM3;HSPA8;GRM5;LIN7A;PTCHD1;GRIK4;GRIA1;KIF1B;KCNQ3;PTPRN2;GABRA2;SLC6A1;RIT2;CACNB4;AMPH;PLP1;HTR2C;GABBR2;CALM1;CHRM2;HOMER1;SNAP25;GABRB3;GLRA3;SNCA;DLGAP1;GRIK1;GRIN2A;GABRA3;DLGAP2;SYN3;GABRA4;GRIA3;SLC1A1;GRIN2B;CDH8;APBA2;PRKAR1A;GABARAP;MBP;STXBP1;EXOC4;RIC3;SLC1A4;CPLX1;SDCBP;GRIA2;SLC1A2;GABRB1;SYN1;SLC12A5;NLGN3;GRIN1;GABRG3;SNPH;LRP6;MINK1;SLC12A6;DVL1;GAD2;RPS6KA1;PRKAR2B;PCDHB16;NAPA;SLC6A5;SHISA6;GABRB2;SYN2;KIF5A;GABRA5;RPS6KA2;GRIK3;HRH1;STAC3;SNAPIN;HTR4;HTR2B;CAMK4;CHRNA4;HTR2A;CACNA1A;AKAP5;GLRA2;SYPL1;GLRA1;HRH2;CAMKK2;APBA3;SLC32A1;GABRA1;PENK;CHRFAM7A;CHRNA7;KCNA1;SLC17A6;ATXN3;DTNA;SLC18A2;SNCG;KCNMB4
prerank,regulation of cation channel activity (GO:2001257),-0.5866029764229987,-2.2949301854477318,0.0,0.00011464003991129459,0.001,38/89,13.61%,PDE4D;NLGN1;DLG2;GRIA4;LRRC7;KCNAB1;MEF2C;CACNB2;DMD;FGF14;FGF12;PTK2B;GRIA1;CACNB4;NETO1;FKBP1A;CALM1;HOMER1;ANK3;GRIN2A;CALM2;OPRM1;GRIA3;GRIN2B;CAMK2A;GRIA2;CAMK2D;CTSS;SHISA9;SELENON;GRIN1;MINK1;NOS1;CAPN1;FGF13;SHISA6;STAC;RELN
prerank,cellular response to copper ion (GO:0071280),-0.8475398520169052,-2.2916754829761805,0.0,0.00010317603592016513,0.001,9/16,4.07%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;SNCA
prerank,glutamate receptor signaling pathway (GO:0007215),-0.7002486135050094,-2.2850490830489907,0.0,9.379639629105922e-05,0.001,19/37,10.73%,GRM7;GRID2;GRIA4;GRM3;PLCB1;GRIK2;GRIN3A;GRM5;GRIK4;PTK2B;HOMER1;GRIK1;GRIN2A;GRIA3;GRIN2B;GRM8;GRIA2;GRIN1;KCNB1
prerank,zinc ion homeostasis (GO:0055069),-0.7499319250565775,-2.277516271276324,0.0,8.598002993347094e-05,0.001,16/28,13.72%,SLC39A10;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;SLC39A6;SLC30A1;SLC39A12;SLC39A14;MT2A;SLC39A13;SLC39A8
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.5049685154844145,-2.267113463086064,0.0,7.93661814770501e-05,0.001,93/224,21.68%,GRM7;NRXN1;NLGN1;DLG2;SLC12A7;KCND2;SYT1;CACNA1E;GRIA4;GRM3;GRIK2;CACNB2;CHRM3;GRM5;PTCHD1;GRIK4;GRIA1;KCNQ3;GABRA2;SLC6A1;RIT2;CACNB4;AMPH;PLP1;HTR2C;GABBR2;CALM1;CHRM2;HOMER1;SNAP25;GABRB3;GLRA3;SNCA;DLGAP1;GRIK1;GRIN2A;GABRA3;GABRA4;GRIA3;SLC1A1;GRIN2B;APBA2;PRKAR1A;GABARAP;MBP;EXOC4;CPLX1;SDCBP;GRIA2;SLC1A2;GABRB1;SYN1;SLC12A5;NLGN3;GRIN1;GABRG3;LRP6;MINK1;SLC12A6;GAD2;RPS6KA1;PRKAR2B;PCDHB16;SLC6A5;GABRB2;SYN2;KIF5A;GABRA5;RPS6KA2;HRH1;HTR4;HTR2B;CAMK4;CHRNA4;HTR2A;CACNA1A;AKAP5;GLRA2;SYPL1;GLRA1;HRH2;CAMKK2;APBA3;GABRA1;PENK;CHRFAM7A;CHRNA7;KCNA1;ATXN3;DTNA;SLC18A2;SNCG;KCNMB4
prerank,cellular zinc ion homeostasis (GO:0006882),-0.7532319992750838,-2.2507005123205137,0.0,7.369716851440367e-05,0.001,16/26,13.72%,SLC39A10;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;SLC39A6;SLC30A1;SLC39A12;SLC39A14;MT2A;SLC39A13;SLC39A8
prerank,response to copper ion (GO:0046688),-0.7836781715870365,-2.225344945288398,0.0,0.0003439201197338838,0.004,9/20,4.07%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;SNCA
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.5445913884433738,-2.2134366616161474,0.0,0.00032242511225051606,0.004,39/107,14.35%,GRM7;NLGN1;GRID2;LRRC4C;NRG3;SLC12A2;RIMS1;SYT1;RIMS2;GRM3;DGKI;CDH2;MEF2C;GRIK2;GRM5;ABR;GRIK4;MCTP1;HOMER1;DLGAP1;GRIK1;DLGAP2;SYN3;DGKZ;BTBD9;CPLX1;CNTNAP4;LRP8;GRM8;CAMK2A;SYN1;NLGN3;BCR;NGF;CLSTN1;USP46;RELN;TMEM108;LGI1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5058710034285442,-2.1841884190059413,0.0,0.00042484250084773875,0.006,83/168,19.55%,RPS24;RPL18A;RPS9;RPL19;RPS12;RPS29;RPL26;RPL41;RPS15;DIS3L2;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;PPP2R1A;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPS6;RPL35A;RPL21;RPS3;RPS17;RPL39;RPL37A;RPS7;RPL4;RPS15A;RPLP0;RPS25;RPL6;RPS21;RPL11;RPL28;RPL8;RPLP2;RPL32;RPS28;RPL30;RPL13A;RPS4X;RPS20;RPS13;RPL18;RPS2;RPL14;RPL22;RPS26;PNRC2;RPS10;ATM;RPL23;RPL17;RPL29;GSPT2;RPS5;RPS14;UBA52;DCP1A;MTPAP;PELO;RPL12;RPL9;XRN2;RPL37;RPS11;CNOT2;PABPC1;RNPS1;ERI1;RPL7A;RPL7;EXOSC4;CNOT8;RPL31;UPF1
prerank,rRNA processing (GO:0006364),-0.48238707424845423,-2.107933502911748,0.0,0.001318360458979888,0.019,84/172,22.46%,RPS24;RPL18A;RPS9;RPL19;RPL26;RPL41;RPS15;RPL24;RPL5;RPS27;RPS19;RPL38;RPLP1;RPL10A;RPL27A;RPL13;RPL27;RPS16;RPS6;RPL35A;RPL21;RPS17;RPL39;RPL37A;RPS7;RPL4;RPLP0;RPS25;RPL6;RPL11;RPL28;RPL8;RPLP2;RPL32;RPS28;RPL30;RPL13A;RPL18;RRP7A;RPS2;DDX54;NOL11;DDX49;RPL14;RPL22;DDX47;WDR36;BYSL;NVL;HELQ;EXOSC2;RPL23;RPL17;RPL29;MAK16;THUMPD1;TEX10;MRPL1;RPS14;UBA52;SART1;NOP56;RPL12;RPL9;XRN2;IMP3;ESF1;RPL37;ERI1;SNU13;RPL7A;RPL7;EXOSC4;RPL31;UTP6;MDN1;RPL3;HEATR1;BMS1;TFB1M;UTP11;WDR46;PIH1D2;RPL23A
prerank,rRNA metabolic process (GO:0016072),-0.4875742427340223,-2.0918163477089036,0.0,0.0016833984808026943,0.025,80/160,22.46%,RPS24;RPL18A;RPS9;RPL19;RPL26;RPL41;RPS15;RPL24;RPL5;RPS27;RPS19;RPL38;RPLP1;RPL10A;RPL27A;RPL13;RPL27;RPS16;RPS6;RPL35A;RPL21;RPS17;RPL39;RPL37A;RPS7;RPL4;RPLP0;RPS25;RPL6;RPL11;RPL28;RPL8;RPLP2;RPL32;RPS28;RPL30;RPL13A;RPL18;RRP7A;RPS2;DDX54;NOL11;DDX49;RPL14;RPL22;DDX47;WDR36;BYSL;NVL;HELQ;EXOSC2;RPL23;RPL17;RPL29;TEX10;RPS14;UBA52;NOP56;MAPT;RPL12;RPL9;XRN2;IMP3;DEDD2;ESF1;RPL37;SNU13;RPL7A;RPL7;EXOSC4;RPL31;UTP6;MDN1;RPL3;HEATR1;BMS1;UTP11;WDR46;PIH1D2;RPL23A
prerank,neurotransmitter secretion (GO:0007269),-0.6034356189765806,-2.08538375129298,0.0,0.0019087566645230552,0.031,17/44,11.07%,NRXN1;RIMS1;SYT1;RIMS2;HSPA8;LIN7A;PTPRN2;PCLO;SNAP25;SNCA;SYN3;STXBP1;CPLX1;SYN1;SNPH;DVL1;GAD2
prerank,regulation of dendritic spine development (GO:0060998),-0.7235807622505448,-2.061690641907648,0.0,0.0028496238492236084,0.048,6/19,2.06%,NLGN1;SHANK3;MEF2C;PPFIA2;GRIN3A;TANC2
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.6395126927132452,-2.048563159799091,0.0,0.0036111612572057796,0.065,17/33,18.29%,NLGN1;GRID2;LRRC4C;NRG3;GRIK2;ABR;GRIK4;GRIK1;BTBD9;LRP8;NLGN3;BCR;NGF;RELN;GRIK3;NTF3;CACNA1A
prerank,cellular response to cadmium ion (GO:0071276),-0.6798571095688312,-2.036960512800461,0.0,0.0046204920433813084,0.088,13/24,13.17%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;MAPK8;MAPK3;AKT1;MT2A;EGFR
prerank,ribosome biogenesis (GO:0042254),-0.4612378908747839,-2.0362786081146584,0.0,0.004427971541573754,0.088,84/187,22.46%,RPS24;RPL18A;RPS9;RPL19;RPL26;RPL41;RPS15;RPL24;RPL5;RPS27;RPS19;RPL38;RPLP1;RPL10A;RPL27A;RPL13;RPL27;RPS16;RPS6;RPL35A;RPL21;RPS17;RPL39;RPL37A;RPS7;RPL4;RPLP0;RPS25;RPL6;RPL11;RPL28;RPL8;RPLP2;RPL32;RPS28;RPL30;RPL13A;RPL18;RRP7A;RPS2;DDX54;NOL11;DDX49;RPL14;RPL22;DDX47;NPM1;WDR36;BYSL;NVL;HELQ;NIP7;EXOSC2;RPL23;RPL17;RPL29;XPO1;TEX10;RPS14;UBA52;NOP56;URB2;RPL12;RPL9;XRN2;IMP3;ESF1;RPL37;SNU13;RPL7A;RPL7;EXOSC4;RPL31;MALSU1;NOC2L;UTP6;MDN1;RPL3;HEATR1;BMS1;UTP11;WDR46;PIH1D2;RPL23A
prerank,positive regulation of cell junction assembly (GO:1901890),-0.5601270562890731,-2.034346651217936,0.0,0.0044159343373830675,0.092,26/56,18.34%,TEK;CNTNAP2;NRXN1;NLGN1;GRID2;PTPRD;PTPRJ;CLDN5;KDR;SYNDIG1;IL1RAPL1;IL1RAP;EPHB1;MYOC;NLGN3;VEGFA;LRRC4B;ACE2;CAV1;CLSTN1;COL16A1;RAC1;SLITRK2;SRPX2;PPM1F;EPHB3
prerank,ribosomal large subunit assembly (GO:0000027),-0.6735833559528474,-2.0300133334052344,0.0,0.004563555434930381,0.097,13/24,22.46%,RPL24;RPL5;RPLP0;RPL6;RPL11;DHX30;TRAF7;FASTKD2;PPAN;NLE1;MDN1;RPL3;RPL23A
prerank,response to cadmium ion (GO:0046686),-0.6665971704564322,-2.02900700242097,0.0,0.004394534863266292,0.097,13/26,13.17%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;MAPK8;MAPK3;AKT1;MT2A;EGFR
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.580281243739578,-2.0267637009856383,0.0,0.004384981526607018,0.101,17/46,9.46%,GRM7;NRXN1;NLGN1;SHANK3;SYT1;GRM3;DGKI;CDH2;MEF2C;GRM5;PTK2B;HOMER1;GRIK1;DGKZ;GRM8;NLGN3;ATAD1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.8341802301736173,-2.016773936346246,0.0,0.004909756192063031,0.115,8/11,9.03%,ADIPOR2;KDR;CD34;GATA2;PRCP;NDNF;MCAM;VEGFA
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.548847379376299,-2.003488019985327,0.0,0.00615617014323652,0.145,22/57,13.61%,NLGN1;DLG2;GRIA4;LRRC7;MEF2C;PTK2B;GRIA1;NETO1;DLGAP1;GRIN2A;DLGAP2;OPRM1;GRIA3;GRIN2B;CAMK2A;GRIA2;SHISA9;GRIN1;MINK1;CAPN1;SHISA6;RELN
prerank,signal release from synapse (GO:0099643),-0.5828168091588222,-1.9999266527754023,0.0,0.006423540300836088,0.153,16/43,11.07%,NRXN1;RIMS1;SYT1;HSPA8;LIN7A;PTPRN2;PCLO;SNAP25;SNCA;SYN3;STXBP1;CPLX1;SYN1;SNPH;DVL1;GAD2
prerank,ribosome assembly (GO:0042255),-0.561635493409081,-1.982734683670537,0.0,0.008737720541988986,0.21,23/47,23.74%,RPS15;RPL24;RPL5;RPS27;RPS19;RPLP0;RPL6;RPL11;RPS28;RRP7A;NPM1;TRAF7;RPS5;RPS14;PPAN;MTERF3;NLE1;C1QBP;MDN1;RPL3;MRPS2;RPL23A;EIF6
prerank,cellular response to zinc ion (GO:0071294),-0.7514049830765511,-1.9793166183594957,0.0,0.008848126716789919,0.218,8/15,2.81%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.5780372129747464,-1.9690070182372883,0.0,0.010226565913263427,0.253,15/39,13.26%,RPS24;RPS15;RPS27;RPS19;RPS16;RPS6;RPS17;RPS7;RPS25;RPS28;RRP7A;NOL11;NPM1;RPS5;RPS14
prerank,neuron cell-cell adhesion (GO:0007158),-0.7460327314661493,-1.9667087522013487,0.0,0.010406040194233798,0.265,9/14,10.81%,NRXN1;NLGN1;CNTN4;NCAM2;ASTN1;ASTN2;NINJ2;NLGN3;RET
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.7851290265556116,-1.9581216820086902,0.0,0.012123184220619403,0.307,10/13,14.23%,PDE4D;CALM1;ANK3;CALM2;SLC8A1;CALM3;CAMK2D;CAV1;SRI;CASQ2
prerank,positive regulation of synapse assembly (GO:0051965),-0.6407491038884618,-1.9521428490979658,0.0,0.012883061782463864,0.332,16/27,18.34%,NRXN1;NLGN1;GRID2;PTPRD;SYNDIG1;SEMA4D;IL1RAPL1;IL1RAP;EPHB1;NLGN3;LRRC4B;CLSTN1;AGRN;SLITRK2;SRPX2;EPHB3
prerank,inorganic anion transmembrane transport (GO:0098661),-0.5331967489968155,-1.9503382862528995,0.0,0.012924156078420684,0.339,31/63,20.05%,SLC12A7;SLC12A2;SLC26A2;ANO1;GABRA2;SLC6A1;ANO3;GABRB3;GLRA3;GABRA3;CLCN3;XPR1;SLC5A5;GABRA4;SLC1A1;SLC5A6;ANO4;GABRB1;SLC12A5;GABRG3;SLC12A6;CLCN1;SLC25A30;ANO2;GABRB2;GABRA5;SLC20A2;ANO5;GLRA2;GLRA1;GABRA1
prerank,chloride transmembrane transport (GO:1902476),-0.5622077150492133,-1.9460832001612436,0.0,0.013730349395529667,0.359,25/48,20.05%,SLC12A7;SLC12A2;ANO1;GABRA2;SLC6A1;ANO3;GABRB3;GLRA3;GABRA3;CLCN3;GABRA4;SLC1A1;ANO4;GABRB1;SLC12A5;GABRG3;SLC12A6;CLCN1;ANO2;GABRB2;GABRA5;ANO5;GLRA2;GLRA1;GABRA1
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.4185231124418072,-1.9388283327097888,0.0,0.014960525208423945,0.394,141/306,24.29%,RPS24;THRB;RPL18A;RPS9;RPL19;RPS12;RPS29;RPL26;RPL41;RPS15;RPL24;RPS23;RPL5;PTMA;RPS27;RPS19;RPL38;RPLP1;FUT9;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPS6;RPL35A;RPL21;EEF1G;RPS3;RPS17;RPL39;RPL37A;RPS7;RPL4;EEF1A1;RPS15A;RPLP0;RPS25;RPL6;RPS21;RPL11;EXT1;RPL28;RPL8;RPLP2;RPL32;RPS28;MRE11;MCM9;RPL30;RPL13A;RPS4X;RPS20;GTPBP1;RPS13;RPL18;EEF2;RPS2;FAM111A;CLSPN;RPL14;RPL22;TBRG1;ALAS1;RPS26;MRPS18A;ASMT;RPS10;POLA1;PWP1;IGHMBP2;ATM;BARD1;RPL23;RPL17;RPL29;GCNT1;GSPT2;PABPC4;RPS5;XAB2;POLR3A;RPS14;ST3GAL4;NFKBIB;ORC6;POLD2;CDK2;COPS5;MRPL28;SRBD1;HBS1L;POLR2J;RMI2;CDC45;RPL12;SET;RPL9;MMS19;BRCA1;RAD1;RPL37;RPS11;RRAGC;POLE;RNPS1;RFC4;KAT7;CHEK1;MRPL35;RPL7A;RPL7;MRPS5;RPL31;MRPL34;UPF1;HARS1;POLD1;RPL3;YARS2;MRPL23;MRPL9;HOXD3;BCL3;MRPL52;FARSB;ATRIP;MRPS12;DONSON;TUFM;RPL23A;MRPL11;GSPT1;ING4;ATR;MCM10;MRPS16;EXO1;POLR2E
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.789079837806058,-1.9271220315740443,0.0,0.017036628370232145,0.427,8/12,12.55%,PDE4D;CALM1;CALM2;GJD3;CALM3;CAMK2D;CAV1;SRI
prerank,action potential (GO:0001508),-0.5747375515024766,-1.9260885913525683,0.0,0.01699948020398911,0.434,21/44,17.44%,KCND2;DMD;KCNMB2;AKAP6;KCNJ2;SCN1A;ANK3;SCN2A;CACNA1G;YWHAH;SCN8A;KCNB1;SCN9A;KCNQ1;SRI;KCNE4;KCNA2;GNA14;GNAQ;SCN3A;CHRNA4
prerank,response to cytokine (GO:0034097),0.5156026950845913,1.9227625946230829,0.0,0.899367956534934,0.549,41/141,13.03%,ALDH1A2;PTPN13;DPYSL3;SMAD3;COL3A1;SELP;SP100;PID1;EIF2AK2;CXCL16;TRIM56;NFAT5;IL6ST;AFF3;TIMP3;IL23R;ANXA1;PTPN14;PTPN4;IKBKE;BCL2;HAX1;MCL1;PTPN2;PTPN9;HDAC4;BST2;STAT1;LGALS9;NUB1;CD274;TIMP2;IFITM1;PTPN6;IRAK3;IFNLR1;BCL2L1;TRIM21;PTPN18;ADAR;CRNN
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.778067393885348,1.9138421179059972,0.0,0.5195805096720841,0.591,6/16,4.08%,IGFBP3;IGFBP5;PHIP;GHRH;BMP2;IGFBP6
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.5226888147574991,-1.9131398191011326,0.0,0.020539229476200314,0.502,20/57,11.99%,RPS24;RPL26;RPS15;RPL5;RPS19;RPL38;RPS16;RPS6;RPL35A;RPS17;RPS7;RPS25;RPL11;RPS28;RPL14;NPM1;BYSL;NVL;NIP7;XPO1
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.5732067550880852,-1.8745459184287838,0.0,0.033063229692598374,0.688,13/34,15.10%,PDE4D;PDE4B;ATP1B1;RYR2;SMAD7;CALM1;CALM2;SLC8A1;CALM3;NOS1;KCNQ1;SRI;ATP2A2
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5971825094493483,1.8732349966632351,0.0,0.6605140753247504,0.795,22/50,19.06%,RORA;DCDC2;GLI3;FBXL17;ZIC1;GLI1;CREBBP;MGRN1;GLIS2;SUFU;IFT81;RAB34;IHH;BTRC;TTC23;EVC;TUBD1;DLG5;GAS8;PTCH1;GAS1;WDR11
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.5786130483456344,-1.8718090194142651,0.0,0.03352074767006254,0.701,12/34,9.50%,GRID2;MEF2C;GABRA2;GRIN2A;GABRA3;GABRA4;GRIN2B;RAB3GAP1;AKT1;NLGN3;GRIN1;GABRG3
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.7812048625780884,1.8712036751439438,0.0018656716417910447,0.5093159840811963,0.806,4/14,2.52%,ENPP3;CMPK2;ENPP1;DCTPP1
prerank,retinoid metabolic process (GO:0001523),0.559573594771927,1.8644513688534294,0.0015479876160990713,0.4520301555453842,0.842,11/71,5.12%,ALDH1A2;ALDH1A1;GPC6;RBP1;HSPG2;ABCA4;APOA2;RDH10;SDC2;RBP4;RDH5
prerank,ganglioside metabolic process (GO:0001573),-0.6459289711977654,-1.8522579753880186,0.0022172949002217295,0.0421003085700326,0.793,8/20,13.93%,ST6GALNAC3;ST8SIA4;ST8SIA6;HEXB;ST6GALNAC4;ST6GALNAC5;NEU1;GM2A
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.7117690025038966,-1.847935846374941,0.00625,0.04386079144010425,0.817,7/15,11.84%,ATP1B1;KCNJ3;KCNJ2;ATP1A1;KCND3;KCNJ8;KCNQ1
prerank,ncRNA processing (GO:0034470),-0.42016670380320864,-1.8452573398544607,0.0,0.044451675475604475,0.83,88/200,22.71%,RPS24;RPL18A;RPS9;RPL19;RPL26;RPL41;RPS15;RPL24;RPL5;RPS27;RPS19;RPL38;RPLP1;LIN28B;RPL10A;RPL27A;INTS7;RPL13;RPL27;RPS16;RPS6;RPL35A;RPL21;RPS17;RPL39;RPL37A;RPS7;RPL4;RPLP0;RPS25;INTS10;RPL6;RPL11;RPL28;RPL8;RPLP2;RPL32;RPS28;RPL30;RPL13A;RPL18;RRP7A;RPS2;DDX54;NOL11;DDX49;RPL14;RPL22;DDX47;WDR36;KARS1;BYSL;NVL;SMAD1;HELQ;EXOSC2;RPL23;RPL17;RPL29;TEX10;RPP30;RPS14;UBA52;NOP56;INTS12;RPL12;RPL9;XRN2;IMP3;ESF1;RPL37;SNU13;RPL7A;RPL7;EXOSC4;DICER1;RPL31;UTP6;MDN1;RPL3;ZCCHC8;HEATR1;BMS1;UTP11;WDR46;PIH1D2;RPL23A;INTS11
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6732326676420861,1.842407810742495,0.0,0.5179512198957528,0.915,9/26,11.91%,EYA2;EYA1;FGFR1;TERT;BCL2;MCL1;BCL2L1;EYA4;MAP2K5
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5878869106191654,1.8404377853303608,0.0,0.45694595555625833,0.917,14/46,9.50%,ALDH1A1;LGR4;RBPJ;LAMA4;WNT10B;ACOT11;FOXC2;NRDC;TLE3;TLR4;NR1H3;NOVA1;MAP2K6;DOCK7
prerank,regulation of humoral immune response (GO:0002920),0.5970209774503125,1.8401980344093387,0.001567398119122257,0.4012940719104243,0.917,12/44,9.67%,CFH;VTN;CFHR2;GATA6;CD55;SERPING1;C5AR2;C2;PROS1;PHB2;C6;CPB2
prerank,regulation of NMDA receptor activity (GO:2000310),-0.5702574918152715,-1.837197814094269,0.0,0.047987384869807415,0.856,15/32,11.33%,NLGN1;DLG2;GRIA4;LRRC7;MEF2C;PTK2B;GRIA1;GRIN2A;OPRM1;GRIA3;GRIN2B;CAMK2A;GRIA2;GRIN1;CAPN1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.6246858392601609,-1.8361580271685585,0.0,0.04793558628850872,0.861,12/24,14.23%,PDE4D;DMD;AKAP6;FKBP1A;CALM1;CALM2;CALM3;CAMK2D;SELENON;NOS1;SRI;CASQ2
prerank,negative regulation of vascular permeability (GO:0043116),-0.7387054717138745,-1.8330758304715455,0.003929273084479371,0.049038962954996136,0.868,9/12,11.46%,SLIT2;PTPRJ;CLDN5;SH3GL2;CEACAM1;RAMP2;PDE2A;VEGFA;PDE3A
prerank,negative regulation of cartilage development (GO:0061037),0.7745300218163973,1.8266971963107619,0.001890359168241966,0.42730839867251563,0.947,4/13,5.09%,EFEMP1;ADAMTS12;PTHLH;TGFBR1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.6352293848080328,1.8263067341685797,0.0017985611510791368,0.38653270653686184,0.951,14/29,16.87%,GHR;IL31RA;STAT2;FER;STAT5B;STAT1;STAMBP;CCL2;PIAS1;STAT4;PKD2;SOCS6;IFNAR2;STAT5A
prerank,regulation of stress fiber assembly (GO:0051492),0.5428885105393433,1.824954866516947,0.0,0.35743655347663084,0.954,20/74,7.13%,PHLDB2;CGNL1;ARHGAP6;LPAR1;ROCK2;CCN2;DLC1;PPM1E;TACSTD2;ARHGAP28;NRP1;ALMS1;S100A10;TPM1;TGFBR1;CLASP1;EPHA1;ASAP3;CD47;ARHGEF10L
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.7549789151240449,1.8206990743770108,0.005474452554744526,0.3444318587164584,0.959,6/14,12.58%,EFEMP1;ADAMTS12;PTHLH;TGFBR1;RFLNA;ADAMTS7
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.6090274279954653,-1.8128961786442785,0.0,0.061925463097468346,0.93,10/24,13.82%,PDE4D;PEX5L;PDE3B;PRKAR1A;PDE11A;RAPGEF2;PDE2A;PDE3A;PRKAR2B;APLNR
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.7224815187666768,1.8127665411832519,0.0018552875695732839,0.35410733338821104,0.973,7/18,5.16%,PDPN;SMAD3;DDR2;BMP2;IL6;EFEMP2;CLASP1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.6380263021023294,1.8115497433821355,0.0016638935108153079,0.33467939562670324,0.975,9/30,6.30%,TGFBR3;SMAD3;FSTL1;SMURF2;FSTL3;TWSG1;LATS2;NREP;DKK3
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7226965074769728,1.8100930857313156,0.0037243947858473,0.319145281387795,0.977,2/16,0.28%,PDK1;RORA
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.65212408906165,1.8047140391125613,0.003367003367003367,0.32033873614895775,0.983,5/26,4.62%,SULF1;RORA;IL6ST;ARNT;IL6
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.7701952818626551,1.8036549151981287,0.007936507936507936,0.30609562868513124,0.985,6/12,15.39%,DPYSL3;CTPS1;DPYD;UMPS;ALDH6A1;DPYSL4
prerank,receptor signaling pathway via STAT (GO:0097696),0.6330503306621279,1.8030093286319848,0.0036496350364963502,0.29142563132647675,0.985,13/25,16.87%,GHR;IL31RA;STAT2;STAT5B;STAT1;STAMBP;CCL2;PIAS1;STAT4;PKD2;SOCS6;IFNAR2;STAT5A
prerank,ribosomal small subunit assembly (GO:0000028),-0.6726103690417173,-1.8028624954963046,0.0045045045045045045,0.06869966618155901,0.954,7/16,13.26%,RPS15;RPS27;RPS19;RPS28;RRP7A;RPS5;RPS14
prerank,modified amino acid transport (GO:0072337),0.7227970204954381,1.8013960670164633,0.0035650623885918,0.28164417586225565,0.985,4/15,3.79%,PDPN;SLC6A13;SLC19A1;SLC16A12
prerank,chloride transport (GO:0006821),-0.4764522852614488,-1.7993393855104827,0.0,0.07067558460531312,0.959,30/74,18.98%,SLC4A10;SLC12A7;SLC26A7;SLC12A2;ANO1;CLIC5;GABRA2;SLC6A1;ANO3;GABRB3;GLRA3;GABRA3;CLCN3;GABRA4;SLC1A1;ANO4;GABRB1;SLC12A5;GABRG3;SLC12A6;CLCN1;TTYH3;ANO2;GABRB2;GABRA5;TTYH1;FXYD1;ANO5;GLRA2;GLRA1
prerank,eye morphogenesis (GO:0048592),0.7001520143392015,1.7986458300604287,0.0017667844522968198,0.27699555487410166,0.987,9/19,11.39%,EFEMP1;FBN1;COL5A2;SHROOM2;COL5A1;SKI;MFAP2;NKD1;MFAP5
prerank,mesenchymal cell differentiation (GO:0048762),0.5640848639754844,1.7948799601723837,0.0032733224222585926,0.2769792619763383,0.989,14/51,7.87%,RANBP3L;TGFBR3;WNT4;ROCK2;RBPJ;FGFR1;FOXC1;FBXL17;LOXL3;BMP2;BMP7;TGFBR1;GSK3B;WNT5A
prerank,epithelial structure maintenance (GO:0010669),0.7984806889001576,1.794673760115321,0.0,0.2651891286857947,0.99,4/11,3.59%,CXADR;MUC2;PIWIL4;RBP4
prerank,epithelial tube morphogenesis (GO:0060562),-0.5603510055663696,-1.794134522541775,0.0023148148148148147,0.07409915306993678,0.968,15/32,13.65%,SLIT2;MEF2C;RYR2;COL4A1;PAK1;ACVRL1;SOX17;MET;RASIP1;CTNNB1;BMP4;RHOB;PRKX;CSF1R;ACVR1
prerank,regulation of bone mineralization (GO:0030500),0.559622081844575,1.791457592219622,0.001579778830963665,0.2644124790928083,0.99,15/55,4.97%,BMP6;WNT4;PTN;ENPP1;DDR2;OSR1;ECM1;BMPR1A;BMP2K;NELL1;KL;ADGRV1;BMP2;BMP7;BCOR
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.688179690113486,1.7910061691316241,0.001736111111111111,0.24521462849698134,0.99,8/21,11.91%,EYA2;EYA1;TERT;BCL2;MCL1;BCL2L1;EYA4;MAP2K5
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.688179690113486,1.7910061691316241,0.001736111111111111,0.24521462849698134,0.99,8/21,11.91%,EYA2;EYA1;TERT;BCL2;MCL1;BCL2L1;EYA4;MAP2K5
prerank,regulation of small molecule metabolic process (GO:0062012),0.6370796089492736,1.7883086980177014,0.0017605633802816902,0.24364148655294193,0.991,5/28,6.63%,PDK1;RORA;PANK2;PPARA;FMO5
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6387793524726416,-1.7870082348125695,0.004347826086956522,0.07962979057981316,0.98,8/18,9.47%,NRXN1;NLGN1;SHANK3;RIMS1;RIMS2;PTK2B;NLGN3;GRIN1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6603206134505579,1.7865886276456497,0.0,0.23943318424176802,0.991,5/24,4.62%,SULF1;RORA;IL6ST;ARNT;IL6
prerank,diterpenoid metabolic process (GO:0016101),0.5527728453475883,1.7814465285238736,0.0031847133757961785,0.24652318094305775,0.992,10/55,5.12%,ALDH1A1;GPC6;RBP1;HSPG2;ABCA4;APOA2;RDH10;SDC2;RBP4;RDH5
prerank,dendrite self-avoidance (GO:0070593),-0.6734440389234069,-1.7774558815556842,0.004576659038901602,0.08751861994280674,0.983,7/16,10.19%,BSG;CNTN4;CNTN6;ROBO4;NPTN;CNTN2;EMB
prerank,vasodilation (GO:0042311),-0.686539787593998,-1.7752398644879004,0.004310344827586207,0.08817993276832045,0.984,6/13,14.60%,NOS3;KCNMA1;KLF2;NOS1;ADRB2;SOD1
prerank,negative regulation of metabolic process (GO:0009892),0.5506900735284812,1.774161811598909,0.0015060240963855422,0.26050658051356707,0.994,14/54,9.50%,ALDH1A1;LGR4;RBPJ;LAMA4;WNT10B;ACOT11;FOXC2;NRDC;TLE3;TLR4;NR1H3;NOVA1;MAP2K6;DOCK7
prerank,detection of calcium ion (GO:0005513),-0.6854805426571482,-1.7716040823899286,0.004329004329004329,0.09074244921859946,0.986,6/13,7.26%,SYT1;KCNMB2;RYR2;CALM1;CALM2;CALM3
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.6076888028098275,-1.7680499366690794,0.00904977375565611,0.09258329623236151,0.988,9/21,11.76%,PDE4D;DMD;SMAD7;INPP5K;PAQR3;RASSF2;DDIT4;RACK1;CAV1
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.46304983636847336,-1.7668278337188112,0.0,0.09230026688792477,0.988,25/75,16.25%,SLC12A7;SLC12A2;SLC9A2;SLC39A10;SLC24A2;ATP1B1;KCNJ3;ABCC9;KCNJ2;SLC6A1;ATP1A1;SLC8A1;HCN2;SLC39A6;SLC12A5;SLC39A12;SLC12A6;KCNJ6;SLC39A14;KCNJ8;KCNJ15;SLC39A8;SLC9A5;ATP1A3;KCNK9
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.4464028859170833,1.7609023421626377,0.0,0.29558575122204295,0.995,69/248,16.13%,BICC1;TCF7L2;RNF220;WLS;LRRK1;MCC;LGR4;PRICKLE1;ZEB2;RBMS3;TLE1;SMURF2;MLLT3;TBL1XR1;WNT3A;PPM1A;KANK1;PTK7;GLI3;INVS;DACT1;BMP2;IGFBP6;TLE3;GLI1;LYPD6;TMEM64;LATS2;SIAH2;LRP4;DKK3;PLEKHA4;GSK3B;CTNND1;WNT5A;PSMB10;LRRK2;STK3;PSMA7;AMFR;USP47;LZTS2;PSMA3;PSME4;USP8;PSMA5;PPM1B;NKD1;CUL3;PTPRU;DVL3;BTRC;NOG;FRMD8;USP34;WNK1;NPHP3;IGFBP4;TLE6;ILK;STK4;SOX4;RNF146;DAB2;COL1A1;WWTR1;AXIN2;TNKS2;TBL1X
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.7403755256494584,-1.760441612577395,0.008368200836820083,0.09733494098339449,0.992,6/11,11.84%,ATP1B1;KCNJ3;KCNJ2;ATP1A1;KCND3;KCNQ1
prerank,dendritic spine organization (GO:0097061),-0.5672659675354649,-1.7596273179598263,0.004651162790697674,0.09657604505098633,0.993,12/26,20.26%,CTNND2;SHANK3;INSR;DOCK10;EPHB1;LGMN;ITGA3;PAK3;SHANK1;EPHB3;MTMR2;CHRNA7
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.46164275561157214,-1.756566680236914,0.0027100271002710027,0.09813008291344455,0.994,23/71,15.35%,MYO10;PLCG2;ELMO1;PIK3R1;ACTB;NCKAP1;PAK1;ACTG1;WIPF3;MAPK3;HSP90AB1;ARPC3;ARPC4;ARPC2;LYN;FCER1G;ARPC1A;SYK;VAV1;HSP90AA1;DOCK1;RAC1;PLCG1
prerank,positive regulation of nervous system development (GO:0051962),-0.5208629396519086,-1.7558542328552793,0.0,0.09736643143604505,0.994,11/42,9.80%,NRXN1;NLGN1;GRID2;PTPRD;SYNDIG1;IL1RAPL1;IL1RAP;OPRM1;EPHB1;NLGN3;LRRC4B
prerank,regulation of complement activation (GO:0030449),0.582215447701786,1.7545103920580507,0.004792332268370607,0.3084403219799505,0.996,11/40,9.67%,CFH;VTN;CFHR2;CD55;SERPING1;C5AR2;C2;PROS1;PHB2;C6;CPB2
prerank,excitatory postsynaptic potential (GO:0060079),-0.6301510733824922,-1.7526160966965518,0.006607929515418502,0.09958050739567455,0.994,7/19,9.47%,GRID2;MEF2C;GRIN2A;GRIN2B;RAB3GAP1;AKT1;GRIN1
prerank,response to interferon-gamma (GO:0034341),0.5233321229775912,1.7518795492929777,0.004497751124437781,0.3079968660932474,0.996,20/67,11.79%,GBP6;SP100;GBP2;CXCL16;IL23R;DAPK1;TLR4;GBP5;BST2;STAT1;CD47;CCL2;GBP4;LGALS9;WNT5A;NUB1;TLR2;IFITM1;GBP7;TRIM21
prerank,regulation of T cell chemotaxis (GO:0010819),0.7673874157672722,1.7515169991759563,0.00819672131147541,0.29996705954785047,0.996,4/11,7.87%,CXCL10;STK39;OXSR1;WNT5A
prerank,cartilage development (GO:0051216),0.5613507631665365,1.7504812231652689,0.0016051364365971107,0.29522730747125003,0.996,9/49,4.70%,SULF1;SOX5;CREB3L2;OSR1;WNT2B;WNT10B;ITGB8;BMP2;WNT5B
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.4852222102026599,-1.7472562712886461,0.0,0.10420779627936679,0.994,26/54,23.74%,RPL26;RPL24;RPL5;RPL10A;RPL35A;RPLP0;RPL6;RPL11;RPL14;NPM1;TRAF7;NVL;NIP7;MAK16;MRPL1;PPAN;NLE1;SNU13;RPL7A;RPL7;MALSU1;NOC2L;MDN1;RPL3;RPL23A;EIF6
prerank,membrane repolarization during action potential (GO:0086011),-0.693514464809696,-1.747026526149974,0.010330578512396695,0.10290292288390587,0.994,6/13,13.12%,ATP1B1;KCNJ2;ATP1A1;KCND3;KCNQ1;KCNE4
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.46090122406854755,-1.7457751883815844,0.002785515320334262,0.10268258531359044,0.994,24/73,15.35%,MYO10;PLCG2;ELMO1;PIK3R1;ACTB;NCKAP1;PAK1;ACTG1;WIPF3;MAPK3;HSP90AB1;ARPC3;ARPC4;ARPC2;LYN;FCER1G;ARPC1A;SYK;VAV1;HSP90AA1;DOCK1;RAC1;NR4A3;PLCG1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.5870455579248399,-1.74538115234382,0.004750593824228029,0.10162839538136266,0.994,16/25,29.50%,NLGN1;SHANK3;MEF2C;SHISA9;NLGN3;MINK1;ADRB2;SHISA6;RELN;SHANK1;GSG1L;SHISA7;CACNG7;MAPK8IP2;CACNG5;SHISA8
prerank,negative regulation of transmembrane transport (GO:0034763),-0.7493027007458436,-1.744212108260675,0.009708737864077669,0.10125783356221277,0.994,4/10,7.35%,PRKCB;THBS1;INPP5K;AKT1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.5546993859402154,-1.7428057645880861,0.0024691358024691358,0.10151375534145138,0.994,8/31,7.35%,CTNNA2;BOC;CDH2;MEF2C;PTBP1;CTNNB1;HDAC9;TCF3
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.5889425551421348,-1.7406123171157333,0.012254901960784314,0.1025400192603833,0.995,6/24,7.35%,CTNNA2;BOC;CDH2;MEF2C;CTNNB1;TCF3
prerank,extracellular structure organization (GO:0043062),0.445744976459648,1.7405202404568556,0.0,0.3206442279820199,0.997,42/204,6.88%,TNC;FBN1;COL23A1;COL4A3;COL4A6;LAMC1;COL4A4;COL5A2;COL3A1;VTN;FN1;LAMA2;ADAMTSL5;LAMA4;COL4A5;DDR2;NID1;ADAMTS12;ECM2;ADAMTS10;HSPG2;NID2;ITGB8;DAG1;ICAM4;ITGA5;DCN;ADAMTS1;ADAMTSL4;ADAMTS6;ITGA9;ITGA10;LAMC3;LOXL1;COL18A1;TGFBR1;MMP14;COL5A1;SERPINE1;THSD4;VCAM1;CD47
prerank,response to peptide hormone (GO:0043434),0.5641090366982532,1.7400708710412642,0.006666666666666667,0.31344819813655617,0.997,18/43,20.47%,TGFBR3;ROCK2;IGFBP5;STAT2;ANXA1;STAT5B;CRY1;EPM2AIP1;STAT1;EIF2B3;STAT4;MEAK7;KHK;STAT5A;TRIM16;SLC27A1;ROCK1;XBP1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.6340410961553327,1.7393916549599542,0.0111731843575419,0.3071167193525873,0.997,8/22,12.87%,ZBTB20;APOA2;SORBS1;PPARA;CREBL2;SIRT4;DISP3;EEF1A2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.5774100318669267,-1.736336598546402,0.0045662100456621,0.10611794721464553,0.996,8/25,9.47%,GRID2;MEF2C;GRIN2A;GRIN2B;RAB3GAP1;AKT1;NLGN3;GRIN1
prerank,regulation of immune effector process (GO:0002697),0.574717427413453,1.7357079676391858,0.006389776357827476,0.31104856872036285,0.998,11/41,9.67%,CFH;VTN;CFHR2;CD55;SERPING1;C5AR2;C2;PROS1;PHB2;C6;CPB2
prerank,integrin-mediated signaling pathway (GO:0007229),0.5115667195829096,1.73483496038216,0.0015455950540958269,0.30595555399847835,0.998,21/73,12.50%,TEC;PTN;COL3A1;FN1;PLPP3;MPIG6B;CCM2;ITGB8;FBLN1;NRP1;ITGA5;ADAMTS1;ITGBL1;ITGA10;PTPRA;CD47;ITGA11;PLEK;PTK2;CUL3;FYB1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.7519445210982006,1.7332752077363616,0.0020242914979757085,0.29601413521689296,0.998,5/12,12.38%,FHL2;RCAN1;ATP2B4;GSK3B;HOMER3
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.7519445210982006,1.7332752077363616,0.0020242914979757085,0.29601413521689296,0.998,5/12,12.38%,FHL2;RCAN1;ATP2B4;GSK3B;HOMER3
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.5178891564823717,-1.7273092422372962,0.002583979328165375,0.11511694247732558,0.998,15/41,13.44%,KCNMB2;AKAP6;KCNMA1;KCNJ3;KCNJ2;GABBR2;NOS1AP;ANK3;CTSS;NOS1;ACE2;KCNJ6;KCNQ1;KCNJ15;STAC
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5241673709016943,1.7250631640418301,0.0015105740181268882,0.3172227194517239,0.999,16/65,8.18%,PDPK1;FBN1;SMAD3;LTBP1;SMURF2;PPM1A;SNX6;LDLRAD4;TGFB1I1;PMEPA1;WFIKKN1;TGFBR1;BCL9L;PPARA;TGFBR2;SKI
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.6477124841243331,-1.7246298482209608,0.0020491803278688526,0.11686043647378702,0.999,11/17,27.34%,NLGN1;RAB27A;SCAMP5;CACNA1G;SYT4;KCNB1;RAB15;CACNA1I;SYT10;DOC2B;UNC13D
prerank,adherens junction organization (GO:0034332),-0.4981167702886173,-1.723830640406895,0.0025974025974025974,0.1163745288268356,1.0,17/48,8.64%,CADM1;CADM2;CDH2;CDH11;CDH12;SMAD7;ACTB;CDH1;CDH10;CTNNB1;CDH8;CDH22;CDH4;CDH7;CDH20;JAM3;RAMP2
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.42541705232434845,-1.7233900484242433,0.0,0.11539842786763084,1.0,35/107,15.27%,SLC39A10;SLC24A2;ATP1B1;RYR2;TPT1;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;HTR2C;ATP2C1;SLC8A1;CCL14;ATP2A3;SLC39A6;NPTN;SLC30A1;SLC39A12;CALR;SLC39A14;SLC10A7;TMCO1;CXCL12;CAV1;CD40;MT2A;SLC39A13;SLC39A8;ATP13A4;ATP2A2;CCL19
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.6391396740398945,1.7222242295445707,0.010968921389396709,0.3194847799086306,0.999,2/22,0.90%,ALDH1A2;RBP1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.4541175577605117,-1.7211927631340496,0.0027472527472527475,0.11645831801267247,1.0,22/70,15.35%,MYO10;PLCG2;ELMO1;PIK3R1;ACTB;NCKAP1;PAK1;ACTG1;WIPF3;MAPK3;HSP90AB1;ARPC3;ARPC4;ARPC2;LYN;ARPC1A;SYK;VAV1;HSP90AA1;DOCK1;RAC1;PLCG1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.45579912197291517,1.7197283190009063,0.0,0.32193284807784567,0.999,31/152,10.43%,RNF220;SULF1;WLS;LRRK1;LGR4;ZEB2;SMURF2;TBL1XR1;WNT3A;PPM1A;KANK1;PTK7;DACT1;TERT;BMP2;WNT5B;LYPD6;SALL1;PLEKHA4;CDC73;PSMB10;SKI;LRRK2;PSMA7;USP47;PSMA3;TLR2;PSME4;USP8;PSMA5;PPM1B
prerank,regulation of gastrulation (GO:0010470),0.7260428116501061,1.7181663528618427,0.009124087591240875,0.32001423593517175,0.999,5/14,5.18%,PHLDB2;OSR1;DAG1;CLASP1;PHLDB1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.5078415310727166,1.715159746902742,0.0015037593984962407,0.32276938855984344,0.999,17/74,7.03%,PHLDB2;PDPN;SMAD3;FOXC1;EPHA3;LDLRAD4;GLIPR2;DAG1;TGFB1I1;BMP2;IL6;TGFBR1;CLASP1;PHLDB1;BCL9L;USF3;TGFBR2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6781403005793774,1.7148517091402289,0.013282732447817837,0.3169627264023094,0.999,5/17,7.20%,BMP6;SASH1;CD55;TRIM5;LY96
prerank,regulation of acute inflammatory response (GO:0002673),0.6821193832182024,1.7148257246994123,0.01289134438305709,0.3104815330021528,0.999,4/18,4.62%,IL6ST;OSM;CREB3L3;IL6
prerank,external encapsulating structure organization (GO:0045229),0.43999547429658137,1.7146272127746325,0.0,0.30486339271983864,0.999,41/205,6.88%,TNC;FBN1;COL23A1;COL4A3;COL4A6;LAMC1;COL4A4;COL5A2;COL3A1;VTN;FN1;LAMA2;ADAMTSL5;LAMA4;COL4A5;DDR2;NID1;ADAMTS12;ECM2;ADAMTS10;HSPG2;NID2;ITGB8;DAG1;ICAM4;ITGA5;DCN;ADAMTS1;ADAMTSL4;ADAMTS6;ITGA9;ITGA10;LAMC3;LOXL1;COL18A1;MMP14;COL5A1;SERPINE1;THSD4;VCAM1;CD47
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.5663567363127855,-1.7083423543538756,0.004842615012106538,0.13054347944798894,1.0,10/27,10.16%,PDE4D;CACNB2;DMD;CACNB4;FKBP1A;CALM1;CALM2;CAMK2D;SELENON;NOS1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.6792173852755214,-1.707236697400166,0.01020408163265306,0.13029477425029248,1.0,9/13,26.08%,SYT1;SCAMP5;CACNA1G;SYT4;KCNB1;CACNA1I;SYT10;DOC2B;HYAL3
prerank,dendritic spine morphogenesis (GO:0060997),-0.6359602303746003,-1.7060175227684438,0.004366812227074236,0.13017795946707664,1.0,7/15,18.34%,CTNND2;SHANK3;DOCK10;EPHB1;PAK3;SHANK1;EPHB3
prerank,cell junction assembly (GO:0034329),-0.4240657469854633,-1.7056876368083522,0.0,0.12903219913871256,1.0,32/100,11.81%,DNM3;ADGRL3;NRXN1;NLGN1;CTNND2;ITGA6;SHANK3;CLDN5;SPOCK2;CDH2;KIRREL3;CDH11;GPM6A;CDH12;ACTB;CDH1;ACTG1;SHANK2;GJC1;CDH10;TLN2;NRCAM;CDH8;CDH22;CDH7;CDH20;NLGN3;DNER;VASP;VMP1;DBNL;PCDHB16
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.7330557245857329,1.7020418676725408,0.013409961685823755,0.34107552177721573,1.0,5/13,4.04%,FBN1;FSTL1;LTBP1;NBL1;BMP2
prerank,metal ion homeostasis (GO:0055065),-0.5095084470131082,-1.7016681165565548,0.005291005291005291,0.13263033760308846,1.0,12/40,11.76%,TMTC2;SLC12A7;SLC12A2;ANK3;SNCA;SLC8A1;CNNM4;SLC12A5;SELENON;GRIN1;SLC12A6;CAV1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.6526133274079826,1.7012016185173247,0.0166358595194085,0.33743549673574114,1.0,5/18,9.46%,FBN1;FSTL3;TLR4;CARTPT;MAFB
prerank,positive regulation of stem cell differentiation (GO:2000738),0.6874005097097903,1.6992294359112678,0.007434944237918215,0.33760137465414597,1.0,4/16,2.33%,SOX5;PTN;FOXC1;TACSTD2
prerank,type I interferon signaling pathway (GO:0060337),0.5583902942988528,1.696998235725742,0.003278688524590164,0.33166908880186236,1.0,18/41,15.80%,RSAD2;SP100;GBP2;STAT2;IFIT2;IFI35;OASL;BST2;STAT1;IFITM1;OAS2;JAK1;IFI27;ADAR;IFIT1;IFIT3;IRF9;IFNAR2
prerank,cellular response to type I interferon (GO:0071357),0.5583902942988528,1.696998235725742,0.003278688524590164,0.33166908880186236,1.0,18/41,15.80%,RSAD2;SP100;GBP2;STAT2;IFIT2;IFI35;OASL;BST2;STAT1;IFITM1;OAS2;JAK1;IFI27;ADAR;IFIT1;IFIT3;IRF9;IFNAR2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6498945332880592,-1.6942299113430117,0.006423982869379015,0.14081708149527478,1.0,5/15,7.76%,GRM7;GRM3;GRM5;HOMER1;GRM8
prerank,positive regulation of behavior (GO:0048520),-0.7356618226696352,-1.693969083929763,0.00211864406779661,0.1395275927618047,1.0,3/10,1.15%,NLGN1;SGIP1;MEF2C
prerank,synapse assembly (GO:0007416),-0.4522690336010751,-1.6934489653456177,0.0,0.13855237099486084,1.0,23/67,11.81%,DNM3;ADGRL3;NRXN1;NLGN1;GRID2;SHANK3;SPOCK2;CDH2;KIRREL3;GPM6A;GABRA2;LRRTM3;CDH1;GABRB3;SHANK2;NRCAM;NLGN3;DNER;DVL1;LGI2;DBNL;FGF13;PCDHB16
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.5361405652262756,-1.693066983278409,0.0023148148148148147,0.137388271467329,1.0,17/31,27.56%,SYT1;SCAMP5;RAB3GAP1;STXBP1;CACNA1G;SYT7;SYT4;KCNB1;SYT9;SYT2;SYT6;SYT5;CACNA1I;SYT10;DOC2B;SYT17;CBARP
prerank,embryonic heart tube development (GO:0035050),-0.6445223262505001,-1.6928463878012305,0.02100840336134454,0.1360532536583211,1.0,7/14,17.68%,RYR2;SOX17;TBX2;NDRG4;SOX18;ACVR1;HES1
prerank,ganglioside biosynthetic process (GO:0001574),-0.6352036201248208,-1.6905929038965408,0.010893246187363835,0.1374534078536422,1.0,5/15,8.83%,ST6GALNAC3;ST8SIA4;ST8SIA6;ST6GALNAC4;ST6GALNAC5
prerank,cAMP-mediated signaling (GO:0019933),-0.5668755771530334,-1.6877140733102114,0.015625,0.14021736661809694,1.0,10/24,11.71%,PDE4D;RIMS2;ADGRG6;AKAP6;CAP2;EPHA5;RAPGEF2;PDE2A;PDE3A;ADCY2
prerank,positive regulation of biomineral tissue development (GO:0070169),0.560966240337606,1.6873057324221516,0.0064,0.36022708251172936,1.0,11/40,4.78%,BMP6;WNT4;PTN;WNT6;OSR1;BMPR1A;NELL1;KL;ADGRV1;BMP2;BMP7
prerank,endothelial cell proliferation (GO:0001935),-0.6228752815743528,-1.6862294894361172,0.00851063829787234,0.14067828201984253,1.0,7/17,9.58%,TEK;BMPER;BMPR2;CD34;ACVRL1;BMP4;PRKX
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5556361081549682,1.6842899103930793,0.01011804384485666,0.364355745124168,1.0,11/40,7.03%,TCF7L2;PDPN;SMAD3;FOXC1;GLIPR2;TGFB1I1;BMP2;IL6;TGFBR1;BCL9L;TGFBR2
prerank,protein mono-ADP-ribosylation (GO:0140289),0.7223524006632184,1.6837948984641204,0.015037593984962405,0.3595413775895948,1.0,8/11,12.84%,PARP14;PARP9;PARP3;PARP10;PARP12;PARP11;TIPARP;PARP16
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.48091342865251363,1.6830221015335471,0.0028328611898017,0.3560559985344917,1.0,22/95,8.18%,PDPK1;TGFBR3;SMAD3;ZEB2;SMURF2;PPM1A;SNX6;LDLRAD4;TGFB1I1;PMEPA1;WFIKKN1;LATS2;TGFBR1;NREP;DKK3;CREBBP;BCL9L;PPARA;CDKN2B;TGFBR2;RNF111;SKI
prerank,regulation of monooxygenase activity (GO:0032768),-0.5603487323594432,-1.6810677420413798,0.013186813186813187,0.14655434779627757,1.0,10/23,13.17%,NOS3;NOSTRIN;CALM1;NOS1AP;SNCA;AKT1;CYGB;CAV1;HSP90AA1;EGFR
prerank,regulation of stem cell proliferation (GO:0072091),0.6644681995527414,1.6782028812973309,0.009191176470588236,0.36779974022038436,1.0,5/17,7.75%,EIF2AK2;GJA1;FBLN1;TERT;YAP1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.6045446904829392,1.6756538001006391,0.0088339222614841,0.37102186786618685,1.0,11/26,20.29%,KMT2A;ETFBKMT;METTL21C;SETD4;SETD1B;TET2;SETD5;ATPSCKMT;KMT5C;SETD2;KMT5B
prerank,positive regulation of synaptic transmission (GO:0050806),-0.43595183589902575,-1.6742479946371847,0.0,0.15537871962615507,1.0,14/72,6.91%,NRXN1;NLGN1;SHANK3;RIMS1;SYT1;RIMS2;GRIK2;SLC24A2;PTK2B;GRIN2A;SHANK2;GRIN2B;LGMN;NPTN
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.5467172947408702,-1.6696568060875334,0.006944444444444444,0.1601943715602564,1.0,14/26,20.26%,NRXN1;NLGN1;SHANK3;RIMS1;RIMS2;PTK2B;NLGN3;GRIN1;RELN;TMEM108;SHANK1;TMEM25;MTMR2;CHRNA7
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6148501927988246,1.6673099632663513,0.0176678445229682,0.3955648480247999,1.0,6/24,5.32%,EFEMP1;SOX5;ADAMTS12;PTHLH;TGFBR1;MBOAT2
prerank,defense response to tumor cell (GO:0002357),0.7620002689401816,1.6658822863217175,0.01486988847583643,0.39456142609274514,1.0,5/10,4.95%,RBMS3;DLEC1;PRF1;DAPK1;PLK5
prerank,gene expression (GO:0010467),-0.35169920619005135,-1.6643043171692244,0.0,0.16698396563454224,1.0,141/348,23.12%,RPS24;THRB;RPL18A;RPS9;RPL19;RPS12;ADARB1;RPS29;RPL26;RPL41;RPS15;RPL24;RPS23;RPL5;PTMA;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;SETX;RPL27A;RPL13;RPS18;RPL27;RPS16;RPS6;RPL35A;RPL21;RPS3;SORL1;RPS17;RPL39;RPL37A;RPS7;TSPAN14;RPL4;EEF1A1;ADARB2;RPS15A;RPLP0;RPS25;RPL6;RPS21;RPL11;RPL28;RPL8;RPLP2;RPL32;RPS28;RPL30;RPL13A;RPS4X;RPS20;RPS13;CPSF2;RPL18;SRSF2;RPS2;SYMPK;DDX54;SRSF1;HNRNPK;RPL14;ZC3H11A;RPL22;APOBEC1;THOC2;RPS26;DDX17;HHEX;MRPS18A;ASMT;RPS10;AAAS;PWP1;IGHMBP2;NUP93;RPL23;RPL17;RPL29;TASP1;GSPT2;PABPC4;RPS5;XAB2;FASTKD2;POLR3A;RPS14;NFKBIB;HNRNPF;COPS5;MRPL28;SRBD1;HBS1L;POLR2J;RAE1;RPL12;RPL9;MMS19;XRN2;DEDD2;RBM3;RPL37;RPS11;RRAGC;DUSP11;RNPS1;MRPL35;POLDIP3;SRSF9;RPL7A;RPL7;MRPS5;RPL31;TSPAN33;MRPL34;UPF1;RBM15B;HARS1;NXT1;RPL3;YARS2;MRPL23;MRPL9;HOXD3;BCL3;NUP62;CHTOP;MRPL52;FARSB;SRSF6;MRPS12;ALKBH5;CDC40;RPL23A;ANGPT2;MRPL11;CPSF3;GSPT1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.433094733893186,1.6625138623229627,0.0,0.4009914895233913,1.0,50/186,16.06%,BICC1;TCF7L2;MCC;PRICKLE1;RBMS3;RNF213;TLE1;MLLT3;GLI3;WWOX;APCDD1;INVS;DACT1;BMP2;IGFBP6;TLE3;GLI1;TMEM64;LATS2;SIAH2;LRP4;DKK3;GSK3B;CTNND1;WNT5A;PSMB10;STK3;PSMA7;AMFR;LZTS2;PSMA3;PSME4;PSMA5;NKD1;CUL3;PTPRU;VGLL4;DVL3;NOG;FRMD8;RNF43;HIC1;NPHP3;IGFBP4;TLE6;STK4;LRP1;DAB2;WWTR1;AXIN2
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.6169879740192934,1.6621572749156333,0.014388489208633094,0.3962840058482052,1.0,6/23,6.30%,TGFBR3;SMAD3;SMURF2;LATS2;NREP;DKK3
prerank,secretion (GO:0046903),-0.6480478562822595,-1.656127596587873,0.02,0.1786966395318324,1.0,5/14,10.06%,RIMS1;TPD52;FBLN5;SLC22A6;NPR1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.44977538630108266,1.6555725077746253,0.0013908205841446453,0.4170931695415271,1.0,36/128,13.61%,TGFBR3;BMP6;SMAD3;COL3A1;ZMIZ1;RGMA;SMURF2;RGMB;BMPR1A;CDH5;TWSG1;TGFB1I1;HIVEP1;LRRC32;BMP2;PARD6A;BMP7;TGFBR1;PRKCZ;APPL2;USP9X;TGFBR2;BMP8B;SLC33A1;RNF111;SKI;SMAD6;APPL1;ZFYVE16;PTK2;TGFBRAP1;SMAD4;COL1A2;MAP3K7;HFE;ACVR1C
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.6212341705340025,1.6553615045656618,0.009259259259259259,0.4114697271498759,1.0,9/23,11.74%,PARP14;PARP9;NR1H3;PTPN2;STAT1;PIAS1;SUMO1;OTOP1;JAK1
prerank,connective tissue development (GO:0061448),0.5621430936011917,1.6532876962709253,0.013377926421404682,0.4130760255915073,1.0,4/35,2.64%,SULF1;SOX5;CREB3L2;ITGB8
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.5523537018973982,1.6523353272638297,0.00487012987012987,0.41073916058439247,1.0,10/38,11.22%,BMP6;SASH1;DDX60;FPR2;IFI35;OASL;GBP5;LY96;ANKRD17;POLR3F
prerank,chondrocyte differentiation (GO:0002062),0.5782301126043358,1.6499202370562167,0.01697792869269949,0.4138396031881761,1.0,8/32,4.70%,SULF1;SOX5;CREB3L2;OSR1;WNT2B;WNT10B;BMP2;WNT5B
prerank,regulation of postsynapse organization (GO:0099175),-0.5295432565656228,-1.6482018194898107,0.0196078431372549,0.19031767360498217,1.0,11/28,15.38%,SHANK3;PPFIA2;TANC2;HOMER1;IL1RAPL1;ARHGAP44;ABI3;LZTS3;SRCIN1;ABHD17A;CFL1
prerank,cellular response to metal ion (GO:0071248),-0.3908494443233948,-1.6477483064711227,0.0,0.1892081749626867,1.0,29/123,8.76%,NLGN1;DLG2;SLC12A2;SYT1;MEF2C;PLCG2;ITPKB;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;CDH1;ANK3;SNCA;MAPK8;RYR3;MAPK3;LGMN;KCNH1;AKT1;SYT7;CAMK2D;SYT4;CPNE4;B2M
prerank,cellular response to BMP stimulus (GO:0071773),0.4939200423704626,1.647598403375386,0.006299212598425197,0.4174659367189251,1.0,21/66,15.81%,TGFBR3;BMP6;SMAD3;RGMA;ADAMTS12;RGMB;BMPR1A;HIVEP1;BMP2;BMP7;USP9X;BMP8B;SLC33A1;SMAD6;ZFYVE16;SMAD4;ADAMTS7;HFE;SMAD2;GDF15;ACVR2B
prerank,regulation of glucose import (GO:0046324),0.5765301195940993,1.6460983488606222,0.012027491408934709,0.41707982454617604,1.0,9/30,10.16%,ENPP1;PRKAG2;PID1;OSBPL8;SORBS1;APPL2;CREBL2;RHOQ;APPL1
prerank,ethanol metabolic process (GO:0006067),0.7115181727361195,1.6458316264431958,0.03420523138832998,0.41218315858223914,1.0,4/12,17.03%,ALDH1A1;ALDH2;ACSS1;SULT1A1
prerank,regulation of actomyosin structure organization (GO:0110020),0.6701799034737324,1.6457859831365476,0.03333333333333333,0.4066707281723179,1.0,4/13,5.92%,ROCK2;AKAP13;ALMS1;ASAP3
prerank,negative regulation of stress fiber assembly (GO:0051497),0.6088152697850061,1.6447912244804692,0.016042780748663103,0.40460989677955284,1.0,7/24,5.16%,PHLDB2;CGNL1;ARHGAP6;DLC1;TACSTD2;ARHGAP28;CLASP1
prerank,central nervous system neuron development (GO:0021954),-0.6133531840581589,-1.6446487157232772,0.019271948608137045,0.19247489500906806,1.0,8/15,20.84%,NTRK2;LHX6;HSP90AB1;RAPGEF2;HSP90AA1;MAP2;MAPT;B4GALT6
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.49565113219324414,-1.6431599957685916,0.005012531328320802,0.19332737423654703,1.0,17/39,13.10%,SLIT2;TIE1;KDR;COL4A1;PAK1;SIX1;MET;RASIP1;CTNNB1;BMP4;SEMA3E;VEGFA;LRP6;NOTCH4;PAX2;FGF2;LRP5
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.5883683285249595,-1.641963663526621,0.008733624454148471,0.19365737330309427,1.0,11/20,29.25%,PLCB1;CHRM3;CHRM2;LYPD1;AGRN;GNAQ;CHRNA7;LY6H;LY6G6D;RGS10;GNA11
prerank,endothelial cell development (GO:0001885),-0.5391564306082471,-1.6414556389726904,0.00663716814159292,0.19261864026299563,1.0,8/25,9.65%,PDE4D;PECAM1;PPP1R16B;MET;ROBO4;RAPGEF2;PDE2A;SOX18
prerank,regulation of neurotransmitter transport (GO:0051588),-0.6157906888490553,-1.6409424248501434,0.02028397565922921,0.19155027899486043,1.0,6/16,8.54%,RIMS1;MEF2C;MCTP1;CPLX1;CAMK2A;SYN1
prerank,canonical Wnt signaling pathway (GO:0060070),0.4925167126507026,1.6399345923667432,0.009523809523809525,0.41748921228715846,1.0,18/68,13.07%,TCF7L2;WNT4;WNT6;PLPP3;WNT2B;WNT10B;WNT3A;FZD2;WNT5B;BCL9L;TCF7L1;GSK3B;WNT5A;LRRK2;TCF7;DVL3;WNT2;PORCN
prerank,cardiac myofibril assembly (GO:0055003),0.6658798700438128,1.6392560011125945,0.014678899082568808,0.4147485753791821,1.0,5/15,8.31%,PDGFRA;CSRP3;NEBL;PDGFRB;MEF2A
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.5696075471162133,-1.6376287605805364,0.027426160337552744,0.1958575950438792,1.0,7/19,5.53%,CSGALNACT1;HS6ST3;HS6ST2;NDST3;HS3ST5;XYLT1;EXT1
prerank,synapse organization (GO:0050808),-0.40063680338800167,-1.6365170870551853,0.0,0.19595659954195893,1.0,35/125,11.93%,APBB2;DNM3;ADGRL3;NRXN1;NLGN1;CTNND2;PTPRD;LRRC4C;SHANK3;SPOCK2;CDH2;CACNB2;PPFIA2;KIRREL3;GRM5;GPM6A;SLC6A1;CACNB4;CDH1;ANK3;GPHN;SNCA;SHANK2;ARHGAP39;NRCAM;SEMA3E;NLGN3;DNER;CNTN2;L1CAM;LRRC4B;DVL1;DBNL;PCDHB16;PAK3
prerank,sodium ion import across plasma membrane (GO:0098719),-0.6063805995210452,-1.6364657140788532,0.006726457399103139,0.19416379993349953,1.0,5/17,6.66%,SLC12A2;SLC9A2;SLC6A1;SLC8A1;HCN2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.7267852472742657,1.6353774840588646,0.0163265306122449,0.4239242721154429,1.0,4/10,14.30%,STK39;OXSR1;WNT5A;WNK1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6693484230822094,1.6343342784169683,0.023032629558541268,0.4223871080147762,1.0,3/14,3.16%,KMT2A;AUTS2;MYB
prerank,protein localization to synapse (GO:0035418),-0.6539655444714064,-1.633371138427156,0.0205761316872428,0.19768719549036823,1.0,3/12,3.13%,NRXN1;NLGN1;PCLO
prerank,carbohydrate homeostasis (GO:0033500),0.490032037782576,1.6317957869162156,0.00764525993883792,0.4264449438374641,1.0,12/67,7.82%,TCF7L2;LEPR;MCU;PRKAA2;GCGR;RBP4;CRY2;CRY1;IL6;APPL2;PTPN2;NGFR
prerank,negative regulation of wound healing (GO:0061045),0.5869690827241525,1.629671289235815,0.02268760907504363,0.42931378283888355,1.0,7/28,7.81%,PHLDB2;TFPI;VTN;CASK;CLASP1;SERPINE1;SERPINE2
prerank,ceramide catabolic process (GO:0046514),-0.6286593126609928,-1.6293789595854986,0.0064516129032258064,0.20305801124398007,1.0,6/14,18.62%,ACER3;ACER2;HEXB;NEU1;GM2A;GLA
prerank,histone H3-K4 trimethylation (GO:0080182),0.7103377979020622,1.6256167886893782,0.020676691729323307,0.4398116891042145,1.0,3/11,12.61%,KMT2A;SETD1B;TET2
prerank,myotube differentiation (GO:0014902),-0.5898656268347545,-1.6232691393587473,0.016877637130801686,0.21220496696889238,1.0,8/17,14.25%,ADGRB3;MEF2C;JAM2;KCNH1;MYEF2;NOS1;SIX4;SORT1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.6008798749935672,-1.6229868214626386,0.00641025641025641,0.21069290145967415,1.0,9/18,16.02%,GRID2;GRIK2;GRIK4;GRIK1;CDH8;SLC1A4;GRIA2;NAPA;GRIK3
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6933010866157814,-1.6223964840939578,0.029473684210526315,0.20987111163689304,1.0,6/10,12.55%,PDE4B;CACNB2;CALM1;NOS1AP;CALM3;SRI
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.6493809463315843,1.6212596897224674,0.028846153846153848,0.45117418233118467,1.0,4/16,4.97%,KMT2A;AUTS2;MYB;BCOR
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.6397743546573069,1.620020623773829,0.029465930018416207,0.4503671021736878,1.0,7/17,9.50%,VTN;DOCK5;IGFBP5;NRP1;ADAMTS1;PDGFRB;DOCK7
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.5513754590246639,-1.6192144720484622,0.019656019656019656,0.2139122273927105,1.0,8/22,6.45%,SLIT2;SSH2;TMSB4X;KANK3;KANK4;TMSB10;HIP1R;CYRIB
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.6136215615668851,1.617375939447219,0.02707581227436823,0.4548278788470275,1.0,9/21,17.46%,DCDC2;GLI1;RAB34;IHH;TTC23;EVC;TUBD1;DLG5;GAS8
prerank,acylglycerol biosynthetic process (GO:0046463),0.6068754218695922,1.6167948559693623,0.023985239852398525,0.45171963208213045,1.0,4/23,6.21%,AGMO;PLA2G4A;PLCE1;MOGAT3
prerank,response to zinc ion (GO:0010043),-0.5488319751257273,-1.6164027069130273,0.012285012285012284,0.2170407471404807,1.0,8/25,2.81%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,negative regulation of cell migration (GO:0030336),0.43872085293832486,1.615992872026476,0.0013458950201884253,0.4495475726117741,1.0,40/137,13.61%,PHLDB2;SULF1;IGFBP3;DPYSL3;ROBO1;PODN;MCC;COL3A1;AFDN;IGFBP5;DLC1;TACSTD2;BMPR1A;GJA1;KANK1;LDLRAD4;DAG1;DUSP10;MIA3;TPM1;CLASP1;VCL;SERPINE1;EPHA1;BST2;CLIC4;RNF20;NGFR;STK24;EPHA4;IFITM1;RAP2C;ATP1B2;FOXO3;PTPRU;EPPK1;SLURP1;NOG;ARPIN;ACVR1C
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.5842156704433498,1.6159722566696977,0.02727272727272727,0.4444253050583421,1.0,7/26,13.15%,LGR4;APPL2;BIRC3;TLR2;APPL1;IRAK3;FLOT2
prerank,positive regulation of cation channel activity (GO:2001259),-0.47993033921072364,-1.6146983753165787,0.010309278350515464,0.21866142151706652,1.0,19/40,24.29%,SHANK3;TMSB4X;AKAP6;CALM1;ANK3;CALM2;CALM3;CTSS;NLGN3;ADRB2;STAC;RELN;STAC3;LRRC38;GSTO1;LRRC55;HAP1;HTT;CASQ1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.4309259606877101,1.613467047774402,0.0013513513513513514,0.44903966821955404,1.0,43/161,16.06%,BICC1;TCF7L2;MCC;PRICKLE1;RBMS3;TLE1;MLLT3;GLI3;INVS;DACT1;BMP2;IGFBP6;TLE3;GLI1;TMEM64;LATS2;SIAH2;LRP4;DKK3;GSK3B;CTNND1;WNT5A;PSMB10;STK3;PSMA7;AMFR;LZTS2;PSMA3;PSME4;PSMA5;NKD1;CUL3;PTPRU;DVL3;NOG;FRMD8;NPHP3;IGFBP4;TLE6;STK4;DAB2;WWTR1;AXIN2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5796587932559,-1.612160959605389,0.020089285714285716,0.22174842685565838,1.0,4/18,2.22%,NRXN1;NLGN1;SHANK3;PTK2B
prerank,glucose homeostasis (GO:0042593),0.465645545615993,1.6103322966004814,0.009104704097116844,0.4561974760474524,1.0,15/83,8.26%,TCF7L2;LEPR;MCU;PRKAA2;GCGR;RBP4;NUCKS1;CRY2;CRY1;IL6;APPL2;PTPN2;CARTPT;NGFR;HKDC1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.6483977751219852,1.6096483464960225,0.0213903743315508,0.4536811691854,1.0,5/17,3.07%,SULF1;FSTL1;FSTL3;CASK;TWSG1
prerank,protein ADP-ribosylation (GO:0006471),0.5671404185211572,1.6089316345969444,0.01896551724137931,0.4512738786206343,1.0,15/28,19.96%,PARP14;ZC3HAV1;PARP9;PARP3;ARF4;PARP10;PARP12;PARP11;SIRT4;TIPARP;PARP16;TNKS2;PARP4;SIRT3;SIRT2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.5044859159878625,1.6076185167830428,0.011164274322169059,0.45163912599906464,1.0,13/51,7.13%,LPAR1;ROCK2;CCN2;PPM1E;NRP1;S100A10;SYNPO2;SYNPO;TPM1;TGFBR1;EPHA1;CD47;ARHGEF10L
prerank,energy reserve metabolic process (GO:0006112),0.6200556662551928,1.6073402337877447,0.02185792349726776,0.4480546884911355,1.0,5/19,9.47%,LEPR;PRKAG2;PID1;GSK3B;PYGM
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.5056172397087464,-1.606687723437523,0.023316062176165803,0.2305411202616134,1.0,13/31,15.38%,NLGN1;SHANK3;PPFIA2;TANC2;ARHGAP44;CAPRIN2;LRP8;ABI3;LZTS3;DBNL;SRCIN1;RELN;CFL1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4971672367248918,1.6061913999208113,0.0048,0.4474584377644781,1.0,11/63,5.98%,TCF7L2;DEPTOR;SP100;FGFR1;PHIP;WWOX;SH3RF1;CFLAR;TGFBR1;SIAH2;TNFRSF12A
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.44379125558624904,1.6053321947002226,0.008595988538681949,0.44586629506524206,1.0,30/112,13.40%,SOX5;TGFBR3;WNT4;SMAD3;COL3A1;ZMIZ1;CLEC3B;BMPR1A;CDH5;TWSG1;WWOX;LRRC32;PARD6A;TGFBR1;PRKCZ;APPL2;USP9X;TGFBR2;PDCD5;WNT5A;SKI;SMAD6;APPL1;PTK2;TGFBRAP1;SMAD4;COL1A2;MAP3K7;WNT2;NR3C1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.6464856527396443,-1.6026377559734941,0.023965141612200435,0.2365004592854768,1.0,4/12,16.87%,ERLIN1;CEACAM1;ACADVL;BRCA1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.5753235856746024,-1.6025721654078067,0.01699029126213592,0.23465178454986124,1.0,7/18,13.62%,ELOVL5;ACSL3;ELOVL7;TECR;ACSL5;HSD17B12;ACSBG1
prerank,positive regulation of bone mineralization (GO:0030501),0.5467131847392992,1.601445764517911,0.009836065573770493,0.45530502799581035,1.0,10/35,4.78%,BMP6;WNT4;PTN;OSR1;BMPR1A;NELL1;KL;ADGRV1;BMP2;BMP7
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.5144954821620689,1.600372349694551,0.00946372239747634,0.45451137910991685,1.0,9/49,4.62%,PARP14;GHR;IL31RA;IL6ST;OSM;IL23R;PARP9;KIT;IL6
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6588829970219915,1.6000434273717075,0.012589928057553957,0.4510505866308796,1.0,5/15,5.16%,PDPN;DPP4;DDR2;IL6;CLASP1
prerank,aerobic electron transport chain (GO:0019646),-0.4287122763809298,-1.5995684120019324,0.006097560975609756,0.23844841701449498,1.0,39/68,35.28%,COX6C;COX4I1;SDHC;NDUFV1;NDUFA8;NDUFC1;NDUFB4;NDUFS7;UQCRH;UQCR11;NDUFA1;COX8A;NDUFA4;NDUFB2;NDUFA12;COX6A1;NDUFA11;NDUFB7;COX7B;SDHD;NDUFC2;UQCC3;NDUFB10;NDUFA13;UQCR10;NDUFA9;UQCRQ;NDUFA10;SDHAF2;COX4I2;NDUFS6;NDUFS1;COX5B;NDUFV3;NDUFA2;NDUFA6;CYCS;UQCRB;NDUFS2
prerank,negative regulation of viral genome replication (GO:0045071),0.5335827784793217,1.5987638825064585,0.01935483870967742,0.45138238942824876,1.0,19/40,20.22%,RSAD2;ZC3HAV1;EIF2AK2;OASL;BST2;PARP10;RESF1;IFITM1;OAS2;ILF3;IFIT1;SRPK1;TASOR;IFIH1;SHFL;TNIP1;SETDB1;MPHOSPH8;RNASEL
prerank,extracellular matrix organization (GO:0030198),0.3971686328319439,1.5986055724337969,0.0,0.44744533411478765,1.0,51/276,8.46%,FLRT2;TNC;FBN1;COL23A1;COL4A3;COL4A6;LAMC1;COL4A4;COL5A2;COL3A1;VTN;FN1;LAMA2;ADAMTSL5;LAMA4;COL4A5;DDR2;NID1;ADAMTS12;ECM2;ADAMTS10;HSPG2;NID2;ITGB8;DAG1;ICAM4;ITGA5;DCN;ADAMTS1;ADAMTSL4;ADAMTS6;ITGA9;LOXL3;ITGA10;LAMC3;LOXL1;BMP1;COL18A1;TGFBR1;MMP14;COL5A1;COL20A1;SERPINE1;THSD4;VCAM1;CD47;ITGA11;COL13A1;NOXO1;TIMP2;ADAM12
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.428227239838514,-1.5984629287155165,0.006172839506172839,0.23879709801191942,1.0,39/69,35.28%,COX6C;COX4I1;SDHC;NDUFV1;NDUFA8;NDUFC1;NDUFB4;NDUFS7;UQCRH;UQCR11;NDUFA1;COX8A;NDUFA4;NDUFB2;NDUFA12;COX6A1;NDUFA11;NDUFB7;COX7B;SDHD;NDUFC2;UQCC3;NDUFB10;NDUFA13;UQCR10;NDUFA9;UQCRQ;NDUFA10;SDHAF2;COX4I2;NDUFS6;NDUFS1;COX5B;NDUFV3;NDUFA2;NDUFA6;CYCS;UQCRB;NDUFS2
prerank,regulation of dendrite extension (GO:1903859),-0.5712540730027562,-1.5974082022430187,0.008602150537634409,0.23870875326906402,1.0,5/18,9.16%,RIMS1;SYT1;RIMS2;SYT4;NEDD4L
prerank,regulation of microtubule-based process (GO:0032886),0.5326944413624068,1.5951317859585998,0.02145214521452145,0.45623662685306904,1.0,8/36,7.53%,PHLDB2;DIAPH1;PRKAA2;EPHA3;MAP6;CLASP1;PHLDB1;GSK3B
prerank,negative regulation of hemostasis (GO:1900047),0.6866622198294664,1.5946082767636494,0.04046242774566474,0.45367094619072496,1.0,4/12,7.81%,TFPI;VTN;SERPINE1;SERPINE2
prerank,response to X-ray (GO:0010165),0.6589952182135093,1.5944398213447604,0.026217228464419477,0.4498643074271774,1.0,6/14,9.47%,PRAP1;XRRA1;ANXA1;NUCKS1;IKBIP;XRCC4
prerank,actin cytoskeleton reorganization (GO:0031532),0.4870623053631602,1.5941291149656796,0.010574018126888218,0.44685465390587603,1.0,13/63,4.42%,MCU;CXADR;NRK;AUTS2;PARVA;INSRR;PTK7;NRP1;FER;ANTXR1;ANXA1;KIT;EFS
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.5403961957828947,-1.5937314156932842,0.024774774774774775,0.24416650841985096,1.0,5/23,10.28%,SLC12A7;SLC12A2;CLCN3;SLC12A5;SLC12A6
prerank,positive regulation of telomerase activity (GO:0051973),-0.4807839036254659,-1.5935397100802442,0.01674641148325359,0.24265505931772385,1.0,12/33,20.24%,PRKCQ;NEK7;CTNNB1;PARM1;MAPK3;HSP90AB1;NVL;KLF4;HSP90AA1;PNKP;PKIB;WRAP53
prerank,positive regulation of dendrite extension (GO:1903861),-0.5778839990803826,-1.591772909437145,0.01079913606911447,0.24417227956722598,1.0,5/17,9.16%,RIMS1;SYT1;RIMS2;SYT4;NEDD4L
prerank,negative regulation of immune effector process (GO:0002698),0.668117412720206,1.5906982925001685,0.03888888888888889,0.4552794248707537,1.0,6/13,10.16%,ENPP3;CD55;FER;RC3H1;CD47;APPL1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.5473188427825009,-1.5886992459939748,0.024719101123595506,0.2488343952017443,1.0,10/22,21.07%,PDE4B;CACNB2;DMD;CACNB4;NOS1AP;SRI;STAC;STAC3;HPCA;GPR35
prerank,actin filament bundle assembly (GO:0051017),0.547476520115418,1.5883452901275281,0.02181208053691275,0.4599208366734737,1.0,6/33,5.11%,DPYSL3;PAWR;CALD1;SHROOM2;MYO1B;BAIAP2L1
prerank,neuronal action potential (GO:0019228),-0.5528217908760178,-1.5866317486836132,0.02517162471395881,0.2506852708967351,1.0,12/22,23.97%,KCNMB2;SCN1A;ANK3;SCN2A;CACNA1G;SCN8A;SCN9A;KCNA2;SCN3A;KCNA1;KCNMB4;CACNA1I
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.4486389756933113,-1.5863543631986543,0.005420054200542005,0.24926685428087395,1.0,18/54,12.33%,DPP10;KCNAB1;KCNMB2;AKAP6;KCNMA1;KCNJ3;KCNJ2;KCNIP4;GABBR2;NOS1AP;KCNIP1;DPP6;NEDD4L;CACNA1D;KCNJ6;CAV1;KCNQ1;KCNJ15
prerank,neural tube development (GO:0021915),0.6394213761062729,1.5851748996789699,0.023853211009174313,0.46737166989537865,1.0,3/15,3.71%,ALDH1A2;ARL13B;DACT1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.6105799586663042,1.5835143228961988,0.03189493433395872,0.4691811459242327,1.0,4/21,5.32%,PLA1A;PLA2G4A;OSBPL8;MBOAT2
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.526393758104877,-1.5832519775292397,0.0215311004784689,0.25404499449086865,1.0,8/25,11.76%,TMTC2;ANK3;SNCA;SLC8A1;CNNM4;SELENON;GRIN1;CAV1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.628182455358571,1.5831330791852183,0.040892193308550186,0.46621304831028587,1.0,4/17,6.62%,PID1;NUPR1;PPARA;HDAC4
prerank,water transport (GO:0006833),0.6947663174696634,1.5820476349860808,0.03508771929824561,0.46600057479116397,1.0,1/12,0.30%,PDPN
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.4300925697969427,1.5817396566332194,0.001375515818431912,0.4628856289416332,1.0,23/129,10.43%,RNF220;WLS;LRRK1;LGR4;ZEB2;SMURF2;TBL1XR1;WNT3A;PPM1A;KANK1;PTK7;DACT1;LYPD6;PLEKHA4;PSMB10;LRRK2;PSMA7;USP47;PSMA3;PSME4;USP8;PSMA5;PPM1B
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.36467005717807377,-1.5814503418448216,0.0,0.25578132966423706,1.0,42/159,10.58%,CADM1;ADGRL3;NLGN1;GRID2;HMCN1;PTPRD;LRRC4C;BSG;PECAM1;ROBO2;CLDN5;CDH2;KIRREL3;TENM2;CDH11;TGFB2;CDH12;CNTN4;TENM3;CNTN6;CDH1;IL1RAPL1;PTPRM;UNC5D;CDH10;ATP2C1;ROBO4;CDH8;TENM4;CDH22;CDH4;NPTN;CEACAM1;CLDN14;CDH7;CDH20;PTPRT;CNTN2;L1CAM;LRRC4B;EMB;FAT2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.6598466597649915,-1.5801539998941911,0.03289473684210526,0.2546259504647954,1.0,7/11,19.38%,FKBP1A;CALM1;CALM2;CALM3;SRI;CASQ2;GSTO1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.6598466597649915,-1.5801539998941911,0.03289473684210526,0.2546259504647954,1.0,7/11,19.38%,FKBP1A;CALM1;CALM2;CALM3;SRI;CASQ2;GSTO1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6456030872284132,1.5793795893141411,0.04204753199268738,0.4674112329231584,1.0,7/14,16.32%,SEC23A;MIA3;SEC24D;SEC24C;SEC31A;SEC24B;SAR1A
prerank,BMP signaling pathway (GO:0030509),0.47924051704855414,1.5791959212354083,0.013050570962479609,0.4639063803504164,1.0,20/62,15.81%,TGFBR3;BMP6;SMAD3;RGMA;RGMB;BMPR1A;HIVEP1;BMP2;BMP7;USP9X;BMP8B;SLC33A1;SMAD6;ZFYVE16;SMAD4;NOG;HFE;SMAD2;GDF15;ACVR2B
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.6946728126204369,1.5791879631223114,0.04222648752399232,0.45987132697421274,1.0,4/11,4.04%,EFNB2;WNT3A;FRS2;BMP2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.6098462038512139,1.5786096689480893,0.04519774011299435,0.4580571109440918,1.0,6/18,7.50%,SMAD3;FN1;LTBP1;ITGB8;LRRC32;LGALS9
prerank,ceramide biosynthetic process (GO:0046513),-0.4660626215792838,-1.5785281071981099,0.010050251256281407,0.2563109944964102,1.0,9/40,11.15%,ST6GALNAC3;SGMS1;ST8SIA4;CERS4;ST8SIA6;DEGS2;ST6GALNAC4;ST6GALNAC5;SGMS2
prerank,negative regulation of blood coagulation (GO:0030195),0.5234048437231891,1.5777329256485773,0.027777777777777776,0.4573781587801768,1.0,9/38,9.67%,TFPI;VTN;PDGFRA;SERPING1;GP1BA;SERPINE1;SERPINE2;PLAU;CPB2
prerank,neuromuscular process controlling balance (GO:0050885),-0.6299917644228905,-1.576550009230719,0.036,0.2583404744174165,1.0,2/12,0.74%,NRXN1;PCDH15
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6691346046252922,-1.575208891958275,0.024439918533604887,0.2593004849406935,1.0,6/10,13.82%,PDE4D;PDE3B;PDE11A;PDE2A;PDE3A;APLNR
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.5422245177913747,-1.5750125584467276,0.04,0.2578338791752009,1.0,11/22,16.79%,NTRK2;SH3GL2;STMN2;RAPGEF2;AKT1;RAB35;NGF;TMEM108;MAPT;RAP1A;NTF3
prerank,epithelial to mesenchymal transition (GO:0001837),0.5067746733040028,1.5748789533673424,0.02321724709784411,0.46368751501173067,1.0,11/47,7.87%,TGFBR3;WNT4;ROCK2;RBPJ;FGFR1;LOXL3;BMP2;BMP7;TGFBR1;GSK3B;WNT5A
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.5806702799020694,-1.5739461067829508,0.026200873362445413,0.25848985991881956,1.0,4/17,3.93%,KCNAB1;AKAP6;NOS1AP;ANK3
prerank,regulation of osteoclast differentiation (GO:0045670),0.5317826467378964,1.5730938202648574,0.023411371237458192,0.46579737800457494,1.0,8/33,11.97%,FBN1;FSTL3;IL23R;PRXL2A;TLR4;CARTPT;MAFB;CSF1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5787863497187311,1.572709014929026,0.01718213058419244,0.4631399950084627,1.0,6/25,6.49%,CBLB;SNX6;SLC6A9;CNRIP1;ERRFI1;PPARA
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.5419138756125025,-1.5726647690260165,0.02511415525114155,0.2590241858300088,1.0,14/22,26.67%,AKAP6;ATP1B1;RYR2;CALM1;CALM2;CALM3;VMP1;STAC;STAC3;GSTO1;HAP1;HTT;CASQ1;JPH2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.520972508373523,-1.5722807828315872,0.03125,0.25787328517283864,1.0,8/23,13.62%,ELOVL5;ACSL3;FAR2;ELOVL7;TECR;ACSL5;HSD17B12;ACSBG1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.5118684443422848,-1.571737032867734,0.016317016317016316,0.2571662695310116,1.0,14/27,26.73%,CTNNA2;HOMER1;IL1RAPL1;CCDC88A;EFHC2;AKT1;MBOAT1;MARK1;BRSK2;NTNG2;NTNG1;FRMD7;CAMK2G;TREM2
prerank,regulation of smooth muscle cell migration (GO:0014910),0.6037038813470286,1.5699077399431385,0.033928571428571426,0.4697242425163432,1.0,7/20,5.76%,IGFBP3;VTN;IGFBP5;BMPR1A;NRP1;SERPINE1;PDGFRB
prerank,potassium ion homeostasis (GO:0055075),-0.5262689727597104,-1.5698190297985273,0.020737327188940093,0.2593962622222648,1.0,8/23,10.28%,SLC12A7;SLC12A2;KCNMA1;ATP1B1;KCNJ2;ATP1A1;SLC12A5;SLC12A6
prerank,nucleoside phosphate catabolic process (GO:1901292),0.6640880307799603,1.5691538445782607,0.043875685557586835,0.4688072620719781,1.0,4/13,4.94%,ENPP3;ENPP1;DCTPP1;ENTPD7
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.49913666794589207,-1.568293471473558,0.020642201834862386,0.2606430113048003,1.0,9/29,12.18%,SLC4A10;GRIK2;NETO1;MCTP1;RAB3GAP1;CAMK2A;SHISA9;ZDHHC2;SHISA6
prerank,positive regulation of transporter activity (GO:0032411),0.6633544343057527,1.5673374895230987,0.051330798479087454,0.4714710548339181,1.0,3/13,6.10%,KMT2A;STK39;NR1H3
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.663353527197654,1.5664322107943343,0.03177570093457944,0.47119855107004793,1.0,5/13,11.74%,IL6ST;OASL;STAT1;OAS2;JAK1
prerank,regulation of response to biotic stimulus (GO:0002831),0.5487069218044485,1.5662338619151144,0.028286189683860232,0.4681475104747322,1.0,8/28,10.33%,GATA6;CD55;PTPN22;APPL2;BIRC3;TRIM5;APPL1;ERAP1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.5451185351646495,1.566197798694815,0.026446280991735537,0.46451963925483014,1.0,10/33,9.76%,TCF7L2;PDPK1;NUPR1;IL11;CDH5;ANGPT1;SERPINE1;PPARA;YAP1;CAST
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5426189630082223,-1.5654333574459467,0.03233830845771144,0.26457798861485704,1.0,4/21,4.49%,PRKCH;SLC39A10;PRKCB;RPS3
prerank,synaptic vesicle exocytosis (GO:0016079),-0.4663714060580416,-1.5653253211383513,0.00997506234413965,0.2629627565490264,1.0,10/40,9.54%,RIMS1;SYT1;RIMS2;PCLO;STX3;SNAP25;SNCA;CPLX1;SYT7;SNPH
prerank,regulation of hormone secretion (GO:0046883),0.6562073989111801,1.5648349508471355,0.04595588235294118,0.46605446125822525,1.0,4/15,3.42%,OSM;SNX6;IL11;ANXA1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.6443471266963795,1.5647895519664203,0.04669260700389105,0.4625694794591776,1.0,5/14,7.90%,CD55;PTPN22;TGFBR2;LGALS9;IL18
prerank,positive regulation of cell differentiation (GO:0045597),0.3995982837129295,1.5647422579625458,0.0,0.45908548942995425,1.0,38/237,8.31%,TCF4;RANBP3L;MEDAG;IGFBP3;PDPN;SOX5;BMP6;WNT4;PTN;RIN2;SMAD3;CCN2;FGFR1;DDR2;FOXC1;IL6ST;TACSTD2;BMPR1A;GJA1;NBL1;GLIPR2;NELL1;TGFB1I1;KCTD11;BMP2;IL6;BMP7;TMEM64;TGFBR1;CPNE1;BCL9L;CREBL2;CTNNA1;TGFBR2;ZEB1;YAP1;IL18;MEF2A
prerank,substantia nigra development (GO:0021762),-0.4701616723429348,-1.564346465603163,0.023316062176165803,0.26329812807957725,1.0,17/37,17.60%,ACTB;PLP1;GNB4;CALM1;CALM2;MBP;YWHAH;CALM3;INA;S100A1;BASP1;TTBK1;YWHAQ;SUDS3;HSPA5;RAD1;CKB
prerank,circulatory system development (GO:0072359),0.43078487943151916,1.5635863193554629,0.009722222222222222,0.45956581021321646,1.0,25/118,8.83%,FBN1;AKAP13;CXADR;COL3A1;FN1;OSR1;FOXC1;HSPG2;HEG1;FOXC2;CDH5;RBP4;ADAP2;MTHFD1;BMP2;BCOR;TGFBR1;SALL1;NCOA6;PLCE1;POPDC2;TGFBR2;MEF2A;CACNA1C;PRICKLE4
prerank,cation transmembrane transport (GO:0098655),0.5077531396867596,1.5632980465490878,0.013136288998357963,0.45703834165786134,1.0,5/44,3.04%,TRPM3;SLC7A2;ATP1A2;TRPM6;SLC6A9
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4531769608291374,1.5624624696145617,0.007288629737609329,0.456653856058735,1.0,14/85,7.75%,TCF7L2;TGFBR3;BMP6;LAMC1;MCC;FGF1;OSR1;NUPR1;TGFA;ANGPT1;DUSP10;CDKN2B;CDC73;YAP1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6603293302300021,-1.5623960723707457,0.032454361054766734,0.26588323119591045,1.0,7/10,20.05%,GABRA2;GABRA3;GABRA4;GABRG3;GABRB2;GABRA5;GABRA1
prerank,response to sterol (GO:0036314),0.6644458948969375,1.5623084493551835,0.03313840155945419,0.45380163788401356,1.0,3/11,7.03%,RORA;TGFBR1;TGFBR2
prerank,positive regulation of neuron migration (GO:2001224),-0.6335067328894418,-1.5619040840357172,0.018367346938775512,0.26519750620459315,1.0,8/11,23.40%,SEMA6A;DAB2IP;ARHGEF2;RAPGEF2;SHTN1;SEMA3A;PLAA;NSMF
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.6133245013787991,-1.5618320692408292,0.03205128205128205,0.2634823160542325,1.0,5/13,12.77%,NOS3;CALM1;AKT1;GCH1;HSP90AA1
prerank,chordate embryonic development (GO:0043009),0.47435674316070725,1.5618178077322016,0.022292993630573247,0.45184493102344336,1.0,9/55,5.09%,ALDH1A2;SULF1;FGFR1;ARNT2;RBP4;DACT1;BMP2;BMP7;TGFBR1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4538890012363911,1.561156693378989,0.007385524372230428,0.4507636867162597,1.0,16/86,8.01%,SULF1;BMP6;FOXD1;ZEB2;RBPJ;BMPR1A;CDH5;TWSG1;TGFB1I1;BMP2;BMP7;TGFBR1;CREBBP;CDKN2B;BMP8B;RNF111
prerank,megakaryocyte differentiation (GO:0030219),0.6892427156534136,1.5606112774606262,0.03441682600382409,0.4491553642511461,1.0,6/11,11.89%,MPIG6B;IL11;KIT;UBA5;CDKN2B;SH2B3
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.6258555446431863,-1.5605045478071904,0.026748971193415638,0.2645184276610945,1.0,5/13,12.18%,SLC4A10;GRIK2;RAB3GAP1;SHISA9;SHISA6
prerank,actin filament bundle organization (GO:0061572),0.5413937132131527,1.5598211740804144,0.025684931506849314,0.44854107940965793,1.0,8/33,10.06%,DPYSL3;PAWR;CALD1;SHROOM2;MYO1B;BAIAP2L1;LIMA1;RFLNA
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.5242435452278782,1.559173285021329,0.02975206611570248,0.44756471229562567,1.0,15/37,20.78%,TNPO1;DYNLL1;IFT88;IFT57;DYNC2I1;DYNC2LI1;IFT81;WDR19;IFT20;IFT52;TTC21B;KIF3C;CEP131;TRIP11;SSX2IP
prerank,peptidyl-methionine modification (GO:0018206),0.680688564646545,1.558400312078884,0.047080979284369114,0.44704877915096575,1.0,5/12,15.58%,APOA2;NAA16;NAA30;NAA15;PDF
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.42982906597864434,-1.557617195021734,0.014164305949008499,0.269076223277396,1.0,22/59,11.25%,CADM1;HMCN1;BSG;PECAM1;ROBO2;CDH2;KIRREL3;CNTN4;TENM3;CNTN6;CDH1;PTPRM;ROBO4;CDH4;NPTN;CEACAM1;PTPRT;CNTN2;L1CAM;EMB;FAT2;CD84
prerank,positive regulation of acute inflammatory response (GO:0002675),0.6569805347798756,1.557399656661473,0.051188299817184646,0.4473912510714207,1.0,4/14,4.62%,IL6ST;OSM;CREB3L3;IL6
prerank,skeletal system development (GO:0001501),0.41707266534510157,1.556883099748453,0.002758620689655172,0.4461786776915311,1.0,39/148,16.27%,SULF1;SOX5;FBN1;BMP6;AKAP13;FGFR1;CREB3L2;GJA1;ITGB8;WWOX;RBP4;PTHLH;BMP2;BMP1;BMP7;TGFBR1;MMP14;BMP8B;WNT5A;COL13A1;PRELP;SUFU;IGF2;RFLNA;ANKRD11;IHH;RPS6KA3;COL1A2;NOG;NPR3;SH3PXD2B;EIF2AK3;GDF11;RAB33B;SPEF2;SOX4;COL1A1;EVC;INHA
prerank,axon development (GO:0061564),-0.4074174498249971,-1.5561682268088086,0.00906344410876133,0.2704032083115639,1.0,33/78,24.84%,GRM7;CTNNA2;CNTN4;DCC;ACTB;PLP1;KLF7;ANK3;S100B;NRCAM;MAP1B;SHTN1;RTN4RL1;L1CAM;PAX2;NEFH;PAK3;GAP43;MAPK8IP3;BRSK2;MAPT;SLITRK2;SLITRK1;EPHB3;CCK;NTNG2;NTNG1;DSCAML1;AMIGO1;TAOK2;PLPPR4;CDK5;ADGRB1
prerank,negative regulation of cell development (GO:0010721),0.5678265981514689,1.5549316143744263,0.03945111492281304,0.4497255771553732,1.0,7/25,10.06%,FBN1;WNT3A;PTHLH;IL6;APPL2;GSK3B;RFLNA
prerank,regulation of membrane repolarization (GO:0060306),-0.624273607308107,-1.5545850881050567,0.023404255319148935,0.27231685585823584,1.0,6/13,14.23%,AKAP6;KCNJ2;NEDD4L;CAV1;KCNQ1;CASQ2
prerank,potassium ion import across plasma membrane (GO:1990573),-0.46173934671436306,-1.5539729838008713,0.01038961038961039,0.27176432990736304,1.0,15/41,16.25%,SLC12A7;SLC12A2;ATP1B1;KCNJ3;ABCC9;KCNJ2;ATP1A1;HCN2;SLC12A5;SLC12A6;KCNJ6;KCNJ8;KCNJ15;ATP1A3;KCNK9
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.6238694791826153,1.552659035428429,0.03074141048824593,0.4543653179065037,1.0,6/16,15.39%,DPYSL3;DPYD;UPP1;NT5C;TET2;DPYSL4
prerank,hepaticobiliary system development (GO:0061008),0.6023244797259301,1.5523981271022218,0.0423572744014733,0.4520834777562459,1.0,3/20,1.07%,TGFBR3;WNT4;PRKCSH
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4737080097951098,-1.5519688834737841,0.024752475247524754,0.2744214565772704,1.0,13/36,13.17%,NOS3;NOSTRIN;CALM1;NOS1AP;SCARB1;AKT1;CYGB;GCH1;NUS1;S100A1;CAV1;HSP90AA1;EGFR
prerank,regulation of glucose metabolic process (GO:0010906),0.5295654317684511,1.5504592841060867,0.017421602787456445,0.4555697875844641,1.0,3/34,3.37%,PDK1;RORA;GCGR
prerank,retinoic acid metabolic process (GO:0042573),0.6561295141809802,1.5502368611862414,0.04814814814814815,0.4530953739646684,1.0,4/14,15.15%,ALDH1A2;SCPEP1;BCO2;ALDH8A1
prerank,protein oxidation (GO:0018158),0.6775989116698884,1.5499823829514725,0.036072144288577156,0.45080216207286694,1.0,4/11,12.13%,APOA2;LOXL3;LOXL1;LOXL4
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.45928830896910683,1.5497896278631254,0.01347305389221557,0.4484270975828685,1.0,17/74,11.91%,TCF7L2;EYA2;EYA1;PHIP;SH3RF1;TERT;CFLAR;BCL2;TGFBR1;SERPINE1;SIAH2;MCL1;GSK3B;ZMYND11;BCL2L1;EYA4;MAP2K5
prerank,response to nitric oxide (GO:0071731),-0.607017353095087,-1.5480547340544673,0.03505154639175258,0.28136437821351357,1.0,5/13,15.27%,FOXO1;KCNC2;GUCY1B1;CDK2;CCL19
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.5049391654889116,-1.547736294629606,0.029885057471264367,0.2803345806738538,1.0,13/27,27.91%,RIMS1;SYT1;RIMS2;SYT7;SYT4;SYT9;SYT2;SYT6;SYT5;SYT10;DOC2B;SYT17;VAMP2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.546894036796,1.547251000904477,0.03389830508474576,0.453838667197112,1.0,5/30,4.34%,ROBO1;LPAR1;AKAP13;COL3A1;F2RL3
prerank,regulation of synapse assembly (GO:0051963),-0.44719291347086,-1.5463867553671369,0.013404825737265416,0.28147999812309,1.0,20/46,18.34%,NRXN1;NLGN1;GRID2;PTPRD;ROBO2;MEF2C;SYNDIG1;IL1RAPL1;SNCA;IL1RAP;EPHB1;NLGN3;LRRC4B;IL1RAPL2;CLSTN1;SLITRK2;LRFN5;SRPX2;SLITRK1;EPHB3
prerank,negative regulation of cholesterol transport (GO:0032375),0.6762789550652155,1.5463397391629388,0.04307116104868914,0.45402729302692213,1.0,1/10,2.13%,APOA2
prerank,regulation of secretion by cell (GO:1903530),-0.43003986771596636,-1.5459145820343407,0.01084010840108401,0.28070411899140624,1.0,15/54,14.27%,RIMS1;SYT1;RIMS2;MEF2C;NSF;MCTP1;STXBP5L;RAB3C;CPLX1;SCG5;CAMK2A;SYN1;CPLANE2;RAB12;RHBDF2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5502369311349954,1.5458952246580644,0.027874564459930314,0.4522647732731758,1.0,13/29,16.32%,TCF7L2;TLE1;TERT;TLE3;CREBBP;BCL9L;TCF7L1;CDC73;TCF7;LEO1;SMARCA4;AXIN2;PYGO1
prerank,negative regulation of cell differentiation (GO:0045596),0.40745140690409154,1.5457108606761116,0.0012919896640826874,0.44981345824969193,1.0,42/181,13.65%,RANBP3L;EFEMP1;RORA;SMAD3;COL5A2;ENPP1;ADAMTS12;OSR1;WNT10B;LDLRAD4;MYB;ADGRV1;PTHLH;SUZ12;EID2B;IL6;BMP7;CRP;TMEM64;TGFBR1;COL5A1;DTX1;NR1H3;USF3;PPARA;CDC73;YAP1;WNT5A;SKI;SUFU;IGF2;SMAD6;NOCT;ABCA1;LRP3;DISP3;IQCB1;ADAMTS7;NOG;EFNA1;PAF1;RUNX1T1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5706012376974607,1.5450845305785879,0.037300177619893425,0.44895079786811787,1.0,6/22,8.28%,SH3D19;TIMP3;NRDC;PTPN3;SNX9;TIMP2
prerank,regulation of ossification (GO:0030278),0.5230458229312064,1.5436375327542564,0.03523489932885906,0.4508468439117505,1.0,11/36,9.72%,PTN;RBPJ;ENPP1;DDR2;ECM1;BMP2K;BMP2;CHSY1;LRP4;WNT5A;SMAD6
prerank,epithelial cell migration (GO:0010631),0.5225064308571504,1.5430513275827815,0.030664395229982964,0.4501664173181209,1.0,8/37,6.82%,DPP4;ZEB2;FSTL1;KANK2;KANK1;NRP1;KIT;STAT1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.5722590982055957,1.5429806555921506,0.023722627737226276,0.4475017811218772,1.0,3/23,4.86%,TNNC1;TGFBR3;TPM1
prerank,negative regulation of growth (GO:0045926),-0.3646443002339816,-1.5429736994569456,0.0035587188612099642,0.2850254214941719,1.0,29/121,10.38%,APBB2;SLIT2;PTPRJ;SMARCA2;TGFB2;BMPR2;NOTCH1;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;ADAM15;PPP2R1A;RERG;ACVRL1;SOX17;CCN3;CAPRIN2;NDRG3;STK11;ING1;IP6K2;NPR1;RACK1;CCAR2
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.5598072613500257,1.5424460749981745,0.03773584905660377,0.4462060712449134,1.0,5/25,2.91%,SULF1;FOXD1;RBPJ;BMPR1A;CDH5
prerank,fluid transport (GO:0042044),0.6556117300504367,1.541506178992447,0.058161350844277676,0.44658936545662603,1.0,2/12,6.14%,PDPN;SLC4A11
prerank,liver development (GO:0001889),0.5214484678293835,1.5411673441856348,0.03986710963455149,0.4447961089384727,1.0,17/32,23.79%,TGFBR3;WNT4;PRKCSH;ANXA1;IL6;DNAAF1;ARID5B;NPHP3;PKD2;PCK2;CEBPB;CCDC39;XBP1;CITED2;CDK5RAP3;CEBPA;CEBPG
prerank,axonogenesis (GO:0007409),-0.3404775670587192,-1.5410359631862756,0.0,0.2872807750152098,1.0,76/237,14.37%,SLIT2;NRXN1;CTNNA2;UNC5C;BSG;SHANK3;ROBO2;NCAM1;SEMA6D;RPS6KA5;EFNA5;ENAH;DAB1;NRP2;TNR;CNTN4;EPHA5;DOK6;DCC;NOTCH1;NTN4;PIK3R1;ACTB;CNTN6;NOTCH3;GAB1;KLF7;SH3KBP1;SEMA3C;SEMA4D;SEMA6A;ANK3;LAMA3;PRKCQ;LAMA1;EPHB1;S100B;UNC5D;ROBO4;NRCAM;SEMA7A;MAPK3;HSP90AB1;SPTB;NPTN;SEMA3E;MAP1B;SHTN1;EPHA6;NLGN3;TUBB3;CNTN2;L1CAM;VASP;SEMA3G;SEMA6B;EMB;RET;PTPRO;PAX2;NEFH;CXCL12;ULK1;PAK3;LRTM1;GFRA2;PIK3CD;VLDLR;HSP90AA1;KIF5C;SEMA3A;RELN;GFRA1;EVL;LGI1;BRSK2
prerank,dicarboxylic acid catabolic process (GO:0043649),0.6409076491813128,1.5409620711540744,0.0531496062992126,0.4426626615709746,1.0,3/13,8.68%,DDO;ASPA;GLUL
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5279281080063397,1.5407519007018087,0.0333889816360601,0.44053144294892527,1.0,6/32,6.49%,ZBTB20;PID1;PRKAA2;NUPR1;ARNT;PPARA
prerank,Wnt signaling pathway (GO:0016055),0.43923754672842696,1.540111404999798,0.013513513513513514,0.4400357492441479,1.0,20/92,13.07%,TCF7L2;WLS;WNT4;WNT6;PLPP3;WNT2B;WNT10B;WNT3A;FZD2;WNT5B;BCL9L;TCF7L1;GSK3B;WNT5A;LRRK2;TCF7;DVL3;BTRC;WNT2;PORCN
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.6108501819599118,1.5396353943890169,0.06382978723404255,0.4388582528647317,1.0,3/15,6.40%,USP18;STAT2;PTPN2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.6444924609493002,-1.5388879121404662,0.037578288100208766,0.2905270551826513,1.0,5/11,12.77%,NOS3;CALM1;AKT1;GCH1;HSP90AA1
prerank,dicarboxylic acid transport (GO:0006835),0.5552451769594449,1.5386024988014,0.026362038664323375,0.43954839646869365,1.0,5/28,2.69%,PDPN;SLC1A3;SLC13A3;GJA1;SLC19A1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.6422456611174139,1.5375387478664335,0.04554079696394687,0.44018243715720257,1.0,5/13,7.26%,CBLB;RANBP2;KPNA7;KPNA6;KPNA4
prerank,positive regulation of T cell migration (GO:2000406),0.5792461242653147,1.5373137386382618,0.04036697247706422,0.4383381967341047,1.0,5/20,8.14%,CXCL10;STK39;OXSR1;WNT5A;TNFRSF14
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.639856787534513,-1.5363338625135294,0.03389830508474576,0.294656747027558,1.0,4/11,10.16%,CACNB2;NOS1AP;CAMK2D;NOS1
prerank,female gamete generation (GO:0007292),0.5389930469025144,1.5351242523229816,0.029616724738675958,0.4429234071955569,1.0,4/29,6.93%,DIAPH2;PTN;NANOS2;USP9X
prerank,regulation of wound healing (GO:0061041),0.505275219983822,1.5347434552710415,0.02003338898163606,0.441588261762079,1.0,14/42,13.09%,VTN;KANK1;CASK;ANXA1;GP1BA;SERPINE1;TNFRSF12A;CLDN1;INSL3;PLAU;PTK2;EPPK1;CADM4;CD109
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.653443804934874,1.5345463002840196,0.043151969981238276,0.43962893279067883,1.0,4/12,11.23%,CRP;NR1H3;PPARA;ABCA1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.42347292328502517,-1.5345155100218353,0.020348837209302327,0.2967608645426443,1.0,22/54,21.68%,SMAD7;RPL5;IVNS1ABP;RPS3;RPL11;CTNNB1;AKT1;GNL3L;CAV1;COPS9;CAMLG;PARK7;PER2;N4BP1;MINAR1;SIRT7;VPS28;UFL1;PRR7;SH3RF2;PRMT3;DCUN1D3
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5566872089453819,1.5334310626481855,0.03616636528028933,0.4406428661240137,1.0,7/27,5.16%,PHLDB2;CGNL1;ARHGAP6;DLC1;TACSTD2;ARHGAP28;CLASP1
prerank,cellular response to cytokine stimulus (GO:0071345),0.37044305358886687,1.532231346282369,0.0,0.4417886316925151,1.0,80/416,13.08%,PTPN13;DPYSL3;RORA;LEPR;TEC;GBP6;SMAD3;FN1;CXCL10;IL16;PID1;AXL;GHR;STK39;ADAMTS12;OXSR1;IL31RA;ZFAND6;GBP2;FOXC1;STAT2;NFAT5;IL6ST;GAB2;SHMT1;OSM;VIM;IL11;IL34;IL23R;FER;ANXA1;PTPN14;DAPK1;STAT5B;KIT;RC3H1;PTPN4;IL6;BCL2;GSDME;TLR4;HAX1;MCL1;TPR;PTPN2;PTPN9;VCAM1;NOS2;GBP5;STAT1;CD47;CCL2;GBP4;LGALS9;ZEB1;GSK3B;OPRD1;WNT5A;IL18;IL13RA1;TLR2;PTPN6;GBP7;IRAK3;IFNLR1;TCF7;BCL2L1;FOXO3;STAT4;JAK1;SH2B3;CSF1;PTPN18;ADAMTS7;COL1A2;POU2F1;IL22;CRNN;IFIT1
prerank,cardiac muscle cell contraction (GO:0086003),-0.5352451490688421,-1.5317299718740538,0.034403669724770644,0.30091542524984255,1.0,7/19,9.32%,FGF12;KCNJ2;SCN1A;ATP1A1;CACNA1G;CAMK2D;CACNA1D
prerank,regulation of regulated secretory pathway (GO:1903305),-0.4647947962567754,-1.530760923472039,0.026726057906458798,0.3010864320943001,1.0,18/34,27.34%,RIMS1;SYT1;RIMS2;RAB27A;SYT7;SYT4;SYN1;SYT9;SYT2;SNAPIN;RIMS4;RAB15;SYT6;VPS18;SYT5;SYT10;SYT17;UNC13D
prerank,regulation of fat cell differentiation (GO:0045598),0.45633382676045015,1.5292895307197938,0.0196078431372549,0.4489007758135813,1.0,21/74,16.15%,MEDAG;RORA;SMAD3;ENPP1;WNT10B;BMP2;IL6;TMEM64;CREBL2;FTO;YAP1;WNT5A;NOCT;AAMDC;LRP3;RARRES2;RUNX1T1;CARM1;PTPRQ;WWTR1;ASXL2
prerank,regulation of biomineral tissue development (GO:0070167),0.5463155160684167,1.5283361057496387,0.031413612565445025,0.4493145462832988,1.0,5/26,2.85%,ROCK2;ENPP1;DDR2;ECM1;BMP2K
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3967205815725953,1.528151775593412,0.005050505050505051,0.4473445818487345,1.0,40/208,12.94%,PDPK1;WLS;RORA;LPAR1;AKAP13;TLE1;ZFAND6;ECM1;PPM1A;GJA1;TRAF5;ROR1;LITAF;CFLAR;IKBKE;MTDH;OPTN;MIER1;GOLT1B;BIRC3;PELI2;CPNE1;TRIM5;BST2;STAT1;JMJD8;LGALS9;VAPA;WNT5A;ZMYND11;RIPK2;ANKRD17;BRD4;PPM1B;NLRX1;UBE2V1;TRIM21;RHOC;MAP3K7;TIFA
prerank,retrograde axonal transport (GO:0008090),-0.5701110501242672,-1.527496047922554,0.04072398190045249,0.30614691718576226,1.0,7/16,15.53%,DLG2;ACTR10;KIF1C;DYNC1H1;TMEM108;SOD1;KIF5A
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4947247652058629,1.5271314259214352,0.03414634146341464,0.4481445803408642,1.0,11/44,7.13%,LPAR1;ROCK2;CCN2;PPM1E;NRP1;S100A10;TPM1;TGFBR1;EPHA1;CD47;ARHGEF10L
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6619473721924817,1.5269991651353299,0.05736137667304015,0.4459021639409194,1.0,4/11,13.36%,PDPN;KANK1;ENPP2;ARPIN
prerank,heart development (GO:0007507),0.40949692914231267,1.5246517385572798,0.008086253369272238,0.4507115417059486,1.0,28/150,8.83%,FLRT2;TGFBR3;FBN1;AKAP13;CXADR;COL3A1;FN1;OSR1;FOXC1;DLC1;HEG1;CSRP3;FOXC2;RBP4;ADAP2;MTHFD1;BMP2;BMP7;BCOR;TGFBR1;SALL1;NCOA6;PLCE1;POPDC2;TGFBR2;MEF2A;CACNA1C;PRICKLE4
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.48035665297263447,-1.523985593899299,0.031630170316301706,0.31239479522558267,1.0,12/35,11.71%,PDE4D;RIMS2;ADGRG6;AKAP6;CAP2;EPHA5;HTR2C;RAPGEF2;GUCY1B1;PDE2A;PDE3A;ADCY2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4773794594347323,1.5232242768640853,0.022222222222222223,0.45273268320487353,1.0,8/61,4.34%,ROBO1;LPAR1;RASGRF1;AKAP13;COL3A1;AUTS2;NOTCH2;F2RL3
prerank,bone development (GO:0060348),0.5070616696291336,1.5226913639458477,0.022328548644338118,0.45193020136360024,1.0,6/39,8.18%,RANBP3L;SULF1;AKAP13;GJA1;SBDS;SKI
prerank,aspartate family amino acid catabolic process (GO:0009068),0.5933967409458774,1.5226136985789873,0.04,0.44964028781536414,1.0,4/19,7.08%,DDO;HYKK;PHYKPL;ASPA
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5114116042517348,1.5222660569023638,0.03571428571428571,0.4483533916167963,1.0,14/36,21.57%,PARP14;AXL;PARP9;ZBP1;CASP4;CPNE1;WNT5A;CSF1;CXCR4;TXK;IL7;UBE2K;HIF1A;RIPK1
prerank,heme catabolic process (GO:0042167),-0.6014771227109236,-1.5216555919972388,0.03305785123966942,0.31367346446995054,1.0,3/14,10.26%,ABCG2;BLVRA;HMOX2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.6014771227109236,-1.5216555919972388,0.03305785123966942,0.31367346446995054,1.0,3/14,10.26%,ABCG2;BLVRA;HMOX2
prerank,wound healing (GO:0042060),0.4699302431238241,1.5210177230570432,0.0109204368174727,0.4498027994003264,1.0,16/62,13.08%,SMAD3;COL3A1;PDGFRA;FGF1;MYOF;PPL;CFLAR;MIA3;TPM1;TGFBR1;CLDN1;WNT5A;DCBLD2;FUT10;EPPK1;NOG
prerank,proteoglycan biosynthetic process (GO:0030166),-0.4908251364879183,-1.5209023432213178,0.014814814814814815,0.31353983480421477,1.0,7/31,5.53%,CSGALNACT1;BMPR2;NDST3;XYLT1;B3GAT2;CHST9;EXT1
prerank,postsynaptic membrane organization (GO:0001941),-0.5641161643048997,-1.5207315255347469,0.04212860310421286,0.3120622560111661,1.0,5/17,8.78%,NRXN1;NLGN1;SHANK3;GPHN;NLGN3
prerank,central nervous system neuron differentiation (GO:0021953),-0.47351584812632075,-1.5205323876709191,0.011737089201877934,0.31072183050166474,1.0,15/33,27.67%,MDGA2;GRID2;NTRK2;TOX;CTNNB1;SPOCK1;LRP6;MAP2;MAPT;LHX1;CBLN1;ZC4H2;CEND1;LMX1A;CHD5
prerank,positive regulation of response to external stimulus (GO:0032103),0.4184254031388928,1.5184623927279455,0.008391608391608392,0.4551465750889913,1.0,22/128,9.33%,BMP6;PTN;SASH1;IL16;DDX60;FPR2;OSM;ZBP1;IFI35;TLR4;SERPINE1;OPTN;PDGFRB;OASL;GBP5;CD47;LY96;WNT5A;IL18;SETD4;TLR2;ANKRD17
prerank,neuron development (GO:0048666),-0.36026998359851525,-1.5163120384672282,0.0,0.31886762638771954,1.0,35/141,11.91%,FRY;CNTNAP2;NLGN1;MEF2C;TENM2;TGFB2;GPM6A;CNTN4;EPHA5;TENM3;MYT1L;PLP1;STX3;PBX3;GPM6B;NTRK2;PTPRM;ATP8A2;VSX1;SH3GL2;RP1;MYOC;HMGB1;TENM4;STMN2;RAPGEF2;UNK;THOC2;RAB35;L1CAM;LYN;MANF;ZFYVE27;MICALL2;ULK1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.6116819095039323,-1.5161199467960143,0.0408997955010225,0.31753907468740017,1.0,6/11,20.51%,PINK1;RACK1;ATF4;NR4A3;PARK7;NONO
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.4816792432197675,-1.516016273329848,0.04047619047619048,0.31592502198754563,1.0,16/27,27.88%,PDE4D;PDE4B;CTNNA3;RYR2;CAMK2D;CAV1;FGF13;SRI;ATP2A2;DSG2;GJA5;STC1;PLN;PKP2;HCN4;RANGRF
prerank,Rac protein signal transduction (GO:0016601),-0.5396800351452993,-1.5154913381960866,0.052060737527114966,0.3154490052763685,1.0,9/18,15.30%,ELMO1;EPS8;TIAM1;NCKAP1;RHOG;DBNL;RHOH;RAC1;HACD3
prerank,regulation of transmembrane transport (GO:0034762),-0.4734699273389612,-1.5150931444166018,0.02810304449648712,0.31446540168277676,1.0,11/31,12.33%,SLC2A1;PRKCB;KCNJ3;KCNJ2;ACTB;SNCA;NEDD4L;ACE2;KCNJ6;KCNJ8;KCNJ15
prerank,regulation of response to interferon-gamma (GO:0060330),0.6272231587016458,1.514878817710833,0.054409005628517824,0.4646253668064798,1.0,6/14,11.74%,PARP9;PTPN2;STAT1;PIAS1;SUMO1;JAK1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.6562004119133118,1.5138792711045663,0.06415094339622641,0.46534641172602664,1.0,4/12,13.56%,MUC2;RBP4;TLR4;STRAP
prerank,negative regulation of reproductive process (GO:2000242),0.5980536455152082,1.5135329264588302,0.048507462686567165,0.4640622403692975,1.0,3/17,7.82%,SULF1;GJA1;NPPC
prerank,histone H3-K4 methylation (GO:0051568),0.5466640016657333,1.5133183256603624,0.05699481865284974,0.46223476531869073,1.0,6/26,12.61%,KMT2A;WDR5B;KMT2C;SETD4;SETD1B;TET2
prerank,regulation of viral genome replication (GO:0045069),0.47681998726272845,1.512079233579361,0.03215926493108729,0.4638039088103689,1.0,21/56,17.86%,RSAD2;ZC3HAV1;EIF2AK2;PPARA;OASL;BST2;PARP10;STAU1;IFITM1;PPID;OAS2;TMEM39A;ILF3;ADAR;IFIT1;SRPK1;TARBP2;IFIH1;PKN2;SHFL;TNIP1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.38527382510782787,-1.510971228483954,0.012012012012012012,0.3221121062988481,1.0,28/91,14.60%,ABCG2;SLC39A10;TFRC;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;SLC40A1;ATOX1;FTH1;FTL;SLC39A6;SLC31A1;SLC30A1;SLC22A17;SLC39A12;HMOX2;SLC39A14;SLC31A2;MT2A;CYBRD1;SLC39A13;SLC39A8;SOD1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.5013926095062995,1.5091673978277387,0.024875621890547265,0.4708058136019079,1.0,5/39,5.50%,TCF7L2;MCU;GHRH;RBP4;UCN
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.45933813266266377,1.5086484107017453,0.02040816326530612,0.47009923778232415,1.0,12/66,7.56%,SULF1;ROBO1;TGFBR3;MCC;NR2F2;NUPR1;CASK;DUSP10;STAT1;CDKN2B;KLF9;CDC73
prerank,cellular response to drug (GO:0035690),-0.5013375936915475,-1.507504820121021,0.033112582781456956,0.32849751190648774,1.0,7/25,11.84%,MEF2C;PDE4B;TFRC;ACER2;GAS6;AIM2;KCNQ1
prerank,regulation of macrophage migration (GO:1905521),-0.6418794640286264,-1.5059729715358288,0.049689440993788817,0.33024356297246626,1.0,3/10,6.62%,MTUS1;PTK2B;EMILIN1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.46807586606163903,1.5058628972852364,0.026397515527950312,0.47688625736472207,1.0,11/57,7.90%,PARP14;GHR;IL31RA;IL6ST;OSM;IL23R;PARP9;KIT;IL6;PTPN2;IL18
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5853761422078255,1.5052844299081387,0.06751824817518248,0.47630879109409296,1.0,4/18,11.59%,KMT2A;SETD4;SETD7;SETD1B
prerank,regulation of protein export from nucleus (GO:0046825),0.5591448404135952,1.505138835021478,0.04903677758318739,0.47432698613447943,1.0,5/23,7.53%,TCF7L2;SP100;PTPN14;TPR;GSK3B
prerank,positive regulation of protein secretion (GO:0050714),0.4537070077534324,1.5048194319630797,0.02204724409448819,0.4729127541667078,1.0,13/69,11.37%,TCF7L2;WLS;BMP6;MCU;RBP4;APBB1;TLR4;UNC13B;TLR2;PPID;DNM1L;HCAR2;NLGN2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5228804980967833,1.5047976799457965,0.04,0.4705506451657813,1.0,6/31,5.09%,TNNC1;TGFBR3;RBPJ;BMPR1A;TPM1;TGFBR1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.4759174220660675,1.5046369223249259,0.03420195439739414,0.46867899045983524,1.0,7/46,7.90%,TCF7L2;IGFBP3;IGFBP5;IL6;PDGFRB;STAT1;IL18
prerank,response to muscle stretch (GO:0035994),-0.5620052153655926,-1.504071872317556,0.04148471615720524,0.33282537067793816,1.0,5/15,5.55%,CDH2;DMD;RYR2;SLC8A1;CTNNB1
prerank,regulation of BMP signaling pathway (GO:0030510),0.44999853568691683,1.5025192160927447,0.02108433734939759,0.4731108376942892,1.0,11/73,4.04%,SULF1;FOXD1;FSTL1;RBPJ;SMURF2;BMPR1A;FSTL3;NBL1;CDH5;TWSG1;BMP2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.523955107139777,1.5009698140180148,0.052083333333333336,0.47580554593023394,1.0,11/29,20.30%,USP18;STAT2;ZBP1;PTPN2;WNT5A;PTPN6;PTPN1;IFNAR2;MUL1;RNASEL;UBE2K
prerank,filopodium assembly (GO:0046847),-0.5616575769856976,-1.5006635249574027,0.046052631578947366,0.3388369047773775,1.0,4/16,6.74%,DNM3;FGD5;SPATA13;FGD6
prerank,regulation of platelet activation (GO:0010543),0.5689095472607137,1.4997823515302378,0.05904761904761905,0.4775596451679733,1.0,5/21,4.94%,TEC;PDGFRA;SELP;PLA2G4A;TLR4
prerank,xenobiotic transport (GO:0042908),-0.5549061095941467,-1.499574627325996,0.046413502109704644,0.3397479740190793,1.0,5/17,5.62%,ABCG2;SLC47A1;SLC7A5;ABCA3;SLC15A2
prerank,protein modification by small protein conjugation (GO:0032446),0.36815644649073576,1.4993289013408502,0.0,0.4767760379151082,1.0,81/361,15.19%,RNF220;PDZRN3;EYA1;RNF152;RNF213;SPSB1;SMURF2;TRIM10;HIF3A;FBXO11;FBXL17;NEDD4;DTX4;UBA5;MYCBP2;EPAS1;TRIM17;RANBP2;KLHL21;SPSB4;TPR;CUL4A;DTX1;ANAPC11;DTX3L;TRIM5;FBXO9;MGRN1;USP9X;FBH1;CDC73;RNF20;KLHL18;RNF111;FBXL3;WAC;TRIM24;NUB1;PIAS1;UBE2Z;PJA2;AMFR;UBE2C;SUMO1;FBXL7;FBXO4;KEAP1;FBXO24;WWP2;KLHL13;HUWE1;RFWD3;RTF1;TRIM21;CUL3;NSMCE2;EGR2;FBXW11;ASB5;TRIM7;TRIM26;BTRC;HECW2;ARRB1;CDC27;UBE2Q2;BRAP;UBE2E3;PEX2;PAF1;RNF103-CHMP3;RNF181;RNF39;RNF43;VHL;POM121;UBE2R2;BIRC6;LEO1;IFIH1;RCHY1
prerank,synaptic vesicle cycle (GO:0099504),-0.4810602172950038,-1.4986845122219776,0.03881278538812785,0.34007157882881817,1.0,8/30,7.93%,NLGN1;RIMS1;SYNDIG1;PCLO;SNAP25;SNCA;CPLX1;SYT7
prerank,renal system development (GO:0072001),0.4740192555093238,1.4981732462558577,0.02627511591962906,0.47825357449543804,1.0,11/52,8.34%,SULF1;WNT4;FOXC1;RBP4;IFT88;ARL3;TGFBR1;SALL1;LRP4;STAT1;GREB1L
prerank,axon guidance (GO:0007411),-0.33134264185707296,-1.4979855378823825,0.00411522633744856,0.3400793685589097,1.0,68/201,13.94%,SLIT2;NRXN1;UNC5C;BSG;SHANK3;ROBO2;PLXNA4;NCAM1;SEMA6D;RPS6KA5;EFNA5;ENAH;DAB1;NRP2;TNR;CNTN4;EPHA5;DOK6;DCC;NOTCH1;NTN4;PIK3R1;CNTN6;NOTCH3;GAB1;KLF7;SH3KBP1;SEMA3C;SEMA4D;SEMA6A;TMEFF1;PTPRM;LAMA3;PRKCQ;LAMA1;EPHB1;UNC5D;ROBO4;SEMA7A;MAPK3;SPTB;NPTN;SEMA3E;EPHA6;TUBB3;VEGFA;CNTN2;L1CAM;VASP;SEMA3G;RHOG;SEMA6B;EMB;RET;PTPRO;NFIB;CXCL12;LRTM1;GFRA2;PIK3CD;VLDLR;GAP43;KIF5C;SEMA3A;RELN;GFRA1;RHOH;EVL
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.4775462541374469,-1.4963727911901143,0.02830188679245283,0.3419841822857043,1.0,10/29,13.62%,ELOVL5;ACSL3;ELOVL7;TECR;ACSL5;ACACA;ACLY;SCD;HSD17B12;ACSBG1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5607404146963898,-1.496046919799976,0.05357142857142857,0.34087265642693704,1.0,6/15,15.12%,SMAD7;RPL5;RPS7;RPL11;RPL23;PARK7
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6356283376813496,1.4959370603488427,0.055970149253731345,0.4833786635523145,1.0,3/13,4.52%,CBLB;SNX6;ERRFI1
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.46671499012715134,-1.4952696603789282,0.030878859857482184,0.34106814384736717,1.0,10/32,9.16%,PTPRD;ADGRB3;TNIK;HECW1;SEMA4D;IL1RAPL1;CAPRIN2;RAPGEF2;YWHAH;NEDD4L
prerank,cellular biogenic amine catabolic process (GO:0042402),0.6768161692854542,1.4951122671633743,0.049800796812749,0.483647410892102,1.0,6/10,19.68%,HNMT;COMT;SARDH;DMGDH;ALDH7A1;LRTOMT
prerank,negative regulation of immune system process (GO:0002683),0.6056792567738292,1.493817818681381,0.0575139146567718,0.4854737761522797,1.0,3/16,6.24%,COL3A1;IL17D;FOXP3
prerank,negative regulation of multicellular organismal process (GO:0051241),0.38836318546840004,1.4937341549513197,0.006345177664974619,0.4833767324362495,1.0,34/199,8.22%,ROBO1;ALDH1A1;MCC;LGR4;ROCK2;RBPJ;LAMA4;WNT10B;APOA2;ACOT11;TACSTD2;GJA1;FOXC2;LDLRAD4;TWSG1;DUSP10;BMP2;NRDC;IL17D;TLE3;PARP3;TLR4;CHSY1;NR1H3;WWC2;FOXP3;LRP4;ATP2B4;USF3;ADM;GSK3B;NOVA1;TIFAB;MAP2K6
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6106008108704978,1.4932930966569902,0.06583629893238434,0.4824350870982301,1.0,4/16,8.30%,SELP;NFAT5;IL6;FUT4
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6148545590196949,1.4932119580378205,0.0562015503875969,0.48032569890563737,1.0,6/14,17.70%,DDX60;OASL;TLR2;ANKRD17;PUM2;USP15
prerank,positive regulation of response to wounding (GO:1903036),0.5534152420418781,1.4931700757464206,0.04020979020979021,0.4781469622731173,1.0,7/24,10.94%,PTN;VTN;KANK1;ANXA1;CLDN1;INSL3;PTK2
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.640225691036145,1.4928493723149627,0.06958250497017893,0.4768116530433848,1.0,3/12,5.07%,UST;DCN;DSE
prerank,embryonic eye morphogenesis (GO:0048048),0.6563117756023684,1.492843820066291,0.07505070993914807,0.47453961234811304,1.0,2/11,0.41%,EFEMP1;FBN1
prerank,regulation of potassium ion transport (GO:0043266),-0.45949985501469315,-1.4923320513337692,0.03424657534246575,0.34644220061193226,1.0,9/31,10.16%,DPP10;KCNAB1;PTK2B;KCNIP4;ANK3;KCNIP1;DPP6;CACNA1D;NOS1
prerank,protein K63-linked ubiquitination (GO:0070534),0.483390562292015,1.4921395591660258,0.045936395759717315,0.4746307322999241,1.0,12/41,13.99%,RNF152;TRIM56;TRAF5;NEDD4;TRIM5;WWP2;UBE2V1;TRIM21;HECTD1;UBE2E3;BFAR;PRPF19
prerank,negative regulation of cell projection organization (GO:0031345),0.47871639470358035,1.4920779650110982,0.04272151898734177,0.47261295012452126,1.0,7/48,6.47%,EFNB2;DPYSL3;LPAR1;WNT3A;KANK1;CBFA2T2;PTPN9
prerank,negative regulation of lipid storage (GO:0010888),0.5866375867490136,1.4889853576929788,0.0481283422459893,0.4805144446199719,1.0,7/19,11.23%,OSBPL8;IL6;CRP;NR1H3;PTPN2;PPARA;ABCA1
prerank,defense response to bacterium (GO:0042742),0.41733144333681166,1.48735867992968,0.014619883040935672,0.48358238471249154,1.0,20/105,11.50%,GBP6;SELP;COLEC12;GBP2;FPR2;IL23R;ANXA3;IL6;CRP;TLR4;SERPINE1;OPTN;NOS2;GBP4;TNFRSF14;PLA2G6;TLR2;ANKRD17;GBP7;OAS2
prerank,regulation of phospholipase activity (GO:0010517),0.6824387426929308,1.487338409003884,0.06378986866791744,0.48143685649722273,1.0,2/10,1.13%,PDPK1;FGFR1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6216531708631259,-1.4866566336871823,0.04365904365904366,0.3583520940214535,1.0,4/11,3.83%,THBS1;KLF2;EPN2;SEMA6A
prerank,collagen fibril organization (GO:0030199),0.4318635866354242,1.4865948248471892,0.017991004497751123,0.4815392457269399,1.0,15/88,5.66%,COL23A1;COL4A3;COL4A6;COL4A4;COL5A2;COL3A1;COL4A5;DDR2;LOXL3;LOXL1;BMP1;COL18A1;TGFBR1;COL5A1;COL20A1
prerank,defense response to protozoan (GO:0042832),0.6363911239428621,1.4864097345887959,0.0633147113594041,0.48002497454670506,1.0,4/12,10.56%,GBP6;GBP2;GBP4;GBP7
prerank,negative regulation of fat cell differentiation (GO:0045599),0.5081198462488011,1.4860971910554752,0.04492512479201331,0.47882649134512917,1.0,7/34,7.87%,RORA;SMAD3;ENPP1;WNT10B;IL6;YAP1;WNT5A
prerank,histone H2B ubiquitination (GO:0033523),0.6700174578400258,1.485811818545558,0.07961165048543689,0.47755380201031006,1.0,6/10,14.88%,DTX3L;CDC73;RNF20;WAC;PAF1;LEO1
prerank,fibrinolysis (GO:0042730),0.6298014111041749,1.4852094775346418,0.07017543859649122,0.4773372663890369,1.0,5/13,12.15%,GP1BA;SERPINE1;PLAU;CPB2;PLAT
prerank,nuclear migration (GO:0007097),0.6303252887315762,1.4851301448351288,0.05956678700361011,0.4754030579731201,1.0,5/13,12.51%,SYNE3;SYNE2;CLMN;DOCK7;FBXW11
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.4119847498719042,-1.4836661903032022,0.017142857142857144,0.3621210173204254,1.0,30/56,35.28%,NDUFV1;NDUFA8;NDUFC1;NDUFB4;NDUFS7;NDUFA1;NDUFB2;NDUFA12;NDUFA11;NDUFAF4;NDUFB7;NDUFC2;NDUFB10;NDUFA13;NDUFA9;NDUFAF8;FOXRED1;TIMM21;NDUFAF7;NDUFA10;NDUFAF3;BCS1L;NDUFS6;NDUFS1;NDUFV3;TMEM126B;NUBPL;NDUFA2;NDUFA6;NDUFS2
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.4119847498719042,-1.4836661903032022,0.017142857142857144,0.3621210173204254,1.0,30/56,35.28%,NDUFV1;NDUFA8;NDUFC1;NDUFB4;NDUFS7;NDUFA1;NDUFB2;NDUFA12;NDUFA11;NDUFAF4;NDUFB7;NDUFC2;NDUFB10;NDUFA13;NDUFA9;NDUFAF8;FOXRED1;TIMM21;NDUFAF7;NDUFA10;NDUFAF3;BCS1L;NDUFS6;NDUFS1;NDUFV3;TMEM126B;NUBPL;NDUFA2;NDUFA6;NDUFS2
prerank,negative regulation of viral process (GO:0048525),0.468412522127473,1.4832209333620319,0.03169572107765452,0.4791881306877306,1.0,20/57,17.86%,RSAD2;ZC3HAV1;EIF2AK2;TRIM5;OASL;BST2;STAT1;PARP10;IFITM1;OAS2;ILF3;TRIM21;TRIM26;IFIT1;SRPK1;CHMP3;IFIH1;PML;SHFL;TNIP1
prerank,cardiac conduction system development (GO:0003161),0.5528423642498732,1.4828296377409964,0.056338028169014086,0.47828461907090597,1.0,5/24,2.36%,NOTCH2;GATA6;GJB6;BMPR1A;GJA1
prerank,negative regulation of signal transduction (GO:0009968),0.37597407665956706,1.4816061376076257,0.00375,0.4798660234065926,1.0,61/249,15.57%,SULF1;IGFBP3;LEPROT;LGR4;KANK2;ENPP1;PID1;TLE1;ADAMTS12;IGFBP5;MPIG6B;KANK1;FSTL3;GLI3;WWOX;APCDD1;DCN;NEDD4;DACT1;BMP2;CRY1;NTN1;DLK1;BCL2;MMP14;PRKCZ;SIAH2;DKK3;PTPN2;MGRN1;CD47;GLIS2;LRRK2;SUFU;APPL1;PLEK;NKD1;IRAK3;WWP2;PTPN1;RPGRIP1L;PTPN18;VGLL4;PALM;BTRC;ARRB1;PIP4K2B;CADM4;NOG;BRAP;NCK1;RNF43;CSNK2A2;HIC1;TRIB1;BDNF;LRPAP1;NIBAN2;TNS2;LRP1;GDF15
prerank,cell-cell junction assembly (GO:0007043),-0.3982224741281031,-1.4815604613128222,0.02023121387283237,0.3654837330442451,1.0,19/63,8.64%,CTNND2;CLDN5;CDH2;CDH11;CDH12;SMAD7;ACTB;ACTG1;GJC1;GJD3;CDH10;CTNNB1;TLN2;CDH8;CDH22;CDH7;CDH20;JAM3;RAMP2
prerank,regulation of vasoconstriction (GO:0019229),-0.47783671148769885,-1.480692816572107,0.0481651376146789,0.3656260885278099,1.0,8/27,11.76%,CHRM3;KCNMB2;BMPR2;ADRA1B;ECE1;ACE;ACE2;CAV1
prerank,sphingoid biosynthetic process (GO:0046520),-0.6074081663069275,-1.478957153874507,0.05060728744939271,0.3660117233433205,1.0,2/11,2.15%,ACER3;ACER2
prerank,sphingosine biosynthetic process (GO:0046512),-0.6074081663069275,-1.478957153874507,0.05060728744939271,0.3660117233433205,1.0,2/11,2.15%,ACER3;ACER2
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5498467023080891,-1.4783414258917964,0.05,0.36573024184472336,1.0,6/16,10.16%,NOS3;KCNC2;NDNF;GUCY1B1;GUCY1A1;NOS1
prerank,ameboidal-type cell migration (GO:0001667),-0.4152779217418426,-1.4773404986070509,0.03314917127071823,0.3663530911801621,1.0,19/51,13.17%,SEMA6D;ERBB4;PHACTR4;TBX1;ITGA4;SEMA3C;SEMA4D;SEMA6A;CCN3;PKN1;SEMA7A;SEMA3E;AKT1;AMOT;SEMA3G;SEMA6B;FAT2;PKN3;SEMA3A
prerank,potassium ion transmembrane transport (GO:0071805),-0.351110949273733,-1.4765886993388289,0.0,0.366388991475895,1.0,36/135,14.60%,SLC12A7;SLC12A2;KCNB2;KCND2;SLC9A2;KCNQ5;KCNAB1;KCNK5;SLC24A2;ATP1B1;KCNJ3;ABCC9;KCNH7;KCNJ2;KCNC2;KCNQ3;HCN1;ATP1A1;KCNK10;SLC9A8;HCN2;TMEM175;KCNH1;KCNH5;SLC12A5;KCND3;SLC12A6;KCNB1;KCNJ6;KCNJ8;KCNQ1;KCNJ15;KCNE4;KCNC1;SLC9A5;KCNA2
prerank,alanine transport (GO:0032328),-0.6312111187640664,-1.475775410226444,0.06652806652806653,0.3666412024441028,1.0,3/10,11.01%,SLC6A6;SLC1A4;SLC36A1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.43946189291544996,-1.475344636133195,0.03431372549019608,0.36594127366908324,1.0,11/38,13.12%,CACNB2;CTNNA3;KCNJ3;KCNJ2;CACNA1G;CAMK2D;KCND3;CACNA1D;CAV1;KCNQ1;KCNE4
prerank,positive regulation of phospholipase activity (GO:0010518),0.5513232651162272,1.4751744979706802,0.06747404844290658,0.49838374062661545,1.0,6/22,6.06%,PDPK1;PDGFRA;FGFR1;KIT;PDGFRB;ARF4
prerank,defense response to virus (GO:0051607),0.41903509766802005,1.4738758740002618,0.03361344537815126,0.5000616181516339,1.0,29/100,16.97%,RSAD2;CXCL10;EIF2AK2;TRIM56;STAT2;PRF1;IFIT2;ZBP1;IL6;BCL2;TRIM5;OASL;BST2;STAT1;ZMYND11;PHB2;MOV10;TLR2;IFITM1;IFNLR1;BCL2L1;OAS2;IFI27;IFIT1;IFIT3;IFIH1;IFNAR2;SHFL;RNF135
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6699906248037256,1.4734810411351875,0.08113207547169811,0.49908606287493845,1.0,4/10,3.39%,ATP1A2;STK39;OSR1;NEDD4
prerank,regulation of steroid metabolic process (GO:0019218),0.5394129659836232,1.4729130906185912,0.06537102473498234,0.4987650767190501,1.0,5/23,15.64%,RORA;PANK2;FMO5;STAR;EPHX2
prerank,regulation of defense response to virus by host (GO:0050691),0.5090671288454948,1.4724548900744256,0.06303236797274275,0.4981982251600717,1.0,9/30,15.88%,IL23R;PARP9;PTPN22;RNF216;DTX3L;STAT1;IFNLR1;TARBP2;MUL1
prerank,cellular response to organic substance (GO:0071310),0.40722680961531826,1.4721486631815275,0.021367521367521368,0.4969746476356746,1.0,34/116,15.96%,PTPN13;DPYSL3;SMAD3;PID1;GHR;IGFBP5;CLEC3B;NFAT5;BMPR1A;NCOA3;PTPN14;STAT5B;PTPN4;PLK5;TGFBR1;HAX1;PTPN2;PTPN9;TGFBR2;CCL2;RAMP1;IL18;LRRK2;PTPN6;TIPARP;MAP2K5;PTPN18;CRNN;ACVR1C;TBK1;NCOA2;CXCR4;ACVR2B;ADRA2A
prerank,positive regulation of ossification (GO:0045778),0.4954396538570062,1.4718230848362488,0.03486529318541997,0.4957574595946819,1.0,10/39,4.78%,BMP6;WNT4;PTN;OSR1;BMPR1A;NELL1;KL;ADGRV1;BMP2;BMP7
prerank,histone ubiquitination (GO:0016574),0.5561641583580827,1.4718027855993627,0.06830122591943957,0.49366633838542084,1.0,8/21,14.88%,UBE2U;DTX3L;CDC73;RNF20;WAC;HUWE1;PAF1;LEO1
prerank,positive regulation of protein polymerization (GO:0032273),-0.4000020625673556,-1.4707712870482876,0.019444444444444445,0.37551480122844655,1.0,30/65,24.12%,NAV3;PTK2B;NCKAP1;PAK1;RPS3;MET;LMOD1;CDC42EP3;PINK1;VASP;CDC42EP1;CDC42EP5;TTBK1;FES;HSP90AA1;EVL;RAC1;MAPT;PYCARD;ARF6;TPPP;CDK5RAP2;PRKCE;PFN2;DCTN1;ARL2;OCLN;CARMIL1;PFN1;MAPRE1
prerank,kidney development (GO:0001822),0.4476499833617324,1.4703580090477757,0.027818448023426062,0.4962114378629445,1.0,13/65,8.34%,SULF1;WNT4;KANK2;OSR1;FOXC1;IFT88;ARL3;BMP7;TGFBR1;SALL1;LRP4;CTSH;GREB1L
prerank,embryonic skeletal system development (GO:0048706),0.4943212435614776,1.47020163807573,0.04835924006908463,0.4944971390425632,1.0,7/35,7.87%,SULF1;PDGFRA;OSR1;RBP4;HOXC4;DYNC2I1;WNT5A
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5181240606513834,-1.4698998999111321,0.07106598984771574,0.3758403117334212,1.0,9/21,8.04%,PDE4D;DMD;AKAP6;RYR2;CALM1;CALM2;SLC8A1;CALM3;CAMK2D
prerank,regulation of osteoblast differentiation (GO:0045667),0.42670718081134795,1.4684340593171419,0.019969278033794162,0.4980613516262301,1.0,19/82,11.64%,RANBP3L;BMP6;WNT4;DDR2;IL6ST;BMPR1A;NELL1;BMP2;IL6;BMP7;TMEM64;YAP1;SKI;SUFU;SMAD6;IFITM1;NOCT;PTK2;LRP3
prerank,positive regulation of cell aging (GO:0090343),-0.6111263541688723,-1.468375415097012,0.051440329218107,0.3778215397717694,1.0,4/11,11.51%,YPEL3;B2M;ABI3;EEF1E1
prerank,cellular response to lipid (GO:0071396),0.38345322255861514,1.4650664641122857,0.007905138339920948,0.5067160535870504,1.0,30/191,8.64%,RORA;TFPI;ATP1A2;ROCK2;CXCL10;WNT6;PID1;AXL;WNT10B;LDOC1;WNT3A;PTK7;EPHA3;VIM;NCOA3;IL6;WNT5B;ADCY5;TLR4;SERPINE1;ZNF35;NR1H3;LY96;ADCY1;CCL2;MAP4K1;CDC73;WNT5A;CD274;FAM210B
prerank,regulation of cell morphogenesis (GO:0022604),0.5186026544862938,1.4646391754062185,0.050505050505050504,0.505985605318051,1.0,13/30,16.40%,PDPN;SH3D19;PHIP;MYO9A;BCL9L;CAPZB;FMNL2;MOV10;ZMYM6;SPARC;PDZD8;ZMYM3;WTIP
prerank,regulation of cellular component movement (GO:0051270),0.4770031303830036,1.462487718403606,0.03594771241830065,0.5110401438951367,1.0,8/49,5.09%,PDPN;TGFBR3;ROCK2;DIAPH1;SP100;ARHGAP18;MYCBP2;TGFBR1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.6694117448859037,1.4612592560581241,0.10266159695817491,0.5131153783075153,1.0,6/10,18.74%,CPEB1;CDC73;PAF1;LEO1;CPEB3;DHX36
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5994798349001562,1.4611891893157427,0.07169117647058823,0.5111811459339338,1.0,3/15,7.53%,TCF7L2;TPR;GSK3B
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.4711494397088234,1.459588746924158,0.051070840197693576,0.5146071026298324,1.0,9/43,4.78%,BMP6;WNT4;DDR2;IL6ST;BMPR1A;NELL1;BMP2;IL6;BMP7
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5423093335532848,1.4595785798067478,0.059782608695652176,0.5124920850642688,1.0,4/21,3.27%,IGFBP5;BMPR1A;GJA1;ADAMTS1
prerank,positive regulation of glycolytic process (GO:0045821),0.5530539976485135,1.4578192700711994,0.06884057971014493,0.514175692846155,1.0,3/20,4.57%,ZBTB20;PRKAA2;ARNT
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5530539976485135,1.4578192700711994,0.06884057971014493,0.514175692846155,1.0,3/20,4.57%,ZBTB20;PRKAA2;ARNT
prerank,membrane lipid biosynthetic process (GO:0046467),-0.39249539131685285,-1.4576081283787985,0.02452316076294278,0.40391153222931764,1.0,11/58,4.57%,SGMS1;ACER3;ELOVL5;ACER2;CERS4;CERT1;PPM1L;ST8SIA6;DEGS2;ELOVL7;SPNS2
prerank,lipid translocation (GO:0034204),-0.5050999560889033,-1.457328808401821,0.06651376146788991,0.40263195881486186,1.0,7/21,9.45%,ATP8A1;ATP10A;ATP11B;ATP8A2;ATP11A;ATP8B2;ATP8B1
prerank,dermatan sulfate metabolic process (GO:0030205),0.6169635146676016,1.4563321220665035,0.08531746031746032,0.5167679815827776,1.0,3/13,5.07%,UST;DCN;DSE
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.4806939914647518,-1.4562877761461772,0.03926096997690531,0.4034482065452139,1.0,6/26,10.16%,ACER3;NOS3;ACER2;AKT1;GCH1;NOS1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.6329195085945276,-1.4555170573757261,0.06289308176100629,0.40346294392492654,1.0,5/10,17.01%,KCNAB1;ANK3;CAV1;KCNE4;KCNRG
prerank,regulation of exocytosis (GO:0017157),-0.4103153969428791,-1.4552610979589211,0.02077922077922078,0.40218907399118914,1.0,25/46,27.91%,SYT1;RIMS2;RAB27A;NSF;CADPS;IL1RAPL1;SNCA;STXBP5L;RAB3C;RAB27B;CPLX1;STXBP6;CPLANE2;RAB12;CLASP2;EXPH5;SYTL4;RAB15;ATP6AP1;HAP1;RAB3B;RAB8B;CHMP6;UNC13D;VAMP2
prerank,negative regulation of proteolysis (GO:0045861),0.498374203365743,1.4545215721072315,0.04957264957264957,0.5205002271254173,1.0,13/34,13.27%,ECM1;TIMP3;CSTB;PTPN3;SNX12;SERPINE2;TIMP2;LRRK2;EPHA4;DNAJC1;TRIM21;PLAT;EFNA1
prerank,negative regulation of cell motility (GO:2000146),0.4066426238869674,1.4537861587975236,0.02097902097902098,0.5207448557805355,1.0,33/108,13.36%,SULF1;DPYSL3;ROBO1;PODN;AFDN;IGFBP5;DLC1;TACSTD2;KANK1;LDLRAD4;FBLN1;DAG1;DUSP10;MIA3;TPM1;VCL;SERPINE1;EPHA1;BST2;SPINT2;CLIC4;RNF20;NGFR;STK24;EPHA4;IFITM1;RAP2C;FOXO3;PTPRU;EPPK1;SLURP1;NOG;ARPIN
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.6698700663720307,1.453694685889447,0.0914179104477612,0.5189334111819702,1.0,3/10,6.71%,ENPP1;ERRFI1;MVP
prerank,glycerolipid metabolic process (GO:0046486),-0.6021771714650224,-1.4536109194965783,0.0736196319018405,0.40461710772234666,1.0,6/11,20.99%,DGKB;DGKZ;DGKG;PGP;GAL3ST1;PNPLA3
prerank,gonad development (GO:0008406),0.4812949911415692,1.4527368113291164,0.057971014492753624,0.5199668090222788,1.0,7/41,7.87%,WNT4;NR2F2;WNT2B;GATA6;KIT;SALL1;WNT5A
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5898056809456995,-1.4525311497785383,0.059322033898305086,0.4055356096209941,1.0,4/12,7.93%,RIMS1;SYT1;RIMS2;SYT7
prerank,protein deneddylation (GO:0000338),-0.6154079647857222,-1.4522749596283844,0.07847082494969819,0.4042748562177489,1.0,6/10,29.74%,COPS6;COPS5;COPS2;GPS1;COPS4;TOR1A
prerank,cellular response to sterol (GO:0036315),0.6068408096637807,1.451520910132433,0.08502772643253234,0.5218242183640682,1.0,3/13,7.40%,RORA;GRAMD1C;INSIG2
prerank,fat cell differentiation (GO:0045444),0.44702880718727617,1.4514908457930993,0.04281345565749235,0.5197916656270967,1.0,12/57,12.41%,TCF7L2;PID1;IL11;OSBPL8;WNT5B;FAM120B;ALOXE3;MAFB;SMAD6;ERAP1;EGR2;NR4A1
prerank,positive regulation of cellular senescence (GO:2000774),-0.6262156567866125,-1.4509326383182517,0.045548654244306416,0.40595652781038866,1.0,4/10,11.51%,YPEL3;B2M;ABI3;EEF1E1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.4872277035295819,1.4506778631954944,0.04713804713804714,0.5204392946816803,1.0,8/37,7.53%,PHLDB2;PRKAA2;EPHA3;SKA1;MAP6;CLASP1;PHLDB1;GSK3B
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.5331618814145797,-1.4506583445120134,0.06060606060606061,0.4047296967922515,1.0,7/16,17.95%,PPP1R16B;THBS1;GATA2;VEGFA;FGF2;APLNR;DLL4
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.4859367188534157,-1.450578093474991,0.06960556844547564,0.40302479184573153,1.0,9/23,15.53%,MYO10;KIF1B;KIF1C;CCDC88A;TUBA1A;KIF5C;DYNC1I2;TUBA1B;KIF5A
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6046079707700143,1.4504191926536643,0.07380073800738007,0.5151968221400176,1.0,5/12,12.97%,ANAPC11;ESPL1;CUL3;NSMCE2;CDC27
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6046079707700143,1.4504191926536643,0.07380073800738007,0.5151968221400176,1.0,5/12,12.97%,ANAPC11;ESPL1;CUL3;NSMCE2;CDC27
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.6046079707700143,1.4504191926536643,0.07380073800738007,0.5151968221400176,1.0,5/12,12.97%,ANAPC11;ESPL1;CUL3;NSMCE2;CDC27
prerank,brain morphogenesis (GO:0048854),-0.5798773609511081,-1.4503215317151101,0.07852193995381063,0.4017894565474393,1.0,5/12,17.09%,CTNNA2;SHANK3;PAX2;VPS51;BBS2
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.6568606841781897,1.4499335188606504,0.096045197740113,0.5127374926114922,1.0,6/10,19.51%,NFAT5;NFATC4;PPP3CB;ADGRB2;NFATC2;NFATC3
prerank,calcineurin-mediated signaling (GO:0097720),0.6568606841781897,1.4499335188606504,0.096045197740113,0.5127374926114922,1.0,6/10,19.51%,NFAT5;NFATC4;PPP3CB;ADGRB2;NFATC2;NFATC3
prerank,anterior/posterior axis specification (GO:0009948),0.6003793308074743,1.4490532443916895,0.08490566037735849,0.5134126652230847,1.0,3/15,13.46%,WLS;SKI;TASOR
prerank,positive regulation of defense response to virus by host (GO:0002230),0.52873259658205,1.4475181805217505,0.06878306878306878,0.5165379057409349,1.0,5/24,6.82%,IL23R;PARP9;PTPN22;DTX3L;STAT1
prerank,heterochromatin organization (GO:0070828),-0.5602169726470537,-1.4469611782920213,0.06437768240343347,0.4089527200704757,1.0,2/14,3.39%,MECOM;PRDM16
prerank,metal ion transport (GO:0030001),-0.3729487192188784,-1.446587880542915,0.012578616352201259,0.4081416804408881,1.0,23/86,13.72%,CACNA1E;GRIN3A;TRPC3;RYR2;TPT1;TRPC5;TRPC4;RYR3;ATP2C1;SLC8A1;CNNM4;ATP2A3;SLC30A1;CAMK2A;NIPAL3;RAMP2;CACNA1D;NIPAL4;NIPA2;NIPA1;CAV1;SLC3A2;SLC39A8
prerank,myoblast differentiation (GO:0045445),0.6041041990005349,1.4455483118290322,0.09416195856873823,0.5208468263978583,1.0,2/14,4.98%,TCF7L2;EPAS1
prerank,regulation of telomerase activity (GO:0051972),-0.415650652234941,-1.4452091758304777,0.0399002493765586,0.4098538467979345,1.0,14/45,17.36%,PRKCQ;NEK7;CTNNB1;PARM1;MAPK3;HSP90AB1;TERF1;NVL;ATM;KLF4;HSP90AA1;PNKP;MEN1;PKIB
prerank,positive regulation of developmental growth (GO:0048639),-0.420071195463892,-1.4451390133751119,0.03571428571428571,0.40820660647850426,1.0,18/49,15.58%,RIMS1;SYT1;RIMS2;PLCB1;INSR;SEMA4D;MACF1;SEMA7A;SHTN1;SYT4;NEDD4L;L1CAM;ZFYVE27;DBNL;NGF;AGRN;SYT2;MAPT
prerank,negative regulation of ossification (GO:0030279),0.5369651711185134,1.4449489242610232,0.08261617900172118,0.5208776749940094,1.0,7/23,9.72%,RBPJ;ENPP1;ECM1;BCOR;CHSY1;LRP4;SMAD6
prerank,phospholipid transport (GO:0015914),-0.4071713766540009,-1.4446735432229025,0.030848329048843187,0.4075733534781148,1.0,16/52,13.72%,ATP8A1;ATP10A;PITPNC1;ATP11B;PITPNA;ABCA3;ATP8A2;ATP11A;ATP8B2;SCARB1;PRELID2;PRELID1;ATP8B1;SCARB2;MFSD2A;TMEM30A
prerank,regulation of glycolytic process (GO:0006110),0.4339550259989397,1.443762358176591,0.0377643504531722,0.5223203383419379,1.0,10/68,7.46%,ZBTB20;PRKAG2;PRKAA2;NUPR1;ARNT;RANBP2;TPR;PPARA;HDAC4;JMJD8
prerank,regulation of inflammatory response (GO:0050727),0.3803370631255073,1.4431558733338816,0.00796812749003984,0.5223789081428823,1.0,29/190,9.79%,ENPP3;RORA;IL16;CASP12;USP18;ADAMTS12;FPR2;OSM;SNX6;CDH5;TNFAIP8L2;ANXA1;ZBP1;CASP4;IFI35;LACC1;IL6;TLR4;SERPINE1;BIRC3;NR1H3;PTPN2;PPARA;CD47;WNT5A;IL18;SETD4;TLR2;BRD4
prerank,heart process (GO:0003015),-0.5566768110475675,-1.4429398522642845,0.08520179372197309,0.41050119588668943,1.0,4/14,14.60%,SGCZ;SGCD;ACE;SOD1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.48298491739518595,1.4427229064974272,0.05709342560553633,0.5218571788462354,1.0,7/32,9.44%,ZBTB20;PRKAG2;PRKAA2;SORBS1;PPARA;CREBL2;SIRT4
prerank,response to calcium ion (GO:0051592),-0.35560947532534476,-1.4424732525532733,0.019736842105263157,0.40981706536612317,1.0,21/102,8.67%,NLGN1;SYT1;MEF2C;KCNMB2;PLCG2;TRPC3;KCNMA1;THBS1;ITPKB;RYR2;CALM1;HOMER1;CALM2;RYR3;LGMN;KCNH1;CALM3;SYT7;CAMK2D;SYT4;CPNE4
prerank,mesoderm formation (GO:0001707),-0.5194959258967151,-1.4420664939266197,0.08158995815899582,0.4091758917380334,1.0,4/17,10.45%,BMPR2;ITGB4;ITGA8;ITGA3
prerank,triglyceride biosynthetic process (GO:0019432),0.5560757677811132,1.4417455810391095,0.08518518518518518,0.5231982735618017,1.0,6/18,17.60%,AGMO;MOGAT3;DGAT2;LPIN2;LPGAT1;PCK2
prerank,regulation of interleukin-2 production (GO:0032663),-0.4149396064612839,-1.4415275847812619,0.03233830845771144,0.40871467029174746,1.0,11/43,10.60%,PDE4D;PDE4B;NAV3;PLCG2;CD34;RPS3;HDAC7;HAVCR2;MALT1;CD80;CD86
prerank,actin filament polymerization (GO:0030041),0.5034607633661703,1.4414242715676189,0.07599309153713299,0.522249470773614,1.0,3/29,0.82%,GAS7;ARHGAP6;DIAPH1
prerank,neurotransmitter uptake (GO:0001504),0.6146224353622217,1.4411857171778908,0.09961685823754789,0.5210725960988297,1.0,6/12,16.94%,ATP1A2;SLC1A3;GLUL;SLC38A1;SLC22A2;SLC29A1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.4587594698900895,1.4410426821373052,0.060995184590690206,0.5196152922628147,1.0,10/48,11.89%,ROBO1;PARP14;USP18;STAT2;IL6;NR1H3;PTPN2;OTOP1;IRAK3;SH2B3
prerank,ceramide metabolic process (GO:0006672),-0.40918702236448257,-1.4400794784018964,0.045576407506702415,0.4105675779810748,1.0,7/49,3.34%,ST6GALNAC3;SGMS1;ACER3;ACER2;CERS4;PPP2R1A;DEGS2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.4891664259903576,-1.4388513977359014,0.06422018348623854,0.4121087225042049,1.0,11/24,18.38%,TEK;PTPRJ;KDR;PIK3R1;MYOC;IQSEC1;VEGFA;COL16A1;RAC1;PPM1F;ARF6
prerank,cellular protein metabolic process (GO:0044267),-0.3009927155513306,-1.4386851174305952,0.0,0.4107854314337241,1.0,123/396,17.43%,ST8SIA4;CDH2;RPS24;CHRM3;ST3GAL6;CST3;SPARCL1;RPL18A;RPS9;RPL19;RPS12;RPS29;RPL26;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;CPE;RPL38;RPLP1;SCG3;RPS8;GAS6;RPL10A;RPL27A;RPL13;RPS18;ABCA3;RPL27;RPS16;IGFBP7;RPS6;RPL35A;RPL21;GOLM1;RPS3;RPS17;RPL39;RPL37A;RPS7;RPL4;EEF1A1;DAB2IP;RPS15A;MSRA;RPLP0;RPS25;RPL6;RPS21;RPL11;RPL28;RPL8;RPLP2;RPL32;RPS28;RPL30;RPL13A;MSLN;RPS4X;RPS20;RPN2;BMP4;MBTPS1;RPS13;LGMN;RPL18;MSRB2;FBXL2;MSRB3;RPS2;RPL14;RPL22;SPCS2;MMP15;FDXR;SEC11C;SCG2;RPS26;MSRB1;QPCT;MRPS18A;SERP1;SPP1;ZDHHC2;ASMT;RPS10;IGHMBP2;SPCS1;EVA1A;RPL23;RPL17;RPL29;PIGH;GSPT2;MGAT4A;PABPC4;RPS5;RAB12;RPS14;UBA52;SEPHS1;PHEX;ERO1A;COPS5;MRPL28;SRBD1;QSOX1;HBS1L;MEN1;FUCA2;RPL12;RPL9;UBE2D3;PLOD2;MMP1;PSENEN;MATN3;RPL37;RPS11;LMCD1
prerank,cellular response to interferon-gamma (GO:0071346),0.418695302509906,1.438475397227729,0.03278688524590164,0.5258800248446012,1.0,27/88,15.76%,GBP6;SP100;GBP2;DAPK1;TLR4;TRIM5;VCAM1;OASL;GBP5;STAT1;CD47;CCL2;GBP4;LGALS9;WNT5A;TLR2;GBP7;OAS2;JAK1;TRIM21;TRIM26;SLC26A6;CCL25;PML;ICAM1;IRF9;GBP3
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3481618446112824,1.4381556214448576,0.001128668171557562,0.5250552867309166,1.0,106/476,16.13%,TCF4;CREB5;KMT2A;RORA;WNT4;SMAD3;ZMIZ1;NR2F2;SP100;ELF1;CREB3L2;TEAD1;ARNT2;IL31RA;MLLT3;TBL1XR1;GATA6;TRIM56;FOXC1;PHIP;RGMB;WNT3A;PPM1A;ZIC2;GLI3;FOXC2;MYB;PARP9;TGFB1I1;FZD2;PRDM11;ZIC1;BMP2;RFX3;APBB1;IL6;GLI1;BMP7;TGFBR1;SALL1;NIF3L1;NCOA6;NSD3;LBHD1;NR1H3;FOXP3;DTX3L;CREBBP;PPARA;HDAC4;NSD1;CREBL2;STAT1;GLIS2;SFR1;NEK4;RNF20;YAP1;WNT5A;RNF111;WAC;ARHGEF11;QRICH1;CRLF3;ELF4;TEAD2;RLF;KAT6B;NAA16;EPC1;MAFB;BRD4;ATF7IP;UBE2V1;NAA15;ELF2;SMAD4;FOXO3;HIVEP3;ILF3;PPP3CB;EGR2;MAP2K1;FBXW11;DVL3;BTRC;PSRC1;MED12;SERTAD3;KAT6A;KDM8;VHL;MAP3K2;NIBAN2;RARA;SP3;ILK;HDAC2;PML;SMARCA4;SMAD2;SMARCC1;SOX4;COL1A1;DNAJC2;TBL1X
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.6117731130396035,-1.437873270491174,0.07261410788381743,0.4111902944199979,1.0,3/10,6.91%,SHANK3;NETO1;NPTN
prerank,negative regulation of cell population proliferation (GO:0008285),0.35513837570660123,1.4375797567706923,0.0035211267605633804,0.5247978576002921,1.0,84/351,16.11%,ALDH1A2;IGFBP3;PDPN;TGFBR3;PODN;COL4A3;MCC;KANK2;EIF2AK2;IGFBP5;NUPR1;GATA6;TPTE;DLC1;LDOC1;PDS5B;OSM;FBLN1;NELL1;ADAMTS1;TGFB1I1;RBP4;PTHLH;DUSP10;PTPN14;SLC16A2;BMP2;IGFBP6;IFI35;IL6;BTG3;GSDME;COL18A1;MORC3;BTG4;APPL2;FOXP3;PTPN2;CDKN2B;PARP10;CLMN;POU1F1;ZBTB7C;CDC73;PDCD5;WNT5A;SKI;MTSS1;SMAD6;IFITM1;PTPN6;CGRRF1;NUPR2;IFNLR1;CDH13;SH2B3;PTPRU;MAP2K1;EPPK1;SLURP1;VGLL4;NUDT6;NOG;PEX2;ACVR1C;RBM5;FRK;TRIB1;ABI1;WDR6;IFIT3;MDM4;VHL;NIBAN2;PKD2;TNS2;PML;P3H3;NF2;KDM2B;SOX4;KAT2B;AXIN2;APP
prerank,inositol phosphate metabolic process (GO:0043647),-0.4145618361345611,-1.437509193524525,0.03233830845771144,0.4103894117443647,1.0,14/46,15.35%,INPP4B;PLCB1;PLCB4;PLCG2;ITPKB;INPP5D;CALM1;IP6K2;IMPA1;FGF2;PLCH1;PPIP5K1;PPIP5K2;PLCG1
prerank,manganese ion transport (GO:0006828),-0.5597228188184313,-1.4372536470788329,0.07157057654075547,0.4093542723845513,1.0,7/14,13.72%,TRPC3;TRPC5;TRPC4;ATP2C1;TRPC6;SLC39A14;SLC39A8
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.33025446948714493,1.4362354494392362,0.0,0.5270782487129066,1.0,357/1668,16.26%,TCF7L2;TCF4;CREB5;KMT2A;RORA;ZBTB20;SOX5;FHL2;BMP6;TSHZ2;ZKSCAN2;EBF1;FOXD1;SMAD3;ZEB2;RBPJ;ZHX2;MXI1;ATXN1;ZMIZ1;ARID4A;NR2F2;KANK2;SP100;CXCL10;KCNIP3;ELF1;CREB3L2;RGMA;PID1;FGF1;AUTS2;PRDM6;TEAD1;SMURF2;ARNT2;OSR1;TBL1XR1;GATA6;FOXC1;STAT2;NFIA;NFAT5;LBX1;NFYC;PHIP;KDM7A;ZNF697;MAF;SPIB;TCF24;POU5F1;WNT3A;HIF3A;PPM1A;CSRP3;BMPR1A;SSBP2;ZNF395;ZBTB4;OSM;NR6A1;FSTL3;ZIC2;GLI3;FOXC2;IL11;ZIC4;NFATC4;TRAK1;MBD2;WWOX;NCOA3;MYB;CDK8;DCN;PARP9;HIVEP2;PRRX2;TNRC6B;IKZF2;LDB2;TGFA;HIVEP1;NUCKS1;DACT1;ZBTB8A;LITAF;HOXC6;CRY2;HOXC4;ZIC1;STAT5B;BMP2;RFX3;KIT;BRWD1;CRY1;GABPB1;GABPB2;CREB3L3;APBB1;CREB3L4;ARNT;IL6;KMT2C;MIER3;GLI1;ZNF276;ZFP30;PRRX1;GLIS3;TLR4;BCOR;EPAS1;HLF;EN2;SIM2;AEBP1;SALL1;MTDH;UXT;GZF1;TCF12;OTP;ZNF3;NCOA6;KDM3B;MGA;SERPINE1;HAX1;ZNF35;MIER1;KLF5;TPR;VGLL3;SP9;HDGFL3;ARF4;NR1H3;RARB;TSHZ3;MLLT10;ANXA4;WWC2;FOXP3;ATP2B4;CREBBP;BCL9L;PPARA;TCF7L1;ZKSCAN4;HDAC4;NSD1;STAT1;USP9X;ZBTB37;CDKN2B;GLIS2;POGZ;KLF9;PCGF5;POU1F1;ZBTB7C;ZEB1;HOXA2;CDC73;YAP1;DPF2;WNT5A;ZSCAN21;IL18;ZNF25;RNF111;BAX;CREBRF;SKI;PIAS1;MEF2A;ZNF182;RIPK2;BAZ1B;CRLF3;ATF7;CRTC1;CCNH;ELF4;ZFP37;TNRC6A;MOV10;SP8;VPS72;TEAD2;GLYR1;RLF;CUX1;KAT6B;RHOQ;DLG1;SOX21;SAP130;ZNF394;MNAT1;TLR2;GATAD2B;SUFU;CDK7;EPC1;IGF2;SP110;TAF7;MAFB;ZBTB3;SUMO1;CREM;SMAD6;BRD4;BAZ1A;CDK12;PPID;E4F1;TOX4;HDGFL2;ZNF292;TCEA1;EBF4;PBX1;NUPR2;EGR3;RFXANK;HEYL;MSC;MAPK14;MYSM1;PFKM;WWP2;FNIP1;TCF7;CUX2;CIR1;CBX7;CRTC3;ZNF235;ELF2;SMAD4;RBBP8;FOXO3;CDH13;HIVEP3;STAT4;RTF1;IFI27;MAP2K5;RFXAP;ATN1;MAML2;PPP3CB;EGR2;LHX9;RPS6KA3;NR4A1;ZNF219;SRCAP;ACTL6A;TET2;KDM5B;KDM2A;DVL3;SS18;ARRB1;ARID5B;POU2F1;ZKSCAN7;WNT2;MZF1;NOG;HOXA10;BPTF;THAP1;NFIC;CBX4;EFNA1;MED12;NR3C1;PRDM5;BRD8;GMEB1;PEX2;PAF1;NRF1;NFE2L1;MED20;BHLHE41;SENP1;ZNF205;PKNOX1;NCK1;WASL;FRK;ZNF462;ZBTB12;HIC1;BRWD3;FUS;KAT6A;MDM4;DMTF1;GTF2H4;VHL;TLE6;TBK1;SALL2;NCOA2;IFRD1;ZNF18;RFX2;ZNF569;PKD2;PRKD2;ZBTB21;RBM14;RARA;SP3;HDAC2;SMARCA4;THAP3;ZNF260;ZFX;SMAD2;IRF9;ZNF383;SMARCC1;LIN9;MAMSTR;ELK4;KDM2B;HOXB4;ACVR2B;SOX4;PER3;KAT2B;ZBTB5;TEF;DAB2;TXK;WWTR1;CTDSP1;APP;VEZF1;TBL1X;ASXL2;RNF2;PHF20L1;NIPBL;BCL11B;POU6F1;TAF9
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.34217617311420556,1.4355662775280988,0.002244668911335578,0.5271926473476793,1.0,133/572,16.76%,TCF7L2;FHL2;BMP6;SMAD3;ZEB2;RBPJ;ZHX2;MXI1;ATXN1;NR2F2;KANK2;SP100;KCNIP3;PRDM6;SMURF2;OSR1;TBL1XR1;GATA6;FOXC1;POU5F1;PPM1A;ZBTB4;NR6A1;GLI3;FOXC2;NFATC4;MBD2;WWOX;MYB;PARP9;NEDD4;LDB2;HIVEP1;DACT1;CRY2;BMP2;CRY1;APBB1;MIER3;GLIS3;BCOR;AEBP1;SALL1;MTDH;UXT;GZF1;OTP;ZNF3;MIER1;TPR;NR1H3;RARB;WWC2;FOXP3;CREBBP;PPARA;HDAC4;NSD1;STAT1;USP9X;GLIS2;ZEB1;CDC73;YAP1;DPF2;ZNF25;SKI;MEF2A;ZFP37;VPS72;CUX1;DLG1;SAP130;GATAD2B;SUFU;EPC1;IGF2;TAF7;SUMO1;CREM;PPID;E4F1;NUPR2;WWP2;FNIP1;CUX2;CIR1;CBX7;SMAD4;FOXO3;RTF1;IFI27;MAP2K5;ATN1;ZNF219;ARID5B;MZF1;NOG;BPTF;THAP1;NFIC;CBX4;EFNA1;NR3C1;PRDM5;PEX2;PAF1;BHLHE41;ZNF205;FRK;HIC1;MDM4;VHL;TLE6;ZBTB21;RARA;HDAC2;SMARCA4;SMAD2;ELK4;KDM2B;ACVR2B;PER3;ZBTB5;DAB2;TBL1X;RNF2;NIPBL;POU6F1;NRIP1;JDP2;DNMT3A;CHD8
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.5708649576259841,1.4352478788272185,0.09437386569872959,0.5263644425979299,1.0,7/16,17.07%,LEPROT;PARP14;PTPN2;SH2B3;VHL;NF2;PPP2CA
prerank,melanocyte differentiation (GO:0030318),0.6403364235227438,1.4349242837569067,0.09944751381215469,0.5255280119869989,1.0,3/11,4.06%,LRMDA;ENPP1;KIT
prerank,response to ethanol (GO:0045471),-0.5588107356359411,-1.434520483893071,0.07051282051282051,0.414918870658602,1.0,7/14,18.98%,GRIN3A;GRIN2A;GRIN2B;GRIN1;SOD1;GLRA2;GLRA1
prerank,polyamine metabolic process (GO:0006595),-0.5726951817767801,-1.4344409870678552,0.05470459518599562,0.41334179815158345,1.0,6/13,26.42%,HDAC6;OAZ2;SMS;SRM;SAT2;PAOX
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.567452363463682,1.4344286161181004,0.08960573476702509,0.5252273318023439,1.0,3/17,4.78%,TFPI;ATP1A2;BMP7
prerank,ganglion development (GO:0061548),-0.6013650950205548,-1.4343432632667406,0.0865979381443299,0.41185757107823867,1.0,6/11,13.17%,UNC5C;NRP2;CTNNB1;FZD3;TUBB3;SEMA3A
prerank,anion transmembrane transport (GO:0098656),0.42696926045160655,1.4341776000752038,0.046476761619190406,0.5241071017028482,1.0,8/67,3.79%,SLC7A2;SLC1A3;SLC6A13;SLC13A3;SLC13A4;SLC19A1;SLC6A9;SLC16A12
prerank,regulation of cytoskeleton organization (GO:0051493),0.40033828981354525,1.4338127899794735,0.030683403068340307,0.5233725786930259,1.0,24/108,12.64%,PHLDB2;ROCK2;DIAPH1;ARHGAP18;PRKAA2;DLC1;EPHA3;SMIM22;MAP6;CLASP1;PHLDB1;PDGFRB;RHOBTB2;RHOF;BST2;CELSR1;CLIC4;GSK3B;SYDE1;RHOQ;IQGAP2;PTK2;RHOC;TJP1
prerank,muscle filament sliding (GO:0030049),0.47941184655215385,1.4335274190471066,0.051926298157453935,0.5203811391643244,1.0,6/38,9.94%,TNNC1;VIM;DES;TPM1;ACTN2;TPM4
prerank,actin-myosin filament sliding (GO:0033275),0.47941184655215385,1.4335274190471066,0.051926298157453935,0.5203811391643244,1.0,6/38,9.94%,TNNC1;VIM;DES;TPM1;ACTN2;TPM4
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.5931562484839601,-1.4332567327780843,0.06751054852320675,0.4130114765536142,1.0,5/11,14.87%,ITPKB;IP6K2;FGF2;PPIP5K1;PPIP5K2
prerank,high-density lipoprotein particle assembly (GO:0034380),0.6540013959305926,1.4321473509257874,0.061601642710472276,0.5226424106731755,1.0,6/10,24.65%,APOA2;BMP1;ABCA1;ABCA7;APOE;PRKACB
prerank,regulation of response to external stimulus (GO:0032101),0.3943302042091126,1.4319847636117897,0.02459016393442623,0.5213182254940291,1.0,23/121,12.10%,EFNB2;PDGFRA;CASP12;USP18;ADAMTS12;GATA6;CD55;ANXA1;ZBP1;CASP4;GP1BA;LACC1;PTPN22;APPL2;BIRC3;TRIM5;WNT5A;STK24;BRD4;APPL1;ERAP1;NLRP6;FNTB
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6385541072752059,1.430461922501316,0.09497206703910614,0.5241910530817027,1.0,4/10,16.00%,PLA2G4A;PLA2G6;ENPP2;PLA2G5
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.40020434623496337,1.4302670504006805,0.024251069900142655,0.522919114411641,1.0,17/113,7.87%,TCF7L2;BMP6;PTN;LAMC1;FGF1;NOTCH2;OSR1;ECM1;NRP1;VEGFD;TGFA;BMP2;ARNT;TGFBR1;CLDN1;YAP1;WNT5A
prerank,epithelium development (GO:0060429),0.4058504231047442,1.4299901846537706,0.03216374269005848,0.5219142951686039,1.0,17/107,7.96%,ALDH1A2;WNT4;KANK2;OSR1;GATA6;DAG1;DACT1;LOXL3;MTHFD1;BMP2;ERRFI1;SALL1;VCL;ANXA4;STAT1;GSTK1;ANXA7
prerank,myofibril assembly (GO:0030239),0.4699295873922049,1.429892391322188,0.06473594548551959,0.5203711439740722,1.0,8/42,7.48%,PDGFRA;TMOD3;CSRP3;CFLAR;TPM1;CSRP1;PDGFRB;ACTN2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.4114099533671453,-1.429686086486196,0.03926701570680628,0.420853301771982,1.0,8/44,3.61%,KCNMB2;AKAP6;KCNMA1;ATP1B1;KCNJ3;KCNJ2;GABBR2;NOS1AP
prerank,potassium ion transport (GO:0006813),-0.3463183792719267,-1.4295282285197988,0.0033444816053511705,0.4194911242713583,1.0,31/120,14.60%,KCNB2;KCND2;SLC9A2;KCNQ5;KCNAB1;KCNMB2;KCNK5;KCNMA1;SLC24A2;KCNJ3;ABCC9;KCNH7;KCNJ2;KCNC2;KCNQ3;HCN1;KCNK10;SLC9A8;HCN2;TMEM175;KCNH1;KCNH5;KCND3;KCNB1;KCNJ6;KCNJ8;KCNQ1;KCNJ15;KCNC1;SLC9A5;KCNA2
prerank,aminoglycan metabolic process (GO:0006022),-0.6082425551997245,-1.4284807378078708,0.09876543209876543,0.42042067073687456,1.0,3/10,5.35%,XYLT1;B3GAT2;CHST9
prerank,neuropeptide signaling pathway (GO:0007218),-0.3913666293136526,-1.4282635800274541,0.0221606648199446,0.4193436726867364,1.0,17/58,20.29%,CPE;SORCS1;SORCS3;GLRA3;OPRM1;SORL1;RAPGEF2;CYSLTR2;NXPH2;CYSLTR1;PPY;SORT1;GPR37;GLRA2;GLRA1;PENK;GRP
prerank,regulation of steroid biosynthetic process (GO:0050810),0.6316689517289173,1.427965704761457,0.10039370078740158,0.5247315719649472,1.0,2/11,4.04%,WNT4;BMP2
prerank,acylglycerol homeostasis (GO:0055090),0.5500731509861221,1.42789574868756,0.059149722735674676,0.5230871727203068,1.0,3/20,7.90%,RORA;NR1H3;IL18
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.6101515610580728,-1.4276922267387215,0.07926829268292683,0.4189720878628106,1.0,7/10,28.10%,SNCA;AKT1;SLC45A3;PRKCE;PTH1R;IRS1;PMAIP1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5078886052115597,1.4274914469927413,0.08041958041958042,0.5225573578675895,1.0,11/26,23.09%,CBLB;SNX6;TGFA;ERRFI1;SOCS4;ADRA2A;APP;SHC1;HBEGF;FBXW7;ZGPAT
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4644163091346722,-1.4258606091030084,0.0688836104513064,0.421934331790365,1.0,14/26,26.64%,NAV3;PAK1;RPS3;MET;STMN2;FES;RAC1;MAPT;CDK5RAP2;DCTN1;ARL2;OCLN;MAPRE1;CLIP1
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.4872922171677437,-1.4256856469371397,0.07021791767554479,0.42062993916725505,1.0,8/24,25.80%,AGBL4;TTLL7;TTLL5;NAA10;TTLL8;CEP41;VKORC1;TTLL3
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.43709188506107044,-1.4250939586651354,0.03875968992248062,0.42040625599173786,1.0,22/38,35.28%,NDUFV1;NDUFA8;NDUFC1;NDUFB4;NDUFS7;NDUFA1;NDUFA4;NDUFB2;NDUFA12;NDUFA11;NDUFB7;NDUFC2;NDUFB10;NDUFA13;NDUFA9;NDUFA10;NDUFS6;NDUFS1;NDUFV3;NDUFA2;NDUFA6;NDUFS2
prerank,response to hexose (GO:0009746),0.5152071570046597,1.4248306915447173,0.07859531772575251,0.5294560352817717,1.0,2/25,2.13%,TCF7L2;APOA2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.4088553764737237,1.4246470558539908,0.03592814371257485,0.5282303529122214,1.0,22/87,12.71%,TGFBR3;SMAD3;COL3A1;ZMIZ1;BMPR1A;CDH5;TWSG1;LRRC32;PARD6A;TGFBR1;PRKCZ;APPL2;USP9X;TGFBR2;SKI;SMAD6;APPL1;PTK2;TGFBRAP1;SMAD4;COL1A2;MAP3K7
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.42439057457646806,-1.42445417163082,0.04580152671755725,0.4203493188013023,1.0,16/41,18.17%,PLCG2;SLC24A2;RYR2;HTR2C;GRIN2A;RYR3;SLC8A1;GRIN2B;GRIN1;FGF2;ERO1A;PTPRC;CCL19;HTR2B;IBTK;HTR2A
prerank,regulation of neuron projection development (GO:0010975),-0.3318238976263063,-1.422947086602489,0.0,0.42247849385905656,1.0,54/163,15.61%,CTNNA2;LRRC4C;ITGA6;CSMD3;SHANK3;LRRC7;CDH2;PPFIA2;TANC2;PTK2B;TENM3;DCC;RIT2;FUT9;NTRK2;PAK1;SETX;IL1RAPL1;SERPINI1;PRAG1;TOX;DAB2IP;ARHGAP44;SNX3;STMN2;NDNF;RAPGEF2;CCDC88A;NPTN;EFHC2;PAQR3;AKT1;RTN4RL1;MBOAT1;NDRG4;SPOCK1;ABI3;LYN;RET;PTPRO;LZTS3;PAK3;SCARB2;SRCIN1;FES;MFSD2A;SEMA3A;MARK1;RELN;BRSK2;PRKD1;TWF1;CFL1;RAP1A
prerank,nucleotide metabolic process (GO:0009117),0.5325190541754692,1.422261569582257,0.07861060329067641,0.534108063564342,1.0,4/23,9.60%,ENPP3;CMPK2;FHIT;AK5
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5729076324313238,1.4221868340668813,0.0935672514619883,0.5307191798119114,1.0,3/16,1.96%,PHLDB2;ARHGAP6;DLC1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5729076324313238,1.4221868340668813,0.0935672514619883,0.5307191798119114,1.0,3/16,1.96%,PHLDB2;ARHGAP6;DLC1
prerank,negative regulation of coagulation (GO:0050819),0.5922360975193728,1.4218675672386414,0.09701492537313433,0.5298716359123814,1.0,4/14,7.81%,TFPI;VTN;SERPINE1;SERPINE2
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5144716342804487,1.4215295472918468,0.0981067125645439,0.5291789595103429,1.0,3/23,4.57%,ZBTB20;PRKAA2;ARNT
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.419622800190023,1.4208745825004843,0.0445468509984639,0.5295147738218237,1.0,10/75,3.27%,SULF1;WNT4;COL4A3;ROCK2;CXCL10;THBS2;FOXC1;HSPG2;DCN;ADAMTS1
prerank,carbohydrate biosynthetic process (GO:0016051),-0.48792987174237223,-1.4208484981938219,0.08584686774941995,0.4261338049414885,1.0,6/21,13.47%,FUT8;ST3GAL6;FUT9;ST8SIA6;ST6GALNAC5;ST3GAL4
prerank,organic anion transport (GO:0015711),-0.3705534906316025,-1.4206787641482768,0.03215434083601286,0.4249140041257877,1.0,22/76,17.28%,ABCG2;ABCC4;SLC4A10;SLC26A7;SLCO1C1;SLCO2A1;CA4;CA2;LRRC8C;SLC22A6;SLC52A3;SLC25A42;SLC35B1;CYB5R1;CYB5RL;SLC35A2;SLC39A8;SLC4A7;ABCC5;SLCO4A1;SLC25A19;SLC52A2
prerank,regulation of neuron migration (GO:2001222),-0.4623213726983683,-1.4202978868496852,0.07575757575757576,0.4243239286937662,1.0,15/26,23.40%,CTNNA2;SEMA6A;ADGRG1;DAB2IP;ARHGEF2;NEXMIF;RAPGEF2;SHTN1;CAMK2A;SEMA3A;NTNG2;NTNG1;SRGAP2;PLAA;NSMF
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.47017292554704326,1.4202872361377645,0.05737704918032787,0.5294434729342599,1.0,9/39,7.75%,ROBO1;TSPAN5;RBPJ;ZMIZ1;IL6ST;BMP2K;AAK1;CREBBP;YAP1
prerank,positive regulation of wound healing (GO:0090303),0.4806169122237039,1.4197924877960375,0.07758620689655173,0.5291364582327284,1.0,9/36,10.94%,VTN;PLPP3;KANK1;FOXC2;ANXA1;SERPINE1;CLDN1;INSL3;PTK2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.49277021401654275,-1.4194514468214878,0.06976744186046512,0.4247537787190476,1.0,16/22,28.10%,RPS15;RPS7;RPS20;UBB;SPRED2;ATM;RPL23;EEF1E1;EIF5A;SPRED3;RPL37;MSX1;SPRED1;ATR;CHD5;PMAIP1
prerank,cellular defense response (GO:0006968),0.47113472885241064,1.4180026612453311,0.06351791530944625,0.5328954580616018,1.0,6/40,9.19%,DCDC2;CCR9;PRF1;ADORA2A;LY96;LSP1
prerank,engulfment of apoptotic cell (GO:0043652),-0.5514029476493364,-1.4176055313266767,0.0851063829787234,0.4278091153393727,1.0,8/15,16.32%,THBS1;XKR4;XKR6;RHOG;MEGF10;RHOH;RAC1;RHOBTB1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.5214435325928622,-1.416919286781816,0.07264957264957266,0.4280777840926693,1.0,6/18,15.48%,PLCB1;CHRM3;CHRM2;OPRM1;AGRN;GNAQ
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.5104467985371688,-1.4155907895571713,0.07205240174672489,0.4299615639744501,1.0,12/17,25.86%,ATP5F1A;ATP5MC1;ATP5PO;ATP5F1B;ATP5PD;ATP5F1D;VPS9D1;ATP5MG;ATP5ME;ATP5F1E;ATP5MC3;ATP5MF
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5618904401157014,1.4153661568071854,0.1063063063063063,0.5397185313075402,1.0,2/16,0.16%,RANBP3L;IGFBP3
prerank,cation transport (GO:0006812),-0.32899625375554015,-1.4153019181940767,0.007633587786259542,0.4289757793850661,1.0,36/167,12.33%,SLC6A6;SLC47A1;SLC12A2;KCNB2;PIEZO2;KCNAB1;KCNMB2;KCNK5;SLC9B2;KCNMA1;ATP1B1;ANO1;KCNJ3;ABCC9;KCNJ2;SCN1A;SLC7A1;SLC5A5;SLC38A5;SLC1A1;SLC8A1;SLC5A6;SCN2A;KCNH1;TRPC6;TMEM63C;KCND3;NEDD4L;GRIN1;SCN8A;KCNJ6;SLC36A1;KCNJ8;SCN9A;FGF13;KCNJ15
prerank,regulation of interleukin-4 production (GO:0032673),-0.5019123971763487,-1.4145987802728168,0.08390022675736962,0.4291391925520381,1.0,8/21,12.31%,LEF1;SLC7A5;PRKCQ;ZFPM1;HAVCR2;FCER1G;CD86;SYK
prerank,presynapse assembly (GO:0099054),-0.5352916014060065,-1.4145547362981505,0.0651685393258427,0.42757363121033143,1.0,7/16,10.52%,NLGN1;PTPRD;LRRTM3;PCLO;IL1RAPL1;NLGN3;DVL1
prerank,carnitine shuttle (GO:0006853),0.626246446902843,1.4143960588374813,0.09746588693957114,0.5411179883798747,1.0,2/11,1.71%,PRKAG2;PRKAA2
prerank,positive regulation of immune system process (GO:0002684),0.5691461521308718,1.4142726882571974,0.09107806691449814,0.5397373059049628,1.0,5/16,10.97%,RSAD2;ANXA1;MIA3;LGALS9;HCAR2
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6276862102145245,1.4138659289162983,0.11363636363636363,0.5392013527904196,1.0,4/10,8.19%,RC3H1;FOXP3;LGALS9;CD274
prerank,gliogenesis (GO:0042063),-0.5358946249153097,-1.411989838584634,0.0851063829787234,0.4326743490706768,1.0,6/15,13.61%,CDH2;TGFB2;CDK6;PAX2;NFIB;RELN
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.5515730293211972,-1.411748030616956,0.1044776119402985,0.4316411616353461,1.0,5/14,10.24%,NOS3;ECE1;ACE;ENPEP;ACE2
prerank,camera-type eye development (GO:0043010),0.5102145968018184,1.410102751931682,0.1001788908765653,0.5497020044120109,1.0,5/25,8.40%,EFEMP1;FBN1;SHROOM2;SKI;CACNA1C
prerank,amino acid transport (GO:0006865),0.4543153068960805,1.4079512026435892,0.06329113924050633,0.5548068230231075,1.0,5/49,4.45%,SLC7A11;PDPN;SLC7A2;SLC6A12;SLC7A14
prerank,response to glucose (GO:0009749),0.45694435343001955,1.407765462472483,0.054313099041533544,0.5535464094798399,1.0,4/46,2.13%,TCF7L2;ZBTB20;PRKAA2;APOA2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4477829533377667,1.4070552175112903,0.06426332288401254,0.5542748290688635,1.0,7/47,3.46%,PDPN;DOCK5;TACSTD2;KANK1;FBLN1;NRP1;S100A10
prerank,cardiac muscle tissue development (GO:0048738),0.4451851989559186,1.4068432616586275,0.06739811912225706,0.553135415221517,1.0,10/50,4.78%,AKAP13;NOTCH2;GATA6;GJB6;CSRP3;BMPR1A;GJA1;RBP4;BMP2;BMP7
prerank,basement membrane organization (GO:0071711),0.5771790244577273,1.406222087812815,0.08076923076923077,0.5531707702549941,1.0,3/14,2.55%,FLRT2;NID1;NID2
prerank,eye development (GO:0001654),0.4376874035207599,1.4061219135427077,0.07087827426810478,0.5517426898568659,1.0,11/54,10.38%,EFEMP1;FBN1;COL5A2;FOXC1;SHROOM2;RBP4;COL5A1;SKI;CACNA1C;MAB21L1;PBX1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.482215391175204,-1.4061132743470235,0.08067940552016985,0.4448806702315771,1.0,10/20,30.08%,GATM;OPLAH;GCLC;PTDSS1;PLOD2;GGT1;MTHFS;HAGH;MGST2;GCLM
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5727473291156912,1.4056619444243807,0.12149532710280374,0.5514616766620029,1.0,3/15,8.31%,ROCK2;IL6ST;MEF2A
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.5183550671887888,-1.405522851983133,0.0824295010845987,0.44459709130910996,1.0,8/18,17.43%,NLGN1;RIMS1;RIMS2;RAB3GAP1;SYN1;RAP1A;SNAPIN;RIMS4
prerank,regulation of lipid storage (GO:0010883),0.5287780978323832,1.4053874700216755,0.09090909090909091,0.5505401486719506,1.0,5/22,7.38%,IKBKE;IL6;CRP;PTPN2;FTO
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.5627557631876232,-1.4053150121161668,0.10061601642710473,0.4434109192941312,1.0,6/12,12.96%,CSGALNACT1;FUT8;PARG;GFPT2;GFPT1;GFUS
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.6056151621465962,-1.404922096375213,0.10105263157894737,0.4410893676086204,1.0,6/10,26.28%,VLDLR;AP2B1;AP2A2;AP2A1;CLTA;AP2M1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.6056151621465962,-1.404922096375213,0.10105263157894737,0.4410893676086204,1.0,6/10,26.28%,VLDLR;AP2B1;AP2A2;AP2A1;CLTA;AP2M1
prerank,T-helper cell differentiation (GO:0042093),-0.5432925035856667,-1.4048933008628353,0.08869179600886919,0.43947891345842205,1.0,3/14,8.95%,LEF1;HMGB1;ZFPM1
prerank,protein ubiquitination (GO:0016567),0.33806679038439036,1.404870916681543,0.0022522522522522522,0.5504615371420075,1.0,105/471,16.07%,RNF220;PDZRN3;SASH1;RNF152;RNF213;SPSB1;SMURF2;TRIM10;HIF3A;HERC6;RNF217;FBXO11;SH3RF1;FBXL17;TRIP12;NEDD4;NHLRC3;DTX4;RC3H1;MYCBP2;BCL2;EPAS1;TRIM17;KLHL22;RNF19A;KLHL21;SIAH2;UBE2U;SPSB4;DZIP3;PELI2;CUL4A;DTX1;ANAPC11;DTX3L;TRIM5;NPEPPS;FBXO9;MGRN1;USP9X;FBH1;CDC73;RNF20;KLHL18;RNF111;FBXL3;WAC;TRIM24;PSMB10;NUB1;UBE2Z;PJA2;PSMA7;AMFR;UBE2C;PSMA3;FBXL20;PSME4;LONRF1;FBXL7;PSMA5;FBXO4;KEAP1;FBXO24;BLMH;WWP2;UBE2V1;KLHL13;HUWE1;RFWD3;RTF1;TRIM21;CUL3;FBXW11;ASB5;TRIM7;TRIM26;BTRC;HECW2;ARRB1;CDC27;UBE2Q2;BRAP;UBE2E3;PEX2;PAF1;RNF103-CHMP3;RNF181;RNF39;RNF43;BFAR;PRPF19;LNPEP;FBXL4;VHL;UBE2R2;DDA1;BIRC6;LEO1;FBXL12;RCHY1;FBXL13;MUL1;RNF146;TNKS2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3817151405806249,1.404726194057821,0.027434842249657063,0.5491723555141796,1.0,31/140,10.58%,ARHGAP29;CGNL1;ARHGAP6;RASGRF1;AKAP13;TIAM2;ARHGAP21;ARHGAP10;ARHGAP20;ARHGAP18;DLC1;ARHGAP32;ARHGAP28;FGD4;TRIP10;ARHGAP12;MYO9A;PLCE1;RHOF;FAM13B;TAGAP;RALBP1;PLEKHG2;ARHGEF11;SYDE1;ARHGAP26;RHOQ;ARHGEF12;GMIP;SOS2;NGEF
prerank,chemokine-mediated signaling pathway (GO:0070098),0.4605791487418954,1.404622936934989,0.07537688442211055,0.5477734296208129,1.0,10/42,15.18%,CXCL10;STK39;OXSR1;FOXC1;CCL2;ACKR3;SH2B3;WNK1;RBM15;CCL25
prerank,central nervous system development (GO:0007417),-0.3128247463030791,-1.4035198457469238,0.0,0.4412612381681093,1.0,49/250,10.13%,ADGRL3;ADGRL2;CNTNAP2;ROBO2;SLC2A1;CDH2;MEIS2;CNTN4;WWP1;COL4A1;ZFHX3;MOG;CNTN6;NCKAP1;PBX3;SHROOM4;VIT;SERPINI1;GRIK1;GRIN2A;SNTG2;S100B;ADGRG1;SH3GL2;MAL;AHI1;ADAM22;GRIN2B;NRCAM;RAB3GAP1;DCLK1;MBP;ZBTB16;EIF2B2;SCYL2;APOD;ALDH5A1;ZIC3;SOX6;LSR;DNER;ADAM23;NDRG4;SPOCK1;BAG6;GRIN1;DHX30;DDIT4;SEMA6B
prerank,regulation of lipid metabolic process (GO:0019216),0.406581009025163,1.4033541073981632,0.044182621502209134,0.5498512700418362,1.0,11/88,6.57%,RORA;CHD9;PRKAG2;C1QTNF2;TBL1XR1;NFYC;NCOA6;PANK2;CREBBP;PPARA;LACTB
prerank,sphingolipid metabolic process (GO:0006665),-0.3432656945311536,-1.4030665925116792,0.026143790849673203,0.44081085323944064,1.0,27/108,17.67%,ST6GALNAC3;SGMS1;ACER3;SERINC1;ELOVL5;ACER2;CERS4;CERT1;PPM1L;PPP2R1A;DEGS2;ELOVL7;SPNS2;HEXB;TECR;GLTP;NEU1;SGMS2;CERK;GM2A;GAL3ST1;PLPP1;PRKD1;HACD3;SGPP1;ORMDL3;SPTSSA
prerank,positive regulation of tissue remodeling (GO:0034105),0.6294648212848063,1.402507798019654,0.10766423357664233,0.550898337413788,1.0,2/10,7.90%,ROCK2;IL18
prerank,negative regulation by host of viral transcription (GO:0043922),-0.5744712403367775,-1.4021300473097336,0.09282700421940929,0.4416244641250497,1.0,4/12,9.94%,PSMC3;INPP5K;TFAP4;HDAC1
prerank,negative regulation of cell junction assembly (GO:1901889),0.5124464790299812,1.4016355042954605,0.08378870673952642,0.5520279692743066,1.0,4/25,1.96%,PHLDB2;ARHGAP6;ROCK2;DLC1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5929460045407695,-1.400282610204027,0.09343936381709742,0.44478145732010965,1.0,4/10,9.05%,PTPRJ;SNCA;APOD;NDRG4
prerank,negative regulation of neuron projection development (GO:0010977),0.4350256193694673,1.400034620908104,0.06466165413533835,0.5551546984530428,1.0,11/56,10.58%,EFNB2;DPYSL3;LPAR1;WNT3A;KANK1;CBFA2T2;LRP4;PTPN9;NGFR;EPHA4;NGEF
prerank,regulation of lamellipodium organization (GO:1902743),0.5652141561976957,1.4000288366755478,0.13035714285714287,0.5534412244486915,1.0,4/14,12.25%,PDPN;FER;CAPZB;EPHA2
prerank,T cell activation (GO:0042110),0.4202417208538271,1.3999969493350828,0.05015197568389058,0.5518145613311116,1.0,9/69,6.40%,LEPR;DPP4;CXADR;CTPS1;NHEJ1;KIT;PTPN22;FOXP3;PTPN2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.48366675135088555,1.3994614991104233,0.0711864406779661,0.5517979440318893,1.0,17/33,24.06%,GLI1;PLK5;APPL2;ATP2B4;CDC73;PHB2;PTPN6;SUSD2;APPL1;CRNN;PAF1;INO80;PTEN;FBXW7;PKD1;PSME3;TAF1
prerank,cardiac muscle cell action potential (GO:0086001),-0.4428500895136117,-1.3991866661905157,0.07281553398058252,0.44599766452534667,1.0,12/30,11.84%,DMD;ATP1B1;FGF12;KCNJ2;SCN1A;ATP1A1;SLC8A1;CACNA1G;HCN2;KCND3;CACNA1D;KCNQ1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.41010921123095967,1.3980751758270056,0.0366412213740458,0.5543146473527045,1.0,20/86,10.98%,TEC;BMP6;EPHA7;VTN;GHR;OSM;IL11;NRP1;IL23R;ITGA5;ANGPT1;IL6;PRKCZ;HAX1;TNFRSF14;RIPK2;IGF2;RAP2C;PTPN6;ENPP2
prerank,peptidyl-tyrosine modification (GO:0018212),0.43613994818840557,1.397863617890003,0.05564387917329094,0.5532555155862227,1.0,15/56,10.94%,EFEMP1;TEC;PDGFRA;FGFR1;DDR2;EPHA3;FER;KIT;TPST1;EPHA1;PDGFRB;TTL;EPHA4;PTPN6;PTK2
prerank,embryonic appendage morphogenesis (GO:0035113),-0.5653577701229172,-1.3975992573800138,0.10526315789473684,0.44870069004165497,1.0,4/12,9.55%,TGFB2;MBNL1;FBXW4;LRP6
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.5966590994793657,1.3973006249340292,0.10881801125703565,0.5533398951576018,1.0,3/12,7.90%,IL23R;IL17D;IL18
prerank,defense response to symbiont (GO:0140546),0.40428454860733587,1.3971379306250067,0.05420827389443652,0.5521013335205149,1.0,25/92,15.80%,RSAD2;EIF2AK2;TRIM56;STAT2;PRF1;IFIT2;ZBP1;IL6;BCL2;TRIM5;OASL;BST2;STAT1;ZMYND11;MOV10;TLR2;IFITM1;IFNLR1;BCL2L1;OAS2;IFI27;IFIT1;IFIT3;IFIH1;IFNAR2
prerank,negative regulation of protein polymerization (GO:0032272),-0.44698921805184727,-1.396821524077931,0.0821256038647343,0.4491252843604788,1.0,13/27,17.89%,SLIT2;SSH2;KANK3;KANK4;SNCA;HIP1R;STMN2;CYRIB;TUBB4A;MAP2;TWF1;SSH3;STMN1
prerank,development of primary male sexual characteristics (GO:0046546),0.4769459066540152,1.396679643090844,0.07973421926910298,0.5518957534101654,1.0,6/34,7.87%,WNT4;WNT2B;GATA6;LHFPL2;KIT;WNT5A
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.3627920413156542,-1.39611603877261,0.041176470588235294,0.4492231302690821,1.0,25/72,17.89%,SLIT2;SHANK3;SSH2;NAV3;KANK3;HSPA8;KANK4;SNCA;HIP1R;ARHGEF2;STMN2;CYRIB;EMILIN1;PFDN5;TUBB4A;FGF13;PFDN2;CLASP2;MAP2;TWF1;SSH3;SHANK1;MID1IP1;PFDN4;STMN1
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.40260426208261574,-1.3960715136037765,0.05958549222797927,0.4476967514513783,1.0,18/43,25.96%,MEF2C;RYR2;NOTCH1;SOX17;AHI1;ZIC3;TBX2;NDRG4;SOX18;ACVR1;APLNR;VANGL2;HES1;DLL1;SRF;TBX6;BBS7;STIL
prerank,response to prostaglandin E (GO:0034695),0.6262335338824592,1.3957639983537784,0.09919028340080972,0.5530206888619102,1.0,1/10,0.38%,TGFBR3
prerank,granulocyte differentiation (GO:0030851),-0.5069176800440504,-1.3957342134196529,0.06756756756756757,0.44684293974171735,1.0,7/18,17.00%,LEF1;CBFA2T3;TAL1;CDK2;CDK4;CDKN1A;RXRA
prerank,T cell differentiation (GO:0030217),0.45928981384724354,1.3949777506708554,0.07131011608623548,0.5537435963651606,1.0,7/40,6.40%,LEPR;GLI3;NHEJ1;ANXA1;KIT;PTPN22;PTPN2
prerank,regulation of ion transport (GO:0043269),-0.3584879588493913,-1.3947701608613867,0.024657534246575342,0.44778776144227295,1.0,23/76,14.78%,NKAIN2;SYT1;KCNJ3;KCNJ2;ANK3;ATP1A1;SNCA;NKAIN3;CA2;YWHAH;NKAIN1;SYT7;SIK1;SYT4;B2M;NEDD4L;NOS1;KCNJ6;KCNJ8;KCNJ15;SYT9;KCNA2;SYT2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.4951932087423711,1.394609576330812,0.07508532423208192,0.5532297870708994,1.0,4/29,4.86%,TNNC1;TGFBR3;BMP2;TPM1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.5935869381236114,-1.3942728192731075,0.09959349593495935,0.4474088103083525,1.0,2/10,6.62%,SLIT2;EMILIN1
prerank,regulation of stem cell differentiation (GO:2000736),0.4032622512088863,1.39411219257563,0.04380664652567976,0.553188672227546,1.0,16/89,10.43%,KMT2A;PTN;PDGFRA;EIF2AK2;TACSTD2;BMPR1A;OSM;MYB;TCF12;SLC4A11;YAP1;PSMB10;PSMA7;PSMA3;PSME4;PSMA5
prerank,negative regulation of cell communication (GO:0010648),0.5397586637347523,1.3940873683021793,0.10746812386156648,0.5516019427761877,1.0,4/21,2.76%,IGFBP3;MPIG6B;OSM;IL11
prerank,negative regulation of phosphorylation (GO:0042326),0.40673245911214984,1.391832763127031,0.04398826979472141,0.557449020428457,1.0,13/85,8.73%,PTPN13;IGFBP3;PID1;PLPP3;NUPR1;DYNLL1;FBLN1;BMP7;PPARA;HDAC4;CDKN2B;MYADM;LRRK2
prerank,cell proliferation in forebrain (GO:0021846),0.647351830526012,1.391331162291633,0.0958904109589041,0.5572551527875412,1.0,3/10,9.50%,WNT3A;NUMB;DOCK7
prerank,positive regulation of biosynthetic process (GO:0009891),0.4588965770115972,1.3904797421246606,0.07588532883642496,0.5582121861567944,1.0,8/40,9.44%,ZBTB20;WNT4;VIM;TLR4;SORBS1;PPARA;CREBL2;SIRT4
prerank,myeloid cell development (GO:0061515),0.5560580798090027,1.390312378615671,0.12267657992565056,0.5571414579085813,1.0,8/18,19.05%,MPIG6B;ANXA2;KIT;TLR2;SH2B3;ALAS2;APP;DMTN
prerank,zinc ion transmembrane transport (GO:0071577),-0.475044522286047,-1.3900703707909539,0.08258928571428571,0.45712965132106786,1.0,7/22,13.72%,SLC39A10;SLC39A6;SLC30A1;SLC39A12;SLC39A14;SLC39A13;SLC39A8
prerank,positive regulation of histone methylation (GO:0031062),0.5218613832670098,1.3896801316714296,0.09814814814814815,0.5574056563281197,1.0,6/24,13.54%,KMT2A;AUTS2;MYB;JARID2;SMAD4;PAF1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5137927798989413,-1.389131567122758,0.08993576017130621,0.45801965461945937,1.0,7/17,21.64%,CALM1;CALM2;HSP90AB1;CALM3;PTPRC;PPP1R15B;PPP1R15A
prerank,positive regulation of cell growth (GO:0030307),-0.3502440277532042,-1.3881931288225273,0.02857142857142857,0.45897005964399795,1.0,28/96,15.58%,RIMS1;SYT1;RIMS2;AKAP6;TGFB2;SEMA4D;H3-3A;MACF1;SEMA7A;AKT1;SHTN1;DDX49;SDCBP;SYT4;NEDD4L;L1CAM;ZFYVE27;EXOSC2;DBNL;RPS6KA1;NGF;CEP43;MFSD2A;EGFR;LGI1;SYT2;TAF9B;MAPT
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.412809164870617,1.3880987557803626,0.06033182503770739,0.5606559654178686,1.0,15/76,10.43%,UACA;SASH1;EIF2AK2;NFAT5;PPM1A;IFI35;BMP7;TLR4;PTPN22;CPNE1;LGALS9;PHB2;DLG1;TLR2;PPM1B
prerank,base conversion or substitution editing (GO:0016553),-0.5812438606979283,-1.387704245986665,0.12331838565022421,0.4586858938825004,1.0,3/11,8.28%,ADARB1;ADARB2;APOBEC1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.5969879983311965,1.38757165902322,0.12595419847328243,0.5607640529299193,1.0,4/11,11.74%,IL6ST;STAT1;STAT4;JAK1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.49033478094316785,1.3871166912759658,0.09392265193370165,0.5605581059525696,1.0,6/26,9.46%,FBN1;FSTL3;TLR4;PTPN2;CARTPT;MAFB
prerank,regulation of lipid kinase activity (GO:0043550),-0.5715582987350549,-1.387060435694644,0.10559006211180125,0.45871697084262847,1.0,4/11,7.40%,PIK3R1;PIK3R3;WDR81;RBL1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.5505802173753932,-1.3865438650521824,0.10940919037199125,0.4584797892257388,1.0,6/13,16.15%,PDE8A;MET;RACK1;NR4A3;PARK7;GPR37
prerank,focal adhesion assembly (GO:0048041),-0.48680984997028126,-1.3853226254676871,0.07621247113163972,0.460077310811664,1.0,9/21,11.94%,ACTN1;PTPRK;THSD1;PEAK1;RCC2;TESK2;TRIP6;BCR;ARHGEF7
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5820230226407954,1.3852572425069254,0.11195445920303605,0.5647854173050724,1.0,7/12,16.07%,PARP3;PARP10;PARP12;PARP11;TIPARP;PARP16;TNKS2
prerank,regulation of innate immune response (GO:0045088),0.4330545254358274,1.3850434573914419,0.05521472392638037,0.5637885722698761,1.0,15/57,12.20%,USP18;FPR2;PARP9;IFI35;PTPN22;APPL2;BIRC3;GBP5;PTPN6;APPL1;ERAP1;IRAK3;POLR3F;TRIM21;PTPN1
prerank,Golgi localization (GO:0051645),0.5951405600189218,1.384534308407093,0.1275797373358349,0.5638321149995643,1.0,3/11,11.14%,ARHGAP21;UVRAG;ARCN1
prerank,lipid oxidation (GO:0034440),-0.5495519024083021,-1.3838293484676103,0.09978768577494693,0.4624400971090313,1.0,1/12,0.46%,ADIPOR2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5487923483881343,1.3834320078071403,0.11397058823529412,0.5656685705893096,1.0,6/18,10.06%,PDPK1;COL4A3;FGFR1;CCL2;IGF2;AKT3
prerank,cellular response to nitrogen compound (GO:1901699),0.5231905437745523,1.3830452333612933,0.10344827586206896,0.5652218750151415,1.0,3/20,7.33%,ROCK2;ATP2B4;SPIDR
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.455819199049571,1.3799874871861435,0.0848,0.5731634240214338,1.0,9/41,12.64%,AFDN;PLPP3;FSTL3;BMP7;CD47;ADAM19;JAK1;PTPRU;TJP1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4086498883412314,1.3799386666109124,0.06146926536731634,0.5716694203109535,1.0,10/72,4.34%,ROBO1;LPAR1;AKAP13;COL3A1;KANK2;DLC1;HEG1;KANK1;NRP1;F2RL3
prerank,regulation of actin filament depolymerization (GO:0030834),0.600166579377834,1.3798486642212737,0.12641509433962264,0.5703385044454152,1.0,3/12,10.63%,PLEKHH2;LIMA1;PLEK
prerank,peptidyl-lysine monomethylation (GO:0018026),0.6204982993966505,1.3796576116178998,0.11637080867850098,0.5692196938060502,1.0,6/10,27.79%,SETD4;SETD7;SETD2;SETD6;SMYD2;EHMT1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.38295186900766676,1.37930329778017,0.03207810320781032,0.5686854414852539,1.0,23/121,9.42%,TEC;BMP6;PARP14;VTN;GHR;IL31RA;IL6ST;OSM;IL11;NRP1;IL34;IL23R;ITGA5;PARP9;ANGPT1;KIT;IL6;HAX1;IL18;TNFRSF14;RIPK2;EPHA4;IGF2
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5747412897494029,1.379091039329653,0.12043795620437957,0.5677448220600962,1.0,3/15,6.74%,EIF2AK2;TLR4;GBP5
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.4436858923319555,1.3782794727561731,0.08346709470304976,0.5687785807875001,1.0,6/46,7.53%,TCF7L2;SMAD3;NEDD4;ZIC1;TPR;GSK3B
prerank,defense response to Gram-positive bacterium (GO:0050830),0.4558471021859894,1.3782062252886247,0.07601351351351351,0.567413780485145,1.0,9/40,12.86%,GBP6;GBP2;IL6;CRP;GBP4;TNFRSF14;TLR2;GBP7;RARRES2
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.4329351002372015,-1.3778188851173057,0.07882882882882883,0.4773017878601132,1.0,8/32,8.54%,RIMS1;RIMS2;MEF2C;MCTP1;CPLX1;SLC30A1;CAMK2A;SYN1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.5561968556493264,-1.3768753896819808,0.11752136752136752,0.4782408376547921,1.0,5/12,15.71%,INSR;SETX;SMCR8;ADRB2;IRGM
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.5583398668054476,-1.3768125947238041,0.12448132780082988,0.47672379170301193,1.0,5/11,26.73%,AKAP6;NOS1AP;LRRC38;LRRC55;TREM2
prerank,polyol metabolic process (GO:0019751),-0.39741476011383686,-1.3762050685386655,0.05037783375314862,0.47679551540138193,1.0,13/46,15.35%,INPP4B;PLCB1;PLCB4;PLCG2;ITPKB;INPP5D;CALM1;IP6K2;IMPA1;PLCH1;PPIP5K1;PPIP5K2;PLCG1
prerank,skeletal muscle contraction (GO:0003009),0.5384230509763773,1.3761957025944749,0.1268939393939394,0.5720353559456688,1.0,1/19,0.28%,TNNC1
prerank,lipid homeostasis (GO:0055088),0.4256757244936963,1.3755961343659353,0.07119741100323625,0.5723102932474337,1.0,21/57,24.93%,ZBTB20;RBP1;PRKAA2;ACOXL;NR1H3;ABCA1;DGAT2;ACOX1;ABHD5;RCN3;ANGPTL3;XBP1;NR1D2;FBXW7;CEBPA;PRKAA1;ABHD8;TM6SF2;THADA;APOE;IRS2
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3170465693658609,1.3755716673564793,0.0,0.570785059884306,1.0,342/1646,16.25%,TCF7L2;TCF4;CREB5;KMT2A;EFEMP1;RORA;ZBTB20;SOX5;TSHZ2;WNT4;ZKSCAN2;EBF1;FOXD1;SMAD3;PRICKLE1;ZEB2;RBPJ;ZHX2;MXI1;ATXN1;ZMIZ1;ARID4A;NR2F2;SP100;ELF1;CREB3L2;TLE1;TEAD1;SMURF2;ARNT2;OSR1;IL31RA;MLLT3;TBL1XR1;GATA6;TRIM56;FOXC1;STAT2;NFIA;NFAT5;LBX1;NFYC;PHIP;KDM7A;ZNF697;RGMB;MAF;SPIB;TCF24;POU5F1;WNT3A;HIF3A;SAMD13;PPM1A;SSBP2;ZNF395;ZBTB4;DENND4A;NR6A1;FSTL3;SNX6;ZIC2;GLI3;FOXC2;RBFOX2;ZIC4;NFATC4;TRAK1;ZMYND15;MBD2;MYB;PARP9;HIVEP2;PRRX2;TGFB1I1;FZD2;TCEAL7;IKZF2;TGFA;HIVEP1;NUCKS1;ZBTB8A;LITAF;HOXC6;EID2B;CRY2;PRDM11;HOXC4;ZIC1;PERM1;STAT5B;LOXL3;BMP2;RFX3;KIT;BRWD1;CRY1;CREB3L3;APBB1;CREB3L4;ARNT;IL6;GLI1;BMP7;ZNF276;ZFP30;PRRX1;GLIS3;BCOR;EPAS1;HLF;EN2;SIM2;TGFBR1;SALL1;NIF3L1;MTDH;UXT;GZF1;CBFA2T2;TCF12;ZNF3;NCOA6;NSD3;KDM3B;MGA;LBHD1;BAZ2A;ZNF35;KLF5;VGLL3;SP9;HDGFL3;NR1H3;TSHZ3;ANXA4;WWC2;FOXP3;DTX3L;DKK3;ATP2B4;TESMIN;CREBBP;PPARA;TCF7L1;ZKSCAN4;HDAC4;NSD1;CREBL2;STAT1;PBXIP1;ZBTB37;GLIS2;KLF9;PCGF5;POU1F1;SFR1;ZBTB7C;ZEB1;HOXA2;NEK4;RNF20;YAP1;DPF2;WNT5A;ZSCAN21;ZNF25;RNF111;WAC;ARHGEF11;CREBRF;NFXL1;QRICH1;ZMYND11;PIAS1;MEF2A;ZNF182;BAZ1B;CRLF3;ATF7;PHB2;CCNH;ELF4;ZFP37;SP8;TEAD2;RLF;CUX1;KAT6B;SOX21;SCMH1;NAA16;ZNF394;USP47;MNAT1;SUFU;EPC1;IGF2;SP110;TAF7;MAFB;ZBTB3;SUMO1;CREM;SMAD6;BRD4;BAZ1A;JARID2;E4F1;TOX4;CDK16;HDGFL2;ZNF292;EBF4;PBX1;NUPR2;EGR3;RFXANK;HEYL;MSC;MAPK14;ATF7IP;PSPC1;GMNN;WWP2;TCF7;CUX2;UBE2V1;CIR1;TGFBRAP1;POLR3F;RRP8;NAA15;ZNF235;ELF2;SMAD4;RBBP8;BCL7A;FOXO3;HIVEP3;STAT4;ILF3;RFXAP;ZNHIT3;SCML4;PPP3CB;EGR2;LHX9;MAP2K1;RPS6KA3;NR4A1;ZNF219;SRCAP;FBXW11;VGLL4;ACTL6A;KDM5B;KDM2A;DVL3;ZFAT;BTRC;ERN2;ARRB1;ARID5B;POU2F1;OGG1;ZKSCAN7;MZF1;HOXA10;BPTF;PSRC1;THAP1;NFIC;CBX4;MED12;NR3C1;PRDM5;GMEB1;NRF1;NFE2L1;MED20;BHLHE41;RUNX1T1;ZNF205;SERTAD3;PKNOX1;CARM1;ZBTB12;HIC1;BRWD3;FUS;KAT6A;MDM4;DMTF1;KDM8;VHL;ERCC6;RBM15;SALL2;NCOA2;MAP3K2;IFRD1;ZNF18;NIBAN2;UIMC1;RFX2;ZNF569;ZBTB21;RARA;SP3;ILK;HDAC2;PML;SMARCA4;ZNF260;ZFX;SMAD2;CCAR1;IRF9;ZNF383;SMARCC1;SETD5;LIN9;MAMSTR;ELK4;KDM2B;HOXB4;ACVR2B;SOX4;ZBTB5;TEF;COL1A1;WWTR1;CTDSP1;DNAJC2;VEZF1;TBL1X;PHF20L1;NIPBL;BCL11B;SPINDOC;POU6F1
prerank,neuron projection development (GO:0031175),-0.3189124462304818,-1.3750771215847697,0.015209125475285171,0.4781636064700097,1.0,59/168,19.94%,FRY;GRM7;CNTNAP2;NLGN1;CTNND2;SHANK3;TNIK;GPM6A;CNTN4;DOCK10;PLP1;NCKAP1;STX3;GPM6B;PAK1;TRIO;PTPRM;NYAP2;EPHB1;DAB2IP;SH3GL2;MYOC;HMGB1;DCLK1;STMN2;RAPGEF2;SHTN1;UBB;RAB35;L1CAM;LYN;MINK1;MANF;ZFYVE27;DBNL;NEFH;MICALL2;ULK1;PAK3;NGF;ALS2;TMEM108;MAPK8IP3;LGI1;BICDL1;MAP2;MYO16;MAPT;SHANK1;SNAPIN;NTF3;STMN4;STMN1;EPHB3;DICER1;NCDN;UHMK1;SRGAP2;OMG
prerank,positive regulation of inflammatory response (GO:0050729),0.40235149588286956,1.3743408611886954,0.04579025110782865,0.5729678174439248,1.0,15/86,9.31%,IL16;NUPR1;IL6ST;OSM;ZBP1;IFI35;CREB3L3;IL6;TLR4;SERPINE1;CD47;WNT5A;IL18;SETD4;TLR2
prerank,regulation of cell killing (GO:0031341),0.5603775030773874,1.3737188697898113,0.09659090909090909,0.5732678833465841,1.0,5/16,8.25%,CFH;CD55;IL11;WNT5A;NOXO1
prerank,cristae formation (GO:0042407),-0.4481343029355258,-1.3734280940509218,0.08133971291866028,0.480786046967773,1.0,15/27,31.06%,ATP5F1A;ATP5MC1;ATP5PO;SAMM50;ATP5F1B;ATP5PD;ATP5F1D;UQCC3;ATP5MG;ATP5ME;ATP5F1E;ATP5MC3;ATP5MF;LETM1;CHCHD3
prerank,intracellular pH reduction (GO:0051452),-0.4235919067120837,-1.3733686984073563,0.07600950118764846,0.4793024959699561,1.0,13/33,21.18%,ATP6V0A1;CLCN3;ATP6V1B2;ATP6V0C;RAB38;DMXL2;ATP6V1D;RAB39A;ATP6V0A2;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V0D2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.4932111757853139,1.3725162345742483,0.10463121783876501,0.5754506260830248,1.0,9/26,18.17%,KANK2;CRY2;CRY1;STRN3;HEYL;SMARCA4;DAB2;CNOT9;CLOCK
prerank,intracellular sterol transport (GO:0032366),0.5865156621178023,1.3721259406448894,0.1441947565543071,0.575174592323472,1.0,7/13,26.26%,NPC1;ABCA1;STAR;SERAC1;VPS4A;ABCG1;OSBPL2
prerank,lipid phosphorylation (GO:0046834),-0.5843582104762397,-1.3717972376980674,0.11224489795918367,0.48206254968307527,1.0,4/10,6.75%,DGKB;DGKI;DGKH;DGKZ
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.4178448165796637,1.368609534322127,0.05359877488514548,0.5846487468863428,1.0,22/62,19.94%,ELOF1;MLLT3;POLR2D;CDC73;CCNH;MNAT1;CDK7;CDK12;TCEA1;IWS1;POLR2C;RTF1;PAF1;POLR2F;GTF2H4;LEO1;MLLT1;CDK13;AFF4;GTF2H2;SETD2;POLR2K
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.4445587261417691,1.3673588211687955,0.08760330578512397,0.5870655121757112,1.0,9/41,10.95%,PTGS1;PLA2G4A;ACSL1;PLA2G4C;PTGR1;ALOXE3;SCP2;SCD5;EPHX1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3685151692638243,1.367289968210217,0.044382801664355064,0.5856825463744683,1.0,26/132,12.52%,ZBTB20;SH3D19;ZC3HAV1;RNF152;PRKAA2;DCN;DACT1;DAPK1;RC3H1;NRDC;ARNT;MTDH;OPTN;DTX3L;TRIM5;PPARA;PIK3C2A;GSK3B;SNX9;MOV10;LRRK2;TPCN1;FOXO3;TRIM21;PTPN1;VGLL4
prerank,prostanoid biosynthetic process (GO:0046457),0.5489053486722774,1.3660460170043973,0.1441947565543071,0.5881342198324722,1.0,2/15,1.39%,PTGS1;PLA2G4A
prerank,membrane organization (GO:0061024),-0.29986300731564247,-1.3658117621675336,0.009708737864077669,0.4969198162875515,1.0,50/227,13.49%,DNM3;SGIP1;SGCZ;RIMS1;SYT1;HIP1;FNBP1L;HSPA8;TFRC;CERT1;ACTB;AMPH;REEP1;EPN2;CHRM2;SH3KBP1;ANK3;LPCAT2;ACTG1;HIP1R;SH3GL2;ATP2C1;SNX3;DYSF;CCDC88A;GLTP;FNBP1;ARPC3;ARPC4;NSFL1C;UBB;ARPC2;REPS2;LDLRAP1;M6PR;VPS33B;CNTN2;MFN2;SERP1;ARPC1A;ADRB2;NUP93;CBL;SYNGR2;SCARB2;NAPA;FZD4;EGFR;UBA52;SYT9
prerank,embryonic organ development (GO:0048568),0.4197300894045183,1.3650855271399867,0.0732899022801303,0.5895654244673076,1.0,16/61,12.86%,KMT2A;RBPJ;TEAD1;BMPR1A;GLI3;RBP4;KIT;SALL1;RARB;TGFBR2;COL13A1;TEAD2;PBX1;NES;SH2B3;RARRES2
prerank,regulation of dopamine secretion (GO:0014059),-0.4544286881486967,-1.3647635756787873,0.08944954128440367,0.4982663047997108,1.0,12/25,26.66%,SYT1;SNCA;SYT7;SYT4;SYT9;KCNA2;SYT2;CHRNA4;SYT6;SYT5;SYT10;SYT17
prerank,negative regulation of cellular protein localization (GO:1903828),0.46455086299476517,1.363692221025346,0.08417508417508418,0.5923696981714011,1.0,6/34,7.53%,LEPROT;ROCK2;LATS2;CTNNA1;ACTN2;GSK3B
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5294178879067293,1.3636851369567593,0.12199630314232902,0.5907662665563924,1.0,6/19,5.09%,TGFBR3;RBPJ;BMPR1A;RBP4;GLI1;TGFBR1
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.5158598509315208,1.3635420648281051,0.11231884057971014,0.5896125200635375,1.0,2/20,4.15%,WNT4;CRY1
prerank,phagosome acidification (GO:0090383),-0.44785622448943113,-1.363249180040181,0.09345794392523364,0.5008705229467254,1.0,11/26,21.18%,ATP6V0A1;ATP6V1B2;ATP6V0C;RAB38;ATP6V1D;RAB39A;ATP6V0A2;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V0D2
prerank,protein import into nucleus (GO:0006606),0.41014097299962826,1.3623818608654539,0.07121212121212121,0.5916070394184417,1.0,13/66,12.53%,CBLB;PRICKLE1;TNPO1;RANBP2;APPL2;TPR;KPNA7;KPNA6;KPNA4;PHB2;APPL1;IPO7;EIF4ENIF1
prerank,stabilization of membrane potential (GO:0030322),0.541777060923941,1.362300027185336,0.14522058823529413,0.5903013736338073,1.0,1/16,0.05%,KCNK2
prerank,protein kinase B signaling (GO:0043491),-0.45785247089031766,-1.3619213860253785,0.0888382687927107,0.5031737884653016,1.0,6/23,11.17%,KDR;GAS6;SETX;PIK3R3;AKT1;PAX2
prerank,diol biosynthetic process (GO:0034312),-0.5099608528840023,-1.3612985675312121,0.10482180293501048,0.5033038573846109,1.0,3/15,10.02%,ACER3;ACER2;GCH1
prerank,negative regulation of anoikis (GO:2000811),0.5691974124883896,1.3610960560763217,0.13108614232209737,0.5925283363235881,1.0,5/14,10.94%,TLE1;ITGA5;BCL2;MCL1;PTK2
prerank,cellular amino acid catabolic process (GO:0009063),0.39458914476476464,1.3610777780198458,0.047128129602356406,0.5909985874968559,1.0,34/87,24.58%,HAL;DDO;SHMT1;HYKK;PHYKPL;NOS2;ALDH4A1;ASPA;ACADSB;HGD;AMT;GLUL;BCKDHA;HNMT;ABAT;BLMH;ACAT1;SARDH;HIBADH;ALDH6A1;ACAD8;MCCC1;CARNMT1;ALDH7A1;DBT;PRODH;HOGA1;HAAO;MCCC2;IVD;ECHS1;QDPR;SDSL;OGDH
prerank,positive regulation of potassium ion transport (GO:0043268),-0.41130956260109214,-1.360957167792434,0.06345177664974619,0.5025680392087021,1.0,10/38,12.33%,KCNMB2;AKAP6;KCNMA1;KCNJ3;KCNJ2;GABBR2;NOS1AP;KCNJ6;KCNQ1;KCNJ15
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.5467182131736129,1.360943366923794,0.12704174228675136,0.5898334755157056,1.0,2/18,1.53%,ATP1A2;STK39
prerank,cardiocyte differentiation (GO:0035051),0.6244179589388976,1.3604898573841597,0.15294117647058825,0.5896704647827684,1.0,3/10,4.04%,AKAP13;GATA6;BMP2
prerank,cardiolipin metabolic process (GO:0032048),0.56797335016537,1.3592319746775297,0.13454545454545455,0.592136041991674,1.0,5/13,20.28%,PLA2G4A;PLA2G6;PLA2G5;HADHA;SLC27A1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3151458854467308,1.3592117579519853,0.0,0.5906236104246195,1.0,226/1082,16.26%,TCF7L2;TCF4;CREB5;KMT2A;RORA;BMP6;WNT4;SMAD3;ZEB2;RBPJ;ZMIZ1;NR2F2;SP100;CXCL10;ELOF1;ELF1;CREB3L2;RGMA;PID1;FGF1;AUTS2;TEAD1;ARNT2;OSR1;IL31RA;MLLT3;TBL1XR1;GATA6;TRIM56;FOXC1;NFIA;NFAT5;PHIP;RGMB;SPIB;POU5F1;WNT3A;PPM1A;CSRP3;BMPR1A;SSBP2;ZNF395;OSM;FSTL3;ZIC2;GLI3;FOXC2;IL11;WWOX;NCOA3;MYB;CDK8;DCN;PARP9;TGFB1I1;FZD2;LDB2;HIVEP1;LITAF;PRDM11;HOXC4;ZIC1;STAT5B;BMP2;RFX3;GABPB1;GABPB2;CREB3L3;APBB1;CREB3L4;ARNT;IL6;KMT2C;GLI1;BMP7;GLIS3;TLR4;EPAS1;HLF;TGFBR1;SALL1;NIF3L1;TCF12;NCOA6;NSD3;LBHD1;SERPINE1;HAX1;KLF5;ARF4;NR1H3;RARB;MLLT10;FOXP3;DTX3L;CREBBP;BCL9L;PPARA;HDAC4;NSD1;CREBL2;STAT1;CDKN2B;GLIS2;POGZ;PCGF5;POU1F1;SFR1;NEK4;RNF20;YAP1;DPF2;WNT5A;ZSCAN21;IL18;RNF111;WAC;ARHGEF11;CREBRF;QRICH1;SKI;MEF2A;RIPK2;CRLF3;CRTC1;ELF4;TEAD2;GLYR1;RLF;KAT6B;RHOQ;NAA16;TLR2;CDK7;EPC1;IGF2;TAF7;MAFB;BRD4;E4F1;TCEA1;PBX1;RFXANK;HEYL;UTP15;ATF7IP;MYSM1;PFKM;UBE2V1;NAA15;CRTC3;ELF2;SMAD4;FOXO3;CDH13;HIVEP3;ILF3;SERTAD2;MAP2K5;RFXAP;MAML2;PPP3CB;EGR2;MAP2K1;RPS6KA3;NR4A1;FBXW11;TET2;DVL3;BTRC;SS18;ARRB1;POU2F1;WNT2;MZF1;HOXA10;BPTF;PSRC1;NFIC;MED12;NR3C1;BRD8;NRF1;SENP1;SERTAD3;NCK1;WASL;ZNF462;THOC5;KAT6A;EIF2AK3;KDM8;VHL;ERCC6;TBK1;SALL2;NCOA2;MAP3K2;NIBAN2;PKD2;PRKD2;RBM14;RARA;SP3;ILK;HDAC2;PML;SMARCA4;THAP3;SMAD2;SMARCC1;ELK4;HOXB4;SOX4;KAT2B;DAB2;COL1A1;TXK;WWTR1;DNAJC2;APP;VEZF1;TBL1X;ASXL2;BCL11B;TAF9
prerank,phosphatidylserine metabolic process (GO:0006658),0.4759409414870979,1.3590757459323928,0.1099476439790576,0.5895340878274905,1.0,4/32,5.32%,PLA1A;PLA2G4A;OSBPL8;MBOAT2
prerank,establishment of endothelial barrier (GO:0061028),-0.43863787299992596,-1.3586509837777379,0.09813084112149532,0.5074425957237303,1.0,13/29,18.15%,PDE4D;PECAM1;PPP1R16B;ROBO4;RAPGEF2;PDE2A;SOX18;RAPGEF6;TJP2;F11R;RAP1A;MARVELD2;RAB1B
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3622658749260337,1.3582303916404959,0.04078947368421053,0.5905373725184406,1.0,32/158,14.78%,WLS;LPAR1;AKAP13;ECM1;PPM1A;GJA1;TRAF5;ROR1;LITAF;CFLAR;IKBKE;MTDH;MIER1;GOLT1B;BIRC3;PELI2;TRIM5;BST2;JMJD8;LGALS9;VAPA;RIPK2;ANKRD17;BRD4;UBE2V1;TRIM21;RHOC;MAP3K7;TIFA;TICAM1;ZDHHC17;TBK1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3815804247592171,1.3579624007859323,0.045845272206303724,0.5897917218461668,1.0,18/108,9.31%,SULF1;WLS;DCDC2;TLE1;KANK1;PTK7;WWOX;APCDD1;DACT1;TERT;BMP2;SALL1;FOXP3;TCF7L1;CDC73;SKI;LRRK2;TLR2
prerank,lipid catabolic process (GO:0016042),0.5240756179654054,1.3577095527429826,0.12195121951219512,0.5890808664047723,1.0,1/18,0.16%,PLA1A
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.49763131896675517,-1.3577083048586105,0.10991379310344827,0.5083403923605059,1.0,11/16,25.86%,ATP5F1A;ATP5MC1;ATP5PO;ATP5F1B;ATP5PD;ATP5F1D;ATP5MG;ATP5ME;ATP5F1E;ATP5MC3;ATP5MF
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.545639799003385,1.357155751751176,0.1374764595103578,0.5893051317617182,1.0,7/16,12.20%,PDGFRA;NRP1;FER;PDGFRB;PIK3C2A;PLAT;PTPN1
prerank,myoblast fusion (GO:0007520),-0.5343773988846047,-1.3565802280728465,0.13414634146341464,0.5098203070911147,1.0,4/12,10.16%,ADGRB3;JAM2;KCNH1;NOS1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.49120480090995394,1.356339348221717,0.07931034482758621,0.5904776467875058,1.0,2/24,1.32%,LEPR;PID1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.4441325720804322,1.3549472188464489,0.08455284552845528,0.5933898889520788,1.0,8/42,8.14%,SELP;IL23R;IL6;TLR4;SERPINE1;OPTN;NOS2;TNFRSF14
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6061762542797611,1.3543729144174146,0.1512770137524558,0.5936622791896525,1.0,3/10,5.73%,ENPP1;PID1;APPL2
prerank,positive regulation of ruffle assembly (GO:1900029),-0.5252905163465199,-1.3535754241988163,0.12058212058212059,0.5171038953756928,1.0,10/13,39.28%,NLGN1;EPS8;HRAS;FAM98A;PFN1;CARMIL2;PLEKHM1;EPS8L2;P2RY12;NDEL1
prerank,regulation of fibroblast proliferation (GO:0048145),0.4347610708450579,1.353362046443005,0.08143322475570032,0.5953348668127997,1.0,9/45,8.18%,PDGFRA;FN1;DDR2;S100A6;MORC3;PARP10;CDC73;WNT5A;SKI
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4518695257873855,1.3532143574962825,0.0896,0.5942357490918204,1.0,7/38,10.52%,RORA;TLE1;PPM1A;STAT1;ZMYND11;PPM1B;NLRX1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.44103600636275553,-1.3529758244107395,0.10401891252955082,0.5170656790863984,1.0,7/29,4.82%,DPP10;KCNAB1;FGF12;KCNIP4;HOMER1;KCNIP1;DPP6
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.5419880862309617,1.3528941952759233,0.13575525812619502,0.593698038311197,1.0,7/18,11.74%,IL6ST;FER;IL6;STAT1;YAP1;SMAD4;JAK1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.44327879550225147,-1.3522973935247602,0.0967741935483871,0.5172592652294615,1.0,12/26,18.17%,PLCG2;RYR2;HTR2C;RYR3;FGF2;ERO1A;PTPRC;CCL19;HTR2B;IBTK;SLC8B1;HTR2A
prerank,histone modification (GO:0016570),0.37306349702206837,1.351758507488715,0.056195965417867436,0.5958312712043937,1.0,26/109,16.16%,EYA2;EYA1;TBL1XR1;MIER3;NSD3;BAZ2A;UBE2U;MIER1;CREBBP;HDAC4;NSD1;BAZ1B;KAT6B;HLCS;HUWE1;ATXN7;EYA4;PRDM5;BRD8;CARM1;USP36;KAT6A;RBM14;HDAC2;TBL1X;PHF20L1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.4864233679741769,1.3510395932786077,0.11131059245960502,0.5966316755135375,1.0,4/27,2.48%,PDGFRA;FN1;DDR2;S100A6
prerank,oxoacid metabolic process (GO:0043436),0.4877094418439442,1.3510176488888819,0.11371237458193979,0.5951770486942052,1.0,11/27,20.81%,ENPP1;DDO;TPST1;LIPT1;THAP4;HAO1;ABHD14B;SULT1A1;GRHPR;SULT6B1;AGXT
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5231172891942495,-1.3509926175296845,0.10699588477366255,0.5194777650638314,1.0,7/13,19.21%,ABHD2;NR3C2;ESR1;BMP4;CALCOCO1;PLPP1;ESR2
prerank,regulation of fatty acid oxidation (GO:0046320),0.5382851379167604,1.3499275672669204,0.13898916967509026,0.5972501284137053,1.0,4/16,9.44%,PRKAG2;APPL2;PPARA;SIRT4
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5773207281759344,1.3497027037297087,0.14068441064638784,0.596372428165818,1.0,4/13,10.06%,PDPK1;FGFR1;IGF2;AKT3
prerank,negative regulation of signaling (GO:0023057),0.5055415249869608,1.3494710432773245,0.1276595744680851,0.5955688436144655,1.0,5/25,5.75%,IGFBP3;MPIG6B;OSM;IL11;OPTN
prerank,synaptic vesicle endocytosis (GO:0048488),-0.4182127701684462,-1.3491749806483293,0.0792838874680307,0.522957040818694,1.0,7/33,9.85%,DNM3;NLGN1;SYT1;AMPH;SNCA;NLGN3;SNAP91
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.41759421430416677,-1.3482546157666053,0.10804597701149425,0.5239420718192934,1.0,15/33,26.97%,MEF2C;THBS1;NOTCH1;ACVRL1;HMGB1;FGF2;KLF4;RGCC;DLL4;CARD10;VASH1;ANGPT2;ANGPT4;CSNK2B;HDAC5
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5076809809415856,-1.3482290092573737,0.11513859275053305,0.5223194396927813,1.0,6/15,13.54%,JMY;ARPC3;ARPC4;ARPC2;ARPC1A;WASHC1
prerank,actin polymerization or depolymerization (GO:0008154),0.42104772779304284,1.3480552353554192,0.0842433697347894,0.5986746713318187,1.0,4/50,0.82%,GAS7;ARHGAP6;MICAL3;DIAPH1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.466587402040617,1.3477369256839418,0.10918544194107452,0.5981440377299354,1.0,11/29,19.93%,SMAD3;TUT4;SNIP1;ADAR;TARBP2;ZC3H7B;SMAD2;HNRNPA2B1;PUM2;TUT7;PUS10
prerank,acylglycerol metabolic process (GO:0006639),-0.40443776690621025,-1.3469334335584187,0.08860759493670886,0.5243754532077588,1.0,11/37,16.42%,DGKB;DGKI;DGKH;MGLL;ABHD2;SEL1L;DGKZ;CAV1;DGKG;ABHD6;PLAAT3
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3146848328008779,1.3466024936460617,0.0010604453870625664,0.6001587635951648,1.0,183/807,16.76%,TCF7L2;FHL2;BMP6;WNT4;FOXD1;SMAD3;PRICKLE1;ZEB2;RBPJ;ZHX2;MXI1;ATXN1;ARID4A;NR2F2;KANK2;SP100;KCNIP3;TLE1;PRDM6;SMURF2;OSR1;TBL1XR1;GATA6;FOXC1;POU5F1;SAMD13;PPM1A;ZBTB4;NR6A1;SNX6;ZIC2;GLI3;FOXC2;RBFOX2;ZMYND15;MBD2;WWOX;MYB;PARP9;TCEAL7;LDB2;HIVEP1;DACT1;EID2B;CRY2;PRDM11;LOXL3;BMP2;RFX3;CRY1;APBB1;MIER3;BMP7;GLIS3;BCOR;AEBP1;SALL1;MTDH;UXT;GZF1;CBFA2T2;OTP;ZNF3;MIER1;TPR;NR1H3;RARB;TSHZ3;WWC2;FOXP3;DKK3;CREBBP;PPARA;HDAC4;NSD1;STAT1;PBXIP1;USP9X;GLIS2;ZEB1;CDC73;YAP1;DPF2;WNT5A;ZNF25;SKI;ZMYND11;MEF2A;PHB2;ZFP37;VPS72;CUX1;KAT6B;DLG1;SCMH1;SAP130;USP47;GATAD2B;SUFU;EPC1;IGF2;TAF7;SUMO1;CREM;JARID2;PPID;E4F1;NUPR2;HEYL;ATF7IP;PSPC1;GMNN;WWP2;FNIP1;CUX2;CIR1;CBX7;SMAD4;BCL7A;FOXO3;RTF1;ILF3;IFI27;MAP2K5;SCML4;ATN1;LHX9;ZNF219;FBXW11;VGLL4;KDM2A;BTRC;ERN2;ARID5B;POU2F1;MZF1;NOG;BPTF;THAP1;NFIC;CBX4;EFNA1;NR3C1;PRDM5;PEX2;PAF1;BHLHE41;RUNX1T1;ZNF205;FRK;HIC1;KAT6A;MDM4;KDM8;VHL;TLE6;RBM15;NIBAN2;UIMC1;ZBTB21;RARA;SP3;HDAC2;PML;SMARCA4;SMAD2;ELK4;KDM2B;ACVR2B;PER3;ZBTB5;DAB2;TBL1X;RNF2;NIPBL;SPINDOC;POU6F1;NRIP1;MUC1;RING1;JDP2;DNMT3A;CHD8
prerank,positive regulation of dendritic spine development (GO:0060999),-0.4814936405680138,-1.346475265404271,0.10904872389791183,0.5241509576258823,1.0,10/20,23.36%,NLGN1;SHANK3;CAPRIN2;LRP8;DBNL;RELN;SHANK1;LLPH;CAPRIN1;FOXO6
prerank,positive regulation of signal transduction (GO:0009967),0.34214196829436205,1.3455642498976768,0.022332506203473945,0.6020229827549005,1.0,40/238,9.42%,SULF1;ROBO1;WLS;BMP6;TSPAN5;DCDC2;SASH1;RBPJ;ZMIZ1;VTN;FGF1;AXL;IL6ST;PHIP;GHRH;KANK1;BMP2K;NRP1;ITGA5;DACT1;TERT;LOXL3;BMP2;ARNT;IL6;GLI1;TGFBR1;SORBS1;SALL1;AAK1;PRKCZ;CREBBP;LY96;CDC73;YAP1;BAX;SKI;LRRK2;TLR2;IGF2
prerank,regulation of chemotaxis (GO:0050920),0.4708011960350721,1.3444109122380286,0.1234991423670669,0.6041922295942913,1.0,5/30,6.40%,EFNB2;PDGFRA;MYCBP2;PDGFRB;PTPN2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.5297711054908466,1.3441974681010693,0.14634146341463414,0.6034227815381724,1.0,4/17,4.57%,EFNB2;ROBO1;NRP1;MIA3
prerank,inorganic cation transmembrane transport (GO:0098662),-0.29339869617952613,-1.3435789132808396,0.0,0.5304679397762477,1.0,56/268,12.09%,SLC6A6;SLC12A2;KCNB2;KCND2;SLC9A2;KCNQ5;KCNAB1;KCNK5;TRPC3;SLC24A2;ATP1B1;ABCC9;KCNH7;KCNJ2;KCNC2;KCNQ3;SLC6A1;SCN1A;SLC40A1;HCN1;FKBP1A;GAS6;TRPC5;ATP1A1;SLC25A27;TRPC4;RYR3;ATP2C1;SLC8A1;KCNK10;SCN2A;ATP2A3;CACNA1G;SLC9A8;HCN2;TMEM175;UCP2;SLC39A6;KCNH1;KCNH5;TRPC6;ATP6V0C;SLC30A1;KCND3;CACNA1D;SCN8A;KCNB1;ATP5PO;SLC39A14;TMCO1;SLC36A1;KCNJ8;SCN9A;ATP5F1B;KCNQ1;SLC6A5
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.4127010097346758,1.3433231935714425,0.08204334365325078,0.6047760720764531,1.0,14/59,14.96%,PDPK1;ROCK2;STK39;OXSR1;TGFBR1;TGFBR2;GSK3B;LRRK2;HIPK3;MAP2K1;CSNK2A2;WNK1;TBK1;PRKD2
prerank,regulation of angiogenesis (GO:0045765),0.3521677334643265,1.3423749570367336,0.03674540682414698,0.6063810240828088,1.0,30/192,8.68%,SULF1;PDPK1;COL4A3;ROCK2;SASH1;SP100;CXCL10;FGF1;ECM1;THBS2;GATA6;FOXC1;HSPG2;CEMIP2;ITGB8;CDH5;DCN;ADAMTS1;VEGFD;ANXA3;IL6;MTDH;SERPINE1;EPHA1;ATP2B4;STAT1;CTSH;WNT5A;ADAM12;GLUL
prerank,negative regulation of gene expression (GO:0010629),0.3342933256596595,1.342162874669991,0.020506634499396863,0.6055486472435284,1.0,62/302,14.61%,ROBO1;WNT4;PARP14;LGR4;ROCK2;RBMS3;SAMD4A;NOTCH2;EIF2AK2;IGFBP5;PRKAA2;SHMT1;PTBP3;BMPR1A;ITGB8;TWSG1;PARP9;TNRC6B;SLC24A3;IGF2BP1;SUZ12;TERT;DAPK1;BMP2;PTPN22;STOX1;SNX12;CPNE1;FOXP3;ATP2B4;NANOS2;NOS2;PARP10;DCP2;LGALS9;YAP1;OPRD1;ANXA7;MYADM;TNRC6A;MOV10;IGF2BP2;EPC1;JARID2;NOCT;TIPARP;WWP2;LRP3;ILF3;MAP2K1;EIF4ENIF1;ATP2B1;SLFN14;DDX6;METTL16;FLOT2;PTBP2;TASOR;EIF2AK3;GIGYF2;SRGN;VHL
prerank,regulation of cellular metabolic process (GO:0031323),0.4322481585990671,1.3419430705295619,0.1069078947368421,0.604749510205906,1.0,7/45,6.56%,PID1;TBC1D16;PANK2;ARF4;PPARA;MPV17;SSH1
prerank,myelination (GO:0042552),-0.40282942000733235,-1.3413920303988291,0.06806282722513089,0.5348997363188419,1.0,21/46,22.95%,ADGRG6;ACER3;PLP1;CMTM8;MAL;MYOC;MBP;SCN2A;EIF2B2;SCN8A;NFASC;ACSBG1;ABCD2;GAL3ST1;TNFRSF21;TPPP;BCAS1;PLLP;B4GALT6;AMIGO1;MAL2
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.515029093898159,1.3413109779970749,0.12612612612612611,0.605335999285725,1.0,8/21,21.33%,SAMD4A;TUT4;PAN3;CNOT3;CNOT9;TUT7;PARN;PAN2
prerank,somite development (GO:0061053),0.5946521323742675,1.3398671725358346,0.15613382899628253,0.6084516291237252,1.0,5/11,19.67%,LOXL3;MTHFD1;IHH;PTCH1;MEOX2
prerank,negative regulation of hormone secretion (GO:0046888),0.6017613709816755,1.3394037577292204,0.16297786720321933,0.6084410109462374,1.0,3/10,2.76%,GJA1;OSM;IL11
prerank,regulation of blood coagulation (GO:0030193),0.4808223098569701,1.339360156184973,0.12478632478632479,0.607082978266641,1.0,5/27,7.81%,TFPI;VTN;GP1BA;SERPINE1;SERPINE2
prerank,transport along microtubule (GO:0010970),0.5602291528038961,1.3391991380176547,0.13940520446096655,0.606064648608381,1.0,7/13,22.87%,ARHGAP21;SPG11;APP;BORCS5;BAG3;CLIP3;COPG1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.42811013420271793,-1.338949948049621,0.08759124087591241,0.5400537957090439,1.0,11/30,13.12%,FGF12;KCNJ2;RYR2;SCN1A;ATP1A1;GJC1;CACNA1G;NEDD4L;CACNA1D;KCNQ1;KCNE4
prerank,eye photoreceptor cell development (GO:0042462),-0.5023469017094186,-1.3383135801155222,0.1400437636761488,0.5402831250933811,1.0,5/15,16.27%,RORB;RP1;VEGFA;RPGRIP1;CEP290
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5399932245301353,1.3382556104600998,0.1417910447761194,0.6074749168944648,1.0,4/16,5.14%,FOXD1;FGF1;BMP2;SALL1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.5130506063888868,1.337268920758684,0.12746858168761221,0.6092359547983476,1.0,2/19,0.85%,MCU;CAMK1D
prerank,positive regulation of interleukin-13 production (GO:0032736),0.602778132488348,1.3370681979494814,0.16184971098265896,0.6083197178768434,1.0,5/10,20.33%,PRKCZ;LGALS9;IL18;RARA;SPHK2
prerank,protein export from nucleus (GO:0006611),0.4847065298204169,1.3367080478379127,0.12115732368896925,0.6081814458924591,1.0,11/27,23.33%,RANBP3L;TPR;DUSP16;EGR2;STRADB;RAN;RANBP17;STYX;XPO5;PKD1;TGFB1
prerank,positive regulation of protein binding (GO:0032092),0.4134427089741681,1.3365444474420811,0.08448540706605223,0.6072272261121141,1.0,21/56,17.26%,TCF7L2;VTN;WNT3A;DACT1;TERT;BMP2;DTX3L;SPPL3;GSK3B;RIPK2;LRRK2;STK3;AMFR;TRIM21;HFE;BDNF;STK4;LRP1;APP;PPP2CA;RAN
prerank,regulation of signal transduction (GO:0009966),0.3450333153811132,1.3361823066955734,0.03870967741935484,0.6069600287635964,1.0,24/190,6.54%,SULF1;IGFBP3;RORA;DCDC2;SP100;ELF1;GRK3;IGFBP5;MPIG6B;CD55;FBXL17;IGFBPL1;NUCKS1;ZIC1;IGFBP6;GLI1;ZDHHC3;DTX1;PLCE1;FOXP3;TRIM5;PTPN2;CREBBP;TCF7L1
prerank,JNK cascade (GO:0007254),-0.3932023698343078,-1.3358852481214434,0.09382716049382717,0.5458143734617398,1.0,13/40,18.37%,NOD1;MAP3K5;MAPK8;ARHGEF6;MAPK10;MAP3K11;UBB;MAP4K3;MINK1;UBA52;NOD2;GPS1;IRAK1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.4776322864589112,1.3358075587882852,0.11937716262975778,0.6066705631163777,1.0,6/26,9.31%,RSAD2;IFI35;PTPN22;NR1H3;PJA2;TLR2
prerank,positive regulation of protein modification process (GO:0031401),-0.30280093330258007,-1.3347749847966084,0.018018018018018018,0.5476289197968307,1.0,50/203,14.29%,TEK;PECAM1;LIMCH1;ERBB4;LIMK2;PPP1R16B;PDE8A;EFNA5;TNIK;INSR;TFRC;KDR;VEGFC;TBX1;NTRK2;PAK1;CALM1;CAMTA1;NOS1AP;CSNK1D;GAS6;SEMA4D;CALM2;PTBP1;RAB3GAP1;PIK3R3;MAPK3;BMP4;NPTN;ACE;CALM3;AKT1;SYMPK;PINK1;FAS;CCND1;VEGFA;ACVR2A;CD74;LYN;RACK1;FGF2;CD40;HSP90AA1;CSF1R;EGFR;KRAS;HRAS;PLAUR;PPIA
prerank,calcium import into the mitochondrion (GO:0036444),0.6068466724448682,1.3345698518592661,0.1485148514851485,0.6091483651887255,1.0,2/10,1.63%,MCU;MICU1
prerank,hippo signaling (GO:0035329),0.48868007239202366,1.3335707726355461,0.1332116788321168,0.6108078434865422,1.0,12/26,18.53%,TEAD1;AMOTL1;LATS2;DCHS1;YAP1;TEAD2;STK3;TJP1;STK4;WWTR1;YWHAE;CASP3
prerank,photoreceptor cell development (GO:0042461),-0.5100041460864824,-1.3333758702360634,0.13596491228070176,0.549931536518908,1.0,6/14,16.27%,RORB;RP1;AHI1;VEGFA;MFSD2A;CEP290
prerank,receptor clustering (GO:0043113),-0.43087922336999984,-1.333127676014133,0.1201923076923077,0.5488965110952785,1.0,5/27,3.69%,NRXN1;NLGN1;DLG2;LRRC7;ITGA4
prerank,axonal transport (GO:0098930),-0.4052099068271253,-1.3327378358814044,0.09768637532133675,0.5484130762099922,1.0,16/36,26.50%,SYBU;KIF1B;DYNC1H1;AP3S2;TMEM108;KIF3B;AP3B2;SOD1;MAPT;SNAPIN;AP3D1;DCTN1;KIF4A;HAP1;BLOC1S4;NEFL
prerank,inositol lipid-mediated signaling (GO:0048017),0.4165593328314574,1.331578694635139,0.08931419457735247,0.6156283113335496,1.0,10/50,6.78%,PDGFRA;FGFR1;GAB2;ADAP2;PLCD3;PI4KA;PDGFRB;PLCE1;PLCB3;PIK3C2A
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.40198971747662837,-1.3309131649489996,0.09473684210526316,0.552205259833408,1.0,9/37,6.20%,CADM1;NLGN1;GRID2;HMCN1;PTPRD;TENM2;TENM3;IL1RAPL1;TENM4
prerank,phospholipid translocation (GO:0045332),-0.42732597888960955,-1.3305769596775667,0.11278195488721804,0.5515339485134877,1.0,11/28,18.22%,ATP8A1;ATP10A;ATP11B;ATP8A2;ATP11A;ATP8B2;ATP8B1;MFSD2A;TMEM30A;P2RX7;ABCB4
prerank,anterograde axonal transport (GO:0008089),-0.40055211310839334,-1.330216148539343,0.0746987951807229,0.5508925334724256,1.0,13/37,17.64%,DLG2;KIF1B;KIF1C;RAB27B;AP3S2;KIF5C;MAPK8IP3;KIF3B;AP3B2;SOD1;KIF5A;SNAPIN;AP3D1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3114171057960325,1.3301115432928223,0.0,0.6187669272610417,1.0,173/834,16.26%,TCF7L2;TCF4;KMT2A;RORA;BMP6;SMAD3;ZEB2;RBPJ;ZMIZ1;NR2F2;CXCL10;ELF1;RGMA;PID1;FGF1;AUTS2;TEAD1;ARNT2;OSR1;TBL1XR1;GATA6;FOXC1;NFIA;NFAT5;PHIP;SPIB;POU5F1;WNT3A;CSRP3;BMPR1A;SSBP2;ZNF395;OSM;FSTL3;GLI3;FOXC2;IL11;WWOX;NCOA3;MYB;CDK8;DCN;LDB2;HIVEP1;LITAF;HOXC4;TERT;STAT5B;BMP2;RFX3;GABPB1;GABPB2;CREB3L3;APBB1;CREB3L4;ARNT;IL6;KMT2C;GLI1;GLIS3;TLR4;EPAS1;HLF;SALL1;TCF12;NCOA6;SERPINE1;HAX1;KLF5;ARF4;NR1H3;RARB;MLLT10;FOXP3;CREBBP;BCL9L;PPARA;HDAC4;STAT1;CDKN2B;GLIS2;POGZ;PCGF5;POU1F1;CDC73;YAP1;DPF2;NGFR;WNT5A;ZSCAN21;IL18;RNF111;CREBRF;SKI;MEF2A;RIPK2;CRLF3;CRTC1;ELF4;GLYR1;RLF;KAT6B;RHOQ;TLR2;CDK7;EPC1;IGF2;TAF7;BRD4;CDK12;E4F1;TCEA1;PBX1;RFXANK;HEYL;MYSM1;PFKM;CRTC3;SMAD4;FOXO3;CDH13;MAP2K5;RFXAP;MAML2;PPP3CB;EGR2;RPS6KA3;NR4A1;TET2;DVL3;SS18;ARRB1;POU2F1;WNT2;MZF1;HOXA10;BPTF;NFIC;MED12;NR3C1;BRD8;NRF1;SENP1;NCK1;WASL;ZNF462;KAT6A;TBK1;SALL2;NCOA2;LEO1;PKD2;PRKD2;RBM14;RARA;SP3;HDAC2;SMARCA4;THAP3;SMAD2;ELK4;HOXB4;SOX4;KAT2B;DAB2;TXK;WWTR1;APP;VEZF1;TBL1X;ASXL2;BCL11B;TAF9
prerank,Rho protein signal transduction (GO:0007266),0.4240176486261322,1.3295599452522584,0.09238249594813615,0.6189648584714763,1.0,14/53,15.96%,ARHGAP29;PDPN;ARHGAP6;ROCK2;NTN1;CELSR1;NGFR;ARHGEF11;CDC42EP4;CDH13;COL1A2;RHOU;LIMK1;ADRA2A
prerank,cellular potassium ion homeostasis (GO:0030007),-0.5288317089297626,-1.3294787124368364,0.13636363636363635,0.5513893979258961,1.0,5/13,4.06%,SLC12A2;KCNMA1;ATP1B1;KCNJ2;ATP1A1
prerank,digestive tract development (GO:0048565),0.46545366214547695,1.329076839317951,0.13410596026490065,0.6189250025162758,1.0,8/32,7.35%,GATA6;GLI3;KIT;GLI1;SALL1;CLMP;RARB;DNAAF1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.37529886121088185,1.3281890165029127,0.07092198581560284,0.620265984797868,1.0,18/104,8.18%,PDPK1;SMAD3;SMURF2;PPM1A;BMPR1A;FSTL3;SNX6;NBL1;LDLRAD4;TGFB1I1;PMEPA1;BMP2;WFIKKN1;TGFBR1;BCL9L;PPARA;TGFBR2;SKI
prerank,glycerolipid catabolic process (GO:0046503),-0.4722560338262207,-1.3279009990366035,0.11135371179039301,0.5545312642644169,1.0,5/19,5.77%,GPCPD1;MGLL;ABHD2;GDPD1;ENPP6
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5331352255143991,1.3275079204505535,0.13518518518518519,0.6209650881724676,1.0,6/17,13.08%,RBPJ;NOTCH2;BMPR1A;BMP2;HEYL;NOG
prerank,regulated exocytosis (GO:0045055),-0.3042877161236281,-1.3273268451531464,0.02158273381294964,0.5545393486153567,1.0,34/173,10.66%,PCDH7;ABCC4;VWF;PECAM1;RIMS1;SYT1;RIMS2;ACTN1;TMSB4X;TGFB2;THBS1;VEGFC;PCLO;SCG3;CALM1;RAB11FIP1;GAS6;SNAP25;SNCA;STXBP1;CDC37L1;CYRIB;RAB27B;CPLX1;SYT7;SYT4;A2M;STEAP2;VEGFA;LYN;CHID1;TGFB3;FAM3C;MANF
prerank,regulation of GTPase activity (GO:0043087),-0.30356041675637513,-1.327172493404181,0.020491803278688523,0.5532743496655527,1.0,43/177,13.71%,CHN2;DOCK9;PRKG1;FGD5;ITGA6;PLXNA4;EFNA5;BCAR3;EPHA5;DOCK10;NET1;LRCH1;NTRK2;SEMA4D;ADAP1;TBC1D30;CPEB2;DAB2IP;ARHGAP44;RASIP1;RAB3GAP1;CCL14;RAPGEF2;FGD6;RGS7;RCC2;RGS6;ARHGAP15;ARHGAP27;TMED2;CAV2;RACK1;DOCK8;RAPGEF6;ARHGEF7;CD40;ALS2;RGP1;VAV1;AGRN;F11R;HRAS;EVI5
prerank,negative regulation of cell growth (GO:0030308),-0.3140742215405651,-1.3269846292305318,0.030612244897959183,0.5521373779904395,1.0,37/121,20.17%,APBB2;SLIT2;PTPRJ;DIP2B;SMARCA2;TGFB2;BMPR2;DCC;ADAM15;PPP2R1A;RERG;ACVRL1;SOX17;CCN3;CAPRIN2;NDRG3;STK11;ING1;IP6K2;SEMA3G;NPR1;RACK1;CCAR2;FGF13;ULK1;JADE1;MAP2;CDKN1A;ENO1;BTG1;CDKN2AIP;WFDC1;MINAR1;ESR2;MSX1;NDUFA13;TRIM46
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5389202113565301,1.326307564002889,0.15,0.6232287010329023,1.0,4/14,14.30%,STK39;OXSR1;WNT5A;WNK1
prerank,calcium ion homeostasis (GO:0055074),-0.33101128867399704,-1.326167863375296,0.04776119402985075,0.5529257403879405,1.0,35/95,25.07%,TMTC2;SLC24A2;ATP1B1;RYR2;TPT1;HTR2C;SNCA;ATP2C1;SLC8A1;CCL14;ATP2A3;NPTN;SLC30A1;SELENON;GRIN1;CALR;SLC10A7;TMCO1;CXCL12;CAV1;CD40;ATP13A4;ATP2A2;CCL19;HTR2B;SLC8B1;HTR2A;CHRNA7;ATP2B3;PTH1R;STC1;ATP13A1;ATP2B2;SLC24A5;EDN1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.49352219106637374,-1.3255755969351686,0.13276231263383298,0.5528945824871849,1.0,5/16,8.83%,ST6GALNAC3;ST8SIA4;ST8SIA6;ST6GALNAC4;ST6GALNAC5
prerank,actin nucleation (GO:0045010),-0.4512007053333892,-1.325334511875951,0.11572052401746726,0.5518663501839227,1.0,7/21,13.54%,LMOD1;JMY;ARPC3;ARPC4;ARPC2;ARPC1A;WASHC1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.4881738884268418,-1.3251666807448164,0.12831858407079647,0.5507943248469009,1.0,9/16,37.25%,CADM1;RAET1E;LAMP1;RASGRP1;SLAMF6;NECTIN2;CD226;IL12A;CRTAM
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.4027551095366266,1.3242745641790092,0.10151515151515152,0.6283131755476368,1.0,11/67,5.76%,EFEMP1;TEC;PDGFRA;FGFR1;DDR2;GHR;EPHA3;FER;KIT;EPHA1;PDGFRB
prerank,clathrin coat assembly (GO:0048268),-0.5004496851920837,-1.324180061318363,0.13191489361702127,0.5521725840183025,1.0,3/15,4.78%,SGIP1;HIP1;HIP1R
prerank,protein monoubiquitination (GO:0006513),0.4472951697329113,1.3241190342528437,0.12100840336134454,0.6273247541485798,1.0,12/36,14.88%,KLHL22;DTX3L;MGRN1;CDC73;RNF20;WAC;HUWE1;TRIM21;CUL3;PAF1;UBE2R2;LEO1
prerank,membrane depolarization (GO:0051899),-0.4153196931355689,-1.3236787570026123,0.0970873786407767,0.5519420687820786,1.0,13/32,18.29%,CACNA1E;CACNB4;SCN1A;SCN2A;CACNA1G;YWHAH;SCN8A;SCN9A;CAV1;SCN3A;CHRNA4;P2RX7;CACNA1A
prerank,ATP transport (GO:0015867),0.6009094710983435,1.323629762319244,0.15789473684210525,0.6274055334296038,1.0,4/10,15.00%,SLC17A9;CD47;SLC25A24;SLC25A4
prerank,amino sugar metabolic process (GO:0006040),-0.5627626219385459,-1.3233002145706827,0.16666666666666666,0.5514278871116982,1.0,4/10,12.88%,CSGALNACT1;FN3K;GFPT2;GFPT1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4996231333721737,1.322640701373821,0.13978494623655913,0.6291578606339985,1.0,4/20,5.09%,TGFBR3;RBPJ;BMP2;TGFBR1
prerank,positive regulation of signaling (GO:0023056),-0.3914355587395911,-1.3219450274564166,0.09718670076726342,0.5539193923649248,1.0,8/37,6.99%,RIMS1;SYT1;RIMS2;GRIK2;NSF;HOMER1;SNCA;ECE1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.5081521230976889,-1.3219098643074827,0.15331807780320367,0.5523644578548638,1.0,12/14,45.85%,CSTF2;CPSF2;CSTF2T;CPSF1;CPSF4L;CPSF6;TUT1;ERN1;NUDT21;CPSF7;NCBP1;CPSF4
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.49468540080383194,1.3215107134194033,0.14656771799628943,0.6314944874903722,1.0,6/22,10.43%,PPM1E;PPM1A;DUSP10;DUSP16;DUSP5;PPM1B
prerank,negative regulation of histone acetylation (GO:0035067),-0.539679263884369,-1.3214851767953388,0.14285714285714285,0.5519733678807548,1.0,5/11,19.82%,SNCA;CTBP1;SET;BRCA1;NOC2L
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5235736695212738,1.3214683880401734,0.13949275362318841,0.6301236530455792,1.0,2/17,0.85%,MCU;CAMK1D
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.5809595932314964,1.3214368452301462,0.18129770992366412,0.6287727886984296,1.0,2/11,2.20%,EFNB2;WNT3A
prerank,iron ion transmembrane transport (GO:0034755),-0.565138444247069,-1.3204932788090622,0.14145383104125736,0.5532133719453507,1.0,5/10,16.21%,SLC40A1;SLC39A14;SLC39A8;ABCC5;SCARA5
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5772115060688097,1.320095367006534,0.16733067729083664,0.6316620688688818,1.0,4/11,7.03%,TGFBR3;BMP2;TGFBR1;TGFBR2
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3993089139018796,1.319892495131644,0.07621951219512195,0.6309212060985703,1.0,22/64,19.94%,ELOF1;MLLT3;POLR2D;CDC73;CCNH;MNAT1;CDK7;CDK12;TCEA1;IWS1;POLR2C;RTF1;PAF1;POLR2F;GTF2H4;LEO1;MLLT1;CDK13;AFF4;GTF2H2;SETD2;POLR2K
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5872365391529479,1.3195865825137598,0.1497005988023952,0.6304720741585881,1.0,2/11,8.78%,PDK1;STK24
prerank,endocardial cushion development (GO:0003197),-0.45745807817077827,-1.3195318457072323,0.12850467289719625,0.5546169812525089,1.0,9/21,14.31%,NOS3;TGFB2;BMPR2;NOTCH1;ACVRL1;BMP4;TBX2;ACVR1;HEY1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.556489626868124,1.3188053563276687,0.16967509025270758,0.6315801361933477,1.0,3/13,5.09%,BMP6;BMPR1A;TGFBR1
prerank,neural crest cell development (GO:0014032),-0.38413315602216125,-1.3187894534757827,0.1056701030927835,0.5551540311499056,1.0,12/44,10.13%,SEMA6D;ERBB4;CDH2;PHACTR4;TBX1;SEMA3C;SEMA4D;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.5466056285454457,-1.3184043463712942,0.13307240704500978,0.5546925766425583,1.0,5/11,13.88%,ANK3;PRKCQ;LYN;SYK;PLAUR
prerank,regulation of muscle contraction (GO:0006937),0.47457811076433376,1.317903795717345,0.1396551724137931,0.6330799744899812,1.0,4/26,6.12%,TNNC1;ATP1A2;TPM1;PLCE1
prerank,triglyceride catabolic process (GO:0019433),-0.46902492794184547,-1.3178598747042434,0.1244343891402715,0.554723990426136,1.0,9/19,43.53%,LPL;PNPLA3;LIPH;FABP3;LIPC;FABP4;FABP7;FABP12;FABP5
prerank,maturation of 5.8S rRNA (GO:0000460),0.5244941381261325,1.3177366659739544,0.17491166077738515,0.632212901791166,1.0,6/17,16.77%,MPHOSPH6;NSA2;C1D;WDR12;RPF1;EXOSC10
prerank,homeostasis of number of cells (GO:0048872),-0.5372725920193886,-1.3176823128617197,0.15417558886509636,0.5536269211631972,1.0,3/12,4.28%,NOS3;NOTCH1;CCN3
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5938953108318796,1.3172259340404604,0.15355086372360843,0.6324523488071959,1.0,3/10,4.57%,VTN;ITGA5;ARNT
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.5879182945072202,1.317144705202386,0.14068441064638784,0.6312276843793493,1.0,1/11,0.24%,ENPP3
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.40244555069053467,1.3169238726469465,0.11755485893416928,0.6305084823348216,1.0,15/56,12.97%,ADAMTS1;ANXA1;CCND3;STOX1;ANAPC11;KLHL18;ESPL1;PHB2;UBE2C;ANKRD17;BRD4;RAD51B;CUL3;NSMCE2;CDC27
prerank,microvillus organization (GO:0032528),-0.5198581166777974,-1.3164872355569606,0.1279826464208243,0.5554841355461578,1.0,7/13,20.41%,TNIK;FXYD5;RAPGEF2;MINK1;RAPGEF6;RAP1A;STK26
prerank,peptidyl-lysine modification (GO:0018205),0.37498744524515737,1.316317538907413,0.08591549295774648,0.6309940046425663,1.0,27/99,16.44%,EYA1;SENP7;LOXL3;LOXL1;LIPT1;RANBP2;TPR;HDAC4;ETFBKMT;METTL21C;PIAS1;SIRT4;SUMO1;ESCO1;SENP6;NSMCE2;LOXL4;EGR2;SENP3;SENP1;POM121;IFIH1;P3H4;P3H3;NUP37;KAT2B;ATPSCKMT
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.47744907611124326,1.3158122207431011,0.1423611111111111,0.631187596585978,1.0,10/25,19.23%,LSM1;SF3B3;DDX23;SLU7;SRSF4;TXNL4A;SCAF11;SNRNP40;PRPF3;KHSRP
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.5917462329387957,1.3154719075116614,0.1825242718446602,0.6307999490020941,1.0,5/10,17.07%,PARP14;PTPN2;SH2B3;NF2;PPP2CA
prerank,regulation of protein targeting to membrane (GO:0090313),-0.42096998782039363,-1.3153842787323213,0.1288888888888889,0.5571655904857407,1.0,8/28,14.68%,ANK3;INPP5K;CEMIP;MTCL1;MFF;KCNB1;HRAS;C2CD5
prerank,blood vessel endothelial cell migration (GO:0043534),0.49220635713101396,1.3146532011490608,0.14336917562724014,0.63195526763719,1.0,5/22,4.57%,EFNB2;ROBO1;NRP1;CDH5;MIA3
prerank,response to iron ion (GO:0010039),0.5675363734924301,1.314630384249199,0.17843866171003717,0.6306032440915779,1.0,4/12,13.14%,BMP6;BCL2;ACO1;HFE
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.4336512396869624,-1.3141269628429932,0.125,0.5591991616386109,1.0,11/24,18.17%,PLCG2;RYR2;HTR2C;RYR3;FGF2;ERO1A;PTPRC;CCL19;HTR2B;IBTK;HTR2A
prerank,positive regulation of type 2 immune response (GO:0002830),0.5465594821854823,1.3139485573062697,0.15770609318996415,0.6314206587805725,1.0,4/14,7.90%,RSAD2;IL6;PRKCZ;IL18
prerank,positive regulation of protein kinase activity (GO:0045860),-0.30704491156488223,-1.3136646795037643,0.0425531914893617,0.5588771524890587,1.0,42/148,15.71%,TNIK;GRM5;TGFB2;INSR;PTK2B;PAK1;CALM1;GAS6;SNCA;CALM2;EMP2;DAB2IP;MMD;HSP90AB1;RAPGEF2;PAK5;CCDC88A;ACE;CALM3;LRP8;CLSPN;RASSF2;STK11;VEGFA;MINK1;LCP2;BORA;ADRB2;PAK3;SRCIN1;ALS2;TTBK1;HSP90AA1;CSF1R;RELN;JTB;PAK4;PTPRC;CCL19;CDKN1A;RAP1A;IRGM
prerank,protein phosphorylation (GO:0006468),0.31888126249685383,1.3135535615065521,0.010356731875719217,0.6313115164209205,1.0,114/478,16.11%,IGFBP3;PDK1;PDPK1;EFEMP1;TGFBR3;TEC;ROCK2;CAMK1D;NRK;PDGFRA;FGFR1;PRKAG2;STK32B;GRK3;FAM20C;DDR2;STK39;EIF2AK2;OXSR1;PRKAA2;TSSK3;INSRR;BMPR1A;EPHA3;BMP2K;FAM20A;EPHA8;FER;CDK8;DAPK1;TAOK3;BMP2;KIT;CRY1;IKBKE;TLR4;TOP1;LATS2;TGFBR1;AAK1;PRKCZ;MAP3K1;MORC3;EPHA1;PDGFRB;MAPK6;TGFBR2;CCL2;MAP4K1;FAM20B;GSK3B;NEK4;MAP2K6;WNK4;BAZ1B;CCNH;SIK3;LRRK2;STK24;STK3;EPHA4;COQ8B;PPP4R1;TLR2;CDK7;TLK2;CDK12;PTPN6;AKT3;MUSK;CDK16;HIPK3;MAPK14;IRAK3;PTK2;GRK5;JAK1;ILF3;PPP3CB;MAP2K1;RPS6KA3;DAPK2;MAP3K7;ERN2;MAPK9;MASTL;MAP3K13;SRPK1;STRADB;ACVR1C;CSNK2A2;FRK;TRIB1;ABI1;WNK1;EIF2AK3;NUAK2;GTF2H4;BIRC6;TBK1;MAPKAPK5;PRKD2;RARA;RYK;ILK;ALK;STK4;SMAD2;CDKL3;ACVR2B;LIMK1;TXK;APP;PKN2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3547750489555019,1.3132365948519797,0.057455540355677154,0.6309213724006238,1.0,25/150,10.22%,PTPN13;IGFBP3;PDPK1;DEPTOR;ENPP1;PRKAG2;PID1;PLPP3;PPM1E;LDLRAD4;FBLN1;PMEPA1;ERRFI1;PRKCZ;EPHA1;MVP;PPEF2;DTNBP1;MYADM;LRRK2;TAF7;SMAD6;GPD1L;PTPN6;DNAJC3
prerank,regulation of axon regeneration (GO:0048679),0.5756815750498092,1.3132222434756124,0.19767441860465115,0.629548860675872,1.0,3/12,8.91%,PTN;STK24;EPHA4
prerank,lung development (GO:0030324),0.4541085563765842,1.3130384191465592,0.131175468483816,0.6287146836634983,1.0,6/33,7.35%,PDPN;FGF1;RBP4;LOXL3;ERRFI1;DNAAF1
prerank,negative regulation of blood pressure (GO:0045776),-0.5154674794675405,-1.3127609789614627,0.14533622559652928,0.5598890703113261,1.0,4/13,10.16%,NOS3;BMPR2;PRCP;NOS1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.46383463926781165,-1.312645045668703,0.13513513513513514,0.5586092896491422,1.0,8/20,8.04%,DMD;ATP1B1;RYR2;CALM1;CALM2;SLC8A1;CALM3;CAMK2D
prerank,regulation of macrophage cytokine production (GO:0010935),-0.5236358576507916,-1.3125771319350614,0.15948275862068967,0.55725702197156,1.0,5/13,9.78%,PLCG2;TGFB2;SEMA7A;CD74;TGFB3
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.394577220583151,1.312500360193499,0.08748114630467571,0.6289528176707776,1.0,16/72,16.60%,FLRT2;FGFR1;FGF1;RBFOX2;FRS2;KL;POLR2D;HNRNPH1;FGF18;FLRT1;POLR2C;SHOC2;NOG;POLR2F;FLRT3;FGF20
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5565500704010193,1.312161435491751,0.16727941176470587,0.6286275767375211,1.0,2/13,1.22%,ZMIZ1;ELOF1
prerank,embryonic organ morphogenesis (GO:0048562),0.42908726059320285,1.3117169245035596,0.11804384485666104,0.6287137916902874,1.0,8/42,11.39%,EFEMP1;FBN1;PDGFRA;RBP4;HOXC4;DYNC2I1;MFAP2;MFAP5
prerank,cellular glucan metabolic process (GO:0006073),0.5857904379862318,1.3106541993540206,0.18497109826589594,0.630690177181084,1.0,3/11,9.47%,PRKAG2;GSK3B;PYGM
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.48173922935697444,1.31044219629662,0.14930555555555555,0.6299593416907271,1.0,4/23,5.39%,MCU;DPP4;CAMK1D;C5AR2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.43968945314897995,1.3103756028097602,0.10766721044045677,0.6287622189073235,1.0,10/37,10.62%,ADCY7;IL17D;IL6;TLR4;APPL2;PPARA;NOS2;GBP5;APPL1;MAPK14
prerank,inositol phosphate-mediated signaling (GO:0048016),0.521608728996022,1.308967666573765,0.14634146341463414,0.6317929408868385,1.0,8/19,19.51%,NFAT5;NFATC4;PLCE1;NMUR1;PPP3CB;ADGRB2;NFATC2;NFATC3
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5989720454713388,1.3089676071707168,0.18333333333333332,0.6304134803172164,1.0,3/10,6.10%,IFI35;PTPN22;NR1H3
prerank,peptidyl-threonine modification (GO:0018210),0.3940618559562102,1.3089669704566158,0.09770992366412214,0.629042160259588,1.0,16/66,14.96%,PDPK1;ROCK2;STK39;OXSR1;TGFBR1;GALNT2;TGFBR2;GALNT1;GSK3B;LRRK2;HIPK3;MAP2K1;CSNK2A2;WNK1;TBK1;PRKD2
prerank,microvillus assembly (GO:0030033),-0.507943737975417,-1.3088029600605042,0.1487964989059081,0.5666044667459195,1.0,7/14,20.41%,TNIK;FXYD5;RAPGEF2;MINK1;RAPGEF6;RAP1A;STK26
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.5961040017319162,1.3084012198328538,0.17870722433460076,0.6294831889542299,1.0,2/10,4.16%,ADGRV1;IFT88
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.4891143530129425,1.3080341344810091,0.15570934256055363,0.6292797774347147,1.0,5/23,6.04%,UACA;PPM1A;IFI35;BMP7;CPNE1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.4852396762848056,-1.3075402717706448,0.14382022471910114,0.5686087189836154,1.0,8/17,15.96%,SMAD7;CALM1;CALM2;INPP5K;CALM3;DDIT4;SPRED2;SPRED3
prerank,body fluid secretion (GO:0007589),-0.4995171588418005,-1.307510309907654,0.15178571428571427,0.5670549071897508,1.0,4/15,12.83%,ERBB4;VEGFA;NPR1;PRLR
prerank,"phagocytosis, engulfment (GO:0006911)",-0.3971777053956869,-1.3074870536449084,0.10459183673469388,0.5655508185364428,1.0,16/36,25.96%,ELMO1;THBS1;XKR4;XKR6;RHOG;MEGF10;DOCK1;RHOH;RAC1;RHOBTB1;FCGR1A;ITGB2;BIN2;ADGRB1;AIF1;MSR1
prerank,regulation of hydrolase activity (GO:0051336),-0.34933152609104917,-1.3073864010689018,0.07492795389048991,0.5642330167735811,1.0,21/71,12.58%,CHN2;PRKG1;FGD5;PLXNA4;EFNA5;EPHA5;NTRK2;ADAP1;DAB2IP;ARHGAP44;RASIP1;RAB3GAP1;FGD6;CAMK2A;ARHGAP15;ARHGAP27;NOS1;CAV1;RAPGEF6;SCARB2;VAV1
prerank,intermediate filament organization (GO:0045109),0.5222854598195813,1.306386883451084,0.15875912408759124,0.6331356592001374,1.0,7/17,19.81%,VIM;DES;EPPK1;KRT9;DNAJB6;BFSP1;DSP
prerank,ether lipid metabolic process (GO:0046485),0.5400723856259517,1.3063739839627169,0.1553784860557769,0.6318019778235772,1.0,2/14,8.42%,AGMO;PLA2G6
prerank,mRNA modification (GO:0016556),-0.45038153651992896,-1.3061764032587835,0.11910112359550562,0.5661835832545219,1.0,12/22,28.96%,PUS7;PUS3;VIRMA;CBLL1;ZC3H13;TRMT6;TRUB1;METTL8;TRMT10C;RPUSD2;METTL14;TRMT61A
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.3850262333110557,-1.3059629807443467,0.0945273631840796,0.5651757187852664,1.0,14/39,14.16%,EFNA5;THBS1;ACER2;NOTCH1;ADAM15;MYOC;NEXMIF;RCC2;SEMA3E;AP1AR;SPOCK1;PTPRO;FZD4;ACTN4
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.5111182700112916,-1.3059306660793135,0.1391304347826087,0.5636764059887162,1.0,10/13,36.76%,TOX;BMP4;SOD1;CAMK4;ADAM8;ZC3H8;CLPTM1;VNN1;FOXJ1;TESPA1
prerank,regulation of osteoblast proliferation (GO:0033688),0.5248285437639229,1.3054865708571137,0.18181818181818182,0.633311958860776,1.0,3/17,4.04%,EIF2AK2;NELL1;BMP2
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5881355739136249,1.3052768629289844,0.1949317738791423,0.6326752943980659,1.0,1/10,0.11%,KMT2A
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3151769834765463,1.3043319151498523,0.015555555555555555,0.6342902018517975,1.0,79/509,11.25%,TCF7L2;PDPK1;WLS;LPAR1;ROCK2;SASH1;AKAP13;PDGFRA;FN1;SELP;FGFR1;FGF1;AXL;EIF2AK2;ECM1;KSR1;NUPR1;NFAT5;DDX60;GAB2;FAM110C;PPM1A;GJA1;OSM;IL11;FRS2;EPHA8;OSBPL8;TRAF5;DCN;NEDD4;KL;ROR1;ADGRV1;TGFA;LITAF;ANGPT1;CFLAR;BMP2;KIT;IFI35;IKBKE;IL6;BCL2;GSDME;TLR4;TGFBR1;MTDH;HAX1;PDGFRB;MIER1;GOLT1B;BIRC3;PELI2;CPNE1;TRIM5;OASL;BST2;JMJD8;LGALS9;VAPA;WNT5A;IL18;BAX;RIPK2;PHB2;MST1R;PIK3R5;TLR2;ANKRD17;IGF2;BRD4;PTPN6;FGF18;DNM1L;FNIP1;PTK2;UBE2V1;BCL2L1
prerank,negative regulation of bone mineralization (GO:0030502),0.5556313493511518,1.3043029104297235,0.166044776119403,0.6330240841820831,1.0,5/13,14.52%,ENPP1;ECM1;BCOR;RFLNA;SRGN
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3530578177189624,1.3042683551153498,0.06914893617021277,0.6317863544351532,1.0,20/150,6.04%,TCF7L2;PDPK1;PDGFRA;FGFR1;FGF1;AXL;GAB2;FAM110C;OSM;FRS2;OSBPL8;KL;TGFA;ANGPT1;KIT;TGFBR1;MTDH;HAX1;PDGFRB;CPNE1
prerank,positive regulation of B cell proliferation (GO:0030890),-0.4095362801943467,-1.304205357442612,0.12926829268292683,0.5669090871986593,1.0,10/29,21.33%,MEF2C;TFRC;CD38;CD74;CD40;CLCF1;PTPRC;CD320;CD81;MIF
prerank,regulation of smooth muscle contraction (GO:0006940),-0.46949654476174923,-1.3036407229458407,0.12962962962962962,0.5670313519492128,1.0,5/20,11.76%,KCNB2;CHRM3;CHRM2;ADRB2;CAV1
prerank,regulation of microtubule polymerization (GO:0031113),-0.3823568171131689,-1.3035800780570976,0.11029411764705882,0.5656196269173386,1.0,18/40,24.12%,NAV3;PAK1;SNCA;RPS3;MET;STMN2;TUBB4A;FES;PRUNE1;MAP2;RAC1;MAPT;STMN1;CDK5RAP2;DCTN1;ARL2;OCLN;MAPRE1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5900462938267415,1.3033178292694974,0.18023255813953487,0.6334157555565296,1.0,2/10,1.79%,FN1;GATA6
prerank,cellular response to organonitrogen compound (GO:0071417),-0.32240470354461065,-1.302113613584331,0.039473684210526314,0.5682856032748463,1.0,29/99,19.45%,SLIT2;MEF2C;AKAP6;ACTB;CDH1;HCN1;GABRB3;SLC5A5;RYR3;CTNNB1;INPP5K;RAPGEF2;HCN2;GABRB1;RRAGB;PDE2A;PDE3A;KCNQ1;GABRB2;SPAAR;RAP1A;CPEB4;HRH1;BRCA1;RRAGC;P2RX7;GLRA2;GLRA1;LAMTOR2
prerank,long-term synaptic potentiation (GO:0060291),-0.4579061140606492,-1.3015365269055343,0.1342281879194631,0.5684030522510135,1.0,6/21,6.91%,SLC24A2;PTK2B;GRIN2A;SHANK2;GRIN2B;NPTN
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5511498899042575,1.3012192268854796,0.17228464419475656,0.6387717232457066,1.0,7/13,18.18%,ENTPD7;LRRK2;RHOQ;EFL1;OPA1;RAN;GNAI3
prerank,nuclear transport (GO:0051169),-0.500015108645254,-1.300436338405647,0.13288288288288289,0.5702764048195618,1.0,7/16,23.15%,NPM1;AAAS;XPO1;ANP32A;RBM15B;NXT1;BANF1
prerank,peptide cross-linking (GO:0018149),0.4797632031018193,1.3000029590539848,0.14097744360902256,0.64121373694245,1.0,3/25,3.42%,COL3A1;FN1;ANXA1
prerank,positive regulation of developmental process (GO:0051094),0.3481816570570835,1.2996815993769346,0.07076101468624833,0.6409197946332936,1.0,40/164,17.34%,PHLDB2;SOX5;PTN;MCU;FOXD1;CCN2;FGFR1;SMURF2;BMPR1A;GJA1;DAG1;NCOA3;DCN;BMP2;BMP1;BMP7;CLASP1;PHLDB1;RALBP1;ADGRL1;WNT5A;SYDE1;TAPT1;DNM1L;ENPP2;RPS6KA3;DVL3;MAP3K13;RTN4;VHL;TLE6;NIBAN2;ALK;MIEF1;SHLD2;MUL1;KMT5C;DLG5;CPEB3;GDNF
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.5010565067974107,-1.2991174251799535,0.15825688073394495,0.5726780204735803,1.0,7/13,20.26%,SHANK3;LGMN;ZDHHC2;RELN;ADCY8;AKAP5;CHRNA7
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3117799208272366,1.2982098775062263,0.010250569476082005,0.6443059144081545,1.0,104/497,15.42%,TCF7L2;WNT4;FOXD1;PRICKLE1;RBPJ;ZHX2;ATXN1;ARID4A;NR2F2;ENPP1;TLE1;SAMD4A;SMURF2;EIF2AK2;IGFBP5;GATA6;SHMT1;SAMD13;ZBTB4;SNX6;ZIC2;GLI3;RBFOX2;ZMYND15;MBD2;MYB;TCEAL7;IGF2BP1;EID2B;CRY2;PRDM11;DAPK1;LOXL3;BMP2;RFX3;CRY1;BMP7;BCOR;SALL1;GZF1;CBFA2T2;CDAN1;TSHZ3;FOXP3;DKK3;HDAC4;NANOS2;PBXIP1;GLIS2;ZEB1;GSK3B;DPF2;WNT5A;ZMYND11;PHB2;KAT6B;SCMH1;IGF2BP2;USP47;EPC1;TAF7;SUMO1;JARID2;HEYL;ATF7IP;PSPC1;GMNN;WWP2;CIR1;SMAD4;BCL7A;ILF3;TSPYL2;SCML4;LHX9;ZNF219;FBXW11;VGLL4;EIF4ENIF1;BTRC;ERN2;ARID5B;POU2F1;DDX6;CBX4;NR3C1;PRDM5;BHLHE41;RUNX1T1;KAT6A;EIF2AK3;GIGYF2;KDM8;PDS5A;RBM15;NIBAN2;UIMC1;ZBTB21;RARA;SP3;HDAC2;PML;SMARCA4;SMAD2
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5241426108714131,-1.2980774664889894,0.1431451612903226,0.5724183920711763,1.0,3/12,5.16%,AKAP6;CAMTA1;PTBP1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5241426108714131,-1.2980774664889894,0.1431451612903226,0.5724183920711763,1.0,3/12,5.16%,AKAP6;CAMTA1;PTBP1
prerank,B cell receptor signaling pathway (GO:0050853),-0.4017692809309981,-1.2977589432469434,0.12408759124087591,0.5716570883925444,1.0,12/32,15.17%,MEF2C;PRKCB;PLCG2;RFTN1;PLEKHA1;BMX;CD38;BCAR1;PIK3CD;SYK;LAT2;PTPRC
prerank,positive regulation of interferon-alpha production (GO:0032727),0.50749283373023,1.2976987593418958,0.18738404452690166,0.6445078500663857,1.0,7/19,19.46%,TLR4;STAT1;RIPK2;TBK1;IFIH1;DHX36;SETD2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5294525648238939,1.2976980785425904,0.177007299270073,0.6431530494849109,1.0,6/15,14.18%,IL17D;IL6;TLR4;GBP5;APPL1;TICAM1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.5121727899890457,-1.2975623095529507,0.14780600461893764,0.5706756265036438,1.0,5/13,15.30%,ELOVL5;ELOVL7;TECR;TECRL;HACD3
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3848588956367267,1.2974617135473867,0.09956709956709957,0.6425597127349001,1.0,12/73,9.01%,ROBO1;COL4A3;SMAD3;CASP12;DLC1;CFLAR;TNFSF15;CASP4;IFT57;NGFR;BAX;CASP8AP2
prerank,neurotransmitter transport (GO:0006836),-0.3427658148749382,-1.297188849247627,0.07923497267759563,0.5702922570806743,1.0,18/73,11.07%,NRXN1;RIMS1;SYT1;PPFIA2;HSPA8;LIN7A;PTPRN2;GABRA2;SNAP25;SYN3;SLC1A1;STXBP1;CPLX1;SLC1A2;SYN1;SNPH;DVL1;GAD2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.5066528331286161,-1.2971561975545314,0.14573991031390135,0.5688568912335634,1.0,11/13,45.85%,CSTF2;CPSF2;CSTF2T;CPSF1;CPSF4L;CPSF6;TUT1;NUDT21;CPSF7;NCBP1;CPSF4
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.42052866098317626,1.2969277731785118,0.14165261382799327,0.6428337194751769,1.0,10/46,5.76%,ATRNL1;LAMC1;FN1;PARVA;RADIL;NRP1;FER;ANTXR1;LAMC3;EPHA1
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.4466712214566875,-1.296814979362796,0.12984054669703873,0.5683831548605777,1.0,9/22,16.84%,CALM1;CALM2;MRE11;ACE;CALM3;RASSF2;VEGFA;NEK10;PDGFD
prerank,positive regulation of RNA splicing (GO:0033120),-0.40888034786550304,-1.2967673869306606,0.1111111111111111,0.5669772793254816,1.0,9/29,27.40%,PIK3R1;CELF4;SETX;TRA2A;RBM3;HNRNPLL;SLC38A2;RBMXL1;RBM20
prerank,regulation of hemopoiesis (GO:1903706),0.5884776007796914,1.2963565304560896,0.17288801571709234,0.6433172285056139,1.0,5/10,10.70%,PTN;IL17D;CREBBP;MAFB;MYSM1
prerank,regulation of adaptive immune response (GO:0002819),0.503369212118549,1.295789654093238,0.17657342657342656,0.6437864735250791,1.0,2/18,4.15%,IL6ST;ADCY7
prerank,positive regulation of cell communication (GO:0010647),-0.41851665322734344,-1.295701280805094,0.13994910941475827,0.5685165546014912,1.0,6/28,3.93%,RIMS1;SYT1;RIMS2;GRIK2;HOMER1;ANK3
prerank,sulfation (GO:0051923),0.560590619415794,1.2955761902254495,0.193158953722334,0.643113260513531,1.0,1/11,0.31%,UST
prerank,positive regulation of secretion (GO:0051047),-0.5351466741909356,-1.29549459820281,0.15732758620689655,0.567597857285193,1.0,2/11,10.06%,ACSL3;NPR1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4184590307715828,1.2951842452216564,0.14,0.6429895564332158,1.0,10/43,12.73%,IGFBP5;BMPR1A;GJA1;ADAMTS1;IL6;PDGFRB;STAT1;IL18;CDH13;P2RY6
prerank,bicarbonate transport (GO:0015701),-0.43432159694832245,-1.2949944196441734,0.15422885572139303,0.567622273774549,1.0,8/25,14.53%,SLC4A10;SLC26A7;CA4;CA2;CYB5R1;CYB5RL;SLC39A8;SLC4A7
prerank,oligosaccharide metabolic process (GO:0009311),-0.374533764537815,-1.2948864667546038,0.12694300518134716,0.5664556455062661,1.0,9/46,9.95%,ST6GALNAC3;ST8SIA4;FUT8;ST3GAL6;FUT9;ST8SIA6;ST6GALNAC4;ST6GALNAC5;NEU1
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5637942345219678,-1.2942805894117002,0.18699186991869918,0.5668059004603067,1.0,3/10,9.03%,CTNNB1;FZD3;VEGFA
prerank,sulfur amino acid metabolic process (GO:0000096),-0.4318272236029145,-1.2941636936345624,0.12709832134292565,0.5656066616747296,1.0,11/24,24.93%,MTHFR;MSRA;TXN2;GCLC;MTRR;SMS;CTH;ADO;MPST;NOX4;AHCY
prerank,embryonic digestive tract development (GO:0048566),0.5120683906579726,1.2932579355023066,0.15992647058823528,0.6476386297686376,1.0,4/18,6.17%,PDGFRA;GLI3;SALL1;RARB
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3402110680385358,1.2928384876128467,0.04509283819628647,0.6476194105234989,1.0,29/182,8.66%,ROBO1;WNT4;PARP14;ROCK2;RBMS3;NOTCH2;PRKAA2;BMPR1A;ITGB8;PARP9;TNRC6B;SLC24A3;TERT;BMP2;PTPN22;STOX1;OPTN;SNX12;CPNE1;ATP2B4;NOS2;PARP10;LGALS9;YAP1;OPRD1;ANXA7;MYADM;TNRC6A;MOV10
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4478535031749083,1.2925388931821995,0.12078152753108348,0.6472670068788426,1.0,6/32,6.45%,PHLDB2;ARHGAP6;DLC1;CASK;SERPINE1;RASA1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.481231548467367,1.2921104821278453,0.16546762589928057,0.6473070859914116,1.0,7/25,11.67%,STAT5B;ARNT;BRD1;STAT1;FAM210B;MAPK14;FOXO3
prerank,gas transport (GO:0015669),-0.560242304799601,-1.29198756852907,0.15560165975103735,0.5702041320226435,1.0,3/10,11.23%,CA2;CYGB;IPCEF1
prerank,leukotriene metabolic process (GO:0006691),0.48731685311631767,1.2917370215743196,0.17304189435336975,0.6471639565031312,1.0,3/19,7.01%,PLA2G4A;DPEP2;PTGR1
prerank,endocrine system development (GO:0035270),0.5095266736465359,1.2917303034879686,0.1760299625468165,0.6458531437891457,1.0,4/21,6.30%,WNT4;TGFBR1;SALL1;DKK3
prerank,positive regulation of phospholipase C activity (GO:0010863),0.42090964654995944,1.291124106107581,0.14285714285714285,0.6463045317016634,1.0,12/40,15.98%,ARHGAP6;LPAR1;PDGFRA;FGFR1;KIT;PDGFRB;PHB2;NMUR1;P2RY6;BDNF;NTRK3;TXK
prerank,regulation of gene expression (GO:0010468),0.30303795555355434,1.2906380747692354,0.0042417815482502655,0.6464841910912611,1.0,174/903,14.87%,ROBO1;EFEMP1;RORA;BMP6;WNT4;PARP14;ROCK2;FOXD1;SMAD3;RBPJ;RBMS3;ATXN1;FN1;AFDN;WNT6;PID1;FGF1;TLE1;PRDM6;NOTCH2;ARNT2;OSR1;PRKAA2;FOXC1;NFIA;NFYC;AFF3;TRIM10;POU5F1;WNT3A;PTBP3;BMPR1A;GJA1;SSBP2;ZNF395;ZBTB4;DENND4A;ITGB8;NELL1;CDH5;MYB;PARP9;GCGR;PRRX2;TNRC6B;SLC26A9;SLC24A3;IGF2BP1;PTHLH;ANGPT1;AHNAK;PRDM11;TERT;PERM1;BMP2;RFX3;RC3H1;PKP3;APBB1;IL6;BMP7;CRP;TLR4;TRIM17;TGFBR1;PTPN22;GZF1;STOX1;NSD3;BAZ2A;ZNF35;SNX12;CPNE1;WWC2;FOXP3;ATP2B4;TESMIN;TRIM5;CREBBP;TCF7L1;HDAC4;NSD1;NOS2;CREBL2;CTSH;POGZ;PARP10;CLK4;POU1F1;LGALS9;GSK3B;NOVA1;RNF20;HNRNPH1;YAP1;PDCD5;OPRD1;WNT5A;ZSCAN21;ANXA7;NFXL1;DTNBP1;ATF7;MYADM;ZFP37;TNRC6A;MOV10;TEAD2;KAT6B;SOX21;IGF2BP2;TAPBP;TLR2;FUBP1;SUFU;IGF2;MAFB;CREM;NOCT;MUSK;TIPARP;ADAM19;RFXANK;FGF18;MSC;MAPK14;PSPC1;TDRD7;WWP2;TCF7;CUX2;UBE2V1;TGFBRAP1;NFKBIZ;LRP3;TRIM21;IHH;CSF1;ZNHIT3;AFF1;MAP2K1;HNRNPH3;ZNF219;TRIM26;ZFAT;MAPK9;METTL16;OGG1;CRNN;MZF1;NOG;HFE;FLOT2;THAP1;PTBP2;NR3C1;PRDM5;ZNF205;SERTAD3;RNF39;CARM1;ZNF462;HIC1;TICAM1;USP36;FUS;EIF2AK3;DMTF1;ZC3H7B;VHL;AFF2;NTRK3;NCOA2;PABPN1
prerank,mesonephros development (GO:0001823),0.5678038422013849,1.2904075859169533,0.17318435754189945,0.6458690877923543,1.0,3/11,4.78%,FGF1;OSR1;BMP7
prerank,regulation of cell growth (GO:0001558),-0.2863069973666204,-1.2903776187406502,0.023474178403755867,0.5733085042257576,1.0,46/204,14.82%,APBB2;SLIT2;NRG3;PTPRJ;AKAP6;SMARCA2;TGFB2;TFRC;BMPR2;NET1;ADAM15;PPP2R1A;RERG;ACVRL1;SOX17;H3-3A;CCN3;PRKCQ;FAM107A;CAPRIN2;PAK5;NDRG3;AKT1;CEACAM1;DDX49;STK11;SDCBP;CAMK2D;ING1;SPOCK1;IP6K2;NPR1;KIF26A;RACK1;CCAR2;EXOSC2;RPS6KA1;BCAR1;CEP43;MFSD2A;EGFR;JADE1;DCUN1D5;LGI1;PAK4;TAF9B
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.44911885222055714,-1.2901421025095714,0.14814814814814814,0.5723914005347366,1.0,7/20,9.16%,SLC12A2;KCNMA1;ATP1B1;KCNJ2;ATP1A1;SLC8A1;NEDD4L
prerank,metanephric mesenchyme development (GO:0072075),0.5804635388467637,1.2896823554888943,0.20656370656370657,0.646787557832342,1.0,3/10,6.82%,WNT4;OSR1;STAT1
prerank,negative regulation of transposition (GO:0010529),0.52451830159769,1.2895459367999778,0.17358490566037735,0.64590212774531,1.0,3/16,8.66%,TUT4;PIWIL4;MOV10
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.5303689759182503,1.289479643244771,0.18164794007490637,0.6448041526457058,1.0,3/15,2.97%,CD55;GLI3;IL23R
prerank,positive regulation of cell population proliferation (GO:0008284),0.31450808200836317,1.2892300972557538,0.024361948955916472,0.644272628817531,1.0,51/423,7.90%,TCF7L2;EFNB2;TGFBR3;BMP6;PTN;LAMC1;DPP4;RBPJ;PDGFRA;FN1;FGFR1;PID1;FGF1;DDR2;OSR1;IL31RA;IL6ST;GAB2;PHIP;GHRH;WNT3A;BMPR1A;GJA1;S100A6;OSM;IL11;IL34;FER;VEGFD;TGFA;PTHLH;TERT;GLP2R;BMP2;IL6;BCL2;GLI1;TGFBR1;STOX1;EPHA1;PDGFRB;HDAC4;BST2;STAT1;CD47;CTSH;TGFBR2;STAMBP;YAP1;WNT5A;IL18
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.5111126121663204,1.2888007153536325,0.19854280510018216,0.6443732446072272,1.0,4/16,11.20%,SLX4;TOP2B;FANCM;CENPX
prerank,cell-substrate junction assembly (GO:0007044),-0.4001181067663888,-1.2880581926837593,0.12289156626506025,0.5769620134315726,1.0,12/33,11.94%,ITGA6;ACTN1;PTPRK;THSD1;PEAK1;ITGB4;LAMA3;RCC2;TESK2;TRIP6;BCR;ARHGEF7
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.5022732737542357,-1.2877747997595246,0.1649269311064718,0.5762879976027521,1.0,6/13,10.55%,KDR;COL4A1;CTNNB1;SEMA3E;VEGFA;NOTCH4
prerank,protein localization to membrane (GO:0072657),-0.2977259803064579,-1.2871649770971336,0.014150943396226415,0.5764154944258599,1.0,48/187,14.68%,DPP10;NRXN1;NLGN1;DLG2;BSG;KCNB2;SHANK3;LRRC7;EFR3B;CACNB2;TNIK;ATP1B1;LIN7A;RFTN1;CPE;CDH1;KCNIP4;ITGA4;GAS6;ANK3;MAP7;EMP2;DPP6;TSPAN14;INPP5K;STXBP1;RAPGEF2;RAB3C;RAB38;TM9SF3;RAMP2;TMED2;LRP6;ZDHHC2;DVL1;KCNB1;ZFYVE27;CAV1;FGF13;RAPGEF6;RAB12;EHD4;AGRN;F11R;RAB40B;ABHD17A;CLASP2;C2CD5
prerank,peptidyl-asparagine modification (GO:0018196),-0.40209606905821627,-1.286860011388535,0.11306532663316583,0.5757437196108165,1.0,12/31,25.91%,FUT8;MGAT5;RPN2;ALG5;LMAN1;DPM2;OSTC;STT3B;HIF1AN;UBE2J1;DDOST;OST4
prerank,protein polyglutamylation (GO:0018095),-0.5286453328398422,-1.286748523667269,0.17057569296375266,0.574567564177591,1.0,2/11,5.60%,TTLL7;TTLL5
prerank,entry into host (GO:0044409),-0.5155282509203667,-1.2864610546234017,0.15932914046121593,0.5739120342228989,1.0,6/13,15.83%,CDH1;MET;CTNNB1;CBL;PPIA;CBLL1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.42450101947375607,1.2863953000965183,0.14426229508196722,0.6506640988664695,1.0,6/41,7.03%,TNNC1;TGFBR3;RBPJ;BMPR1A;TPM1;TGFBR2
prerank,positive regulation of T cell cytokine production (GO:0002726),0.4977655539029354,1.286378470604433,0.15135135135135136,0.6494060562540837,1.0,5/20,7.90%,RSAD2;CD55;IL6;PRKCZ;IL18
prerank,negative regulation of interleukin-17 production (GO:0032700),0.5812980362764171,1.286218939817603,0.20378151260504201,0.6485986669604953,1.0,2/10,6.24%,TLR4;FOXP3
prerank,membrane assembly (GO:0071709),-0.39412304176103746,-1.285327515838571,0.13350785340314136,0.5756823927917688,1.0,9/34,8.78%,NRXN1;NLGN1;PTPRD;RFTN1;IL1RAPL1;ANK3;EMP2;NSFL1C;NLGN3
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.4683722125686747,-1.2850273234691862,0.14285714285714285,0.5750936757940824,1.0,9/17,37.25%,CADM1;RAET1E;LAMP1;RASGRP1;SLAMF6;NECTIN2;CD226;IL12A;CRTAM
prerank,protein autoubiquitination (GO:0051865),0.382925464918745,1.2849468349158428,0.1283987915407855,0.6513698088967068,1.0,13/61,16.64%,RNF220;RNF213;SH3RF1;TRIM17;DTX3L;AMFR;WWP2;TRIM21;CUL3;RNF181;BFAR;RNF146;RNF185
prerank,cell differentiation in spinal cord (GO:0021515),-0.5390722932040791,-1.284786526667528,0.1794871794871795,0.5744021562826198,1.0,2/10,7.03%,MDGA2;SOX6
prerank,second-messenger-mediated signaling (GO:0019932),0.3784415493338467,1.2839434524522577,0.10752688172043011,0.6532285431609068,1.0,13/82,9.82%,PDPK1;RCAN2;MCU;FPR2;ACKR2;CCR9;DGKD;RCAN1;PLCE1;NOS2;ACKR3;LRRK2;NMUR1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3556319825626424,1.2837675379407012,0.08011444921316166,0.6524925061385247,1.0,23/117,10.96%,ALDH1A2;PCCA;ACOT11;LDHAL6B;PANK2;PPARA;ALDH4A1;ME2;PTGR1;NPC1;ACADSB;GLO1;AMACR;PCCB;ECHDC3;NAAA;SCP2;BTD;HLCS;ACOT1;ABAT;HACL1;SCPEP1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5656741958036161,1.2837057515021828,0.1797752808988764,0.6513855087412649,1.0,2/11,1.22%,ZMIZ1;ELOF1
prerank,post-translational protein modification (GO:0043687),0.3185203333554778,1.2831671219626333,0.04260355029585799,0.6516064274422229,1.0,49/332,12.80%,IGFBP3;CP;TNC;FBN1;LAMC1;FSTL1;FN1;PRKCSH;LTBP1;FAM20C;SPSB1;IGFBP5;APOA2;HIF3A;SDC2;FSTL3;FBXO11;RCN1;ITIH2;MIA3;IL6;EPAS1;KLHL22;KLHL21;APLP2;SPSB4;CUL4A;FBXO9;FBXL3;PSMB10;NUB1;CHM;PSMA7;PSMA3;FBXL20;PSME4;FBXL7;DNAJC3;PSMA5;FBXO4;KEAP1;KLHL13;ESCO1;CUL3;CSF1;FBXW11;ASB5;ANO8;BTRC
prerank,cellular response to growth factor stimulus (GO:0071363),0.3436175439622695,1.2828677259202468,0.09014084507042254,0.6512717351054418,1.0,34/151,13.61%,PDPK1;SOX5;BMP6;WNT4;SMAD3;ADAMTS12;FOXC1;CLEC3B;BMPR1A;NRP1;WWOX;ANXA1;STAT5B;BMP2;BMP7;PLK5;TGFBR1;APPL2;TGFBR2;CCL2;PDCD5;WNT5A;ACAP2;APPL1;EGR3;MAPK14;SMAD4;DSTYK;MAP2K5;NR4A1;ADAMTS7;WNT2;NR3C1;ACVR1C
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.4130997891950229,1.2824827394028964,0.1421232876712329,0.6512984251918533,1.0,20/44,23.44%,ROCK2;ZC3HAV1;TNRC6B;RC3H1;NANOS2;FTO;TNRC6A;MOV10;EIF4ENIF1;METTL16;GIGYF2;CPEB3;DHX36;KHSRP;NANOS1;ROCK1;ZC3H12A;PNPT1;YTHDF3;ZFP36L2
prerank,neuron projection regeneration (GO:0031102),0.5776167696298571,1.2823790264835022,0.20696324951644102,0.6503068646706583,1.0,2/10,5.51%,PTN;NREP
prerank,neutral amino acid transport (GO:0015804),-0.41972965097069725,-1.282319787000548,0.14009661835748793,0.58011056042775,1.0,8/28,13.49%,SLC6A6;SLC7A5;SLC38A5;SLC1A1;SLC1A4;SLC43A2;SLC36A1;SLC3A2
prerank,regulation of collagen biosynthetic process (GO:0032965),0.48618347583800586,1.2820231162992015,0.1697792869269949,0.6502080944318612,1.0,3/19,4.62%,WNT4;VIM;IL6
prerank,protein import into peroxisome matrix (GO:0016558),-0.514694164976923,-1.2813622945669547,0.17446808510638298,0.5814206507857245,1.0,4/12,15.71%,PEX5L;PEX26;PEX10;PEX16
prerank,protein dephosphorylation (GO:0006470),0.34551932718578715,1.2800217444846524,0.08049113233287858,0.6552227322676804,1.0,36/135,13.86%,PTPN13;EYA2;EYA1;PPP2R2B;TPTE;PPM1E;PPM1A;DUSP10;PTPN14;PTPN4;PTPN3;PTPN22;PTPRA;MTMR3;PTPN2;PTPN9;SSH1;DUSP16;PTPN21;PPP4R2;PPEF2;CTDSP2;PPP4R1;PTPN6;DUSP5;PPM1B;PPP1CB;EYA4;PTPRU;PPP3CB;PTPN1;PTPN18;FBXW11;BTRC;PPM1M;NCK1
prerank,pulmonary valve development (GO:0003177),-0.4610067657896829,-1.2797078395339605,0.15417558886509636,0.5847455892247914,1.0,8/18,8.13%,SLIT2;ROBO2;NOS3;TGFB2;BMPR2;NOTCH1;BMP4;TNFRSF1B
prerank,regulation of neutrophil migration (GO:1902622),-0.5445699841058856,-1.279463339965945,0.20040899795501022,0.5839423204536432,1.0,7/10,32.46%,JAM3;RHOG;RHOH;RAC1;BST1;MPP1;RAC2
prerank,cellular response to oxygen levels (GO:0071453),-0.5502134069796636,-1.2793310233372062,0.18052738336713997,0.5828087762687343,1.0,10/10,45.02%,CPEB4;ATP6V0A2;ATP6AP1;TMEM199;ATP6V1A;PICK1;ATP6V1G1;NDUFS2;ATP6V0D1;CCDC115
prerank,positive regulation of neutrophil migration (GO:1902624),0.502315240478493,1.279027134293075,0.1564748201438849,0.6569603670542531,1.0,2/18,0.85%,MCU;CAMK1D
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.534711878563887,1.278278315901402,0.20113851992409867,0.6581084768902846,1.0,1/14,0.13%,SULF1
prerank,smooth muscle cell differentiation (GO:0051145),-0.5157486853929629,-1.2781862984554895,0.17269076305220885,0.5848726399838049,1.0,6/12,14.31%,MEF2C;MRTFB;BMP4;TMEM204;APLNR;HEY1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.49249572973413774,-1.2779368360051013,0.18201284796573874,0.5841556868970136,1.0,6/14,17.36%,PRKAR1A;RAPGEF2;ADRB2;PRKAR2B;PKIG;PKIB
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5359052947183094,-1.2770540735027283,0.16597510373443983,0.58532957664357,1.0,7/11,29.37%,FOXO1;FAS;CAV1;ATP6V0A2;ATP6AP1;TMEM199;ATP6V1A
prerank,positive regulation of binding (GO:0051099),0.37050858912916285,1.276994204773258,0.11145510835913312,0.6608054981927673,1.0,17/84,8.91%,TCF7L2;VTN;FOXC1;WNT3A;PARP9;DACT1;TERT;BMP2;DTX3L;SPPL3;CLN5;GSK3B;SKI;RIPK2;LRRK2;STK3;AMFR
prerank,long-term memory (GO:0007616),0.4839780936195567,1.2763534021445726,0.1893939393939394,0.6614795568054904,1.0,3/19,8.56%,RASGRF1;NFATC4;PJA2
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.33133432642385563,-1.276268561594537,0.0701219512195122,0.5862700260615479,1.0,36/79,26.28%,ACTR10;SH3GL2;MFSD6;OSBPL1A;LGMN;CTSD;AP1S1;AP1S2;CTSS;DYNC1H1;CD74;KIF26A;FCER1G;KIF18A;CTSL;DYNC1I2;KIF15;KIF3B;KIF5A;DYNLL2;AP1B1;CAPZA2;ACTR1B;SAR1B;AP2B1;KIF23;AP1S3;DCTN1;KIF4A;RACGAP1;KIF22;DCTN6;AP2A2;AP2A1;CLTA;AP2M1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.4902297480343958,-1.2753490492733128,0.17819706498951782,0.5874404987141543,1.0,5/14,15.35%,THBS1;ITGA4;CD40;RGCC;PLCG1
prerank,activin receptor signaling pathway (GO:0032924),0.5210652838317721,1.2751772803902561,0.19136960600375236,0.6638374453480509,1.0,5/15,15.81%,SMAD3;TGFBR1;ACVR1C;SMAD2;ACVR2B
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5162199381207819,1.2749465618506883,0.2040072859744991,0.6633085925753608,1.0,6/15,15.21%,WNT6;FOXC1;BMP2;EDA;ANKRD11;HDAC2
prerank,alpha-amino acid catabolic process (GO:1901606),0.45345940493825604,1.2744027027360312,0.17597292724196278,0.663537277868949,1.0,7/29,13.37%,DDO;ALDH4A1;ACADSB;HGD;BLMH;ACAT1;SARDH
prerank,positive regulation of insulin secretion (GO:0032024),0.4313428112269123,1.2743761289579776,0.15130434782608695,0.6623157666936936,1.0,10/36,18.52%,TCF7L2;MCU;RBP4;PLA2G6;NLGN2;PPP3CB;BAIAP3;SOX4;C2CD2L;BLK
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5442672904158804,-1.2743204307909846,0.19665271966527198,0.5890708408922226,1.0,4/10,8.05%,PDE3B;ACER2;NEXMIF;JAM3
prerank,regulation of cartilage development (GO:0061035),0.4979489768247633,1.2742967172058521,0.1773049645390071,0.6612483587249152,1.0,5/18,5.32%,SOX5;PTHLH;BMP2;BMP1;MBOAT2
prerank,2-oxoglutarate metabolic process (GO:0006103),0.5393913603525755,1.2742835169247462,0.1931166347992352,0.6600171104894986,1.0,6/13,24.58%,IDH1;D2HGDH;IDH2;PHYH;ADHFE1;OGDH
prerank,negative regulation of GTPase activity (GO:0034260),-0.4372786498451585,-1.273939878264862,0.17687074829931973,0.5887168145107353,1.0,7/22,13.50%,LRCH1;CPEB2;DAB2IP;RCC2;TMED2;F11R;HRAS
prerank,smoothened signaling pathway (GO:0007224),0.4481878785076445,1.2738716124143588,0.18416523235800344,0.659994209453921,1.0,8/32,11.93%,EVC2;GLI3;ARL13B;GLI1;GPC2;CC2D2A;IHH;DISP3
prerank,cellular copper ion homeostasis (GO:0006878),-0.49500407048665274,-1.2734641135612677,0.16735537190082644,0.5886973710063179,1.0,7/14,26.62%,ATOX1;SLC31A1;SLC31A2;MT2A;CCDC22;COX19;ABCB6
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5521376849726708,1.273273070102239,0.22666666666666666,0.6606011796627926,1.0,7/11,19.98%,TPR;RESF1;ATF7IP;TASOR;PPHLN1;SETDB1;MPHOSPH8
prerank,protein polyubiquitination (GO:0000209),0.31666867688878375,1.2724764997854154,0.04727272727272727,0.6617143083691956,1.0,68/297,16.07%,SASH1;RNF152;RNF213;SPSB1;SMURF2;TRIM56;HERC6;RNF217;TRAF5;FBXO11;FBXL17;TRIP12;NEDD4;TTC3;NHLRC3;RC3H1;BCL2;RNF19A;SIAH2;UBE2U;DZIP3;RNF216;PELI2;ANAPC11;DTX3L;TRIM5;NPEPPS;FBXO9;RNF20;FBXL3;PSMB10;ANAPC1;PSMA7;AMFR;UBE2C;PSMA3;FBXL20;PSME4;LONRF1;FBXL7;FBXO38;PSMA5;FBXO4;BLMH;WWP2;UBE2V1;HUWE1;TRIM21;IFI27;CUL3;HECTD1;FBXW11;BTRC;HECW2;CDC27;UBE2Q2;UBE2E3;BFAR;PRPF19;LNPEP;FBXL4;UBE2R2;DDA1;FBXL12;FBXL13;MUL1;RNF146;TNKS2
prerank,positive regulation of leukocyte migration (GO:0002687),0.4555444810231727,1.272467046477767,0.16552901023890784,0.6604672566530168,1.0,3/27,4.62%,PTN;MIA3;IL6
prerank,positive regulation of JNK cascade (GO:0046330),-0.33561412818809955,-1.2721666883222837,0.11209439528023599,0.591014807738728,1.0,29/70,23.10%,PLCB1;PTK2B;TPD52L1;MAP3K5;DAB2IP;HMGB1;MAP3K11;RASSF2;SDCBP;MFHAS1;DUSP22;MINK1;MAPK8IP1;GADD45G;ANKRD6;SEMA3A;HRAS;CCL19;NOD2;CD27;DUSP15;LTBR;PYCARD;SH3RF3;UNC5CL;SH3RF2;TRAF1;TAOK2;FLT4
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.535030886667236,-1.2720584936203612,0.17894736842105263,0.5898433857951504,1.0,3/10,5.26%,CSGALNACT1;XYLT1;B3GAT2
prerank,male gonad development (GO:0008584),0.4343512505916701,1.2717551109231982,0.14261744966442952,0.6614474122597196,1.0,5/34,7.87%,WNT4;WNT2B;GATA6;KIT;WNT5A
prerank,androgen receptor signaling pathway (GO:0030521),0.5607905611119346,1.2714756742365567,0.22777777777777777,0.6610768643505442,1.0,2/11,3.70%,ZMIZ1;PMEPA1
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.3725353668372514,-1.2711651943549303,0.11345646437994723,0.5910030071337321,1.0,18/42,33.60%,LARS2;KARS1;CARS1;EEF1E1;EARS2;IARS1;TARS3;RARS2;VARS2;HARS1;YARS2;FARSB;WARS2;QARS1;NARS1;PARS2;YARS1;TARS1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.4035420758281319,1.2709367660273947,0.132569558101473,0.6615661310088957,1.0,12/51,12.86%,PTN;CXCL10;FPR2;IL34;VEGFD;IL6;SERPINE1;LGALS9;PTK2;ANO6;CSF1;RARRES2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.4241660680941389,-1.269809582081666,0.16455696202531644,0.5935866913713618,1.0,11/26,28.61%,PDE8A;AKT1;PINK1;ATF4;PPIA;PARK7;GPR37;GPR37L1;PYCR1;HSPB1;VNN1
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.46086605139820813,-1.2697802692808704,0.15021459227467812,0.59220262911324,1.0,8/19,17.99%,TEK;PTPRJ;KDR;MYOC;VEGFA;COL16A1;RAC1;PPM1F
prerank,negative regulation of immune response (GO:0050777),0.33624846740840847,1.269749052964044,0.07607192254495158,0.6640365626510699,1.0,22/154,10.75%,ENPP3;COL3A1;GHRH;ADORA2A;FER;PTHLH;GLP2R;RC3H1;ADCY7;IL6;ADCY5;MC2R;RXFP2;FOXP3;ADCY1;ADM;RAMP1;GPR39;INSL3;PPM1B;MAPK14;IRAK3
prerank,regulation of T cell mediated immunity (GO:0002709),-0.5504305144728241,-1.2696154921377871,0.20892494929006086,0.5912037311054763,1.0,2/10,8.13%,HMGB1;TNFRSF1B
prerank,negative regulation of glycolytic process (GO:0045820),0.576127994055832,1.2693682868594094,0.212890625,0.662685844537974,1.0,3/10,6.62%,NUPR1;PPARA;HDAC4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.576127994055832,1.2693682868594094,0.212890625,0.662685844537974,1.0,3/10,6.62%,NUPR1;PPARA;HDAC4
prerank,DNA damage checkpoint signaling (GO:0000077),-0.4096140944012816,-1.2690857261078883,0.15186915887850466,0.5912792134603375,1.0,13/28,24.60%,INTS7;CLSPN;DOT1L;MAP3K20;ATM;HINFP;RAD1;CHEK1;ATRIP;DONSON;ATR;FBXO6;RHNO1
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.4198195537026424,-1.2690742370937464,0.15777262180974477,0.5898732126603601,1.0,9/25,15.17%,PDE4D;PDE4B;PLCG2;RPS3;MALT1;CD80;CD86;PNP;PTPRC
prerank,Notch signaling involved in heart development (GO:0061314),0.5527369265743487,1.2690531990305538,0.2125237191650854,0.662316457890174,1.0,2/11,1.56%,RBPJ;NOTCH2
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.40839510370481585,-1.2682591271604824,0.14388489208633093,0.5908455833695184,1.0,13/28,26.64%,NAV3;PAK1;RPS3;MET;FES;RAC1;MAPT;CDK5RAP2;DCTN1;ARL2;OCLN;MAPRE1;CLIP1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.3813384753250463,-1.2681522096248135,0.1377672209026128,0.5897147496158495,1.0,9/35,7.75%,NLGN1;CDH11;CDH12;CDH10;ATP2C1;CDH8;CDH22;CDH7;CDH20
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.44353424599096436,-1.2679786246330977,0.15172413793103448,0.5887538623626989,1.0,5/20,13.47%,FUT8;ST3GAL6;FUT9;ST6GALNAC5;ST3GAL4
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.505380421547223,1.267624087732432,0.19784172661870503,0.6658034262476858,1.0,4/17,17.38%,PLA2G4A;PLA2G5;SERAC1;LPGAT1
prerank,negative regulation of cell cycle (GO:0045786),0.37649544584526834,1.2675752103910154,0.12444444444444444,0.6646931575759054,1.0,18/73,13.02%,SMAD3;NR2F2;NUPR1;FOXC1;BMP2;PTPN3;BTG3;BMP7;LATS2;BTG4;NPPC;NUPR2;GMNN;IPO7;TSPYL2;NR4A1;HECA;NUDT6
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3653390283393083,1.2673376090013226,0.1054172767203514,0.6642265284579627,1.0,16/87,12.98%,FLRT2;FGFR1;FGF1;RBFOX2;FRS2;KL;POLR2D;CCL2;HNRNPH1;EGR3;FGF18;FLRT1;POLR2C;DSTYK;NR4A1;SHOC2
prerank,prostaglandin biosynthetic process (GO:0001516),0.4884745602152447,1.2668719852944736,0.20840950639853748,0.6644072525463933,1.0,2/18,1.39%,PTGS1;PLA2G4A
prerank,regulation of epithelial cell migration (GO:0010632),0.39709043340264416,1.266799459130689,0.151033386327504,0.6633552637886451,1.0,13/51,10.98%,PTN;MCC;SASH1;DOCK5;TACSTD2;GLIPR2;DUSP10;CLASP1;CTSH;GLUL;INSL3;PTK2;ENPP2
prerank,negative regulation of translation (GO:0017148),0.366743604416744,1.266654587563531,0.09715994020926756,0.6625721576253948,1.0,26/87,21.23%,ROCK2;SAMD4A;EIF2AK2;IGFBP5;SHMT1;IGF2BP1;DAPK1;CPEB1;TPR;NANOS2;FTO;IGF2BP2;ILF3;EIF4ENIF1;DDX6;METTL16;EIF2AK3;GIGYF2;CNOT9;CPEB3;FXR2;DHX36;NANOS1;ROCK1;RNF139;EPRS1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.3666015656865323,-1.2666077606113832,0.14324324324324325,0.5912608400610524,1.0,18/48,15.35%,PDE4D;DMD;UBASH3B;AKAP6;PTK2B;FKBP1A;CALM1;SNCA;CALM2;CEMIP;CALM3;CAMK2D;SELENON;NOS1;SRI;APLNR;CASQ2;PLCG1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.5343896390905427,1.26639647049092,0.22202166064981949,0.6621932165046859,1.0,7/13,15.53%,NUPR1;LRRK2;TMEM39A;SCFD1;CHMP4A;CHMP4B;FEZ2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3080406059332677,1.266219187064437,0.037209302325581395,0.6614989309325663,1.0,88/417,15.42%,TCF7L2;WNT4;FOXD1;PRICKLE1;RBPJ;ZHX2;ATXN1;ARID4A;NR2F2;TLE1;SMURF2;GATA6;SAMD13;ZBTB4;SNX6;ZIC2;GLI3;RBFOX2;ZMYND15;MBD2;MYB;TCEAL7;EID2B;CRY2;PRDM11;LOXL3;BMP2;RFX3;CRY1;BMP7;BCOR;SALL1;NIF3L1;GZF1;CBFA2T2;TSHZ3;FOXP3;DKK3;HDAC4;PBXIP1;GLIS2;ZEB1;DPF2;WNT5A;ZMYND11;PHB2;KAT6B;SCMH1;USP47;EPC1;TAF7;SUMO1;JARID2;HEYL;ATF7IP;PSPC1;GMNN;WWP2;CIR1;SMAD4;BCL7A;ILF3;SCML4;LHX9;ZNF219;FBXW11;VGLL4;BTRC;ERN2;ARID5B;POU2F1;CBX4;NR3C1;PRDM5;BHLHE41;RUNX1T1;KAT6A;KDM8;RBM15;NIBAN2;UIMC1;ZBTB21;RARA;SP3;HDAC2;PML;SMARCA4;SMAD2
prerank,brain development (GO:0007420),-0.3014200507592511,-1.2646692812060505,0.04198473282442748,0.5953778113159471,1.0,27/136,11.57%,ADGRL3;ADGRL2;CNTNAP2;CTNNA2;SHANK3;ROBO2;CDH2;MEIS2;CNTN4;COL4A1;ZFHX3;PBX3;SHROOM4;GRIN2A;ADGRG1;GRIN2B;RAB3GAP1;SCYL2;APOD;RAPGEF2;SOX6;NDRG4;BAG6;GRIN1;DDIT4;PAX2;NFIB
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.559669887674718,1.2635329744261063,0.21747967479674796,0.6686623412582025,1.0,1/10,0.60%,DPP4
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.4987677226296502,1.2631895036708483,0.19964973730297722,0.6685843496194619,1.0,2/16,2.60%,WNT4;VIM
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.48056469206605346,-1.2631312948628868,0.19700214132762311,0.5985051326827919,1.0,8/15,19.65%,RYR2;RAB3GAP1;SRP14;SPCS2;SPCS1;ZFAND2B;SEC61A1;SEC61G
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.5134956105132059,-1.263105554918789,0.17959183673469387,0.5971670986181193,1.0,5/12,11.57%,THRB;LMO2;CTSB;CTSS;CTSL
prerank,regulation of mitochondrial fission (GO:0090140),0.4660794110345412,1.2629915325192367,0.1660839160839161,0.6679852741102167,1.0,9/24,17.15%,MCU;STAT2;DCN;RALBP1;LRRK2;DNM1L;MIEF1;MUL1;MYO19
prerank,regulation of cell population proliferation (GO:0042127),0.29852085142508794,1.2623766954747742,0.017391304347826087,0.6686406474734614,1.0,135/691,16.11%,TCF7L2;ALDH1A2;IGFBP3;EFNB2;PDPN;PODN;BMP6;COL4A3;PTN;DPP4;KANK2;PDGFRA;FN1;CXCL10;FGFR1;FGF1;EIF2AK2;IL31RA;KSR1;NUPR1;TPTE;STAT2;IL6ST;GAB2;DLC1;PHIP;GHRH;LDOC1;WNT3A;PDS5B;BMPR1A;OSM;IL11;RBFOX2;IL34;FER;ADAMTS1;SMIM22;TGFB1I1;VEGFD;TGFA;PTHLH;PTPN14;STAT5B;GLP2R;BMP2;KIT;IGFBP6;IFI35;IL6;BTG3;BCL2;GSDME;GLI1;COL18A1;TGFBR1;BTG4;STOX1;EPHA1;PDGFRB;FOXP3;PTPN2;HDAC4;STAT1;CD47;CTSH;CDKN2B;TGFBR2;CLMN;STAMBP;POU1F1;ZBTB7C;CDC73;YAP1;PDCD5;SKI;PIAS1;SETD4;MST1R;IL13RA1;DNAJA2;IGF2;SMAD6;IFITM1;PTPN6;CGRRF1;NUPR2;FGF18;PTK2;IFNLR1;GRK5;CDH13;STAT4;CUL3;SH2B3;CSF1;PTPRU;MAP2K1;SLURP1;TJP1;TCIRG1;CADM4;NUDT6;WNT2;TRAPPC14;RBM5;FRK;ABI1;WDR6;NPR3;IFIT3;MDM4;VHL;NTRK3;BIRC6;NIBAN2;PKD2;RAB33B;RARA;TNS2;HDAC2;PML;ALK;CCAR1;PDF;P3H3;NF2;MEAK7;SOX4;KAT2B;CCKBR;ADRA2A;WWTR1;AXIN2;APP
prerank,neurotransmitter biosynthetic process (GO:0042136),0.5195450263002683,1.2620468445603799,0.21052631578947367,0.6684693381736129,1.0,3/14,16.42%,MOXD1;SLC5A7;SLC22A2
prerank,secondary palate development (GO:0062009),0.5116863389336679,1.2613982597845825,0.19,0.6692222241071978,1.0,6/14,11.55%,TGFBR3;WNT3A;LRRC32;TGFBR2;WNT5A;SMAD4
prerank,positive regulation by host of viral transcription (GO:0043923),-0.477129540241419,-1.2611777457952245,0.18018018018018017,0.6013611559953987,1.0,5/15,14.80%,LEF1;CTDP1;TFAP4;SMARCB1;TAF11
prerank,inhibitory synapse assembly (GO:1904862),-0.5256627930322115,-1.2608033797081282,0.2088607594936709,0.6010446275360706,1.0,7/11,24.45%,GABRA2;GABRB3;LGI2;FGF13;GABRB2;GABRA1;PLXNB1
prerank,regulation of stem cell population maintenance (GO:2000036),0.49994386467790863,1.2606595632871673,0.2146690518783542,0.6702634578245922,1.0,2/18,3.13%,PTN;NCOA3
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.41980739824463525,-1.2604109747510774,0.18777292576419213,0.6007688145700105,1.0,7/23,15.05%,PDE4B;RYR2;SNCA;MAPK3;KCNQ1;ATF4;NR4A3
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.5419395939699763,-1.259855681876531,0.18125,0.6009955193754396,1.0,8/10,24.51%,ATP5F1A;ATP5MC1;ATP5PO;ATP5PD;ATP5F1D;VPS9D1;ATP5MG;ATP5MC3
prerank,striated muscle tissue development (GO:0014706),-0.4048974576101647,-1.2595551463180847,0.13138686131386862,0.6004308677600835,1.0,7/29,5.20%,SGCZ;PGM5;MEF2C;SGCD;BMPR2;SIX1;MYL6
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.31228307644021674,-1.259498341464981,0.07051282051282051,0.5991680612385496,1.0,30/94,23.73%,PLCB1;ST18;RPS6KA5;IL1R1;NOD1;IL1RAP;PSMC3;MAPK3;UBB;PSMD3;PSMD14;PSMD6;PSMD4;PSMA6;PSMA4;PSMB8;UBA52;PSMA8;NOD2;PSME1;TOLLIP;IRAK1;IKBKB;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;SKP1;PSMD8
prerank,negative regulation of chemotaxis (GO:0050922),-0.39829019688321615,-1.2594503734449816,0.15454545454545454,0.5979136250073739,1.0,12/31,10.13%,SLIT2;ROBO2;SEMA6D;THBS1;NOTCH1;SEMA3C;SEMA4D;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.5214316205829075,-1.2593028889394045,0.19096509240246407,0.5969460269783807,1.0,7/11,35.18%,UQCRH;UQCR11;UQCC3;UQCR10;UQCRQ;CYCS;UQCRB
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.49580272972686595,-1.259113503055278,0.18625277161862527,0.5961400205639218,1.0,7/13,20.63%,SORL1;GCC2;INSIG1;TMEM30A;BRSK2;SAR1B;CD81
prerank,actin filament network formation (GO:0051639),-0.529039554825941,-1.2583453279338854,0.1962025316455696,0.5970782734769687,1.0,7/11,31.40%,ACTN1;PLS3;LCP1;FHOD3;CARMIL1;SPIRE2;CARMIL2
prerank,ERBB2 signaling pathway (GO:0038128),-0.39293484322850075,-1.2583278500595871,0.14553990610328638,0.5957297732741451,1.0,9/31,18.69%,ERBB4;PIK3R1;GAB1;MYOC;HSP90AA1;EGFR;EGF;ERBIN;NRG2
prerank,transcription by RNA polymerase II (GO:0006366),0.3122501206314631,1.2580092344257028,0.06242350061199511,0.6773456850471377,1.0,85/305,20.50%,RORA;SOX5;RBPJ;CCN2;ELOF1;NOTCH2;TEAD1;MLLT3;TBL1XR1;MAF;NR6A1;POLR2D;PCF11;PRRX1;GLIS3;PIR;DTX1;NR1H3;RARB;RPRD2;CREBBP;PPARA;CDC73;INTS9;YAP1;TRIM24;CCNH;TEAD2;MNAT1;CDK7;TAF7;CDK12;NABP1;NOCT;TCEA1;IWS1;INTS14;POLR2C;RTF1;MAML2;NR4A1;POU2F1;NFIC;NR3C1;PAF1;MED20;PKNOX1;POLR2F;INTS3;GTF2H4;ERCC6;SNAPC3;INTS8;PABPN1;LEO1;MLLT1;RARA;CSTF3;IRF9;KAT2B;WWTR1;TBL1X;TAF9;DDX21;CDK13;AFF4;SLBP;GTF2H2;INTS13;PMF1;ESRRA;SNAPC5;NFYA;INTS6;E2F2;SETD2;PGR;RPRD1B;POLR2K;WDR33;MED26;NABP2;DDX5;XBP1;TRIP11
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.5265663151628553,1.2578514974000277,0.192090395480226,0.6766064451155928,1.0,4/13,4.75%,TGFBR3;RBPJ;BMPR1A;GLI1
prerank,pyroptosis (GO:0070269),0.5126724228756748,1.2577313930972671,0.2031523642732049,0.6757626787634177,1.0,3/15,4.69%,ZBP1;CASP4;GSDME
prerank,regulation of cellular pH (GO:0030641),-0.4016242563699155,-1.2574535826711084,0.14805825242718446,0.5969261555374632,1.0,8/29,14.53%,SLC4A10;SLC9A2;CA2;SLC9A8;SLC9B1;ATP5F1B;SLC9A5;SLC4A7
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.4751064113592193,1.2568856567447102,0.1925925925925926,0.6772606767739553,1.0,3/19,5.09%,ZMIZ1;AXL;MMP14
prerank,regulation of multicellular organism growth (GO:0040014),0.5209368160331477,1.2565451042929159,0.20555555555555555,0.6770972181520447,1.0,7/15,18.49%,GHR;GHRH;STAT5B;GDF15;APP;STAT5A;PTCH1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5143253398416627,1.2561363560593015,0.20772058823529413,0.6772347357129774,1.0,3/14,7.90%,IL23R;IL17D;IL18
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.5454455289062172,-1.2560073602611763,0.18217821782178217,0.5997711541434304,1.0,4/10,18.17%,SORL1;HSP90AB1;HSP90AA1;NAB2
prerank,regulation of catecholamine secretion (GO:0050433),-0.4048704669564985,-1.255674085366388,0.16166281755196305,0.5993333519879185,1.0,13/29,26.66%,SYT1;SNCA;SYT7;SYT4;KCNB1;SYT9;KCNA2;SYT2;CHRNA4;SYT6;SYT5;SYT10;SYT17
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.4267474343023175,1.2551831925312436,0.17346938775510204,0.6789365819753853,1.0,6/35,7.82%,SULF1;COL4A3;NR2F2;STAT1;CCL2;NGFR
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.5075606520644446,1.2548085141985188,0.19926873857404023,0.6788311885384414,1.0,3/15,7.99%,SH3D19;NRDC;SNX9
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.508861598524604,-1.254787333570741,0.19874476987447698,0.6005726933354776,1.0,6/12,15.98%,DMD;ATP1B1;ANK3;NOS1;GLRX;FXYD1
prerank,mRNA destabilization (GO:0061157),0.4210903834404776,1.2541831479012415,0.1686746987951807,0.6795499546102426,1.0,16/38,23.44%,ROCK2;TUT4;POLR2D;RC3H1;FTO;MOV10;METTL16;GIGYF2;CPEB3;TUT7;DHX36;KHSRP;ROCK1;ZC3H12A;YTHDF3;ZFP36L2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.4237662642332493,1.2539840341993937,0.17263843648208468,0.6789868098790696,1.0,9/34,12.97%,PHIP;TGFA;PDGFRB;ANAPC11;ESPL1;IGF2;CUL3;NSMCE2;CDC27
prerank,respiratory tube development (GO:0030323),0.44792997987084665,1.2538131597550923,0.17725752508361203,0.6782548392460583,1.0,5/28,7.35%,PDPN;FGF1;RBP4;LOXL3;DNAAF1
prerank,amino acid import (GO:0043090),-0.4324561877632527,-1.2536467724868952,0.1580135440180587,0.6024006554367356,1.0,6/21,5.48%,SLC6A6;SLC47A1;SLC7A5;SLC6A1;SLC7A1;SLC1A1
prerank,cell chemotaxis (GO:0060326),0.38049604810296495,1.2532074388445684,0.14580031695721077,0.6789232915709178,1.0,15/60,15.42%,LPAR1;PDGFRA;PARVA;ACKR2;CCR9;NRP1;KIT;PDGFRB;ACKR3;EGR3;EPHA2;NR4A1;CXCR4;CCL25;CCRL2
prerank,cellular response to virus (GO:0098586),0.4360511531498578,1.2525245809674348,0.19332161687170474,0.679854359244226,1.0,13/30,23.34%,CXCL10;IL6;GSDME;LGALS9;BAX;MAPK14;IFIH1;GBF1;ARF1;HIF1A;ZC3H12A;LGALS8;RIOK3
prerank,cell part morphogenesis (GO:0032990),0.5314146141772772,1.2518003523641734,0.22281639928698752,0.6808574225105141,1.0,5/13,13.73%,PID1;PACSIN2;DNM1L;SUPV3L1;WASF1
prerank,protein O-linked glycosylation (GO:0006493),0.35159537528433715,1.2511672161029208,0.12518195050946143,0.6815735929453316,1.0,15/96,7.63%,TMTC4;GALNT18;GALNT14;GALNT15;MUC2;GXYLT2;GALNT12;TRAK1;TMTC1;LARGE1;GALNT2;GALNT1;RXYLT1;POMT2;GCNT4
prerank,positive regulation of neuron death (GO:1901216),0.40047430910470627,1.2509784815996934,0.16881028938906753,0.6809465328983578,1.0,7/46,8.04%,EFNB2;EPHA7;NUPR1;TLR4;GSK3B;WNT5A;BAX
prerank,endothelial cell differentiation (GO:0045446),-0.5041774043222673,-1.2491686809779732,0.20682730923694778,0.6137290114594577,1.0,6/12,10.48%,TIE1;KDR;BMPR2;ACVRL1;SOX18;SCUBE1
prerank,regulation of phospholipase C activity (GO:1900274),0.5005416604569646,1.2489085583139647,0.21660649819494585,0.6863422390304018,1.0,4/15,5.76%,PDGFRA;FGFR1;KIT;PDGFRB
prerank,positive regulation of collagen metabolic process (GO:0010714),0.4868117435221401,1.24869215425778,0.2084063047285464,0.6857785035895504,1.0,2/17,2.60%,WNT4;VIM
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.35414067194372423,1.2484639872201553,0.1303724928366762,0.6853053254098668,1.0,16/108,9.01%,UACA;ROBO1;COL4A3;SMAD3;CASP12;DLC1;DAPK1;CFLAR;TNFSF15;CASP4;IFT57;LGALS9;PDCD5;NGFR;BAX;CASP8AP2
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.4824687698205462,1.2478416656152231,0.20357142857142857,0.685981261158407,1.0,5/20,7.90%,TLR4;MTDH;PTPN22;CCL2;IL18
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.44766706013227436,1.2477461318399834,0.1918819188191882,0.6850560816441238,1.0,6/26,7.53%,FHL2;RCAN1;ATP2B4;EFHB;SPPL3;GSK3B
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4096511922146609,1.2474876838843338,0.1888,0.6846471385206019,1.0,8/43,7.82%,SMAD3;TEAD1;POU5F1;NFATC4;TERT;KLF5;PPARA;NGFR
prerank,negative regulation of dephosphorylation (GO:0035305),-0.4404155579689957,-1.2474595645648918,0.18202247191011237,0.6171370465959621,1.0,7/18,21.84%,PPP1R16B;INPP5K;MFHAS1;SH3RF2;PPP1R26;PPP1R15A;PPP1R8
prerank,regulation of synapse maturation (GO:0090128),-0.5451845383468346,-1.2472604093486686,0.20734341252699784,0.6163552227271083,1.0,3/10,5.06%,NRXN1;ARHGEF15;DAB2IP
prerank,negative regulation of neuron death (GO:1901215),-0.31458725273444366,-1.2467676064739606,0.10191082802547771,0.6164438359813683,1.0,27/93,17.70%,MEF2C;PTK2B;CD34;NTRK2;SIX1;SNCA;SORL1;FOXQ1;NDNF;LGMN;AKT1;PINK1;TNFRSF1B;TGFB3;NGF;ATF4;GRN;SIX4;SOD1;CLCF1;PARK7;BTBD10;CPEB4;SET;TOX3;NTF3;ADAM8
prerank,sphingolipid catabolic process (GO:0030149),-0.467284650191618,-1.2466226526345547,0.2017353579175705,0.6154297776297649,1.0,2/15,2.15%,ACER3;ACER2
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.3391552641325471,-1.2463490187251545,0.12359550561797752,0.6148963453454823,1.0,16/64,7.31%,LIMCH1;EFNA5;PEAK1;THBS1;ACER2;PTK2B;ADAM15;GPM6B;UTRN;MACF1;ACTG1;EMP2;MYOC;CDK6;NEXMIF;SEMA3E
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3724045761208733,1.2462807011740338,0.15695067264573992,0.6873033923032026,1.0,13/68,10.23%,MMAB;ENPP1;PCCA;SHMT1;SLC19A1;AOX1;MTHFD1;PANK2;PCCB;BTD;LMBRD1;PDXK;HLCS
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.30871506945111193,1.2459878001238174,0.06588235294117648,0.6869538914943931,1.0,61/348,13.14%,ROBO1;BMP6;ROCK2;FOXD1;SMAD3;RBPJ;RBMS3;FN1;AFDN;WNT6;PID1;FGF1;TLE1;OSR1;WNT3A;GJA1;ITGB8;ANXA2;CDH5;GCGR;TNRC6B;SLC26A9;SLC24A3;ANGPT1;BMP2;PKP3;IL6;BMP7;CRP;TLR4;TGFBR1;PTPN22;STOX1;DTX3L;CTSH;LGALS9;GSK3B;YAP1;PDCD5;WNT5A;DTNBP1;TNRC6A;MOV10;TLR2;FUBP1;RESF1;MUSK;ADAM19;FGF18;MAPK14;ATF7IP;CUX2;LRP3;MAP2K5;CSF1;PTPN1;MAP2K1;ARRB1;MAPK9;NOG;HFE
prerank,endodermal cell fate commitment (GO:0001711),0.5710148208903101,1.2459640554136013,0.2546201232032854,0.6858221856219866,1.0,5/10,14.88%,POU5F1;CDC73;RTF1;PAF1;LEO1
prerank,apical protein localization (GO:0045176),-0.520603230765091,-1.2449241824679353,0.1950207468879668,0.6176360827816815,1.0,8/10,16.89%,ACTB;GOPC;MAL;JAM3;ATP8B1;SHROOM3;INSC;VANGL2
prerank,presynaptic endocytosis (GO:0140238),-0.4202147227380352,-1.244776305227318,0.17422434367541767,0.6166915701728658,1.0,5/24,8.78%,NLGN1;SYT1;AMPH;SNCA;NLGN3
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5185709023986711,-1.2446812488367862,0.21370967741935484,0.61556499931683,1.0,4/10,16.79%,RAPGEF2;NGF;RAP1A;NTF3
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.4736597559208027,1.2446407178741121,0.20035149384885764,0.6887659600463367,1.0,6/22,10.16%,IFI35;BPIFB1;PTPN22;APPL2;NR1H3;APPL1
prerank,blood vessel morphogenesis (GO:0048514),0.38974911681358315,1.2444556783657856,0.1337579617834395,0.688148656105511,1.0,10/54,7.50%,EFNB2;TGFBR3;RBPJ;CCM2;ITGB8;NRP1;TGFBR1;RASA1;TGFBR2;ADM
prerank,positive regulation of MAPK cascade (GO:0043410),0.31751111594416187,1.2437100987459997,0.08094645080946451,0.6894681497590313,1.0,38/245,9.42%,ROBO1;LPAR1;ROCK2;PDGFRA;CCN2;FGFR1;FGF1;NOTCH2;EIF2AK2;KSR1;FPR2;MTURN;OSM;IL11;GLIPR2;NRP1;IL34;EPHA8;ROR1;ANGPT1;TAOK3;BMP2;KIT;IL6;GSDME;PRKCZ;PTPN22;PDGFRB;PELI2;TRIM5;CCL2;LGALS9;ACKR3;PHB2;LRRK2;MST1R;PIK3R5;IGF2
prerank,pancreas development (GO:0031016),0.53645103615363,1.2435232763393251,0.2131782945736434,0.6888347143688354,1.0,2/12,7.35%,TCF7L2;DNAAF1
prerank,regulation of lymphocyte activation (GO:0051249),-0.511421637663646,-1.2433797965713325,0.2112676056338028,0.6182591574056616,1.0,8/12,37.29%,KAT2A;PAG1;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.43209361662887047,-1.243120825339576,0.17738359201773837,0.6176952192718866,1.0,5/20,6.48%,MEIS2;PTK2B;CDK6;ZBTB16;HOXB8
prerank,glucose transmembrane transport (GO:1904659),-0.44534375892322636,-1.242876365874345,0.1781115879828326,0.6170158284429283,1.0,9/18,33.89%,SLC2A1;PPARD;SLC2A9;SORT1;SLC2A4;SLC2A2;SLC2A10;SLC5A3;SLC2A3
prerank,organonitrogen compound catabolic process (GO:1901565),0.38472940021525404,1.242769307731402,0.1588502269288956,0.6899900278566944,1.0,16/57,18.72%,PLA2G4A;CPQ;ANPEP;GGACT;NPEPPS;CLN5;TRIM24;PLA2G6;ERAP1;ENPP2;CLPX;AMDHD2;LNPEP;PLA2G5;SGPL1;NAGK
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.533138553735464,1.242446632212123,0.25,0.6896945135414739,1.0,4/11,17.92%,GRK3;ADM;ARRB1;GTF2H2
prerank,cellular glucose homeostasis (GO:0001678),0.40737773975294883,1.2417751052361927,0.17235772357723578,0.6905999293508198,1.0,7/41,8.26%,ZBTB20;PRKAA2;NUCKS1;UNC13B;CARTPT;NGFR;HKDC1
prerank,regulation of striated muscle contraction (GO:0006942),-0.4054688387908365,-1.2415798238758193,0.19014084507042253,0.6194093683956169,1.0,8/27,12.55%,DMD;RYR2;SMAD7;CALM1;CALM2;CALM3;NOS1;SRI
prerank,cardiac muscle contraction (GO:0060048),0.4256515139025301,1.2414306376206643,0.1774193548387097,0.6905093848187849,1.0,5/34,8.38%,TNNC1;ATP1A2;CSRP3;TPM1;SCN3B
prerank,icosanoid metabolic process (GO:0006690),0.40616316683449616,1.241425896964199,0.1853146853146853,0.6893485579891953,1.0,8/40,12.44%,PTGS1;PLA2G4A;DPEP2;PLA2G4C;PTGR1;ALOXE3;EPHX1;PON3
prerank,GTP metabolic process (GO:0046039),0.5081903568922204,1.2411973673404069,0.2116788321167883,0.6888367033019103,1.0,7/15,18.18%,ENTPD7;LRRK2;RHOQ;EFL1;OPA1;RAN;GNAI3
prerank,primary miRNA processing (GO:0031053),0.5444724447988433,1.2403295706482755,0.24,0.6903542366662296,1.0,5/10,22.17%,SMAD3;SMAD2;HNRNPA2B1;PUS10;SRRT
prerank,purine ribonucleotide metabolic process (GO:0009150),0.36949437045834854,1.2402994188222471,0.1674347158218126,0.689255195664889,1.0,19/68,19.19%,AMPD3;ENPP1;ACOT11;PTHLH;TPST1;ENTPD7;LRRK2;RHOQ;ACOT9;ACOT1;ACAT1;EPHA2;EFL1;OPA1;ABHD14B;SULT1A1;RAN;GNAI3;SULT6B1
prerank,heart looping (GO:0001947),-0.3684164106040255,-1.2402408032998082,0.14358974358974358,0.6219419202756329,1.0,15/39,25.96%,MEF2C;NOTCH1;SOX17;AHI1;ZIC3;TBX2;NDRG4;SOX18;APLNR;VANGL2;DLL1;SRF;TBX6;BBS7;STIL
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.49423341291710887,-1.240170608784189,0.19507186858316222,0.62076356061428,1.0,7/12,30.33%,OPLAH;GCLC;GGT1;HAGH;MGST2;GCLM;BDH2
prerank,retina homeostasis (GO:0001895),-0.41503521404713106,-1.2397542076579395,0.18969555035128804,0.6206657616813454,1.0,6/23,16.27%,ACTB;POTEF;ACTG1;B2M;SOD1;CDH3
prerank,response to metal ion (GO:0010038),-0.3320335591988612,-1.2395153235973957,0.11977715877437325,0.6199804531820051,1.0,15/67,12.07%,TRPC3;KCNMA1;THBS1;MT1X;MT1A;CALM1;HOMER1;GPHN;SNCA;CALM2;CALM3;NEDD4L;PPP1CA;CAV1;MT2A
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.48272502802657274,-1.2394333249800304,0.20292887029288703,0.6188507765114152,1.0,7/13,17.68%,MGAT5;DOT1L;PTPRT;PIGU;PTPRC;EGF;HES1
prerank,cellular response to interleukin-6 (GO:0071354),0.45118594776054816,1.239280205732413,0.21715328467153286,0.691305972417232,1.0,8/26,11.74%,PID1;IL6ST;FER;IL6;STAT1;YAP1;SMAD4;JAK1
prerank,leukotriene biosynthetic process (GO:0019370),0.4995521653163105,1.2388032115219587,0.20656370656370657,0.6915873980778783,1.0,2/14,3.06%,PLA2G4A;GGTA1
prerank,visual perception (GO:0007601),0.36009271132792187,1.2387286353891196,0.14595375722543352,0.6906525883311764,1.0,17/84,15.96%,EFEMP1;RDH10;ZIC2;ADGRV1;COL18A1;MYO9A;TULP2;CRYBB3;IMPG2;ATXN7;EYA4;CRYBA1;OPA1;EML2;PDE6C;CEP250;COL1A1
prerank,positive regulation of bone resorption (GO:0045780),-0.5118066480097556,-1.2386935645962316,0.2267818574514039,0.6196233420760486,1.0,5/11,21.26%,SPP1;SYK;ADAM8;ATP6AP1;TNFRSF11A
prerank,regulation of myoblast differentiation (GO:0045661),0.43185393318384496,1.2385623637981,0.17880794701986755,0.6899716344808221,1.0,3/32,3.84%,RANBP3L;IGFBP3;EID2B
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.39574177290823565,1.2385566610615482,0.17252396166134185,0.6888042177721428,1.0,13/45,16.27%,BMP6;BMPR1A;TWSG1;BMP2;BMP7;TGFBR1;BMP8B;SMAD4;HFE;GDF11;GDF15;DAB2;INHA
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3215310947236064,-1.2385153767271324,0.09523809523809523,0.6174190045773784,1.0,35/78,26.28%,ACTR10;SH3GL2;OSBPL1A;LGMN;CTSD;AP1S1;AP1S2;CTSS;DYNC1H1;CD74;KIF26A;FCER1G;KIF18A;CTSL;DYNC1I2;KIF15;KIF3B;KIF5A;DYNLL2;AP1B1;CAPZA2;ACTR1B;SAR1B;AP2B1;KIF23;AP1S3;DCTN1;KIF4A;RACGAP1;KIF22;DCTN6;AP2A2;AP2A1;CLTA;AP2M1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.3215310947236064,-1.2385153767271324,0.09523809523809523,0.6174190045773784,1.0,35/78,26.28%,ACTR10;SH3GL2;OSBPL1A;LGMN;CTSD;AP1S1;AP1S2;CTSS;DYNC1H1;CD74;KIF26A;FCER1G;KIF18A;CTSL;DYNC1I2;KIF15;KIF3B;KIF5A;DYNLL2;AP1B1;CAPZA2;ACTR1B;SAR1B;AP2B1;KIF23;AP1S3;DCTN1;KIF4A;RACGAP1;KIF22;DCTN6;AP2A2;AP2A1;CLTA;AP2M1
prerank,apoptotic cell clearance (GO:0043277),-0.39242128009973276,-1.2383036600223525,0.17647058823529413,0.6167121283891204,1.0,11/30,16.32%,THBS1;XKR4;GAS6;HMGB1;SCARB1;XKR6;RHOG;MEGF10;RHOH;RAC1;RHOBTB1
prerank,calcium-mediated signaling (GO:0019722),0.35632203527718287,1.2382579541394043,0.14641288433382138,0.6885334184833709,1.0,15/93,9.82%,PDPK1;RCAN2;MCU;SELP;FPR2;ACKR2;CCR9;RCAN1;PLCE1;VCAM1;ADGRL1;ACKR3;CACNA1C;LRRK2;NMUR1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.4433832065789084,1.2380770484550818,0.19896193771626297,0.6879476575688774,1.0,6/28,6.99%,ARHGAP18;ARHGAP28;HAX1;RASA1;DBN1;PLEKHG2
prerank,maintenance of blood-brain barrier (GO:0035633),-0.39272736802641023,-1.2379226008022985,0.18564356435643564,0.6164079553429962,1.0,12/30,8.05%,PECAM1;SLC12A2;CLDN5;ESAM;DMD;ACTB;JAM2;ACTG1;SLC1A1;MBP;LSR;JAM3
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.38978277441266684,-1.237492534544212,0.15577889447236182,0.6163371440066755,1.0,11/30,25.91%,FUT8;MGAT5;RPN2;ALG5;LMAN1;DPM2;OSTC;STT3B;UBE2J1;DDOST;OST4
prerank,photoperiodism (GO:0009648),0.4382525686979946,1.2374835576539476,0.19830508474576272,0.6886734031092977,1.0,11/28,18.98%,FBXL17;CRY2;CRY1;FBXL3;CRTC1;PPP1CB;FBXL12;PML;PER3;CLOCK;BHLHE40
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4350007164587432,1.2373827762377885,0.20136518771331058,0.687829256500351,1.0,8/33,11.67%,MTURN;STAT5B;ARNT;BRD1;STAT1;FAM210B;MAPK14;FOXO3
prerank,amino acid import across plasma membrane (GO:0089718),0.4467651340180713,1.2372646118246398,0.19818181818181818,0.6869912747661074,1.0,5/24,3.96%,SLC7A2;SLC1A3;SLC6A13;SLC6A9;SLC16A2
prerank,aortic valve development (GO:0003176),-0.3830993311889272,-1.2372092466355067,0.15196078431372548,0.6157856026176393,1.0,10/34,8.13%,SLIT2;ROBO2;NOS3;TIE1;BMPR2;NOTCH1;ELN;EMILIN1;BMP4;TNFRSF1B
prerank,gland development (GO:0048732),0.39064546106095455,1.2372034131736975,0.15141955835962145,0.6860157629387482,1.0,7/59,6.30%,TGFBR3;WNT4;PRKCSH;ANXA1;TGFBR1;SALL1;DKK3
prerank,regulation of endothelial cell migration (GO:0010594),0.3587844180823688,1.2369251255004265,0.15350223546944858,0.6856996531725066,1.0,12/85,3.81%,PTN;RIN2;ROCK2;SASH1;NR2F2;SP100;FGF1;FOXC2;NRP1;DCN;ANXA3;ANGPT1
prerank,response to thyroid hormone (GO:0097066),-0.49150908419425615,-1.2361805037672808,0.21106557377049182,0.6174502580923205,1.0,5/13,11.57%,THRB;LMO2;CTSB;CTSS;CTSL
prerank,regulation of p38MAPK cascade (GO:1900744),0.42175737685509435,1.236108243220635,0.19344262295081968,0.6870682071844546,1.0,8/35,8.93%,SASH1;RELL1;DUSP10;BMP2;PTPN22;LGALS9;PJA2;DLG1
prerank,positive regulation of calcium ion transport (GO:0051928),-0.3797488054863247,-1.2360714894774487,0.17357512953367876,0.6163772195340833,1.0,9/36,11.76%,CACNB2;TRPC3;TRPC6;CAMK2A;MYLK;CACNA1D;GRIN1;CXCL12;CAV1
prerank,lymphocyte chemotaxis (GO:0048247),0.4248771351418209,1.2357801506167005,0.18425460636515914,0.6869715506506563,1.0,6/34,7.35%,CXCL10;CYP7B1;CXCL16;CKLF;MSMP;CCL2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.39637936446465,1.2356711750512244,0.1621160409556314,0.6861485989667215,1.0,10/44,13.00%,PRKAG2;CYP7B1;HSD17B1;CYP27A1;AMACR;INSIG2;SCP2;SLC27A2;CH25H;LBR
prerank,regulation of ion transmembrane transport (GO:0034765),-0.3906563305493317,-1.2354691164464204,0.15384615384615385,0.6167425710791447,1.0,10/33,14.23%,CHRM3;AKAP6;KCNJ3;KCNJ2;NEDD4L;KCNJ6;KCNJ8;KCNQ1;KCNJ15;CASQ2
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.47625174974428686,-1.234881842757892,0.200836820083682,0.6171598266102336,1.0,5/14,15.11%,DMD;ATP1B1;ANK3;ACTN4;GLRX
prerank,regulation of establishment of cell polarity (GO:2000114),0.4926394449909759,1.2348593998417696,0.21072088724584104,0.6874358373475288,1.0,3/16,2.91%,ROCK2;KANK1;CDH5
prerank,positive regulation of growth (GO:0045927),-0.3274322082325947,-1.2345738855264772,0.10704225352112676,0.6167191893625406,1.0,19/64,18.92%,PLCB1;AKAP6;TGFB2;INSR;RFTN1;H3-3A;AKT1;DDX49;SDCBP;EXOSC2;RPS6KA1;CEP43;MFSD2A;EGFR;LGI1;TAF9B;CDKN2AIP;PPM1F;EXOSC4
prerank,regulation of receptor internalization (GO:0002090),-0.3785774208566619,-1.2341950796029413,0.16136919315403422,0.6165333950297816,1.0,14/35,19.50%,INSR;ANKRD13A;ATXN2;AHI1;SCYL2;SDCBP;VEGFA;ATAD1;SFRP4;EGF;NTF3;TBC1D5;RIN3;MTMR2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.4418761035130082,-1.2338984502632517,0.1752136752136752,0.6159919315357224,1.0,10/18,30.89%,GINS3;POLA1;POLD2;POLE;RFC4;LIG3;POLE3;GINS4;PCNA;GINS2
prerank,transition metal ion transport (GO:0000041),-0.3768027955960461,-1.2338573143462428,0.17464114832535885,0.6147899858558551,1.0,10/35,7.63%,TRPC3;TFRC;ATOX1;TRPC5;FTH1;TRPC4;ATP2C1;SLC31A1;TRPC6;SLC30A1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.383949566091273,-1.233642070642289,0.1574074074074074,0.614093624562523,1.0,18/32,33.73%,FOXN3;MRE11;CLSPN;BABAM1;ATM;CDKN1A;BRCA1;CHEK1;DONSON;DTL;TAOK2;CDC14B;BLM;TOPBP1;CDK1;PLK1;TICRR;ABRAXAS1
prerank,histone monoubiquitination (GO:0010390),0.456817216445153,1.2333680151600614,0.21754385964912282,0.6908161405996711,1.0,10/24,16.68%,BCOR;DTX3L;CDC73;RNF20;WAC;PAF1;LEO1;KDM2B;RNF2;RING1
prerank,positive regulation of embryonic development (GO:0040019),0.4896006994590655,1.2332047042108831,0.1873873873873874,0.6901606212148113,1.0,3/19,2.20%,WNT4;OSR1;WNT3A
prerank,O-glycan processing (GO:0016266),0.38388894270826357,1.2329091028496282,0.17165354330708663,0.690000961696796,1.0,9/54,9.71%,GALNT14;GALNT15;MUC2;GXYLT2;GALNT12;GALNT2;GALNT1;GCNT4;C1GALT1C1
prerank,osteoclast differentiation (GO:0030316),0.4722228823296109,1.232761724762846,0.21288014311270126,0.6892904232745051,1.0,6/22,12.25%,GAB2;ANXA2;GLO1;MAPK14;CSF1;EPHA2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.4424915983120993,1.2326809846740954,0.20435510887772193,0.6883613981929049,1.0,12/27,23.92%,TNRC6B;IL6;MAP2K1;EIF4ENIF1;DDX6;WTIP;PUM2;AJUBA;DDX5;RIPK1;TGFB1;DHX9
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.2922836223108252,-1.2325210306187102,0.05639097744360902,0.6159939331755565,1.0,45/132,23.74%,RPS15;RPL24;CELF4;RPL5;RPS27;RPS19;RPL38;SETX;LUC7L3;RPLP0;RPL6;RPL11;RPS28;PUF60;HSP90AB1;RRP7A;SRSF1;SART3;TRAF7;HSP90AA1;RPS5;EIF3A;XAB2;RPS14;PPAN;SART1;SNRPB;NLE1;LUC7L;SNRPF;GCFC2;SRSF9;DICER1;MDN1;LSM4;PRMT5;RPL3;SNRPD1;SNRPD2;CELF6;SRSF6;RPL23A;ABT1;GEMIN8;EIF6
prerank,negative regulation of defense response (GO:0031348),0.36520063425417737,1.2319693149296869,0.16507936507936508,0.6893387243030312,1.0,8/77,6.49%,ENPP3;RORA;FPR2;CDH5;TNFAIP8L2;NR1H3;PTPN2;PPARA
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.46082011569133335,-1.231746232083646,0.21311475409836064,0.6170387947335305,1.0,7/16,8.04%,DMD;RYR2;CALM1;CALM2;SLC8A1;CALM3;CAMK2D
prerank,response to progesterone (GO:0032570),-0.44110988246685795,-1.231660241804231,0.19369369369369369,0.6159631250173969,1.0,5/18,11.76%,TGFB2;THBS1;ABHD2;TGFB3;CAV1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.4799429621429293,1.231184231725148,0.20855614973262032,0.6906624101859925,1.0,6/19,15.04%,ROBO1;DCN;CCBE1;CADM4;SMOC2;MYO1C
prerank,regulation of protein kinase B signaling (GO:0051896),0.3227683841229283,1.2305542521121255,0.10191082802547771,0.6914323398935198,1.0,23/193,6.49%,TCF7L2;PDPK1;PDGFRA;FGFR1;FGF1;AXL;TPTE;GAB2;FAM110C;OSM;FRS2;OSBPL8;DAG1;KL;TGFA;ANGPT1;KIT;TGFBR1;MTDH;HAX1;PDGFRB;CPNE1;PPARA
prerank,cellular response to peptide (GO:1901653),0.38814192794111124,1.2301760058294102,0.17034700315457413,0.6914447705439367,1.0,13/56,8.91%,FPR2;LDOC1;GJA1;SNX6;VIM;CASP4;TLR4;PTPN22;VCAM1;GSK3B;NGFR;RIPK2;EPHA4
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.4996641054526539,-1.229590169072549,0.23194748358862144,0.620608227925722,1.0,4/12,7.35%,SLIT2;PLCB1;CCN3;AKT1
prerank,retinal metabolic process (GO:0042574),0.5279962576457009,1.229269426506871,0.22928709055876687,0.6930998708513785,1.0,4/12,15.15%,ABCA4;RDH10;BCO2;ALDH8A1
prerank,cellular metal ion homeostasis (GO:0006875),-0.30514408242006946,-1.2283511798589368,0.096875,0.6228364284226746,1.0,26/102,15.32%,SLC12A2;KCNMA1;SLC24A2;ATP1B1;KCNJ2;RYR2;TPT1;HTR2C;ATP1A1;ATP2C1;SLC8A1;CCL14;ATP2A3;NPTN;SLC30A1;NEDD4L;CALR;SLC10A7;TMCO1;CXCL12;CAV1;CD40;ATP13A4;ATP2A2;CCL19;ATP1A3
prerank,negative regulation of axonogenesis (GO:0050771),-0.3944028594126699,-1.228202940845317,0.18226600985221675,0.6219207653790274,1.0,11/27,20.17%,DIP2B;DCC;SEMA3G;FGF13;ULK1;MCF2;ARHGDIA;MAP2;EFNB3;OMG;TRIM46
prerank,negative regulation of protein modification process (GO:0031400),0.36189930825474625,1.2280757676095766,0.1661676646706587,0.6957544340955131,1.0,11/79,8.73%,PTPN13;IGFBP3;PID1;PLPP3;PRKAA2;FBLN1;SNTA1;ATP2B4;GSK3B;MYADM;LRRK2
prerank,negative regulation of synaptic transmission (GO:0050805),-0.4242226653929937,-1.2279521706500311,0.19090909090909092,0.6212478917366423,1.0,9/23,23.49%,SLC24A2;SHANK2;STXBP1;SLC30A1;ATAD1;GRIK3;TMEM25;MTMR2;CBLN1
prerank,odontogenesis (GO:0042476),0.4120155495616589,1.2277106699902969,0.18225806451612903,0.6957276022443384,1.0,10/35,16.06%,WNT6;OSR1;FOXC1;BMP2;BCOR;EDA;ANKRD11;COL1A2;HDAC2;AXIN2
prerank,negative regulation of cellular component movement (GO:0051271),0.5027386858629429,1.2271749258882345,0.23540489642184556,0.696258556243984,1.0,5/15,7.07%,TGFBR3;SP100;TACSTD2;FBLN1;SPINT2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.32356190543271135,-1.226971122748818,0.11011904761904762,0.6227345712553715,1.0,24/70,21.90%,PSMC3;NCF2;MFSD6;PSMD3;PSMD14;B2M;CALR;FCER1G;PSMD6;PSMD4;PSMA6;PSMA4;PSMB8;CYBB;PSMA8;PSME1;IKBKB;PSMD7;FCGR1A;PSMC6;PSMB5;SEC22B;PSMC5;PSMB1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3807088009217531,-1.226837808290655,0.18414322250639387,0.6218054134592408,1.0,12/33,21.42%,H3-3A;ESR1;PKN1;HDAC6;TRIM68;CALR;KDM4C;CBFB;PARK7;RUNX1;UFL1;SAFB2
prerank,cellular response to cAMP (GO:0071320),-0.3877681180394452,-1.226788018551844,0.18159203980099503,0.6206642939051021,1.0,8/30,11.84%,AKAP6;HCN1;SLC5A5;INPP5K;RAPGEF2;HCN2;PDE2A;KCNQ1
prerank,muscle cell differentiation (GO:0042692),-0.38673396447512803,-1.2266438636907828,0.17727272727272728,0.6197454917526077,1.0,6/32,3.41%,SYNE1;SGCZ;MEF2C;DMD;MRTFB;TBX1
prerank,vasculogenesis (GO:0001570),0.4225107786863751,1.2263156390017393,0.18537414965986396,0.6977445466818433,1.0,7/32,7.50%,TGFBR3;CCM2;ITGB8;PDGFRB;RASA1;TGFBR2;ADM
prerank,protein localization to cell surface (GO:0034394),-0.4079376020110189,-1.226021039729828,0.19194312796208532,0.6201374143974043,1.0,8/26,10.96%,PTPRK;EMP2;FBLN5;CTNNB1;RIC3;JAM3;PIGU;PIGK
prerank,cholesterol efflux (GO:0033344),0.467339774747238,1.2257824069672891,0.22141560798548093,0.6982049788172168,1.0,4/20,11.23%,APOA2;NPC1;SOAT1;ABCA1
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.4138490694402933,-1.2251989479320728,0.18101545253863136,0.6212677434426892,1.0,7/24,14.68%,ANK3;CEMIP;MTCL1;MFF;KCNB1;HRAS;C2CD5
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.45460818473861364,1.224471963949234,0.23049001814882034,0.7011660512970725,1.0,4/23,8.42%,PLA2G4A;MBOAT2;PLA2G4C;PLA2G6
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.4774228579133879,1.2240524622430293,0.20640569395017794,0.7013710373543507,1.0,5/19,12.64%,BMP6;AFDN;ADAM19;PTPRU;TJP1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.43341502009420757,1.223614931059405,0.2209106239460371,0.7014895210362342,1.0,7/30,14.31%,LEPROT;NPEPPS;PDCD5;HUWE1;CSNK2A2;RHOU;USP36
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.5147359513780978,-1.2234221282028155,0.21341463414634146,0.6249642208973323,1.0,5/11,19.05%,NOL11;DDX11;SMARCB1;PWP1;SIRT7
prerank,triglyceride homeostasis (GO:0070328),0.44640219610640564,1.2233673707970678,0.18181818181818182,0.7010410715404325,1.0,4/26,12.39%,RORA;NR1H3;IL18;DGAT2
prerank,androgen metabolic process (GO:0008209),-0.4431991893019296,-1.2232753542770438,0.18973214285714285,0.6240633506803462,1.0,4/18,17.68%,SRD5A3;SPP1;HSD17B7;HSD17B10
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3993380292091299,1.223162388334646,0.18270799347471453,0.7005085181714357,1.0,12/43,15.21%,ENPP1;PID1;KANK1;NUCKS1;SORBS1;PRKCZ;PTPN2;IGF2;PTPN1;PIP4K2B;NCK1;TNS2
prerank,cellular response to alkaloid (GO:0071312),-0.4519350340271843,-1.2229701293951714,0.19954128440366972,0.6236266581039006,1.0,6/17,16.40%,RYR2;RYR3;CASP7;SLC8A1;CASQ2;RAD51
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.4641199515384347,1.2214884641890593,0.21942446043165467,0.7045792455182104,1.0,4/20,11.34%,MCU;MICU1;PHB2;PMPCB
prerank,positive regulation of phosphorylation (GO:0042327),0.3115481684500311,1.2210031195522162,0.08375,0.704955520302997,1.0,57/240,16.11%,ZBTB20;LEPR;ROCK2;EPHA7;PDGFRA;FGFR1;FGF1;AXL;DDR2;PRKAA2;FPR2;WNT3A;INSRR;LMO4;EPHA3;NRP1;IL34;FAM20A;EPHA8;VEGFD;ROR1;ANGPT1;BMP2;KIT;SLCO3A1;ARNT;CCND3;RAD50;EPHA1;PDGFRB;PELI2;RALBP1;FBH1;LRRK2;EPHA4;MST1R;IGF2;MUSK;FGF18;FNIP1;PTK2;DSTYK;EPHA2;DVL3;ARRB1;RARRES2;EFNA1;KCTD20;NTRK3;P2RY1;RYK;ILK;ALK;STK4;DAB2;AXIN2;APP
prerank,positive regulation of endothelial cell migration (GO:0010595),0.35386673912188,1.2205799987766301,0.16323529411764706,0.7051303363288707,1.0,11/84,3.81%,PDPK1;RIN2;ROCK2;SASH1;FGFR1;FGF1;PLPP3;FOXC2;NRP1;ANXA3;ANGPT1
prerank,nuclear membrane disassembly (GO:0051081),-0.46888476396779827,-1.2204392398050223,0.22123893805309736,0.6294333846595179,1.0,9/14,37.62%,PRKCB;CTDNEP1;VRK1;NEK9;DCTN1;CDK1;PLK1;CCNB1;CCNB2
prerank,cellular protein modification process (GO:0006464),0.28360256718966814,1.2203840219602087,0.022703818369453045,0.7045647186204814,1.0,199/982,16.34%,PTPN13;IGFBP3;CP;PDK1;PDPK1;TNC;UST;TEC;FBN1;LAMC1;PARP14;ROCK2;FSTL1;COL3A1;NRK;ZC3HAV1;FN1;PRKCSH;FGFR1;LTBP1;PRKAG2;GRK3;FAM20C;SPSB1;STK39;GALNTL5;EIF2AK2;IGFBP5;OXSR1;PRKAA2;TPTE;TSSK3;APOA2;HIF3A;PPM1E;PPM1A;BMPR1A;SDC2;FSTL3;BMP2K;FAM20A;MAN2A1;FER;FBXO11;CDK8;PARP9;RCN1;ANXA1;DUSP10;ITIH2;PTPN14;DAPK1;TAOK3;BMP2;PTPN4;IKBKE;LARGE1;LOXL1;MIA3;PTPN3;IL6;PARP3;ARAF;EPAS1;LATS2;TGFBR1;AAK1;PRKCZ;MAP3K1;MORC3;PTPN22;KLHL22;LIPT1;KLHL21;APLP2;SPSB4;CUL4A;PTPRA;ARF4;MAPK6;MTMR3;PTPN9;SSH1;FBXO9;DUSP16;TGFBR2;NPC1;PARP10;CCL2;MAP4K1;PTPN21;FAM20B;GSK3B;NEK4;FBXL3;PSMB10;NUB1;PPP4R2;FUT4;WNK4;MANBA;PPEF2;CHM;SIK3;CTDSP2;LRRK2;STK24;STK3;PSMA7;COQ8B;PPP4R1;PSMA3;FBXL20;PSME4;CDK7;SIRT4;TLK2;FBXL7;CDK12;PTPN6;AKT3;CDK16;DNAJC3;HLCS;HIPK3;TRIOBP;DUSP5;TIPARP;FUT10;PSMA5;PPM1B;FBXO4;KEAP1;IRAK3;PPP1CB;WWP2;GRK5;KLHL13;JAK1;ILF3;CUL3;CSF1;PTPRU;FNTB;PLAT;PPP3CB;PTPN1;MAP2K1;PTPN18;FBXW11;ASB5;ANO8;DAPK2;BTRC;ERN2;PARP16;MAPK9;PORCN;MAP3K13;SRPK1;STRADB;PPM1M;WDR45B;ACVR1C;ALG1;FRK;TRIB1;WNK1;EIF2AK3;NUAK2;FBXL4;IGFBP4;VHL;DDA1;BIRC6;TBK1;CHRDL1;PRKD2;FBXL12;RARA;ASB3;RYK;ILK;PTPRR;STK4;FBXL13;PDF;SOCS6;CDKL3;ACVR2B;LIMK1;TXK;CTDSP1;TNKS2;APP;PKN2;MACROD1;RAB5A;AGA
prerank,thymus development (GO:0048538),-0.48439533641672644,-1.2203599427876894,0.21748400852878466,0.6283908869189532,1.0,8/13,29.72%,TBX1;SIX1;SOD1;HES1;EPHB3;FOXE1;FADD;FGF10
prerank,negative regulation of cation channel activity (GO:2001258),-0.40669508616331723,-1.220050336733986,0.1825,0.6280030820444171,1.0,10/26,24.11%,KCNAB1;FKBP1A;CALM1;CALM2;CALM3;SRI;CASQ2;GSTO1;GPR35;EPO
prerank,skin development (GO:0043588),0.3750001665625585,1.2199546162316455,0.18025078369905956,0.7046987376192166,1.0,21/65,20.27%,COL5A2;COL3A1;GATA6;ANXA1;ERRFI1;COL5A1;CLIC4;CLDN1;WNT5A;ALOXE3;EPHA2;KRT9;DACT2;COL1A2;COL1A1;OPN3;TXNIP;CASP3;DSP;WNT10A;PIP5K1A
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.3926014760012482,-1.2198309693265295,0.1873589164785553,0.6273250982358222,1.0,15/28,24.21%,NOTCH3;BEND6;GATA2;AKT1;LFNG;YTHDF2;EGFL7;EGFR;HEY1;EGF;DLL4;DLL1;HIF1AN;RITA1;TCIM
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.41228160603050645,1.2198126527805977,0.211864406779661,0.7040179430154687,1.0,7/34,8.54%,RBP4;LACC1;IL6;PTPN22;WNT5A;TNFRSF14;PHB2
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.5322767908335013,1.2193276596570255,0.26286764705882354,0.7043169043115061,1.0,7/11,25.55%,CDC73;ZC3H3;PAF1;LEO1;DHX36;PAPOLA;ZFP36L1
prerank,glycoprotein biosynthetic process (GO:0009101),-0.31614067903883236,-1.2192042007302852,0.14121037463976946,0.6277955844531242,1.0,17/79,15.31%,CSGALNACT1;ST8SIA4;ST3GAL6;BMPR2;FUT9;ST8SIA6;XYLT1;CHST9;B3GNT2;ALG5;SERP1;NUS1;GCNT1;BMPR1B;ST3GAL4;B3GNT9;B3GALNT2
prerank,regulation of mononuclear cell migration (GO:0071675),-0.40986535478945224,-1.2191264347887505,0.2144469525959368,0.6267291435800333,1.0,7/23,13.04%,SLIT2;THBS1;STK10;MAPK3;LYN;CMKLR1;CSF1R
prerank,regulation of insulin secretion (GO:0050796),0.34232264065843115,1.2190838069465797,0.1512481644640235,0.7040533905028813,1.0,9/101,4.75%,TCF7L2;MCU;DPP4;RAPGEF4;ITPR1;RBP4;RFX3;IL6;ADCY5
prerank,positive regulation of phosphatase activity (GO:0010922),-0.4269670567948304,-1.2188844516455049,0.2043956043956044,0.6261503559948498,1.0,5/21,7.26%,MEF2C;CALM1;CALM2;HSP90AB1;CALM3
prerank,nervous system development (GO:0007399),-0.25903014762674736,-1.218765420137031,0.02027027027027027,0.6252048361981843,1.0,82/429,12.23%,RAPGEF5;DNM3;ADGRL3;NRXN1;NLGN1;NAV2;LSAMP;SHANK3;ROBO2;SLC2A1;ST8SIA4;MERTK;SPOCK2;ERBB4;CDH2;MEF2C;ADGRG6;CHRM3;KIRREL3;NAV3;EFNA5;GPM6A;FGF12;CNTN4;WWP1;MBNL1;MYT1L;MOG;CNTN6;NCKAP1;CDH1;GPM6B;RBFOX3;CHRM2;TRPC5;SEMA6A;RBFOX1;SERPINI1;GRIK1;SNTG2;MET;SHANK2;EPHB1;S100B;PCDH1;SH3GL2;MAL;AHI1;ADAM22;NRCAM;MOBP;APBA2;DCLK1;MBP;SCN2A;ZBTB16;EIF2B2;ALDH5A1;ZIC3;SOX6;NINJ2;MBD5;NLGN3;DNER;ADAM23;VEGFA;SPOCK1;CNTFR;L1CAM;DHX30;SEMA6B;DVL1;SCN8A;NFASC;DBNL;NRSN1;FGF2;FGF13;PCDHB16;IL1RAPL2;NGF;GFRA2
prerank,negative regulation of receptor binding (GO:1900121),-0.51454610942567,-1.2187611200759072,0.22483940042826553,0.6239471363312428,1.0,4/10,15.10%,ADAM15;ATP2A3;B2M;ATP2A2
prerank,cellular response to amyloid-beta (GO:1904646),0.42316431235258717,1.2184878262599848,0.2147887323943662,0.704754237880862,1.0,15/35,19.01%,FPR2;GJA1;SNX6;CASP4;TLR4;VCAM1;GSK3B;NGFR;EPHA4;CACNA2D1;ICAM1;LRP1;APP;IGF1R;CD36
prerank,cellular response to interleukin-4 (GO:0071353),-0.5237151877707443,-1.2179030342172346,0.23517382413087934,0.6252112717529084,1.0,1/10,0.14%,LEF1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.3095112626689289,-1.2178672619244912,0.1458966565349544,0.6240711961760195,1.0,39/87,32.81%,NDUFV1;NDUFA8;NDUFC1;NDUFB4;NDUFS7;NDUFA1;SAMM50;COX20;NDUFB2;NDUFA12;NDUFA11;NDUFAF4;NDUFB7;IMMP2L;NDUFC2;UQCC3;NDUFB10;NDUFA13;COX19;NDUFA9;NDUFAF8;FOXRED1;PET100;TIMM21;NDUFAF7;NDUFA10;NDUFAF3;SDHAF2;BCS1L;COA5;OMA1;NDUFS6;NDUFS1;NDUFV3;TMEM126B;NUBPL;SCO2;COA3;NDUFA2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.42771878223101834,1.2176483528866415,0.21972318339100347,0.706272951540588,1.0,6/31,7.32%,PDGFRA;OSR1;HOXC4;TGFBR1;TGFBR2;DYNC2I1
prerank,supramolecular fiber organization (GO:0097435),0.29959038735183546,1.217422336677456,0.07776427703523693,0.7059079564688829,1.0,54/333,12.68%,CGNL1;COL23A1;TNXB;COL4A3;TSPAN5;COL4A6;COL4A4;COL5A2;COL3A1;COL4A5;DDR2;TMOD3;HSPG2;SHROOM2;MYO1B;VIM;ARHGAP12;LOXL3;DES;LOXL1;BMP1;EFEMP2;TPM1;COL18A1;TGFBR1;CLIP4;COL5A1;NCKAP5L;COL20A1;KATNAL1;SIAH2;RHOBTB2;HDGFL3;FAT1;RHOF;MYO1A;DBN1;USP9X;CCDC13;COL13A1;SERF1A;DLG1;TUBGCP4;FIGN;TPM4;TRIOBP;FSD1;SLAIN2;RHOC;LOXL4;EPPK1;KRT9;DPT;COL1A2
prerank,positive regulation of cyclase activity (GO:0031281),-0.46830754577760136,-1.2171869266743813,0.22532188841201717,0.6247641800888322,1.0,5/14,10.16%,NOS3;MAPK8;MAPK3;CACNA1D;NOS1
prerank,cytoskeleton organization (GO:0007010),0.3411196928218156,1.2171097358497651,0.13817663817663817,0.7057788018484958,1.0,22/114,12.12%,MICAL3;DIAPH1;ARHGAP10;SH3D19;SYNE3;PHIP;FGD4;BRWD1;DES;TPM1;RHOBTB2;PLCE1;RHOF;PACSIN2;CCL2;CAPZB;FMNL2;CNN2;CECR2;SPRYD3;RHOC;ZMYM6
prerank,primary neural tube formation (GO:0014020),0.42414319634845093,1.216772592658249,0.21061359867330018,0.7056935049701456,1.0,6/30,8.18%,PRICKLE1;DLC1;LMO4;MTHFD1;CELSR1;SKI
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3770266201545694,1.2167536681340612,0.17384370015948963,0.7046076658991657,1.0,17/56,16.27%,BMP6;BMPR1A;LDLRAD4;TWSG1;PMEPA1;BMP2;BMP7;TGFBR1;BMP8B;SMAD6;SMAD4;NOG;HFE;GDF11;GDF15;DAB2;INHA
prerank,negative regulation of centrosome duplication (GO:0010826),-0.4981906835285231,-1.2163193322775439,0.2094017094017094,0.6259588376424103,1.0,6/11,19.63%,NPM1;CCNF;TRIM37;BRCA1;KAT2A;CDK5RAP2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.38584495492060955,1.2163151809977186,0.1808,0.7049127373278116,1.0,14/51,15.81%,FBN1;FSTL1;SMURF2;BMPR1A;FSTL3;NBL1;BMP2;SKI;SMAD6;SMAD4;NOG;GREM2;CHRDL1;ACVR2B
prerank,regulation of viral entry into host cell (GO:0046596),-0.39164659552181,-1.216038003010257,0.18298969072164947,0.6255347589812791,1.0,10/30,18.49%,LY6E;HS3ST5;SNX3;MID2;TRIM68;CD74;TRIM62;IFITM3;IFITM2;LGALS1
prerank,regulation of sensory perception of pain (GO:0051930),-0.5002780768885149,-1.2159163970367632,0.2413793103448276,0.6246058043067567,1.0,2/11,4.28%,MGLL;CCN3
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.5326411715736662,1.2151853084416822,0.25,0.7072152344112543,1.0,3/10,7.50%,CD55;TGFBR2;LGALS9
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.3822251861410362,-1.2149881156199105,0.18393782383419688,0.626123773981522,1.0,9/33,11.17%,NET1;MAP3K5;SETX;RPS3;PLEKHA1;RHOB;HDAC6;SIGMAR1;PAX2
prerank,organic substance transport (GO:0071702),-0.295116460016185,-1.2147940546303975,0.0975609756097561,0.6254465396619143,1.0,31/121,19.68%,ATP8A1;ABCG2;SLC47A1;LRP1B;SLCO2A1;ABCA3;SPNS2;SCAMP5;LMAN2L;RAB38;SCAMP1;SCAMP2;RAMP2;VPS33B;SLC22A6;MFSD2A;ABCD2;SLC22A5;GM2A;SLC50A1;CHMP1A;CHMP1B;CEP290;CD320;MFSD12;PEX19;CHMP2B;SLC35F3;DISP1;CHKA;SLC19A2
prerank,regulation of feeding behavior (GO:0060259),0.5253313622646234,1.2146472424114623,0.23104693140794225,0.7077110537414569,1.0,2/11,5.50%,LEPR;UCN
prerank,sphingolipid biosynthetic process (GO:0030148),-0.3175929766589957,-1.214645009255872,0.13043478260869565,0.624679515008592,1.0,10/71,4.57%,SGMS1;ACER3;ELOVL5;ACER2;CERS4;CERT1;PPM1L;DEGS2;ELOVL7;SPNS2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.360766432595515,1.2144288512744326,0.1831610044313146,0.7072985539447055,1.0,14/72,12.20%,USP18;ELF1;AXL;ZBP1;CFLAR;BIRC3;PTPN2;STAT1;PIAS1;SUMO1;PTPN6;IRAK3;JAK1;PTPN1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.41683815783340356,1.2143575811489697,0.1934931506849315,0.7063924161209197,1.0,6/34,14.18%,LGR4;BPIFB1;TLR4;LY96;IRAK3;TICAM1
prerank,response to interleukin-4 (GO:0070670),-0.528862163745385,-1.2138742944980137,0.2260127931769723,0.6256057400278117,1.0,1/10,0.14%,LEF1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2999694912730172,1.2136083629541394,0.08543922984356198,0.7075547660506865,1.0,71/327,16.01%,EFEMP1;RORA;ATXN1;ZMIZ1;ARNT2;FOXC1;NFIA;NFYC;POU5F1;SSBP2;ZNF395;ZBTB4;DENND4A;MYB;PRRX2;PERM1;BMP2;RFX3;APBB1;TGFBR1;NIF3L1;GZF1;NSD3;BAZ2A;ZNF35;WWC2;FOXP3;TESMIN;CREBBP;TCF7L1;NSD1;CREBL2;POU1F1;RNF20;ZSCAN21;NFXL1;ATF7;ZFP37;TEAD2;KAT6B;SOX21;SUFU;IGF2;MAFB;CREM;MSC;PSPC1;TCF7;UBE2V1;TGFBRAP1;ZNHIT3;ZNF219;ZFAT;OGG1;MZF1;THAP1;NR3C1;ZNF205;SERTAD3;CARM1;HIC1;FUS;DMTF1;VHL;NCOA2;SP3;PML;CCAR1;ACVR2B;SOX4;WWTR1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4526555123653241,-1.2132891171187212,0.2328159645232816,0.6259755607870654,1.0,7/16,16.57%,NOS1AP;SCARB1;AKT1;GCH1;NUS1;S100A1;HTR2B
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.38440860188287507,-1.213071795925993,0.2216867469879518,0.625371406155233,1.0,7/29,6.45%,SLIT2;SHANK3;SSH2;KANK3;KANK4;HIP1R;CYRIB
prerank,cholesterol homeostasis (GO:0042632),0.372732905760471,1.2126690307727146,0.17656500802568217,0.7094183060720016,1.0,11/64,12.39%,RORA;CYP7B1;APOA2;NR1H3;NPC1;IL18;LIMA1;SOAT1;ABCA1;DISP3;DGAT2
prerank,polyol biosynthetic process (GO:0046173),-0.4438805882664947,-1.212590273671344,0.22444444444444445,0.6253874722706373,1.0,6/16,14.87%,ACER3;ITPKB;IP6K2;FGF2;PPIP5K1;PPIP5K2
prerank,skeletal system morphogenesis (GO:0048705),0.40195805052151806,1.2124090761666464,0.20352564102564102,0.7091816493760692,1.0,12/42,15.77%,PDGFRA;FGFR1;WWOX;HOXC4;TGFBR1;DYNC2I1;SKI;RFLNA;ANKRD11;RAB33B;SPEF2;HOXB4
prerank,regulation of focal adhesion assembly (GO:0051893),0.37776671515826893,1.212367231847035,0.19169329073482427,0.7082125518329624,1.0,10/54,6.05%,PHLDB2;ARHGAP6;ROCK2;DLC1;EPHA3;NRP1;S100A10;CLASP1;VCL;PTPRA
prerank,diol metabolic process (GO:0034311),-0.43203753086500246,-1.212337788213633,0.20758928571428573,0.6248662270111698,1.0,8/19,16.63%,NOS3;DEGS2;CALM1;AKT1;GCH1;HSP90AA1;PLPP1;SGPP1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.49895150309664943,1.2118514755027001,0.26151012891344383,0.7087395276279261,1.0,6/14,15.06%,MYB;ANXA1;PRKCZ;IL18;NFKBIZ;RARA
prerank,positive regulation of fat cell differentiation (GO:0045600),0.392045954712669,1.2117946010808156,0.19218241042345277,0.7078243868673827,1.0,16/47,21.91%,MEDAG;BMP2;BMP7;TMEM64;CREBL2;NOCT;AAMDC;RARRES2;CARM1;ASXL2;NAPEPLD;CEBPB;PTGS2;XBP1;CDS1;ZC3H12A
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3619311666392028,1.2115828983767114,0.17099236641221374,0.7074107616737181,1.0,14/66,10.16%,KANK2;ADAMTS1;ANXA1;DACT1;PLK5;CCND3;APPL2;CDKN2B;CCL2;CDC73;DLG1;ANKRD17;PTPN6;APPL1
prerank,positive regulation of hydrolase activity (GO:0051345),-0.2867547860742719,-1.2115495822085331,0.08664259927797834,0.6259413879967656,1.0,32/137,13.71%,DOCK9;ITGA6;BCAR3;DOCK10;NET1;CALM1;SEMA4D;MAPK8;CALM2;RPS3;TBC1D30;RAB3GAP1;CCL14;RAPGEF2;RGS7;RGS6;CALM3;MTCL1;PINK1;ARHGAP27;CAV2;RACK1;DOCK8;RAPGEF6;ARHGEF7;CD40;ALS2;RGP1;AGRN;F11R;HRAS;EVI5
prerank,aortic valve morphogenesis (GO:0003180),-0.38372003961883944,-1.2115447180861316,0.18048780487804877,0.6247258299113386,1.0,8/30,6.66%,SLIT2;ROBO2;NOS3;TIE1;NOTCH1;ELN;EMILIN1;BMP4
prerank,immunoglobulin mediated immune response (GO:0016064),-0.5252428919040787,-1.2111621880215122,0.24539877300613497,0.6245528682581495,1.0,7/10,40.68%,CD74;FCER1G;CD27;CD81;TLR8;FCGR2B;CARD9
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.4748999485425976,1.211086919260153,0.23713235294117646,0.7077847304441391,1.0,3/17,7.90%,CD55;TLR4;IL18
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.4213251455257507,-1.211068468793399,0.21350762527233116,0.6236395736724345,1.0,6/21,13.04%,MTUS1;THBS1;PTK2B;MAPK3;CMKLR1;CSF1R
prerank,regulation of anoikis (GO:2000209),0.47207330203460274,1.2109878242587437,0.22702702702702704,0.7070208258240332,1.0,5/19,10.94%,TLE1;ITGA5;BCL2;MCL1;PTK2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4350527913004113,1.210907158671518,0.21217391304347827,0.7061760562606164,1.0,5/26,5.92%,ROCK2;ALMS1;SYNPO2;SYNPO;ASAP3
prerank,negative regulation of protein processing (GO:0010955),0.514990471854381,1.210644720555274,0.26579925650557623,0.705871790306707,1.0,4/12,8.73%,SERPINE1;SNX12;SERPINE2;LRRK2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.4310738458916055,1.2106334280756172,0.22372881355932203,0.7048081282162932,1.0,9/27,15.83%,FBXL17;CRY2;CRY1;FBXL3;CRTC1;PPP1CB;FBXL12;PML;PER3
prerank,regulation of cell migration (GO:0030334),0.2973084220378734,1.210623943281306,0.06777645659928656,0.7037537690837284,1.0,71/382,12.64%,PLXNA2;SULF1;DPYSL3;ROBO1;SEMA3D;PDPN;PODN;ROCK2;SASH1;PDGFRA;AFDN;FGF1;IGFBP5;CXCL16;SYNE2;DLC1;FAM110C;LMO4;KANK1;LDLRAD4;CDH5;FER;DAG1;NUMB;SMIM22;ANXA1;LDB2;DUSP10;BMP2;KIT;MIA3;AMOTL1;WNT5B;TPM1;TGFBR1;MMP14;VCL;FAM83H;SERPINE1;APPL2;EPHA1;PDGFRB;MGAT3;SEMA4B;BST2;CTSH;CLIC4;CLDN1;RNF20;SERPINE2;NGFR;MYADM;STK24;EPHA4;PLAU;IFITM1;RAP2C;APPL1;FGF18;NKD1;PTK2;ENPP2;FOXO3;CDH13;CSF1;PTPRU;RHOC;EPPK1;SLURP1;ARSB;TJP1
prerank,regulation of tissue remodeling (GO:0034103),0.4678665138626654,1.2104798361952294,0.2509090909090909,0.7030560846845911,1.0,3/18,7.90%,LEPR;DDR2;IL18
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.452052462819589,-1.2103263443783245,0.25279642058165547,0.6245737152543778,1.0,6/17,12.31%,SLC7A5;PRKCQ;HAVCR2;FCER1G;CD86;SYK
prerank,tube closure (GO:0060606),0.419393966825178,1.2102794506882724,0.21357615894039736,0.7026218307331455,1.0,6/31,8.18%,PRICKLE1;DLC1;LMO4;MTHFD1;CELSR1;SKI
prerank,retinol metabolic process (GO:0042572),0.49614052865445,1.209862952581869,0.2523540489642185,0.7028186343454091,1.0,2/14,3.59%,RDH10;RBP4
prerank,carboxylic acid transmembrane transport (GO:1905039),0.40634342410159263,1.209838882167896,0.19932432432432431,0.7017977332714262,1.0,3/40,2.69%,SLC7A11;SLC13A3;SLC19A1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.32306117024467834,1.209669007868325,0.12757201646090535,0.7012268878366205,1.0,17/142,8.40%,ATP1A2;LPAR1;SMAD3;PDGFRA;FPR2;ACKR2;CCR9;CD55;ADCY5;C5AR2;PLCE1;ATP2B4;BDKRB2;SPPL3;WNT5A;ACKR3;CACNA1C
prerank,cellular response to lipopolysaccharide (GO:0071222),0.34523936911246356,1.2095258106685418,0.16220238095238096,0.7005891313988266,1.0,16/101,8.19%,CXCL10;AXL;LDOC1;VIM;IL6;TLR4;MTDH;PTPN22;SERPINE1;NR1H3;LY96;CCL2;CDC73;WNT5A;IL18;CD274
prerank,neuron differentiation (GO:0030182),-0.2773444236135366,-1.2092201395071467,0.08898305084745763,0.626389155617773,1.0,28/165,10.66%,PTPRD;MEF2C;TENM2;TGFB2;EPHA5;ACSL3;TENM3;MYT1L;RORB;FUT9;PBX3;NTRK2;IL1RAPL1;ATP8A2;VSX1;MET;LHX6;CTNNB1;TENM4;FZD3;MYEF2;THOC2;VEGFA;SPOCK1;SNPH;LRP6;DDIT4;MANF
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.4513968329433263,-1.2089287438461183,0.2205240174672489,0.626077806448009,1.0,5/15,12.95%,NLGN1;SYN3;STXBP1;CNTNAP4;USP46
prerank,inner mitochondrial membrane organization (GO:0007007),-0.35039895915385294,-1.2088124785855094,0.17066666666666666,0.6251866751310046,1.0,21/47,25.86%,ATP5F1A;GHITM;ATP5MC1;ATP5PO;SAMM50;TIMM8B;ATP5F1B;ATP5PD;ATP5F1D;MAIP1;MTX3;MTX1;TIMM22;UQCC3;NDUFA13;ATP5MG;ATP5ME;TIMM10;ATP5F1E;ATP5MC3;ATP5MF
prerank,negative regulation of cellular process (GO:0048523),0.28939309229470417,1.2087934914532092,0.06375838926174497,0.7018056429916174,1.0,106/521,16.11%,ALDH1A2;PLXNA2;IGFBP3;PDPN;TGFBR3;PODN;COL4A3;SMAD3;KANK2;CCN2;SP100;ENPP1;EIF2AK2;NUPR1;TPTE;DLC1;LDOC1;PDS5B;GJA1;OSM;CASK;FBLN1;ADAMTS1;PIWIL4;TGFB1I1;PTHLH;ANGPT1;SUZ12;PRDM11;PTPN14;BMP2;IGFBP6;IFI35;APBB1;MIA3;IL6;BTG3;BCL2;GSDME;BMP7;COL18A1;BTG4;APPL2;NR1H3;FOXP3;PTPN2;RASA1;BST2;CDKN2B;CLMN;POU1F1;ZBTB7C;CDC73;PDCD5;SKI;CRLF3;TLR2;SMAD6;IFITM1;PTPN6;SUSD2;DCBLD2;CGRRF1;NUPR2;GMNN;IFNLR1;SMAD4;CDH13;SERTAD2;SH2B3;PTPRU;TSPYL2;MAP2K1;NR4A1;SLURP1;DACT2;VGLL4;PARP16;NUDT6;NDUFS3;PSRC1;SERTAD3;NCK1;RBM5;FRK;RTN4;ABI1;WDR6;CHMP4B;IFIT3;EIF2AK3;MDM4;VHL;LRPAP1;NIBAN2;PKD2;TNS2;PML;SMARCA4;P3H3;NF2;SOX4;KAT2B;MUL1;AXIN2;APP
prerank,actin filament depolymerization (GO:0030042),0.5149541104354879,1.2083530698126181,0.2558139534883721,0.7020751000119546,1.0,2/11,7.88%,MICAL3;DSTN
prerank,activation of protein kinase B activity (GO:0032148),0.42473808736070556,1.2082885287693717,0.21311475409836064,0.7011759978034795,1.0,10/29,17.11%,PDPK1;FGF1;OSBPL8;WNT5A;IL18;ADRA2C;NTRK3;ADRA2A;RICTOR;MAPKAP1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4294651957907313,1.207993804975514,0.2110912343470483,0.7010480359089659,1.0,10/28,15.21%,ENPP1;PID1;KANK1;PRKCZ;APPL2;PTPN2;PTPN1;PIP4K2B;NCK1;TNS2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.43063768526905183,1.207547539803921,0.23652173913043478,0.701230026835272,1.0,5/29,8.42%,PLA2G4A;MBOAT2;NR1H3;PLA2G4C;PLA2G6
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5151908665538307,1.20749641350821,0.24857685009487665,0.7003200155001378,1.0,4/13,14.18%,AXL;IL23R;IL18;TICAM1
prerank,regulation of neuron apoptotic process (GO:0043523),-0.30510013867604713,-1.2074844242454537,0.14426229508196722,0.6277062064394139,1.0,28/96,17.70%,GRID2;MEF2C;TGFB2;PTK2B;TRIM2;NTRK2;SIX1;CTNNB1;FOXQ1;NDNF;LGMN;PINK1;SIGMAR1;TGFB3;KCNB1;NGF;AKT1S1;ATF4;GRN;SIX4;SOD1;CLCF1;PARK7;CPEB4;SET;TOX3;NTF3;ADAM8
prerank,cell-cell junction maintenance (GO:0045217),0.5232909374905235,1.2074635125934925,0.2618110236220472,0.6993463020482501,1.0,4/11,12.64%,PARD6A;MYADM;NLGN2;TJP1
prerank,peroxisome organization (GO:0007031),-0.40300046748879026,-1.2073455442262728,0.2058165548098434,0.6268213597330867,1.0,12/25,26.85%,ABCD4;TMEM135;MFF;PEX10;ABCD2;PEX16;PLAAT3;PEX19;PEX11A;PEX3;LONP2;PEX11B
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3677240078750944,1.207180979713299,0.18351477449455678,0.6991289802589975,1.0,14/66,12.74%,ROBO1;SASH1;FGFR1;FGF1;IL34;TAOK3;KIT;PDGFRB;LRRK2;MST1R;PIK3R5;FGF18;MAP3K7;DVL3
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.43638193968414163,-1.2071529703195807,0.22538293216630198,0.6261012664678947,1.0,5/18,15.17%,NAV3;CD34;HDAC7;HAVCR2;PTPRC
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.430478877726184,1.2071370575986697,0.2411467116357504,0.6981923829022793,1.0,6/27,5.76%,PDGFRA;FPR2;AMBRA1;EPHA8;KIT;PDGFRB
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.4337863028161947,-1.2068313573955138,0.22077922077922077,0.6258431709474155,1.0,6/19,13.61%,PTPRD;IL1RAPL1;CAPRIN2;LRP8;DBNL;RELN
prerank,sterol homeostasis (GO:0055092),0.36920016584406457,1.2068128129693492,0.18341307814992025,0.6980935827643389,1.0,11/65,12.39%,RORA;CYP7B1;APOA2;NR1H3;NPC1;IL18;LIMA1;SOAT1;ABCA1;DISP3;DGAT2
prerank,negative regulation of peptidase activity (GO:0010466),0.3891874084358982,1.2064061865018458,0.18858954041204437,0.6982328675611359,1.0,9/47,8.28%,VTN;ECM1;TIMP3;SERPING1;CSTB;SERPINB7;SERPINE1;SERPINE2;TIMP2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.38871280767104277,-1.2058953432379345,0.18518518518518517,0.6272468054494224,1.0,8/29,15.28%,SMAD7;RPS2;PINK1;FEM1A;DCUN1D2;DCUN1D5;PARK7;DCUN1D1
prerank,motor neuron axon guidance (GO:0008045),-0.4672079810644156,-1.2054254022779611,0.21444201312910285,0.627417237088264,1.0,8/15,21.92%,SLIT2;TMEFF1;RHOG;SEMA3A;RHOH;RAC1;CHN1;LHX1
prerank,bile acid metabolic process (GO:0008206),0.42434828234795746,1.2053056392636705,0.21403508771929824,0.7005555204095774,1.0,9/27,17.51%,CYP7B1;CYP27A1;NPC1;AMACR;SCP2;SLC27A2;CH25H;OSBPL9;GBA2
prerank,actin crosslink formation (GO:0051764),0.5187348976829116,1.2046702150401254,0.25660377358490566,0.7013551016552276,1.0,2/12,5.11%,DPYSL3;BAIAP2L1
prerank,negative regulation of inflammatory response (GO:0050728),0.3160999068166977,1.2046352886838816,0.12634408602150538,0.700417793003726,1.0,21/182,7.80%,ENPP3;RORA;GHRH;FPR2;ADORA2A;CDH5;TNFAIP8L2;PTHLH;GLP2R;ADCY7;IL6;ADCY5;MC2R;RXFP2;NR1H3;PTPN2;PPARA;ADCY1;ADM;RAMP1;GPR39
prerank,replicative senescence (GO:0090399),0.5222735059800252,1.204499810313043,0.26296296296296295,0.6998247036087916,1.0,3/12,5.67%,PLA2R1;TERT;SERPINE1
prerank,regulation of MAPK cascade (GO:0043408),0.3215525510613637,1.2044227112303307,0.13404825737265416,0.6990818653267435,1.0,21/157,6.40%,TGFBR3;LPAR1;ROCK2;EPHA7;NRK;FN1;FGFR1;KSR1;OSM;IL11;EPHA8;DAG1;ROR1;PRDM11;TAOK3;BMP2;KIT;IL6;GSDME;PELI2;TRIM5
prerank,regulation of cell junction assembly (GO:1901888),-0.392482688148462,-1.2044095329820659,0.2198581560283688,0.6290397817553347,1.0,9/27,18.07%,PRKCH;CLDN5;MEF2C;RAPGEF2;CBFB;F11R;APLNR;RAP1A;RUNX1
prerank,regulation of embryonic development (GO:0045995),0.4180552914394729,1.2042964097817443,0.2159468438538206,0.6984430684839367,1.0,5/34,5.18%,PHLDB2;DAG1;TRIP12;CLASP1;PHLDB1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.40452704144248136,1.2033448635320847,0.21639344262295082,0.700218874590279,1.0,15/38,24.94%,LEPROT;HAX1;NPEPPS;LRRK2;HUWE1;CSNK2A2;RHOU;USP36;ATP5IF1;SREBF1;FBXW7;ATG13;HPS4;RNF31;TOMM7
prerank,glial cell differentiation (GO:0010001),-0.38994154279023796,-1.2026814749332306,0.19954648526077098,0.6327965805340682,1.0,13/28,30.01%,CDH2;ADGRG6;PAX2;NFIB;RELN;TPPP;SOX2;PTPRZ1;CDK5;SOX11;SLC8A3;FGF10;PICK1
prerank,response to cholesterol (GO:0070723),0.4743748444181175,1.2025656215612823,0.26217228464419473,0.7014672649638317,1.0,3/17,7.03%,GRAMD1C;TGFBR1;TGFBR2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.5070041682542556,-1.202404654205271,0.2439516129032258,0.6324316890325495,1.0,5/10,19.82%,SNCA;CTBP1;SET;BRCA1;NOC2L
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.40993490146603523,1.2023038521452354,0.2003454231433506,0.7012303888996669,1.0,6/36,5.75%,AFDN;SPTBN1;VAMP5;RAB10;TRARG1;OPTN
prerank,protein neddylation (GO:0045116),-0.4769262103935207,-1.201186128227139,0.23255813953488372,0.634662327925601,1.0,8/13,35.41%,DCUN1D2;DCUN1D5;DCUN1D1;DCUN1D3;UBE2F;NEDD8;UBE2M;RBX1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.35753146579996387,1.200901026857325,0.18429003021148035,0.7043781231877173,1.0,16/77,14.77%,TCF7L2;PHIP;SH3RF1;CFLAR;BCL2;TGFBR1;SIAH2;MCL1;ZMYND11;BCL2L1;NDUFS3;OPA1;TMEM14A;CSNK2A2;BDNF;BIRC6
prerank,regulation of axon guidance (GO:1902667),0.5192799242392667,1.2006432279851234,0.27165354330708663,0.7041232074710362,1.0,2/10,4.55%,NRP1;MYCBP2
prerank,motile cilium assembly (GO:0044458),0.5037860277426924,1.2002817142670161,0.23552123552123552,0.7042280642086578,1.0,3/12,8.41%,SPATA6;DNAAF1;RSPH9
prerank,positive regulation of cell killing (GO:0031343),0.5089628801759962,1.2001211120457203,0.25757575757575757,0.7036069902513783,1.0,4/13,8.25%,PRF1;NOS2;WNT5A;NOXO1
prerank,aerobic respiration (GO:0009060),-0.42296736173681454,-1.2000787948949805,0.23593073593073594,0.6366039877138007,1.0,8/20,23.66%,SDHC;ME3;NDUFS7;UQCRH;ATP5F1D;MTFR1L;MDH2;UQCR10
prerank,mitochondrion morphogenesis (GO:0070584),0.5314722329433706,1.1998403245512528,0.2504604051565378,0.7034175879614347,1.0,7/11,24.66%,PID1;DNM1L;SUPV3L1;WASF1;PNPT1;MTM1;SLIRP
prerank,urogenital system development (GO:0001655),0.5344766590265912,1.1997968213003571,0.24150943396226415,0.7025066866260918,1.0,2/11,3.42%,OSR1;ANXA1
prerank,negative regulation of interleukin-6 production (GO:0032715),0.4392620446651829,1.1994043288177083,0.2392086330935252,0.7027021689847895,1.0,6/27,12.85%,TLR4;PTPN22;C5AR2;PTPN6;IRAK3;ARRB1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5159673831831699,1.199396969924138,0.26022304832713755,0.701699085764584,1.0,4/12,11.51%,ELF1;RC3H1;PTPN22;ELF2
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3148752031585721,1.198698489517778,0.11780104712041885,0.7028098662376902,1.0,37/190,13.10%,UACA;RORA;CGNL1;DEPTOR;ITPR1;TLE1;PRKAA2;PPM1A;ARHGAP12;DGKD;DAG1;IFI35;BCL2;BMP7;MCL1;CPNE1;WWC2;ATP2B4;PPARA;MGRN1;STAT1;STAMBP;ZMYND11;PPEF2;MYADM;GPD1L;PPM1B;NLRX1;MAPK14;PLEK;FNIP1;BCL2L1;SH2B3;EPHA2;VGLL4;TBC1D7;NDUFS3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.4183316121961678,-1.1986729276482724,0.21300448430493274,0.639315525192753,1.0,7/21,5.53%,HS6ST3;HS6ST2;NDST3;HS3ST4;HS3ST5;XYLT1;EXT1
prerank,regulation of activated T cell proliferation (GO:0046006),0.42266052711605967,1.1982416814585952,0.22297297297297297,0.7031824392628657,1.0,7/30,9.42%,IL23R;RC3H1;FOXP3;LGALS9;IL18;CD274;IGF2
prerank,diacylglycerol metabolic process (GO:0046339),-0.3987585648409921,-1.198015486746442,0.21806167400881057,0.6400607460154198,1.0,5/23,7.12%,DGKB;DGKI;DGKH;DGKZ;LIPE
prerank,glycogen metabolic process (GO:0005977),0.4300869533961692,1.1978351945691184,0.2286212914485166,0.7033130951898336,1.0,9/27,19.43%,PRKAG2;PYGB;GYG1;GSK3B;PYGM;STBD1;PGM1;PHKB;PHKA2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.48746265078390016,1.1975987955054646,0.25675675675675674,0.7030378270067482,1.0,3/15,5.07%,UST;DCN;DSE
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.4196940982816112,-1.1966525554644156,0.24161073825503357,0.6426677295257076,1.0,4/19,2.17%,PTPRJ;GRM5;RYR2;KDR
prerank,cell-matrix adhesion (GO:0007160),0.3454778400071297,1.196574755622948,0.19909502262443438,0.7050808342764014,1.0,18/95,8.22%,COL3A1;VTN;FN1;ADAMTS12;ECM2;DLC1;NID2;ITGB8;ITGBL1;ITGA10;SORBS1;VCL;THBS3;VCAM1;ACTN2;ITGA11;SIGLEC1;COL13A1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.5022619995516039,1.196435078520159,0.26373626373626374,0.7044845627224522,1.0,5/14,5.67%,IGFBP3;IGFBP5;BMPR1A;TPM1;SERPINE1
prerank,regulation of DNA repair (GO:0006282),0.3858625728507483,1.1963821977139413,0.22128378378378377,0.7036094982955752,1.0,4/44,3.36%,EYA2;EYA1;POLH;TRIP12
prerank,magnesium ion transport (GO:0015693),-0.4767176311734884,-1.1962655502366024,0.23026315789473684,0.6425200034633635,1.0,5/12,10.30%,CNNM4;NIPAL3;NIPAL4;NIPA2;NIPA1
prerank,negative regulation of axon extension (GO:0030517),-0.37572817809801007,-1.1962575955624033,0.20047169811320756,0.6413294151396887,1.0,11/30,14.54%,SEMA6D;DIP2B;SEMA3C;SEMA4D;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B;SEMA3A;MAP2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.4459734476757775,1.1962076365577046,0.23089983022071306,0.703107624146112,1.0,4/23,6.71%,CBLB;SNX6;ERRFI1;MVP
prerank,regulation of interleukin-8 production (GO:0032677),0.3553413521192817,1.1957376201793184,0.19374068554396423,0.7034477445030786,1.0,15/69,12.85%,APOA2;ANXA1;IL17D;IL6;CRP;TLR4;PTPN22;C5AR2;SERPINE1;ANXA4;NOS2;LGALS9;TLR2;MAP2K5;ARRB1
prerank,negative regulation of angiogenesis (GO:0016525),0.3472772152648368,1.1957336990812102,0.1837037037037037,0.7024481854381733,1.0,12/84,6.82%,SULF1;COL4A3;ROCK2;CXCL10;THBS2;FOXC1;HSPG2;DCN;ADAMTS1;SERPINE1;ATP2B4;STAT1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.5015501544172246,1.1954274105106522,0.25139664804469275,0.7023741451055853,1.0,6/15,12.64%,PDPK1;FGF1;ITGA5;JMJD8;JAK1;TJP1
prerank,respiratory system development (GO:0060541),0.41875789488273135,1.1944098146601112,0.21143847487001732,0.7044537935056637,1.0,5/32,7.35%,PDPN;FGF1;RBP4;LOXL3;DNAAF1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.41649869400284945,1.1940432346703511,0.22053872053872053,0.7034324198748217,1.0,14/31,27.07%,POLR2D;CCNH;MNAT1;CDK7;POLR2C;POLR2F;GTF2H4;GTF2H2;POLR2K;RNGTT;POLR2H;GTF2F1;CMTR1;ERCC2
prerank,7-methylguanosine RNA capping (GO:0009452),0.41649869400284945,1.1940432346703511,0.22053872053872053,0.7034324198748217,1.0,14/31,27.07%,POLR2D;CCNH;MNAT1;CDK7;POLR2C;POLR2F;GTF2H4;GTF2H2;POLR2K;RNGTT;POLR2H;GTF2F1;CMTR1;ERCC2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5498408204968831,1.1940088510303302,0.283495145631068,0.7025296772101514,1.0,3/10,3.39%,STK39;OSR1;NEDD4
prerank,regulation of defense response (GO:0031347),0.3536352033916985,1.193726367424097,0.18998527245949925,0.7024280792703744,1.0,15/76,11.30%,CASP12;USP18;ADAMTS12;ANXA1;ZBP1;CASP4;LACC1;PTPN22;APPL2;BIRC3;WNT5A;BRD4;APPL1;ERAP1;NLRP6
prerank,regulation of filopodium assembly (GO:0051489),-0.3570413784921297,-1.1934582103477114,0.2066326530612245,0.6480075663521229,1.0,8/38,5.07%,MYO10;NLGN1;PPP1R16B;FNBP1L;TENM2;GPM6A;PIK3R1;ARHGAP44
prerank,regulation of fatty acid metabolic process (GO:0019217),0.46817084993759944,1.1933320113927324,0.2411214953271028,0.7025655789404992,1.0,4/17,6.49%,PRKAG2;PRKAA2;PANK2;PPARA
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.32476201709456815,1.1932898945212131,0.1664392905866303,0.7016665416896128,1.0,38/138,15.29%,STYK1;PTN;EPHA7;PDGFRA;FGFR1;AXL;DDR2;IL31RA;IL6ST;INSRR;EPHA3;FRS2;EPHA8;FER;ROR1;KIT;EFS;EPHA1;PDGFRB;BDKRB2;NPPC;EPHA4;MST1R;MTSS1;POLR1G;MUSK;PTK2;CSF1;PTPRU;EPHA2;FRK;BDNF;ABI1;SHC2;NTRK3;GUCY2C;RYK;ALK
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.41594731772934307,1.1931847683311194,0.21258503401360543,0.7009427426635992,1.0,6/29,9.44%,ZBTB20;SORBS1;NR1H3;PPARA;CREBL2;SIRT4
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.4787322005953437,-1.192593325685577,0.24628450106157113,0.6493663538031286,1.0,8/12,22.97%,ACTB;LAMA3;ACTG1;AHI1;ZDHHC7;VANGL2;TRAF3IP1;LAMA5
prerank,mitotic chromosome condensation (GO:0007076),-0.3905935893473845,-1.1924329566158673,0.23357664233576642,0.6485792460239894,1.0,13/26,33.08%,MCPH1;SMC2;CHMP1A;SET;NCAPH2;NCAPH;TTN;TENT4A;CSNK2B;NCAPD2;CDK1;PLK1;NCAPD3
prerank,neutrophil activation (GO:0042119),-0.49081145945202087,-1.1923220709656768,0.24701195219123506,0.6477237253145096,1.0,3/12,12.31%,PREX1;FCER1G;SYK
prerank,RNA metabolic process (GO:0016070),0.32870350843009477,1.192239599074558,0.16574585635359115,0.7027435049329075,1.0,40/127,22.61%,CELF2;RBMS1;ATXN1;RBFOX2;POLR2D;RBMS2;PAPOLG;FTO;LSM1;NOVA1;HNRNPH1;HNRNPC;RBM39;SND1;POLR2C;HNRNPH3;DHX8;ADAR;SUPV3L1;RBM6;RBM5;POLR2F;ALKBH1;TENT2;PABPN1;HNRNPR;HNRNPA2B1;NUFIP1;RNASEH1;PCBP2;SNRNP40;DHX36;RNASE3;POLR2K;RNASEL;PARN;RNGTT;ZC3H12A;RNASEH2B;PNPT1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.3550600481356456,1.1918706546556856,0.20890937019969277,0.7028825525055727,1.0,16/67,16.46%,PLEKHA2;DOCK5;FN1;ECM2;NRP1;S100A10;EPHA1;GSK3B;MYADM;TRIOBP;CDH13;CSF1;CCL25;ILK;RSU1;FBLN2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2928318438165383,1.191815433215902,0.10259433962264151,0.7020782974911621,1.0,80/366,16.11%,EFEMP1;RORA;ATXN1;ARNT2;FOXC1;NFIA;NFYC;POU5F1;SSBP2;ZNF395;ZBTB4;DENND4A;ORC5;MYB;PRRX2;NUCKS1;PERM1;BMP2;RFX3;PKP3;APBB1;TGFBR1;GZF1;NSD3;BAZ2A;ZNF35;WWC2;FOXP3;TESMIN;CREBBP;TCF7L1;NSD1;CREBL2;POU1F1;RNF20;ZSCAN21;NFXL1;ATF7;ZFP37;TEAD2;KAT6B;SOX21;ANKRD17;SUFU;IGF2;MAFB;CREM;MSC;PSPC1;GMNN;TCF7;UBE2V1;TGFBRAP1;ESCO1;FOXO3;ZNHIT3;ZNF219;ZFAT;OGG1;MZF1;THAP1;NR3C1;ZNF205;SERTAD3;CARM1;HIC1;GEMIN5;FUS;DMTF1;VHL;MAPKAPK5;NCOA2;SP3;ORC3;PML;CCAR1;ACVR2B;SOX4;WWTR1;APP
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.4293110101784703,-1.1917861406274595,0.22988505747126436,0.6480340521766282,1.0,6/19,20.26%,SLCO1C1;KLF2;MAPK8;KLF4;EGF;CHRNA7
prerank,phosphorylation (GO:0016310),0.29399666923426715,1.191609614516013,0.10377358490566038,0.7016377185234969,1.0,89/384,16.11%,IGFBP3;PDK1;PDPK1;TEC;ROCK2;EPHA7;NRK;FGFR1;PRKAG2;GRK3;FAM20C;STK39;EIF2AK2;OXSR1;PRKAA2;TSSK3;BMPR1A;BMP2K;FAM20A;DGKD;FER;CDK8;DAPK1;TAOK3;BMP2;IKBKE;PI4KA;TOP1;LATS2;TGFBR1;AAK1;PRKCZ;MAP3K1;MORC3;PANK2;MAPK6;TGFBR2;CCL2;MAP4K1;FAM20B;GSK3B;NEK4;WNK4;SIK3;LRRK2;STK24;STK3;COQ8B;PPP4R1;GK5;CDK7;TLK2;CDK12;AKT3;CDK16;HIPK3;XYLB;IRAK3;GRK5;JAK1;ILF3;PPP3CB;MAP2K1;DAPK2;ERN2;MAPK9;MAP3K13;SRPK1;STRADB;ACVR1C;FRK;TRIB1;WNK1;EIF2AK3;NUAK2;BIRC6;TBK1;PRKD2;RARA;RYK;ILK;ALK;STK4;CDKL3;ACVR2B;LIMK1;TXK;APP;PKN2
prerank,nitric oxide metabolic process (GO:0046209),-0.45693771892931984,-1.1909670275759858,0.22899159663865545,0.6491463439855291,1.0,4/14,10.16%,NOS3;AKT1;GCH1;NOS1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.28865555752029803,1.1908785566310063,0.10011778563015312,0.7028396591267491,1.0,80/390,14.46%,SULF1;FLRT2;EFNB2;STYK1;COL4A6;ROCK2;EPHA7;PDGFRA;FGFR1;FGF1;AXL;DDR2;GHR;IL31RA;FOXC1;PHIP;INSRR;EPHA3;SDC2;FOXC2;RBFOX2;NRP1;FRS2;EPHA8;NFATC4;FER;KL;VEGFD;ROR1;POLR2D;SHB;ANGPT1;KIT;EFS;SORBS1;EPHA1;PDGFRB;PTPN2;RASA1;MVP;PIK3C2A;BDKRB2;GSK3B;HNRNPH1;NGFR;EPHA4;RHOQ;DNM1;MST1R;IGF2;ZNF106;MTSS1;POLR1G;MUSK;APPL1;FGF18;NGEF;MAPK14;PTK2;FLRT1;POLR2C;CSF1;PLAT;EPHA2;TCIRG1;RARRES2;EFNB1;SHOC2;EFNA1;NCK1;WASL;FRK;ATP6V0B;BDNF;ABI1;SHC2;BAIAP2;POLR2F;EIF2AK3;GIGYF2
prerank,positive regulation of cell migration (GO:0030335),0.3001183693973377,1.1907736951739114,0.12692307692307692,0.7021714249450202,1.0,36/253,9.20%,SEMA3D;PDPN;ROCK2;VTN;PDGFRA;DOCK5;FN1;FGF1;DDR2;SMURF2;CXCL16;SYNE2;FAM110C;GLIPR2;NRP1;CDH5;FER;NUMB;SMIM22;BMP2;KIT;MIA3;WNT5B;TGFBR1;MMP14;CLASP1;FAM83H;EPHA1;PDGFRB;SEMA4B;CTSH;CLDN1;SYDE1;MYADM;INSL3;PLAU
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.45694099074839595,-1.1905964209760076,0.256198347107438,0.649146029714065,1.0,5/14,18.40%,THBS1;NOTCH1;KLF4;DLL4;CARD10
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.32500375074904586,1.1905880214966202,0.14814814814814814,0.701702245109092,1.0,29/138,16.26%,RORA;RBPJ;CCN2;NOTCH2;TEAD1;TBL1XR1;NR6A1;POLR2D;NR1H3;RARB;CREBBP;PPARA;YAP1;CCNH;TEAD2;MNAT1;CDK7;TAF7;POLR2C;MAML2;NR4A1;NR3C1;POLR2F;GTF2H4;RARA;KAT2B;WWTR1;TBL1X;TAF9
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.44196878894407543,1.1903939410457347,0.24077328646748683,0.7012715622506969,1.0,5/23,10.63%,NUPR1;CRY1;PPARA;HDAC4;PLEK
prerank,nitric oxide biosynthetic process (GO:0006809),-0.46646094925242093,-1.1901035432486229,0.2459016393442623,0.6493926499785563,1.0,4/13,10.16%,NOS3;AKT1;GCH1;NOS1
prerank,regulation of autophagosome assembly (GO:2000785),0.406777848855232,1.1894430509209026,0.22383252818035426,0.7029746043312198,1.0,13/33,16.33%,NUPR1;IFT88;MTMR3;LRRK2;TMEM39A;IFT20;SCFD1;PIP4K2B;CHMP4A;CHMP4B;NPRL3;FEZ2;RAB5A
prerank,positive regulation of dendrite development (GO:1900006),0.5358656559106926,1.1891541636684277,0.2584493041749503,0.7027904836952101,1.0,2/10,4.78%,PTN;BMP7
prerank,heart trabecula morphogenesis (GO:0061384),0.4765003397956345,1.1891356520846732,0.25225225225225223,0.7018665010027357,1.0,6/18,5.09%,TGFBR3;RBPJ;BMPR1A;RBP4;BMP7;TGFBR1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.48930204495059537,1.1889731480988746,0.2702702702702703,0.7013640667252745,1.0,4/15,7.03%,PDGFRA;MTHFD1;TGFBR1;TGFBR2
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.3750998631145478,-1.1889122850427492,0.22274881516587677,0.6516388255311125,1.0,8/32,7.52%,PPP1R16B;CALM1;CAMTA1;CALM2;PTBP1;HSP90AB1;CALM3;SYMPK
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4419760955210922,1.1880590018958141,0.24080882352941177,0.7031435877998516,1.0,4/24,4.52%,ROCK2;FOXC1;NCOA3;ERRFI1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.35713971691354524,1.1879730558332504,0.1918876755070203,0.7023977451894929,1.0,12/70,10.43%,KMT2A;EIF2AK2;FOXC1;OSM;MYB;TCF12;YAP1;PSMB10;PSMA7;PSMA3;PSME4;PSMA5
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.4906226826836301,1.1876504801819034,0.26678765880217786,0.7024161361582172,1.0,6/14,20.14%,DPYD;UPP1;NT5C;UMPS;ERH;NT5C1A
prerank,embryonic digit morphogenesis (GO:0042733),0.47396334664104367,1.187642726437439,0.25177304964539005,0.7014623481267773,1.0,6/18,15.21%,OSR1;GLI3;SALL1;CREBBP;NOG;HDAC2
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.38411133271195785,1.1872702691921184,0.22916666666666666,0.7015812418873355,1.0,6/45,6.78%,PDPK1;EFEMP1;DGKD;TGFA;PLCE1;PIK3C2A
prerank,negative regulation of protein binding (GO:0032091),-0.31744399338777796,-1.1863128861863292,0.15072463768115943,0.6581048169159146,1.0,22/71,15.51%,ACTB;ADAM15;ITGA4;MAPK8;SORL1;ATP2A3;AKT1;SYMPK;DDX11;B2M;ZFPM1;GNL3L;RACK1;DVL1;ADRB2;PPP1CA;CAV1;TTBK1;MAP2;ATP2A2;PARK7;CDKN1A
prerank,response to interferon-alpha (GO:0035455),0.47504837913531595,1.1862470387550224,0.24731182795698925,0.7035409028347022,1.0,7/16,15.80%,AXL;EIF2AK2;TPR;BST2;IFITM1;ADAR;IFNAR2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.4404369132296368,1.1861535807875982,0.25045045045045045,0.7028335779007125,1.0,8/22,20.81%,ROCK2;IL6ST;MEF2A;SMAD4;P2RX4;SLC9A1;ROCK1;AGT
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.31617636216438966,-1.1860537152005972,0.1676300578034682,0.657667277081299,1.0,17/65,14.27%,PTPRJ;HIP1;BCAR3;SH3KBP1;HIP1R;DAB2IP;SH3GL2;CCDC88A;AKT1;CEACAM1;MVB12B;CBL;ARHGEF7;EGFR;PLAUR;RNF126;RHBDF2
prerank,regulation of kinase activity (GO:0043549),0.34684881897175174,1.185560249065471,0.20087976539589442,0.7035525997211388,1.0,22/89,12.25%,EPHA7;PDGFRA;FGFR1;AXL;DDR2;INSRR;LMO4;EPHA3;EPHA8;ROR1;LDB2;KIT;RAD50;EPHA1;PDGFRB;PLCE1;EPHA4;MST1R;MUSK;DSTYK;TSPYL2;EPHA2
prerank,blood circulation (GO:0008015),0.3757394747784818,1.1855049924203214,0.22150882825040127,0.7027471592780378,1.0,8/49,7.14%,COL4A3;ROCK2;CXCL10;MYOF;SERPING1;ADORA2A;STAT1;BDKRB2
prerank,inflammatory response (GO:0006954),0.31043695271327415,1.1854288139458362,0.14583333333333334,0.7019628471705822,1.0,28/195,9.31%,CXCL10;HSPG2;FPR2;ADORA2A;NFATC4;ANXA1;LOXL3;BMP2;KIT;IL17D;IL6;TPST1;CRP;TLR4;C5AR2;PLA2G4C;HDAC4;NOS2;BDKRB2;ADCY1;CCL2;ADM;LGALS9;IL18;SIGLEC1;RIPK2;PJA2;TLR2
prerank,ion homeostasis (GO:0050801),-0.37802859627679836,-1.1850974132683911,0.2282051282051282,0.6593176708637601,1.0,6/30,9.16%,SLC4A10;KLHL3;UNC80;CAMK2D;SLC12A5;NEDD4L
prerank,response to retinoic acid (GO:0032526),0.3571347875968065,1.1847723099717875,0.2124031007751938,0.7030131440394516,1.0,11/59,7.87%,WNT6;GATA6;WNT10B;WNT3A;PTK7;EPHA3;RBP4;WNT5B;ZNF35;CTSH;WNT5A
prerank,positive regulation of cellular component organization (GO:0051130),-0.2942287220832828,-1.1844160592619137,0.1588447653429603,0.660066793180949,1.0,30/107,18.60%,ATP10A;NRXN1;SHANK3;TGFB2;INSR;TFRC;SNCA;RPS3;DAB2IP;SLF1;VEGFA;NEDD4L;GNL3L;TGFB3;TAL1;RACK1;SYK;LMAN1;RELN;TMEM30A;MPP7;BMF;PARK7;CCL19;ADD1;CBLL1;MMP1;RUNX1;ABCB4;TPPP
prerank,anion transport (GO:0006820),0.40682920808825257,1.1841776052509718,0.25383304940374785,0.7037804712694451,1.0,5/33,3.58%,SLC13A3;SLC13A4;SLC19A1;SLC26A9;VDAC2
prerank,organic acid transport (GO:0015849),0.33842161655734865,1.1838886380235327,0.20057306590257878,0.7036931678455507,1.0,9/94,5.93%,SLC7A11;PDPN;SLC7A2;SLC6A13;SLC13A3;SLC19A1;SLC6A12;SLC7A14;ACSL1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.4683544022771772,1.1837039960566684,0.27522935779816515,0.7032730845976587,1.0,2/17,3.92%,GJA1;TERT
prerank,regulation of protein neddylation (GO:2000434),-0.5099339332871237,-1.1830297263702765,0.266384778012685,0.6628785802820913,1.0,6/10,15.28%,RPL5;RPL11;DCUN1D2;COPS9;DCUN1D5;DCUN1D1
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.32607499063008755,-1.1829748045048067,0.19060773480662985,0.6618289183241581,1.0,17/50,20.97%,SMAD7;IVNS1ABP;RPS3;AKT1;GNL3L;CAV1;CAMLG;PARK7;PER2;N4BP1;MINAR1;SIRT7;VPS28;UFL1;PRR7;SH3RF2;PRMT3
prerank,mRNA polyadenylation (GO:0006378),0.43241345573979406,1.1828694032080658,0.2702702702702703,0.7038317570986549,1.0,15/26,24.73%,PCF11;PAPOLG;CDC73;PAF1;TENT2;LEO1;CSTF3;APP;PAPOLB;GRSF1;WDR33;TENT4B;PNPT1;CLP1;PAPOLA
prerank,RNA polyadenylation (GO:0043631),0.43241345573979406,1.1828694032080658,0.2702702702702703,0.7038317570986549,1.0,15/26,24.73%,PCF11;PAPOLG;CDC73;PAF1;TENT2;LEO1;CSTF3;APP;PAPOLB;GRSF1;WDR33;TENT4B;PNPT1;CLP1;PAPOLA
prerank,positive regulation of immune response (GO:0050778),0.36212680830351374,1.1820357217005923,0.20426829268292682,0.7052774188978411,1.0,8/64,7.50%,RSAD2;IL6ST;FPR2;IL23R;MYB;IFI35;GBP5;LGALS9
prerank,outflow tract septum morphogenesis (GO:0003148),0.4359959774558574,1.181988751563816,0.26024955436720143,0.7044608283327319,1.0,8/24,11.55%,ROBO1;PARVA;GATA6;BMPR1A;NRP1;TGFBR2;SMAD6;SMAD4
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4684973935444471,1.1818897518668259,0.24814814814814815,0.7037865003011002,1.0,4/16,4.75%,TGFBR3;RBPJ;BMPR1A;GLI1
prerank,mRNA methylation (GO:0080009),-0.45281818302726695,-1.1817074391477553,0.25690021231422505,0.664170738869044,1.0,8/15,28.96%,VIRMA;CBLL1;ZC3H13;TRMT6;METTL8;TRMT10C;METTL14;TRMT61A
prerank,actin filament organization (GO:0007015),0.3106888948562234,1.1816686328143153,0.15343203230148048,0.7035135630266933,1.0,30/151,15.04%,DPYSL3;CGNL1;MCU;TMOD3;SHROOM2;MYO1B;ARHGAP12;EFS;TPM1;BAIAP2L1;NEBL;RHOBTB2;FAT1;RHOF;VILL;MYO1A;DBN1;DSTN;DLG1;TPM4;RFLNA;TRIOBP;RHOC;WASL;ABI1;BAIAP2;MYO15A;TLE6;MYO1E;MYO1C
prerank,fatty acid elongation (GO:0030497),-0.4636458137466599,-1.1816635954415002,0.251131221719457,0.6630604182860657,1.0,3/13,6.22%,ELOVL5;ELOVL7;TECR
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.37555010001989153,1.1807945955711343,0.2296416938110749,0.7051632653585831,1.0,8/50,9.31%,SASH1;EIF2AK2;NFAT5;IFI35;TLR4;LGALS9;PHB2;TLR2
prerank,histone H4-K16 acetylation (GO:0043984),0.4558149805094455,1.180605344008863,0.2672566371681416,0.7047643459729075,1.0,1/19,0.11%,KMT2A
prerank,positive regulation of defense response (GO:0031349),0.3412327522791826,1.1799964852447142,0.1925925925925926,0.7055894712860621,1.0,16/89,11.48%,IL16;FPR2;OSM;ZBP1;IFI35;TLR4;SERPINE1;OPTN;GBP5;CD47;WNT5A;IL18;SETD4;TLR2;POLR3F;NFKBIZ
prerank,epidermal cell differentiation (GO:0009913),0.39243214991364567,1.1797267090472032,0.22185970636215335,0.705428163492286,1.0,13/41,21.59%,GATA6;ANXA1;GLI1;CLIC4;WNT5A;EPHA2;HDAC2;OPN3;TXNIP;CASP3;DSP;PIP5K1A;TGM1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.32950904102495066,1.179653535176979,0.18926553672316385,0.7046667259021837,1.0,16/110,7.83%,LPAR1;ADGRD1;LGR4;CXCL10;GHRH;ADORA2A;GCGR;PTHLH;ADCY7;ADCY5;MC2R;RXFP2;ADCY1;ADM;RAMP1;ADGRL1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.4552871033430993,-1.1794305596624162,0.267260579064588,0.6684303651693438,1.0,7/15,14.57%,TMSB4X;THBS1;NOTCH1;MET;LGMN;FGF2;PRKD1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.4995402499170261,1.1792714941195535,0.28,0.7047977310968497,1.0,2/13,2.87%,PLXNA2;NRP1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.48504899018353786,-1.1788713250184784,0.2589641434262948,0.6687889407624362,1.0,5/11,38.18%,PINK1;PARK7;STK26;MMP3;GATA4
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.3287015006170064,-1.1786026175808226,0.16666666666666666,0.6683578824854559,1.0,19/54,15.35%,MEF2C;NOS3;TMSB4X;THBS1;KDR;ACVRL1;GATA2;HMGB1;PRCP;ATP5F1A;AKT1;VEGFA;NUS1;ATP5F1B;FGF2;CD40;RGCC;PRKD1;PLCG1
prerank,non-motile cilium assembly (GO:1905515),0.40942365168589523,1.1784335280256086,0.24664429530201343,0.7062885428303136,1.0,9/30,15.40%,ARL13B;IFT88;IFT57;TMEM107;CCDC13;C2CD3;RPGRIP1L;CEP250;TOGARAM1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.438969074217761,1.1783140637392557,0.2482638888888889,0.7057226945821313,1.0,3/25,4.34%,PDPK1;CXCL10;F2RL3
prerank,negative regulation of complement activation (GO:0045916),0.5290002969285024,1.1779213569863325,0.2903225806451613,0.7058675381376663,1.0,2/10,2.68%,CD55;SERPING1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.3443358245964848,-1.1774979453357024,0.185378590078329,0.6704199377508121,1.0,15/42,25.96%,MEF2C;NOTCH1;SOX17;AHI1;ZIC3;TBX2;NDRG4;SOX18;APLNR;VANGL2;DLL1;SRF;TBX6;BBS7;STIL
prerank,positive regulation of mitochondrial fission (GO:0090141),0.46394830954272814,1.177440033891752,0.27075812274368233,0.7063325945105989,1.0,6/18,15.88%,MCU;DCN;RALBP1;DNM1L;MIEF1;MUL1
prerank,sterol metabolic process (GO:0016125),0.3584537985423512,1.1773348209687258,0.19967532467532467,0.7056849862163135,1.0,11/60,13.00%,PRKAG2;CYP7B1;APOA2;APOF;CYP27A1;INSIG2;SOAT1;ABCA1;OSBPL5;CH25H;LBR
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5175779924489246,1.176626596280638,0.2751540041067762,0.7067347985640284,1.0,3/11,6.24%,ANXA1;RC3H1;FOXP3
prerank,translational elongation (GO:0006414),-0.2882374728118608,-1.176595018146789,0.14156626506024098,0.6718886894658609,1.0,51/101,37.55%,EEF1G;EEF1A1;MRPL4;GTPBP1;EEF2;GFM1;MRPS18A;RACK1;MRPL1;MRPS30;MRPS23;MRPL57;MRPL28;AURKAIP1;MRPL35;MRPL47;MRPS5;MRPL34;MRPL23;MRPL9;MRPS31;MRPL52;MRPS2;MRPS12;TUFM;MRPL11;MRPL49;LTN1;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;EEF1D;MRPL51;MRPL54;MRPL32;MRPL43;MRPL2;ERAL1;MRPL24;EEF1B2;MRPL37;EEF2K;MRPL30;MRPL45;MRPS24;GTPBP2;MRPS15;MRPL12
prerank,aorta morphogenesis (GO:0035909),0.4701608491156313,1.1761241165248337,0.2894736842105263,0.7071876655840752,1.0,4/17,5.76%,RBPJ;BMPR1A;EFEMP2;PDGFRB
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4153263070903622,1.1759662813968361,0.24381625441696114,0.7066800447009984,1.0,7/26,12.97%,ANAPC11;ESPL1;UBE2C;CUL3;NSMCE2;HECW2;CDC27
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.32452763328519807,-1.1754239525752295,0.19298245614035087,0.6739760372403004,1.0,20/53,25.37%,PSMC3;OAZ1;OAZ2;PSMD3;PSMD14;PSMD6;PSMD4;BCKDK;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;PSMD8;PSMD11
prerank,cardiac muscle cell development (GO:0055013),0.4443289226246105,1.175113504255936,0.26013513513513514,0.7082920735187995,1.0,4/20,5.76%,CXADR;PDGFRA;CSRP3;PDGFRB
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4396868274681025,1.174945204932993,0.2670250896057348,0.7077895474747823,1.0,2/21,1.63%,MCU;MICU1
prerank,muscle contraction (GO:0006936),0.32336128758019245,1.1749269819172643,0.18544935805991442,0.7069030576329108,1.0,17/126,9.94%,TNNC1;ROCK2;MYOF;TMOD3;CALD1;VIM;DES;TPM1;SORBS1;VCL;SNTA1;BDKRB2;ACTN2;ARHGEF11;SSPN;NMUR1;TPM4
prerank,nucleoside catabolic process (GO:0009164),0.517814617541619,1.174325202700953,0.30343511450381677,0.7076698813405717,1.0,4/11,10.29%,DPYD;UPP1;NT5C;DERA
prerank,regulation of JNK cascade (GO:0046328),-0.29210965002948985,-1.1741890967193873,0.15064102564102563,0.6764648491291101,1.0,32/101,17.77%,MECOM;PLCB1;PTK2B;TPD52L1;PHLPP1;MAP3K5;EPHB1;DAB2IP;HMGB1;MAP3K11;RASSF2;PINK1;SDCBP;MFHAS1;DUSP22;MINK1;MAPK8IP1;GADD45G;ANKRD6;EGFR;SEMA3A;HRAS;MAPK8IP3;CYLD;COPS5;CCL19;NOD2;MEN1;CD27;DUSP15;LTBR;PYCARD
prerank,microtubule anchoring at centrosome (GO:0034454),0.5296197992988655,1.1741406173761768,0.27486437613019893,0.7072727445471632,1.0,2/10,10.01%,NINL;NIN
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.5016782566854555,1.1735379708574878,0.2851919561243144,0.7080487125923076,1.0,4/13,9.42%,SORBS1;PRKCZ;ECHDC3;IGF2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.4357912595704173,1.1732986072058693,0.2469352014010508,0.707799733233384,1.0,3/23,5.09%,EFNB2;WNT3A;MMP14
prerank,cellular response to purine-containing compound (GO:0071415),-0.5038866596701245,-1.172796490009462,0.2654690618762475,0.6794012067455923,1.0,4/10,14.23%,RYR2;RYR3;SLC8A1;CASQ2
prerank,positive regulation of cell adhesion (GO:0045785),-0.30619690496896973,-1.172378934270396,0.17117117117117117,0.6794873644592219,1.0,21/74,19.25%,FRMD5;PTPRJ;TGFB2;ZFHX3;SMAD7;STX3;VIT;ADGRG1;NDNF;VEGFA;RET;ATM;CXCL12;MEGF10;SYK;EPB41L4B;RAC1;ADAM8;PPM1F;RAC3;C1QBP
prerank,neuron projection extension (GO:1990138),0.4203223536128482,1.171695636324352,0.23793677204658903,0.711473345797325,1.0,11/32,16.23%,ALCAM;AUTS2;NRP1;CPNE1;USP9X;FLRT1;SPG11;PPP3CB;IQGAP1;CDKL3;FLRT3
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.37197732871977496,1.1715522518490311,0.23338485316846985,0.7109583503627814,1.0,13/52,18.26%,SAMD4A;TUT4;POLR2D;RC3H1;DCP2;LSM1;PAN3;DDX6;CNOT3;DIS3;CNOT9;TUT7;PATL1
prerank,neuron projection morphogenesis (GO:0048812),-0.2771987161697361,-1.171400187729622,0.13229571984435798,0.6810801751788048,1.0,34/137,12.19%,CNTNAP2;NLGN1;CTNND2;CTNNA2;SHANK3;TNIK;GPM6A;CNTN4;DOCK10;DCC;ACTB;NCKAP1;PAK1;TRIO;KLF7;ANK3;NYAP2;EPHB1;S100B;DAB2IP;CTNNB1;NRCAM;DCLK1;MAP1B;SHTN1;UBB;MINK1;DVL1;PAX2;DBNL;NEFH;PAK3;NGF;ALS2
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.3725422654086479,-1.1707773455791322,0.23821989528795812,0.6817388873615047,1.0,10/29,23.10%,RPS19;RPS8;RPS16;RPS21;RPS14;UTP6;HEATR1;BMS1;WDR46;ABT1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.3991782277349552,1.1704778741508144,0.24429967426710097,0.7130588855573189,1.0,6/33,3.85%,MCC;NR2F2;SP100;TACSTD2;DCN;DUSP10
prerank,response to lipopolysaccharide (GO:0032496),0.3185169816304885,1.170383108880559,0.19047619047619047,0.712392464969693,1.0,23/138,10.75%,SELP;CXCL10;AXL;LDOC1;VIM;IL23R;FER;IL6;TLR4;PTPN22;SERPINE1;NR1H3;NOS2;LY96;CCL2;LGALS9;CDC73;WNT5A;CD274;SMAD6;NOCT;MAPK14;IRAK3
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3577154526447903,-1.1703642423936746,0.20813397129186603,0.6817301300548525,1.0,11/34,10.85%,KDR;NOTCH1;MT1G;VEGFC;FLT1;GAB1;SEMA6A;DAB2IP;RAMP2;VEGFA;NUS1
prerank,response to unfolded protein (GO:0006986),-0.33529529333264274,-1.1701118764655216,0.215633423180593,0.6812229956666845,1.0,14/48,18.19%,HSPA8;TM7SF3;DAB2IP;HSPA14;HSP90AB1;HSPA4;HSPE1;DNAJB4;HSP90AA1;TOR1B;HSPA5;HSPA4L;STT3B;PACRG
prerank,cellular calcium ion homeostasis (GO:0006874),-0.27739118698926046,-1.1698274767608123,0.14285714285714285,0.6808241466336946,1.0,49/133,25.63%,TRPC3;SLC24A2;ATP1B1;RYR2;TPT1;HTR2C;SLC35G1;MCUB;TRPC5;TRPC4;ATP2C1;SLC8A1;CCL14;ATP2A3;NPTN;TRPC6;SLC30A1;CAMK2D;CALR;SMDT1;CAV2;SLC10A7;TMCO1;CXCL12;CAV1;CD40;CCDC47;ATP13A4;ATP2A2;CCL19;MAIP1;TMEM178A;ADCY8;HTR2B;SLC8B1;HTR2A;TRPC7;CHRNA7;ATP2B3;PTH1R;CALB2;CLN3;STC1;ATP13A1;ATP2B2;SLC24A5;SELENOK;EDN1;PLN
prerank,regulation of Rac protein signal transduction (GO:0035020),0.48557854818842244,1.1697134085543142,0.2648648648648649,0.7134282621343848,1.0,2/16,1.40%,RASGRF1;AUTS2
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.4361534951324277,1.1697011913847408,0.2852173913043478,0.7125190352788174,1.0,8/22,18.12%,CDC73;BRD4;CDK12;THOC5;ERCC6;LEO1;CDK13;EAPP
prerank,negative regulation of neurogenesis (GO:0050768),0.4041248758456508,1.169459548301349,0.25779967159277506,0.7122549304186256,1.0,6/34,7.82%,PTN;WNT3A;IL6;APPL2;LRP4;NGFR
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.4681758647026064,1.169198331987576,0.2732342007434944,0.7120337982285413,1.0,6/18,17.70%,DDX60;BIRC3;OASL;ANKRD17;PUM2;USP15
prerank,ion transport (GO:0006811),-0.2889669428237643,-1.1685490227808797,0.18,0.6833607257235249,1.0,23/111,11.01%,SLC12A7;SLC26A7;SLC12A2;PIEZO2;SLC9A2;SLC26A2;SLC24A2;ANO1;ATP11B;SLC5A5;AQP11;SLC1A1;SLC8A1;SLC15A2;SLC9A8;TRPC6;TMEM63C;SLC1A2;GABRB1;SLC12A5;GRIN1;SLC12A6;SLC36A1
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.3079527311833115,-1.1680352912428849,0.1807909604519774,0.6837955193362164,1.0,20/69,17.70%,MEF2C;PTK2B;NTRK2;SIX1;FOXQ1;NDNF;LGMN;PINK1;TGFB3;NGF;GRN;SIX4;SOD1;CLCF1;PARK7;CPEB4;SET;TOX3;NTF3;ADAM8
prerank,long-chain fatty acid import into cell (GO:0044539),-0.49918881583040875,-1.1678520282356297,0.2714570858283433,0.683083793776439,1.0,2/10,2.16%,SLC2A1;ACSL3
prerank,blood vessel diameter maintenance (GO:0097746),-0.3644606898859944,-1.1678453266017697,0.21553884711779447,0.6818896922371069,1.0,12/34,16.60%,EDNRA;NOS3;KCNMB2;KLF2;ECE1;ACE;NPR1;NOS1;ACE2;GCLC;HTR2B;PER2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.39373026652141874,1.1674990659459368,0.2608695652173913,0.7160267930076397,1.0,11/35,20.47%,ZMIZ1;RBFOX2;NEDD4;PMEPA1;YAP1;NR3C1;TMF1;UBR5;PPARGC1B;PGR;DDX5
prerank,cellular response to inorganic substance (GO:0071241),-0.4029368694520225,-1.1674297855049185,0.226457399103139,0.6818825967587266,1.0,4/21,8.39%,FOXO1;KCNC2;DDX11;GUCY1B1
prerank,modulation by host of symbiont process (GO:0051851),-0.367725194072432,-1.1673938343051091,0.20558375634517767,0.6807910879995599,1.0,6/31,9.94%,LEF1;INPP5K;CTDP1;TFAP4;SMARCB1;HDAC1
prerank,positive regulation of vascular permeability (GO:0043117),0.505040218602492,1.167289371873794,0.2701688555347092,0.7157220801928645,1.0,2/12,3.81%,BMP6;ANGPT1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.43785949656517953,1.1671525200141004,0.27797202797202797,0.7151884458765042,1.0,4/22,8.56%,SASH1;RELL1;BMP2;PJA2
prerank,central nervous system myelination (GO:0022010),-0.4883809365776646,-1.1670121318782054,0.2620967741935484,0.6807116034534594,1.0,8/11,41.39%,PLP1;TENM4;B4GALT6;CLU;CNTNAP1;ABCA2;B4GALT5;HES5
prerank,histone mRNA catabolic process (GO:0071044),0.47830551100211965,1.16643724953861,0.28998242530755713,0.7163385987459159,1.0,8/15,17.91%,TUT4;DCP2;LSM1;XRN1;TENT2;SSB;EXOSC10;TUT7
prerank,cellular response to calcium ion (GO:0071277),-0.3091101785255605,-1.1654964607654987,0.1884498480243161,0.6839304107381613,1.0,12/67,8.67%,NLGN1;SYT1;MEF2C;PLCG2;ITPKB;RYR3;LGMN;KCNH1;SYT7;CAMK2D;SYT4;CPNE4
prerank,mitochondrion distribution (GO:0048311),0.5000331660161941,1.1654317768987228,0.30353817504655495,0.7183831386851837,1.0,5/12,12.04%,TRAK1;MEF2A;LRRK2;DNM1L;ATCAY
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3560515915093363,-1.1653391701509075,0.22921914357682618,0.6832186999253541,1.0,13/34,15.34%,TEK;PTK2B;PIK3R1;FLT1;DAB2IP;PIK3R3;WDR81;PIK3IP1;FGF2;WASHC1;PRKD1;CCL19;NOD2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5049081351726215,1.164863654172059,0.2846975088967972,0.7190748601880074,1.0,2/12,10.01%,NINL;NIN
prerank,maturation of SSU-rRNA (GO:0030490),-0.3525319506370589,-1.16418026345945,0.22422680412371135,0.6853450148228453,1.0,11/34,21.90%,RPS19;RPS8;RPS16;RPS28;NOL11;RPS14;SNU13;UTP6;HEATR1;BMS1;WDR46
prerank,protein localization to cell periphery (GO:1990778),-0.2756041088571794,-1.1640046325043076,0.1183206106870229,0.6846225156250217,1.0,35/133,14.68%,DPP10;BSG;KCNB2;EFR3B;CACNB2;TNIK;ATP1B1;LIN7A;CDH1;KCNIP4;GAS6;ANK3;MAP7;EMP2;DPP6;TSPAN14;INPP5K;STXBP1;RAPGEF2;RAB3C;RAMP2;TMED2;LRP6;ZDHHC2;KCNB1;ZFYVE27;CAV1;FGF13;RAPGEF6;RAB12;EHD4;F11R;RAB40B;CLASP2;C2CD5
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.5055831385611496,-1.1636079424339436,0.28270042194092826,0.6845460359515708,1.0,7/10,33.25%,DLGAP1;DLGAP2;BEGAIN;NPTX2;CACNG5;NPTXR;NPTX1
prerank,zinc ion transport (GO:0006829),-0.40440545350259677,-1.1635278420131032,0.21541950113378686,0.6836121154218566,1.0,11/21,31.49%,SLC39A6;SLC30A1;SLC39A14;SLC39A13;SLC39A8;TRPM2;SLC30A5;SLC30A10;SLC30A3;SLC30A9;MT3
prerank,negative regulation of developmental process (GO:0051093),-0.3067876220976066,-1.1633383897428442,0.17897727272727273,0.6829393777615597,1.0,17/69,11.57%,NOS3;GRIN3A;CST3;TFRC;DCC;NOTCH1;TBX1;KLF7;GAS6;ARHGEF15;CDK6;BMP4;BCL11A;PINK1;TBX2;NOTCH4;NFIB
prerank,canonical glycolysis (GO:0061621),-0.3923501189697985,-1.1627589446351687,0.2631578947368421,0.682282775941272,1.0,8/24,19.65%,PGK1;PKM;ALDOC;TPI1;GPI;PGAM1;ENO1;GAPDHS
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.3923501189697985,-1.1627589446351687,0.2631578947368421,0.682282775941272,1.0,8/24,19.65%,PGK1;PKM;ALDOC;TPI1;GPI;PGAM1;ENO1;GAPDHS
prerank,regulation of protein kinase C signaling (GO:0090036),0.4896705656022088,1.1624332476967278,0.30451127819548873,0.7251960330608076,1.0,5/14,9.89%,DGKD;ADGRV1;WNT5A;MYADM;GPD1L
prerank,acidic amino acid transport (GO:0015800),0.4616306974604177,1.162430948136221,0.27695167286245354,0.7242630491569607,1.0,3/17,2.36%,SLC1A3;SLC6A13;GJA1
prerank,cellular amide metabolic process (GO:0043603),0.3270000446311362,1.162278904610805,0.20899854862119013,0.7237845469084219,1.0,16/102,11.10%,SMPD3;PLPP3;PCCA;SHMT1;ACOT11;SLC19A1;MTHFD1;AEBP1;PANK2;PCCB;NAAA;BTD;ACOT9;HLCS;ACOT1;NLN
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5052035398867338,-1.161496673520163,0.29045643153526973,0.6848144552019223,1.0,7/10,36.34%,RNF125;GPATCH3;C1QBP;UFD1;SEC14L1;TSPAN6;TKFC
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5154097514032222,1.161461741331364,0.3005671077504726,0.7252067858641869,1.0,6/10,22.73%,NCK1;VHL;SIRT2;CITED2;BAG3;DNAJB1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.4755443467374183,1.1613393111132186,0.2783882783882784,0.7246752541136148,1.0,7/16,20.68%,CREBBP;NAA16;NAA30;NAA15;KAT2B;NAA35;NAA40
prerank,striated muscle contraction (GO:0006941),0.3639466193356898,1.1603442438917424,0.2448,0.726665342553194,1.0,6/53,8.38%,TNNC1;ATP1A2;CSRP3;TPM1;ARHGEF11;SCN3B
prerank,bone morphogenesis (GO:0060349),-0.4451791511414839,-1.1603081853431219,0.2741228070175439,0.6871043690046819,1.0,5/14,13.21%,BMPR2;LRP6;SFRP4;LRP5;BMPR1B
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.48730280802182235,-1.1600514754778792,0.3068893528183716,0.6866089936002177,1.0,3/10,9.74%,MAPK3;FAS;LYN
prerank,SNARE complex assembly (GO:0035493),-0.49204803710102196,-1.1599610475747009,0.29916317991631797,0.6856987162479813,1.0,3/10,7.62%,SNCA;STXBP1;STXBP6
prerank,positive regulation of vasoconstriction (GO:0045907),-0.45978030551587323,-1.1596910771524858,0.2753623188405797,0.6852906292490886,1.0,4/13,27.75%,ADRA1B;CAV1;SMTNL2;ADRA1A
prerank,bile acid and bile salt transport (GO:0015721),-0.3922761723554279,-1.1593291121947633,0.27209302325581397,0.6851100790652225,1.0,8/24,24.05%,ABCC4;SLCO1C1;CEACAM1;ATP8B1;RXRA;SLC10A3;STARD5;SLCO1B1
prerank,organophosphate ester transport (GO:0015748),-0.38395723751924826,-1.1591433929534407,0.25219298245614036,0.6844504216722366,1.0,6/24,8.32%,PITPNC1;PITPNA;ABCA3;SCARB1;PRELID2;PRELID1
prerank,regulation of phagocytosis (GO:0050764),-0.3297078593070023,-1.1589806104267697,0.20168067226890757,0.6837137849253632,1.0,14/53,12.31%,MERTK;RAB27A;GAS6;DOCK2;GATA2;SNX3;DYSF;SCARB1;SYT7;CALR;FCER1G;TUB;RACK1;SYK
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.3069337821916387,-1.1589376151086563,0.18397626112759644,0.6826808517771771,1.0,22/67,21.90%,PSMC3;NCF2;PSMD3;PSMD14;B2M;CALR;PSMD6;PSMD4;PSMA6;PSMA4;PSMB8;CYBB;PSMA8;PSME1;IKBKB;PSMD7;FCGR1A;PSMC6;PSMB5;SEC22B;PSMC5;PSMB1
prerank,cellular response to mechanical stimulus (GO:0071260),-0.33213673402711213,-1.1587658028581578,0.21927710843373494,0.6820409741834793,1.0,18/46,27.96%,PIEZO2;CRADD;TMEM150C;MAPK8;MAPK3;PDE2A;FAS;CD40;F11R;LTBR;CHEK1;BAD;TNFRSF10B;CASP1;TLR7;MYD88;FADD;TNFRSF1A
prerank,positive regulation of peptidase activity (GO:0010952),-0.3976252235438732,-1.1586672228607175,0.2597701149425287,0.6811685394880063,1.0,6/20,20.07%,PINK1;PRELID1;GRN;PSENEN;PSME1;NDUFA13
prerank,positive regulation of interferon-beta production (GO:0032728),0.39586009630772373,1.1582393714851766,0.273972602739726,0.7318563914458388,1.0,9/33,16.97%,TRIM56;TLR4;RIPK2;TLR2;POLR3F;OAS2;TBK1;IFIH1;RNF135
prerank,positive regulation of glial cell differentiation (GO:0045687),0.4647732996037233,1.1581554508226448,0.30916030534351147,0.7311510214269512,1.0,6/17,15.10%,PTN;IL34;BMP2;SERPINE2;EGR2;CXCR4
prerank,determination of bilateral symmetry (GO:0009855),-0.3911773663918139,-1.1577089149731021,0.26573426573426573,0.6827473071184201,1.0,10/24,25.96%,NOTCH1;TBX1;ZIC3;KIF3B;DNAH11;DLL1;ODAD2;ODAD3;BBS7;STIL
prerank,peptidyl-amino acid modification (GO:0018193),0.5227903386205772,1.1576810814992728,0.30241187384044527,0.7316210559462307,1.0,4/10,22.05%,APOA2;PDF;TTLL4;METAP2
prerank,protein polymerization (GO:0051258),0.360315193744216,1.1576077610378892,0.22764227642276422,0.7308600731901295,1.0,10/55,14.25%,GAS7;ARHGAP6;DIAPH1;HDGFL3;UBE2C;CHMP3;WASF1;WASL;CHMP4A;CHMP4B
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3428861156352722,-1.1575897182849966,0.23237597911227154,0.6819586816840951,1.0,11/39,9.16%,DMD;FGF14;FGF12;HECW1;FXYD5;NETO1;UTRN;ANK3;YWHAH;CAMK2D;NEDD4L
prerank,inositol phosphate catabolic process (GO:0071545),-0.47347623008458284,-1.1574737382685252,0.27194860813704497,0.6811674920095525,1.0,7/12,24.22%,INPP5K;IMPA1;IMPA2;INPP5J;NUDT3;INPP5B;SYNJ1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.31119573175157994,1.1572362043308215,0.19246298788694483,0.7311162145325018,1.0,20/152,8.81%,LPAR1;ADGRD1;LGR4;CXCL10;GHRH;FPR2;AKAP12;ADORA2A;GCGR;PTHLH;GLP2R;ADCY7;ADCY5;MC2R;RXFP2;ADCY1;ADM;RAMP1;ADGRL1;INSL3
prerank,regulation of axon extension (GO:0030516),-0.34924880741499653,-1.157192529807857,0.23076923076923078,0.6808330845156179,1.0,12/37,15.58%,DIP2B;MACF1;NRCAM;SEMA7A;SHTN1;L1CAM;SEMA3G;ZFYVE27;DBNL;SEMA3A;MAP2;MAPT
prerank,carbohydrate derivative transport (GO:1901264),-0.4215086447657951,-1.1561116439865864,0.25059101654846333,0.6827613383056369,1.0,6/18,16.59%,SLC15A2;SCARB1;SLC10A7;VLDLR;MFSD2A;SLC25A19
prerank,regulation of transport (GO:0051049),-0.3507462475545276,-1.1560786415262367,0.23658536585365852,0.6816936066051623,1.0,9/36,7.95%,EPB41;ICA1;ACTB;SNCA;ACTG1;MBTPS1;WWC1;REEP5;PINK1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.3836057494408028,-1.1556419993184983,0.26252983293556087,0.6817425819086602,1.0,12/25,27.64%,CSGALNACT1;NDST3;FUT9;EXT1;B3GNT2;B3GNT9;NDST4;B3GNT3;HAS1;HAS3;B3GNT6;B4GAT1
prerank,protein targeting (GO:0006605),-0.2794688732099388,-1.1555030787047929,0.1368421052631579,0.6809912171838208,1.0,40/118,23.24%,NLGN1;AKAP6;RASSF9;SORL1;AQP11;RPL11;VPS37B;GABARAP;SRP14;MFF;SDCBP;SPCS2;ZDHHC14;ZDHHC20;MFN2;ZDHHC2;GDAP1;SPCS1;TIMM8B;NACA;ZDHHC24;RABGEF1;ZFAND2B;VPS37A;PEX16;ZDHHC7;AP4S1;AIP;PEX19;SEC61A1;TOMM20;YIF1B;TIMM22;SEC61G;AP1S3;ZDHHC23;TIMM10;TAOK2;HAP1;ZDHHC9
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3454838566228433,1.1552673674815241,0.23283582089552238,0.7357989454787738,1.0,15/72,10.94%,PDGFRA;FN1;SELP;FGFR1;OSM;DCN;NEDD4;ROR1;KIT;HAX1;PDGFRB;IL18;PIK3R5;PTPN6;PTK2
prerank,glutathione biosynthetic process (GO:0006750),-0.478329940879009,-1.1552447261980163,0.2717842323651452,0.6805615554621621,1.0,6/11,30.08%,OPLAH;GCLC;GGT1;HAGH;MGST2;GCLM
prerank,negative regulation of cellular catabolic process (GO:0031330),0.357212055424173,1.155124474385091,0.2241112828438949,0.7353043098324968,1.0,11/63,9.54%,LEPR;NUPR1;TIMP3;NELL1;PTPN3;BCL2;PTPN22;KLHL22;MCL1;TIMP2;TLK2
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.40062498279274494,-1.155015786805595,0.26976744186046514,0.6800971564381664,1.0,5/22,7.50%,PDE3B;ASXL3;CCDC3;APOD;CEACAM1
prerank,lipid modification (GO:0030258),-0.3429176952262622,-1.1547423795972183,0.22572815533980584,0.6796824542276799,1.0,12/37,16.63%,DGKB;DGKI;DGKH;PLPPR1;PLPP5;DGKZ;MBOAT1;DGKG;PLPP1;MBOAT7;PLPPR2;SGPP1
prerank,positive regulation of neurogenesis (GO:0050769),-0.3071778138162659,-1.1547385285881193,0.21635883905013192,0.6785635521782402,1.0,14/68,9.03%,SLIT2;PTPRD;SHANK3;ROBO2;PLXNA4;TIAM1;NTRK2;IL1RAPL1;OPRM1;CAPRIN2;CTNNB1;NPTN;FZD3;VEGFA
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.31717094863153594,-1.1545162565549483,0.21839080459770116,0.6780927891639478,1.0,25/60,29.75%,PRKCQ;NEK7;CTNNB1;PARM1;MAPK3;HSP90AB1;NVL;ATM;FGF2;KLF4;HSP90AA1;RGCC;PNKP;CCT5;PKIB;RFC4;WRAP53;FGFR4;ATR;RFC5;RFC2;MAP3K4;CHTF18;PCNA;MYC
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.43170022976685896,1.154456983711926,0.2814569536423841,0.7363815479978003,1.0,6/21,16.01%,BMP6;BMPR1A;TGFBR1;SMAD4;DAB2;WWTR1
prerank,regulation of plasminogen activation (GO:0010755),0.49932867503950584,1.1541400437401612,0.29300567107750475,0.7363350701150377,1.0,4/12,11.44%,CLEC3B;SERPINE1;SERPINE2;PLGRKT
prerank,response to glucagon (GO:0033762),0.44462738657363504,1.1540563358751335,0.28284671532846717,0.7356585802318567,1.0,5/19,7.23%,GCGR;ADCY7;CRY1;ADCY5;ADCY1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.3887662979990894,-1.153620073840007,0.275609756097561,0.679509159552423,1.0,11/23,37.25%,CADM1;PIK3R6;RAET1E;LAMP1;RASGRP1;LILRB1;SLAMF6;NECTIN2;CD226;IL12A;CRTAM
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.4401927795349988,-1.1535259514125757,0.2694063926940639,0.678676248727706,1.0,10/14,37.29%,RPS3;CD81;CARD11;RELA;BCL10;NECTIN2;IKBKG;CD226;TESPA1;LCK
prerank,regulation of intracellular pH (GO:0051453),-0.3511510204269669,-1.1529676320119897,0.23786407766990292,0.6791404815960198,1.0,8/34,14.53%,SLC4A10;SLC9A2;CA2;SLC9A8;SLC9B1;ATP5F1B;SLC9A5;SLC4A7
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.4628488911303847,-1.1526704430799546,0.2878787878787879,0.6789000189295368,1.0,8/12,37.62%,PRKCB;CTDNEP1;VRK1;NEK9;CDK1;PLK1;CCNB1;CCNB2
prerank,negative regulation of innate immune response (GO:0045824),0.3888933029753872,1.152547471735642,0.2867012089810017,0.7391478286215264,1.0,9/34,17.70%,USP18;STAT2;SERPING1;PTPN2;IRAK3;TRIM21;MUL1;FAM3A;USP15
prerank,protein autophosphorylation (GO:0046777),0.3117976629349846,1.1524064179393658,0.2,0.7386409008917634,1.0,26/157,11.01%,PDPK1;TEC;PDGFRA;FGFR1;DDR2;STK39;EIF2AK2;OXSR1;INSRR;EPHA8;FER;DAPK1;TAOK3;KIT;AAK1;EPHA1;PDGFRB;MAP4K1;GSK3B;LRRK2;STK24;EPHA4;CDK12;MUSK;PTK2;GRK5
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.36864432400767877,-1.1522552634015433,0.2668213457076566,0.6789952032417944,1.0,15/28,27.37%,STMN2;MAP1B;PRUNE1;CLASP2;MAP2;MAPT;SKA2;STMN4;STMN1;FKBP4;ARL2;GAS2L1;MAPRE1;SKA3;STMN3
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.4582603574900887,1.152034540841698,0.2946593001841621,0.7387753969820658,1.0,4/17,17.38%,PLA2G4A;PLA2G4C;PLA2G5;LPGAT1
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.47202927013705165,1.1518897465893427,0.3016157989228007,0.7382466852011607,1.0,7/15,13.54%,GLI1;CDC73;KLHL18;PHB2;CUL3;CRNN;PAF1
prerank,positive regulation of T cell activation (GO:0050870),0.35198297346714713,1.15184867971216,0.25,0.737445838735724,1.0,10/62,8.19%,ZMIZ1;IL6ST;IL23R;ANXA1;IL6;VCAM1;CD47;CCL2;LGALS9;CD274
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3032558651827676,-1.1517438611315898,0.19631901840490798,0.6793089841292372,1.0,28/75,20.61%,CTNNA2;MEF2C;CNTN4;DCC;ACTB;KLF7;ANK3;S100B;NRCAM;UNK;MAP1B;SHTN1;MINK1;DVL1;PAX2;NEFH;PAK3;MFSD2A;BRSK2;MAP2;SLITRK2;SLITRK1;CELSR2;CCK;NTNG2;NTNG1;DSCAML1;ABITRAM
prerank,response to purine-containing compound (GO:0014074),-0.4237042730988773,-1.1515797486995898,0.26595744680851063,0.6786509649385232,1.0,3/17,2.16%,TRPC3;ABCC9;RYR2
prerank,glutamate metabolic process (GO:0006536),-0.41095109738446267,-1.151346403543807,0.26371308016877637,0.6781811583345202,1.0,6/19,20.30%,ALDH5A1;GCLC;GLS;GGT1;MTHFS;GLS2
prerank,positive regulation of neuron differentiation (GO:0045666),0.38325314985868525,1.15125210752259,0.2586490939044481,0.7382573569227107,1.0,7/40,7.51%,TCF4;FGFR1;NBL1;KCTD11;BMP2;CPNE1;ZEB1
prerank,response to UV-B (GO:0010224),-0.46445290887710877,-1.1511380580247144,0.2899786780383795,0.6776841826423036,1.0,8/12,37.03%,STK11;CDKN1A;MFAP4;HYAL3;RELA;HYAL2;CRIP1;IL12A
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.4912172481697541,1.1509009643507493,0.29924242424242425,0.7382879759358424,1.0,5/13,19.19%,ENPP1;TPST1;ABHD14B;SULT1A1;SULT6B1
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.32199325034528675,-1.1508871788392183,0.22807017543859648,0.677259638137131,1.0,19/50,25.37%,PSMC3;OAZ1;OAZ2;PSMD3;PSMD14;PSMD6;PSMD4;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;PSMD8;PSMD11
prerank,regulation of actin filament polymerization (GO:0030833),-0.30063309809079547,-1.1507269471377155,0.17897727272727273,0.6765436136752035,1.0,25/69,20.72%,SLIT2;ESAM;SSH2;KANK3;KANK4;PTK2B;NCKAP1;HIP1R;LMOD1;CYRIB;CDC42EP3;VASP;CDC42EP1;DBNL;CDC42EP5;PAK3;EVL;TWF1;SSH3;PYCARD;ARF6;PRKCE;PFN2;ABITRAM;HCLS1
prerank,regulation of peptidase activity (GO:0052547),0.4410718413152894,1.1504001245338338,0.2866666666666667,0.738826412344539,1.0,5/19,9.23%,ECM1;CSTB;NRDC;CTSH;PSMA3
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3824521427649109,1.1502608303120183,0.26812816188870153,0.7382677232955802,1.0,6/37,4.86%,IGFBP5;BMPR1A;GJA1;ADAMTS1;EFEMP2;TPM1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.35969201416196517,-1.1500402495864679,0.24939467312348668,0.6773977267768901,1.0,12/32,18.40%,THBS1;KDR;NOTCH1;GATA2;HDAC7;HDAC9;VEGFA;FGF2;KLF4;SRPX2;DLL4;CARD10
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.3422024181669632,1.1500178419944882,0.2453125,0.738042445972236,1.0,11/70,5.76%,ATRNL1;LAMC1;FN1;PARVA;RADIL;NRP1;FER;ANTXR1;ARL13B;LAMC3;EPHA1
prerank,response to amyloid-beta (GO:1904645),0.3793025385675194,1.149463346181966,0.2587646076794658,0.7386098642495036,1.0,14/44,17.46%,FPR2;GJA1;SNX6;CASP4;TLR4;VCAM1;GSK3B;NGFR;EPHA4;CACNA2D1;ICAM1;LRP1;APP;IGF1R
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.518423677595057,1.1491823449797804,0.29615384615384616,0.7385073796492116,1.0,5/10,24.02%,PCGF5;IGF2;DNMT3A;PCGF3;MECP2
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4169820880892564,-1.1491064388493881,0.2920168067226891,0.6789620674012714,1.0,5/17,2.33%,SLIT2;ROBO2;NOS3;TGFB2;NOTCH1
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.4700716845391762,-1.1489716546300859,0.28661087866108786,0.6782333669024089,1.0,3/12,17.68%,NOTCH1;YTHDF2;HES1
prerank,lipid transport (GO:0006869),-0.29457744671178815,-1.1484509281650754,0.18627450980392157,0.6786123665630764,1.0,16/97,9.45%,ATP8A1;ABCC4;SLCO1C1;SLCO2A1;CERT1;PITPNC1;PITPNA;ABCA3;SPNS2;PPARD;GLTP;SCARB1;CEACAM1;PRELID2;PRELID1;ATP8B1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.46083444829901765,-1.1483730808292807,0.3106212424849699,0.6777396728445152,1.0,6/12,11.53%,PTPRJ;F3;SNCA;APOD;NDRG4;CBL
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.38369369846655077,1.1481719018516705,0.2782608695652174,0.7405036281332731,1.0,12/34,15.32%,PTPN13;DUSP10;PTPN22;PTPN2;PTPN9;DUSP16;PTPN6;DUSP5;PTPN1;PTPN18;TNS2;PTPRQ
prerank,response to molecule of bacterial origin (GO:0002237),0.343599856488118,1.148107281899136,0.235202492211838,0.7397823875592067,1.0,13/69,12.36%,SELP;IL23R;FER;IL6;TLR4;PTPN22;NOS2;LY96;LGALS9;SMAD6;NOCT;IRAK3;RPS6KA3
prerank,vascular transport (GO:0010232),0.33589429194634884,1.1480691314198272,0.2319277108433735,0.7389639707326633,1.0,12/81,4.30%,SLC7A2;LEPR;ATP1A2;SLC1A3;SLC6A13;SLC13A3;SLC19A1;SLC6A9;SLC24A3;SLC16A12;SLC16A2;SLCO3A1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.4663642616335076,1.1476425109550448,0.3069852941176471,0.7392301292527075,1.0,9/16,25.64%,PARP9;PARP3;DTX3L;SHLD2;KMT5C;RIF1;KMT5B;SMCHD1;SHLD1
prerank,acute-phase response (GO:0006953),0.49378704540527313,1.1475091323107542,0.2958579881656805,0.7386862611344344,1.0,4/12,19.38%,IL6;CRP;IL22;CEBPB
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.4070011892905084,-1.1474745654452116,0.2987012987012987,0.6791500058768828,1.0,8/20,24.34%,ACSL3;FAR2;ACACA;ACLY;SCD;HSD17B8;GCDH;FASN
prerank,sprouting angiogenesis (GO:0002040),0.3626795221848881,1.147327788907229,0.2566929133858268,0.7382727922266358,1.0,8/51,4.57%,EFNB2;ROBO1;RNF213;PARVA;NRP1;VEGFD;ANGPT1;MIA3
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.2854640004551328,-1.1471724127006413,0.19195046439628483,0.678888331577017,1.0,27/93,15.71%,PDE4D;DMD;BCAR3;TFRC;SMAD7;PAK1;GAS6;SNCA;CAPRIN2;INPP5K;HSP90AB1;PAQR3;AKT1;RASSF2;PINK1;HDAC6;VEGFA;DDIT4;NOS1;RACK1;CAV1;NGF;HSP90AA1;EGFR;PRKD1;PARK7;IRGM
prerank,gene silencing by miRNA (GO:0035195),0.3921851701063554,1.1470341084238669,0.27504244482173174,0.7381947210189747,1.0,12/32,22.20%,TNRC6B;SNIP1;TNRC6A;MOV10;ADAR;TARBP2;ZC3H7B;WTIP;PUM2;RAN;AJUBA;XPO5
prerank,transport across blood-brain barrier (GO:0150104),0.33314552868031433,1.147033203116058,0.24,0.7372813520755938,1.0,12/83,4.30%,SLC7A2;LEPR;ATP1A2;SLC1A3;SLC6A13;SLC13A3;SLC19A1;SLC6A9;SLC24A3;SLC16A12;SLC16A2;SLCO3A1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.4019459010591075,1.1470225336176278,0.2857142857142857,0.7363969327140174,1.0,6/31,10.04%,RANBP3L;TMEM64;SKI;SUFU;SMAD6;NOCT
prerank,intraciliary retrograde transport (GO:0035721),0.5007335239012456,1.1463425258277118,0.31237721021611004,0.7374504710677691,1.0,4/12,18.45%,DYNC2I1;DYNC2LI1;WDR19;TTC21B
prerank,regulation of macromolecule metabolic process (GO:0060255),0.30225704477035636,1.1463019784487818,0.20154043645699615,0.7366611914430706,1.0,38/170,17.34%,ROCK2;PRDM6;AFF3;TRIM10;POU5F1;NELL1;TBC1D16;IGF2BP1;PTHLH;PRDM11;TRIM17;STOX1;MTMR3;TRIM5;RASA1;POGZ;NOVA1;IGF2BP2;TAPBP;FUBP1;RFXANK;NFKBIZ;TRIM21;IHH;AFF1;TRIM26;CRNN;PRDM5;RNF39;ZNF462;AFF2;HNRNPDL;C1D;TXK;APP;ARF1;AFF4;GDNF
prerank,C4-dicarboxylate transport (GO:0015740),-0.4477388317424687,-1.1459665908272687,0.30578512396694213,0.681272528195748,1.0,7/14,31.65%,SLC1A1;SLC1A2;SLC25A30;SLC25A13;SLC25A12;LRRC8E;SLC13A5
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.40973206715101895,-1.1458205481982289,0.2799097065462754,0.6806118347647433,1.0,9/20,13.17%,SEMA6D;SEMA3C;SEMA4D;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B;SEMA3A
prerank,cyclooxygenase pathway (GO:0019371),0.5031590744231113,1.145650025854037,0.33659491193737767,0.7375462514840272,1.0,4/10,23.15%,PTGS1;PTGES2;PTGS2;PTGES3
prerank,triglyceride metabolic process (GO:0006641),0.3645782067113672,1.1453059089995425,0.26009693053311794,0.7376325845231209,1.0,5/48,12.39%,AGMO;APOA2;MOGAT3;GK5;DGAT2
prerank,regulation of RNA metabolic process (GO:0051252),0.35785273256341676,1.1452926329031745,0.2702265372168285,0.7367712656206657,1.0,17/59,15.99%,PTBP3;IGF2BP1;AHNAK;RC3H1;RASA1;OASL;CLK4;NOVA1;HNRNPH1;IGF2BP2;OAS2;HNRNPH3;PTBP2;USP36;FUS;AFF2;MBNL2
prerank,ether lipid biosynthetic process (GO:0008611),0.5008857778818514,1.1443732672292881,0.30927835051546393,0.7386124354113037,1.0,2/10,6.62%,PLA2G4A;PLA2G4C
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.4260625057813028,1.1429287058041768,0.30472854640980734,0.7419953981316294,1.0,6/23,12.80%,ENPP1;GLI3;MGRN1;GLIS2;SUFU;BTRC
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4033968361848761,1.1429278923031343,0.30642504118616143,0.7410874587255677,1.0,16/30,27.07%,POLR1C;CCNH;MNAT1;CDK7;POLR1G;POLR2F;GTF2H4;GTF2H2;CAVIN1;TTF1;POLR2K;UBTF;POLR1A;TAF1D;POLR2H;ERCC2
prerank,regulation of MAP kinase activity (GO:0043405),0.3277176482251608,1.1426513916668661,0.24005891016200295,0.7409961923669778,1.0,17/92,12.20%,ROBO1;FGFR1;FGF1;KSR1;IL34;KIT;BMP7;PDGFRB;PPEF2;LRRK2;MST1R;PIK3R5;CDK12;FGF18;IRAK3;SH2B3;PTPN1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.4411255566695393,1.1414913324870342,0.31616341030195383,0.7424858974572307,1.0,11/20,23.75%,ACADSB;BCKDHA;ACAT1;HIBADH;ALDH6A1;ACAD8;MCCC1;DBT;MCCC2;IVD;ECHS1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.4411255566695393,1.1414913324870342,0.31616341030195383,0.7424858974572307,1.0,11/20,23.75%,ACADSB;BCKDHA;ACAT1;HIBADH;ALDH6A1;ACAD8;MCCC1;DBT;MCCC2;IVD;ECHS1
prerank,regulation of neuron death (GO:1901214),-0.29459849164047464,-1.1414494611676944,0.20512820512820512,0.6915924466167743,1.0,15/82,10.07%,GRID2;MEF2C;DCC;CD34;TRIM2;MAP3K5;SNCA;SORL1;EPHB1;GRIN2B;AKT1;UBB;TNFRSF1B;SIGMAR1;DDIT4
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.4248680877457414,1.1413533726737655,0.2916666666666667,0.7419833444536227,1.0,5/24,5.67%,PDPK1;IL11;CDH5;ANGPT1;SERPINE1
prerank,pyruvate metabolic process (GO:0006090),-0.32256609519589297,-1.1412154638336571,0.2103825136612022,0.6911719656276896,1.0,14/52,16.38%,BSG;ME1;PGK1;PKM;ME3;SLC16A1;ALDOC;TPI1;GPI;VDAC1;PGAM1;PGAM4;NR4A3;ENO1
prerank,response to muramyl dipeptide (GO:0032495),0.4984375843764282,1.1410227190315028,0.33396946564885494,0.7420668919387187,1.0,4/12,8.39%,LDOC1;VIM;PTPN22;RIPK2
prerank,regulation of actin filament-based process (GO:0032970),0.3396312062949785,1.1408832994707119,0.25726744186046513,0.7415458088812169,1.0,14/70,9.90%,ROCK2;ARHGAP18;DLC1;EPHA3;SMIM22;PDGFRB;RHOBTB2;RHOF;BST2;CELSR1;RHOQ;ABRACL;CNN2;IQGAP2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.35216132990262317,1.140799756548688,0.24267100977198697,0.7408688213362967,1.0,26/61,24.20%,EYA2;EYA1;WRN;PARP3;RAD50;PDGFRB;USP9X;EYA4;SMOC2;ERCC6;UIMC1;PRKD2;PML;DHX36;BRCC3;STPG4;USP7;ERCC8;EYA3;RTEL1;CEBPG;DHX9;ATRX;MECP2;SMCHD1;ZCWPW1
prerank,protein O-linked mannosylation (GO:0035269),0.4393729594010634,1.1405140392946653,0.300796812749004,0.7408261686717839,1.0,5/18,7.08%,TMTC4;TMTC1;LARGE1;RXYLT1;POMT2
prerank,mitochondrial genome maintenance (GO:0000002),0.5091292529922935,1.1404444844559223,0.3270321361058601,0.7401267565389141,1.0,6/11,20.64%,MPV17;MEF2A;AKT3;OPA1;SLC25A4;LONP1
prerank,ceramide transport (GO:0035627),-0.4702930814489513,-1.1400367263355333,0.32421052631578945,0.6934122956796481,1.0,5/12,22.82%,CERT1;GLTP;SGPP1;ABCB4;ABCA13
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.5011800527562658,1.1399569102150022,0.31861804222648754,0.740621349939289,1.0,5/11,24.47%,TAF7;HDAC2;XBP1;TMEM106A;JAK2
prerank,glucose metabolic process (GO:0006006),-0.31437478511240574,-1.139914063357574,0.234375,0.6926490778192542,1.0,24/58,30.84%,PPARD;PGK1;APOD;ALDOC;SLC39A14;TPI1;GPI;MDH1;ATF4;LRP5;PGAM1;ENO1;PER2;SLC25A13;CRTC2;GAPDHS;SLC25A12;MDH2;G6PC3;OMA1;ADPGK;PFKFB1;ENO3;ALDOA
prerank,regulation of astrocyte differentiation (GO:0048710),0.4946841658936413,1.139734027161647,0.34104046242774566,0.7403445346129125,1.0,5/12,13.08%,BMP2;IL6;SERPINE2;EPHA4;NOG
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.37953290362654407,-1.1394259768733432,0.29055690072639223,0.6928591694447452,1.0,9/25,22.14%,ITGA6;THBS1;SNCA;SDCBP;EGFR;BTBD10;EGF;MIF;PTH1R
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4725841127501779,1.1389337127441224,0.32815533980582523,0.7417170098745631,1.0,3/14,8.70%,ACOXL;AMACR;SCP2
prerank,extracellular matrix disassembly (GO:0022617),-0.31470726593887355,-1.138912648024402,0.2545454545454545,0.693211526942847,1.0,16/53,18.76%,BSG;TLL1;ADAM15;MMP16;A2M;CTSS;MMP15;HTRA1;SCUBE1;CAPN1;CTSL;WASHC1;CAPNS1;MMP1;ADAM8;LCP1
prerank,protein-containing complex assembly (GO:0065003),0.2858686927163098,1.1386493201616132,0.18610421836228289,0.7416286707141422,1.0,55/259,16.86%,TCF7L2;KMT2A;MCU;LAMC1;FN1;AFDN;TLE1;TEAD1;TGFA;TERT;SEC23A;TLE3;ST13;SEC24D;CREBBP;BCL9L;TCF7L1;GSK3B;CDC73;CLDN1;YAP1;SNX9;RSPH9;LRRK2;TEAD2;MNAT1;TAPBP;TUBGCP4;FBXL7;PPID;DNM1L;TCF7;PPP6R3;ANO6;CUL3;WDR19;SEC24C;SCFD1;HFE;TUBGCP2;OPA1;WASF1;WASL;GEMIN5;SH3PXD2B;MDM4;LEO1;PML;SMARCA4;SEC31A;SEC24B;AXIN2;PYGO1;FARP2;GOLGA2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.3888774827036582,1.1385850096462886,0.2745762711864407,0.7409159838524086,1.0,4/33,4.86%,IGFBP3;IGFBP5;EFEMP2;TPM1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.4899392622406573,1.1385706655347716,0.32251908396946566,0.740069406012577,1.0,4/13,12.98%,DCTPP1;NTHL1;NT5C;OGG1
prerank,negative regulation of protein kinase activity (GO:0006469),-0.2909356638066709,-1.1384267390822493,0.18674698795180722,0.6934479417698195,1.0,29/88,15.51%,PTPRB;UBASH3B;ADARB1;SNCA;SORL1;DAB2IP;SLC8A1;INPP5K;AKT1;CEACAM1;SMCR8;NPM1;PTPRT;LRP6;SH3BP5L;DVL1;PTPRO;CEP85;CAV1;SRCIN1;AKT1S1;CEP43;LRP5;PPIA;PRKRIP1;PARK7;PTPRC;GNAQ;CDKN1A
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.36900062487285584,1.1382641226309833,0.2724358974358974,0.7400870176009916,1.0,7/43,6.71%,CBLB;SNX6;TGFA;ERRFI1;PTPN3;PTPN2;MVP
prerank,positive regulation of interleukin-12 production (GO:0032735),0.3937625477315927,1.1382009185418878,0.2716049382716049,0.7393775824117401,1.0,7/31,10.62%,IL16;IL23R;TLR4;LGALS9;RIPK2;TLR2;MAPK14
prerank,cellular component disassembly (GO:0022411),-0.3154903827688222,-1.1375794202293976,0.22879177377892032,0.6946973515693189,1.0,16/53,18.76%,BSG;TLL1;ADAM15;MMP16;A2M;CTSS;MMP15;HTRA1;SCUBE1;CAPN1;CTSL;WASHC1;CAPNS1;MMP1;ADAM8;LCP1
prerank,myelination in peripheral nervous system (GO:0022011),-0.4568956041272188,-1.1374363644308942,0.2845360824742268,0.6939970091547943,1.0,5/13,19.11%,ADGRG6;MYOC;SOD1;NCMAP;DICER1
prerank,negative regulation of receptor internalization (GO:0002091),-0.4659265688774093,-1.1373099249546557,0.291220556745182,0.6932694974338829,1.0,7/12,28.19%,ANKRD13A;ATXN2;SDCBP;RIN3;MTMR2;ANKRD13B;WDR54
prerank,regulation of protein binding (GO:0043393),0.31281393117429035,1.1366144912016012,0.24561403508771928,0.743106533986473,1.0,33/114,18.31%,TCF7L2;VTN;CFHR2;WNT3A;IFIT2;DACT1;TERT;BMP2;DTX3L;EFHB;HDAC4;SPPL3;GSK3B;BAX;RIPK2;LRRK2;STK3;AMFR;TRIM21;NES;IFIT1;HFE;LRPAP1;STK4;LRP1;DAB2;APP;GOLGA2;PPP2CA;RAN;GAS8;DNAJB2;KDM1A
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.2758087397979791,-1.1363280002667928,0.16333333333333333,0.6949549850726888,1.0,31/124,16.44%,FRY;CNTNAP2;NLGN1;GPM6A;CNTN4;PLP1;STX3;GPM6B;PTPRM;PLEKHA1;SH3GL2;MYOC;HMGB1;STMN2;RAPGEF2;RAB35;L1CAM;LYN;MANF;ZFYVE27;MICALL2;ULK1;CSF1R;TMEM108;LGI1;BICDL1;MAP2;RAC1;MAPT;SNAPIN;MNS1
prerank,cellular response to hexose stimulus (GO:0071331),0.4248129342409679,1.1362697865355962,0.2852233676975945,0.7431908496195561,1.0,3/23,5.74%,ZBTB20;PRKAA2;UNC13B
prerank,regulation of interleukin-17 production (GO:0032660),0.40185775135592666,1.135600649348771,0.29525483304042177,0.7442490204699204,1.0,6/31,7.90%,OSM;IL23R;IL6;TLR4;FOXP3;IL18
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.305964749451065,1.1354185359784943,0.2155525238744884,0.7438552718142252,1.0,25/136,15.21%,TCF7L2;SP100;NUPR1;MTURN;TCEAL7;BMP7;ANXA4;FOXP3;HDAC4;GLIS2;PARP10;PHB2;SUFU;SUMO1;HEYL;KEAP1;IRAK3;WWP2;TRIM21;MAP2K5;BTRC;ARRB1;TRIB1;PKD2;HDAC2
prerank,renal filtration (GO:0097205),0.508422251064089,1.1354106315426256,0.3352380952380952,0.7429830329818959,1.0,1/10,0.13%,SULF1
prerank,positive regulation of gene expression (GO:0010628),0.2745579216330959,1.135252523971907,0.16146993318485522,0.7425672107701886,1.0,55/442,10.62%,ROBO1;BMP6;ROCK2;FOXD1;SMAD3;RBPJ;RBMS3;FN1;PLD1;AFDN;WNT6;PID1;FGF1;TLE1;SAMD4A;EIF2AK2;OSR1;WNT3A;GJA1;VIM;ITGB8;CDH5;PLA2R1;GCGR;TNRC6B;SLC26A9;SLC24A3;ANGPT1;BMP2;PKP3;IL6;BMP7;CRP;TLR4;TGFBR1;PTPN22;STOX1;CTSH;LGALS9;GSK3B;POLR1C;YAP1;PDCD5;WNT5A;DTNBP1;BAZ1B;TNRC6A;MOV10;TLR2;FUBP1;POLR1G;MUSK;ADAM19;FGF18;MAPK14
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.44039514569547317,1.135183447991639,0.31362007168458783,0.7418794068876297,1.0,6/20,17.12%,SULF1;DSTYK;NOG;SMOC2;PRKD2;GPC1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.4281262194772244,1.1349740909672286,0.275,0.7415637652185262,1.0,4/21,4.97%,ROCK2;ENPP1;ECM1;BCOR
prerank,positive regulation of myelination (GO:0031643),-0.47848503440238055,-1.1340643301055457,0.3305439330543933,0.7001568109481426,1.0,5/11,19.11%,TENM4;TNFRSF1B;NCMAP;TPPP;DICER1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.44737170639433926,-1.134037034986546,0.319910514541387,0.6991500661453784,1.0,5/13,27.38%,PIK3AP1;IRAK1;PIK3C3;TLR7;MYD88
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.47880238071191666,1.133967923713456,0.31433823529411764,0.7436031988040053,1.0,2/12,3.92%,POU5F1;TERT
prerank,multivesicular body organization (GO:0036257),-0.3529248262484265,-1.133896840537362,0.2894736842105263,0.6984352503261732,1.0,13/31,27.72%,RAB27A;VPS37B;VPS37A;CHMP1A;CHMP1B;CHMP2B;CHMP7;VPS28;SNF8;CHMP2A;CHMP6;CHMP4C;HGS
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.4499655383590427,1.1338303926216495,0.31597845601436264,0.7431072493062322,1.0,4/18,6.49%,TNFAIP8L2;MIA3;PTPN22;PPARA
prerank,folic acid-containing compound metabolic process (GO:0006760),0.43751685279600105,1.133624424488638,0.29084380610412924,0.7428574518092654,1.0,3/19,4.01%,SHMT1;SLC19A1;MTHFD1
prerank,synaptic vesicle recycling (GO:0036465),-0.3536821095461039,-1.1335473427037712,0.2805755395683453,0.6983203547647132,1.0,6/31,8.78%,NLGN1;SYT1;AMPH;SNCA;SYT7;NLGN3
prerank,hemidesmosome assembly (GO:0031581),-0.47041187989331174,-1.1335409199042372,0.3055555555555556,0.6972452149050671,1.0,3/11,4.04%,ITGA6;ITGB4;LAMA3
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.34910376578950564,-1.1331330868724065,0.28078817733990147,0.6972714010610334,1.0,18/32,36.61%,HINT1;JMY;STK11;PPP1R13B;BAG6;DDIT4;PYCARD;BCL3;MYBBP1A;HIPK2;CDIP1;PMAIP1;TP53;TMEM109;POU4F1;BOK;AEN;PDK2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.4485097209635537,1.1326431811034563,0.30592734225621415,0.7446329728943614,1.0,3/17,5.24%,ROCK2;CDH5;VCL
prerank,histone lysine methylation (GO:0034968),0.39184495930290525,1.1318331100711614,0.29747899159663865,0.745966463217085,1.0,2/33,4.02%,KMT2A;WDR5B
prerank,muscle tissue morphogenesis (GO:0060415),0.4484088637691378,1.1318128847458797,0.32035398230088497,0.7451565468742782,1.0,3/16,4.77%,TGFBR3;BMP2;EFEMP2
prerank,negative regulation of programmed cell death (GO:0043069),0.27889102663905585,1.1307964208197225,0.1793020457280385,0.7471946024749091,1.0,68/355,15.63%,PDPN;FHL2;FSTL1;ARHGAP10;KANK2;AXL;NOTCH2;OSR1;PRKAA2;IL31RA;ZFAND6;NUPR1;GATA6;IL6ST;PHIP;PRAP1;SH3RF1;ANXA1;ANGPT1;CFLAR;IL6;BCL2;ARAF;MTDH;HAX1;SIAH2;MCL1;BIRC3;ARF4;ANXA4;RASA1;CTSH;GLO1;GSK3B;NGFR;WNT5A;ANXA5;RIPK2;PHB2;UBE2Z;NAA16;USP47;SMAD6;DNAJC3;HIPK3;EGR3;PTK2;GRK5;BCL2L1;NAA15;DSTYK;RPS6KA3;TJP1;API5;CBX4;OPA1;TMEM14A;SUPV3L1;BFAR;IFIT3;NUAK2;VHL;BIRC6;NIBAN2;ERCC5;HDAC2;FIGNL1;MGMT
prerank,positive regulation of heart rate (GO:0010460),-0.4142083416094344,-1.1303141334789923,0.29836829836829837,0.7045536825364602,1.0,3/17,3.31%,PDE4D;RYR2;ADRA1B
prerank,regulation of histone modification (GO:0031056),-0.45378078666246013,-1.1300243913896668,0.2915766738660907,0.7043349917937876,1.0,5/13,17.34%,MTHFR;PARG;PARK7;HPF1;NNMT
prerank,regulation of protein phosphorylation (GO:0001932),0.28756756323124527,1.1299875265650787,0.1909424724602203,0.7486034448847507,1.0,53/256,16.11%,PTPN13;IGFBP3;LEPR;ROCK2;EPHA7;FN1;PID1;FGF1;PLPP3;STAT2;PHIP;FPR2;WNT3A;FBLN1;IL34;CDH5;FAM20A;FER;VEGFD;ANGPT1;BMP2;SLCO3A1;BMP7;CCND3;PELI2;PLCE1;NSD1;RALBP1;FBH1;MYADM;LRRK2;IGF2;BRD4;MUSK;FGF18;FNIP1;PTK2;TSPYL2;DVL3;ARRB1;RARRES2;CADM4;EFNA1;EIF2AK3;NTRK3;P2RY1;ILK;PML;STK4;DAB2;WWTR1;AXIN2;APP
prerank,receptor-mediated endocytosis (GO:0006898),-0.2709600485101879,-1.129909898966227,0.16923076923076924,0.7035786027040009,1.0,29/132,12.77%,DNM3;LRP1B;SGIP1;FNBP1L;INSR;TFRC;SNCA;SORL1;STAB1;HIP1R;SCARB1;AP1S1;RAMP2;ARHGAP27;LDLRAP1;NLGN3;M6PR;LRP6;SNAP91;CALR;CAV2;FCER1G;ADRB2;CTSL;CAV1;SCARB2;SYK;VLDLR;HSP90AA1
prerank,vacuolar acidification (GO:0007035),-0.39277833733539813,-1.1298239665936483,0.31601731601731603,0.7027459407068716,1.0,9/21,23.81%,ATP6V0A1;DMXL2;GRN;ATP6AP2;ATP6V0A2;ATP6V0E2;ATP6V0D2;CLN3;TMEM199
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.39290916554263355,1.1298014956445084,0.29411764705882354,0.7482532511124798,1.0,8/33,15.26%,SMAD3;TEAD1;TERT;KLF5;NGFR;FOXO3;NR3C1;SMARCA4
prerank,cellular response to exogenous dsRNA (GO:0071360),0.48166776771522857,1.1294253306612372,0.3278084714548803,0.7484819059481895,1.0,4/12,15.88%,COLEC12;IFIT1;IFIH1;MUL1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.40640697253116403,1.1292116234519083,0.29508196721311475,0.7481970840147021,1.0,9/27,15.21%,ENPP1;PID1;KANK1;PRKCZ;PTPN2;PTPN1;PIP4K2B;NCK1;TNS2
prerank,cellular response to chemical stress (GO:0062197),-0.2843757838732756,-1.1291780232553053,0.247557003257329,0.7035195790879334,1.0,22/96,15.12%,FOXO1;PRR5L;SETX;SNCA;CPEB2;MSRA;NCF2;CHCHD2;PINK1;NUDT2;FAS;ATM;CAV1;ATF4;PYROXD1;CYBB;PPIA;PRKD1;SOD1;ERO1A;PYCR2;PARK7
prerank,response to peptide (GO:1901652),0.38645774616699574,1.1290244658736253,0.2982758620689655,0.7479071877857244,1.0,6/33,11.72%,STAT2;ANXA1;STAT5B;STAT1;EIF2B3;STAT4
prerank,serine family amino acid metabolic process (GO:0009069),0.45578121618131306,1.12889509910549,0.3157894736842105,0.7473850524695412,1.0,4/16,11.13%,SHMT1;MTHFD1;SEPSECS;SEPHS2
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.34482756782814095,-1.128548669980938,0.26811594202898553,0.704177244969359,1.0,8/36,5.90%,SLIT2;MEF2C;THBS1;NOTCH1;ACVRL1;PTPRM;DAB2IP;HMGB1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3887459856496288,-1.1285280821509074,0.30303030303030304,0.703130310425596,1.0,9/23,25.50%,UBB;COPS6;UBA52;COPS5;COPS2;GPS1;COPS4;DDB2;RAD23B
prerank,heterotypic cell-cell adhesion (GO:0034113),0.40503477357380674,1.1284804459404723,0.3155080213903743,0.7476445960199951,1.0,5/25,9.79%,CXADR;PARVA;ITGA5;VCAM1;DSC2
prerank,carboxylic acid transport (GO:0046942),0.35080460643240335,1.1282333751228788,0.2634920634920635,0.747427336508068,1.0,9/55,7.17%,SLC6A13;SLC13A3;SLC16A11;SLC6A9;SLC16A12;SLC16A2;SLC6A12;SLC16A5;SLC38A6
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.28993154045189556,1.1281024027691695,0.23790849673202613,0.7468938741402317,1.0,43/214,16.11%,TGFBR3;EPHA7;PDGFRA;CCN2;FN1;NOTCH2;FPR2;MTURN;TIMP3;FBLN1;GLIPR2;NRP1;ROR1;ANGPT1;DUSP10;BMP2;TLR4;PRKCZ;PTPN22;PDGFRB;PTPN2;CCL2;LGALS9;ACKR3;PHB2;DLG1;PTPN6;SMAD4;DSTYK;PTPN1;EPHA2;MAP2K1;P2RY6;ARRB1;ZDHHC17;NTRK3;P2RY1;PRKD2;CCL25;ICAM1;PTPRR;PLA2G5;APP
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.4141564042818843,1.1279908670923948,0.29948364888123924,0.7463468118477229,1.0,3/26,3.99%,PDPK1;FOXC1;STAT5B
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.3251606901000782,1.1277734770620844,0.26126126126126126,0.746053119390601,1.0,16/88,12.05%,SMAD3;SMPD3;CDH5;SYNPO2;SYNPO;BMP7;SLX4;TPR;SPIDR;GSK3B;BAX;SLF2;SUMO1;PLEK;FNIP1;RHOC
prerank,cholesterol biosynthetic process (GO:0006695),-0.3587600669850006,-1.1277428844805666,0.3050847457627119,0.7041309966694435,1.0,14/31,31.46%,HMGCS1;NSDHL;SQLE;INSIG1;ACLY;SC5D;HSD17B7;DHCR7;MVD;LSS;MSMO1;DHCR24;IDI1;PLPP6
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.4216025867661195,-1.127699084587074,0.315450643776824,0.7031733448059032,1.0,6/16,21.83%,CELF4;PUF60;SRSF1;DDX17;SRSF9;SRSF6
prerank,"wound healing, spreading of cells (GO:0044319)",0.4228744586268357,1.1276375526023517,0.30918727915194344,0.7455573048318497,1.0,3/24,5.33%,PDPN;ITGA5;COL5A1
prerank,cell-cell junction organization (GO:0045216),0.3298598262694041,1.1270812398101424,0.26348228043143296,0.7462780682914811,1.0,13/79,8.61%,SDK1;SDK2;SMAD3;CXADR;AFDN;CDH5;PKP3;PARD6A;CTNNA1;DCHS1;CLDN1;CTNND1;MYADM
prerank,regulation of endopeptidase activity (GO:0052548),0.35004513753122823,1.1268977399221218,0.26582278481012656,0.7459456952943878,1.0,11/59,10.90%,VTN;TIMP3;SERPING1;NRDC;SERPINB7;SERPINE1;BIRC3;SERPINE2;TIMP2;PSMA3;SERPINB8
prerank,icosanoid biosynthetic process (GO:0046456),0.5000658289615898,1.1265682218240016,0.32454361054766734,0.7460387315560669,1.0,1/10,1.39%,PLA2G4A
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.444409331620586,1.1264688024242084,0.32849364791288566,0.7454579105685488,1.0,4/18,9.37%,LATS2;CTNNA1;GSK3B;SUFU
prerank,striated muscle cell differentiation (GO:0051146),0.46231427178529766,1.1263228485156012,0.31467181467181465,0.7449747204275753,1.0,4/16,8.18%,AKAP13;BMP2;POPDC2;SKI
prerank,cellular sodium ion homeostasis (GO:0006883),-0.4176391038834176,-1.1262505116251016,0.30434782608695654,0.7062423505276734,1.0,5/15,9.16%,SLC12A2;ATP1B1;ATP1A1;SLC8A1;NEDD4L
prerank,regulation of cholesterol esterification (GO:0010872),0.5123739795534678,1.1259657393130955,0.3414141414141414,0.7450810034237514,1.0,5/10,26.18%,APOA2;AGT;APOE;LAMTOR1;ABCG1
prerank,negative chemotaxis (GO:0050919),0.38356397904552736,1.1252467951112672,0.2967409948542024,0.7461804365494593,1.0,5/33,6.61%,ROBO1;SEMA3D;EPHA7;NTN1;SEMA4B
prerank,regulation of cell development (GO:0060284),-0.3449738871916509,-1.1252344523639977,0.256857855361596,0.7080828486074274,1.0,14/36,20.33%,FOXO1;RPS19;CTNNB1;HDAC9;AKT1;YTHDF2;PRUNE1;GRN;HEY1;PER2;HES6;HES1;DLL1;FBXO22
prerank,positive regulation of nervous system process (GO:0031646),-0.40358425591479974,-1.124922044355394,0.3036876355748373,0.707904887927818,1.0,7/18,19.11%,RIMS1;RIMS2;TENM4;TNFRSF1B;NCMAP;TPPP;DICER1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.29797363241939845,1.1245441021734481,0.24242424242424243,0.7473349013159342,1.0,33/166,16.48%,RORA;RBPJ;CCN2;NOTCH2;TEAD1;TBL1XR1;NR6A1;POLR2D;NCOA6;NR1H3;RARB;CREBBP;PPARA;POLR1C;YAP1;CCNH;TEAD2;MNAT1;CDK7;TAF7;POLR1G;POLR2C;MAML2;NR4A1;NR3C1;POLR2F;GTF2H4;RARA;KAT2B;WWTR1;TBL1X;TAF9;POLR3H
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2669808400032702,-1.1242621004367315,0.1987179487179487,0.708748156317295,1.0,27/119,13.32%,PIP5K1B;INPP4B;EFR3B;PLCG2;ITPKB;INPP5D;PIK3R1;PIK3R6;PLEKHA1;MTMR6;BMX;PIK3C2B;PIK3R3;INPP5K;MPPE1;MTMR12;IP6K2;PIGU;PIGM;PI4K2A;IMPA1;PIGQ;FGF2;PIGH;PIK3CD;DPM2;CDIPT
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.45243176915836714,1.1242614870918526,0.3278985507246377,0.7471968015702906,1.0,4/17,11.39%,CXCL10;FPR2;SERPINE1;ANO6
prerank,cGMP metabolic process (GO:0046068),-0.45485648912886484,-1.1242501705091015,0.3236607142857143,0.7076896444792998,1.0,4/12,10.06%,GUCY1B1;PDE2A;GUCY1A1;NPR1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.4149791016296146,1.1239593574429425,0.32867132867132864,0.7471896635388449,1.0,2/23,0.82%,ATP1A2;DIAPH1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.42795187418246416,1.1235698225536048,0.3400735294117647,0.7474469031075439,1.0,5/20,12.29%,GRK3;CRY1;MGRN1;PLEK;RPGRIP1L
prerank,negative regulation of JUN kinase activity (GO:0043508),0.4936483488769627,1.1233369620880986,0.3424657534246575,0.7472495974797828,1.0,3/10,10.25%,DUSP10;PTPN22;HIPK3
prerank,platelet degranulation (GO:0002576),-0.2735485646416788,-1.1227011146985553,0.21568627450980393,0.7110942879305081,1.0,23/118,10.66%,PCDH7;ABCC4;VWF;PECAM1;ACTN1;TMSB4X;TGFB2;THBS1;VEGFC;SCG3;CALM1;GAS6;STXBP1;CDC37L1;CYRIB;RAB27B;A2M;VEGFA;LYN;CHID1;TGFB3;FAM3C;MANF
prerank,cellular response to interleukin-7 (GO:0098761),0.4509581243377379,1.1226463948088485,0.34476190476190477,0.7474146371634061,1.0,7/17,19.15%,STAT5B;BRWD1;JAK1;SMARCA4;STAT5A;IL7;IL7R
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4509581243377379,1.1226463948088485,0.34476190476190477,0.7474146371634061,1.0,7/17,19.15%,STAT5B;BRWD1;JAK1;SMARCA4;STAT5A;IL7;IL7R
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.3710477665423276,-1.122290736187995,0.29931972789115646,0.7111049916283307,1.0,8/25,19.65%,PGK1;PKM;ALDOC;TPI1;GPI;PGAM1;ENO1;GAPDHS
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.3740348111300737,-1.1219912121797742,0.3055555555555556,0.7108923243224914,1.0,9/25,24.07%,HSPA8;HSPA14;BAG1;HSPE1;DNAJB4;ERO1A;HSPA5;SDF2;HSPA2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5014157344331795,1.121813911921846,0.3320825515947467,0.7490063460219086,1.0,4/10,16.87%,GHR;STAT5B;PTPN1;STAT5A
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.43370597530658106,1.1216205155830723,0.31702544031311153,0.7486985455895121,1.0,3/18,4.62%,PTN;CAMK1D;IL6
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.49368248383784885,1.1215244244995246,0.34137291280148424,0.7472480890206606,1.0,3/12,2.84%,TACSTD2;KANK1;FBLN1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.49368248383784885,1.1215244244995246,0.34137291280148424,0.7472480890206606,1.0,3/12,2.84%,TACSTD2;KANK1;FBLN1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4934662651151923,1.121161350672528,0.33723196881091616,0.7473925621643364,1.0,4/11,15.65%,LEPROT;SH2B3;VHL;NF2
prerank,cGMP-mediated signaling (GO:0019934),-0.45232129424999024,-1.1206829728157155,0.3243801652892562,0.7135148971733806,1.0,6/13,16.57%,KCNC2;HTR2C;GUCY1B1;PDE2A;PDE3A;HTR2B
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.47250980206190807,1.120405415782564,0.32014388489208634,0.7487124670346592,1.0,3/13,9.37%,SP100;TPR;SUFU
prerank,regulation of receptor binding (GO:1900120),-0.46656099453559474,-1.1196422781942308,0.3347022587268994,0.7153831188439024,1.0,4/10,15.10%,ADAM15;ATP2A3;B2M;ATP2A2
prerank,cellular response to osmotic stress (GO:0071470),0.4281718313745354,1.1195872423818978,0.32014388489208634,0.7501216765934013,1.0,5/21,14.95%,STK39;OXSR1;SLC4A11;RCSD1;PKD2
prerank,melanosome transport (GO:0032402),-0.3945890728068555,-1.1194455468750684,0.2863741339491917,0.7137999554145897,1.0,12/18,41.68%,RAB27A;RAB27B;MLPH;BBS2;BBS7;MREG;MKKS;RAB11A;GPR143;RAB17;BBS5;BLOC1S3
prerank,pigment granule transport (GO:0051904),-0.3945890728068555,-1.1194455468750684,0.2863741339491917,0.7137999554145897,1.0,12/18,41.68%,RAB27A;RAB27B;MLPH;BBS2;BBS7;MREG;MKKS;RAB11A;GPR143;RAB17;BBS5;BLOC1S3
prerank,positive regulation of multicellular organismal process (GO:0051240),0.27953889048400044,1.1191862241439066,0.22771084337349398,0.7504279128041227,1.0,34/308,8.24%,PDPN;SOX5;LEPR;PTN;FOXD1;SMAD3;GHR;SMURF2;EIF2AK2;FOXC1;GHRH;BMPR1A;GJA1;GLIPR2;NCOA3;PLA2R1;ALMS1;TGFB1I1;TERT;BMP2;RFX3;IL6;BMP1;EPAS1;TGFBR1;UCN;SERPINE1;APPL2;ACSL1;BCL9L;TGFBR2;WNT5A;IL18;SYDE1
prerank,peptidyl-lysine methylation (GO:0018022),0.39975380415968,1.1190213791916672,0.308529945553539,0.7500366134187679,1.0,12/26,27.79%,ETFBKMT;METTL21C;SETD4;SETD7;ATPSCKMT;SETD2;SMYD3;EHMT2;SUV39H1;SETD6;SMYD2;EHMT1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.268612299124085,1.1186245550378648,0.16194790486976218,0.7502702082343375,1.0,85/532,13.08%,RORA;LEPR;TEC;RSAD2;FN1;SP100;CXCL10;IL16;GHR;IL31RA;GBP2;FOXC1;STAT2;IL6ST;GAB2;OSM;VIM;ANXA2;IL11;IL34;IL23R;FER;TRAF5;ANXA1;IFIT2;STAT5B;TNFSF15;KIT;BRWD1;IFI35;IL6;BCL2;APPL2;MCL1;BIRC3;PELI2;TNFRSF12A;TRIM5;VCAM1;EDA;OASL;NOS2;BST2;STAT1;SNRPA1;CCL2;ZEB1;YAP1;OPRD1;IL18;ACKR3;PSMB10;TNFRSF14;RIPK2;PSMA7;IL13RA1;PSMA3;PSME4;CNN2;IFITM1;PTPN6;APPL1;PSMA5;IRAK3;IFNLR1;UBE2V1;BCL2L1;OAS2;SMAD4;FOXO3;STAT4;JAK1;TRIM21;IFI27;SH2B3;CSF1;FBXW11;COL1A2;MAP3K7;TRIM26;BTRC;ADAR;POU2F1;IL22;IFIT1
prerank,positive regulation of immune effector process (GO:0002699),0.404911539569653,1.1183653874970376,0.3069139966273187,0.7502065697705582,1.0,6/27,9.33%,DDX60;IL23R;MYB;APPL2;LGALS9;ANKRD17
prerank,positive regulation of neuron projection development (GO:0010976),-0.2862112918397627,-1.118219725054304,0.23974763406940064,0.7162305591852854,1.0,29/85,15.61%,ITGA6;LRRC7;PTK2B;TENM3;RIT2;FUT9;NTRK2;SETX;SERPINI1;TOX;DAB2IP;CAPRIN2;SNX3;STMN2;NDNF;RAPGEF2;NPTN;LRP8;NDRG4;LYN;RET;DBNL;SCARB2;FES;VLDLR;RELN;PRKD1;TWF1;RAP1A
prerank,positive regulation of angiogenesis (GO:0045766),0.3187003423561676,1.118119906481906,0.26906474820143883,0.7500302783006886,1.0,18/108,8.46%,PDPK1;SASH1;FGF1;ECM1;GATA6;ITGB8;FOXC2;CDH5;ITGA5;VEGFD;ANXA3;MTDH;SERPINE1;EPHA1;CTSH;JMJD8;WNT5A;ADAM12
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.25490697971642895,-1.1180257284686954,0.1796875,0.7157221864556796,1.0,30/163,12.43%,PDE4D;PTPRJ;MEF2C;PDE4B;PRKCB;PLCG2;INPP5D;RFTN1;PIK3R1;MOG;PAK1;PRKCQ;PSMC3;PLEKHA1;BMX;EIF2B2;CD38;PSMD3;PSMD14;MALT1;LCP2;PSMD6;PSMD4;PAK3;BCAR1;PSMA6;PSMA4;PIK3CD;SYK;PSMB8
prerank,positive regulation of vasculature development (GO:1904018),0.3219557885279866,1.1176744806329555,0.26255380200860834,0.750417732881098,1.0,15/94,8.46%,PDPK1;SASH1;FGF1;ECM1;GATA6;ITGB8;CDH5;VEGFD;ANXA3;MTDH;SERPINE1;EPHA1;CTSH;WNT5A;ADAM12
prerank,hexose transmembrane transport (GO:0008645),-0.38135450771988333,-1.1174414786759599,0.30973451327433627,0.7164105085998688,1.0,6/21,18.99%,SLC2A1;PPARD;SLC2A9;SLC50A1;SLC45A3;SLC2A4
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5038684318951545,1.1169217517283236,0.3428030303030303,0.7516649309221873,1.0,2/11,7.48%,LEPROT;ACTN2
prerank,regulation of interferon-alpha production (GO:0032647),0.41924451430121845,1.1166910806919756,0.33094812164579607,0.7514622429634163,1.0,7/23,19.46%,TLR4;STAT1;RIPK2;TBK1;IFIH1;DHX36;SETD2
prerank,cardiac muscle cell differentiation (GO:0055007),0.42364640913669027,1.1162343282203253,0.3225255972696246,0.7518974160904731,1.0,3/21,4.04%,AKAP13;CXADR;BMP2
prerank,RNA biosynthetic process (GO:0032774),0.3897846124671816,1.1159623503797613,0.3105924596050269,0.7518070851902631,1.0,5/31,9.45%,TERT;NCOA6;POLA2;PRIM2;TAF7
prerank,regulation of neuron differentiation (GO:0045664),-0.29183499849836897,-1.1159409531133504,0.245014245014245,0.7195860347367578,1.0,16/76,7.56%,NLGN1;BRINP3;MEF2C;CNTN4;BRINP1;ZFHX3;TIAM1;BEND6;SIX1;BRINP2;MMD;NRCAM;ARHGEF2;YWHAH;TCF3;VWC2
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.47076809960115606,-1.1158887273400924,0.32286995515695066,0.7186482417723502,1.0,9/10,43.84%,RCC2;ECT2;KNSTRN;SPAG5;RACGAP1;CCNB1;APC;NEK2;CDC42
prerank,oogenesis (GO:0048477),0.4560939829990468,1.1158169892222185,0.33154121863799285,0.75140171716906,1.0,2/15,6.73%,PTN;NANOS2
prerank,regulation of mitochondrion organization (GO:0010821),0.358826372624867,1.114728896024144,0.3322314049586777,0.7536600781134419,1.0,16/47,22.06%,PID1;STAT2;STOX1;HAX1;GSK3B;LRRK2;DNM1L;CSNK2A2;USP36;MUL1;MYO19;RHOT1;RHOT2;SREBF1;VPS35;FBXW7
prerank,negative regulation of myoblast differentiation (GO:0045662),0.47569405337585535,1.114552372029908,0.33152173913043476,0.7533028587100418,1.0,2/13,3.84%,PRICKLE1;EID2B
prerank,DNA biosynthetic process (GO:0071897),0.4504091826762393,1.1144656068419627,0.3473491773308958,0.7526771412862836,1.0,3/16,4.39%,POLH;TERT;WRN
prerank,regulation of programmed necrotic cell death (GO:0062098),0.4262159041083011,1.114401329713902,0.338768115942029,0.7520462627793628,1.0,3/20,5.94%,NUPR1;CFLAR;BIRC3
prerank,neural tube closure (GO:0001843),0.37882404101494066,1.114380391574547,0.31751227495908346,0.7512715233035735,1.0,6/34,8.18%,PRICKLE1;DLC1;LMO4;MTHFD1;CELSR1;SKI
prerank,protein sumoylation (GO:0016925),0.35905410140574195,1.1138441141064086,0.2868462757527734,0.7519714202092351,1.0,10/49,15.72%,EYA1;RANBP2;TPR;PIAS1;SUMO1;NSMCE2;EGR2;POM121;IFIH1;NUP37
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.36866271668021455,-1.113247166404725,0.319910514541387,0.725059522695725,1.0,10/24,13.17%,SEMA6D;SEMA3C;SEMA4D;SEMA6A;SEMA7A;SEMA3E;VEGFA;SEMA3G;SEMA6B;SEMA3A
prerank,organophosphate catabolic process (GO:0046434),0.48856642838173914,1.1132325510471732,0.3443223443223443,0.7528593862997771,1.0,2/11,10.98%,APOA2;ENPP2
prerank,activation of GTPase activity (GO:0090630),0.32000068482214417,1.113173244993491,0.2607407407407407,0.7522028110762677,1.0,16/89,13.06%,ARHGAP29;RASGRF1;TIAM2;ARHGAP42;TBC1D16;EPHA1;GRTP1;SYDE1;GMIP;DOCK7;NGEF;SIPA1L2;EPHA2;RAP1GAP;TBC1D7;GPR65
prerank,regulation of interferon-beta production (GO:0032648),0.3567045806824671,1.1125359203537266,0.2857142857142857,0.7531755364395749,1.0,11/46,16.97%,TRIM56;TLR4;RNF216;RIPK2;TLR2;PPM1B;POLR3F;OAS2;TBK1;IFIH1;RNF135
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2848253671739472,1.1125029112915163,0.2360939431396786,0.7524440354712891,1.0,43/234,13.20%,SMAD3;CAMK1D;DDR2;PLPP3;EIF2AK2;ZIC2;FER;TRAF5;FZD2;ROR1;ANXA3;CFLAR;KIT;SLCO3A1;IKBKE;IL6;TLR4;MTDH;PRKCZ;TRIM5;HDAC4;EDA;ADCY1;LGALS9;OPRD1;WNT5A;IL18;RIPK2;PHB2;CRTC1;STK3;TLR2;IRAK3;UBE2V1;CRTC3;TRIM21;MAP3K7;TRIM26;ARID5B;WNT2;CRNN;FLOT2;MAP3K13
prerank,acylglycerol catabolic process (GO:0046464),-0.35728341269529346,-1.1122962861866057,0.2833333333333333,0.7267955094016431,1.0,10/30,28.13%,MGLL;ABHD2;LIPE;ABHD6;LPL;PNPLA3;FAAH;LIPH;FABP3;LIPC
prerank,glycolipid metabolic process (GO:0006664),-0.3160706037309833,-1.1117053206682215,0.2724867724867725,0.7273941423400361,1.0,10/47,13.93%,ST6GALNAC3;ST3GAL6;ST8SIA6;HEXB;GLTP;ST6GALNAC4;NEU1;CERK;ST3GAL4;GM2A
prerank,protein heterooligomerization (GO:0051291),-0.4107702662772267,-1.1116571224071488,0.32091097308488614,0.7264132713720912,1.0,7/17,23.40%,KCNC2;GRIN2B;GRIN1;TMEM120B;HSD17B8;FARSB;MAT2A
prerank,polarized epithelial cell differentiation (GO:0030859),0.46735374679730024,1.1114564598582086,0.35700934579439253,0.7546175851875921,1.0,2/13,5.79%,RAB10;MYO9A
prerank,B cell activation (GO:0042113),-0.29854475026790817,-1.1112491931670325,0.2492836676217765,0.7264948076714098,1.0,19/68,17.44%,PTPRJ;MEF2C;PRKCB;PLCG2;TPD52;ITGA4;HDAC9;TCF3;HHEX;MALT1;CD86;CD40;PIK3CD;DCAF1;CLCF1;LAT2;PTPRC;RABL3;CHRNA4
prerank,sensory perception of light stimulus (GO:0050953),0.32223844487474684,1.1109050227168713,0.29814550641940085,0.7553026141481175,1.0,16/87,15.96%,EFEMP1;RDH10;ZIC2;ADGRV1;COL18A1;MYO9A;TULP2;CRYBB3;IMPG2;ATXN7;EYA4;CRYBA1;OPA1;EML2;PDE6C;COL1A1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.3106613697529682,-1.1108102349027036,0.25142857142857145,0.7266791232128567,1.0,19/53,26.73%,PSMC3;DAB2IP;HSP90AB1;PINK1;UBB;RAD23A;PSMD14;XPO1;TMTC3;GNA12;FOXF2;PSME1;UBQLN4;UFL1;PSMC6;PSMC5;RAD23B;F8A1;TREM2
prerank,regulation of B cell proliferation (GO:0030888),-0.3229054467257856,-1.11057645331473,0.28211586901763225,0.726241070336804,1.0,13/44,21.33%,MEF2C;TFRC;CD38;CD74;LYN;ATM;CD40;CLCF1;PTPRC;TNFRSF21;CD320;CD81;MIF
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.44198613499981615,-1.1102295311434498,0.3103448275862069,0.7261615260334795,1.0,5/12,20.25%,MAOA;OAZ2;DDC;SMS;SRM
prerank,regulation of nuclear division (GO:0051783),-0.3828138018191086,-1.1097723604682186,0.31222707423580787,0.7263715392917216,1.0,13/20,42.36%,CAV2;CCDC8;BORA;L3MBTL1;MKI67;PRMT5;KIF20B;DAPK3;PIN1;CUL9;CDC25C;PDXP;NEK2
prerank,sodium ion transport (GO:0006814),-0.28690874285801254,-1.1092664691995031,0.23659305993690852,0.7267750540893742,1.0,18/85,12.09%,SLC6A6;SLC12A2;SLC9B2;SLC24A2;ATP1B1;SLC6A1;SCN1A;HCN1;SLC5A5;SLC8A1;SLC5A6;SCN2A;HCN2;NEDD4L;SCN8A;SCN9A;FGF13;SLC6A5
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.29094265764974525,-1.1090268710781204,0.25,0.7263821869687732,1.0,21/75,18.37%,PTPRJ;SORL1;DAB2IP;RASIP1;SLC8A1;PRKAR1A;INPP5K;BMP4;PAQR3;AKT1;TFAP4;HHEX;LRP6;LYN;PRKAR2B;LRP5;PKIG;MEN1;PKIB;PYCARD;CDKN1C
prerank,positive regulation of viral genome replication (GO:0045070),0.3891175987074535,1.1089295388629457,0.31711409395973156,0.7600815433039873,1.0,10/29,16.11%,TOP2B;PPARA;STAU1;PPID;TMEM39A;ADAR;IFIT1;SRPK1;TARBP2;PKN2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3229223710573464,1.1084944177360565,0.296137339055794,0.7605254329160062,1.0,11/85,7.45%,RASGRF1;AKAP13;KANK2;NOTCH2;DLC1;KANK1;DENND4A;PLCE1;SYNGAP1;STAMBP;DENND1A
prerank,regulation of chemokine production (GO:0032642),0.37426464181781727,1.1084935783016145,0.3322314049586777,0.7596861535137407,1.0,7/36,9.31%,EIF2AK2;IL6;TLR4;LGALS9;WNT5A;IL18;TLR2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.4716220137113557,-1.1082915479121984,0.359504132231405,0.7274565860221651,1.0,2/11,2.33%,FOXO1;NOTCH1
prerank,folic acid metabolic process (GO:0046655),0.437587816121616,1.1080211751582796,0.3121495327102804,0.7601316576492672,1.0,3/18,4.01%,SHMT1;SLC19A1;MTHFD1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.34142378172664356,1.1077618701218557,0.2957074721780604,0.7601051763519102,1.0,6/59,8.92%,ALDH1A2;CYP7B1;CYP27A1;AMACR;SCP2;SLC27A2
prerank,cellular response to oxygen-containing compound (GO:1901701),0.27645962650781053,1.1075976915213999,0.22964763061968407,0.7596793261761208,1.0,35/291,8.64%,RORA;ROCK2;PDGFRA;CXCL10;WNT6;PID1;AXL;IGFBP5;WNT10B;LDOC1;WNT3A;SHMT1;PTK7;EPHA3;VIM;FER;NCOA3;DAPK1;IL6;WNT5B;TPM1;TLR4;SERPINE1;ZNF35;CPEB1;NR1H3;ATP2B4;MPV17;SSH1;LY96;CCL2;CDC73;WNT5A;CD274;FAM210B
prerank,steroid biosynthetic process (GO:0006694),0.3402113221135509,1.107310806678804,0.3090332805071315,0.7596114586447723,1.0,12/56,16.24%,PRKAG2;CYP7B1;HSD17B1;CYP27A1;AMACR;INSIG2;SCP2;SLC27A2;CH25H;LBR;STAR;OSBPL9
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.48017112604865264,-1.107093026052672,0.3389473684210526,0.7287176022704234,1.0,4/10,13.54%,CDC42EP3;CDC42EP1;CDC42EP5;WASHC1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.48017112604865264,-1.107093026052672,0.3389473684210526,0.7287176022704234,1.0,4/10,13.54%,CDC42EP3;CDC42EP1;CDC42EP5;WASHC1
prerank,response to axon injury (GO:0048678),0.4328572609601159,1.1065894186908476,0.34290843806104127,0.7608070664994042,1.0,2/18,5.51%,DPYSL3;NREP
prerank,response to chemokine (GO:1990868),0.4657004439800133,1.106504758684501,0.3259109311740891,0.7602294711770028,1.0,3/13,1.84%,STK39;OXSR1;FOXC1
prerank,heart morphogenesis (GO:0003007),0.3515185520416942,1.1064796765912153,0.32102728731942215,0.7594494812889688,1.0,6/50,5.09%,FLRT2;TGFBR3;DLC1;BMPR1A;BMP2;TGFBR1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.42864045598475653,1.1061258215343222,0.3175438596491228,0.7595973789953401,1.0,7/19,16.26%,ELF1;PARP9;WNT5A;SH2B3;MAP2K5;IFIH1;TAF9
prerank,protein localization to cilium (GO:0061512),0.3836597136205536,1.1059704322125306,0.31551724137931036,0.7591930623579861,1.0,7/32,12.60%,INVS;ARL3;ODAD4;TMEM107;TULP2;WDR19;IFT20
prerank,endocardial cushion morphogenesis (GO:0003203),-0.4098095727288984,-1.1059027855615797,0.327313769751693,0.73110539053029,1.0,8/18,14.31%,NOS3;TGFB2;NOTCH1;ACVRL1;BMP4;TBX2;ACVR1;HEY1
prerank,endothelial cell migration (GO:0043542),0.37358938297317906,1.1057547700403625,0.3163265306122449,0.7589733919918802,1.0,8/37,12.41%,DPP4;FSTL1;NRP1;CDH5;STAT1;EGR3;CDH13;NR4A1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.40690222919369906,1.1057001437062626,0.3117117117117117,0.7582931620523105,1.0,5/24,11.67%,EPHA7;NUPR1;MCL1;BAX;FOXO3
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.37566261478340235,1.1054846899916153,0.33444259567387685,0.7580877448240754,1.0,9/33,13.54%,ADAMTS1;ANXA1;GLI1;CCND3;CDC73;PHB2;ANKRD17;CRNN;PAF1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3698974108174739,1.105132467120761,0.3250414593698176,0.7582576182660121,1.0,10/40,13.75%,PID1;BCL2;STOX1;SLC4A11;OPRD1;BAX;LRRK2;HEBP2;BCL2L1;BCO2
prerank,sarcomere organization (GO:0045214),0.4002188445284541,1.1050414958954202,0.3194192377495463,0.7576952712873246,1.0,4/27,7.48%,CSRP3;TPM1;CSRP1;ACTN2
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.3860553048398526,-1.1044885887508638,0.3462414578587699,0.7341543105697285,1.0,6/21,4.29%,LIMCH1;EFNA5;PEAK1;GPM6B;MACF1;ACTG1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.47946481718599454,-1.1043931833600198,0.3541666666666667,0.7333350216408347,1.0,2/10,7.50%,PRKG1;CEACAM1
prerank,tyrosine metabolic process (GO:0006570),0.4890884238639213,1.1042046928790785,0.3479923518164436,0.7591934274019804,1.0,2/11,13.60%,HGD;THAP4
prerank,digestive tract morphogenesis (GO:0048546),0.45705954762241996,1.1039044975689323,0.342911877394636,0.7591906573093922,1.0,2/14,4.75%,PDGFRA;GLI1
prerank,V(D)J recombination (GO:0033151),-0.45950579215287424,-1.1038630379494705,0.35294117647058826,0.7336949126499731,1.0,4/11,19.17%,HMGB1;TCF3;DCAF1;LIG3
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.3989982524630962,-1.103611303414817,0.3325942350332594,0.7332995405573292,1.0,6/17,16.52%,COX6C;COX4I1;COX8A;NDUFA4;COX6A1;COX7B
prerank,cell junction maintenance (GO:0034331),0.46067247110126675,1.1033484909701894,0.3301158301158301,0.7600021846887332,1.0,4/14,11.37%,PARD6A;CLDN1;MYADM;NLGN2
prerank,protein localization to plasma membrane (GO:0072659),-0.26163393160179793,-1.1032696238699358,0.2593984962406015,0.7332261475897878,1.0,34/129,14.68%,DPP10;BSG;KCNB2;EFR3B;CACNB2;TNIK;ATP1B1;CDH1;KCNIP4;GAS6;ANK3;MAP7;EMP2;DPP6;TSPAN14;INPP5K;STXBP1;RAPGEF2;CCDC88A;RAB3C;RAMP2;TMED2;LRP6;ZDHHC2;KCNB1;ZFYVE27;FGF13;RAPGEF6;RAB12;EHD4;F11R;RAB40B;CLASP2;C2CD5
prerank,positive regulation of kinase activity (GO:0033674),0.31127490246521516,1.1030947781054392,0.28892005610098176,0.7598883952037888,1.0,28/107,15.48%,EPHA7;PDGFRA;FGFR1;PRKAG2;AXL;DDR2;INSRR;LMO4;EPHA3;EPHA8;ROR1;KIT;RAD50;EPHA1;PDGFRB;SNX9;EPHA4;MST1R;MUSK;PTK2;DSTYK;CSF1;EPHA2;EEF1A2;NTRK3;RYK;ALK;IQGAP1
prerank,positive regulation of receptor internalization (GO:0002092),-0.38085266389490324,-1.1030945694001515,0.32779097387173395,0.7326897292509651,1.0,9/22,17.31%,INSR;AHI1;SCYL2;VEGFA;ATAD1;SFRP4;EGF;NTF3;TBC1D5
prerank,calcium ion import (GO:0070509),-0.3510734898798311,-1.1026998876186278,0.2976190476190476,0.7328066687470348,1.0,8/28,10.03%,CACNA1E;CACNB2;MCUB;TRPC4;SLC8A1;CACNA1G;CACNA1D;SMDT1
prerank,synaptic vesicle localization (GO:0097479),-0.4393684103649623,-1.1023447920169915,0.3731958762886598,0.7327463094038925,1.0,6/13,16.35%,NLGN1;RAB27A;SYNDIG1;KIF5C;KIF5A;SNAPIN
prerank,cAMP biosynthetic process (GO:0006171),0.48675516095128446,1.1023122271394523,0.3418467583497053,0.7612909378927187,1.0,3/10,7.23%,ADCY7;ADCY5;ADCY1
prerank,transferrin transport (GO:0033572),-0.34326400374721233,-1.1021892805169535,0.2882205513784461,0.7320676680438214,1.0,12/33,21.22%,ATP6V0A1;TFRC;ATP6V1B2;ATP6V0C;ARHGAP1;ATP6V1D;ATP6V0A2;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V0D2;ATP6AP1
prerank,regulation of phosphorylation (GO:0042325),0.3059832496471365,1.1021533583650782,0.27977839335180055,0.7609202467323611,1.0,26/120,17.07%,FN1;PRKAG2;STAT2;DYNLL1;PHIP;NRP1;CDH5;FER;LDB2;BMP7;RANBP2;TPR;CDKN2B;JMJD8;FNIP1;PTK2;CADM4;KCTD20;POM121;ILK;PML;NUP37;APP;INHA;NDUFS4;PPP2CA
prerank,mesenchyme morphogenesis (GO:0072132),-0.400635264825989,-1.102013253422194,0.3561946902654867,0.7314702449181817,1.0,7/17,14.31%,NOS3;TGFB2;NOTCH1;ACVRL1;TBX2;ACVR1;HEY1
prerank,positive regulation of autophagy (GO:0010508),0.32060659232384625,1.101965863468801,0.3068862275449102,0.7606231991779007,1.0,19/81,14.78%,RNF152;PRKAA2;DCN;DAPK1;MTDH;OPTN;TRIM5;PIK3C2A;GSK3B;WAC;PHB2;LRRK2;TPCN1;FOXO3;SESN1;TRIM21;MAP3K7;TICAM1;TBK1
prerank,organophosphate biosynthetic process (GO:0090407),-0.3338477772587327,-1.1018800606923937,0.3060240963855422,0.7307715242259233,1.0,10/37,14.87%,ITPKB;GPHN;MBOAT1;PCYT2;IP6K2;TKT;TPI1;FGF2;PPIP5K1;PPIP5K2
prerank,carnitine metabolic process (GO:0009437),0.46376167588882156,1.1014917169923246,0.3546511627906977,0.7611145462004205,1.0,2/12,9.32%,SHMT1;TMLHE
prerank,negative regulation of interleukin-8 production (GO:0032717),0.42669693921810786,1.1014147511094772,0.3321616871704745,0.7605187581478502,1.0,5/17,12.85%,ANXA1;PTPN22;ANXA4;MAP2K5;ARRB1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.40286117913544506,-1.101293198197052,0.3173913043478261,0.7312795373654849,1.0,2/17,3.05%,CTNNA2;NCKAP1
prerank,protein secretion (GO:0009306),0.34069814895177575,1.100857253851797,0.32786885245901637,0.7613090613584622,1.0,7/56,5.91%,WLS;ARFGAP3;STEAP3;ANXA1;RAB10;MIA3;FAM3B
prerank,negative regulation of interferon-gamma production (GO:0032689),0.40195391633056465,1.1007135038324638,0.3357664233576642,0.7609266786627075,1.0,5/23,8.19%,AXL;TLR4;FOXP3;LGALS9;CD274
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.44978820429364147,1.1005698750604886,0.3327205882352941,0.7604915661046925,1.0,1/15,0.84%,MOXD1
prerank,neuron migration (GO:0001764),-0.3092977483367884,-1.100543078081029,0.29581151832460734,0.7323726840624004,1.0,20/48,15.76%,ADGRL3;MEF2C;GPM6A;NTRK2;NRCAM;NDNF;RAPGEF2;ASTN1;MAP1B;ASTN2;DNER;VEGFA;SPOCK1;DDIT4;FGF13;SEMA3A;MARK1;RELN;RAC1;POMGNT2
prerank,cognition (GO:0050890),-0.32300901344821775,-1.100494541227651,0.289544235924933,0.7314422736677471,1.0,13/42,22.10%,GRM5;PTCHD1;SHROOM4;FAM107A;DOP1B;SLC1A4;MFSD2A;ST3GAL4;CHRNA4;CHMP2B;CHRNA7;TTC8;LHCGR
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.34822483942324284,1.1003929265253591,0.31981279251170047,0.760159130467384,1.0,8/49,9.72%,PPM1A;LDLRAD4;PMEPA1;DACT1;PRKCZ;GSK3B;OPRD1;SMAD6
prerank,secondary alcohol metabolic process (GO:1902652),0.35825845751278595,1.1001030362902602,0.31711409395973156,0.7601888897443042,1.0,9/42,12.78%,APOA2;APOF;CYP27A1;IDH1;SOAT1;ABCA1;OSBPL5;CH25H;IDH2
prerank,prostanoid metabolic process (GO:0006692),0.47100950490008947,1.0999656780530132,0.3745173745173745,0.7597277050580408,1.0,4/13,19.35%,PTGS1;PTGR1;ACOX1;PTGR2
prerank,L-amino acid transport (GO:0015807),0.3811284012146291,1.0997361191715262,0.32926829268292684,0.7595215715148377,1.0,2/28,0.77%,SLC7A2;SLC1A3
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4748514400814725,1.0996782051727774,0.36095764272559855,0.7588375356602572,1.0,3/12,7.90%,NUPR1;IL6;IL18
prerank,regulation of cellular component size (GO:0032535),-0.35047630684030434,-1.0994040188956102,0.29694323144104806,0.7335400480685501,1.0,12/30,26.85%,EPS8;RAP1GAP2;PPP1CA;VAV1;RAC1;RIN3;PEX11A;PPP1R15A;LAMTOR4;RAB3B;AP2M1;PEX11B
prerank,sensory perception of sound (GO:0007605),0.3208541052298754,1.0993910966698515,0.2919605077574048,0.7588216297650734,1.0,9/88,6.66%,COL4A3;EYA1;DCDC2;ROR1;ADGRV1;KIT;GSDME;CCDC50;MYO1A
prerank,artery morphogenesis (GO:0048844),-0.3518331134937902,-1.0993043510692933,0.3069544364508393,0.7327959358084993,1.0,8/30,9.03%,TGFB2;BMPR2;NOTCH1;SMAD7;TBX1;BMP4;TBX2;VEGFA
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.4240422839642287,1.0992890570262897,0.3483754512635379,0.7582982114382757,1.0,8/20,23.33%,PID1;NUMB;RHOQ;BCL2L1;DAB2;PPFIA1;LZTFL1;TGFB1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.36695723904576993,-1.0991983673038046,0.3062645011600928,0.7320332347098419,1.0,5/24,8.40%,PTK2B;CTSC;PINK1;UBB;PSMD14
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.43444321373715494,-1.0990005051784666,0.3389830508474576,0.73156539600849,1.0,3/12,2.22%,UBASH3B;RYR2;PTK2B
prerank,I-kappaB phosphorylation (GO:0007252),0.4812564402023424,1.0989467910482043,0.3616600790513834,0.7584245006248393,1.0,3/10,12.71%,TLR4;TLR2;MAP3K7
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4726297761019863,1.0983437887879337,0.344106463878327,0.7593564995641914,1.0,4/12,13.01%,ADAMTS12;DCN;ATP2B4;CADM4
prerank,negative regulation of response to stimulus (GO:0048585),0.33726032566818437,1.0978479873231217,0.3313253012048193,0.7598585044221534,1.0,13/60,13.34%,IGFBP3;COL3A1;MPIG6B;CASK;TERT;APPL2;NR1H3;FOXP3;AKT3;SH2B3;MAP2K5;PTPN1;BRAP
prerank,negative regulation of response to external stimulus (GO:0032102),0.3065279974944026,1.0977257305965675,0.30491329479768786,0.7593611143028178,1.0,16/105,13.09%,ENPP3;RORA;FPR2;CASK;CDH5;TNFAIP8L2;SERPINE1;NR1H3;PTPN2;PPARA;EPHA4;PPM1B;IRAK3;TRIM21;EPPK1;CD109
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.4730247541999927,1.0977059661760467,0.3686131386861314,0.7586211631249202,1.0,4/12,11.86%,NEDD4;PTPN14;TPR;IFI27
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.47235837792454793,1.097520524806487,0.3524590163934426,0.758332215082735,1.0,3/12,10.02%,KDELR3;INSIG2;TAPT1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.31236373126589667,1.0972221800820914,0.30935251798561153,0.7583790467533573,1.0,18/88,14.46%,SAMD4A;EIF2AK2;IGFBP5;SHMT1;NELL1;CSTB;IGF2BP1;DAPK1;NANOS2;SERPINE2;IGF2BP2;DNAJC1;ILF3;PLAT;EIF4ENIF1;DDX6;EIF2AK3;GIGYF2
prerank,bile acid biosynthetic process (GO:0006699),0.40125497443994973,1.096980279854512,0.34124087591240876,0.7582335714447198,1.0,6/24,12.60%,CYP7B1;CYP27A1;AMACR;SCP2;SLC27A2;CH25H
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.47763107243670844,1.0968092745852924,0.3685185185185185,0.7578871078011156,1.0,3/12,4.62%,DOCK11;NOTCH2;IL6
prerank,T cell mediated immunity (GO:0002456),-0.4310903650489718,-1.0966468812816779,0.34615384615384615,0.7373676888134789,1.0,3/13,10.63%,CADM1;EMP2;CD46
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3229067579319625,1.0965763713332253,0.31164901664145234,0.7576908985223088,1.0,16/79,13.08%,SULF1;ADAMTS12;SMURF2;BMPR1A;FSTL3;NBL1;CASK;NEDD4;BMP2;ATP2B4;SKI;SMAD6;SMAD4;PTPN1;CADM4;NOG
prerank,protein localization to kinetochore (GO:0034501),-0.425083758574134,-1.0965466124791812,0.3211845102505695,0.7365943556412429,1.0,11/14,41.74%,RCC2;ZWILCH;CENPT;SPDL1;ZW10;CDK1;MIS12;BUB3;KNL1;AURKB;CHAMP1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.3167747011922367,1.0963752678924135,0.3119266055045872,0.7574384467313193,1.0,25/84,21.23%,SAMD4A;EIF2AK2;IGFBP5;SHMT1;IGF2BP1;RTN1;DAPK1;NANOS2;IGF2BP2;ILF3;EIF4ENIF1;DDX6;RTN4;EIF2AK3;GIGYF2;CNOT9;CPEB3;ABCA7;FXR2;DHX36;NANOS1;ROCK1;GGA3;RNF139;EPRS1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.40570525577061534,-1.0962534034070341,0.3530751708428246,0.7363854720033286,1.0,2/16,7.70%,CLDN5;CLDN14
prerank,neuromuscular junction development (GO:0007528),0.4068939375020534,1.0960215586504718,0.3333333333333333,0.7576238620945895,1.0,6/24,10.09%,PDZRN3;NEDD4;UNC13B;LRP4;LRRK2;MUSK
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.49551179024004954,1.09569906062293,0.3716475095785441,0.7569286669902335,1.0,4/10,15.63%,ASCC3;FTO;ALKBH1;MGMT
prerank,DNA dealkylation (GO:0035510),0.49551179024004954,1.09569906062293,0.3716475095785441,0.7569286669902335,1.0,4/10,15.63%,ASCC3;FTO;ALKBH1;MGMT
prerank,cellular response to retinoic acid (GO:0071300),0.3549148623057243,1.0951670607838355,0.32247557003257327,0.7575551214888079,1.0,8/42,7.87%,WNT6;WNT10B;WNT3A;PTK7;EPHA3;WNT5B;ZNF35;WNT5A
prerank,potassium ion export across plasma membrane (GO:0097623),0.4585570626403925,1.0951577169464244,0.3590733590733591,0.7567774339210551,1.0,1/13,0.48%,KCNT2
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.43759583807643976,-1.0948901226129706,0.33620689655172414,0.7392048563244332,1.0,7/12,29.69%,PFDN5;PFDN2;PFDN4;VBP1;TREM2;CLU;LDLR
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.40323946787543924,1.094729557027325,0.3644214162348877,0.7571908418582173,1.0,6/25,11.87%,FBXL17;ZYG11B;POMT2;KLHL15;UGGT2;CUL3
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.3256577418284942,-1.094647582178638,0.3106060606060606,0.7388079292460258,1.0,10/36,17.83%,AQP11;RPL11;HSP90AB1;SDCBP;BAG6;RYBP;CCAR2;CAMLG;PARK7;N4BP1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.4549884722868961,-1.0946243639422253,0.35368421052631577,0.7378185744810843,1.0,5/11,20.56%,ST18;FAS;PLAUR;PARK7;PRR7
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3022354769156292,1.0946058680124178,0.29112081513828236,0.7567679478453462,1.0,20/124,12.74%,TCF7L2;WNT4;PRICKLE1;SMURF2;TNRC6B;FZD2;PARD6A;PLCB3;CELSR1;WNT5A;PSMB10;TNRC6A;MOV10;PSMA7;PSMA3;PSME4;PSMA5;PPP3CB;MAP3K7;DVL3
prerank,prostaglandin metabolic process (GO:0006693),0.3964191648399086,1.0937787859695163,0.3588850174216028,0.7582377524609862,1.0,3/26,7.01%,PTGS1;PLA2G4A;PTGR1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4460897795056182,1.093399073462393,0.349146110056926,0.7585401756673279,1.0,6/15,20.66%,LARGE1;MGAT3;AMDHD2;EXTL2;NAGK;CHST3
prerank,membrane fusion (GO:0061025),-0.34309606095347867,-1.0931617035724601,0.3183023872679045,0.7410044360191411,1.0,7/33,12.04%,DNM3;RIMS1;NSF;DYSF;NSFL1C;VPS33B;NAPA
prerank,protein destabilization (GO:0031648),0.3795169428704527,1.092974679611702,0.3209076175040519,0.7589133239249661,1.0,12/32,15.88%,CREBBP;CTSH;CDC73;FBXL3;SERF1A;TRIM21;CUL3;FBXW11;BTRC;PEX2;KDM8;MUL1
prerank,sulfur compound transport (GO:0072348),-0.3618909250835744,-1.0924728361730645,0.3422330097087379,0.7420183753834098,1.0,11/27,22.91%,ABCG2;SLC6A6;SLC26A7;SLC5A6;SLC36A1;SLC25A30;SLC25A19;SLC35F3;SLC19A2;RACGAP1;SLC26A8
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.30932439802445577,1.092292166319669,0.30153846153846153,0.7599781429453416,1.0,18/95,11.86%,UST;GPC6;CHST15;HSPG2;SDC2;DCN;ANGPT1;NDST1;OMD;DSE;CHSY1;NDST2;B4GALT1;GLCE;PRELP;GPC2;SLC35D2;HS3ST3B1
prerank,metal ion export (GO:0070839),0.3812207698637258,1.09211634550912,0.33104631217838765,0.7596796701129808,1.0,2/31,0.48%,ATP1A2;KCNT2
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.4678407202498841,-1.0920766520259229,0.351129363449692,0.7420297917989065,1.0,6/10,28.05%,PDE8A;PARK7;GPR37;STK26;GPR37L1;PYCR1
prerank,relaxation of cardiac muscle (GO:0055119),-0.4337764382196078,-1.0919335482677481,0.35920177383592017,0.7413781096321042,1.0,5/13,8.04%,ATP1B1;KCNJ2;ATP1A1;SLC8A1;CAMK2D
prerank,regulation of cytoplasmic translation (GO:2000765),-0.4251305214871867,-1.0918885724907286,0.3348314606741573,0.7404503162321933,1.0,6/14,19.74%,CPEB2;PKM;UNK;CNBP;CPEB4;RBM24
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.40351333093270975,-1.0918812424747801,0.3430493273542601,0.7394263198497109,1.0,2/17,1.15%,PRKG1;MEF2C
prerank,relaxation of muscle (GO:0090075),-0.4327372840916226,-1.0916242123969546,0.35294117647058826,0.7391656011338762,1.0,5/13,8.04%,ATP1B1;KCNJ2;ATP1A1;SLC8A1;CAMK2D
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.39355735218780014,-1.0913339686442856,0.3493150684931507,0.738970824347249,1.0,6/17,28.61%,AKT1;PPIA;SOD1;TREM2;HSPB1;VNN1
prerank,sensory perception of smell (GO:0007608),0.4887033330743431,1.0910895369544704,0.387523629489603,0.7616519841432597,1.0,1/11,2.40%,BEST2
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.3411893523519912,-1.0908453734438888,0.3350383631713555,0.7392888564256018,1.0,7/30,16.55%,HSPA8;HSPA14;BAG1;HSPE1;DNAJB4;ERO1A;HSPA5
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.34142017395199853,1.0907940452055276,0.31795716639209226,0.7617594616999458,1.0,7/49,8.66%,KMT2A;MTURN;TNRC6B;GP1BA;KMT2C;TNRC6A;MOV10
prerank,regulation of catabolic process (GO:0009894),-0.39365084905603925,-1.0904787456538008,0.3439635535307517,0.7392331766876649,1.0,11/18,34.42%,FAP;NEDD4L;ZDHHC2;ZDHHC7;HPGD;SNF8;CHMP6;HGS;FAM83D;FURIN;MDM2
prerank,cellular response to acid chemical (GO:0071229),-0.35057435291594186,-1.0903959107719043,0.3225058004640371,0.7384359396558068,1.0,11/27,25.81%,KLF2;RRAGB;VEGFA;SPAAR;CPEB4;RRAGC;GLRA2;GLRA1;LAMTOR2;NSMF;LAMTOR4
prerank,dendritic cell migration (GO:0036336),-0.4096192074666629,-1.0902788767493117,0.3579175704989154,0.7377345949387696,1.0,13/16,46.36%,EPS8;HMGB1;CCL19;TRPM2;ALOX5;CCL5;PIK3CG;CCR1;CCR5;CCR6;CXCR2;TRPM4;CCR2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.42516514221598933,1.0898341041858615,0.36116152450090744,0.7635511044391823,1.0,3/18,2.40%,DLC1;HEG1;KANK1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.4483512160704093,-1.0897521577777765,0.3731656184486373,0.7382036715621868,1.0,2/12,8.68%,STARD3NL;FDXR
prerank,negative regulation of cell death (GO:0060548),-0.2788705593316787,-1.0896490991715273,0.26791277258566976,0.7374543092197395,1.0,42/88,33.04%,MECOM;PDE8A;CD34;SNCA;TM7SF3;CCN3;SORL1;CCN5;BMP4;AKT1;PINK1;TNFRSF1B;PAX2;FGF2;NPAS2;PRKD1;PARK7;BTBD10;HTR2B;BNIP3L;PACRG;SRGAP2;PSMC5;NUP62;SRSF6;CHMP2A;ADNP2;CDK5;EIF4G1;SOX11;CLU;AMIGO2;WNT16;DCPS;RAD18;GPNMB;TMEM109;TRAF2;MT3;POU4F1;IKBKG;WNT11
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.4306423621986879,1.0893203343600106,0.3474264705882353,0.7641618931706086,1.0,7/17,15.86%,RBPJ;CREBBP;STAT1;PBX1;HEYL;MAML2;KAT2B
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.40997252642992354,-1.0892044496073274,0.351129363449692,0.7377057868420897,1.0,13/16,48.68%,SLC39A14;ACP3;GRP;PRMT5;C3;MRAP2;PDE6G;NECAB2;MRAP;CHGA;F2;PDE6H;PRKCA
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3488159305335689,-1.0891278816839758,0.33016627078384797,0.7368904135443138,1.0,8/30,18.34%,DACH1;BMPR2;ACVRL1;TERF1;GNL3L;CDKN1A;MEN1;TINF2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.4399772629690982,1.0891218569327978,0.37777777777777777,0.7638940296048191,1.0,5/15,12.97%,TPR;ANAPC1;UBE2C;HECW2;CDC27
prerank,cell cycle G2/M phase transition (GO:0044839),0.29518187615500724,1.0887807837485415,0.29958391123439665,0.7640199736511573,1.0,40/129,21.33%,PHLDA1;NINL;DYNLL1;ALMS1;FBXL17;SDCCAG8;CLASP1;OPTN;CEP152;CDKN2B;HAUS8;FBXL3;CCNH;MNAT1;CDK7;FBXL7;PPP1R12B;PPP1CB;NEDD1;NES;CCDC57;FBXW11;BTRC;MASTL;KDM8;ACTR1A;FBXL12;CEP250;YWHAE;PPP2R2A;KHDRBS1;CCNY;CEP131;AJUBA;CUL1;CEP78;CEP63;PKMYT1;OFD1;CHEK2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.33216353767757284,-1.0879778910352669,0.3110539845758355,0.7391768761475452,1.0,11/35,15.27%,SGIP1;HIP1;HIP1R;HNRNPK;LDLRAP1;B2M;SNAP91;TNK2;CBL;RAC1;CCL19
prerank,actin filament-based transport (GO:0099515),0.4036908624964876,1.0879537385346452,0.37082601054481545,0.7655150688069275,1.0,10/21,19.65%,SYNE2;MYO1B;MYO1A;WASL;MYO15A;MYO1E;MYO1C;MYO5A;MYO19;MYO5B
prerank,negative regulation of response to wounding (GO:1903035),0.42664493570973416,1.0878134288505903,0.3608617594254937,0.7650630277091316,1.0,5/19,13.09%,CASK;SERPINE1;EPHA4;EPPK1;CD109
prerank,lamellipodium assembly (GO:0030032),-0.3541550491680206,-1.0875061468600677,0.3341708542713568,0.7395135229422993,1.0,8/26,14.95%,PARVB;SPATA13;ARHGEF6;CCDC88A;S1PR1;PTPRO;ARHGEF7;RAC1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.4193597396116928,1.0874983935825684,0.3546617915904936,0.7651007055877357,1.0,6/20,11.25%,BCL2;MCL1;GSK3B;BAX;APPL1;BCL2L1
prerank,activation of phospholipase C activity (GO:0007202),0.37593167163313734,1.087300994105027,0.3422818791946309,0.7648403018803113,1.0,7/29,15.98%,ARHGAP6;LPAR1;PHB2;NMUR1;P2RY6;BDNF;TXK
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.32648144514747096,1.087202891635237,0.3230769230769231,0.7643239717033767,1.0,12/73,10.43%,KMT2A;EIF2AK2;FOXC1;OSM;MYB;TCF12;YAP1;PSMB10;PSMA7;PSMA3;PSME4;PSMA5
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.29566817071410423,1.0871630874890421,0.3071528751753156,0.7636559883226933,1.0,40/128,21.33%,PHLDA1;NINL;DYNLL1;ALMS1;FBXL17;SDCCAG8;CLASP1;OPTN;CEP152;CDKN2B;HAUS8;FBXL3;CCNH;MNAT1;CDK7;FBXL7;PPP1R12B;PPP1CB;NEDD1;NES;CCDC57;FBXW11;BTRC;MASTL;KDM8;ACTR1A;FBXL12;CEP250;YWHAE;PPP2R2A;KHDRBS1;CCNY;CEP131;AJUBA;CUL1;CEP78;CEP63;PKMYT1;OFD1;CHEK2
prerank,positive regulation of dephosphorylation (GO:0035306),-0.35335217033611604,-1.087035857891899,0.33101851851851855,0.739840676160643,1.0,7/27,7.52%,PPP1R16B;CALM1;CAMTA1;CALM2;PTBP1;CALM3;SYMPK
prerank,neurotrophin signaling pathway (GO:0038179),-0.38270994395513314,-1.0869844887496485,0.3119266055045872,0.7389456291935274,1.0,9/21,16.79%,NTRK2;RAPGEF2;DDIT4;ZFYVE27;BCAR1;NGF;SORT1;RAP1A;NTF3
prerank,regulation of intracellular transport (GO:0032386),-0.32712375408318994,-1.0869478133542092,0.32418952618453867,0.7380359739086516,1.0,13/38,22.90%,WWC1;REEP5;DYNC1H1;AAAS;NEFH;CAPN10;MAP2;MLC1;LAMP1;LCP1;SPAG5;ATP9A;HAP1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.38153138403286546,1.0863600577847998,0.3656093489148581,0.7650458948986663,1.0,3/32,4.34%,PDPK1;CXCL10;F2RL3
prerank,positive regulation of axonogenesis (GO:0050772),0.3545963227233613,1.0859683450659205,0.32516339869281047,0.7653611283713663,1.0,7/43,7.82%,PLXNA2;ROBO1;TIAM2;NTN1;MAP6;DBN1;NGFR
prerank,activation of protein kinase activity (GO:0032147),0.30179006221309024,1.085821706043218,0.3106796116504854,0.7649695790138066,1.0,16/106,8.78%,PDPK1;NRK;FGF1;GHR;OSBPL8;ANGPT1;TAOK3;TNFSF15;ADCY7;ADCY5;TGFBR2;ADCY1;WNT5A;IL18;PHB2;STK3
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.3984385348537158,1.0857515922402834,0.3592400690846287,0.7643717096035293,1.0,8/24,14.96%,VTN;ITGA5;NEDD4;ARNT;PTPN1;CADM4;NIBAN2;PRKD2
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.32132079504662614,1.0854803705526421,0.32756132756132755,0.7642938366913808,1.0,16/78,12.25%,PDPK1;PID1;SPTBN1;EPHA3;NUMB;MMP14;SORBS1;ATP2B4;PTPN9;KIF5B;RHOQ;DLG1;STX8;APPL1;BCL2L1;EPHA2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.4167144208210363,1.0853834210236137,0.35753176043557167,0.7637887463443626,1.0,7/20,19.52%,PID1;NUMB;RHOQ;BCL2L1;DAB2;PPFIA1;CSK
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.39985756821318374,1.0849826453604887,0.3574144486692015,0.7641415602130742,1.0,4/21,10.48%,DAG1;SPPL3;ERAP1;ADAM19
prerank,response to lipid (GO:0033993),0.3053561006343833,1.0844990055097705,0.3149492017416546,0.7646730261389788,1.0,20/105,12.36%,SELP;GATA6;IL23R;FER;ANXA1;RBP4;STAT5B;TLR4;PTPN22;PPARA;NOS2;CTSH;LY96;LGALS9;STRN3;SMAD6;NOCT;IRAK3;FOXO3;RPS6KA3
prerank,negative regulation of kinase activity (GO:0033673),0.3292310460503491,1.0840104765181167,0.3328100470957614,0.7651795178239149,1.0,7/62,9.45%,PDPK1;DEPTOR;PRKAG2;PPM1E;EPHA1;DTNBP1;TAF7
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.3570985860867519,-1.0839361785406938,0.32027649769585254,0.7456301888432166,1.0,9/26,16.57%,NOS1AP;SCARB1;AKT1;GCH1;NUS1;S100A1;PARK7;CDH3;HTR2B
prerank,regulation of cell adhesion (GO:0030155),-0.2576866022936851,-1.0839195577742031,0.2604166666666667,0.7446556540207793,1.0,28/129,13.34%,FRMD5;PLXNA4;PTPRJ;EFNA5;PDE3B;PTK2B;ZFHX3;CYTH1;PPP2R1A;STX3;ACVRL1;SEMA4D;TGFBI;ADGRG1;ADAM22;ARHGDIB;YTHDF2;VEGFA;PRKX;LYN;MINK1;ZDHHC2;RET;ATM;CXCL12;FES;ARHGDIA;EPB41L4B
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.48003834879208007,1.0833444529457292,0.36470588235294116,0.7662617774221709,1.0,5/10,24.00%,MYB;JARID2;KDM1A;RIF1;ATRX
prerank,homotypic cell-cell adhesion (GO:0034109),0.3589038080766906,1.0833428350229604,0.3299319727891156,0.7654900103892832,1.0,8/39,10.63%,PDGFRA;FN1;PLPP3;GP1BA;CSRP1;VCL;DSC2;PLEK
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.47729515727463034,1.0828219872745148,0.357421875,0.7660973459551716,1.0,3/11,8.19%,TWSG1;LGALS9;CD274
prerank,protein targeting to mitochondrion (GO:0006626),-0.3066180539376561,-1.0823606776059487,0.30997304582210244,0.7482487691799812,1.0,16/52,22.24%,MFF;HSPA4;MFN2;GDAP1;SAMM50;TIMM8B;HSP90AA1;DNLZ;GRPEL2;AIP;TOMM40L;IMMP2L;TOMM20;TIMM22;NDUFA13;TIMM10
prerank,regulation of protein dephosphorylation (GO:0035304),-0.32759154218925357,-1.0822236761848871,0.3358024691358025,0.7475903452077074,1.0,8/37,8.04%,PPP1R16B;CALM1;CAMTA1;CALM2;PTBP1;CALM3;SYMPK;MFHAS1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.4602108607586406,-1.0820399545561523,0.3667334669338677,0.7471089830607563,1.0,3/10,7.35%,LRCH1;APOD;AKT1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.44247335111555536,1.081882942915763,0.3781818181818182,0.7679467332011615,1.0,1/16,0.36%,LEPROT
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.4143025702338663,-1.081299726941452,0.3581081081081081,0.7483198392922149,1.0,3/14,8.52%,GAS6;CCDC3;RFFL
prerank,mitotic cytokinesis (GO:0000281),0.3485584991707644,1.0812664659539322,0.3465818759936407,0.768868283373917,1.0,9/47,9.39%,ROCK2;SPTBN1;ARL3;RASA1;STAMBP;KLHDC8B;SNX9;ESPL1;USP8
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3921119031328919,1.0811084946507976,0.3593220338983051,0.7684680454522177,1.0,5/25,9.64%,AMPD3;SHMT1;MTHFD1;PAICS;PRPSAP1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3232583336230298,1.0810359801312166,0.3221884498480243,0.7678818004680388,1.0,10/69,6.78%,PDGFRA;FGFR1;TPTE;GAB2;PLCD3;PI4KA;PDGFRB;PLCE1;PLCB3;PIK3C2A
prerank,insulin receptor signaling pathway (GO:0008286),-0.29217111029876897,-1.0808769028167242,0.2976190476190476,0.7485054933749248,1.0,17/69,12.69%,GRB14;BCAR3;ATP6V0A1;FOXO1;INSR;PIK3R1;GAB1;ATP6V1B2;PIK3R3;NAMPT;ATP6V0C;AKT1;CAV2;SLC39A14;ATP6V1D;BCAR1;FOXO4
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.30804195229582104,1.0808375528739387,0.3293768545994065,0.7676620957063991,1.0,15/95,10.62%,CXCL10;AXL;LDOC1;VIM;IL6;TLR4;SERPINE1;NR1H3;LY96;CCL2;CDC73;WNT5A;CD274;TLR2;MAPK14
prerank,axon extension (GO:0048675),0.40840291580197974,1.0805947403865492,0.3752244165170557,0.7675404930862704,1.0,6/23,12.19%,ALCAM;AUTS2;NRP1;USP9X;SPG11;PPP3CB
prerank,positive regulation of B cell activation (GO:0050871),-0.3081060248925362,-1.0804042833696863,0.3024523160762943,0.7487948022440132,1.0,15/50,21.33%,MEF2C;TFRC;SH3KBP1;CD38;CD74;CD40;SYK;CLCF1;PTPRC;HMCES;NOD2;CD27;CD320;CD81;MIF
prerank,positive regulation of epithelial cell migration (GO:0010634),0.30926112049792204,1.0802591891592401,0.3288084464555053,0.7676812673346324,1.0,14/92,8.81%,RIN2;ROCK2;SASH1;DOCK5;FGF1;FOXC2;GLIPR2;NRP1;ANXA3;ANGPT1;CLASP1;CTSH;WNT5A;INSL3
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.4266550067103939,-1.0800714831915845,0.3662551440329218,0.7488120288691451,1.0,2/13,1.76%,PLCB1;IL33
prerank,positive regulation of cell projection organization (GO:0031346),0.30271493158058094,1.0797267595006463,0.30823863636363635,0.7683041459593737,1.0,12/115,5.36%,PLXNA2;DPYSL3;ROBO1;PTN;TIAM2;CAMK1D;PTK7;EPHA3;ROR1;MAP6;PLK5;CBFA2T2
prerank,regulation of protein modification process (GO:0031399),0.3435135011406649,1.0795193434925119,0.35782747603833864,0.7681321072129388,1.0,17/50,19.14%,FN1;STAT2;PHIP;CDH5;FER;IGF2;PPP1R16A;FNIP1;PTK2;CADM4;PML;KAT2B;NDUFS4;PPP2CA;ATG10;PLXNB2;FKTN
prerank,cellular response to chemokine (GO:1990869),0.3487494884375857,1.0792401998772874,0.34517766497461927,0.7681392267791353,1.0,6/46,7.94%,CXCL10;STK39;OXSR1;FOXC1;CCL2;ACKR3
prerank,aorta development (GO:0035904),0.4505146049146107,1.0791215853149303,0.3807763401109057,0.7677350836054703,1.0,6/14,15.43%,ROBO1;EFEMP2;PDGFRB;HECTD1;PKD2;LRP1
prerank,modulation by symbiont of host process (GO:0044003),-0.4601977918426856,-1.0791010172668434,0.38125,0.7505403866842314,1.0,5/10,16.38%,PGK1;UBB;B2M;UBA52;ENO1
prerank,membrane raft organization (GO:0031579),0.43964827710822263,1.0788018350418296,0.36046511627906974,0.7678406386491541,1.0,5/15,13.15%,ANXA2;S100A10;NPC1;MYADM;FLOT2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3065701477332538,1.0787959313205038,0.31098430813124106,0.7670839931798217,1.0,16/100,9.92%,PTPN13;PDGFRA;FN1;SELP;FGFR1;OSM;DCN;NEDD4;ROR1;KIT;HAX1;PDGFRB;STAMBP;IL18;PIK3R5;PTPN6
prerank,synaptic membrane adhesion (GO:0099560),-0.4176633481153731,-1.0785912519219423,0.35913978494623655,0.750992571453902,1.0,7/14,19.14%,PTPRD;LRRC4C;LRRC4B;SLITRK2;LRFN5;SLITRK1;NTNG1
prerank,cellular component assembly (GO:0022607),0.27409636406312277,1.0782850590000779,0.301143583227446,0.7676753506437004,1.0,50/253,15.44%,KMT2A;DPYSL3;PAWR;LAMC1;SPTBN1;PARVA;CALD1;TEAD1;QRICH2;WNT3A;SHROOM2;MYO1B;FLNC;BAIAP2L1;MYO9A;CDAN1;ST13;CREBBP;FBLIM1;YAP1;WNT5A;SNX9;RSPH9;SYCP2;TEAD2;LIMA1;RHOQ;MNAT1;TAPBP;TUBGCP4;PPID;DNM1L;NLGN2;GORASP2;WDR19;EPPK1;HFE;TEX12;TUBGCP2;WASF1;WASL;RTN4;RHOU;GEMIN5;BAIAP2;MDM4;ILK;PML;TOGARAM1;P3H4
prerank,membrane depolarization during action potential (GO:0086010),-0.35270296256523104,-1.0774999433596928,0.3340961098398169,0.7530716665739282,1.0,10/26,11.45%,KCNJ2;SCN1A;SLC8A1;SCN2A;CACNA1G;HCN2;YWHAH;CACNA1D;SCN8A;SCN9A
prerank,positive regulation of protein metabolic process (GO:0051247),0.2978476520898156,1.07720693920133,0.32716927453769556,0.7698081369528819,1.0,20/110,12.83%,ROCK2;SMURF2;IL23R;SLC6A9;NEDD4;DACT1;IL17D;NR1H3;GSK3B;WNT5A;IL18;TIPARP;SLC25A37;NKD1;WWP2;HUWE1;MAP2K5;CSF1;ASB5;HECW2
prerank,regulation of melanin biosynthetic process (GO:0048021),0.486381481108388,1.076986024633815,0.408203125,0.7696494711478583,1.0,2/10,10.16%,ZEB2;APPL1
prerank,positive regulation of viral process (GO:0048524),0.33024792987436924,1.076640447236204,0.348159509202454,0.7697974675439033,1.0,14/60,16.11%,AXL;POLR2D;PPARA;KPNA6;STAU1;PPID;POLR2C;TMEM39A;ADAR;IFIT1;SRPK1;TARBP2;POLR2F;PKN2
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.4475125846938255,-1.0760224828071965,0.38016528925619836,0.7551257210795739,1.0,6/11,24.22%,INPP5K;IMPA1;IMPA2;INPP5J;INPP5B;SYNJ1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.4475125846938255,-1.0760224828071965,0.38016528925619836,0.7551257210795739,1.0,6/11,24.22%,INPP5K;IMPA1;IMPA2;INPP5J;INPP5B;SYNJ1
prerank,neutrophil activation involved in immune response (GO:0002283),-0.2245074816689786,-1.0756682119513643,0.22033898305084745,0.7550087683656321,1.0,92/428,16.34%,PTPRB;ATP8A1;PECAM1;PTPRJ;LRRC7;CST3;ATP6V0A1;HSPA8;RAB27A;PTPRN2;ACTR10;CD93;ATP11B;CTSC;CTSB;STK10;SNAP25;FTH1;STOM;DOCK2;PSMC3;HEXB;TSPAN14;FTL;EEF1A1;ATP11A;HMGB1;PKM;PRG2;PRCP;HSP90AB1;SRP14;CTSD;ATP6V0C;EEF2;KPNB1;SCAMP1;CEACAM1;SDCBP;TNFRSF1B;PSMD3;PSMD14;CTSS;B2M;ALDOC;DYNC1H1;MLEC;ARL8A;RHOG;QPCT;NEU1;FCER1G;HMOX2;GDI2;PSMD6;CD53;NBEAL2;NFASC;DBNL;CAPN1;FRMPD3;ATP6V1D;GPI;GUSB;SYK;HRNR;ACLY;HSP90AA1;GRN;PGLYRP1;TNFAIP6;RAB5C;TMEM30A;CYBB;TMBIM1;LAIR1;TUBB4B;PLAUR;GM2A;PNP;ARHGAP45;PPIA;CFP;PGAM1;RAC1;PTPRC;LAMP1;QSOX1;RAP1A;FUCA2;CEP290;ATP6AP2
prerank,innate immune response (GO:0045087),0.2753202780212335,1.07508453340029,0.2964376590330789,0.7731858798033474,1.0,39/217,15.23%,STYK1;SP100;CXCL10;COLEC12;CXCL16;TRIM56;TRIM10;IL23R;FER;BPIFB1;CRP;TLR4;TRIM17;TRIM5;NOS2;BST2;NUB1;RIPK2;PHB2;PJA2;TLR2;ANKRD17;IFITM1;PTK2;IFNLR1;TRIM21;IFI27;TRIM26;ADAR;RARRES2;TIFA;IFIT1;ANKHD1;SRPK1;RNF39;FRK;TBK1;IFIH1;PML
prerank,response to ATP (GO:0033198),-0.38692147724337844,-1.0747269006164373,0.3739130434782609,0.7567843881666472,1.0,3/18,4.64%,TRPC3;ABCC9;RYR3
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.3304628148309468,-1.0739643653253863,0.3544973544973545,0.7579684256075743,1.0,16/37,31.49%,ANKRD13A;ATXN2;PINK1;SDCBP;SIRT5;AP1AR;PAX2;BRCA1;RIN3;MTMR2;EDNRB;ANKRD13B;EDN1;WDR54;TFAP2A;MT3
prerank,response to steroid hormone (GO:0048545),0.3692192272327736,1.0738662529726972,0.3517915309446254,0.7756951257198884,1.0,5/31,9.69%,TFPI;ATP1A2;NR1H3;YAP1;CATSPER4
prerank,regulation of intracellular signal transduction (GO:1902531),0.26094155638218736,1.0737285562111951,0.2885057471264368,0.7753075103480185,1.0,55/420,9.48%,ARHGAP29;PTPN13;PDPK1;ARHGAP6;AKAP13;TIAM2;ARHGAP21;ARHGAP10;NRK;ARHGAP20;PRKAG2;ARHGAP18;FGF1;PRKAA2;ZFAND6;TPTE;DLC1;AKAP12;ARHGAP32;ARHGAP28;FGD4;TRIP10;ARHGAP12;TRAF5;PRDM11;TAOK3;WRN;NEK8;ARAF;PTPN22;RAD50;OPTN;MYO9A;BIRC3;CPNE1;WWC2;RHOF;FAM13B;FBXO9;TAGAP;RALBP1;PLEKHG2;WNT5A;ARHGEF11;MAP2K6;SYDE1;PJA2;LRRK2;STK3;ARHGAP26;RHOQ;DLG1;ARHGEF12;TAF7;GMIP
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.33299201439577775,-1.0735663069121026,0.3444976076555024,0.7580078128598802,1.0,12/32,31.75%,CDK17;CDK14;CDK15;POLA1;HINFP;CDC45;E2F7;CDK5;PCNA;CCNE1;KLF11;CDC6
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.4078691317913126,1.0734914879714,0.3870967741935484,0.7743850892536311,1.0,6/23,11.55%,ZEB2;TGFB1I1;CREBBP;CDKN2B;RNF111;SMAD4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.4078691317913126,1.0734914879714,0.3870967741935484,0.7743850892536311,1.0,6/23,11.55%,ZEB2;TGFB1I1;CREBBP;CDKN2B;RNF111;SMAD4
prerank,presynapse organization (GO:0099172),-0.45766916629664023,-1.0729885221179711,0.4036885245901639,0.7585865495815743,1.0,4/10,10.52%,NLGN1;LRRTM3;NLGN3;DVL1
prerank,anterior/posterior pattern specification (GO:0009952),0.3367369113869709,1.072815460656985,0.34796238244514105,0.7754827747978209,1.0,12/53,15.81%,WLS;HOXC6;HOXC4;BMP2;TGFBR1;TIFAB;SKI;HEYL;BHLHE41;SMAD2;HOXB4;ACVR2B
prerank,regulation of cell division (GO:0051302),0.3181500729139524,1.0726271742094804,0.33384146341463417,0.7752218887035502,1.0,20/72,19.96%,FGF1;MLLT3;POU5F1;NCOA3;PLK5;KLHL21;UVRAG;SUSD2;KLHL13;BCL2L1;FSD1;ENTR1;AHCTF1;TLE6;BIRC6;MYO19;TXNIP;NLRP5;SETD2;SIRT2
prerank,extracellular matrix assembly (GO:0085029),-0.36665923249349025,-1.0724956792309013,0.3680555555555556,0.7589753844478391,1.0,11/23,19.14%,NTN4;GPM6B;GAS6;MYH11;FBLN5;EMILIN1;RAMP2;QSOX1;MFAP4;NTNG2;NTNG1
prerank,regulation of RNA splicing (GO:0043484),-0.2897790583964508,-1.0720630228141625,0.3176470588235294,0.7592635967730919,1.0,12/69,9.37%,QKI;PIK3R1;MBNL1;KHDRBS2;SETX;PTBP1;KHDRBS3;RPS13;HNRNPK;HNRNPH2;AHNAK2;RPS26
prerank,sodium ion transmembrane transport (GO:0035725),-0.2742220396171765,-1.071867213049256,0.314540059347181,0.7587844685039571,1.0,12/84,6.66%,SLC6A6;SLC12A2;SLC9A2;SLC24A2;ATP1B1;SLC6A1;SCN1A;HCN1;ATP1A1;SLC8A1;SCN2A;HCN2
prerank,regulation of RNA export from nucleus (GO:0046831),0.48197726341205854,1.071809038255022,0.38461538461538464,0.7767076016450117,1.0,5/11,23.92%,TPR;IWS1;KHDRBS1;SETD2;DHX9
prerank,regulation of JUN kinase activity (GO:0043506),0.36711837677275094,1.0713620650048477,0.37305699481865284,0.7771876612484749,1.0,8/33,12.74%,SASH1;DUSP10;TAOK3;PTPN22;PPEF2;HIPK3;MAP3K7;DVL3
prerank,regulation of cellular localization (GO:0060341),-0.3133640760329389,-1.070962059664772,0.3087071240105541,0.7603315199993229,1.0,19/46,21.03%,EFNA5;EPHA5;HSP90AB1;WWC1;REEP5;PINK1;CAMK2D;DYNC1H1;LYN;DVL1;FES;HSP90AA1;LRP5;BRSK2;MAP2;PPM1F;SPAG5;TRIM46;MAD1L1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4630356874896989,-1.070907590370202,0.375,0.7594651629883675,1.0,5/10,21.28%,ESR1;PSMC3;HMGB1;PSMC6;PSMC5
prerank,TOR signaling (GO:0031929),-0.35146502495091675,-1.0706459771676657,0.3721461187214612,0.7591830291053645,1.0,5/26,7.95%,PRR5L;RPS6;CCDC88A;AKT1;PINK1
prerank,B cell homeostasis (GO:0001782),-0.45772193209660383,-1.069740172302031,0.37160751565762007,0.7607934362108922,1.0,4/10,13.42%,MEF2C;DOCK10;LYN;CAMLG
prerank,regulation of leukocyte activation (GO:0002694),-0.4137683684991229,-1.0689651335017936,0.36268343815513626,0.7620442066844463,1.0,5/14,21.33%,MFHAS1;CD74;LYN;MYO18A;MIF
prerank,regulation of protein sumoylation (GO:0033233),0.4236692214178418,1.0688878872992957,0.351985559566787,0.7832037814048551,1.0,3/17,8.29%,ZMIZ1;HDAC4;PIAS1
prerank,arachidonic acid metabolic process (GO:0019369),0.3587450339730054,1.0688508005778703,0.38144329896907214,0.7825194112313594,1.0,7/35,15.71%,PTGS1;PLA2G4A;PLA2G4C;ALOXE3;EPHX1;EPHX2;PTGES2
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.34094073968600863,-1.0686962094119643,0.3615023474178404,0.7618474645955227,1.0,13/30,31.46%,HMGCS1;NSDHL;SQLE;INSIG1;ACLY;HSD17B7;DHCR7;MVD;LSS;MSMO1;DHCR24;IDI1;PLPP6
prerank,regulation of macrophage differentiation (GO:0045649),0.43913471515142183,1.068080673087018,0.39892665474060823,0.7839621802239712,1.0,4/15,16.27%,IL34;PTPN2;CSF1;INHA
prerank,cellular response to ketone (GO:1901655),0.3583102091550228,1.0680673138834305,0.36486486486486486,0.7832186975005722,1.0,9/35,17.60%,ROCK2;ADCY5;ADCY1;KLF9;MAP4K1;NR3C1;GNG2;ADCY6;PCK2
prerank,cellular response to organic cyclic compound (GO:0071407),0.289931170499801,1.0680177530009314,0.3351278600269179,0.7825805936580325,1.0,16/141,8.73%,RORA;TFPI;ATP1A2;ROCK2;DIAPH1;IGFBP5;NCOA3;ADCY5;SSH1;CTNNA1;ADCY1;SPIDR;CCL2;IL18;FAM210B;LRRK2
prerank,modification-dependent protein catabolic process (GO:0019941),0.276588980608142,1.0676640028853446,0.32,0.7827492578658611,1.0,35/193,15.19%,RNF213;SPSB1;SMURF2;RNF217;FBXO11;TRIP12;NEDD4;TTC3;RC3H1;RNF19A;SIAH2;SPSB4;ANAPC11;DTX3L;NTAN1;RNF20;KLHL15;RNF111;NUB1;UBR4;ANAPC1;AMFR;UBE2C;FBXL7;KEAP1;CUL3;BTRC;ARRB1;CDC27;RNF43;BFAR;FBXL4;UBE2R2;BIRC6;RCHY1
prerank,phospholipid metabolic process (GO:0006644),0.318103645365763,1.067363039803639,0.3328100470957614,0.7828138795334914,1.0,10/71,12.99%,SMPD3;PLA2G4A;PLPP3;APOA2;AGPAT4;PLA2G4C;PLPPR3;ENPP2;AGPAT3;PIP4K2B
prerank,cell differentiation in hindbrain (GO:0021533),-0.45421158071541057,-1.0672675802009568,0.3603411513859275,0.7648436805996962,1.0,1/11,0.36%,GRID2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3152058715201442,-1.0671174321324635,0.3560606060606061,0.7642638453060104,1.0,16/40,17.31%,SGIP1;HIP1;INSR;AHI1;SCYL2;HNRNPK;LDLRAP1;B2M;VEGFA;ATAD1;CBL;SFRP4;CCL19;EGF;NTF3;TBC1D5
prerank,neutrophil mediated immunity (GO:0002446),-0.22217039675181272,-1.066981397025019,0.2231404958677686,0.7636282239481724,1.0,92/432,16.34%,PTPRB;ATP8A1;PECAM1;PTPRJ;LRRC7;CST3;ATP6V0A1;HSPA8;RAB27A;PTPRN2;ACTR10;CD93;ATP11B;CTSC;CTSB;STK10;SNAP25;FTH1;STOM;DOCK2;PSMC3;HEXB;TSPAN14;FTL;EEF1A1;ATP11A;HMGB1;PKM;PRG2;PRCP;HSP90AB1;SRP14;CTSD;ATP6V0C;EEF2;ACE;KPNB1;SCAMP1;CEACAM1;SDCBP;TNFRSF1B;PSMD3;PSMD14;CTSS;B2M;ALDOC;DYNC1H1;MLEC;ARL8A;RHOG;QPCT;NEU1;FCER1G;HMOX2;GDI2;PSMD6;CD53;NBEAL2;NFASC;DBNL;CAPN1;FRMPD3;ATP6V1D;GPI;GUSB;HRNR;ACLY;HSP90AA1;GRN;PGLYRP1;TNFAIP6;RAB5C;TMEM30A;CYBB;TMBIM1;LAIR1;TUBB4B;PLAUR;GM2A;PNP;ARHGAP45;PPIA;CFP;PGAM1;RAC1;PTPRC;LAMP1;QSOX1;RAP1A;FUCA2;CEP290;ATP6AP2
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.48904384451695593,1.0665999983794812,0.4044265593561368,0.782557932976077,1.0,5/10,18.27%,WRN;SLX4;ERCC1;DNA2;SMARCAL1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.48904384451695593,1.0665999983794812,0.4044265593561368,0.782557932976077,1.0,5/10,18.27%,WRN;SLX4;ERCC1;DNA2;SMARCAL1
prerank,t-circle formation (GO:0090656),0.48904384451695593,1.0665999983794812,0.4044265593561368,0.782557932976077,1.0,5/10,18.27%,WRN;SLX4;ERCC1;DNA2;SMARCAL1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.4433852206257338,-1.066566547995104,0.3918918918918919,0.7637916132281795,1.0,2/11,4.28%,SLIT2;CCN3
prerank,negative regulation of TOR signaling (GO:0032007),0.36384114204881135,1.0665597055217306,0.3717728055077453,0.7819203957598744,1.0,8/36,14.82%,DEPTOR;RNF152;PRKAA2;FNIP1;SESN1;TBC1D7;NPRL3;MAPKAPK5
prerank,secretory granule organization (GO:0033363),0.47774756706753996,1.066462289598696,0.4110898661567878,0.7814255330368983,1.0,4/10,14.52%,F2RL3;DTNBP1;ABCA1;SRGN
prerank,protein mannosylation (GO:0035268),0.39468775405312234,1.0664080483795615,0.37573385518590996,0.7808008481516483,1.0,5/22,7.08%,TMTC4;TMTC1;LARGE1;RXYLT1;POMT2
prerank,regulation of autophagy (GO:0010506),0.2716951521634119,1.0663637468131726,0.31954887218045114,0.7801459090539096,1.0,37/216,14.31%,LEPR;ITPR1;RNF152;PRKAG2;PRKAA2;NUPR1;SNX6;DCN;NEDD4;DAPK1;BCL2;MTDH;PTPN22;KLHL22;HAX1;OPTN;MCL1;MTMR3;TRIM5;PIK3C2A;GSK3B;LRRK2;TLK2;TPCN1;KEAP1;DNM1L;FOXO3;TRIM21;SLC38A9;DAPK2;EEF1A2;PIP4K2B;CSNK2A2;ATP6V0B;WDR6;TICAM1;USP36
prerank,glycosaminoglycan catabolic process (GO:0006027),0.32683745474941706,1.0662742427442866,0.37083993660855785,0.7796103939693819,1.0,10/55,12.46%,GPC6;HSPG2;CEMIP2;SDC2;DCN;OMD;PRELP;GPC2;LYVE1;ARSB
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.487815723810051,1.0660922450292754,0.398406374501992,0.7793767137161701,1.0,4/10,15.19%,WNT3A;WNT5A;WNT2;RYK
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3203522383777587,-1.0659282240302088,0.36553524804177545,0.7646024842396111,1.0,9/39,9.32%,CHRM3;FGF12;FXYD5;HOMER1;UTRN;YWHAH;TRPC6;NEDD4L;CACNA1D
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.4813917156098414,1.065757814560731,0.3996212121212121,0.7795077009251251,1.0,1/11,1.08%,SP100
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.3764776715556764,-1.065643564373503,0.37844036697247707,0.76436450516065,1.0,3/21,1.42%,PRKCH;SLC39A10;PRKCB
prerank,cilium assembly (GO:0060271),0.2659063221966241,1.06415116503897,0.31157635467980294,0.7832428215377953,1.0,78/296,22.26%,DCDC2;TNPO1;NINL;PARVA;SPATA6;CYS1;DYNLL1;ASAP1;ALMS1;ARL13B;SDCCAG8;RFX3;IFT88;ARL3;CLASP1;IFT57;TTC39C;HYLS1;ARF4;TMEM107;CEP152;EXOC2;DYNC2I1;DNAAF1;NPHP1;CCDC13;C2CD3;HAUS8;RSPH9;DYNC2LI1;IFT81;NUDCD3;CC2D2A;NEDD1;CDC14A;CCDC57;IQCB1;RAB3IP;RPGRIP1L;WDR19;CFAP221;IFT20;TRAPPC14;FBF1;CCDC66;NPHP3;ACTR1A;RFX2;CPLANE1;CEP250;TOGARAM1;GBF1;AVIL;EXOC7;EXOC1;TTBK2;YWHAE;GAS8;IFT52;RPGR;TTC21B;WDR11;KIF3C;ARL6;B9D2;CCDC39;CEP131;TRIP11;SSX2IP;CEP78;CEP63;OFD1;DZIP1L;CFAP410;RP2;ACTR3;LZTFL1;PKD1
prerank,regulation of cellular senescence (GO:2000772),-0.3400388925387702,-1.0640266075321918,0.35365853658536583,0.7680220476984092,1.0,7/28,11.51%,YPEL3;CDK6;YBX1;RBL1;B2M;ABI3;EEF1E1
prerank,N-glycan processing (GO:0006491),0.40485024526341923,1.0636472669509813,0.3694390715667311,0.7838870608580327,1.0,3/18,2.99%,MAN1C1;PRKCSH;MAN2A1
prerank,embryonic hemopoiesis (GO:0035162),0.4505181816450511,1.063025987839359,0.39194139194139194,0.7848666544398784,1.0,5/12,14.02%,KMT2A;KIT;TGFBR2;SH2B3;THOC5
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.33784088158481035,-1.0629143427959478,0.3621495327102804,0.7702206324056007,1.0,7/30,15.12%,H3-3A;PKN1;HDAC6;TRIM68;HDAC1;KDM4C;PARK7
prerank,ERBB signaling pathway (GO:0038127),0.3227112404947834,1.0628180370362195,0.3731117824773414,0.7847303700630582,1.0,7/64,6.78%,PDPK1;EFEMP1;DGKD;TGFA;PLCE1;MVP;PIK3C2A
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.448391234261143,1.0625673393649597,0.39552238805970147,0.784641666772437,1.0,3/13,6.49%,POU5F1;NFATC4;PPARA
prerank,renal absorption (GO:0070293),-0.4545693586140616,-1.0623905443085222,0.3696581196581197,0.7706979079992451,1.0,3/10,11.84%,KLHL3;SLC15A2;KCNQ1
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.3639335182896634,-1.062216222897193,0.37757437070938216,0.7701867961572347,1.0,10/23,22.24%,HSPA4;SAMM50;TIMM8B;HSP90AA1;BMF;MAIP1;TIMM22;NDUFA13;BAD;TIMM10
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.3269368814640713,-1.0621354693010843,0.35436893203883496,0.7694271850445854,1.0,14/36,24.60%,INTS7;CLSPN;DOT1L;MAP3K20;ATM;HINFP;CDC45;RAD1;CHEK1;ATRIP;DONSON;ATR;FBXO6;RHNO1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.35047388302609656,1.0620715922476485,0.369281045751634,0.7851705003686127,1.0,18/42,19.88%,MBD2;ANP32E;HNRNPC;VPS72;GATAD2B;CECR2;SRCAP;ACTL6A;ERCC6;HDAC2;SMARCA4;SMARCC1;CHD8;ARID1B;CHD4;ACTR8;NASP;INO80
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.2922139604458576,1.0620379066543186,0.3509272467902996,0.7845252234251606,1.0,19/118,8.91%,PHLDB2;SH3D19;SP100;PID1;STAT2;PHIP;SDC2;DAG1;NEDD4;RC3H1;IL6;CLASP1;PHLDB1;BCL9L;GSK3B;CAPZB;FMNL2;LRRK2;EPHA4
prerank,Notch signaling pathway (GO:0007219),0.3212080349366461,1.0619963071023502,0.36550632911392406,0.783871756148918,1.0,12/59,12.14%,RBPJ;NOTCH2;GMDS;DTX4;BMP2;DTX1;DTX3L;CREBBP;STAT1;PBX1;HEYL;MAML2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3465889439007396,-1.0619912579330788,0.36754176610978523,0.7688556813199036,1.0,8/25,11.79%,CTNNA3;RYR2;CALM1;NOS1AP;CALM3;CAMK2D;CAV1;FGF13
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.41870233965759474,-1.061967733900893,0.3921971252566735,0.767900443319396,1.0,6/13,36.04%,TMSB4X;HEY1;PER2;SOX11;HEY2;DDIT3
prerank,neutrophil degranulation (GO:0043312),-0.22283529970474608,-1.0618747098582149,0.24347826086956523,0.767172342810398,1.0,91/425,16.34%,PTPRB;ATP8A1;PECAM1;PTPRJ;LRRC7;CST3;ATP6V0A1;HSPA8;RAB27A;PTPRN2;ACTR10;CD93;ATP11B;CTSC;CTSB;STK10;SNAP25;FTH1;STOM;DOCK2;PSMC3;HEXB;TSPAN14;FTL;EEF1A1;ATP11A;HMGB1;PKM;PRG2;PRCP;HSP90AB1;SRP14;CTSD;ATP6V0C;EEF2;KPNB1;SCAMP1;CEACAM1;SDCBP;TNFRSF1B;PSMD3;PSMD14;CTSS;B2M;ALDOC;DYNC1H1;MLEC;ARL8A;RHOG;QPCT;NEU1;FCER1G;HMOX2;GDI2;PSMD6;CD53;NBEAL2;NFASC;DBNL;CAPN1;FRMPD3;ATP6V1D;GPI;GUSB;HRNR;ACLY;HSP90AA1;GRN;PGLYRP1;TNFAIP6;RAB5C;TMEM30A;CYBB;TMBIM1;LAIR1;TUBB4B;PLAUR;GM2A;PNP;ARHGAP45;PPIA;CFP;PGAM1;RAC1;PTPRC;LAMP1;QSOX1;RAP1A;FUCA2;CEP290;ATP6AP2
prerank,cellular response to alcohol (GO:0097306),0.3514286312602142,1.061587880351436,0.3747927031509121,0.7842452004450396,1.0,8/42,7.41%,GRAMD1C;ADCY7;ADCY5;CTNNA1;ADCY1;KLF9;SPIDR;MAP4K1
prerank,response to cAMP (GO:0051591),-0.32113276036697364,-1.0615428958660331,0.3695090439276486,0.7670869583070735,1.0,8/37,11.84%,AKAP6;HCN1;SLC5A5;INPP5K;RAPGEF2;HCN2;PDE2A;KCNQ1
prerank,dopaminergic neuron differentiation (GO:0071542),-0.377711084645762,-1.0614473956094168,0.3886138613861386,0.7663282670010018,1.0,4/19,10.66%,CTNNB1;VEGFA;LRP6;MANF
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.35556023499809347,-1.0611464645106667,0.375,0.7662575999631422,1.0,8/25,22.93%,ANKRD13A;ATXN2;SDCBP;RAC1;RIN3;ARF6;MTMR2;ANKRD13B
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3390196307992778,-1.0604633277587414,0.35910224438902744,0.7671399221727889,1.0,3/31,1.93%,DLG2;LRRC7;LIN7A
prerank,signal transduction in response to DNA damage (GO:0042770),-0.3043427200445567,-1.0600881275976257,0.3252032520325203,0.7671739685381429,1.0,17/49,24.60%,ACER2;INTS7;CLSPN;DOT1L;MAP3K20;ATM;HINFP;CASP9;RAD1;CHEK1;E2F7;BCL3;ATRIP;DONSON;ATR;FBXO6;RHNO1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.4268333183740709,1.0598564940646313,0.4102079395085066,0.7882607534351089,1.0,3/15,9.60%,CMPK2;ENTPD7;AK5
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.2670203862314066,-1.0597858821162913,0.33121019108280253,0.7670757867427056,1.0,20/88,10.37%,EXOC6;HSPA8;SORCS1;FTH1;SORL1;FTL;SH3GL2;GOPC;DOP1B;CLINT1;EXOC4;CLVS1;AP1S1;SCAMP1;STXBP6;SCAMP2;AP1S2;STEAP2;CORO7;KLHL20
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.4027147668871323,-1.0597235468312551,0.3864628820960699,0.7662780211940513,1.0,7/15,14.57%,TMSB4X;KDR;MET;LGMN;VEGFA;FGF2;PRKD1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.3807413458141112,-1.0596486633957194,0.37757437070938216,0.7655169282911214,1.0,6/17,5.51%,ATP1B1;RYR2;ATP1A1;GJC1;GJD3;SLC8A1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3662888855770678,1.0594333363031745,0.35,0.7885935012030507,1.0,7/33,8.93%,KANK2;DACT1;PLK5;CDKN2B;CCL2;CDC73;DLG1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.34096426290433746,1.05942752161781,0.39865996649916247,0.7878493378441892,1.0,4/47,6.37%,WNT4;ROCK2;CRY1;ATP2B4
prerank,gluconeogenesis (GO:0006094),-0.3189617898816974,-1.0592019100366876,0.3448275862068966,0.7658467296149856,1.0,15/39,21.97%,PGK1;ALDOC;SLC39A14;TPI1;GPI;MDH1;ATF4;PGAM1;ENO1;PER2;SLC25A13;CRTC2;GAPDHS;SLC25A12;MDH2
prerank,regulation of cellular respiration (GO:0043457),-0.38112218031705913,-1.0589596595026969,0.38018433179723504,0.7655834489274576,1.0,4/17,8.32%,PRDM16;CBFA2T3;IFNAR1;PRELID1
prerank,regulation of interleukin-10 production (GO:0032653),0.3505037854750638,1.0585059142928859,0.35800344234079173,0.789605474565643,1.0,8/44,8.19%,IL23R;IL6;TLR4;PRKCZ;FOXP3;CD47;LGALS9;CD274
prerank,macrophage activation involved in immune response (GO:0002281),-0.4182360915024474,-1.058375460618716,0.3632286995515695,0.7663022109483925,1.0,4/13,12.87%,PLCG2;DYSF;SYK;GRN
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.46016533846916463,-1.0583199086748285,0.3905579399141631,0.7654814205931081,1.0,5/10,8.13%,CST3;NOTCH1;EMILIN1;FAP;TNFRSF1B
prerank,necroptotic process (GO:0070266),0.42778758448698107,1.0580171198165893,0.41404805914972276,0.7901207934344754,1.0,6/16,21.57%,TLR4;LY96;DNM1L;TICAM1;TRPM7;RIPK1
prerank,vasculature development (GO:0001944),0.42788523777045967,1.0578390171927974,0.40655105973025046,0.7898243845644262,1.0,4/16,5.76%,PDGFRA;CDH5;ERRFI1;PDGFRB
prerank,activation of adenylate cyclase activity (GO:0007190),0.35657225154396577,1.057835781128631,0.35906040268456374,0.7890790842788181,1.0,6/35,9.05%,LGR4;ADCY7;ADCY5;RXFP2;ADCY1;ACR
prerank,positive regulation of protein phosphorylation (GO:0001934),0.2586854255209082,1.0574992126258873,0.3094384707287933,0.7892772361304642,1.0,73/348,16.27%,LEPR;TEC;BMP6;ROCK2;VTN;PRKAG2;FGF1;DDR2;GHR;FPR2;WNT3A;BMPR1A;OSM;IL11;NRP1;IL34;FAM20A;TWSG1;ITGA5;VEGFD;ANGPT1;BMP2;SLCO3A1;IL6;BMP7;ARAF;TGFBR1;CCND3;STOX1;HAX1;RAD50;PELI2;ATP2B4;CREBL2;RALBP1;FBH1;BMP8B;OPRD1;SNX9;TNFRSF14;RIPK2;LRRK2;IGF2;DOCK7;RAP2C;MUSK;FGF18;FNIP1;PTK2;ENPP2;SMAD4;CSF1;DVL3;ARRB1;RARRES2;HFE;EFNA1;MTCP1;BDNF;GDF11;NTRK3;TBK1;P2RY1;PRKD2;ILK;STK4;IQGAP1;GDF15;DAB2;CNOT9;AXIN2;APP;INHA
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.389242695402937,1.0573180841467378,0.3843478260869565,0.7889993063364173,1.0,5/24,9.42%,ENPP1;SORBS1;EPM2AIP1;GSK3B;IGF2
prerank,peroxisomal membrane transport (GO:0015919),-0.3499297333037755,-1.0570765587269848,0.35362997658079626,0.7680635757047698,1.0,12/27,26.85%,ABCD4;ATAD1;PEX26;GDAP1;PEX10;ABCD2;PEX16;PEX19;PXMP4;PEX3;RAB8B;PEX11B
prerank,neural crest cell migration (GO:0001755),0.35345962389532043,1.0568196760561144,0.37755102040816324,0.789611714416004,1.0,4/36,2.87%,SEMA3D;FN1;RADIL;NRP1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.48371108705739346,1.0566397534548932,0.4072727272727273,0.7893423910590703,1.0,1/10,0.48%,ATP1A2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.35479272789243166,-1.0564730725452947,0.38028169014084506,0.7687975384336525,1.0,4/26,3.56%,EFNA5;ANO1;EPHA5;KLF7
prerank,regulation of immune response (GO:0050776),0.28892789713541783,1.0563555038909518,0.3448275862068966,0.7893848392158552,1.0,14/135,10.33%,CXADR;RSAD2;COL3A1;COLEC12;ICAM4;ADCY7;PTPN22;APPL2;BIRC3;FOXP3;VCAM1;IFITM1;APPL1;ERAP1
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.3025480951917299,-1.0563028000022499,0.32151898734177214,0.7683144689166497,1.0,6/48,8.95%,PDE4D;PDE4B;SLC7A5;IL1R1;CYRIB;ZFPM1
prerank,substrate-dependent cell migration (GO:0006929),0.43672386543588454,1.0556535807855119,0.3885819521178637,0.7905686403851695,1.0,4/14,7.91%,NRP1;EPHA8;NTN1;ITGA11
prerank,DNA metabolic process (GO:0006259),0.2647511045853797,1.0555287406058915,0.3167082294264339,0.7901745369579072,1.0,67/270,20.64%,TCF7L2;SP100;PDS5B;DCTPP1;ORC5;POLH;TERT;WRN;PARP3;TOP1;SLX4;RAD50;UBE2U;POLA2;TOP2B;PRIM2;RFC1;POLG;NTHL1;DDX23;MNAT1;PSME4;SUMO1;UVRAG;NABP1;RAD51B;XRCC1;RPA3;MCM4;GMNN;RBBP8;ADPRS;OGG1;SUPV3L1;MCM6;INTS3;GTF2H4;RAD9A;ALKBH1;PDS5A;ORC3;ERCC5;DNASE1L1;MGMT;ORC4;ERCC1;AXIN2;DDX21;USP45;KMT5C;LRWD1;FANCC;RAN;DNA2;PARP4;RNASEH1;SMARCAL1;DFFB;RIF1;XPC;CTC1;INO80;USP7;KMT5B;NSMCE3;NABP2;LONP1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.4706777882897831,1.0553633817606198,0.38943248532289626,0.7898434427092221,1.0,1/10,0.34%,SOX5
prerank,cell junction organization (GO:0034330),0.31320478113617767,1.0553076129777403,0.35968992248062015,0.7892335378763886,1.0,9/71,7.67%,SDK1;SDK2;SMAD3;CXADR;FLNC;MYO9A;LRP4;FBLIM1;CLDN1
prerank,response to tumor necrosis factor (GO:0034612),0.30135837625095097,1.0553065207689951,0.3443609022556391,0.7884865944322286,1.0,9/91,8.11%,PID1;ADAMTS12;ZFAND6;GBP2;CXCL16;AFF3;GSDME;CCL2;NUB1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.4511901032809551,-1.0548526080110407,0.4,0.7714905729579837,1.0,5/10,34.46%,CALM1;CALM3;GPR35;CBARP;DRD3
prerank,T cell migration (GO:0072678),0.452863016496017,1.05479287100521,0.3951612903225806,0.7891152300685119,1.0,2/13,1.78%,CXCL10;CXCL16
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.3774932228687358,1.0544918090084843,0.37949640287769787,0.7891742751509384,1.0,5/27,11.62%,CTPS1;RRM1;NUDT13;AK5;RRM2B
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.31976966357173064,1.053794481832874,0.37089201877934275,0.7902838460814089,1.0,10/60,13.59%,TCF7L2;CDK8;TNRC6B;IL6;BAX;TNRC6A;MOV10;ATF7IP;MED12;MED20
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.4883591067752572,1.0536805785568297,0.4217557251908397,0.789815004765269,1.0,1/10,1.08%,SP100
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.37221613530359865,-1.053455030351081,0.38496583143507973,0.7746164620253674,1.0,9/19,35.32%,BAG6;DDIT4;PYCARD;BCL3;HIPK2;CDIP1;TP53;TMEM109;AEN
prerank,peptidyl-serine phosphorylation (GO:0018105),0.28453223915594145,1.0531859829948957,0.35994587280108253,0.7903624702810566,1.0,36/153,17.63%,PDPK1;ROCK2;CAMK1D;STK32B;STK39;IKBKE;TOP1;LATS2;TGFBR1;PRKCZ;MORC3;TGFBR2;MAP4K1;GSK3B;LRRK2;TLK2;AKT3;HIPK3;MAPK14;RPS6KA3;MAPK9;MASTL;MAP3K13;CSNK2A2;WNK1;EIF2AK3;TBK1;MAPKAPK5;PRKD2;STK4;PKN2;RICTOR;TTBK2;SMG1;MKNK2;DMPK
prerank,regulation of sequestering of triglyceride (GO:0010889),0.4421330102209832,1.0529123292765716,0.40264650283553877,0.7903039137336406,1.0,5/15,22.93%,OSBPL8;PPARA;PLIN3;ABHD5;OSBPL11
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.2613086972442813,-1.0527842489094843,0.33440514469453375,0.7756182925495032,1.0,21/98,12.61%,SLCO1C1;THBS1;INSR;NSF;SNCA;PPARD;AHI1;SCYL2;CHCHD2;ECE1;AKT1;IFNAR1;PRELID1;VEGFA;ATAD1;GHITM;ACE2;KLF4;ACACA;SFRP4;ACLY
prerank,regulation of cytokine production (GO:0001817),0.29029533500291976,1.0524734561463005,0.3658872077028886,0.7907872332900743,1.0,16/126,7.50%,LGR4;EIF2AK2;TRIM56;TWSG1;PLA2R1;ANXA1;IGF2BP1;ZBP1;DTX4;IL6;CRP;C5AR2;FOXP3;NOS2;CD47;LGALS9
prerank,ventricular septum development (GO:0003281),0.3486957641956513,1.0521341149376582,0.3805601317957166,0.7909355001606343,1.0,11/37,14.40%,ROBO1;TGFBR3;BMPR1A;TGFBR1;SALL1;TGFBR2;HEYL;SMAD4;HECTD1;NOG;MDM4
prerank,DNA replication initiation (GO:0006270),0.3580299358314709,1.0520860856140037,0.37966101694915255,0.7903036361074517,1.0,10/37,16.78%,ORC5;POLA2;PRIM2;RPA3;MCM4;GMNN;MCM6;ORC3;ORC4;LRWD1
prerank,cellular modified amino acid catabolic process (GO:0042219),0.42516108043854545,1.0518688396005205,0.4180790960451977,0.7901268333492041,1.0,6/15,21.36%,GGACT;ALDH4A1;SARDH;DPEP1;PRODH;HOGA1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3101955507032273,1.0517348773667452,0.3536776212832551,0.7897309821886943,1.0,22/72,21.06%,POLR2D;CUL4A;RFC1;CCNH;MNAT1;CDK7;XRCC1;TCEA1;RPA3;POLR2C;PRPF19;POLR2F;GTF2H4;ERCC6;ERCC5;ERCC1;GTF2H2;UVSSA;USP7;POLR2K;ERCC8;POLD3
prerank,glycolytic process (GO:0006096),-0.3386502446181727,-1.0516332302783093,0.38848920863309355,0.7778291703388999,1.0,9/28,19.65%,PGK1;PKM;ALDOC;TPI1;GPI;PGAM1;PGAM4;ENO1;GAPDHS
prerank,regulation of vasculogenesis (GO:2001212),-0.40189481028821694,-1.0515164569159392,0.39919354838709675,0.7771816843453211,1.0,7/14,15.61%,KDR;CD34;EMP2;RAPGEF2;CEACAM1;HEY1;RAP1A
prerank,lamellipodium organization (GO:0097581),-0.3316045869764272,-1.0513270787096671,0.38046272493573263,0.7767741416986482,1.0,8/29,14.95%,PARVB;SPATA13;ARHGEF6;CCDC88A;S1PR1;PTPRO;ARHGEF7;RAC1
prerank,dephosphorylation (GO:0016311),0.28218753367560395,1.051268761105599,0.360054347826087,0.7902593417084662,1.0,33/147,12.80%,PTPN13;PLPP3;TPTE;PPM1E;PPM1A;DUSP10;PTPN14;DUSP28;PTPN4;PTPN3;PTPN22;PTPRA;MTMR3;PTPN9;SSH1;DUSP16;PTPN21;PPP4R2;PPEF2;CTDSP2;PLPPR3;PPP4R1;NT5C;PTPN6;DUSP5;PPM1B;PPP1CB;PTPRU;PPP3CB;PTPN1;PTPN18;FBXW11;BTRC
prerank,serine family amino acid catabolic process (GO:0009071),0.4782262830941551,1.0507674599795271,0.4300202839756592,0.7908389336474612,1.0,2/10,7.60%,SHMT1;AMT
prerank,endoderm formation (GO:0001706),-0.3175565259869513,-1.0506184040355864,0.3669064748201439,0.7777786199808372,1.0,9/35,9.44%,COL8A1;ITGA4;SOX17;LAMA3;COL12A1;MMP15;SOX7;COL6A1;ITGA7
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3629727034922041,-1.0499901128799891,0.4107142857142857,0.7786186080844117,1.0,4/22,9.32%,GRM3;CAP2;GABBR2;CACNA1D
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.43055691445597416,-1.0496582127792164,0.40585774058577406,0.778548627558136,1.0,5/12,15.22%,LY6E;SNX3;MID2;IFITM3;IFITM2
prerank,recombinational repair (GO:0000725),0.30845307497917795,1.0493534468051335,0.39156626506024095,0.793789063697324,1.0,16/77,12.08%,NUCKS1;WRN;TONSL;SLX4;RAD50;FBH1;SPIDR;SFR1;AP5Z1;NABP1;RAD51B;XRCC1;RPA3;RFWD3;RBBP8;NSMCE2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.41206613759260485,1.04933559393992,0.4042145593869732,0.7930931490139361,1.0,8/18,22.96%,RFX3;ODAD4;DNAAF1;NPHP3;SPEF2;CCDC39;OFD1;DNAAF4
prerank,regulation of erythrocyte differentiation (GO:0045646),0.36645529239478053,1.0492632007662681,0.37735849056603776,0.7925227874848618,1.0,8/35,11.67%,STAT5B;ARNT;BRD1;STAT1;FAM210B;MAFB;MAPK14;FOXO3
prerank,protein K48-linked ubiquitination (GO:0070936),0.3263445340298078,1.0492417543928751,0.40279937791601866,0.7918530866446953,1.0,14/54,15.90%,RNF152;TTC3;RNF216;DTX3L;AMFR;UBE2C;FBXO38;IFI27;CUL3;UBE2Q2;UBE2E3;BFAR;UBE2R2;RNF146
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.4417708049142965,-1.048807436819672,0.40976645435244163,0.7800095288287222,1.0,6/11,20.72%,MERTK;GAS6;CXCL12;CCL19;NOD2;HCLS1
prerank,regulation of protein secretion (GO:0050708),0.28784889674536956,1.048308500062832,0.35520684736091296,0.7935601762169228,1.0,14/119,10.80%,BMP6;DPP4;RAPGEF4;RSAD2;ITPR1;RFX3;APBB1;IL6;UNC13B;NOS2;CACNA1C;DNAJC1;PPID;DNM1L
prerank,regulation of cellular component organization (GO:0051128),-0.24867816992215952,-1.0482728512934478,0.3023255813953488,0.7805507818074808,1.0,30/135,15.71%,NRG3;HIP1;HSPA8;TFRC;NET1;RIT2;SEMA4D;PRKCQ;HIP1R;FAM107A;DAB2IP;RAPGEF2;PAK5;ERMN;CEACAM1;STK11;PINK1;SSRP1;CAMK2D;SPOCK1;ANKRA2;BCAR1;HSP90AA1;RAB5C;DCUN1D5;PAK4;PARK7;SLITRK2;RAP1A;IRGM
prerank,regulation of protein polymerization (GO:0032271),0.36101762706733986,1.048194077494496,0.3838383838383838,0.7931230786840507,1.0,6/35,6.99%,ARHGAP18;ARHGAP28;HAX1;RASA1;DBN1;PLEKHG2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.411688047052838,-1.0481722522027388,0.4164859002169197,0.7798548980009016,1.0,8/13,23.67%,RPL26;SPRED2;ATM;EEF1E1;SPRED3;MSX1;SPRED1;ATR
prerank,positive regulation of cartilage development (GO:0061036),0.41558718678153,1.0480316310311417,0.4010791366906475,0.7928479036551936,1.0,3/17,4.65%,SOX5;BMP2;BMP1
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.4470719634159126,1.048023702907931,0.4057142857142857,0.7921394705947754,1.0,4/12,11.97%,IL34;BST2;PTK2;CSF1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.40717268076649504,1.0476217011745679,0.3917525773195876,0.792497146676399,1.0,2/18,4.25%,ENPP3;IFI35
prerank,negative regulation of apoptotic process (GO:0043066),0.2531808742023895,1.0475927193784522,0.34522439585730724,0.791863877131514,1.0,79/444,15.68%,PDPN;FHL2;FSTL1;ARHGAP10;RNF213;TLE1;AXL;NOTCH2;OSR1;PRKAA2;IL31RA;ZFAND6;NUPR1;GATA6;IL6ST;PHIP;PRAP1;SNX6;NFATC4;SH3RF1;ITGA5;ANXA1;ANGPT1;CFLAR;IL6;BCL2;ARAF;MTDH;HAX1;SIAH2;MCL1;BIRC3;ARF4;ANXA4;RASA1;CTSH;GLO1;CCL2;GSK3B;YAP1;NGFR;WNT5A;ANXA5;RIPK2;PHB2;UBE2Z;NAA16;USP47;SMAD6;DNAJC3;HIPK3;EGR3;FNIP1;PTK2;GRK5;BCL2L1;NAA15;DSTYK;MAP2K5;RPS6KA3;TJP1;API5;CBX4;OPA1;TMEM14A;SUPV3L1;BFAR;CSNK2A2;BDNF;IFIT3;NUAK2;VHL;BIRC6;NIBAN2;ERCC5;HDAC2;FIGNL1;MGMT;KDM2B
prerank,regulation of ERAD pathway (GO:1904292),-0.42748666125812246,-1.0474787963420091,0.4091816367265469,0.7808933435618033,1.0,6/11,27.47%,AQP11;BAG6;USP13;ATXN3;TMEM259;HERPUD1
prerank,regulation of interleukin-12 production (GO:0032655),0.33320446794317504,1.0474752510505574,0.3957307060755337,0.7914394489172021,1.0,9/47,10.75%,IL16;IL23R;TLR4;CD47;LGALS9;RIPK2;TLR2;MAPK14;IRAK3
prerank,regulation of sprouting angiogenesis (GO:1903670),0.36273007455810313,1.0469462156655247,0.3976311336717428,0.7920966652611168,1.0,10/33,12.64%,PDPK1;FGF1;CEMIP2;ITGA5;JMJD8;GLUL;FGF18;JAK1;EPN1;TJP1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.45421035443233426,1.046428681295375,0.40687160940325495,0.7928151206458207,1.0,2/13,4.62%,NFAT5;IL6
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.4638888303624972,1.0464099620227258,0.43664717348927873,0.7921278321597061,1.0,2/11,7.48%,STK39;ACTN2
prerank,positive regulation of type I interferon production (GO:0032481),0.310878276090172,1.0455315976588835,0.3965785381026439,0.7937719092714354,1.0,32/73,28.17%,TRIM56;ZBP1;TLR4;PTPN22;CREBBP;STAT1;POLR1C;RIPK2;TLR2;POLR3F;OAS2;POLR2F;TBK1;IFIH1;POLR3H;RNF135;DHX36;SETD2;POLR2K;GAPDH;RIOK3;DHX9;POLR3B;TOMM70;STAT6;POLR2H;CRCP;CGAS;ISG15;NFKB1;IRF7;PTPN11
prerank,protein modification process (GO:0036211),-0.27529997915992505,-1.0452970896737985,0.36901408450704226,0.7860860335709938,1.0,17/76,16.53%,ST8SIA4;CHRM3;ST3GAL6;CPE;MSRA;RPN2;FBXL2;MMP15;QPCT;SERP1;PIGH;UBA52;SEPHS1;PHEX;ERO1A;UBE2D3;PLOD2
prerank,response to ketone (GO:1901654),-0.3485506056655856,-1.044698406888449,0.40093240093240096,0.7867282776090173,1.0,4/24,2.52%,SLIT2;TGFB2;THBS1;ABHD2
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.32846546165832696,-1.04450031433325,0.38902743142144636,0.786295777804668,1.0,5/31,8.02%,HSPA8;TM7SF3;DAB2IP;HSPA14;HDAC6
prerank,toxin transport (GO:1901998),0.4750682451480617,1.0443370129741865,0.4139344262295082,0.7962009668361832,1.0,4/10,21.82%,ANTXR1;ANTXR2;SLC22A2;SLC22A3
prerank,regulation of apoptotic process (GO:0042981),0.24753049566257496,1.0437300925605246,0.3643243243243243,0.7970870362734567,1.0,95/676,11.70%,IGFBP3;PDPN;FHL2;PAWR;AKAP13;TIAM2;FSTL1;ARHGAP10;PHLDA1;CXCL10;AXL;NOTCH2;OSR1;PRKAA2;IL31RA;ZFAND6;NUPR1;GATA6;WNT10B;IL6ST;PHIP;PRAP1;FGD4;STEAP3;PNMA3;FBXO11;SH3RF1;ANXA1;IFIT2;ADAMTSL4;ZBP1;ANGPT1;DAPK1;CFLAR;BMP2;WRN;APBB1;IL6;BCL2;ARAF;PLK5;LATS2;MTDH;IFT57;HAX1;SIAH2;UNC13B;MCL1;BIRC3;TNFRSF12A;ARF4;ANXA4;CREBBP;RASA1;STAT1;CTSH;PLEKHG2;USP27X;GLO1;ACTN2;GSK3B;ANP32E;PDCD5;NGFR;WNT5A;ANXA5;BAX;ARHGEF11;TRIM24;QRICH1;RIPK2;CHM;PHB2;UBE2Z;CALHM2;STK3;NAA16;USP47;ARHGEF12;SMAD6;PTPN6;PPID;DNAJC3;HIPK3;SOS2;EGR3;NGEF;DNM1L;PTK2;GRK5;BCL2L1;NAA15;ANO6;FOXO3;DSTYK
prerank,B cell mediated immunity (GO:0019724),-0.44851704387375224,-1.0435637584276223,0.3983903420523139,0.7879911557365062,1.0,7/10,43.56%,CD74;FCER1G;CD27;TLR8;FCGR2B;CARD9;SLA2
prerank,embryonic limb morphogenesis (GO:0030326),0.3577416100576781,1.0435280442691195,0.38971807628524047,0.796857849086765,1.0,7/34,8.40%,OSR1;AFF3;GLI3;SALL1;CREBBP;SKI;CACNA1C
prerank,regulation of cellular response to heat (GO:1900034),-0.26916462712753275,-1.0428887554817114,0.36990595611285265,0.7889200822581547,1.0,26/77,26.30%,HSPA8;CD34;MAPK3;HSP90AB1;BAG1;CAMK2A;CAMK2D;HSBP1;CCAR2;AAAS;ATM;NUP93;AKT1S1;HSP90AA1;MAPT;RAE1;FKBP4;MLST8;NUP62;BAG4;ATR;NUP188;NUP54;CAMK2G;NUP210;NUP42
prerank,double-strand break repair (GO:0006302),0.2768039560093317,1.0427187123598383,0.383008356545961,0.7982745766340087,1.0,45/158,21.49%,EYA1;PARP9;NHEJ1;NUCKS1;WRN;APBB1;TONSL;PARP3;SLX4;RAD50;DTX3L;FBH1;SPIDR;SFR1;AP5Z1;BAZ1B;XRCC4;SUMO1;NABP1;RAD51B;XRCC1;RPA3;DCLRE1A;RFWD3;RBBP8;NSMCE2;KDM2A;PRPF19;UIMC1;ERCC5;ERCC1;DNA2;SMARCAL1;TDP2;ACTR8;RIF1;BRCC3;INO80;CYREN;NABP2;SMC6;PALB2;CHEK2;UBXN1;EYA3
prerank,aminoglycan catabolic process (GO:0006026),0.3717502654428499,1.0424336122027347,0.39829059829059826,0.7983226122242673,1.0,3/28,2.54%,GPC6;HSPG2;SDC2
prerank,regulation of microtubule depolymerization (GO:0031114),-0.3480313816164422,-1.0421538825110066,0.38095238095238093,0.7900476314551991,1.0,7/25,17.19%,NAV3;ARHGEF2;STMN2;MAP1B;FGF13;CLASP2;MID1IP1
prerank,positive regulation of cell motility (GO:2000147),0.2670647553549564,1.0421412102375476,0.3537234042553192,0.7983876311162441,1.0,23/205,6.89%,SEMA3D;PDPN;ROCK2;PDGFRA;FGF1;CXCL16;SYNE2;FAM110C;CDH5;FER;NUMB;SMIM22;BMP2;KIT;NTN1;WNT5B;TGFBR1;MMP14;FAM83H;EPHA1;PDGFRB;SEMA4B;CTSH
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3424233792427798,-1.0421336748679255,0.39663461538461536,0.7891152805116479,1.0,7/27,15.51%,DACH1;BMPR2;ACVRL1;ATM;FGF2;RGCC;CDKN1A
prerank,negative regulation of cell adhesion (GO:0007162),-0.2719624168274403,-1.041802591271022,0.37575757575757573,0.7891013727038353,1.0,17/72,13.00%,PLXNA4;PDE3B;ACER2;NOTCH1;CDH1;ACVRL1;SEMA4D;SEMA6A;TGFBI;ADAM22;NEXMIF;JAM3;ARHGDIB;SPOCK1;PTPRO;ARHGDIA;FZD4
prerank,eye photoreceptor cell differentiation (GO:0001754),0.4480820832445,1.041654808597029,0.4266666666666667,0.7989211197237059,1.0,1/12,0.29%,SDK2
prerank,positive regulation of cytokine production (GO:0001819),0.2602738985571693,1.0414794158073504,0.3808353808353808,0.7986464583711368,1.0,32/292,8.48%,SULF1;RORA;ROCK2;IL16;SPTBN1;EIF2AK2;IL6ST;APOA2;OSM;IL23R;PLA2R1;ANXA1;ZBP1;LACC1;ARNT;IL17D;IL6;TLR4;PRKCZ;PTPN22;SERPINE1;CREBBP;NOS2;GBP5;LGALS9;POLR1C;WNT5A;IL18;TNFRSF14;CD274;RIPK2;SETD4
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3763453390732556,1.0413838118424712,0.40683760683760684,0.7981500839149809,1.0,9/27,19.85%,TLR4;MAP3K1;LY96;TLR2;IRAK3;MAP3K7;TNIP1;CD36;TAB1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.42132078616298274,1.0410531887749,0.41834862385321103,0.7983296100483165,1.0,3/16,8.19%,IL23R;FOXP3;CD274
prerank,cortical actin cytoskeleton organization (GO:0030866),0.39642939941182265,1.0405996275607259,0.4235500878734622,0.7987511887574661,1.0,6/20,13.68%,ROCK2;FMNL2;RHOQ;DLG1;PLEK;LLGL2
prerank,peptidyl-proline modification (GO:0018208),-0.3449021588840828,-1.040454812617015,0.39473684210526316,0.792014670362384,1.0,8/25,24.62%,FKBP1A;FKBP7;PPIA;PPIB;FKBP4;NKTR;PPIL6;PPIL3
prerank,ureteric bud development (GO:0001657),0.41706386577855203,1.0404070393337865,0.411214953271028,0.7985214722822285,1.0,5/17,5.14%,OSR1;FOXC1;BMP2;BMP7;SALL1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.465674252674079,1.0401627384709418,0.45161290322580644,0.798426089608653,1.0,5/11,21.57%,COLEC12;SCARA3;TICAM1;UNC93B1;RIPK1
prerank,negative regulation of DNA replication (GO:0008156),0.4411156900814985,1.0401526624036401,0.42528735632183906,0.7977297087414633,1.0,5/13,16.74%,CDAN1;GMNN;TSPYL2;PDS5A;S100A11
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.363069859050577,1.0401153302188189,0.3927958833619211,0.7970960857215612,1.0,3/27,3.04%,SLC7A2;SLC1A3;SLC6A9
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.31609942827707516,1.0400657810996379,0.39456869009584666,0.7964929974772612,1.0,7/59,8.66%,TCF7L2;CDK8;TNRC6B;IL6;BAX;TNRC6A;MOV10
prerank,negative regulation of cytokine production (GO:0001818),0.27784464134495057,1.0398698249001186,0.3804945054945055,0.7962663808870611,1.0,31/163,15.06%,LGR4;FN1;AXL;APOA2;IL23R;TWSG1;ANXA1;ADCY7;IKBKE;IL6;TLR4;PTPN22;C5AR2;APPL2;RNF216;ANXA4;FOXP3;PPARA;LGALS9;CD274;PTPN6;NLRX1;IRAK3;MAP2K5;HOMER3;ATP2B1;ARRB1;SRGN;TBK1;IFIH1;RARA
prerank,autonomic nervous system development (GO:0048483),0.4158141068809199,1.039546597771636,0.40823970037453183,0.7964045447679137,1.0,2/17,2.87%,FN1;NRP1
prerank,endothelial tube morphogenesis (GO:0061154),0.4657902554449888,1.0393609135250048,0.4092741935483871,0.7961748685868203,1.0,2/10,2.50%,RBPJ;CCM2
prerank,copper ion homeostasis (GO:0055070),-0.38268822330761787,-1.0390727005392488,0.391025641025641,0.7950194201356426,1.0,9/17,34.36%,ATOX1;SLC31A1;SLC31A2;MT2A;CCDC22;COX19;ABCB6;XIAP;ANKRD9
prerank,maintenance of protein localization in organelle (GO:0072595),-0.3677780846558395,-1.038813041771769,0.39814814814814814,0.794831825897437,1.0,9/19,23.35%,AKT1;TAF3;PINK1;TAF8;HSPA5;ARL2;BCL3;CHCHD10;SKP1
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3987601387741679,-1.0387240909763986,0.44493392070484583,0.7940872647098688,1.0,3/15,2.60%,STOX2;TGFB2;CELF4
prerank,epiboly involved in wound healing (GO:0090505),0.42210371283188025,1.0380399850867479,0.40875912408759124,0.7988552664821177,1.0,1/16,0.30%,PDPN
prerank,keratinocyte differentiation (GO:0030216),0.36607180653807037,1.0379029003726252,0.4106529209621993,0.7984793202108363,1.0,10/29,21.59%,ANXA1;CLIC4;WNT5A;EPHA2;OPN3;TXNIP;CASP3;DSP;PIP5K1A;TGM1
prerank,regulation of mast cell degranulation (GO:0043304),0.42670615748527113,1.037692659035623,0.4318181818181818,0.7983298533130345,1.0,3/14,7.50%,GAB2;FER;LGALS9
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.34904114667016084,1.037429477490349,0.3904109589041096,0.7982726638956299,1.0,3/35,2.87%,PLXNA2;SEMA3D;NRP1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3247447324241912,1.0371994839831666,0.40342679127725856,0.7981660804839665,1.0,8/57,8.81%,LPAR1;FPR2;AKAP12;ADCY7;HRH3;ADCY5;ADCY1;INSL3
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3687015433014429,1.0371931261306877,0.410958904109589,0.7974715557644453,1.0,10/30,19.05%,PARP14;PRKCZ;PTPN2;MVP;PTPN6;SH2B3;CADM4;NF2;PPP2CA;DMTN
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2784324576808787,1.037101727484689,0.3950617283950617,0.7969785638219776,1.0,28/140,18.35%,LPAR1;PDGFRA;FPR2;ACKR2;CCR9;CD55;F2RL3;ADCY5;C5AR2;PLCE1;BDKRB2;SPPL3;ACKR3;CACNA1C;JPH1;GPR65;JPH3;CIB2;CACNA2D1;P2RY1;CXCR4;CCRL2;CCKBR;P2RX4;JPH4;TAC4;ABL2;GPR157
prerank,regulation of trophoblast cell migration (GO:1901163),0.4419031526352919,1.036642591548049,0.42213883677298314,0.7974367085893532,1.0,4/14,13.61%,SMURF2;GJA1;SYDE1;ACVR1C
prerank,oligodendrocyte differentiation (GO:0048709),-0.371880865487361,-1.0364135805132364,0.4054669703872437,0.799657694039959,1.0,8/19,33.71%,EIF2B2;SOX6;TPPP;PTPRZ1;CDK5;SLC8A3;PRDM8;SOX8
prerank,heart contraction (GO:0060047),0.3419392390896701,1.0363726638163588,0.4305993690851735,0.797434303944583,1.0,4/41,4.86%,TNNC1;ATP1A2;CSRP3;TPM1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.29453316131132423,-1.0362636918948767,0.4155495978552279,0.7990913837616597,1.0,13/50,15.12%,THBS1;GAS6;SNCA;ARL6IP1;AKT1;RFFL;VEGFA;PAX2;RPS6KA1;NGF;KLF4;PLAUR;PARK7
prerank,positive regulation of lyase activity (GO:0051349),-0.40043506826490916,-1.0361935805218434,0.42430703624733473,0.798297191700521,1.0,5/14,18.48%,NOS3;CACNA1D;NOS1;PARK7;AKAP5
prerank,phosphate ion homeostasis (GO:0055062),0.4716765613406883,1.0360334589751583,0.430939226519337,0.7975718084392831,1.0,1/10,1.24%,ENPP1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3704540252927211,1.035789193640261,0.38308457711442784,0.7975068695903473,1.0,2/27,4.34%,LPAR1;F2RL3
prerank,phosphatidic acid metabolic process (GO:0046473),0.3275400183292108,1.0355002223107421,0.38925081433224756,0.7975369063525564,1.0,7/48,11.36%,PLD1;PLA2G4A;AGPAT4;DGKD;PLA2G6;GPD1L;AGPAT3
prerank,aggrephagy (GO:0035973),0.37473780349546615,1.0351362793183796,0.40569395017793597,0.7977845178411511,1.0,4/27,4.16%,DYNLL1;VIM;ARL13B;IFT88
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.46955691277530465,1.0350995548801118,0.4296724470134875,0.7971637048004921,1.0,3/10,9.30%,DPYD;UPP1;NT5C
prerank,regulation of protein localization to membrane (GO:1905475),0.3701144732305849,1.0344481549150186,0.4182776801405975,0.7981750460288283,1.0,6/28,10.16%,GPC6;SPTBN1;MMP14;STX8;GPC2;APPL1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.39861009097838296,1.0339394017299774,0.4044943820224719,0.7987679916953232,1.0,2/20,4.04%,WNT4;BMP2
prerank,erythrocyte differentiation (GO:0030218),0.33914899895676975,1.0335886820402826,0.41883116883116883,0.7989585292260982,1.0,13/44,19.05%,TGFBR3;MPIG6B;KIT;UBA5;PTPN2;ACIN1;SH2B3;ALAS2;INHA;HSPA9;ATP5IF1;CASP3;DMTN
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4110510354435772,1.033301701896878,0.40925925925925927,0.7990045799267407,1.0,3/16,8.31%,ROCK2;IL6ST;MEF2A
prerank,monoacylglycerol metabolic process (GO:0046462),0.4315132854129258,1.0332044856473495,0.437847866419295,0.7985320851115921,1.0,3/13,12.39%,PLA2G4A;MOGAT3;DGAT2
prerank,proteoglycan metabolic process (GO:0006029),0.3776724680214822,1.0328148681566565,0.4176991150442478,0.7988705725542113,1.0,2/26,1.59%,SULF1;ADAMTS12
prerank,regulation of axonogenesis (GO:0050770),0.3267060573944085,1.0328023669032205,0.3950617283950617,0.7981969029263511,1.0,8/51,8.91%,PLXNA2;ROBO1;TIAM2;MAP6;LRP4;GSK3B;NGFR;EPHA4
prerank,microtubule depolymerization (GO:0007019),-0.3728798588099241,-1.032733524899166,0.41098901098901097,0.8074256330119802,1.0,8/17,28.28%,STMN2;KIF18A;NCKAP5;STMN4;STMN1;KIF14;STMN3;KIF19
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.32999544368737166,1.032701886638048,0.3878887070376432,0.7977699146603886,1.0,4/46,3.11%,PLD1;PLA2G4A;AGPAT4;DGKD
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.3642064215408927,-1.0323183863889194,0.41920374707259955,0.8075799257850176,1.0,7/20,24.62%,FKBP1A;PPIA;PPIB;FKBP4;NKTR;PPIL6;PPIL3
prerank,regulation of heart contraction (GO:0008016),-0.26003263879929633,-1.0322465586366811,0.38801261829652994,0.8068074121032416,1.0,25/90,15.98%,PDE4D;TGFB2;ATP1B1;ABCC9;RYR2;SMAD7;CALM1;ATP1A1;CALM2;RYR3;SLC8A1;ATP2A3;CALM3;CAMK2D;TBX2;NPR1;NOS1;ACE2;S100A1;KCNQ1;SRI;CASQ2;ATP2A2;ATP1A3;FXYD1
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.3084943482010424,-1.0322236984148594,0.41919191919191917,0.8058846942252239,1.0,7/38,13.66%,PTPRJ;PHLPP1;PLEKHA1;INPP5K;AKT1;RACK1;PPP2R5B
prerank,phospholipid biosynthetic process (GO:0008654),-0.3197659161081432,-1.0312503530533303,0.4132029339853301,0.8078278504187034,1.0,16/36,30.49%,SGMS1;SRD5A3;MBOAT1;PCYT2;NUS1;SGMS2;DOLPP1;CPNE7;AGPAT5;DHDDS;CLN3;HDHD5;FADS1;MVD;SAMD8;IDI1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3516699892178812,1.0311764678072295,0.42625607779578606,0.8010191551607942,1.0,9/35,15.74%,LEPROT;GHR;KIT;IL6;CRLF3;SH2B3;VHL;NF2;OCIAD1
prerank,phagosome maturation (GO:0090382),-0.31323575774225887,-1.0305660645385912,0.3894230769230769,0.8088634536601523,1.0,12/35,21.81%,ATP6V0A1;ATP6V1B2;ATP6V0C;RAB38;ATP6V1D;RAB39A;ATP6V0A2;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V0D2;RAB32
prerank,protein homotetramerization (GO:0051289),0.3281068554404106,1.0303704929587947,0.3978328173374613,0.8024517179569104,1.0,4/49,6.74%,ALDH1A2;SHMT1;APPL2;GBP5
prerank,vasoconstriction (GO:0042310),-0.4181557038909194,-1.030197101991749,0.44372294372294374,0.8089241160410527,1.0,3/11,6.19%,EDNRA;SLC8A1;ACTA2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.45860110203628557,1.0299572029885116,0.4324853228962818,0.8027921667857355,1.0,7/11,29.70%,WTIP;PUM2;AJUBA;XPO5;DHX9;STAT3;FMR1
prerank,sulfur amino acid catabolic process (GO:0000098),-0.43205878148429155,-1.0298361048583138,0.4396551724137931,0.8089896753861036,1.0,5/10,22.61%,TXN2;MTRR;CTH;ADO;MPST
prerank,catecholamine biosynthetic process (GO:0042423),-0.4277259993288443,-1.0297142487891568,0.39149888143176736,0.8083533768083638,1.0,4/11,10.02%,TGFB2;SNCA;DDC;GCH1
prerank,negative regulation of viral release from host cell (GO:1902187),0.43738912381111145,1.0295261069514532,0.41929499072356213,0.8032057415071385,1.0,6/13,19.51%,TRIM5;TRIM21;TRIM26;CHMP3;PML;TRIM8
prerank,macromolecule catabolic process (GO:0009057),0.3690040870767356,1.0294982480612243,0.42327150084317033,0.802577744098872,1.0,5/26,12.28%,NEDD4;CLN5;TRIM24;UVRAG;CLPX
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.4275862504516616,1.0294784986961922,0.4417744916820702,0.8019153582639613,1.0,6/15,16.67%,BMP2K;DGKD;AAK1;WASL;DAB2;NEU3
prerank,muscle organ development (GO:0007517),-0.28695146632021573,-1.0290474017578448,0.3900523560209424,0.8093342159115635,1.0,9/54,7.03%,MEF2C;DMD;SGCD;TEAD4;COL6A3;TBX1;UTRN;MKX;SOX6
prerank,mammary gland epithelium development (GO:0061180),0.4172186781412304,1.0289909539521074,0.43253234750462105,0.8024419402957866,1.0,3/14,13.02%,WNT4;EPHA2;WNT2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.3329699139890759,-1.0289491354101867,0.41204819277108434,0.8086286718728186,1.0,5/27,5.35%,CSGALNACT1;CSPG4;XYLT1;B3GAT2;CHST9
prerank,sodium ion homeostasis (GO:0055078),-0.3623036842933131,-1.0283818591373404,0.41594827586206895,0.8092126621608601,1.0,5/21,9.16%,SLC12A2;ATP1B1;ATP1A1;SLC8A1;NEDD4L
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.4354195746943784,1.0282424425423313,0.4247104247104247,0.8036167140244743,1.0,1/12,0.67%,ROCK2
prerank,negative regulation of insulin secretion (GO:0046676),-0.37613045237495174,-1.0274157363798773,0.43415637860082307,0.8110087740128518,1.0,4/17,14.73%,KLF7;CCN3;KCNB1;INHBB
prerank,monocarboxylic acid transport (GO:0015718),-0.2881232139807396,-1.0273992071481273,0.3922077922077922,0.8100721212454207,1.0,10/51,10.44%,ABCG2;ABCC4;SLCO1C1;SLCO2A1;SLC16A9;SLC5A6;CEACAM1;SLC16A1;ATP8B1;SLC16A7
prerank,mitochondrial translation (GO:0032543),-0.2521278584487739,-1.0272947114694704,0.3898809523809524,0.8093803591631048,1.0,46/104,35.90%,MRPL4;LARS2;GFM1;MRPS18A;MRPL1;MRPS30;MRPS23;EARS2;FASTKD2;MRPL57;MRPL28;RARS2;AURKAIP1;MTRF1;MRPL35;MRPL47;MRPS5;MRPL34;HARS1;MRPL23;MRPL9;MRPS31;MRPL52;MRPS2;MRPS12;TUFM;MRPL11;MRPL49;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;MRPL54;MRPL32;MRPL43;MRPL2;ERAL1;MRPL24;MRPL37;MRPL30;MRPL45;MTIF2;MRPS24
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4728036280538104,1.0265542469030562,0.44341372912801486,0.8073015697568292,1.0,4/10,13.27%,ANXA2;NELL1;EPHA4;EFNA1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.3304418927693447,1.0261192679402833,0.43431221020092736,0.8077400357473137,1.0,13/45,15.47%,SP100;GBP2;TRIM5;VCAM1;OASL;STAT1;OAS2;JAK1;TRIM21;TRIM26;PML;ICAM1;IRF9
prerank,positive chemotaxis (GO:0050918),0.4050217418898678,1.0260004291856617,0.41467889908256883,0.8073475664955182,1.0,3/17,3.81%,FPR2;NRP1;ANGPT1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3926415725054144,-1.025993211110756,0.4470338983050847,0.8121565371787905,1.0,4/15,12.61%,HMGCS1;HMGCS2;ACACA;ACLY
prerank,amide transport (GO:0042886),-0.33869440434265763,-1.025741997819757,0.3931034482758621,0.8118918523775355,1.0,6/26,6.71%,ABCG2;CERT1;SLC38A5;AQP11;SLC5A6;GLTP
prerank,cellular protein localization (GO:0034613),-0.22082702468352233,-1.025373419053315,0.32608695652173914,0.8119480513708667,1.0,70/285,18.82%,CNTNAP2;GRID2;ESAM;PTPRK;DMD;TBC1D8;CPE;NSF;SYNDIG1;REEP1;STX3;ID1;EMP2;ARF5;TBC1D30;FBLN5;AHI1;CTNNB1;ARHGEF2;STXBP1;RAB6B;CEP68;STX16;YWHAH;RIC3;RAB38;ARL1;AMOT;HERC2;TM9SF3;SCG5;CNTLN;HDAC6;JAM3;SGSM1;NPM1;TMED2;RRAGB;VPS33B;CNTN2;CD74;HHEX;ATG9A;MFN2;PIGU;PIGK;TBC1D22B;TBC1D14;CPLANE2;NAPA;TBC1D8B;RUNDC1;EGFR;RAB5C;EVI5;ABHD17A;SNX8;VIPAS39;TBC1D12;TMED7;DNAJC27;RABL3;BBS2;TBC1D5;RRAGC;AP3D1;RAB1B;ARF6;SAR1B;ARL4D
prerank,cellular response to glucagon stimulus (GO:0071377),0.4015147832731594,1.02523734088844,0.42495479204339964,0.8086129272492741,1.0,4/17,7.23%,GCGR;ADCY7;ADCY5;ADCY1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.46040457503129006,1.0251794167513388,0.427255985267035,0.8080629016854721,1.0,5/11,21.73%,NUPR1;BIRC3;SLC25A4;RIPK1;PELI1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.32354890836367106,1.0250570060468613,0.424483306836248,0.807688379680056,1.0,8/49,9.31%,APOA2;IL17D;IL6;TLR4;SERPINE1;NOS2;LGALS9;TLR2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.39859587399287555,1.025017071134254,0.4702702702702703,0.807075706101106,1.0,7/20,17.29%,STK39;OSR1;NEDD4;ACTN2;HECW2;ADRA2A;YWHAE
prerank,detection of mechanical stimulus (GO:0050982),-0.363240326481173,-1.0247251885983955,0.4367816091954023,0.8128155837251302,1.0,3/19,5.55%,PIEZO2;CDH2;CTNNB1
prerank,positive regulation of macrophage activation (GO:0043032),-0.37898676039756785,-1.0246978095654782,0.42298850574712643,0.811907143673021,1.0,4/17,12.29%,IL33;THBS1;KARS1;TTBK1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.45500677677718093,1.024617489440781,0.44573643410852715,0.8073953354120156,1.0,4/11,15.19%,WNT3A;WNT5A;WNT2;RYK
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3265861656194828,-1.024553147682706,0.43705463182897863,0.8113237031076707,1.0,8/32,17.36%,PRKCQ;NEK7;CTNNB1;MAPK3;ATM;PNKP;CCT5;PKIB
prerank,organelle transport along microtubule (GO:0072384),0.35806880147258646,1.0245338344189152,0.435,0.8068980440397125,1.0,10/31,22.87%,ARHGAP21;TRAK1;UXT;KIF5B;FBXW11;RHOT1;RHOT2;BORCS5;PEX14;COPG1
prerank,negative regulation of developmental growth (GO:0048640),-0.3207691072250958,-1.0245071458399604,0.41687979539641945,0.8104961259197347,1.0,10/30,20.17%,DIP2B;DCC;WWC1;SEMA3G;FGF13;ULK1;MAP2;CDKN1A;BBS2;TRIM46
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.4117423684237637,-1.0243661364570242,0.44008264462809915,0.809929404757548,1.0,4/12,13.53%,SIX1;VEGFA;PAX2;SIX4
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.30599611655352316,1.0239875996851955,0.4116719242902208,0.8075848228614609,1.0,6/67,3.68%,SULF1;ROCK2;AXL;NRP1;VEGFD;SHB
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4468399886083796,1.0233737577705393,0.41767068273092367,0.8084835476857842,1.0,4/11,9.11%,IGF2BP1;RASA1;NOVA1;IGF2BP2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.29215803898845943,1.0232408643933333,0.4153400868306802,0.8081431239244037,1.0,12/87,6.91%,ROCK2;PDGFRA;ARHGAP18;NOTCH2;DLC1;EPHA3;SMIM22;PDGFRB;RHOBTB2;RHOF;BST2;CELSR1
prerank,cellular response to unfolded protein (GO:0034620),-0.3360702202214713,-1.0232397322928763,0.4117647058823529,0.8120993210012596,1.0,4/26,5.41%,HSPA8;TM7SF3;DAB2IP;HSPA14
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.427200771663267,1.0231986135956876,0.4501915708812261,0.8075589018430094,1.0,3/13,8.66%,ZC3HAV1;RC3H1;MOV10
prerank,regulation of myotube differentiation (GO:0010830),-0.3422143139719926,-1.0230871172159812,0.4296482412060301,0.811592583677209,1.0,6/24,9.94%,NOTCH1;CCN3;ATP11A;HDAC9;SIK1;HDAC1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.41672248364978265,-1.0226466157725431,0.424507658643326,0.8118584105865904,1.0,3/12,9.47%,PLCG2;RAB27A;GRIN1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.2808651975115089,-1.022074434833039,0.3994708994708995,0.8125895585974765,1.0,19/57,20.27%,NOD1;MAP3K5;GRIN2A;PERP;GRIN2B;HMGB1;LGMN;CTSD;SOX7;GRIN1;MALT1;AIM2;TTBK1;SYK;FOXL2;PYCARD;PPM1F;NDUFA13;BAD
prerank,regulation of integrin activation (GO:0033623),0.4095743021570744,1.0220139521981662,0.4288389513108614,0.8099647710701953,1.0,3/15,10.63%,SELP;FBLIM1;PLEK
prerank,regulation of ERBB signaling pathway (GO:1901184),0.41549735510537933,1.02182707794033,0.43233743409490333,0.8097348400229976,1.0,4/15,12.37%,RBPJ;FER;CDH13;PTPN18
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.4708572617312021,1.021790913146795,0.44597249508840864,0.808419525208471,1.0,5/10,23.45%,SMPD3;PLA2G6;SIRT3;SPHK2;NSMAF
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.4708572617312021,1.021790913146795,0.44597249508840864,0.808419525208471,1.0,5/10,23.45%,SMPD3;PLA2G6;SIRT3;SPHK2;NSMAF
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.3633268449664613,-1.0217406457985012,0.4232456140350877,0.8125802310575956,1.0,4/20,21.41%,STARD3NL;FDXR;HSD17B10;CYP46A1
prerank,positive regulation of cellular component movement (GO:0051272),0.37027356695614316,1.021472098385292,0.42190305206463197,0.808550578678567,1.0,3/24,5.09%,PDPN;NTN1;TGFBR1
prerank,cellular respiration (GO:0045333),-0.3077914882902823,-1.0210769237306117,0.39119804400978,0.8135547258567386,1.0,17/41,35.92%,SDHC;ME3;NDUFS7;UQCRH;NR4A3;ATP5F1D;SLC25A13;MTFR1L;COQ10B;MDH2;UQCR10;COX4I2;NDUFS1;MTLN;CYCS;UQCRB;BLOC1S1
prerank,cellular response to superoxide (GO:0071451),-0.4396475929630125,-1.020871321565597,0.44967880085653106,0.8132175474028969,1.0,3/10,20.96%,NOS3;SOD1;PRDX2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.29301665193245446,-1.0207572281082005,0.41968911917098445,0.8125781448684187,1.0,9/52,5.94%,NOVA2;MBNL1;CELF4;KHDRBS2;RBFOX3;RBFOX1;PTBP1;KHDRBS3;PUF60
prerank,positive regulation of heart contraction (GO:0045823),0.3978655800031096,1.0203005254243602,0.4308510638297872,0.8109272739282284,1.0,3/19,8.38%,ATP1A2;ADM;SCN3B
prerank,arachidonate transport (GO:1903963),0.4636988136200945,1.020163986368711,0.4496124031007752,0.8099029760458364,1.0,3/10,16.00%,ANXA1;BDKRB2;PLA2G5
prerank,arachidonic acid secretion (GO:0050482),0.4636988136200945,1.020163986368711,0.4496124031007752,0.8099029760458364,1.0,3/10,16.00%,ANXA1;BDKRB2;PLA2G5
prerank,regulation of mast cell activation (GO:0033003),-0.4456994160336973,-1.020130211400881,0.46107784431137727,0.8134107034219584,1.0,9/10,52.45%,LYN;CD84;NECTIN2;TSLP;CD226;MILR1;PLSCR1;CD300LF;HAVCR1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.417949332567278,-1.0201258500221049,0.4407484407484408,0.8124531469080003,1.0,3/12,11.84%,PROM1;PTPRO;BASP1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.39188873783448985,1.0199713872866571,0.4134275618374558,0.8090109904850487,1.0,6/21,17.92%,CUL4A;RPA3;GTF2H4;ERCC5;ERCC1;GTF2H2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.39188873783448985,1.0199713872866571,0.4134275618374558,0.8090109904850487,1.0,6/21,17.92%,CUL4A;RPA3;GTF2H4;ERCC5;ERCC1;GTF2H2
prerank,regulation of lymphocyte migration (GO:2000401),-0.42929145188248935,-1.0193683654631776,0.45419103313840153,0.8136481752102311,1.0,3/10,7.35%,STK10;JAM2;AKT1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.4416071731993102,1.0189648540435843,0.44083969465648853,0.8108615503474145,1.0,4/11,10.64%,MLLT3;WNT5B;PLEKHA4;NKD1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3147292402250551,-1.0188943114805593,0.42995169082125606,0.8140601444282795,1.0,11/32,18.70%,NAV3;SNCA;ARHGEF2;STMN2;TUBB4A;FGF13;CLASP2;MAP2;MID1IP1;STMN1;FKBP4
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.4237382430480089,-1.0185994759419565,0.44467640918580376,0.813901598248948,1.0,5/11,16.85%,GFPT2;PGM3;GFPT1;RENBP;GNPNAT1
prerank,positive regulation of locomotion (GO:0040017),-0.3238854808374141,-1.0185141321971514,0.4327354260089686,0.81317455738793,1.0,3/27,3.26%,SPOCK2;THBS1;STX3
prerank,platelet aggregation (GO:0070527),0.3532733409244518,1.0176418457458165,0.436077057793345,0.8135655541598925,1.0,5/33,5.24%,PDGFRA;FN1;GP1BA;CSRP1;VCL
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.34442120218020505,1.0176320548413582,0.4312393887945671,0.8128877336428778,1.0,9/36,12.71%,TCF7L2;TNRC6B;FZD2;PLCB3;WNT5A;TNRC6A;MOV10;PPP3CB;MAP3K7
prerank,regulation of calcium ion transport (GO:0051924),-0.2857186162508114,-1.0173460345487362,0.40437158469945356,0.8154204090727758,1.0,12/54,12.55%,EPB41;CACNB2;HOMER1;CTNNB1;INPP5K;TRPC6;CAMK2A;MYLK;CACNA1D;NOS1;CD84;SRI
prerank,macrophage chemotaxis (GO:0048246),0.4592435210608785,1.0173352425329187,0.4538310412573674,0.8129978703658965,1.0,2/10,7.35%,CKLF;CCL2
prerank,regulation of protein localization to cell periphery (GO:1904375),0.39838988035476175,1.0173226335574814,0.44090056285178236,0.8123318308766797,1.0,5/18,10.16%,SPTBN1;MMP14;MISP;STX8;APPL1
prerank,myotube cell development (GO:0014904),-0.43533360019148615,-1.0171355628824532,0.4334677419354839,0.8150651631950487,1.0,3/10,10.18%,SIX1;SELENON;CAV2
prerank,fatty acid biosynthetic process (GO:0006633),-0.2742484403653682,-1.0170545617981013,0.4066265060240964,0.8143162565820449,1.0,33/63,43.67%,ELOVL5;ABHD2;ELOVL7;TECR;ACACA;ACLY;TECRL;SCD;ACSBG1;HACD3;LPL;HPGD;HSD17B8;MCAT;FADS1;LIPH;LIPC;ELOVL2;ALOX5;LIAS;CYP2E1;ACOT7;OLAH;GSTM4;CBR4;GPX4;ABCD1;DEGS1;LTC4S;ACSM3;ELOVL4;CYP1A1;ALOX12
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.36365638773306186,1.0167389598120407,0.41968911917098445,0.813182179223398,1.0,9/29,19.60%,CUL4A;CCNH;MNAT1;CDK7;RPA3;GTF2H4;ERCC5;GTF2H2;XPC
prerank,regulation of microtubule-based movement (GO:0060632),-0.4197494733651187,-1.0165438281743961,0.4282744282744283,0.8148554763548684,1.0,6/11,26.49%,HDAC6;NEFH;MAP2;LAMP1;HAP1;CCDC65
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.32084071827291344,1.0165172022709432,0.42207792207792205,0.8130560148799453,1.0,8/46,12.20%,TIMP3;FBLN1;DUSP10;TLR4;PTPN2;DLG1;SMAD4;PTPN1
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.2842910810385807,-1.015936599150024,0.42036553524804177,0.8156889110198275,1.0,14/54,14.09%,GPC5;HS3ST1;HS6ST2;HS3ST5;XYLT1;SDC3;B3GAT2;CHST9;EXT1;HS3ST2;GUSB;SGSH;AGRN;NAGLU
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.2973792805356253,-1.0155832513457002,0.434052757793765,0.8157934419975532,1.0,19/43,31.82%,FOXN3;MRE11;CLSPN;BABAM1;ATM;CDKN1A;BRCA1;CHEK1;DONSON;DTL;TAOK2;CDC14B;BLM;HUS1B;TOPBP1;CDK1;PLK1;CDC6;TICRR
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.35659925839594464,1.0154941662900792,0.44093178036605657,0.8150198211142303,1.0,3/32,4.34%,PDPK1;CXCL10;F2RL3
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.4313261611171334,-1.015251130177321,0.45569620253164556,0.8156959670713654,1.0,4/10,16.57%,DGKH;GAP43;PLPP1;HTR2B
prerank,nuclear export (GO:0051168),0.29951075221003864,1.0151511092823413,0.42792792792792794,0.8151478245626941,1.0,16/80,17.88%,RANBP3L;ATXN1;WASHC4;TPR;SLU7;SRSF4;EGR2;MAGOHB;STRADB;DDX39A;THOC5;POM121;SRSF5;RAN;LSG1;RANBP17
prerank,histone H4-K8 acetylation (GO:0043982),-0.3841300817649581,-1.0150876604934274,0.4584269662921348,0.8143445860329193,1.0,6/15,24.02%,JADE3;PHF20;JADE1;KAT7;ING4;MCRS1
prerank,histone H4-K5 acetylation (GO:0043981),-0.3841300817649581,-1.0150876604934274,0.4584269662921348,0.8143445860329193,1.0,6/15,24.02%,JADE3;PHF20;JADE1;KAT7;ING4;MCRS1
prerank,inorganic anion transport (GO:0015698),0.3214320489494135,1.0148574094422882,0.4479495268138801,0.815159710141418,1.0,12/53,14.99%,ENPP3;ENPP1;SLC13A4;SLC26A9;SLC4A11;CLIC4;ANO10;NMUR1;ANO6;ANO8;SLC26A6;SLC25A10
prerank,neuron projection organization (GO:0106027),-0.38025391953900367,-1.014263410483714,0.43018018018018017,0.8157516364381513,1.0,6/15,20.80%,INSR;LGMN;ABCD2;ATP1A3;CHRNA7;DCTN1
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3403130806094933,-1.0142189718397285,0.4439140811455847,0.8149355589600539,1.0,5/24,5.61%,DACH1;BMPR2;ACVRL1;RPS3;MSH3
prerank,negative regulation of viral life cycle (GO:1903901),-0.3930323500686066,-1.0142153043054212,0.43832599118942733,0.8139988675102657,1.0,6/15,15.22%,LY6E;SNX3;MID2;IFITM3;PPIA;IFITM2
prerank,mitochondrion localization (GO:0051646),0.38607284202749576,1.0140842888582482,0.4380610412926391,0.8164453582584469,1.0,6/19,15.88%,TRAK1;MEF2A;LRRK2;ATCAY;TLE6;MUL1
prerank,negative regulation of calcium ion transport (GO:0051926),0.4161149656713158,1.013954358031919,0.45604395604395603,0.8160838612460319,1.0,1/15,0.48%,ATP1A2
prerank,positive regulation of endocytosis (GO:0045807),-0.28817179895881334,-1.0136482762287604,0.43007915567282323,0.814662383248101,1.0,8/45,9.16%,NLGN1;SGIP1;HIP1;SNCA;HNRNPK;LDLRAP1;B2M;NEDD4L
prerank,regulation of dendrite development (GO:0050773),0.338993149491383,1.0134676731146348,0.4454225352112676,0.8166444329966023,1.0,7/37,7.53%,PTN;CAMK1D;SDC2;NEDD4;BMP7;DBN1;GSK3B
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.32788002695608154,-1.0134495351340669,0.41705069124423966,0.8142913990311077,1.0,12/27,28.10%,CD74;SPRED2;ATM;EEF1E1;PTTG1IP;SPRED3;MSX1;MIF;SPRED1;ATR;YJU2;PMAIP1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.35241753334412945,1.0134211446731975,0.4178082191780822,0.8160615891047781,1.0,7/31,10.02%,KANK2;DACT1;CDKN2B;CCL2;CDC73;DLG1;SUSD2
prerank,positive regulation of transport (GO:0051050),0.29411782156242594,1.013306734338505,0.432510885341074,0.8156637169308834,1.0,10/85,8.04%,KMT2A;CAMK1D;FPR2;APOA2;ANXA2;ANXA1;NR1H3;CD47;GSK3B;BAX
prerank,lysine catabolic process (GO:0006554),0.4353631570950543,1.013306439934993,0.45724907063197023,0.8142722803073734,1.0,2/12,6.29%,HYKK;PHYKPL
prerank,lysine metabolic process (GO:0006553),0.4353631570950543,1.013306439934993,0.45724907063197023,0.8142722803073734,1.0,2/12,6.29%,HYKK;PHYKPL
prerank,regulation of Notch signaling pathway (GO:0008593),0.2955877152557973,1.0133061103759546,0.4305343511450382,0.8135775087371453,1.0,11/76,7.75%,TSPAN5;RBPJ;ZMIZ1;IL6ST;BMP2K;DLK1;MMP14;AAK1;DTX1;CREBBP;YAP1
prerank,RNA processing (GO:0006396),0.2702025946926898,1.0132787431589836,0.4342629482071713,0.8129514268738823,1.0,45/176,19.23%,CELF2;RBMS1;ATXN1;TUT4;RBMS2;FASTKD5;SNRPA1;ZRSR2;LSM1;NOVA1;HNRNPH1;HNRNPC;SF3B3;DDX23;SLU7;RBM39;CDK12;RNPC3;SRSF4;DHX16;USB1;HNRNPH3;DHX8;ADAR;MAGOHB;SRPK1;ZMAT5;RBM6;RBM5;FUS;TENT2;PABPN1;CSTF3;SRSF5;HNRNPR;HNRNPA2B1;PPP2CA;NUFIP1;TUT7;SCAF11;WBP4;SNRNP40;PRPF3;USP39;KHSRP
prerank,negative regulation of autophagy (GO:0010507),0.31864090066756245,1.0132107232739125,0.44565217391304346,0.8124446530622974,1.0,8/54,9.54%,LEPR;NUPR1;BCL2;PTPN22;KLHL22;MCL1;LRRK2;TLK2
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.4028061536372717,-1.0128281536068844,0.45569620253164556,0.8150739266405008,1.0,4/12,20.24%,GNL3L;CCT5;GNL3;WRAP53
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.37566974784345075,1.0128224556305119,0.4399260628465804,0.8127815353134166,1.0,4/22,8.14%,APOA2;LACC1;WNT5A;TNFRSF14
prerank,protein-containing complex subunit organization (GO:0043933),0.2823755108899594,1.012692025211976,0.4366812227074236,0.8124112648855978,1.0,22/109,15.23%,KMT2A;LAMC1;TEAD1;TPR;ST13;CREBBP;YAP1;SNX9;TEAD2;MNAT1;TAPBP;TUBGCP4;PPID;DNM1L;WDR19;HFE;TUBGCP2;WASF1;WASL;GEMIN5;MDM4;PML
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3302788922261218,1.012524859093498,0.432258064516129,0.8121396301901661,1.0,12/47,17.06%,VTN;TIMP3;SERPING1;SERPINB7;SERPINE1;SERPINE2;TIMP2;SERPINB8;SERPINE3;RECK;ANXA8;ANXA8L1
prerank,negative regulation of organelle assembly (GO:1902116),0.3406431423149604,1.0124132230170335,0.4408783783783784,0.8117497868415778,1.0,13/35,16.77%,NUPR1;YAP1;LRRK2;TMEM39A;SMAD4;SCFD1;TBC1D7;CHMP4A;CHMP4B;RBM14;FEZ2;KAT2B;ODF2L
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.33325864949415973,1.0122468321175764,0.44901315789473684,0.8115139984988168,1.0,11/45,13.50%,SMAD3;FOXC1;PTPN3;BTG3;BMP7;PRCC;BTG4;ZWINT;NABP1;HECA;TOM1L2
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.40444408245390484,1.0121264048197225,0.4642857142857143,0.8111369444320166,1.0,8/16,22.28%,MIA3;VAPA;LRRK2;TAPT1;GBF1;SEC16A;ANK2;BCAP31
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.3770607295368509,-1.012078314444116,0.4551569506726457,0.8163902475125863,1.0,3/16,7.19%,BMPR2;PRCP;ACE
prerank,peptidyl-serine modification (GO:0018209),0.27034148902330596,1.0120718912526003,0.42990654205607476,0.8105643519248601,1.0,38/166,17.63%,PDPK1;ROCK2;CAMK1D;STK32B;STK39;IKBKE;TOP1;LATS2;TGFBR1;PRKCZ;MORC3;GALNT2;TGFBR2;GALNT1;MAP4K1;GSK3B;LRRK2;TLK2;AKT3;HIPK3;MAPK14;RPS6KA3;MAPK9;MASTL;MAP3K13;CSNK2A2;WNK1;EIF2AK3;TBK1;MAPKAPK5;PRKD2;STK4;PKN2;RICTOR;TTBK2;SMG1;MKNK2;DMPK
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4474559213730739,1.0120549935468166,0.4491362763915547,0.8085510141407803,1.0,7/11,30.79%,PANK2;ACAT1;PANK3;PPCS;DCAKD;COASY;PPCDC
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4474559213730739,1.0120549935468166,0.4491362763915547,0.8085510141407803,1.0,7/11,30.79%,PANK2;ACAT1;PANK3;PPCS;DCAKD;COASY;PPCDC
prerank,coenzyme A biosynthetic process (GO:0015937),0.4474559213730739,1.0120549935468166,0.4491362763915547,0.8085510141407803,1.0,7/11,30.79%,PANK2;ACAT1;PANK3;PPCS;DCAKD;COASY;PPCDC
prerank,membrane repolarization (GO:0086009),-0.38245837333452387,-1.0119669242919267,0.44,0.8157713590062778,1.0,6/15,13.12%,ATP1B1;KCNJ2;ATP1A1;KCND3;KCNQ1;KCNE4
prerank,regulation of macrophage activation (GO:0043030),0.36062052842865977,1.0118212502187012,0.44405594405594406,0.8084841104190463,1.0,6/30,8.56%,IL31RA;IL6;TLR4;NR1H3;WNT5A;PJA2
prerank,superoxide anion generation (GO:0042554),-0.41075406132738035,-1.0117878102440274,0.4419551934826884,0.815353096808639,1.0,9/13,43.67%,NCF2;CYBB;TAFA4;NOX4;NCF1;NOX3;NCF4;DUOX1;ALOX12
prerank,tetrahydrofolate metabolic process (GO:0046653),0.4498424166305415,1.0115360646912404,0.4497153700189753,0.8085335403587972,1.0,2/10,4.01%,SHMT1;MTHFD1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.2903637138542038,1.0110592223020396,0.4316546762589928,0.8090934984678116,1.0,16/94,12.82%,PDK1;ITPR1;CASP4;IKBKE;BCL2;MCL1;CUL4A;FHIT;BAX;QRICH1;STK24;BCL2L1;RRP8;CUL3;EPHA2;ERN2
prerank,response to hydrogen peroxide (GO:0042542),-0.2887241178431104,-1.0109888553593107,0.4217506631299735,0.8166156875334825,1.0,13/45,21.87%,NET1;MAP3K5;SETX;RPS3;PLEKHA1;RHOB;HDAC6;PAX2;SOD1;PARK7;ECT2;STK26;TRPM2
prerank,neutrophil migration (GO:1990266),-0.27911123134272886,-1.0109373875584609,0.4250681198910082,0.8158237453393947,1.0,10/58,15.27%,BSG;PECAM1;PDE4B;TGFB2;CCL14;FCER1G;PIK3CD;SYK;PPIA;CCL19
prerank,positive regulation of protein import (GO:1904591),0.3535609957936769,1.0101235910164768,0.462738301559792,0.8107551645431159,1.0,4/30,7.77%,SMAD3;ZIC1;TPR;PDCD5
prerank,import into cell (GO:0098657),0.32764613555868133,1.0098913407205257,0.44093178036605657,0.8106438786712247,1.0,5/41,3.96%,ATP1A2;SLC1A3;SLC6A13;SLC19A1;SLC16A2
prerank,positive regulation of T cell differentiation (GO:0045582),0.34395167064997156,1.0097642324667035,0.43973941368078173,0.8102871541319971,1.0,4/36,3.85%,ZMIZ1;GLI3;IL23R;DUSP10
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.3576640930613818,-1.009644181794934,0.45662100456621,0.8184950174890666,1.0,11/21,31.49%,PINK1;HDAC6;SIRT5;PAX2;ABCD2;PARK7;BRCA1;SLC18A2;SLC30A10;TFAP2A;MT3
prerank,negative regulation of macroautophagy (GO:0016242),0.3701363742556847,1.0096430726416565,0.4608695652173913,0.8099343118300002,1.0,9/26,17.17%,NUPR1;LRRK2;TMEM39A;SCFD1;CHMP4A;CHMP4B;USP36;FEZ2;SMG1
prerank,Ras protein signal transduction (GO:0007265),0.2758883055331267,1.009545098394386,0.4412171507607192,0.809509071550275,1.0,33/137,18.77%,ARHGAP29;PDPN;ARHGAP6;ROCK2;PLD1;KSR1;RRAS2;NTN1;PLCE1;CELSR1;NGFR;ARHGEF11;RALGDS;USP8;CDC42EP4;RAP2C;MAPK14;CDH13;COL1A2;SHOC2;BRAP;WASF1;SHC2;MAPKAPK5;LIMK1;ADRA2A;RIT1;FARP2;RAP2B;RAPGEF3;RASSF1;SOS1;SHC1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.437962150672237,-1.0095414711034207,0.44,0.8178748932541466,1.0,3/10,6.24%,IL33;KDR;NAMPT
prerank,regulation of mitochondrial fusion (GO:0010635),0.44321959768551344,1.009494577809102,0.44466403162055335,0.8089468807853071,1.0,3/11,15.88%,PID1;HUWE1;MUL1
prerank,regulation of viral life cycle (GO:1903900),0.38218652639591766,1.0084445520891325,0.45166959578207383,0.8109319087005437,1.0,4/21,11.79%,AXL;TRIM5;KPNA6;TRIM21
prerank,organic hydroxy compound transport (GO:0015850),-0.31117619932559976,-1.00823221680266,0.45363408521303256,0.8205637573988628,1.0,5/36,9.45%,ABCC4;SLCO1C1;CEACAM1;SLC16A1;ATP8B1
prerank,negative regulation of protein localization to membrane (GO:1905476),0.37262383634161284,1.0081557698561059,0.4501779359430605,0.8109830082650558,1.0,9/24,23.33%,PID1;NUMB;RHOQ;BCL2L1;DAB2;PPFIA1;DMTN;LZTFL1;TGFB1
prerank,response to organophosphorus (GO:0046683),-0.38159814835440903,-1.0080935645495168,0.45064377682403434,0.8200090178811361,1.0,2/16,2.03%,TRPC3;ABCC9
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.3900904614412446,1.0077697147379516,0.45585585585585586,0.8112547121311037,1.0,3/18,2.91%,ROCK2;KANK1;CDH5
prerank,regulation of blood circulation (GO:1903522),0.34377811771399364,1.0075507409519529,0.44276094276094274,0.8110833178827028,1.0,4/34,7.14%,CELF2;DES;TPM1;BDKRB2
prerank,muscle cell migration (GO:0014812),-0.4314192778335435,-1.0074276283628376,0.4759916492693111,0.8208884197327084,1.0,3/10,12.26%,SIX1;CCN3;MEGF10
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.4358539846636323,1.0074120501046835,0.4691119691119691,0.8107498247939037,1.0,3/13,10.63%,BMP2;DKK3;PLEK
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.27936973443853763,-1.0074068069976485,0.4296875,0.8200178417733273,1.0,27/57,33.73%,FOXN3;MRE11;CLSPN;BABAM1;CCND1;ATM;MDC1;CDK2;CDKN1A;BRCA1;CHEK1;DONSON;DTL;TAOK2;CDC14B;BLM;HUS1B;TOPBP1;TP53;CDK1;PLK1;MUS81;TICRR;NEK11;PRKDC;FBXO31;ABRAXAS1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.30414757686387756,1.007092754061113,0.4537037037037037,0.8108710236395729,1.0,11/64,11.13%,PLA2G4A;AIG1;ACSL1;PLA2G4C;ALOXE3;SCP2;SLC27A2;ACOT1;HACL1;EPHX1;SLC27A3
prerank,positive regulation of GTPase activity (GO:0043547),-0.2270120073415094,-1.0069764847679483,0.4448818897637795,0.8202093484346346,1.0,50/188,17.60%,DOCK9;ITGA6;BCAR3;RALGAPA2;ABR;TBC1D8;DOCK10;NET1;TIAM1;SEMA4D;ARHGEF15;TBC1D30;RAP1GAP2;RAB3GAP1;CCL14;RAPGEF2;RGS7;RGS6;CCDC125;SGSM1;ARHGAP27;RHOG;BCR;CAV2;RACK1;RALGAPA1;ARHGEF26;TBC1D22B;DOCK8;TBC1D14;RAPGEF6;ARHGEF7;CD40;ALS2;RGP1;TBC1D8B;RUNDC1;AGRN;F11R;HRAS;EVI5;ARHGAP45;SIPA1L3;CCL19;RAP1A;SNX18;TBC1D12;NTF3;TBC1D5;ARHGAP24
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.35537737880452036,1.0065959883644042,0.4283154121863799,0.8114376312409927,1.0,10/27,20.81%,CRP;NR1H3;PPARA;IL18;ABCA1;CSF1;MAPK9;PLA2G5;CD36;AGT
prerank,amino sugar biosynthetic process (GO:0046349),-0.4114893567433847,-1.0065118739208192,0.44142259414225943,0.8205890821178272,1.0,5/12,16.85%,GFPT2;PGM3;GFPT1;RENBP;GNPNAT1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.44531263715334557,1.006315937436204,0.4653846153846154,0.8114384024743297,1.0,3/11,7.50%,GATA6;BMPR1A;LGALS9
prerank,positive regulation of blood coagulation (GO:0030194),-0.3692934910777681,-1.0062971908262663,0.42919389978213507,0.8202706861206389,1.0,4/17,13.47%,THBS1;F3;USF1;ST3GAL4
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.23450244644010046,-1.0062829062478469,0.4351145038167939,0.8193683128069982,1.0,33/151,19.45%,SGMS1;ACER3;DMD;ELOVL5;ACER2;CERS4;CERT1;PPM1L;DEGS2;ELOVL7;PCYT1B;LPCAT2;GPHN;SPNS2;SLC44A5;ALAS1;GCH1;SGMS2;GCNT1;GSTM5;MFSD2A;ST3GAL4;PLPP1;PRKD1;HACD3;SGPP1;STARD7;GSTO2;SPTSSA;TYW5;LPIN3;GSTO1;CHKA
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.3288736164387936,1.0057189164621987,0.447098976109215,0.8123280977449808,1.0,7/42,7.53%,PLEKHA2;RIN2;NRP1;S100A10;EFEMP2;EPHA1;GSK3B
prerank,negative regulation of transferase activity (GO:0051348),-0.3281157077342227,-1.005645130042506,0.44254278728606355,0.8202365591826805,1.0,8/28,18.89%,SMAD7;INPP5K;TERF1;PARK7;MAPT;MEN1;CDKN1C;EIF4A2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.312899466710583,1.0055514985301868,0.4354587869362364,0.8120827182580835,1.0,10/56,12.05%,ROCK2;SPTBN1;ARL3;RASA1;STAMBP;SNX9;ESPL1;USP8;CECR2;RHOC
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.37699918096672413,1.0054068720250133,0.4838709677419355,0.8117614241661935,1.0,5/20,17.17%,TERT;SNIP1;TARBP2;ZC3H7B;PUM2
prerank,positive regulation of protein catabolic process (GO:0045732),0.28687209348637077,1.0053202133571089,0.46397694524495675,0.8113124835327163,1.0,15/84,12.83%,SH3D19;SMURF2;NEDD4;DACT1;NRDC;GSK3B;WNT5A;SNX9;TIPARP;NKD1;WWP2;HUWE1;VGLL4;ASB5;HECW2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.2972446212947861,-1.0051717323022296,0.4489795918367347,0.8206192290387468,1.0,11/37,15.12%,RPL5;RPS7;RPL11;HSP90AB1;SDCBP;BAG6;RYBP;CCAR2;RPL23;CAMLG;PARK7
prerank,negative regulation of catabolic process (GO:0009895),0.32023249141423243,1.0048941202439803,0.43729903536977494,0.8117372949180887,1.0,12/47,15.96%,NUPR1;APOA2;SNX12;PPARA;HDAC4;AZIN2;SF3B3;IRAK3;HCAR2;MDM4;ALK;ADRA2A
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3762791359205661,1.0048925474863795,0.46195652173913043,0.811067199994045,1.0,3/22,5.06%,AKAP13;EFEMP2;AEBP1
prerank,GPI anchor biosynthetic process (GO:0006506),-0.3293109298742074,-1.0044510998063505,0.4752252252252252,0.8217244338969898,1.0,8/30,15.68%,MPPE1;PIGU;PIGM;PIGK;PIGQ;PIGH;DPM2;PIGO
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.3310882507061167,-1.0044178001405955,0.43946188340807174,0.8208936038372322,1.0,10/26,17.77%,GRIN2B;MBP;PRELID1;GRIN1;LYN;AIM2;TTBK1;PSENEN;PSME1;PYCARD
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.40463251245118703,-1.0042790181783774,0.46296296296296297,0.8203547672346192,1.0,6/12,17.89%,SNCA;STMN2;TUBB4A;ARHGEF7;MAP2;STMN1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3539027479586397,1.0040418975384642,0.45166666666666666,0.8125807614490639,1.0,9/28,20.29%,PARP9;PARP3;DTX3L;ERCC6;SHLD2;KMT5C;RIF1;CYREN;KMT5B
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.31526923536166424,1.0039943056871858,0.45799011532125206,0.8120202357518193,1.0,18/53,24.14%,EYA2;EYA1;PLA2R1;FBH1;EYA4;HIC1;ERCC6;UIMC1;FXR2;BRCC3;ERCC8;DDX5;EYA3;NACC2;NSMCE1;CEBPG;DHX9;SMCHD1
prerank,negative regulation of telomere maintenance (GO:0032205),0.4139792256996712,1.0039873569213489,0.4584103512014787,0.8113669187181793,1.0,5/15,16.07%,SLX4;RAD50;SMG6;ERCC1;TNKS2
prerank,stress granule assembly (GO:0034063),-0.358418067678916,-1.003862225151169,0.4563758389261745,0.8205754891216178,1.0,5/20,15.58%,RPS23;ATXN2;YTHDF2;DYNC1H1;MAPT
prerank,positive regulation of exocytosis (GO:0045921),-0.31186114133082227,-1.0037373477166973,0.45083932853717024,0.8199938797749676,1.0,15/35,27.72%,RAB27A;CADPS;SNCA;RAB27B;SDCBP;CLASP2;EXPH5;SYTL4;RAB15;ATP6AP1;SNF8;CHMP2A;SDC4;UNC13D;HGS
prerank,ephrin receptor signaling pathway (GO:0048013),0.29010284237495326,1.003385517858421,0.4453125,0.8122710492876175,1.0,16/82,13.89%,EFNB2;ROCK2;EPHA7;EPHA3;SDC2;EPHA8;EPHA1;RASA1;EPHA4;DNM1;NGEF;PTK2;EPHA2;EFNB1;EFNA1;WASL
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.4414324260476505,1.0031672587994256,0.4851301115241636,0.8121396534898172,1.0,3/12,9.42%,SORBS1;PRKCZ;IGF2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.399462739588191,-1.0030226282270576,0.45376344086021503,0.8210772255145028,1.0,3/13,6.24%,IL33;KDR;NAMPT
prerank,limb development (GO:0060173),0.35542930060433203,1.0026778453146155,0.4462081128747795,0.8126789949120831,1.0,9/28,20.57%,GLI3;SALL1;LRP4;IQCE;NOG;KAT2B;PTCH1;RSPO2;MEGF8
prerank,positive regulation of innate immune response (GO:0045089),0.3548130914252283,1.0026467674583956,0.44065040650406506,0.8120917078769918,1.0,6/30,11.22%,FPR2;ZBP1;IFI35;GBP5;WNT5A;POLR3F
prerank,cellular response to light stimulus (GO:0071482),-0.26994877233747056,-1.0024064385051483,0.47297297297297297,0.8218996034309887,1.0,26/66,33.15%,PTPRK;RPL26;NPM1;YY1;ATF4;COPS9;CASP9;BMF;PDE6A;N4BP1;GPR88;NOC2L;POLD1;POLK;SAG;ATR;RHNO1;PCNA;MYC;PDE6G;TP53;RRH;TMEM161A;RUVBL2;OPN1MW3;OPN1MW
prerank,import into nucleus (GO:0051170),0.2969227201436882,1.001562048316017,0.4633093525179856,0.8140607576088533,1.0,11/73,14.67%,PRICKLE1;TNPO1;GEMIN4;APPL2;TPR;PHB2;APPL1;IPO7;EIF4ENIF1;GEMIN5;POM121
prerank,positive regulation of protein sumoylation (GO:0033235),0.45507850810115746,1.0014008907459304,0.46946564885496184,0.8137956744648468,1.0,3/10,15.88%,HDAC4;PIAS1;MUL1
prerank,cytoplasmic sequestering of protein (GO:0051220),0.42082512082290835,1.0013314223539396,0.46393762183235865,0.8132932604268479,1.0,7/13,22.26%,DBN1;SUFU;KEAP1;PKD2;NFKBIE;GET4;PKD1
prerank,positive regulation of telomere capping (GO:1904355),-0.3739217623589919,-1.0009283514144238,0.4525862068965517,0.8251454036621333,1.0,7/17,26.90%,PRKCQ;NEK7;MAPK3;PNKP;PKIB;MAP3K4;HNRNPD
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.39000761585001836,1.000824548068652,0.4500941619585687,0.8138687683559903,1.0,5/18,13.54%,MORC3;PARP10;CDC73;SKI;PEX2
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.40884115293629264,-1.0006571214034496,0.4849137931034483,0.8250016250575817,1.0,6/12,32.15%,B3GNT2;B3GNT9;B3GNT3;B3GNT6;B4GAT1;B3GALT1
prerank,regulation of protein autophosphorylation (GO:0031952),0.3346738980044346,1.0002527924638913,0.45187601957585644,0.8146558481133349,1.0,6/36,9.86%,EPHA7;ENPP1;ERRFI1;RAD50;MVP;RAP2C
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.31548734436750575,1.000148987113434,0.43213728549141966,0.8142397024950953,1.0,9/52,8.93%,PDPK1;SPTBN1;EPHA3;SORBS1;EPB41L2;ATP2B4;PTPN9;KIF5B;DLG1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.4333341413093525,0.9999356540346334,0.46065259117082535,0.8140876470431817,1.0,6/12,20.59%,IDH1;SIRT4;ACO1;IDH2;IREB2;ASS1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.32489124670599073,0.9999152581657864,0.47474747474747475,0.8134726528372634,1.0,7/43,10.75%,TLR4;PTPN22;C5AR2;LGALS9;CD274;PTPN6;IRAK3
prerank,response to interleukin-1 (GO:0070555),0.2959783891831814,0.9998979623028832,0.4496951219512195,0.8128498717759798,1.0,14/73,16.26%,ADAMTS12;GBP2;ANXA1;RC3H1;HDAC4;CD47;CCL2;LGALS9;IRAK3;ADAMTS7;CCL25;GBP3;APP;TAF9
prerank,positive regulation of interleukin-1 production (GO:0032732),0.31456452479049263,0.9996747677466353,0.470125786163522,0.8127552314937402,1.0,8/51,10.17%,IL16;IL6;TLR4;GBP5;LGALS9;WNT5A;RIPK2;PANX1
prerank,negative regulation of secretion by cell (GO:1903531),0.33672102605092796,0.9995920041136576,0.44607843137254904,0.8122904646864668,1.0,5/38,4.43%,RSAD2;OSM;IL11;ANXA1;HRH3
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.4563746081646052,0.9995510397781027,0.46108949416342415,0.8117299744663492,1.0,2/10,4.06%,FPR2;KIT
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.4316003944881876,0.9992656389601579,0.46705426356589147,0.8117113698495875,1.0,7/12,27.74%,PCGF5;RBM15;LRIF1;PCGF3;RLIM;SMCHD1;YTHDC1
prerank,negative regulation of double-strand break repair (GO:2000780),0.356280345798386,0.9992103241433813,0.4642233856893543,0.811184902922446,1.0,15/30,27.76%,TRIP12;FBH1;KLHL15;OGG1;ERCC6;SHLD2;UBR5;RIF1;CYREN;SMCHD1;SHLD1;TFIP11;CGAS;HMGA2;FANCB
prerank,intracellular protein transmembrane transport (GO:0065002),-0.28954697226818654,-0.9990425575756262,0.4606205250596659,0.8286033787773864,1.0,15/42,27.57%,PEX26;PEX10;ZFAND2B;C2CD5;PEX16;DNLZ;GRPEL2;HSPA5;TOMM40L;SEC61A1;TOMM20;SEC61G;TIMM21;RTN2;SEC61B
prerank,calcium ion transmembrane transport (GO:0070588),0.2877555217125069,0.9986613761140728,0.4572713643178411,0.811850039747099,1.0,13/86,11.39%,TRPM3;MCU;TRPM6;MICU1;NALCN;SLC24A3;ATP2B4;CACNA1C;PHB2;TMEM165;TRPC1;PMPCB;ANO6
prerank,regulation of protein localization to nucleus (GO:1900180),0.3193506947565404,0.9986350614832308,0.4533762057877814,0.8112535811044298,1.0,9/43,8.68%,PARP9;LATS2;TPR;DTX3L;CTNNA1;GSK3B;YAP1;NGFR;GLUL
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.2927576949760021,0.9985768475786805,0.45319465081723626,0.8107414751613494,1.0,24/80,23.45%,ROCK2;PLD1;SMPD3;SAMD4A;VIM;IL6;PLA2G6;EPHA4;ZCCHC4;EFNA1;SOX4;CPEB3;UPF3A;FXR2;PLXNB2;SIRT3;CASP3;ERBB2;SPHK2;ELAVL1;METTL5;YTHDF3;SP1;NSMAF
prerank,cellular response to glucose stimulus (GO:0071333),0.3511426034422457,0.9982264758763654,0.44991511035653653,0.8109371959441727,1.0,3/30,5.74%,ZBTB20;PRKAA2;UNC13B
prerank,T cell receptor signaling pathway (GO:0050852),-0.23174254052533194,-0.998215140505854,0.4452296819787986,0.8299677407239504,1.0,42/138,23.73%,PDE4D;PTPRJ;PDE4B;PLCG2;INPP5D;RFTN1;PIK3R1;MOG;PAK1;PRKCQ;PSMC3;EIF2B2;PSMD3;PSMD14;MALT1;LCP2;PSMD6;PSMD4;PAK3;BCAR1;PSMA6;PSMA4;PIK3CD;PSMB8;PSMA8;PTPRC;PLCG1;TNFRSF21;PSME1;PRAM1;IKBKB;PSMD7;PSMC6;CD247;PSMB5;PSMC5;PSMB1;ICOSLG;CD276;RBCK1;SKP1;PSMD8
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.37220012099823935,0.9981036623361906,0.4584070796460177,0.81056571741182,1.0,5/22,14.94%,ROCK2;CRY2;GSK3B;MASTL;BOD1L1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.2837665653344022,0.9979342951957075,0.45132743362831856,0.8103469432062893,1.0,18/95,12.08%,NUCKS1;WRN;TONSL;SLX4;RAD50;FBH1;SPIDR;SFR1;AP5Z1;NABP1;RAD51B;XRCC1;RPA3;MCM4;FANCM;RFWD3;RBBP8;NSMCE2
prerank,cellular response to hormone stimulus (GO:0032870),0.29625535911125667,0.9974665355368335,0.45481927710843373,0.8108464662029371,1.0,10/69,8.06%,TFPI;ATP1A2;GHR;NCOA3;STAT5B;CTSH;KLF9;SFR1;RAMP1;TRIM24
prerank,error-free translesion synthesis (GO:0070987),0.37843482257663746,0.9974157884879365,0.4750889679715303,0.8103177792500169,1.0,6/22,15.19%,POLH;RFC1;REV1;RPA3;POLDIP2;RCHY1
prerank,lymphocyte differentiation (GO:0030098),0.2991716692854988,0.9971949007108143,0.4634920634920635,0.8101842957998773,1.0,9/68,6.62%,LEPR;AXL;IL11;NHEJ1;KIT;PTPN22;PTPN2;VCAM1;HDAC4
prerank,regulation of chromatin binding (GO:0035561),0.45664217289355136,0.9970428979730147,0.46875,0.8098788865534179,1.0,3/10,10.85%,PARP9;DTX3L;GMNN
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.430181993352458,0.9965103179541333,0.45817490494296575,0.8105562781797692,1.0,7/12,21.35%,RESF1;ATF7IP;TASOR;PPHLN1;SETDB1;MPHOSPH8;TET1
prerank,nucleoside salvage (GO:0043174),-0.42426542368898623,-0.9957905887233526,0.4732334047109208,0.8359331694093388,1.0,5/10,22.32%,UCK2;UPP2;UCKL1;UCK1;HPRT1
prerank,ncRNA metabolic process (GO:0034660),0.3343531322239455,0.9953592937187463,0.4599659284497445,0.812765160783427,1.0,11/37,22.20%,TUT4;PIWIL4;EXD1;DTD2;TARBP2;RAN;TUT7;KHSRP;PARN;TENT4B;XPO5
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.3616170627535279,-0.9953558460617788,0.4617117117117117,0.8361388264334216,1.0,7/17,19.88%,KLF7;APOLD1;CEACAM1;PRKX;CAV1;MAFF;DLL1
prerank,endochondral bone morphogenesis (GO:0060350),-0.41532720553945546,-0.995242810442349,0.47863247863247865,0.8355144551798394,1.0,4/11,13.21%,MEF2C;BMPR2;BMP4;BMPR1B
prerank,nucleic acid metabolic process (GO:0090304),0.30028043694789797,0.995034324308364,0.4654895666131621,0.8129168694681931,1.0,17/69,18.50%,ENPP1;RBFOX2;POLR2D;WRN;RAD50;LSM1;POLG;HNRNPH1;HNRNPC;POLR2C;POLR2F;DNASE1L1;HNRNPR;HNRNPA2B1;RAN;DNA2;PCBP2
prerank,positive regulation of exosomal secretion (GO:1903543),0.4036819941837775,0.9949581299095653,0.4632768361581921,0.8124638437356457,1.0,1/15,1.26%,SMPD3
prerank,sensory perception of mechanical stimulus (GO:0050954),0.29080187934850876,0.9949375061937862,0.4672364672364672,0.8118581865852661,1.0,8/85,6.66%,COL4A3;EYA1;DCDC2;ROR1;ADGRV1;GSDME;CCDC50;MYO1A
prerank,regulation of cell motility (GO:2000145),0.2765378170556913,0.9947220020848353,0.47790055248618785,0.811718715160653,1.0,14/121,7.81%,PLXNA2;ROCK2;DIAPH1;ARHGAP18;FGF1;LMO4;TACSTD2;FBLN1;LDB2;AMOTL1;NTN1;MGAT3;SPINT2;SERPINE2
prerank,negative regulation of heart contraction (GO:0045822),0.43962834699986125,0.9946915418746817,0.4746376811594203,0.8111483930456991,1.0,1/11,0.48%,ATP1A2
prerank,synaptic vesicle membrane organization (GO:0048499),-0.36135062348681696,-0.9946784265893487,0.46444444444444444,0.8361286698855092,1.0,9/17,31.59%,STX3;SNAP25;SYNGR2;AP3D1;SNAP29;STX1B;TOR1A;SYNGR1;STX19
prerank,insulin secretion (GO:0030073),-0.3620734989964843,-0.994491592496408,0.4634146341463415,0.8357316549776906,1.0,10/19,28.70%,RIMS2;PTPRN2;SNX19;RAB11FIP5;PARK7;PTPRN;SELENOT;CAMK2G;MAFA;CYB5R4
prerank,negative regulation of protein transport (GO:0051224),0.36536687726800887,0.9941759971427354,0.47038327526132406,0.8117636866463039,1.0,3/25,10.91%,RSAD2;SNX12;WWP2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.3314161662921857,0.9940681175502775,0.4819672131147541,0.811387876494138,1.0,5/41,7.46%,PRKAG2;LACC1;RANBP2;TPR;JMJD8
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.29160330670621526,0.99393320024496,0.47058823529411764,0.8110612339701643,1.0,27/76,24.06%,PRICKLE1;RNF217;ZYG11B;RNF19A;GSK3B;NUB1;PIAS1;LRRK2;SUMO1;KEAP1;PTK2;HECTD1;TRIB1;DDA1;RCHY1;DAB2;RNF180;DNAJB2;SIRT2;RNF139;PTEN;FBXW7;CDK5RAP3;RNF14;CEBPA;COP1;TAF1
prerank,positive regulation of glucose import (GO:0046326),0.3729600240328485,0.9937203564976137,0.4717314487632509,0.8109534836748582,1.0,5/21,10.16%,OSBPL8;SORBS1;CREBL2;RHOQ;APPL1
prerank,base-excision repair (GO:0006284),0.31618739835427606,0.9936120612208013,0.4816,0.8105948648112874,1.0,12/48,15.17%,WRN;RFC1;POLG;NTHL1;USP47;XRCC1;RPA3;HUWE1;ADPRS;OGG1;ERCC6;ERCC5
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.30990827112677327,-0.9929925968104838,0.47783251231527096,0.8389777785140357,1.0,11/33,22.90%,HIP1;BCAR3;HIP1R;CCDC88A;AKT1;CBL;PLAUR;EGF;AFAP1L2;NUP62;HAP1
prerank,calcium ion transport (GO:0006816),-0.2449068457184525,-0.9928906823497485,0.46075085324232085,0.8383047167340846,1.0,23/113,11.76%,CACNA1E;CACNB2;GRIN3A;TRPC3;SLC24A2;RYR2;TPT1;FKBP1A;GAS6;TRPC5;TRPC4;RYR3;ATP2C1;SLC8A1;ATP2A3;CACNA1G;TRPC6;CAMK2A;RAMP2;CACNA1D;CRACR2B;TMCO1;CAV1
prerank,pore complex assembly (GO:0046931),0.3883433305467424,0.9928087031518148,0.45935727788279773,0.8118395403014181,1.0,5/19,14.10%,AFDN;TPR;ANO6;AHCTF1;RTN4
prerank,regulation of oxidative phosphorylation (GO:0002082),0.3957291475401009,0.9928072514355891,0.476280834914611,0.811195791022579,1.0,1/16,1.78%,NUPR1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3744937806267942,0.9927232734083022,0.45300751879699247,0.8107605989239953,1.0,5/20,19.92%,TNRC6B;TNRC6A;MOV10;WTIP;AJUBA
prerank,regulation of cellular component biogenesis (GO:0044087),-0.2969917628289557,-0.9926903644747515,0.4475,0.8379353287826747,1.0,12/39,15.71%,TIE1;HSPA8;NOTCH1;DAB2IP;RAPGEF2;PINK1;ANKRA2;HSP90AA1;CCL19;SPTY2D1;RAP1A;IRGM
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.29198501462359494,-0.992350658556318,0.46736292428198434,0.8379294280942353,1.0,14/47,15.34%,TGFB2;FOXO1;MID1;PHLPP1;EPHB1;DAB2IP;MAPK3;FAS;MAPK8IP1;EGFR;MAPK8IP3;PPIA;COPS5;NOD2
prerank,positive regulation of lipid catabolic process (GO:0050996),0.38013459671437594,0.9915458206848606,0.4827586206896552,0.812989093196836,1.0,7/19,27.22%,APOA2;PPARA;ABHD5;ANGPTL3;DAGLB;IRS2;PRKCD
prerank,purine nucleotide metabolic process (GO:0006163),0.3648123516658731,0.9914512225621376,0.4825174825174825,0.8125788708349809,1.0,9/24,20.70%,MTHFD1;FHIT;NT5C;PRPSAP1;ITPA;PRPSAP2;NT5C1A;XDH;ADSL
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.3608425831751455,-0.9913961824905662,0.497787610619469,0.8398047835733814,1.0,5/18,15.05%,SLC2A1;PRKCB;INPP5K;C2CD5;NR4A3
prerank,regulation of neuroinflammatory response (GO:0150077),0.3883987240045598,0.9906101632296488,0.4777777777777778,0.8140287156786331,1.0,3/19,7.90%,NUPR1;IL6;IL18
prerank,response to exogenous dsRNA (GO:0043330),0.3907531292658238,0.9900508713698615,0.4468864468864469,0.81480898369926,1.0,6/18,15.88%,COLEC12;IRAK3;IFIT1;TICAM1;IFIH1;MUL1
prerank,positive regulation of DNA repair (GO:0045739),0.3190537751316049,0.9900047780058772,0.47297297297297297,0.8142692967228264,1.0,9/46,15.63%,EYA2;EYA1;SPIDR;SLF2;XRCC1;EYA4;ERCC6;UIMC1;MGMT
prerank,cellular response to fluid shear stress (GO:0071498),-0.39677963057316873,-0.9899240113540204,0.48459958932238195,0.8430821934478008,1.0,3/12,12.14%,MEF2C;KLF2;KLF4
prerank,regulation of cell-cell adhesion (GO:0022407),0.33055782088905017,0.9896711134839395,0.487012987012987,0.814451806327235,1.0,12/39,15.95%,DPP4;EPHA7;AFDN;FSTL3;CD47;SPINT2;FUT4;PTK2;FLOT2;PTPRR;NF2;MDGA1
prerank,amino acid transmembrane transport (GO:0003333),0.32166500805468323,0.9894646012809841,0.4737704918032787,0.8143167026536112,1.0,3/45,3.96%,SLC7A11;SLC6A13;SLC16A2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.3958361768117339,-0.9892817213498237,0.47577092511013214,0.844009714147726,1.0,6/13,32.15%,B3GNT2;B3GNT9;B3GNT3;B3GNT6;B4GAT1;B3GALT1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.3086363207058367,-0.9890516721527253,0.46568627450980393,0.843740029557369,1.0,6/30,11.65%,TPT1;RPS3;CD74;CCAR2;CXCL12;PTTG1IP
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.3775972282568082,0.9889694237694624,0.44712430426716143,0.814898907491654,1.0,5/18,15.88%,GSK3B;BAX;TMEM14A;ZNF205;MUL1
prerank,plasma membrane organization (GO:0007009),0.30326379943855336,0.9888421910958369,0.4566929133858268,0.8145490931566646,1.0,13/61,15.10%,SPTBN1;MYOF;A4GALT;COL5A1;PACSIN2;SNX9;MICALL1;PLSCR4;STX2;ANO6;PLSCR2;CHMP4A;CXCR4
prerank,cellular response to decreased oxygen levels (GO:0036294),0.30447939429484244,0.9888233901462735,0.4886535552193646,0.8139506017384471,1.0,8/65,7.85%,RORA;GATA6;TERT;BMP7;EPAS1;CPEB1;NPEPPS;OPRD1
prerank,peptide hormone secretion (GO:0030072),0.35329535303601134,0.9887830903453978,0.48063380281690143,0.813411835475797,1.0,5/26,10.22%,GHRH;ANXA1;IL6;FAM3B;CDK16
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.29513781775648407,0.9887816975841348,0.4699537750385208,0.8127734588811084,1.0,21/73,16.11%,WNT3A;OSM;IL11;IL6;ARAF;STOX1;HAX1;ATP2B4;CREBL2;OPRD1;RIPK2;DOCK7;FNIP1;MTCP1;BDNF;NTRK3;TBK1;PRKD2;STK4;CNOT9;APP
prerank,programmed necrotic cell death (GO:0097300),0.38864757792139043,0.9887575385761201,0.48608534322820035,0.8121901430477116,1.0,6/18,21.57%,TLR4;LY96;DNM1L;TICAM1;TRPM7;RIPK1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.3918485959079909,-0.9884931239761781,0.48,0.8444148197305523,1.0,3/13,6.85%,GRIN2A;PERP;LGMN
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.24825820148352262,-0.9883394992180953,0.4827586206896552,0.8438830681578544,1.0,18/91,13.56%,SYT1;RIMS2;HIP1;RIT2;NSF;HIP1R;STXBP5L;MAPK3;MBTPS1;SCARB1;RAB3C;CPLX1;SYT7;CPLANE2;SYK;FES;RAB12;RAB5C
prerank,peptide catabolic process (GO:0043171),0.3619887708001259,0.9881233152146182,0.5081081081081081,0.8131061287763102,1.0,6/23,14.33%,CPQ;ANPEP;NPEPPS;CTSH;ERAP1;LNPEP
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2828035443157477,0.9880941074927468,0.46439169139465875,0.8125296382999307,1.0,9/93,4.04%,SASH1;CCN2;EIF2AK2;MTURN;RELL1;TRAF5;SH3RF1;TAOK3;BMP2
prerank,selective autophagy (GO:0061912),0.3097945784354767,0.9879072682220059,0.45454545454545453,0.8123353795371234,1.0,9/56,11.74%,DYNLL1;VIM;AMBRA1;ARL13B;IFT88;UBA5;PHB2;UBE2V1;STBD1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.37225850431763624,-0.9878293062119553,0.4781704781704782,0.8444389135893772,1.0,7/17,20.27%,AHI1;BMP4;FGF2;SFRP4;NKX6-1;BTG1;BAD
prerank,superoxide metabolic process (GO:0006801),-0.3165762614558025,-0.9877256099466462,0.46099290780141844,0.8438127535702775,1.0,9/29,23.90%,NOS3;SH3PXD2A;NCF2;PREX1;CYBB;SOD1;PRDX2;TAFA4;NOX4
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.352235427545459,-0.9874981496101656,0.47702407002188185,0.843516363445283,1.0,7/18,28.61%,AKT1;PINK1;PPIA;PARK7;NONO;HSPB1;VNN1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.3229992757524361,-0.9869612456628287,0.47641509433962265,0.8439890542261517,1.0,11/24,25.47%,UBB;UBA52;POLD2;POLE;RFC4;LIG3;POLD1;POLB;POLK;RFC5;RFC2
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.3282612613988398,-0.9869428937332714,0.4738095238095238,0.8431160162514434,1.0,8/24,18.60%,STMN2;KIF18A;FGF13;NCKAP5;MAPT;STMN4;STMN1;TPPP
prerank,response to estradiol (GO:0032355),0.33880908078878985,0.9867632304603394,0.48986486486486486,0.8144591234730926,1.0,5/31,8.88%,NCOA3;ANXA1;STAT5B;FAM210B;STRN3
prerank,regulation of mRNA polyadenylation (GO:1900363),0.4003897572453666,0.986453967913933,0.4795539033457249,0.8145997654275995,1.0,3/17,7.71%,CPEB1;ZC3H3;RNF20
prerank,cell projection organization (GO:0030030),0.3458163095561786,0.9863991084113458,0.4712460063897764,0.8140823220731185,1.0,8/30,14.11%,PARVA;QRICH2;PACSIN2;NPHP1;RHOQ;PLEK;ATP1B2;RHOU
prerank,oligodendrocyte development (GO:0014003),-0.3775055060768085,-0.9863269777155286,0.4647577092511013,0.843914285461601,1.0,6/15,30.91%,PLP1;EIF2B2;TPPP;B4GALT6;CNTNAP1;PRDM8
prerank,cilium organization (GO:0044782),0.25540550856310473,0.9862268293857296,0.5051020408163265,0.813849825472019,1.0,54/209,22.26%,DCDC2;PARVA;CYS1;DYNLL1;ASAP1;ARL13B;RFX3;IFT88;ARL3;TTC39C;HYLS1;ARF4;TMEM107;EXOC2;DYNC2I1;DNAAF1;IFT81;NUDCD3;CC2D2A;CDC14A;CCDC57;IQCB1;RAB3IP;WDR19;CFAP221;IFT20;TRAPPC14;FBF1;CCDC66;NPHP3;RFX2;PKD2;CPLANE1;CEP250;GBF1;AVIL;EXOC7;EXOC1;TTBK2;IFT52;RPGR;WDR11;ARL6;B9D2;CEP131;SSX2IP;CEP78;OFD1;DZIP1L;CFAP410;RP2;ACTR3;LZTFL1;PKD1
prerank,endoderm development (GO:0007492),0.4141446552249249,0.9862171870424631,0.48841698841698844,0.8132340306450975,1.0,1/13,0.58%,LAMC1
prerank,negative regulation of mRNA processing (GO:0050686),-0.3752286822441477,-0.9861172508486274,0.4827586206896552,0.8435862757951501,1.0,6/15,21.83%,PTBP1;BARD1;RNPS1;SRSF9;C1QBP;SRSF6
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.42309748392953483,0.9860453601519462,0.4742647058823529,0.8130224989107752,1.0,5/13,18.78%,AXL;WNT5A;IFIH1;TAF9;IL7
prerank,membrane protein proteolysis (GO:0033619),0.32623709175523236,0.9858372780020552,0.4708904109589041,0.8128794837419112,1.0,6/37,10.48%,DAG1;CTSH;SPPL3;NGFR;ERAP1;ADAM19
prerank,negative regulation of T cell proliferation (GO:0042130),0.3486743237154363,0.985787674960839,0.47048300536672627,0.8123745998117432,1.0,5/28,8.19%,RC3H1;FOXP3;LGALS9;TNFRSF14;CD274
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.39220959687508045,-0.9857303328917993,0.4734607218683652,0.8437347471041174,1.0,5/13,16.85%,GFPT2;PGM3;GFPT1;RENBP;GNPNAT1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.32058804409534075,-0.9857008050553877,0.4613583138173302,0.8428770965064475,1.0,10/26,26.28%,SGIP1;FNBP1L;SNAP91;AP2B1;DLL1;ITSN2;AP2A2;AP2A1;CLTA;AP2M1
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.2895184213636225,-0.9856693644100555,0.46904761904761905,0.8420461279077915,1.0,8/44,10.61%,PTPRJ;SORL1;DAB2IP;INPP5K;BMP4;PAQR3;LYN;MAPK8IP1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.37737994531026087,-0.9852870967800796,0.4717832957110609,0.8422002998449218,1.0,6/14,21.36%,PCYT2;ETNK1;SELENOI;LPIN3;CHKA;CEPT1
prerank,growth hormone receptor signaling pathway (GO:0060396),0.40075440155409425,0.9850733317396472,0.45901639344262296,0.8134577249108341,1.0,5/14,16.87%,GHR;STAT5B;PTK2;PTPN1;STAT5A
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.43469161047703014,0.9847387301906316,0.4798387096774194,0.8136785244250246,1.0,5/12,9.50%,DOCK5;IGFBP5;ADAMTS1;TPM1;DOCK7
prerank,skeletal muscle organ development (GO:0060538),0.3589632555582924,0.984516605693692,0.45555555555555555,0.8135927233773295,1.0,6/26,10.61%,CSRP3;CFLAR;LARGE1;IGSF8;POPDC2;MSC
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.36162740632439255,0.9842743289011054,0.4965753424657534,0.8134933198881908,1.0,9/24,20.54%,SUZ12;EPC1;JARID2;TASOR;DNMT3A;PPHLN1;BMI1;MPHOSPH8;PHF1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.3886900211982498,-0.984206235214917,0.497907949790795,0.8442218805632958,1.0,4/13,9.53%,EPN2;DAB2IP;EMILIN1;HHEX
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.38495262811289527,0.9840669102924876,0.5008787346221442,0.8133887337078805,1.0,3/20,5.09%,ZMIZ1;EPAS1;TGFBR1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3675712389076126,0.983809609207749,0.4847942754919499,0.8133963162965747,1.0,9/23,24.33%,PLK5;PRCC;ZWINT;NABP1;INTS3;NABP2;CDK5RAP3;WEE1;VPS4A
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.306056928121568,-0.9835301559991824,0.4634146341463415,0.845215164060897,1.0,8/28,17.01%,CRADD;DAB2IP;GABARAP;DDX47;DEDD;NGF;SORT1;DEDD2
prerank,transepithelial transport (GO:0070633),0.40244595858088644,0.9834915215641695,0.478584729981378,0.8135637706505652,1.0,2/15,0.80%,SLC1A3;CXADR
prerank,regulation of interleukin-6 production (GO:0032675),0.2803028301844164,0.9832825304429339,0.4732272069464544,0.8134479624467462,1.0,14/96,10.75%,IL16;IL17D;IL6;TLR4;PTPN22;C5AR2;NOS2;CD47;LGALS9;WNT5A;SETD4;TLR2;PTPN6;IRAK3
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.4163902514876399,0.983022619083845,0.48880597014925375,0.8134417982966462,1.0,6/13,28.01%,UBA5;SENP6;ATG10;ATG7;DESI1;DESI2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3787224881374425,0.9829453096271266,0.5009345794392523,0.8130080026328366,1.0,2/18,2.90%,PTN;IL34
prerank,regulation of cell communication (GO:0010646),0.33476624034386326,0.9829096471768693,0.4789915966386555,0.8124587557189183,1.0,4/35,3.42%,CXADR;GRK3;IGFBPL1;ANXA1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.2383238688494293,-0.9828532343310433,0.5284280936454849,0.8462208809836065,1.0,36/114,25.37%,ST18;TMSB4X;PTK2B;PSMC3;COMMD7;TNFRSF1B;PSMD3;PSMD14;PSMD6;PSMD4;AIM2;EIF5A;PSMA6;CD40;PSMA4;PSMB8;ACTN4;PSMA8;CD27;PSME1;LTBR;PYCARD;IKBKB;PSMD7;PSMC6;PSMB5;TNFRSF11A;PSMC5;TRAF1;BAG4;PSMB1;TNFSF13;PSMD8;TNFRSF9;TXNDC17;PSMD11
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.3901426419042061,0.9821147942452018,0.4934579439252336,0.8137798098701842,1.0,6/18,18.89%,BCL2;HEBP2;BCL2L1;SLC25A4;MUL1;SLC25A31
prerank,endodermal cell differentiation (GO:0035987),0.33849794598200444,0.982054424230194,0.4864864864864865,0.8132937143651433,1.0,8/31,14.88%,VTN;FN1;ITGA5;MMP14;CDC73;RTF1;PAF1;LEO1
prerank,response to growth factor (GO:0070848),0.3233966382525415,0.9819638319058474,0.48925619834710743,0.8128681924669253,1.0,15/41,19.73%,GATA6;BMPR1A;STAT5B;PLK5;TGFBR1;TGFBR2;MAP2K5;EPHA2;TBC1D7;ACVR1C;ACVR2B;URI1;SHC1;EMD;ERBB2
prerank,response to organic cyclic compound (GO:0014070),0.3077785619548796,0.9819202319772614,0.48171701112877585,0.8123411833952658,1.0,9/52,10.39%,IGFBP5;ANXA1;STAT5B;CCL2;IL18;LRRK2;STRN3;HLCS;TIPARP
prerank,inorganic ion transmembrane transport (GO:0098660),-0.39395845320536704,-0.9815085518191119,0.5020408163265306,0.8490748513398346,1.0,2/12,11.22%,ABCC9;KCNJ8
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.36348983516009725,0.9813693790283734,0.4894366197183099,0.8130488646307426,1.0,9/24,21.40%,SLX4;DCP2;HNRNPC;XRN1;TNKS2;EXOSC10;TEN1;CTC1;TENT4B
prerank,mesoderm development (GO:0007498),-0.35180581873121985,-0.9809892017199983,0.4592760180995475,0.8495880002744681,1.0,12/18,36.27%,TIE1;TBX1;BMX;VEGFA;IKZF1;TBX6;MEST;TCF15;MESD;IKZF3;HES7;BTK
prerank,regulation of keratinocyte proliferation (GO:0010837),0.3693174818825342,0.9805422837089721,0.4807017543859649,0.8143960878103663,1.0,5/22,13.03%,NOTCH2;CASK;KLF9;EPPK1;CRNN
prerank,tRNA aminoacylation (GO:0043039),-0.2945880001450944,-0.9803450747103885,0.494949494949495,0.8504849878920693,1.0,14/37,33.60%,LARS2;KARS1;CARS1;EEF1E1;IARS1;RARS2;HARS1;YARS2;FARSB;WARS2;QARS1;NARS1;YARS1;TARS1
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.28581833562807474,-0.9800798937387107,0.4740932642487047,0.8503225613438633,1.0,12/46,19.47%,AKT1;MFF;PINK1;MFN2;GDAP1;TIMM8B;DNLZ;GRPEL2;AIP;TOMM40L;TOMM20;TIMM22
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.2782879011731333,0.9799020405232172,0.48542274052478135,0.8153003784927038,1.0,14/102,10.12%,PDPK1;ENPP1;FER;GCGR;RAB10;TRARG1;ADCY7;ADCY5;SORBS1;CPEB1;ADCY1;INSIG2;RHOQ;OTOP1
prerank,mesenchyme development (GO:0060485),0.3984153851184662,0.9797446632438749,0.4906716417910448,0.8150672966262313,1.0,3/15,5.09%,BMP2;BMP7;TGFBR1
prerank,protein N-linked glycosylation (GO:0006487),-0.2585621834094526,-0.9797376796546073,0.49303621169916434,0.8503759947549888,1.0,20/66,19.08%,FUT8;MGAT5;ALG14;RPN2;SRD5A3;ALG5;DOLPP1;GFPT2;LMAN1;PGM3;MGAT4A;DPM2;GFPT1;SLC39A8;GAL3ST1;OSTC;STT3B;ALG6;MOGS;PMM2
prerank,regulation of monocyte chemotaxis (GO:0090025),0.3627741322008318,0.9795920316038914,0.4648370497427101,0.8148277907034294,1.0,4/24,5.67%,CXCL10;FPR2;NBL1;SERPINE1
prerank,positive regulation of protein processing (GO:0010954),0.37689097912105507,0.9794623515686923,0.48947368421052634,0.8144847206961633,1.0,3/19,11.44%,CLEC3B;CCBE1;PLGRKT
prerank,cellular response to DNA damage stimulus (GO:0006974),0.24113759070802981,0.9794567938650833,0.5270588235294118,0.8138720102902771,1.0,84/336,20.54%,PRAP1;PDS5B;ZBTB4;POLH;TRIP12;TAOK3;CRY1;SPATA18;IKBKE;WRN;APBB1;BCL2;PARP3;PLK5;SLX4;NCOA6;RAD50;MCL1;UBE2U;CUL4A;DTX3L;SUSD6;FBH1;SPIDR;NEK4;CCDC13;YAP1;WAC;BAX;MAP2K6;BAZ1B;SLF2;USP47;MNAT1;PSME4;SIRT4;TLK2;SUMO1;UVRAG;NABP1;RAD51B;SETD7;NUPR2;MAPK14;BCL2L1;RFWD3;RBBP8;ADPRS;EPHA2;OGG1;MASTL;HIC1;INTS3;GTF2H4;RAD9A;ALKBH1;PDS5A;BOD1L1;PML;MGMT;ERCC1;NIPBL;TAF9;MACROD1;USP45;KMT5C;FANCC;ATF2;NFATC2;PARP4;UBR5;SMARCAL1;SHPRH;USP10;BLK;BCL6;RIF1;XPC;INO80;KMT5B;NSMCE3;ERCC8;NABP2;PHF1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2936887240558113,0.9790235487536227,0.5037369207772795,0.8142641356779705,1.0,14/76,12.88%,PRICKLE1;ANGPT1;CRY1;MYCBP2;BIRC3;HDAC4;PIAS1;RIPK2;LRRK2;FBXO4;CENPX;HUWE1;CUL3;TBC1D7
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.37690438257312076,0.9790027987822351,0.4880294659300184,0.8136938638335364,1.0,5/19,12.86%,CAMK1D;IL34;PTK2;CSF1;RARRES2
prerank,nucleic acid-templated transcription (GO:0097659),0.3201583545170103,0.9783532218814592,0.49455676516329705,0.8146388815674472,1.0,11/42,14.28%,POLR2D;TERT;BAZ2A;DTX1;CREBL2;MEF2A;EPC1;POLR2C;THAP1;MED20;POLR2F
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3534319163591614,0.9779034127541547,0.47884940778341795,0.8150910359724508,1.0,4/27,7.35%,NFAT5;IL6;CD47;CCL2
prerank,female gonad development (GO:0008585),0.37796710540311107,0.9774770510503419,0.4852173913043478,0.8154922687840354,1.0,2/19,4.06%,NR2F2;KIT
prerank,positive regulation of viral life cycle (GO:1903902),0.36612088319733904,0.9773434196885955,0.49910873440285203,0.8151804937703341,1.0,3/22,7.50%,AXL;KPNA6;LGALS9
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.38133490520520763,0.9773042661386079,0.492831541218638,0.8146491298083041,1.0,4/21,7.33%,CGNL1;ARHGAP12;SYNGAP1;STAMBP
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.3273166407059387,0.9771920910581802,0.5047770700636943,0.8142726571578872,1.0,6/39,7.35%,PDPK1;IL11;CDH5;ANGPT1;SERPINE1;CCL2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.3087968891402711,0.9770108410123961,0.4660493827160494,0.8140753841246163,1.0,9/48,10.62%,PDPK1;FGFR1;FOXC2;ANXA1;ANGPT1;PIK3C2A;AKT3;FGF18;MAPK14
prerank,positive regulation of macrophage differentiation (GO:0045651),0.43921526224164936,0.9766629125696545,0.492619926199262,0.8142854237750177,1.0,4/11,23.33%,IL34;CSF1;RIPK1;TGFB1
prerank,neural crest cell differentiation (GO:0014033),-0.358133654538462,-0.9764285807513743,0.5098901098901099,0.8587280121722095,1.0,2/18,1.15%,CDH2;MEF2C
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.3570372914014649,-0.9762602286852127,0.4827586206896552,0.8582630581083828,1.0,13/17,44.65%,ZWILCH;SPDL1;CENPA;CTCF;ZW10;CDK1;MIS12;BUB3;KNL1;BOD1;AURKB;CHAMP1;HASPIN
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.37884427471809723,-0.9759347570419732,0.506198347107438,0.8582587803514362,1.0,3/15,9.71%,AKT1;PRELID1;GHITM
prerank,regulation of receptor recycling (GO:0001919),0.3918247277350765,0.975743001742527,0.49544626593806923,0.8158786709581597,1.0,3/16,5.75%,ANXA2;TBC1D16;OPTN
prerank,apoptotic process (GO:0006915),-0.21747516790241767,-0.9756510512364607,0.5270935960591133,0.858116647283038,1.0,32/203,10.07%,HIP1;EFNA5;ELMO1;FOXO1;PTK2B;DCC;CIT;ADAM15;NCKAP1;PPP2R1A;TBX1;PLAGL1;TRPC5;SEMA6A;ARHGEF6;PPARD;CASP7;MAL;PRUNE2;SCN2A;ZBTB16;PAK5;AKT1;RHOB;STK11;RFK;FAP;NUDT2;FAS;BAG6;TRAF7;DDIT4
prerank,positive regulation of chromatin organization (GO:1905269),-0.3882367876612498,-0.9753529329858242,0.4947589098532495,0.8579925900293699,1.0,4/12,18.34%,H3-3A;TERF1;TAL1;TINF2
prerank,thyroid hormone generation (GO:0006590),0.44023332453956276,0.9752233358082187,0.4959677419354839,0.8164844569886801,1.0,2/10,10.21%,CPQ;DIO2
prerank,regulation of endothelial cell proliferation (GO:0001936),0.2825128327397516,0.9752118430237394,0.488822652757079,0.8158829993753064,1.0,17/88,12.43%,SULF1;NR2F2;ECM1;NRP1;VEGFD;ANGPT1;BMP2;ARNT;TGFBR1;STAT1;WNT5A;AKT3;EGR3;FGF18;CDH13;NR4A1;SPARC
prerank,negative regulation of macrophage activation (GO:0043031),0.396237521753225,0.9750491895542139,0.498134328358209,0.8156480243844262,1.0,2/16,6.10%,IL31RA;NR1H3
prerank,epidermis development (GO:0008544),0.2977286080268071,0.9749049137510979,0.47244094488188976,0.8153754646772797,1.0,5/56,6.35%,CCN2;GATA6;PTHLH;GLI1;SVEP1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2910814220542685,0.9744956654807597,0.4908814589665654,0.815741901981643,1.0,10/70,11.86%,PDPK1;SMAD3;BCL2;MCL1;GSK3B;BAX;CASP8AP2;APPL1;BCL2L1;IFI27
prerank,amide biosynthetic process (GO:0043604),-0.2787392533720625,-0.9738695792143959,0.5231958762886598,0.8611793080728682,1.0,4/47,3.34%,SGMS1;DMD;CERS4;DEGS2
prerank,telomere maintenance via recombination (GO:0000722),0.43832309089060484,0.9732412767677326,0.5027522935779817,0.8181832697620195,1.0,5/11,21.63%,RAD50;NSMCE2;ERCC1;SMC6;TEP1
prerank,protein localization to cell-cell junction (GO:0150105),0.4013971267355861,0.9728791948581339,0.5044404973357016,0.8183822339624339,1.0,4/15,12.64%,CGNL1;CDH5;JAK1;TJP1
prerank,L-glutamate transmembrane transport (GO:0015813),0.4438794873323602,0.9726490805097691,0.5100401606425703,0.8183390987632645,1.0,1/10,0.77%,SLC1A3
prerank,sodium ion export across plasma membrane (GO:0036376),0.4149237418566307,0.9723963696386185,0.5038461538461538,0.8183249337317712,1.0,1/13,0.48%,ATP1A2
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.43095267036428364,0.9721695913718472,0.5048732943469786,0.8182559867790611,1.0,3/11,20.81%,APOA2;PLA2G5;AGT
prerank,regulation of amyloid fibril formation (GO:1905906),-0.37059011578341416,-0.972167618306846,0.49330357142857145,0.8650507146534825,1.0,8/15,29.69%,PFDN5;PFDN2;PFDN4;CHRNA7;VBP1;TREM2;CLU;LDLR
prerank,hemopoiesis (GO:0030097),0.2820255834311778,0.9721528123259069,0.5164992826398852,0.8176743064462652,1.0,16/87,12.61%,KMT2A;TGFBR3;NOTCH2;WNT2B;WNT10B;FSTL3;KIT;NCOA6;SBDS;TGFBR2;WNT5A;FUT10;PLEK;MFAP5;SH2B3;TET2
prerank,response to histamine (GO:0034776),0.447349103759622,0.9721416211239791,0.5357142857142857,0.8170846325236629,1.0,1/10,0.82%,DIAPH1
prerank,myeloid dendritic cell activation (GO:0001773),-0.40398062312103733,-0.9721186237410029,0.5,0.86426757076121,1.0,4/12,17.77%,DOCK2;HMGB1;CAMK4;PYCARD
prerank,tight junction assembly (GO:0120192),-0.2759070438552153,-0.9720471155141687,0.49869451697127937,0.8635458216676313,1.0,15/49,22.25%,PECAM1;CLDN5;ESAM;ACTG1;LSR;CLDN14;RAMP2;MICALL2;F11R;MPP7;MARVELD2;ECT2;CLDN12;ARL2;OCLN
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.35554160427800585,-0.9714720613073837,0.5032537960954447,0.864311397179313,1.0,8/17,26.47%,ALG14;SRD5A3;NUS1;DOLPP1;ALG6;DHDDS;ALG13;MVD
prerank,copper ion transport (GO:0006825),-0.40649429629465894,-0.971396623374679,0.5073375262054507,0.8635878345998429,1.0,4/11,10.98%,ATOX1;SLC31A1;STEAP2;SLC31A2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3754378069436091,0.9713912333273973,0.49727767695099817,0.8182160253489253,1.0,8/21,23.16%,LRRK2;BCL2L1;OPA1;NCK1;EIF2AK3;XBP1;SYVN1;TXNDC12
prerank,Golgi to endosome transport (GO:0006895),-0.35942775926504544,-0.9709376784208688,0.5135746606334841,0.8638777369080929,1.0,6/16,14.69%,DOP1B;AP1AR;CORO7;KLHL20;SORT1;KIF16B
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.30796975427418216,0.9708436407351695,0.5056910569105691,0.818893839630744,1.0,8/51,8.73%,GAS7;NRK;NBL1;TAOK3;BMP7;DBN1;DTNBP1;LRRK2
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.2875985373735503,-0.9707655396413467,0.4920212765957447,0.8634303633519647,1.0,4/39,2.06%,MYO1D;PPFIA2;FNBP1L;TANC2
prerank,chemical homeostasis (GO:0048878),0.2955844139094078,0.9701209571636358,0.5030864197530864,0.8199985499228266,1.0,6/61,8.36%,ZBTB20;RBP1;ACOXL;NR1H3;SLC4A11;WNK4
prerank,protein homooligomerization (GO:0051260),0.27185480595430717,0.9698054272665739,0.5129251700680272,0.8201328669417239,1.0,6/114,2.72%,ALDH1A2;RNF213;MICU1;SHMT1;PRF1;CLYBL
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4345962013970683,0.9697564059565694,0.5115830115830116,0.8196363837623082,1.0,1/10,0.43%,BMP6
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.317186760053835,-0.9692005139398352,0.524390243902439,0.8668799939956279,1.0,7/27,10.16%,FGF12;FXYD5;UTRN;YWHAH;CAMK2D;NEDD4L;NOS1
prerank,actin filament capping (GO:0051693),0.3753082894502485,0.9691719022606424,0.5174825174825175,0.8198085966216136,1.0,10/18,24.64%,ADD3;VILL;CAPZB;TRIOBP;AVIL;CAPZA1;CAPG;TWF2;ADD2;SVIL
prerank,barbed-end actin filament capping (GO:0051016),0.3753082894502485,0.9691719022606424,0.5174825174825175,0.8198085966216136,1.0,10/18,24.64%,ADD3;VILL;CAPZB;TRIOBP;AVIL;CAPZA1;CAPG;TWF2;ADD2;SVIL
prerank,positive regulation of nuclear division (GO:0051785),0.3524552743448915,0.9689982587591692,0.5042735042735043,0.8196310048932378,1.0,4/25,9.42%,PHIP;TGFA;PDGFRB;IGF2
prerank,peripheral nervous system development (GO:0007422),-0.3265508899865869,-0.9683688670494993,0.49095022624434387,0.868258756464778,1.0,6/23,16.79%,ADGRG6;SERPINI1;SCN8A;NFASC;NGF;NTF3
prerank,positive regulation of intracellular transport (GO:0032388),-0.293039366570183,-0.968234972585872,0.5113924050632911,0.8677510739325147,1.0,10/38,16.27%,PRR5L;SORL1;OAZ1;STK11;OAZ2;DYNC1H1;PCNT;CAPN10;MLC1;CEP290
prerank,regulation of superoxide anion generation (GO:0032928),0.4038691434067959,0.9680036415403765,0.49906191369606,0.821369166602473,1.0,2/14,4.88%,FPR2;CRP
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.3431325210945295,-0.967682096370881,0.48642533936651583,0.8683584646096176,1.0,4/21,9.03%,TOX;CTNNB1;FZD3;VEGFA
prerank,multivesicular body assembly (GO:0036258),-0.30593637909604293,-0.9675570325572777,0.5401459854014599,0.8677728934479035,1.0,12/30,27.72%,VPS37B;VPS37A;CHMP1A;CHMP1B;CHMP2B;CHMP7;VPS28;SNF8;CHMP2A;CHMP6;CHMP4C;HGS
prerank,positive regulation of apoptotic process (GO:0043065),0.24239295479947318,0.9675191138651419,0.5535279805352799,0.8219341251289999,1.0,38/293,10.80%,IGFBP3;PAWR;AKAP13;TIAM2;EPHA7;PHLDA1;NUPR1;WNT10B;DLC1;FGD4;PNMA3;IFIT2;ADAMTSL4;ZBP1;PRDM11;DAPK1;BMP2;APBB1;IL6;LATS2;TGFBR1;UNC13B;TNFRSF12A;PLEKHG2;USP27X;PDCD5;NGFR;BAX;ARHGEF11;QRICH1;UBE2Z;CALHM2;STK3;ARHGEF12;PPID;SOS2;NGEF;DNM1L
prerank,ventricular septum morphogenesis (GO:0060412),0.3447721342204512,0.9674826360336287,0.505338078291815,0.8214187245801261,1.0,8/27,13.08%,ROBO1;TGFBR3;BMPR1A;TGFBR1;TGFBR2;HEYL;SMAD4;NOG
prerank,sensory perception (GO:0007600),-0.27943910225538127,-0.967194435211177,0.49246231155778897,0.8679106870575537,1.0,13/45,21.33%,PCDH15;TMEM150C;GNAS;OPRM1;SCN9A;KCNA2;NTSR2;CHRNA4;GNAL;P2RX7;PENK;CHRNA7;TTC8
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.3696323782532387,-0.9670422227148071,0.5258426966292135,0.8673935018087492,1.0,5/14,27.84%,THBS1;CMKLR1;C1QBP;JAK3;LILRB1
prerank,regulation of vacuole organization (GO:0044088),0.3700912023927816,0.966916537247598,0.5052631578947369,0.8221725977664813,1.0,10/20,25.19%,ANXA2;IFT88;MTMR3;IFT20;NPRL3;RAB5A;ADPRH;NPRL2;MTM1;UBQLN2
prerank,positive regulation of catabolic process (GO:0009896),0.28828568891285317,0.9667584865263673,0.5015060240963856,0.8219140834958771,1.0,12/65,12.83%,SMURF2;APOA2;NEDD4;DACT1;GSK3B;WNT5A;TIPARP;NKD1;WWP2;HUWE1;ASB5;HECW2
prerank,negative regulation of phagocytosis (GO:0050765),-0.35404441111439716,-0.96657311778376,0.5186813186813187,0.8678021741205177,1.0,4/17,10.27%,SNX3;DYSF;HMGB1;RACK1
prerank,cobalamin metabolic process (GO:0009235),0.38556853927927903,0.9662457921205022,0.4774774774774775,0.8224893818462955,1.0,2/17,8.88%,MMAB;LMBRD1
prerank,GPI anchor metabolic process (GO:0006505),-0.3277659537398543,-0.9662388090069424,0.5200892857142857,0.8678522473387962,1.0,7/26,15.68%,MPPE1;PIGU;PIGM;PIGQ;PIGH;DPM2;PIGO
prerank,glucan catabolic process (GO:0009251),0.39713374012197106,0.966177338346537,0.48859315589353614,0.82200654825457,1.0,6/15,19.43%,PYGB;MGAM;PYGM;STBD1;PHKB;PHKA2
prerank,protein transport (GO:0015031),-0.2080719006695646,-0.9660673160553732,0.5747126436781609,0.8674250120208898,1.0,89/332,21.22%,LRP1B;PRKCB;ATP6V0A1;TBC1D8;TFRC;NSF;SYNDIG1;STX3;ANK3;MACF1;ARF5;TBC1D30;SCAMP5;ATP6V1B2;SEL1L;ARHGEF2;LMAN2L;STXBP1;RAB6B;STX16;YWHAH;TANGO6;TVP23B;ATP6V0C;RAB3C;RAB38;SCAMP1;ARL1;HERC2;SCG5;HDAC6;GCC2;SCAMP2;SGSM1;NPM1;RAMP2;TMED2;VPS33B;SCG2;CD74;VMP1;SLC10A7;TBC1D22B;ARHGAP1;ATP6V1D;TBC1D14;NAPA;TBC1D8B;VLDLR;RUNDC1;RAB12;RAB5C;EVI5;KIF3B;PPY;MIA2;SNX8;VIPAS39;CHMP1A;CHMP1B;CEP290;TBC1D12;TMED7;DNAJC27;ATP6V0A2;RABL3;BBS2;TVP23A;TBC1D5;LRSAM1;ATP6V1G2;AP3D1;BBS1;NECAB3;CHMP2B;RAB1B;ARF6;SAR1B;ARL4D;RAB15;ATP6V0E2;IFT22;SNX17;TBC1D1;TBC1D2;RAB18;ATP6V1F;ATP6V0D2;ATP6AP1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.31263769984139095,-0.9659505443229756,0.5121951219512195,0.8668430433055891,1.0,11/26,29.58%,PLCG2;RAB27A;SNCA;GRIN1;ABCD2;PARK7;SLC18A2;ADGRB1;SLC30A10;TLR6;ALOX5
prerank,regulation of metal ion transport (GO:0010959),0.39645744882604006,0.9657752458981755,0.4943609022556391,0.8223456568843256,1.0,5/16,14.17%,IL16;BCL2;DLG1;GRIN3B;CACNA2D1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.2642433491944992,0.9652150448700715,0.5140056022408963,0.8230872618222674,1.0,14/116,8.81%,GHRH;ADORA2A;PTHLH;GLP2R;ADCY7;IL6;ADCY5;MC2R;RXFP2;ADCY1;ADM;RAMP1;GPR39;INSL3
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.3620451650568701,-0.9651635510413277,0.5033112582781457,0.8681127290358012,1.0,6/15,11.64%,KDR;VEGFC;F3;VEGFA;SCG2;CXCL12
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2823298302450459,-0.9650985764789941,0.53315649867374,0.8673987618537561,1.0,10/44,12.14%,THBS1;GAS6;SNCA;ARL6IP1;AKT1;VEGFA;PAX2;RPS6KA1;NGF;KLF4
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.23682588033312557,0.9650312658858355,0.5513126491646778,0.8229180325657861,1.0,58/341,15.23%,RNF213;SPSB1;SMURF2;TBL1XR1;RNF217;FBXO11;FBXL17;TRIP12;NEDD4;TGFB1I1;TTC3;NHLRC3;RC3H1;KLHL22;RNF19A;SIAH2;UBE2U;SPSB4;RNF216;CUL4A;ANAPC11;DTX3L;NTAN1;USP9X;RNF20;KLHL15;RNF111;PSMB10;NUB1;UBR4;ANAPC1;PSMA7;AMFR;UBE2C;PSMA3;PSME4;FBXL7;UBXN2A;PSMA5;KEAP1;WWP2;SPOPL;HUWE1;IFI27;CUL3;FBXW11;BTRC;HECW2;ARRB1;CDC27;RNF43;BFAR;KCTD5;FBXL4;UBE2R2;BIRC6;RCHY1;PML
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.3255464510341984,0.964701289020891,0.5374376039933444,0.8231113630929103,1.0,10/39,15.65%,BMP6;BMP2;MIA3;PPARA;SPINT2;MYADM;PTK2;MAP2K5;WNK1;NF2
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.39986017364997467,-0.9639722148648026,0.4894957983193277,0.8696698303417099,1.0,3/11,14.45%,C1QTNF3;SIK1;PGP
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.3033861071719843,-0.9639402672946908,0.5197044334975369,0.8688408465997729,1.0,5/33,9.71%,TFRC;AKT1;PINK1;PRELID1;GHITM
prerank,"transcription, DNA-templated (GO:0006351)",0.25081278579231775,0.9639060722776284,0.5614266842800528,0.8243744919417961,1.0,41/207,16.48%,SOX5;MLLT3;MAF;POLR2D;GLIS3;PIR;NCOA6;BAZ2A;DTX1;CREBL2;CDC73;POLR1C;TRIM24;MEF2A;CCNH;MNAT1;CDK7;EPC1;TAF7;NOCT;HIPK3;TCEA1;IWS1;POLR2C;FOXO3;RTF1;THAP1;NFIC;PAF1;MED20;PKNOX1;POLR2F;GTF2H4;ERCC6;SNAPC3;LEO1;MLLT1;IRF9;TAF9;DDX21;POLR3H
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.2804182207593183,0.9638122877407984,0.5372492836676218,0.823959378891477,1.0,17/78,16.54%,PRICKLE1;RNF217;ZYG11B;RNF19A;GSK3B;NUB1;PIAS1;SGTA;LRRK2;SUMO1;KEAP1;HECTD1;TRIB1;DDA1;RCHY1;DAB2;RNF180
prerank,microtubule anchoring (GO:0034453),0.41797625348449136,0.9632510572362977,0.5077519379844961,0.8246526551445152,1.0,2/12,5.16%,DAG1;CLASP1
prerank,regulation of nervous system process (GO:0031644),-0.3445168519732144,-0.9632505115053854,0.5145228215767634,0.8698281150398988,1.0,4/18,4.20%,NOS3;HTR2C;DLGAP1;DLGAP2
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.38078667739974703,0.9629006864851049,0.4971857410881801,0.824853569698084,1.0,3/18,13.27%,ROCK2;EPHA4;EFNA1
prerank,camera-type eye morphogenesis (GO:0048593),-0.41052850927703666,-0.9625802745001808,0.5177865612648221,0.8707797869307421,1.0,4/10,9.55%,TENM3;TBX2;VEGFA;LRP6
prerank,regulation of primary metabolic process (GO:0080090),0.26308442231435414,0.962306828888515,0.5424200278164116,0.8256664403733182,1.0,14/126,10.43%,CHD9;ROCK2;C1QTNF2;TBL1XR1;NFYC;NCOA6;CREBBP;PPARA;LACTB;PSMB10;PSMA7;PSMA3;PSME4;PSMA5
prerank,cAMP metabolic process (GO:0046058),0.39663216841880433,0.9621348886129398,0.5046040515653776,0.8254794837429177,1.0,6/13,16.08%,PTHLH;ADCY7;ADCY5;ADCY1;EPHA2;ADCY6
prerank,positive regulation of cellular process (GO:0048522),0.23037396293160176,0.9619653724109726,0.5869324473975637,0.8252659719791539,1.0,59/565,9.42%,EFNB2;PDPN;BMP6;PTN;DPP4;CAMK1D;PDGFRA;CCN2;FN1;FGFR1;COLEC12;FGF1;PRKAA2;IL31RA;NUPR1;CXCL16;IL6ST;GAB2;PHIP;GHRH;FPR2;APOA2;WNT3A;OSM;IL11;IL34;FER;VEGFD;TGFA;PTHLH;GLP2R;IL6;BCL2;GLI1;TPM1;TLR4;TGFBR1;MMP14;KLHL22;STOX1;EPHA1;PDGFRB;HDAC4;CD47;CTSH;TGFBR2;STAMBP;WNT5A;NOXO1;ECHDC3;RIPK2;EPHA4;MST1R;IL13RA1;USP47;TLR2;ANKRD17;DNAJA2;IGF2
prerank,morphogenesis of an epithelium (GO:0002009),-0.31978248437941237,-0.9618727296219483,0.5249406175771971,0.8718569503175059,1.0,6/25,9.58%,ACTB;LAMA3;ACTG1;AHI1;LRP6;PRKX
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.32117296719548605,0.9617780671969811,0.49917627677100496,0.8250643714128552,1.0,5/34,10.27%,DOCK5;NRP1;S100A10;MYADM;TRIOBP
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2827883459417417,0.9616482175906418,0.5294117647058824,0.8247580708395874,1.0,14/80,12.88%,PRICKLE1;ANGPT1;CRY1;MYCBP2;SPSB4;BIRC3;RIPK2;LRRK2;FBXO4;FANCM;CENPX;HUWE1;CUL3;TBC1D7
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.40458731898955724,-0.9616122961603726,0.49710982658959535,0.8716216540778635,1.0,3/10,14.04%,SNCA;HDAC6;AOC3
prerank,myeloid cell differentiation (GO:0030099),0.31212753048112885,0.9615717650038201,0.5318471337579618,0.8243255949699699,1.0,15/47,18.53%,MPIG6B;IL11;KIT;UBA5;NCOA6;PTPN2;CDKN2B;ACIN1;TET2;KAT6A;ALAS2;INHA;HSPA9;ATP5IF1;CASP3
prerank,positive regulation of superoxide anion generation (GO:0032930),0.41045284798874065,0.9615644718080016,0.5316698656429942,0.8237354092446789,1.0,2/13,4.88%,FPR2;CRP
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.3540944915179888,-0.9613479304029534,0.5074309978768577,0.8714375211917862,1.0,5/17,13.12%,RYR2;NEDD4L;KCNJ8;KCNQ1;KCNE4
prerank,small GTPase mediated signal transduction (GO:0007264),0.27500067952772694,0.9612864398712855,0.5128939828080229,0.8238007019331828,1.0,17/103,10.65%,RIN2;TIAM2;PLD1;ARHGAP18;KSR1;RRAS2;ARHGAP32;NTN1;ARL3;SIAH2;PLCE1;RALBP1;RRAD;RALGDS;USP8;MAPK14;NUCB2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.31256127005368667,0.9612365010279119,0.5103668261562998,0.8233135761632574,1.0,6/48,7.46%,PRKAG2;GCGR;RANBP2;TPR;NOS2;JMJD8
prerank,calcium ion transport into cytosol (GO:0060402),-0.3331517057800806,-0.96104536012953,0.5158371040723982,0.8713507021868159,1.0,5/21,9.47%,RYR2;GRIN2A;SLC8A1;GRIN2B;GRIN1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.40667344457612337,0.9610153086104406,0.5028571428571429,0.823201605439745,1.0,6/14,23.16%,LRRK2;BCL2L1;OPA1;XBP1;SYVN1;TXNDC12
prerank,sulfur compound biosynthetic process (GO:0044272),0.2662233021071586,0.9608946928172123,0.5151953690303908,0.8228742433855342,1.0,12/104,8.74%,UST;CHST15;GGTA1;DCN;ANGPT1;OMD;DSE;CHSY1;B4GALT1;GSTK1;GLCE;PRELP
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.34583647699861153,0.960754089139837,0.5215231788079471,0.822611478824444,1.0,8/29,17.34%,TENT5A;PKP3;DHX34;NOCT;EIF4ENIF1;FUS;AXIN2;GDNF
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.3842503160471944,0.960606669590225,0.5215827338129496,0.8223462217991849,1.0,8/16,25.55%,RC3H1;MOV10;CPEB3;DHX36;KHSRP;ZC3H12A;ZFP36L2;ZFP36L1
prerank,microtubule-based transport (GO:0099111),-0.38634753311650605,-0.9602225865483884,0.525879917184265,0.8727068073525432,1.0,7/12,33.69%,DYNC1I2;ADCY10;SPAG17;HTT;CABYR;DNAAF2;CCDC40
prerank,positive regulation of proteolysis (GO:0045862),0.2964332459926925,0.9600757706727272,0.5195783132530121,0.8229661350233617,1.0,16/55,21.91%,SH3D19;NRDC;CTSH;SNX9;CCBE1;FBXW11;BTRC;HDAC2;ADRA2A;ATP5IF1;CYFIP2;TNIP1;ASPH;RCN3;IST1;ZC3H12A
prerank,protein deacetylation (GO:0006476),0.31555117315404135,0.9598606040419653,0.5331125827814569,0.8228382989291464,1.0,15/41,21.50%,TBL1XR1;MIER3;BAZ2A;MIER1;HDAC4;SIRT4;PRDM5;RBM14;HDAC2;TBL1X;MIDEAS;SIRT3;SIRT2;RCOR1;MTA3
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.39384119330109335,0.9597806961763334,0.5084427767354597,0.8224096929763114,1.0,1/15,2.13%,APOA2
prerank,RNA destabilization (GO:0050779),0.37068241252497675,0.9596328856287578,0.5135623869801085,0.8221317259000239,1.0,4/18,14.46%,ROCK2;FTO;METTL16;GIGYF2
prerank,positive regulation of lipid kinase activity (GO:0090218),0.34000447610336965,0.9594752276888411,0.4982758620689655,0.8218950483648244,1.0,5/29,5.76%,PDGFRA;AMBRA1;EPHA8;KIT;PDGFRB
prerank,glycine metabolic process (GO:0006544),0.41579577968593406,0.9594192740282772,0.5236294896030246,0.8214394087710735,1.0,2/12,7.60%,SHMT1;AMT
prerank,sodium-independent organic anion transport (GO:0043252),-0.40414275868482297,-0.9594021802585181,0.5214723926380368,0.8740880308089041,1.0,2/10,1.09%,SLCO1C1;SLCO2A1
prerank,ubiquinone biosynthetic process (GO:0006744),-0.3712061323848789,-0.9593882043905947,0.5159235668789809,0.8732106788629802,1.0,7/15,24.04%,COQ9;FDXR;COQ8A;COQ10B;COQ3;COQ5;NDUFA9
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.3259573346860043,-0.9593616759943066,0.5111607142857143,0.8723651813806211,1.0,6/24,13.29%,PECAM1;ITGA4;SEMA4D;SYK;GFUS;F11R
prerank,ESCRT III complex disassembly (GO:1904903),-0.40878473886497424,-0.9593247640731397,0.5170212765957447,0.8706612539042723,1.0,5/10,22.95%,CHMP1A;CHMP1B;CHMP2B;CHMP7;CHMP2A
prerank,ESCRT complex disassembly (GO:1904896),-0.40878473886497424,-0.9593247640731397,0.5170212765957447,0.8706612539042723,1.0,5/10,22.95%,CHMP1A;CHMP1B;CHMP2B;CHMP7;CHMP2A
prerank,regulation of cellular protein localization (GO:1903827),0.3061474740330855,0.9591402250187133,0.5275080906148867,0.8214692847717062,1.0,14/45,19.46%,GPC6;PRKAA2;SPIDR;GPC2;PTPN1;DVL3;HFE;CCDC66;BDNF;GBF1;GPC1;KDM1A;GPC4;SETD2
prerank,protein localization to Golgi apparatus (GO:0034067),-0.30870133414059764,-0.9590734333886123,0.49264705882352944,0.8704390138364464,1.0,5/27,8.15%,CSNK1D;SORL1;PAQR3;ARL1;GCC2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.43040216088908445,0.9589154341878644,0.5188866799204771,0.8213552719736368,1.0,4/10,22.06%,TGFA;ADRA2A;HBEGF;FBXW7
prerank,apical junction assembly (GO:0043297),0.3057543183314717,0.958809667503167,0.5248344370860927,0.82100472009438,1.0,13/53,16.33%,AFDN;CDH5;PARD6G;PARD6A;VCL;CTNNA1;CLDN1;DLG1;RHOC;FBF1;CLDN11;PKN2;PATJ
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.2428113149663816,-0.9586792874636729,0.5476190476190477,0.8705953324097107,1.0,19/80,15.27%,NLGN1;FNBP1L;TENM2;GPM6A;EPS8;PIK3R1;NCKAP1;CCDC88A;CDC42EP3;ARPC2;TGFB3;CDC42EP1;ANLN;CDC42EP5;AGRN;HRAS;WASHC1;RAC1;CCL19
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2699845997903147,0.9582891330895174,0.5309352517985612,0.8216501196031468,1.0,12/109,6.78%,PTPN13;PLEKHA2;PLA2G4A;TPTE;PI4KA;PDGFRB;PLCB3;MTMR3;MTMR11;PLEKHA4;PLA2G4C;PIK3C2A
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.391165497963985,-0.9580346445813461,0.5159362549800797,0.8714181841653476,1.0,8/12,45.94%,CLSPN;HUS1B;TOPBP1;CDC6;TICRR;RAD17;HUS1;SETMAR
prerank,actomyosin structure organization (GO:0031032),0.2810444563115421,0.9580175948068005,0.5296735905044511,0.8216569038736553,1.0,13/75,12.90%,ROCK2;TMOD3;CSRP3;TPM1;CSRP1;EPB41L5;SORBS1;EPB41L2;ACTN2;CUL3;TJP1;ARRB1;FRMD6
prerank,cellular response to hypoxia (GO:0071456),0.26406241491365506,0.9576775013028255,0.5513888888888889,0.821854911667881,1.0,17/126,10.43%,RORA;GATA6;HIF3A;TERT;ARNT;BMP7;EPAS1;STOX1;CPEB1;CREBBP;NPEPPS;OPRD1;PSMB10;PSMA7;PSMA3;PSME4;PSMA5
prerank,vitamin transport (GO:0051180),0.33279561314944545,0.9575022061477992,0.5130434782608696,0.8216725818355138,1.0,2/29,2.69%,PDPN;SLC19A1
prerank,histone deacetylation (GO:0016575),0.3116237382862155,0.9574789941794093,0.5320197044334976,0.8211207212621225,1.0,14/43,21.50%,TBL1XR1;MIER3;BAZ2A;MIER1;HDAC4;PRDM5;RBM14;HDAC2;ELK4;TBL1X;MIDEAS;SIRT2;RCOR1;MTA3
prerank,limb morphogenesis (GO:0035108),-0.33452361484982973,-0.9573728859690419,0.4801864801864802,0.8723256711333649,1.0,5/20,13.21%,TGFB2;MBNL1;FBXW4;LRP6;BMPR1B
prerank,organelle disassembly (GO:1903008),0.33412018476410643,0.9572100162711742,0.5157545605306799,0.821134991330094,1.0,10/33,21.50%,UBA5;PLK5;KIF5B;KLC1;ATG2A;GBF1;GOLGA2;MCTS1;MRRF;ZFAND1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.2851868474017564,0.9567354665504771,0.540500736377025,0.8216579490064427,1.0,14/75,12.41%,PDPK1;FGFR1;ECM1;NRP1;VEGFD;BMP2;ARNT;TGFBR1;WNT5A;IGF2;AKT3;EGR3;CDH13;NR4A1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.38699636658237246,0.9564648363102423,0.5247148288973384,0.8217101995986855,1.0,4/17,11.25%,BCL2;BAX;DNM1L;BCL2L1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.3613322495231449,0.9562524042653628,0.5220458553791887,0.8215819209299562,1.0,5/22,10.43%,PSMB10;PSMA7;PSMA3;PSME4;PSMA5
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.27609903945235625,-0.9561755436290509,0.5185185185185185,0.8747794579861531,1.0,15/44,23.87%,PTK2B;NCKAP1;LMOD1;ARPC4;CDC42EP3;VASP;CDC42EP1;CDC42EP5;EVL;PYCARD;ARF6;PRKCE;PFN2;CARMIL1;PFN1
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.3717949799765032,-0.9561562133142675,0.5394736842105263,0.8739371890398945,1.0,8/14,42.56%,TNFRSF1B;GRN;PTPRC;TREM2;LDLR;IL4;CST7;TAFA3
prerank,regulation of protein kinase activity (GO:0045859),0.27010609351694914,0.9558709418105233,0.5387994143484627,0.8218705575964204,1.0,15/106,12.08%,PDPK1;DEPTOR;PRKAG2;DDR2;PPM1E;EPHA1;PLCE1;SNX9;DTNBP1;TAF7;UVRAG;RAP2C;PTK2;CSF1;TSPYL2
prerank,stress-activated MAPK cascade (GO:0051403),-0.2556917304650471,-0.955607622974386,0.5315068493150685,0.8744896908133124,1.0,11/61,9.79%,NOD1;MAP3K5;MAPK8;ARHGEF6;MAPK10;MAPK3;MAP3K11;UBB;MAP4K3;MAP3K20;MINK1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.38085891266035293,0.9553437972362828,0.5183150183150184,0.8225056792752523,1.0,5/16,19.04%,PDS5B;POGZ;PDS5A;NIPBL;DSCC1
prerank,regulation of peptide hormone secretion (GO:0090276),0.2868820093196837,0.9553363972401716,0.5230524642289348,0.8219333310752246,1.0,7/67,8.40%,DPP4;RAPGEF4;ITPR1;RFX3;IL6;NOS2;CACNA1C
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.34367688264754304,-0.954821081407909,0.546485260770975,0.8757872774930799,1.0,6/17,9.32%,CACNB2;KCNJ2;SLC8A1;CACNA1G;HCN2;CACNA1D
prerank,protein-DNA complex assembly (GO:0065004),0.2643671637907742,0.9547934153044233,0.527007299270073,0.8225944055004797,1.0,20/116,15.69%,TCF4;ORC5;CUL4A;PSMB10;CCNH;KAT6B;PSMA7;PSMA3;MNAT1;PSME4;CDK7;RPA3;PSMA5;MCM4;GMNN;MCM6;GTF2H4;ORC3;ERCC5;ORC4
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3354555947688115,0.9544463154938245,0.5256198347107438,0.8227561793099687,1.0,2/29,1.56%,RASGRF1;NOTCH2
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.4056357318647862,-0.9544093182496081,0.51931330472103,0.8760069605987572,1.0,6/10,28.76%,INSIG1;YOD1;UBAC2;UBE2J1;SVIP;UBE2G2
prerank,carbohydrate transport (GO:0008643),-0.3924360243129868,-0.95437812176995,0.5384615384615384,0.8751933729483429,1.0,5/11,29.16%,AQP11;SLC50A1;SLC2A2;SLC23A1;SLC23A2
prerank,response to insulin (GO:0032868),0.2813577391772901,0.9543242114957389,0.5370919881305638,0.8224466161134946,1.0,11/80,10.12%,PDPK1;ENPP1;FER;RAB10;TRARG1;SORBS1;CPEB1;EPM2AIP1;INSIG2;RHOQ;OTOP1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.30316948342417616,0.9542023066847991,0.5145631067961165,0.8221565855423056,1.0,14/48,20.33%,ZMIZ1;ELOF1;POLR1C;BAZ1B;POLR1G;SERTAD2;POLR2F;ERCC6;MYO1C;KAT2B;DDX21;ARID1B;POLR2K;SPHK2
prerank,response to amino acid (GO:0043200),-0.297649454208565,-0.9541480261485318,0.5273159144893111,0.8749095038564338,1.0,11/31,25.81%,GLRA3;RRAGB;GRIN1;SPAAR;CPEB4;RRAGC;GLRA2;GLRA1;LAMTOR2;NSMF;LAMTOR4
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.3695105284419746,0.9540338388010245,0.5203703703703704,0.8219686869782102,1.0,4/18,17.60%,ANXA1;KLF9;NR3C1;PCK2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.25203053307050854,-0.9539690022992967,0.5589123867069486,0.8744972464185832,1.0,15/71,14.52%,CTSC;CTSB;OTUD7A;LGMN;FAP;HDAC6;UBB;CTSS;BAG6;MALT1;ZRANB1;CTSL;PSMA6;UBA52;PSMA8
prerank,positive regulation of protein import into nucleus (GO:0042307),0.33840939192252584,0.9538607053767139,0.5320623916811091,0.8217860005543235,1.0,3/28,5.97%,SMAD3;ZIC1;TPR
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.28433426321008864,-0.9536461368234994,0.5137844611528822,0.8744670667745377,1.0,9/35,10.45%,TGFB2;MET;DAB2IP;ARHGAP44;RASIP1;MYOC;CCDC125;MFN2;ITGA3
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.3863618384711977,0.9526377929919186,0.5259259259259259,0.824047512411707,1.0,7/16,22.35%,SLX4;SMG5;SMG6;TNKS2;HNRNPA2B1;DHX36;RTEL1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2446148682143428,-0.9525835916332013,0.5498652291105122,0.8764740953236482,1.0,13/84,9.49%,QKI;NOVA2;MBNL1;CELF4;KHDRBS2;RBFOX3;RBFOX1;PTBP1;KHDRBS3;PUF60;HNRNPK;TRA2A;DDX17
prerank,intracellular protein transport (GO:0006886),0.2368712387328349,0.95238422072522,0.5952662721893491,0.8240116010845989,1.0,82/304,22.31%,RANBP3L;WLS;PRICKLE1;TNPO1;COPZ2;ARFGAP3;SNX6;TRAK1;TBC1D16;TRARG1;RAB22A;LAMP2;RAB43;APPL2;TPR;ARF4;SIL1;GRTP1;SRPRA;NGFR;SNX9;SCFD2;PHB2;SLU7;ARF3;AP4E1;STX8;APPL1;STX2;STX11;FUT10;KIF13B;ARCN1;IPO7;COX18;SNX27;EGR2;HOMER3;EIF4ENIF1;SCFD1;STRADB;COPZ1;ARL4A;POM121;TMED9;VPS26C;MYO1C;AP4M1;SEC31A;SAR1A;RAB5A;ARF1;AP3B1;TRIM23;RAN;RANBP17;SEC16A;RPGR;RAB19;WDR11;USP6NL;ARL6;ARFIP2;VPS26B;TBC1D25;SNX15;NUP85;VPS33A;GGA3;UNC93B1;FAM91A1;VPS35;HIKESHI;BAG3;RAB14;MYO6;NAPG;OXA1L;CLIP3;XPO5;PKD1;SEC23IP
prerank,atrioventricular valve morphogenesis (GO:0003181),0.36521398652473175,0.9520133559433207,0.5335892514395394,0.8243025385301023,1.0,9/19,15.82%,BMPR1A;BMP2;TGFBR2;SMAD6;HEYL;SMAD4;EFNA1;MDM4;SOX4
prerank,RNA modification (GO:0009451),-0.2626114305830417,-0.9519554714769318,0.5190217391304348,0.8771891675744515,1.0,20/54,29.56%,ADARB1;PUS7;FTSJ3;THUMPD1;ELP5;QTRT2;PUS3;DTWD2;WDR4;TYW5;CDKAL1;RBM15B;TRMT9B;TRMT6;TFB1M;TRUB1;ADAT2;CTU2;TRMT61A;NOP10
prerank,regulation of spindle organization (GO:0090224),0.37511397213743997,0.9518080028954368,0.5165441176470589,0.8241989308066076,1.0,5/18,13.16%,MAP9;PARP3;FSD1;SENP6;PSRC1
prerank,negative regulation of cellular senescence (GO:2000773),-0.3655430937976327,-0.9514330314618518,0.52,0.8777753896742702,1.0,3/13,7.40%,CDK6;YBX1;RBL1
prerank,protein localization to cell junction (GO:1902414),0.3592365443455019,0.9513564724690637,0.5206463195691203,0.8246609177619253,1.0,5/22,12.64%,CGNL1;HEG1;NLGN2;JAK1;TJP1
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3237893055974764,-0.9513556353016989,0.5254629629629629,0.8761904395418643,1.0,9/22,28.58%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;ZDHHC4;GOLGA7B
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3237893055974764,-0.9513556353016989,0.5254629629629629,0.8761904395418643,1.0,9/22,28.58%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;ZDHHC4;GOLGA7B
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.39978943046087045,-0.9506957360579452,0.51931330472103,0.8771075633052037,1.0,8/11,36.37%,ARL6IP1;VCPIP1;ATL2;STX18;TRDN;BNIP1;LPCAT3;MOSPD3
prerank,transition metal ion homeostasis (GO:0055076),0.3383659573529751,0.9506615098456447,0.5261324041811847,0.8256310567696712,1.0,1/28,0.18%,CP
prerank,generation of neurons (GO:0048699),0.24942740558392157,0.9505875411187626,0.5688311688311688,0.8251994554279788,1.0,21/190,7.87%,WNT4;DCDC2;FGFR1;WNT6;AUTS2;WNT2B;WNT10B;WNT3A;NRP1;SH3RF1;FZD2;SDCCAG8;WNT5B;EN2;NIF3L1;BTG4;OTP;CELSR1;USP9X;YAP1;WNT5A
prerank,regulation of fibrinolysis (GO:0051917),-0.3800967717031529,-0.9504947383739736,0.5290322580645161,0.8767729669509666,1.0,3/13,13.41%,THBS1;FAP;USF1
prerank,protein targeting to membrane (GO:0006612),-0.24682097651502646,-0.9503817876019863,0.5350877192982456,0.8761572798922458,1.0,34/83,28.91%,ARL6IP1;AQP11;VPS37B;SRP14;SDCBP;ZDHHC14;ZDHHC20;ATAD1;PEX26;ZDHHC2;TRAM1;GDAP1;NACA;ZDHHC24;RABGEF1;ABCD2;SSR2;VPS37A;PEX16;ZDHHC7;PEX19;SEC61A1;YIF1B;PXMP4;ZDHHC23;SGTB;TAOK2;ZDHHC9;PEX3;RAB8B;PEX11B;ZDHHC4;GOLGA7B;NACAD
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.3846475781932219,-0.9499586067537872,0.5071868583162218,0.8764343830973759,1.0,5/12,18.77%,HMGB1;MBP;CD74;KLF4;LPL
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.37910277285864236,-0.9494150013095768,0.5195652173913043,0.8770036227707596,1.0,3/13,5.01%,CACNB2;KCNJ3;GJC1
prerank,regulation of multicellular organismal development (GO:2000026),0.34608586629288224,0.9493424243176365,0.5401069518716578,0.8275489099793075,1.0,4/25,11.50%,PTN;TRIP12;MYSM1;OAS2
prerank,regulation of aerobic respiration (GO:1903715),-0.36178706707968644,-0.9490591362669382,0.5426695842450766,0.8770506084982036,1.0,2/15,7.95%,CBFA2T3;PINK1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.3062335141244808,-0.9487541019843911,0.5302663438256658,0.8770202997483617,1.0,10/27,23.35%,MAP3K5;MAPK8;MAPK3;UBB;MAP3K20;UBA52;KAT7;IKBKB;TAOK2;SKP1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.4009092462945069,0.9486478393910922,0.5357833655705996,0.8285331225245499,1.0,2/14,9.60%,CMPK2;AK5
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.39519029324822985,-0.9484793082646115,0.5440313111545988,0.8768629060022342,1.0,7/11,42.12%,SORL1;MTMR2;MSN;EZR;PTPN23;EIPR1;RDX
prerank,metanephros development (GO:0001656),0.34469220199698186,0.948275250249111,0.5328596802841918,0.8287955326618127,1.0,4/26,6.89%,FOXD1;OSR1;BMP7;CTSH
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.2619911369978002,-0.9479142801208318,0.5619596541786743,0.8774835544113192,1.0,11/56,15.34%,PLCG2;NOD1;CTSB;HMGB1;LGMN;UBB;CTSS;S100A1;CTSL;UBA52;NOD2
prerank,negative regulation of platelet activation (GO:0010544),-0.36378639303025506,-0.9476038782342054,0.5413223140495868,0.877462261612656,1.0,3/16,7.50%,PRKG1;NOS3;CEACAM1
prerank,cellular response to dsRNA (GO:0071359),0.38296924748293193,0.9467422134692796,0.5107142857142857,0.8317493963233279,1.0,4/15,15.88%,COLEC12;IFIT1;IFIH1;MUL1
prerank,response to alcohol (GO:0097305),-0.30470070765504187,-0.9465630386711879,0.5288888888888889,0.8794006290587577,1.0,7/27,15.27%,SLIT2;GRIN3A;GRIN2A;GRIN2B;GRIN1;SOD1;CCL19
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3780748364749104,0.9463172359329382,0.5238970588235294,0.8315230715696971,1.0,7/15,25.55%,TNRC6B;NANOS2;CPEB3;DHX36;NANOS1;ZFP36L2;ZFP36L1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3780748364749104,0.9463172359329382,0.5238970588235294,0.8315230715696971,1.0,7/15,25.55%,TNRC6B;NANOS2;CPEB3;DHX36;NANOS1;ZFP36L2;ZFP36L1
prerank,tRNA processing (GO:0008033),-0.25621817299886407,-0.946052123809788,0.5532544378698225,0.8799182423547564,1.0,23/61,30.17%,CSTF2;KARS1;THUMPD1;ELP5;RPP30;QTRT2;PUS3;DTWD2;WDR4;TSEN54;TYW5;CDKAL1;TRMT9B;TRMT6;TRUB1;TRMT10C;CPSF1;ADAT2;POP7;CTU2;TRMT61A;TSEN34;ADAT1
prerank,regulation of ruffle assembly (GO:1900027),-0.3182699524456207,-0.9454103653472521,0.5315315315315315,0.8807282706809682,1.0,10/23,23.87%,NLGN1;EPS8;ABI3;CAV1;HRAS;EVL;ARHGAP24;PFN2;FAM98A;PFN1
prerank,negative regulation of leukocyte activation (GO:0002695),0.3870655449222403,0.9451316117671468,0.5277777777777778,0.8337377419549306,1.0,2/15,6.10%,IL31RA;NR1H3
prerank,histone H3 acetylation (GO:0043966),-0.28247244916329106,-0.944856498303436,0.5403422982885085,0.881313953089629,1.0,13/40,25.70%,LEF1;TADA2A;JADE3;JADE1;BRCA2;TAF5L;KAT7;KAT2A;SGF29;ING4;BRPF1;POLE3;PHF14
prerank,negative regulation of endocytosis (GO:0045806),-0.3177137779922406,-0.9448539391719893,0.5443645083932853,0.8804393010235739,1.0,11/24,27.84%,MCTP1;SCAMP5;CAV1;PRKD1;RAC1;LRSAM1;ARF6;MTMR2;SNX33;NR1H2;LILRB1
prerank,cellular response to oxidative stress (GO:0034599),-0.22752089701239292,-0.9447052100469124,0.5756578947368421,0.8799458166488607,1.0,26/118,15.58%,PTPRK;FOXO1;PRR5L;SETX;SNCA;MAPK8;RPS3;CPEB2;MSRA;NCF2;MAPK3;CHCHD2;AKT1;PINK1;NUDT2;ATF4;PYROXD1;EGFR;CYBB;PPIA;PRKD1;SOD1;ERO1A;PYCR2;PARK7;MAPT
prerank,positive regulation of metabolic process (GO:0009893),-0.2308843261334542,-0.9446079053321422,0.5928338762214984,0.8792746470154965,1.0,20/103,13.05%,ADIPOR2;EBF2;INSR;GATM;PRDM16;KSR2;GNAS;UCP2;VEGFA;DYNC1H1;MFN2;ADRB2;GADD45G;CAV1;ACACA;SYK;CMKLR1;ACLY;PRLR;SCD
prerank,positive regulation of mitochondrion organization (GO:0010822),0.2942350681989819,0.944505619110288,0.5507692307692308,0.8345596971017998,1.0,10/57,15.88%,MCU;DCN;RALBP1;GSK3B;PDCD5;BAX;DNM1L;ZNF205;MIEF1;MUL1
prerank,positive regulation of programmed cell death (GO:0043068),0.24016462347279072,0.9442564221903472,0.6027568922305765,0.8345089658327683,1.0,38/272,11.67%,IGFBP3;PAWR;AKAP13;TIAM2;PHLDA1;WNT10B;PRF1;FGD4;PNMA3;IFIT2;ADAMTSL4;ZBP1;DAPK1;BMP2;APBB1;IL6;LATS2;UNC13B;TNFRSF12A;NOS2;PLEKHG2;USP27X;PDCD5;NGFR;BAX;ARHGEF11;QRICH1;UBE2Z;CALHM2;LRRK2;STK3;ARHGEF12;PPID;SOS2;NGEF;DNM1L;ANO6;FOXO3
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.3344961521342391,-0.9438855426555866,0.5231481481481481,0.8804114321103611,1.0,5/20,10.16%,RPS6KA5;DIP2B;TADA2A;MAPK3;NOS1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.32709143391424167,-0.9438761264904707,0.5424107142857143,0.8795514840731127,1.0,10/22,35.70%,ESR1;PSMC3;MED30;PSMC6;PSMC5;SRF;MED13;TP53;PAXIP1;SUB1
prerank,positive regulation of filopodium assembly (GO:0051491),0.349851912075275,0.9437807757123766,0.5384615384615384,0.834951974763112,1.0,3/24,2.87%,DPYSL3;DOCK11;NRP1
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.255507584003451,-0.943500720918885,0.5925925925925926,0.8796755872122646,1.0,28/62,26.35%,MEF2C;MEIS2;PRKCB;THBS1;PTK2B;H3-3A;PRKCQ;CDK6;ZBTB16;HOXB8;ZFPM1;LYN;HDAC1;CBFB;FES;NR4A3;KMT2B;RUNX1;L3MBTL1;PURB;ASH2L;RBBP5;TNRC6C;HOXA9;EIF6;PRMT6;DPY30;MYL9
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.2378382877722726,-0.9433353920620946,0.5798816568047337,0.879225442607934,1.0,37/84,34.74%,PSMC3;CDC26;UBB;PSMD3;PSMD14;PTTG1;PSMD6;PSMD4;PSMA6;PSMA4;UBE2E1;PSMB8;UBA52;PSMA8;CDK2;BUB1B;PSME1;UBE2D1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;ECRG4;PSMD8;PSMD11;ANAPC2;ANAPC15;AURKA;CDK1;PSMD5;PLK1;CDC20;FBXO31;BUB3;PSMC1;PSMD2
prerank,pinocytosis (GO:0006907),-0.40256175820391077,-0.9432127229923252,0.5577299412915852,0.8787207016189539,1.0,5/10,27.26%,DOCK2;PYCARD;CARMIL1;SNX33;AHSG
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.34487900052797094,0.9429415077108511,0.5309090909090909,0.8362890099413708,1.0,4/23,8.39%,PRKAG2;BMP7;STOX1;RIPK2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.3116408000981019,-0.9429240158448645,0.5439814814814815,0.8786142698249877,1.0,3/24,8.64%,ABCG2;ALAS1;SUCLA2
prerank,negative regulation of locomotion (GO:0040013),0.3961223926701303,0.9429051814859254,0.55637707948244,0.8357845748747598,1.0,4/12,7.07%,TACSTD2;FBLN1;PTPN2;SPINT2
prerank,iron ion transport (GO:0006826),-0.2721800240153182,-0.9427526591912757,0.5904255319148937,0.8781829322951574,1.0,17/47,21.22%,ATP6V0A1;TFRC;SLC40A1;FTH1;ATP6V1B2;ATP6V0C;SLC39A14;ARHGAP1;ATP6V1D;TTYH1;SCARA5;ATP6V0A2;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V0D2;ATP6AP1
prerank,negative regulation of nervous system development (GO:0051961),-0.3515219370492967,-0.9426045283482724,0.5315904139433552,0.87765818932542,1.0,4/17,8.76%,ROBO2;NOTCH1;SORL1;B2M
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.37397167093745864,-0.9423567394887766,0.5352697095435685,0.8774610069117584,1.0,3/13,6.88%,STX3;HSP90AB1;RIC3
prerank,artery development (GO:0060840),0.3549775595836776,0.9421818822541649,0.5495495495495496,0.8368881145413364,1.0,4/23,5.09%,ROBO1;NRP1;EFEMP2;TGFBR1
prerank,homocysteine metabolic process (GO:0050667),-0.38793709310821367,-0.9421307017328642,0.513184584178499,0.8771977491179971,1.0,5/11,23.90%,MTHFR;MTRR;CTH;MPST;NOX4
prerank,cellular response to fatty acid (GO:0071398),0.40729061113564313,0.942054283836355,0.5461847389558233,0.8366002052484074,1.0,2/12,12.39%,PID1;DGAT2
prerank,positive regulation of chemokine production (GO:0032722),0.30500174023345966,0.942024627070536,0.5434083601286174,0.8360771703535452,1.0,7/44,9.31%,EIF2AK2;IL6;TLR4;LGALS9;WNT5A;IL18;TLR2
prerank,atrial septum morphogenesis (GO:0060413),-0.4021538775372031,-0.9417032462261257,0.5409836065573771,0.8774886899680722,1.0,4/10,13.65%,TGFB2;BMPR2;ZFPM1;ACVR1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.28424163880133074,0.941134847442721,0.5520361990950227,0.8375162748341599,1.0,10/59,14.78%,ROCK2;TLR4;BIRC3;LY96;RIPK2;TLR2;MAP3K7;TIFA;TICAM1;TBK1
prerank,regulation of organelle organization (GO:0033043),0.27690974639163185,0.9411258152363067,0.5486322188449848,0.8369496223712768,1.0,19/80,20.10%,ZEB2;DIAPH1;STOX1;CLIC4;SYDE1;ARMH3;DNM1L;PTK2;TJP1;TMEM33;TMED9;RAB33B;MYO5A;MUL1;SAR1A;RHOT1;USP6NL;RHOT2;TBC1D25
prerank,protein localization to nucleus (GO:0034504),0.2651352831424908,0.9410866879806803,0.573997233748271,0.8364517185209994,1.0,22/102,18.44%,PRICKLE1;TNPO1;GBP2;WRN;BMP7;MORC3;APPL2;TPR;PHB2;TOR1AIP1;APPL1;IPO7;EIF4ENIF1;PAF1;POM121;PML;COL1A1;RAN;YWHAE;ABCA7;RANBP17;INTS13
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3008115661340305,0.9410097772602524,0.5382113821138211,0.8360383520523397,1.0,11/45,17.17%,PARP9;RC3H1;PKP3;TDRD7;FOXO3;METTL16;GEMIN5;ZC3H7B;MAPKAPK5;APP;PUM2
prerank,positive regulation of cell death (GO:0010942),0.28863139735793275,0.940456909712657,0.5700636942675159,0.8366986868761199,1.0,7/59,9.18%,EFNB2;SLC6A13;GSK3B;WNT5A;RIPK2;LRRK2;HEBP2
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.35507414289628064,0.9401947923230467,0.5470383275261324,0.8367326611589734,1.0,3/20,11.18%,NR2F2;LATS2;IPO7
prerank,Golgi ribbon formation (GO:0090161),-0.36858054337912644,-0.9401536654103952,0.5517241379310345,0.880666147311205,1.0,7/13,27.83%,STX16;GCC2;MYO18A;VTI1A;PRMT5;TMED5;GOLPH3
prerank,lipid droplet formation (GO:0140042),0.42262514416146074,0.9401073035287218,0.5372233400402414,0.8363420963313838,1.0,2/10,6.62%,SMIM22;PLA2G4C
prerank,lymphocyte mediated immunity (GO:0002449),0.39404769393312494,0.9400622144290143,0.525830258302583,0.8358574350444592,1.0,1/12,2.57%,CD55
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.2347808396141342,-0.9398419123266749,0.5945121951219512,0.8806421304641953,1.0,17/90,13.05%,ADIPOR2;EBF2;GATM;PRDM16;KSR2;GNAS;UCP2;VEGFA;DYNC1H1;MFN2;ADRB2;GADD45G;CAV1;SYK;CMKLR1;PRLR;SCD
prerank,response to ionizing radiation (GO:0010212),0.2824781711876674,0.9397615970920336,0.5540334855403348,0.8359561365155205,1.0,14/70,15.55%,EYA1;XRRA1;NHEJ1;ANXA1;IKBIP;SPIDR;XRCC4;NABP1;MAPK14;RFWD3;INTS3;RAD9A;UIMC1;FIGNL1
prerank,amyloid fibril formation (GO:1990000),-0.2631749824676137,-0.9396181747473424,0.5793450881612091,0.8803604755745558,1.0,9/51,8.76%,CST3;FKBP1A;H3-3A;SNCA;TGFBI;SORL1;TSPAN14;UBB;B2M
prerank,regulation of T cell proliferation (GO:0042129),0.28500345147225176,0.9388139085119782,0.5687789799072643,0.8374862200392215,1.0,7/61,8.19%,IL6ST;IL23R;ANXA1;IL6;FOXP3;VCAM1;CD274
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.2772884390144327,-0.9386410875400997,0.5725190839694656,0.8821367918447633,1.0,8/39,12.24%,EFR3B;ITPKB;PIK3R1;PIK3C2B;PIK3R3;IP6K2;PI4K2A;PIK3CD
prerank,receptor internalization (GO:0031623),-0.27611508287454933,-0.9386246871285587,0.5322997416020672,0.8813154676526824,1.0,10/44,12.31%,DNM3;TFRC;SNCA;SCYL2;CEACAM1;RAMP2;LDLRAP1;FCER1G;CAV1;SYK
prerank,positive regulation of protein transport (GO:0051222),-0.2497859332996531,-0.9384230846809611,0.5452127659574468,0.8809395390564233,1.0,20/67,20.41%,TGFB2;PRR5L;ACSL3;FRMD4A;ATP2C1;OAZ1;OAZ2;TGFB3;PCNT;RACK1;PPIA;MYO18A;MYOM1;EXPH5;CEP290;ADAM8;ARF6;SYTL4;VPS28;TTN
prerank,cellular response to interleukin-1 (GO:0071347),-0.22008992974234098,-0.9379166928072773,0.6717557251908397,0.8814692959051993,1.0,35/143,21.90%,PLCB1;ST18;RPS6KA5;IL1R1;NOD1;IL1RAP;PSMC3;DAB2IP;MAPK3;CCL14;UBB;PSMD3;PSMD14;PSMD6;PSMD4;PSMA6;CD40;PSMA4;PSMB8;PTGIS;UBA52;PSMA8;CCL19;NOD2;PSME1;PYCARD;TOLLIP;IRAK1;UPF1;IKBKB;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1
prerank,cardiac atrium morphogenesis (GO:0003209),-0.3512633462490848,-0.9376330984128819,0.5111607142857143,0.8813392258903419,1.0,4/16,8.95%,TGFB2;BMPR2;NOTCH1;ZFPM1
prerank,DNA geometric change (GO:0032392),0.3431857165479334,0.9376246248880266,0.5615942028985508,0.8396290932111913,1.0,11/24,24.40%,ANXA1;WRN;ASCC3;RAD50;SUPV3L1;HNRNPA2B1;DNA2;DHX36;RTEL1;DHX9;ZRANB3
prerank,cellular response to glucose starvation (GO:0042149),0.30553891218526047,0.9373926083038107,0.5468998410174881,0.8395382314121952,1.0,8/41,14.48%,PRKAG2;PRKAA2;MTMR3;RRP8;FOXO3;SESN1;EIF2AK3;NUAK2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.4262317477376242,0.9371871243891498,0.5533596837944664,0.8394151412694705,1.0,2/10,3.13%,FOXC1;NCOA3
prerank,mRNA catabolic process (GO:0006402),0.3033172487909163,0.9369411127722942,0.55,0.8393802816933242,1.0,9/44,13.44%,TUT4;RC3H1;DHX34;NANOS2;DCP2;XRN1;SLFN14;METTL16;SUPV3L1
prerank,glycerophospholipid metabolic process (GO:0006650),-0.24905659767894556,-0.9368680078203574,0.589041095890411,0.8825327779849116,1.0,26/75,24.35%,GPCPD1;PLCB1;DGKH;SERINC1;GDPD1;ABCA3;SERINC5;ENPP6;PIGM;PIGQ;PIGH;DPM2;CSF1R;PGP;GDE1;PLCG1;ABHD6;PNPLA6;CPNE7;PNPLA3;PIGB;PLA2G4F;CLN3;PLA2G7;SYNJ1;HDHD5
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3322819999435307,-0.9365922901457335,0.5503355704697986,0.8823968627309896,1.0,9/20,23.35%,SYNE1;TAF3;TAF8;BARD1;PARK7;ARL2;BCL3;CHCHD10;SKP1
prerank,T cell homeostasis (GO:0043029),-0.4061755545602763,-0.9362140795474858,0.5356415478615071,0.8825502278818075,1.0,6/10,28.10%,AKT1;FAS;ZC3H8;JAK3;FADD;PMAIP1
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.29111941178760975,-0.9360952400883049,0.5591939546599496,0.8820178082829193,1.0,9/36,14.57%,SGMS1;CRADD;TPD52L1;RPS3;DAB2IP;FAS;TRAF7;PPIA;CYLD
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3239490582609388,0.9360135400642848,0.5648464163822525,0.8408881404533275,1.0,8/33,13.27%,DPP4;FOXC2;EPHA8;SERPINE1;PLAU;PTK2;EPHA2;EFNA1
prerank,regulation of type I interferon production (GO:0032479),0.27169705068037886,0.9356146920361789,0.5705794947994056,0.8411669320019206,1.0,33/84,27.31%,TRIM56;ZBP1;DTX4;IKBKE;PTPN22;RNF216;CREBBP;POLR1C;NLRX1;POLR3F;TRIM21;POLR2F;TBK1;IFIH1;POLR3H;RNF135;PCBP2;DHX36;POLR2K;NLRP4;GAPDH;OTUD5;TAX1BP1;DHX9;TRIM32;POLR3B;STAT6;POLR2H;UBE2L6;CRCP;CGAS;ISG15;NFKB1
prerank,transcription by RNA polymerase I (GO:0006360),0.3256282549605263,0.9352887664971236,0.5370370370370371,0.8412997943070821,1.0,17/34,27.07%,POLR1C;CCNH;MNAT1;CDK7;POLR1G;POLR2F;GTF2H4;GTF2H2;CAVIN1;TTF1;POLR2K;UBTF;TAF1;POLR1A;TAF1D;POLR2H;ERCC2
prerank,sulfate transport (GO:0008272),-0.35767917770916946,-0.9352872148462451,0.5442477876106194,0.8832393127734645,1.0,2/14,1.61%,SLC26A7;SLC26A2
prerank,response to interferon-beta (GO:0035456),0.34936689302539004,0.935140468065055,0.5676156583629893,0.8410695672791787,1.0,9/22,24.70%,IKBKE;BST2;STAT1;IFITM1;IFNAR2;SHFL;UBE2K;PNPT1;XAF1
prerank,translational termination (GO:0006415),-0.2332278657182935,-0.9350545264959071,0.6180758017492711,0.8829964351446905,1.0,40/95,35.01%,MRPL4;MRPS18A;GSPT2;MRPL1;MRPS30;MRPS23;MRPL57;MRPL28;AURKAIP1;MTRF1;MRPL35;MRPL47;MRPS5;MRPL34;MRPL23;MRPL9;MRPS31;MRPL52;MRPS2;MRPS12;MRPL11;MRPL49;N6AMT1;GSPT1;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;MRPL54;MRPL32;MRPL43;MRPL2;ERAL1;MRPL24;MRPL37;MRPL30;MRPL45
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.24254776729584243,-0.9350110884664042,0.5761772853185596,0.8822416743280376,1.0,24/72,23.73%,PSMC3;AKT1;PSMD3;PSMD14;MALT1;PSMD6;PSMD4;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;IRAK1;CARD10;DICER1;PSMD7;PSMC6;PSMB5;TNFRSF10B;PSMC5;PSMB1;SKP1;NFKB2;PSMD8
prerank,cellular response to nutrient levels (GO:0031669),0.2883732276948487,0.9346098566276663,0.5671406003159558,0.8416732745253753,1.0,11/62,10.91%,PRKAA2;GCGR;WRN;LAMP2;CARTPT;PPARA;CDKN2B;LRRK2;STK24;NUPR2;FNIP1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.38003475959604105,-0.9345998118746796,0.5493562231759657,0.8825000328515309,1.0,2/12,3.73%,STX3;SNAP25
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.35435460637939786,0.9343068942509709,0.5636042402826855,0.8418102980692346,1.0,3/21,7.82%,EPHA7;BIRC3;NGFR
prerank,dendrite morphogenesis (GO:0048813),0.31111578700770604,0.933961359198532,0.5726210350584308,0.8420135335303873,1.0,6/35,8.31%,PTN;DCDC2;SDC2;MAP6;LRP4;MEF2A
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.26482787925525747,0.9339238538477613,0.5884057971014492,0.8415139174652292,1.0,26/101,20.28%,ROBO1;FGFR1;FGF1;IL34;KIT;CCND3;PDGFRB;ATP2B4;WNT5A;LRRK2;MST1R;PIK3R5;FGF18;MAP2K1;PARP16;PSRC1;MTCP1;PKD2;ADRA2A;PPP2CA;TENM1;MAPRE3;CCNY;DIRAS1;ERBB2;SLC27A1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.3819684798416541,0.9335395320215228,0.5850467289719626,0.8417847541308543,1.0,3/14,3.51%,FOXC1;NRP1;VEGFD
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.33866752100633307,0.933303820439661,0.5581395348837209,0.8417457496821968,1.0,12/24,22.28%,SEC23A;SEC24D;TAPBP;ERAP1;SEC24C;HFE;SEC31A;SEC24B;TAP2;PDIA3;ABCB9;BCAP31
prerank,negative regulation of neuron differentiation (GO:0045665),-0.31995401580296157,-0.9330525478522932,0.5928411633109619,0.8857215621078363,1.0,8/22,19.89%,CNTN4;B2M;CALR;HEY1;HES1;NEPRO;DLL1;SOX2
prerank,mitochondrial translational elongation (GO:0070125),-0.2359516317150915,-0.9330044736321799,0.6311239193083573,0.8849914444472794,1.0,41/88,37.55%,MRPL4;GFM1;MRPS18A;MRPL1;MRPS30;MRPS23;MRPL57;MRPL28;AURKAIP1;MRPL35;MRPL47;MRPS5;MRPL34;MRPL23;MRPL9;MRPS31;MRPL52;MRPS2;MRPS12;TUFM;MRPL11;MRPL49;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;MRPL54;MRPL32;MRPL43;MRPL2;ERAL1;MRPL24;MRPL37;MRPL30;MRPL45;MRPS24;MRPS15;MRPL12
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.3746601602890367,0.9328427530457816,0.5688729874776386,0.8421955866419261,1.0,3/16,6.49%,ADCY7;APPL2;PPARA
prerank,striated muscle cell development (GO:0055002),-0.3611283062606163,-0.9320875482415385,0.5448717948717948,0.8865979935621373,1.0,2/14,6.12%,PGM5;LMOD1
prerank,positive regulation of double-strand break repair (GO:2000781),0.3092002320285866,0.9319285398537183,0.5641025641025641,0.8437424345410486,1.0,16/39,24.20%,PARP9;PARP3;DTX3L;SPIDR;SLF2;FUS;ERCC6;MGMT;SHLD2;KMT5C;RIF1;SPIRE1;KMT5B;ARID2;SMCHD1;ZCWPW1
prerank,cellular response to UV (GO:0034644),-0.24498918310583714,-0.9318713172511738,0.6068376068376068,0.8862611126633999,1.0,28/76,32.98%,PTPRK;RPL26;STK11;NPM1;YY1;ATF4;COPS9;CASP9;BMF;CDKN1A;MMP1;MFAP4;N4BP1;CHEK1;NOC2L;POLD1;POLK;DDB2;ATR;TIMP1;RHNO1;HYAL3;PCNA;MYC;TP53;HYAL2;TMEM161A;RUVBL2
prerank,histone H3-K36 demethylation (GO:0070544),0.4128935133600733,0.9318710854102286,0.562962962962963,0.8432767587121105,1.0,4/10,15.68%,KDM7A;KDM2A;KDM8;KDM2B
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.3052951606401593,-0.9311012159315534,0.5802752293577982,0.8873559398882858,1.0,7/25,12.77%,INSR;KLF2;NOS1AP;HSP90AB1;AKT1;KLF4;HSP90AA1
prerank,tetrapyrrole metabolic process (GO:0033013),0.36695718764901397,0.9310931463809775,0.5361010830324909,0.8444644107926399,1.0,2/18,8.88%,MMAB;LMBRD1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.35171264490197074,0.9308417932691411,0.552536231884058,0.8444434181877776,1.0,4/22,12.71%,CD55;IL23R;FBXO38;MAP3K7
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.38023919861553335,-0.9307273291326762,0.5826446280991735,0.8874148854602024,1.0,4/11,12.24%,MEF2C;RAPGEF2;LYN;PIK3CD
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.2912392243943842,-0.9306477164057686,0.6032863849765259,0.8867575773354189,1.0,8/30,15.30%,ELOVL5;ELOVL7;ABCD4;TECR;TECRL;ACSBG1;ABCD2;HACD3
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.3159558961466151,-0.9303966432043262,0.5751633986928104,0.8865365962250081,1.0,2/23,7.50%,GAS6;CEACAM1
prerank,mitochondrial fission (GO:0000266),-0.34932357479482834,-0.9302719801461767,0.5717344753747323,0.886009006198256,1.0,3/16,10.90%,DNM3;MFF;GDAP1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.2569802876921803,0.9301008515898902,0.5916905444126075,0.8454993507149747,1.0,14/117,8.81%,GHRH;ADORA2A;PTHLH;GLP2R;ADCY7;IL6;ADCY5;MC2R;RXFP2;ADCY1;ADM;RAMP1;GPR39;INSL3
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.29207724643300115,-0.9296649412847267,0.5291375291375291,0.886819938702837,1.0,18/35,30.49%,FAR2;HMGCS2;GGT5;ACACA;ACLY;SCD;GGT7;GGT1;HPGD;HSD17B8;GCDH;HMGCLL1;BDH1;FASN;HMGCL;ALOX5;BDH2;ALOX5AP
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.2751306712507115,0.928952803320865,0.5852187028657617,0.8475041958981749,1.0,11/74,10.43%,RBPJ;HIF3A;ARNT;EPAS1;STOX1;CREBBP;PSMB10;PSMA7;PSMA3;PSME4;PSMA5
prerank,axonal transport of mitochondrion (GO:0019896),-0.3863248693539869,-0.9288216615692378,0.5662921348314607,0.888161604020498,1.0,2/11,2.75%,SYBU;ACTR10
prerank,steroid metabolic process (GO:0008202),0.2751405422319907,0.9285084976340537,0.5738993710691824,0.847915913833146,1.0,12/72,17.51%,CYP7B1;HSD17B1;CYP27A1;RDH5;NPC1;AMACR;SCP2;HSD17B14;STAR;CUBN;SULT1A1;GBA2
prerank,dendritic cell chemotaxis (GO:0002407),-0.35962151883554316,-0.9282298623682583,0.5572033898305084,0.8888516095643689,1.0,11/14,46.36%,HMGB1;CCL19;TRPM2;CCL5;PIK3CG;CCR1;CCR5;CCR6;CXCR2;TRPM4;CCR2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.2748057867848015,-0.928112567444668,0.5859375,0.8882920455388422,1.0,10/39,16.43%,PTPRJ;SH3KBP1;DAB2IP;SH3GL2;LGMN;CBL;ARHGEF7;EGFR;RNF126;EGF
prerank,piRNA metabolic process (GO:0034587),0.3593073307764499,0.9268780869796195,0.5493230174081238,0.8510004529123159,1.0,2/19,8.50%,PIWIL4;EXD1
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.3930398811078596,-0.9268426938536517,0.548,0.890721694330591,1.0,4/10,17.00%,TBX1;RXRB;ACTN4;RXRA
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.39606596665957217,0.9266966088821499,0.5770750988142292,0.8507986134759455,1.0,4/13,17.08%,TNRC6B;TNRC6A;EIF4ENIF1;CPEB3
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.3764072355544451,0.926696216793454,0.5287569573283859,0.8502092784970203,1.0,3/15,4.70%,RNF213;DACT1;WNT5B
prerank,regulation of mRNA catabolic process (GO:0061013),0.25432123981887617,0.9264911023805934,0.601115760111576,0.8500489146567941,1.0,16/121,10.81%,TNPO1;ZC3HAV1;SAMD4A;VIM;IGF2BP1;RC3H1;PKP3;DCP2;PSMB10;MOV10;PSMA7;IGF2BP2;PSMA3;PSME4;PSMA5;XRN1
prerank,regulation of interferon-gamma production (GO:0032649),-0.24749145945196177,-0.926063450756904,0.6219839142091153,0.8919513793463735,1.0,9/71,8.96%,PDE4D;PDE4B;SLC7A5;IL1R1;GAS6;HMGB1;CYRIB;ZFPM1;HAVCR2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3355919341892669,0.9258248791297042,0.5576923076923077,0.8509678953247145,1.0,5/25,8.14%,CD55;KIT;LACC1;WNT5A;TNFRSF14
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.40409322090316824,0.9258106019648853,0.5527831094049904,0.850412139770458,1.0,2/12,7.90%,IL23R;IL18
prerank,regulation of protein processing (GO:0070613),0.35256307466236786,0.9254220040089066,0.5608465608465608,0.8507123610151949,1.0,4/21,10.35%,SNX12;SERPINE2;LRRK2;CCBE1
prerank,ovarian follicle development (GO:0001541),-0.36466757781351733,-0.9251646280893262,0.5637149028077754,0.8934212965291167,1.0,6/13,22.10%,EIF2B2;VEGFA;SOD1;INHBB;FOXL2;LHCGR
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.319871409203191,-0.9248089503997157,0.5609195402298851,0.893533158557045,1.0,4/21,8.60%,PPP1R16B;FKBP1A;MFHAS1;PPP1R11
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.3409503259222745,0.9246736907576788,0.5437956204379562,0.8517789581377424,1.0,9/25,23.38%,CDC73;ZMYND11;BRD4;CDK12;LEO1;CDK13;EAPP;HEXIM1;ELL
prerank,positive regulation of T cell proliferation (GO:0042102),0.28829394808055725,0.9244840570842149,0.5769230769230769,0.8516113128064267,1.0,8/55,9.42%,IL6ST;IL23R;ANXA1;IL6;VCAM1;IL18;CD274;IGF2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.3098794784294096,0.924225207361727,0.5819112627986348,0.8516044665577354,1.0,5/38,6.88%,ROCK2;SMAD3;TLR4;ATP2B4;CD47
prerank,reverse cholesterol transport (GO:0043691),0.38340052119920215,0.9241734364644041,0.5630885122410546,0.8511371587519109,1.0,2/13,11.23%,APOA2;ABCA1
prerank,regulation of histone acetylation (GO:0035065),0.31707993637502924,0.9237538418711072,0.5618556701030928,0.8515301671889334,1.0,6/33,12.85%,KMT2A;FOXP3;GLYR1;TAF7;IWS1;ARRB1
prerank,cell cycle checkpoint signaling (GO:0000075),0.3997000413317989,0.9236943626315761,0.5404339250493096,0.8510729798714709,1.0,3/12,9.92%,PRCC;ZWINT;NABP1
prerank,cholesterol transport (GO:0030301),0.30122415709903744,0.9236303570928591,0.5782312925170068,0.8506312233865497,1.0,10/45,19.01%,APOA2;NPC1;LIMA1;SOAT1;ABCA1;OSBPL5;STAR;SERAC1;ABCA7;CD36
prerank,positive regulation of interleukin-17 production (GO:0032740),0.3520317564364064,0.9228218079307149,0.5668449197860963,0.851909905320943,1.0,4/22,7.90%,OSM;IL23R;IL6;IL18
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.36738264931538395,-0.9228173463921929,0.558695652173913,0.8977955663556545,1.0,4/12,27.42%,KLF2;CALR;ASXL1;CYP26B1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.3507587098057864,0.9227319445029363,0.5413005272407733,0.8515246181090441,1.0,5/22,14.30%,BMP7;MYADM;MAP2K5;FLOT2;WNK1
prerank,sterol transport (GO:0015918),0.3539154351106288,0.9225270457262971,0.573502722323049,0.8513714968024505,1.0,3/19,12.55%,APOA2;NPC1;OSBPL5
prerank,response to laminar fluid shear stress (GO:0034616),-0.3966955549226322,-0.9225237190097946,0.5508130081300813,0.8976966763175968,1.0,3/10,12.14%,SMAD7;KLF2;KLF4
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.2763508751118032,0.9219260601436092,0.5835913312693498,0.8521572444600748,1.0,8/66,7.82%,SMAD3;PARP9;ZIC1;TERT;TPR;DTX3L;YAP1;NGFR
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3652428498164779,-0.9219191576632386,0.5443037974683544,0.8983505883198324,1.0,3/13,2.99%,RYR2;NOTCH1;CPE
prerank,telomere maintenance (GO:0000723),0.29669867241256326,0.9216579950149901,0.5834658187599364,0.8521882839417917,1.0,16/50,23.15%,SP100;TERT;WRN;PARP3;RAD50;RPA3;NSMCE2;DNA2;TEN1;RIF1;CTC1;SMC6;POLD3;TEP1;RTEL1;PTGES3
prerank,establishment of spindle localization (GO:0051293),0.38105421806739226,0.9214353390716246,0.5614366729678639,0.8520591436888345,1.0,6/14,18.45%,CLASP1;ESPL1;MAP4;LLGL2;TLE6;NLRP5
prerank,negative regulation of cilium assembly (GO:1902018),-0.37216561625089617,-0.9211191139378526,0.5576923076923077,0.8995600273315661,1.0,2/12,4.83%,LIMK2;TBC1D30
prerank,positive regulation of leukocyte activation (GO:0002696),-0.33842827428411565,-0.9205235941715673,0.567032967032967,0.9002050063784834,1.0,3/18,9.85%,IL33;THBS1;KARS1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.3459756427967975,-0.9202362273527673,0.5701754385964912,0.9000323962392892,1.0,5/17,27.50%,RFFL;CD74;PTTG1IP;MIF;YJU2
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.3208127237186855,-0.9201754185224051,0.571753986332574,0.8993019816584298,1.0,6/21,17.19%,NAV3;ARHGEF2;STMN2;FGF13;CLASP2;MID1IP1
prerank,regulation of cell size (GO:0008361),0.3416694430041466,0.9200081587811585,0.5526315789473685,0.8546312303229586,1.0,1/23,0.51%,DEPTOR
prerank,regulation of protein localization to centrosome (GO:1904779),0.41210750419813874,0.919847892213105,0.5739644970414202,0.8543868455641419,1.0,3/10,15.36%,PARD6A;GSK3B;CEP250
prerank,intracellular lipid transport (GO:0032365),0.35398802079548175,0.9195473416939952,0.5724907063197026,0.8544630809498088,1.0,2/21,1.71%,PRKAG2;PRKAA2
prerank,regulation of intracellular protein transport (GO:0033157),-0.28553156248692807,-0.9194544770759675,0.611764705882353,0.9002565621729013,1.0,10/32,19.56%,PRR5L;OAZ1;BMP4;OAZ2;GCC2;PCNT;CEP290;LCP1;SIRT7;UHMK1
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.3128487563763107,-0.9193958699893906,0.581140350877193,0.8995675343201364,1.0,4/20,11.23%,PDE4D;ADRA1B;RAPGEF2;ADRB2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.2797422196163777,-0.9191939335295278,0.5849056603773585,0.8991708244943312,1.0,11/35,13.50%,TEK;ESAM;PTK2B;SEMA3E;ARHGDIB;ABI3;FES;ARHGDIA;CSF1R;F11R;HRAS
prerank,mitochondrion organization (GO:0007005),0.2449162125743605,0.9191903309993775,0.6347941567065073,0.8547075980466241,1.0,30/165,13.90%,CXADR;PID1;TRAK1;IFIT2;TERT;SPATA18;GABPB1;HAX1;TIMM17A;MPV17;BAX;MEF2A;PHB2;LRRK2;DNM1;SIRT4;NIPSNAP2;MTFP1;AFG1L;AKT3;TMEM70;DNM1L;BCL2L1;ATCAY;MTFR1;OPA1;SUPV3L1;NRF1;WASF1;TIMM9
prerank,glutathione metabolic process (GO:0006749),-0.27281215338720355,-0.9188270571274392,0.6038647342995169,0.8992799797207076,1.0,20/38,42.52%,OPLAH;GGT5;GSTM5;GCLC;SOD1;PARK7;GGT7;GGT1;HAGH;ETHE1;MGST2;GCLM;GSR;GSTA4;HPGDS;NAT8;GSTM4;GPX1;GSTP1;GLRX2
prerank,pre-miRNA processing (GO:0031054),0.3723173675981084,0.9184281105761269,0.5762411347517731,0.8558245195207655,1.0,4/14,17.91%,TUT4;ADAR;TARBP2;TUT7
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.283847633562792,-0.9182944171785347,0.6229508196721312,0.8997742489481009,1.0,8/35,17.36%,PRKCQ;NEK7;CTNNB1;MAPK3;ATM;PNKP;CCT5;PKIB
prerank,positive regulation of transferase activity (GO:0051347),0.2487417545663486,0.9181802843323824,0.6128170894526035,0.8558041955597274,1.0,16/142,6.26%,EPHA7;PDGFRA;FGFR1;AXL;DDR2;INSRR;LMO4;EPHA3;EPHA8;ROR1;KIT;RAD50;EPHA1;PDGFRB;DTX3L;EPM2AIP1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.29817284930317045,-0.9181371026183599,0.592255125284738,0.8992924903564242,1.0,7/26,12.77%,INSR;KLF2;NOS1AP;HSP90AB1;AKT1;KLF4;HSP90AA1
prerank,negative regulation of catalytic activity (GO:0043086),-0.3066645838401648,-0.9177348968758796,0.6009501187648456,0.89947638202189,1.0,10/24,25.63%,NOTCH1;CAMK2A;HDAC6;NOS1;CCAR2;TMBIM1;APBA3;CLN3;TIMP1;PLN
prerank,endomembrane system organization (GO:0010256),0.24204540254243725,0.9172746636379407,0.6382165605095541,0.8572776001848501,1.0,44/178,19.26%,ARHGAP21;SPTBN1;MYOF;A4GALT;RAB22A;MIA3;WASHC4;CLASP1;RAB43;OPTN;VAPA;GOLGA8B;GOLGA5;LRRK2;DNM1;FAM174B;USP8;UBXN2A;DNM1L;HUWE1;TMCC1;GORASP2;TJAP1;COG2;LMAN1L;EIF2AK3;SRGN;TMED9;SEC31A;GBF1;ATL1;GOLGA2;ANXA8;ANXA8L1;DMPK;HOOK1;ARFGEF2;SEC16A;DNAJC28;PLEKHF1;LYSMD3;USP6NL;COG4;PLEKHM2
prerank,purine-containing compound catabolic process (GO:0072523),0.3896838912224141,0.9169301650302136,0.5523255813953488,0.8574788830666442,1.0,5/13,20.46%,DPYD;NT5C;ITPA;NT5C1A;XDH
prerank,protein localization to condensed chromosome (GO:1903083),-0.3668943410581319,-0.916767236390674,0.5770065075921909,0.901105170728004,1.0,9/12,41.74%,ZWILCH;SPDL1;ZW10;CDK1;MIS12;BUB3;KNL1;AURKB;CHAMP1
prerank,regulation of establishment of planar polarity (GO:0090175),0.26637442933020244,0.9164750222906992,0.6109422492401215,0.8578730091741319,1.0,15/88,14.38%,PRICKLE1;SMURF2;FZD2;DACT1;PARD6A;CELSR1;WNT5A;PSMB10;PSMA7;PSMA3;PSME4;PSMA5;DVL3;VANGL1;NPHP3
prerank,cGMP biosynthetic process (GO:0006182),-0.3835051405841957,-0.9162570099609941,0.561965811965812,0.9015539555707301,1.0,3/10,10.06%,GUCY1B1;GUCY1A1;NPR1
prerank,acute inflammatory response (GO:0002526),0.33770445192994225,0.9160759696527154,0.5721925133689839,0.8581847460115662,1.0,7/23,20.25%,IL6;CRP;ANO6;IL22;CEBPB;HP;HPR
prerank,regulation of immunoglobulin production (GO:0002637),0.3381753517701104,0.9160654649680449,0.5684575389948007,0.8576222273841472,1.0,3/23,8.54%,RBP4;IL6;PHB2
prerank,regulation of glycogen metabolic process (GO:0070873),-0.37283552385972374,-0.9156798718571687,0.5805084745762712,0.9021741781624123,1.0,4/12,15.44%,PPP1R3B;INPP5K;AKT1;PPP1R3C
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.32808595882532693,0.915113762050115,0.5734513274336284,0.8591704647466438,1.0,8/26,17.86%,LARGE1;RRM1;GBGT1;GK5;ALG11;RRM2B;SCCPDH;TNIP1
prerank,positive regulation of histone acetylation (GO:0035066),-0.3106281110758099,-0.9150042746439853,0.5737704918032787,0.9031102475325263,1.0,7/23,18.25%,RPS6KA5;TADA2A;MAPK3;SMARCB1;NOS1;BRCA1;KAT7
prerank,regulation of lipid catabolic process (GO:0050994),0.35076702256847553,0.9144658590966116,0.5724381625441696,0.859988731027863,1.0,6/19,20.17%,APOA2;HCAR2;RARRES2;ALK;ADRA2A;ANGPTL3
prerank,regulation of interleukin-1 production (GO:0032652),0.3739924931411471,0.9144111366835053,0.5918762088974855,0.8595296646027052,1.0,2/15,4.94%,ANXA1;TLR4
prerank,regulation of centrosome cycle (GO:0046605),-0.31416283927619515,-0.914226060232632,0.5700934579439252,0.9042699480369102,1.0,11/21,35.52%,NPM1;CHMP1A;CHMP1B;CHMP2B;GEN1;CHMP2A;CHMP4C;AURKA;FBXW5;PKHD1;VPS4B
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.23541997360159655,-0.9137371430992552,0.6827195467422096,0.9046723306104685,1.0,17/83,16.11%,USP29;CDK17;CDK14;CDK6;MAX;CAMK2A;CCND1;CDK15;POLA1;BCAT1;HINFP;ACVR1;USP37;CDK2;CDK4;CDKN1A;CDC45
prerank,stress fiber assembly (GO:0043149),0.3796557277208161,0.9137327848325784,0.5679702048417132,0.8598653564514027,1.0,3/15,12.85%,SORBS1;CUL3;ARRB1
prerank,contractile actin filament bundle assembly (GO:0030038),0.3796557277208161,0.9137327848325784,0.5679702048417132,0.8598653564514027,1.0,3/15,12.85%,SORBS1;CUL3;ARRB1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.40082596912944796,0.9134757902014552,0.5594149908592322,0.8598497317038909,1.0,4/12,14.30%,MIA3;PPARA;FUT4;WNK1
prerank,tRNA 5'-end processing (GO:0099116),-0.35756035039880113,-0.9129716772705105,0.5902335456475584,0.9057139585523782,1.0,6/15,26.17%,PRORP;RPP30;HSD17B10;RPP25L;TRMT10C;POP7
prerank,peptidyl-arginine modification (GO:0018195),-0.34163479217654297,-0.912541290853304,0.5416666666666666,0.905956316981136,1.0,3/15,20.50%,ART3;PARK7;PRMT5
prerank,negative regulation of protein catabolic process (GO:0042177),0.29888256286239,0.9124692590649177,0.5980392156862745,0.861541076658065,1.0,8/40,10.75%,TIMP3;NELL1;PTPN3;SNX12;AZIN2;TIMP2;SF3B3;IRAK3
prerank,negative regulation of T cell differentiation (GO:0045581),0.4100477122945878,0.9121816903954341,0.5772200772200772,0.8616215675313654,1.0,2/10,11.83%,GLI3;IHH
prerank,histone H4 acetylation (GO:0043967),0.2952458275071403,0.912100515083094,0.6252045826513911,0.8611989517828814,1.0,10/47,17.35%,KMT2A;APBB1;EPC1;JADE2;ACTL6A;BRD8;ZZZ3;KANSL1;TRIM16;ATF2
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.3350745759823007,-0.912075682780237,0.5964523281596452,0.9062746832443398,1.0,12/18,49.81%,PRELID1;XRCC6;IKZF3;PRKDC;CRTAM;PRDM1;CCR2;TBX21;NCKAP1L;SLAMF8;ABL1;CD2
prerank,fatty acid catabolic process (GO:0009062),0.27739584006823503,0.91202339268868,0.5860979462875198,0.8607987043918758,1.0,23/67,23.75%,PCCA;AIG1;PCCB;SCP2;SLC27A2;HACL1;ACAT1;ABCD3;PECR;PEX2;HAO1;PHYH;ACADS;LPIN2;ABHD3;ACOX1;HADHA;ACBD5;NUDT19;MMUT;LPIN1;HADH;ECHS1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.3332701835121495,0.912017057389109,0.5628318584070796,0.8602346383662978,1.0,10/27,23.91%,PCF11;NYNRIN;XRN1;SLFN14;ZC3H12B;CSTF3;RNASEH1;PARN;ZC3H12A;KHNYN
prerank,negative regulation of potassium ion transport (GO:0043267),-0.360877327059953,-0.9117473133247666,0.5711297071129707,0.9062955919978892,1.0,5/13,14.23%,PTK2B;NEDD4L;NOS1;CAV1;CASQ2
prerank,spindle assembly (GO:0051225),0.27544563539390554,0.9116380110662898,0.6037195994277539,0.8605018096073135,1.0,22/67,22.61%,MAP9;STAG1;CLASP1;HAUS8;GOLGA8B;MISP;TUBGCP4;TUBGCP2;TOGARAM1;TUBGCP5;TOGARAM2;SPICE1;GOLGA2;CCDC61;MAPRE3;INO80;NEK6;CEP63;OFD1;CHEK2;STAG2;MAPRE2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3183094928281784,0.9109432175288199,0.5819397993311036,0.8614891115919813,1.0,16/32,27.07%,POLR1C;CCNH;MNAT1;CDK7;POLR1G;POLR2F;GTF2H4;GTF2H2;CAVIN1;POLR2K;UBTF;TAF1;POLR1A;TAF1D;POLR2H;ERCC2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.2375413222973653,0.9106774741034726,0.6636125654450262,0.8615054140251494,1.0,27/198,10.72%,ENPP3;EPHA7;ENPP1;PLA2G4A;PLPP3;TPTE;PPM1A;ACYP2;DUSP10;DUSP28;PLCD3;PI4KA;TOP1;PANK2;PLCE1;PLCB3;PLA2G4C;DUSP16;HKDC1;LRRK2;PLPPR3;GK5;NT5C;INPP1;DUSP5;XYLB;PFKM
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.35961209835882657,-0.9106397795577268,0.5831578947368421,0.908262122049121,1.0,2/13,3.37%,GRM3;GABBR2
prerank,regulation of transferase activity (GO:0051338),0.355482537979829,0.910596113520161,0.5683060109289617,0.8611082827932752,1.0,6/17,20.44%,LDB2;JMJD8;SMG6;PARP4;HMBOX1;NABP2
prerank,regulation of cilium assembly (GO:1902017),0.2777860839609245,0.910038275941026,0.6022544283413849,0.8617839911735923,1.0,10/62,12.88%,DCDC2;TBC1D16;SDCCAG8;IFT88;YAP1;DYNC2LI1;TAPT1;ENTR1;IFT20;TBC1D7
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.36871846854853935,-0.9099890987755864,0.5849462365591398,0.9090416817912008,1.0,4/12,15.09%,UCK2;UPP2;UCKL1;UCK1
prerank,apoptotic DNA fragmentation (GO:0006309),-0.339138747156877,-0.9097662441280415,0.6021052631578947,0.9087629532405992,1.0,8/16,33.82%,HMGB1;KPNB1;H1-0;FOXL2;DICER1;KPNA1;ENDOG;DFFA
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.3308325545745873,-0.9092229374379199,0.5907172995780591,0.9093036026194302,1.0,6/18,20.54%,MTHFR;MSRA;SMS;SLC25A13;ASNS;SLC25A12
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.2849944259802506,-0.9090370404191126,0.5717948717948718,0.9089106166560749,1.0,9/30,17.83%,RPL11;HSP90AB1;SDCBP;BAG6;RYBP;CCAR2;CAMLG;PARK7;N4BP1
prerank,regulation of acrosome reaction (GO:0060046),-0.3868926758196879,-0.9087303548391664,0.5645161290322581,0.9088106792678583,1.0,1/10,0.94%,PLCB1
prerank,regulation of organelle assembly (GO:1902115),0.27088312133182596,0.9086171584897568,0.6184012066365008,0.8642719371498154,1.0,12/72,16.33%,DCDC2;TBC1D16;ALMS1;SDCCAG8;IFT88;MTMR3;DYNC2LI1;SENP6;IFT20;NPRL3;SPICE1;RAB5A
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.2360433592749339,-0.908608064079468,0.6835820895522388,0.9082709407905003,1.0,15/75,16.80%,PLCB1;RGS5;RGS3;MGLL;CALM1;RGS12;RGS4;RGS6;CAMK2A;SLC39A14;RGS20;KCTD8;PDE6A;ZDHHC7;FRMPD1
prerank,telomere organization (GO:0032200),0.2984782150521876,0.9085497921116182,0.589018302828619,0.8638481254675412,1.0,5/43,5.71%,SP100;TERT;WRN;PARP3;RAD50
prerank,PERK-mediated unfolded protein response (GO:0036499),0.4169531541089374,0.908506067121518,0.5841209829867675,0.863371047543742,1.0,3/10,14.39%,CCL2;QRICH1;EIF2AK3
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.3835147616164094,-0.9082433850958787,0.6019607843137255,0.908338785591254,1.0,3/11,7.35%,PLCB1;PIK3R1;AKT1
prerank,positive regulation of histone modification (GO:0031058),-0.28281525648141753,-0.9079679597592227,0.6142506142506142,0.9081878784854097,1.0,8/33,16.87%,RPS6KA5;TADA2A;MAPK3;SART3;NOS1;CTBP1;APLNR;BRCA1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.2985028653296449,0.9079250268059544,0.5806451612903226,0.8640565451046256,1.0,15/42,24.14%,FBH1;SPIDR;KLHL15;PPP4R2;FUS;ERCC6;FIGNL1;SHLD2;KDM1A;SETD2;RIF1;PPP4C;RTEL1;ARID2;SMCHD1
prerank,dopamine metabolic process (GO:0042417),-0.33993519730901506,-0.9078229837722295,0.6040723981900452,0.9077124913911181,1.0,4/18,10.02%,TGFB2;MAOA;SNCA;GCH1
prerank,regulation of transposition (GO:0010528),0.38069196465725247,0.9069686600900321,0.5681818181818182,0.8656354294916847,1.0,1/13,3.37%,PIWIL4
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.41339454051821334,0.9069512026079235,0.5821782178217821,0.8650932470886851,1.0,2/10,11.96%,EMC2;EMC9
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.2984101733216582,-0.9069418899328353,0.6052631578947368,0.9090028898966007,1.0,7/25,13.88%,HIP1;BCAR3;HIP1R;CCDC88A;AKT1;CBL;PLAUR
prerank,mesonephric tubule development (GO:0072164),0.37500733019512367,0.9068895566508998,0.5714285714285714,0.8646552448836776,1.0,4/15,5.14%,OSR1;FOXC1;BMP7;SALL1
prerank,AMP metabolic process (GO:0046033),0.37876722126558554,0.9068601749779408,0.5536723163841808,0.8641484697031918,1.0,1/13,1.06%,AMPD3
prerank,lipoprotein localization (GO:0044872),0.3930317782082126,0.9068075844567243,0.5803921568627451,0.8636848756943701,1.0,5/11,19.01%,MIA3;ZDHHC3;ZDHHC17;LRP1;CD36
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.31997079622192837,0.906250616277742,0.5851063829787234,0.8643164443949274,1.0,4/30,5.75%,SPTBN1;VAMP5;RAB10;OPTN
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.27792967234095667,-0.9061238184400547,0.6096385542168675,0.9101990995313748,1.0,6/35,8.60%,FKBP1A;CALM1;CALM2;HSP90AB1;CALM3;PPP1R11
prerank,histone mRNA metabolic process (GO:0008334),0.32669189884487665,0.9060090501480427,0.6093489148580968,0.864292841317975,1.0,9/27,17.91%,TUT4;DCP2;LSM1;XRN1;TENT2;SSB;EXOSC10;SLBP;TUT7
prerank,negative regulation of cyclase activity (GO:0031280),-0.3538628047379335,-0.9058454379563138,0.6,0.9100756888378078,1.0,2/14,3.37%,GRM3;GABBR2
prerank,membrane lipid metabolic process (GO:0006643),0.3366232322052554,0.9057247837919674,0.6007067137809188,0.8643808619641238,1.0,1/22,0.19%,AGMO
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.34502642171218467,0.9054985599982939,0.5833333333333334,0.8643005102962846,1.0,2/20,4.04%,RBPJ;BMP2
prerank,cellular response to insulin stimulus (GO:0032869),0.24893172269032765,0.9053085272528771,0.6335664335664336,0.8641185980819592,1.0,30/124,17.60%,PDPK1;ENPP1;PHIP;FOXC2;FER;RAB10;TRARG1;SORBS1;CPEB1;PTPN2;PIK3C2A;INSIG2;GSK3B;RHOQ;IGF2;ZNF106;OTOP1;APPL1;TCIRG1;RARRES2;DENND4C;ATP6V0B;BAIAP2;MYO5A;KAT2B;ATP6V1E1;ATP6V1C1;LPIN2;IGF1R;PCK2
prerank,MAPK cascade (GO:0000165),0.22560218365533807,0.90530392249645,0.7148102815177478,0.863549415630644,1.0,49/295,12.98%,RASGRF1;NRK;PDGFRA;FGFR1;FGF1;SPTBN1;IL31RA;KSR1;CCM2;FRS2;KL;TGFA;ANGPT1;TAOK3;KIT;PTPN3;ARAF;PDGFRB;PTPRA;RASA1;SYNGAP1;CTSH;CCL2;ACTN2;LGALS9;IL18;PSMB10;MEF2A;LRRK2;PSMA7;DLG1;RGL3;PSMA3;RALGDS;PSME4;DUSP5;PSMA5;FGF18;PPP1CB;PTK2;BCL2L1;JAK1;CUL3;FNTB;MAP2K1;FBXW11;MAP3K7;BTRC;SHOC2
prerank,cellular response to reactive oxygen species (GO:0034614),0.2836236452871752,0.9051866327450813,0.5971563981042654,0.8632244082730117,1.0,7/59,6.56%,PDGFRA;OSER1;FER;ANXA1;IL6;TPM1;MPV17
prerank,regulation of defense response to virus (GO:0050688),0.37474771937039586,0.9051490714270659,0.5722433460076045,0.8627378800385538,1.0,4/14,18.50%,RNF216;PPM1B;IFNLR1;PCBP2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.236634301865732,0.9048334605936879,0.6435246995994659,0.8628857318410792,1.0,48/173,23.05%,SPTBN1;COPZ2;DYNLL1;ARFGAP3;CD55;KDELR3;TGFA;SEC23A;MIA3;ARF4;SEC24D;VAPA;CAPZB;PROS1;ERGIC1;DCTN5;COPE;GOSR1;ARCN1;CUL3;SEC24C;SCFD1;COG2;LMAN1L;COPZ1;ACTR1A;TMED9;SEC31A;GBF1;SEC24B;SPTBN2;SAR1A;GOLGA2;CAPZA1;SEC16A;COG4;DCTN4;ANK2;F5;TRIP11;COG1;VAMP7;BCAP31;IER3IP1;SPTAN1;COPG1;COG3;SPAST
prerank,positive regulation of vasculogenesis (GO:2001214),-0.38609804017078,-0.9045853380545933,0.6194331983805668,0.912314770013261,1.0,4/10,7.50%,KDR;CD34;RAPGEF2;CEACAM1
prerank,chromatin remodeling (GO:0006338),0.2582502600481379,0.9043604121509112,0.6168359941944848,0.8632880110534306,1.0,29/100,19.88%,MBD2;MYB;TOP1;BAZ2A;FOXP3;HDAC4;HNRNPC;BAZ1B;GATAD2B;BAZ1A;JARID2;CECR2;MYSM1;SRCAP;ACTL6A;KDM5B;BPTF;ERCC6;HDAC2;SMARCA4;SMARCC1;KAT2B;CHD8;INO80C;ARID1B;HCFC2;CHD4;ACTR8;INO80
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.24142555240376923,0.9041362218257238,0.6848404255319149,0.8631665657676022,1.0,41/166,20.93%,SMAD3;ZEB2;PLD1;SAMD4A;VIM;SLC6A9;ARNT;IL6;GLI1;TLR4;SORBS1;PDGFRB;NR1H3;EPM2AIP1;PTPN2;IGF2;APPL1;SLC25A37;ZCCHC4;SMOC2;ZNF205;PKD2;PRKD2;STAR;SOX4;P2RX4;OPN3;CPEB3;UPF3A;LPGAT1;DNA2;FXR2;PLXNB2;CD36;ERBB2;CTC1;PTGS2;SLC27A1;SREBF1;ASS1;ELAVL1
prerank,regulation of actin filament-based movement (GO:1903115),0.4059957193424676,0.9038196772388729,0.5973282442748091,0.8633332994379692,1.0,1/10,0.30%,PDPN
prerank,chromosome condensation (GO:0030261),-0.2772298095571901,-0.9036413302244192,0.6211340206185567,0.9138059295227919,1.0,19/36,39.16%,MCPH1;SMC2;H1-0;CHMP1A;SET;NCAPH2;NCAPH;TTN;TENT4A;BANF1;CSNK2B;NCAPD2;CDK1;PLK1;NCAPD3;CCNB1;BANF2;INCENP;TOP2A
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.343360013204035,0.9034893628235443,0.6101398601398601,0.8634693438251578,1.0,2/19,3.92%,AMPD3;TERT
prerank,mRNA splice site selection (GO:0006376),0.31187382165557426,0.903479128944065,0.6063829787234043,0.862918509228568,1.0,1/30,0.15%,CELF2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.31743802176271846,0.9029899103917683,0.5996621621621622,0.8633919434737143,1.0,6/29,16.01%,KANK2;UBA5;YAP1;STRN3;CARM1;CNOT9
prerank,regulation of mitotic spindle organization (GO:0060236),0.3042383148523674,0.9028599327323293,0.6026272577996716,0.8631162050972724,1.0,8/35,15.98%,MAP9;PARP3;TPR;FSD1;PSRC1;CHMP3;CHMP4B;EML3
prerank,positive regulation of chemotaxis (GO:0050921),-0.26353346999310245,-0.9028262527424884,0.6282722513089005,0.9149370775330432,1.0,11/43,15.27%,TMSB4X;THBS1;KDR;F3;STX3;MET;LGMN;VEGFA;FGF2;PRKD1;CCL19
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.31625071060844834,-0.9026398982827213,0.6136865342163356,0.9145727510971619,1.0,8/21,22.32%,PDE4D;HINT1;PDE2A;PNP;NT5C2;NUDT18;NUDT3;HPRT1
prerank,mitotic DNA replication (GO:1902969),-0.39140490992780835,-0.902606472099285,0.6212424849699398,0.913814459779993,1.0,3/10,16.11%,GINS3;POLA1;CDC45
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3156527740378632,0.9021167845898193,0.5903814262023217,0.8641785300839857,1.0,11/29,23.03%,COPZ2;GOLGA5;COPE;GOSR1;COG2;COPZ1;RAB33B;COG1;NAPG;COPG1;COG3
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.31835247648896847,0.9017478835287652,0.6026272577996716,0.864423406000985,1.0,5/29,11.39%,CXCL10;FPR2;SERPINE1;LGALS9;ANO6
prerank,cardiac cell development (GO:0055006),-0.37521271167832837,-0.9017381781427315,0.5990783410138248,0.9151144352771022,1.0,4/11,9.03%,NOTCH1;MYH11;SLC8A1;VEGFA
prerank,negative regulation of protein depolymerization (GO:1901880),0.33692511508910233,0.901414519956649,0.5975820379965457,0.864560128293531,1.0,5/24,11.40%,PLEKHH2;CLASP1;HDGFL3;LIMA1;ATXN7
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3213635556862126,0.9011204754113901,0.5870307167235495,0.8646127858684935,1.0,5/28,8.17%,ITPR1;CASP4;BCL2;BAX;QRICH1
prerank,neurogenesis (GO:0022008),0.2921296303701151,0.9008023414627053,0.6053962900505903,0.8647163161481051,1.0,9/43,15.19%,LPAR1;TRAK1;ANXA1;CLN5;DCHS1;WNT2;ERCC6;CXCR4;RYK
prerank,histone methylation (GO:0016571),0.32399349465604566,0.9005894955607371,0.5737122557726465,0.8646154311501839,1.0,11/26,27.79%,NSD3;CREBBP;NSD1;CARM1;SMYD3;PRMT1;EHMT2;SUV39H1;SETD6;SMYD2;EHMT1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.3349252106150985,0.9001868529764564,0.5906642728904847,0.8649004279148512,1.0,4/22,8.52%,GHR;KIT;IL6;CRLF3
prerank,T cell proliferation (GO:0042098),-0.3534659905200127,-0.8996423529351686,0.6078838174273858,0.9194313654675197,1.0,1/13,0.07%,CADM1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.2941597294763172,0.8996051332005776,0.6230899830220713,0.8655744057165684,1.0,6/41,10.75%,TLR4;PTPN22;C5AR2;LGALS9;PTPN6;IRAK3
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.3297180155639223,-0.8996023020126991,0.6131386861313869,0.9186801824804732,1.0,6/18,11.79%,KDR;GATA2;HDAC7;HDAC9;VEGFA;FGF2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.390852065125629,0.8994010205878538,0.6035502958579881,0.8654152726380574,1.0,3/12,11.49%,PLK5;WAC;RFWD3
prerank,neuron fate commitment (GO:0048663),-0.3512420684089757,-0.8988805760636311,0.6053215077605322,0.9195988180044719,1.0,7/14,34.91%,MYT1L;POU3F2;DLL4;DLL1;POU4F1;PAX6;ASCL1
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.22506243985941124,-0.8987050783039469,0.7039473684210527,0.9191650138003709,1.0,27/98,20.63%,DPP10;PRKCH;PIK3R1;STX3;ANK3;MAPK8;CEMIP;YWHAH;AKT1;MTCL1;MFF;PPP1R13B;RHOG;ITGA3;KCNB1;EGFR;STAC;HRAS;C2CD5;YWHAQ;STAC3;ARF6;AKAP5;ITGB2;BAD;PRKCE;CD81
prerank,protein import into peroxisome membrane (GO:0045046),-0.31349635698319567,-0.8982708910693624,0.6065573770491803,0.9194204755448555,1.0,10/22,26.85%,ATAD1;PEX26;GDAP1;ABCD2;PEX16;PEX19;PXMP4;PEX3;RAB8B;PEX11B
prerank,organelle organization (GO:0006996),0.2200442161394956,0.8982371239229072,0.7511682242990654,0.8673663915434874,1.0,87/388,19.28%,MICAL3;CXADR;DIAPH1;ARHGAP21;ARHGAP10;SH3D19;SYNE3;PHIP;FGD4;TERT;BRWD1;DES;GABPB1;MIA3;TPM1;CLASP1;RAB43;HAX1;OPTN;PLCE1;PACSIN2;CCL2;VAPA;CAPZB;GOLGA8B;GOLGA5;FMNL2;PHB2;LRRK2;FAM174B;SIRT4;NIPSNAP2;CNN2;AFG1L;PPID;UBXN2A;ZFYVE16;RAB34;CECR2;SPRYD3;DNM1L;GEM;HUWE1;ATXN7;TMCC1;GORASP2;ZMYM6;TJAP1;ABCD3;MTFR1;OPA1;PEX2;NRF1;CHMP3;WASL;COG2;RHOU;BRWD3;LMAN1L;CHMP4A;CHMP4B;EIF2AK3;TMED9;PKD2;PDZD8;FAF2;SEC31A;GBF1;ATL1;ZMYM3;SAR1A;WTIP;GOLGA2;PYROXD2;RHOT1;SEC16A;SIRT3;DNAJC28;PLEKHF1;LYSMD3;PLD2;ESRRA;DMTN;USP6NL;COG4;PLEKHM2;RHOT2
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.32131674321097364,-0.8979882250038219,0.6146993318485523,0.9192332863996009,1.0,6/20,15.35%,THBS1;ITGA4;CD40;SFRP4;RGCC;PLCG1
prerank,steroid catabolic process (GO:0006706),-0.3873023127218444,-0.8978025378870795,0.6067653276955602,0.9188283824650645,1.0,3/10,16.70%,YWHAH;SPP1;HSD11B1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.2851262262361183,0.8976114859193844,0.6114649681528662,0.8681697335497518,1.0,8/48,11.05%,AMPD3;ADCY7;ADCY5;PANK2;ADCY1;NPPC;AK5;ACAT1
prerank,regulation of biosynthetic process (GO:0009889),-0.3710752747384607,-0.8969550770325327,0.5938775510204082,0.9201331307962889,1.0,10/11,52.90%,SNCA;MID1IP1;ALOX5;THRSP;GSTP1;CCN6;SLC25A33;PIKFYVE;UCP1;PCK1
prerank,negative regulation of myotube differentiation (GO:0010832),-0.3576585553934377,-0.8966883938712454,0.6089743589743589,0.9199589951279412,1.0,3/12,9.94%,NOTCH1;CCN3;HDAC1
prerank,positive regulation of response to stimulus (GO:0048584),-0.27177950555577296,-0.8965065961637148,0.6469072164948454,0.9195677167847405,1.0,8/40,11.51%,TGFB2;HOMER1;YPEL3;SELENON;B2M;ABI3;CD80;EEF1E1
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.3325089991922703,-0.8961825990945831,0.6100217864923747,0.919554303948127,1.0,6/16,23.12%,INSR;HDAC6;MTRF1;UPF1;CLN3;GSPT1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2686112194709646,0.8961415269749406,0.6289308176100629,0.8707365318088517,1.0,6/67,4.16%,DCDC2;PLD1;TBC1D16;FER;SDCCAG8;IFT88
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.30489180751166445,0.896025843421309,0.6106346483704974,0.8704172732769947,1.0,8/37,13.86%,NUPR1;BCL2;GSDME;FBH1;BAX;DNM1L;BCL2L1;NCK1
prerank,vesicle transport along actin filament (GO:0030050),0.34296495451477343,0.8959352832476117,0.5956678700361011,0.8700375354007529,1.0,10/19,21.94%,MYO1B;MYO1A;WASL;MYO15A;MYO1E;MYO1C;MYO5A;MYO19;MYO5B;MYO6
prerank,negative regulation of protein metabolic process (GO:0051248),-0.25116490239544076,-0.8957929403680204,0.6467532467532467,0.9196799870667368,1.0,18/48,29.69%,FMN2;SNX3;HSP90AB1;PFDN5;CD84;PFDN2;EGFR;INHBB;EIF2AK1;PFDN4;EDNRB;VBP1;ADGRB1;EDN1;TREM2;CLU;AZIN1;LDLR
prerank,replication fork processing (GO:0031297),0.297412429120772,0.8951587443019413,0.6235679214402619,0.8711284996855599,1.0,10/38,18.27%,NUCKS1;WRN;TONSL;FBH1;FANCM;CENPX;RFWD3;BOD1L1;DNA2;SMARCAL1
prerank,regulation of fibroblast migration (GO:0010762),-0.31183322271883834,-0.8950709787874163,0.6158940397350994,0.9206438054305968,1.0,10/20,23.08%,THBS1;PRR5L;RFFL;FGF2;ARHGEF7;GNA12;RAC1;PRKCE;HAS1;CLN3
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.34225680027416383,-0.8949238287966184,0.6017316017316018,0.92015202725492,1.0,6/15,14.25%,NTRK2;DDIT4;ZFYVE27;BCAR1;NGF;SORT1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.3649551381090014,-0.8948110122702915,0.5903846153846154,0.9196002301264761,1.0,3/12,10.95%,PIK3R1;DAB2IP;ATF6
prerank,ubiquinone metabolic process (GO:0006743),-0.34397318086745793,-0.8947824153222914,0.6215644820295984,0.9188472019242292,1.0,7/15,26.55%,COQ9;FDXR;COQ8A;COQ10B;COQ3;COQ5;AIFM2
prerank,regulation of developmental growth (GO:0048638),-0.2868197771662293,-0.8946539649042365,0.6172839506172839,0.9183219090468522,1.0,9/29,15.56%,PLCB1;INSR;SIX1;NRCAM;MBD5;MFSD2A;SIX4;SOD1;SPAAR
prerank,establishment of spindle orientation (GO:0051294),0.3161210296235857,0.8942745402422985,0.6073825503355704,0.8724542660842571,1.0,6/28,13.68%,GJA1;CLASP1;MISP;FBXW11;MAP4;LLGL2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.2884687468087753,0.8937395937704847,0.6351351351351351,0.8730144076605975,1.0,6/47,7.03%,PID1;FPR2;CRP;TLR4;PDGFRB;TGFBR2
prerank,positive regulation of DNA replication (GO:0045740),-0.32651336396695124,-0.8932786766115378,0.5906040268456376,0.9208881760368978,1.0,5/16,18.25%,BCAR3;ATAD5;EGFR;EGF;KAT7
prerank,cytosolic calcium ion transport (GO:0060401),0.31726150546629445,0.8929932656226612,0.6056572379367721,0.8740610050921283,1.0,7/28,14.17%,MCU;MICU1;CACNA1C;JPH1;ATP2B1;JPH3;CACNA2D1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.3601618764947033,-0.8927982447065027,0.6004273504273504,0.9212182079206339,1.0,4/12,14.57%,VEGFA;CTBP1;APLNR;PRKD1
prerank,regulation of cell differentiation (GO:0045595),0.24193162628461565,0.8927949643645418,0.6885474860335196,0.873913977668467,1.0,14/148,6.42%,PHLDB2;CCN2;FGFR1;EIF2AK2;EPHA3;DAG1;PTHLH;SUZ12;TGFBR1;CLASP1;PHLDB1;MBOAT2;NREP;CREBBP
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.2758968765961736,-0.8923922865359423,0.6095717884130982,0.9213675980203796,1.0,10/33,19.25%,PIK3R1;NYAP2;PLEKHA1;PIK3C2B;AKT1;PIK3CD;MYO16;HTR2B;HTR2A;C1QBP
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.2085902416108031,-0.8917708299313292,0.7653846153846153,0.9220256081525775,1.0,48/145,24.12%,PPP2R1A;CSNK1D;PSMC3;KCNH5;RCC2;PSMD3;PSMD14;CCND1;DYNC1H1;PCNT;PSMD6;TUBA1A;TUBB4A;PSMD4;PRKAR2B;PSMA6;PSMA4;PSMB8;CEP43;HSP90AA1;DYNC1I2;NDE1;TUBB4B;PLK4;PSMA8;CEP135;CDK2;CDK4;CEP290;PSME1;SSNA1;PSMD7;CDK5RAP2;PSMC6;PSMB5;DCTN1;TUBG1;PSMC5;CENPF;CEP41;PSMB1;DTL;HMMR;CEP70;SKP1;KIF14;PSMD8;MAPRE1
prerank,negative regulation of JNK cascade (GO:0046329),0.31114714388739384,0.8914374573982644,0.6126126126126126,0.8763269683263439,1.0,6/31,10.25%,DACT1;DUSP10;TAOK3;PTPN22;ZMYND11;HIPK3
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.2838604848039801,-0.8913973700177825,0.6143958868894601,0.9221293026948564,1.0,19/29,43.73%,CADM1;CYRIB;RAET1E;LAMP1;STX7;RASGRP1;FADD;TYROBP;SLAMF6;NECTIN2;CD226;IL12A;CRTAM;IL12RB1;STAP1;IL23A;ITGAM;KLRD1;CD160
prerank,regulation of neuroblast proliferation (GO:1902692),0.36359888894978143,0.8909845696405744,0.6055776892430279,0.8767331653028083,1.0,1/15,0.47%,PTN
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.3723922723563648,0.8909580093084927,0.581888246628131,0.8762173749146069,1.0,5/13,20.66%,LARGE1;MGAT3;EXTL2;NAGK;CHST3
prerank,N-terminal protein amino acid modification (GO:0031365),0.3748622592795525,0.8906352321590433,0.570631970260223,0.8763624698626143,1.0,6/14,22.05%,NAA16;NAA15;PDF;NAA35;NAA40;METAP2
prerank,protein depolymerization (GO:0051261),0.3131892403117077,0.890397903471288,0.5809199318568995,0.8763042187174062,1.0,3/27,7.88%,MICAL3;NCKAP5L;DSTN
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3674808481485289,0.8897306816278143,0.6,0.87715106297549,1.0,3/13,12.84%,PARP9;PARP10;PARP16
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.24558578345886853,-0.8897049082286377,0.6792452830188679,0.9254322907323652,1.0,20/61,21.90%,PSMC3;OAZ1;OAZ2;SIRT5;PSMD3;PSMD14;PSMD6;PSMD4;CAV1;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;FGFR4;PSMB1
prerank,sympathetic nervous system development (GO:0048485),-0.34226877887801643,-0.8895989698926879,0.6063829787234043,0.9248588318223149,1.0,4/15,13.17%,NRP2;CTNNB1;FZD3;SEMA3A
prerank,regulation of mRNA stability (GO:0043488),0.23898811056941485,0.8893142444728869,0.6878378378378378,0.8774822592531263,1.0,33/145,20.93%,ROCK2;TNPO1;SAMD4A;TENT5A;VIM;IGF2BP1;RC3H1;DCP2;FTO;PSMB10;PSMA7;IGF2BP2;PSMA3;PSME4;NOCT;PSMA5;XRN1;EIF4ENIF1;METTL16;FUS;GIGYF2;DIS3;AXIN2;PUM2;GDNF;FXR2;DHX36;KHSRP;ROCK1;PSMC2;PARN;ZC3H14;ELAVL1
prerank,lipoprotein biosynthetic process (GO:0042158),0.3833566972977782,0.8891218862324375,0.592,0.8772975421382282,1.0,6/11,24.61%,PORCN;WDR45B;ATG10;WIPI2;ATG7;APOE
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3623697166528163,0.8890927256340273,0.6015325670498084,0.8767859367149113,1.0,6/16,19.43%,PYGB;MGAM;PYGM;STBD1;PHKB;PHKA2
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.3545261418102158,-0.8890188474333575,0.6046511627906976,0.9254704686600612,1.0,6/12,19.80%,SERINC3;SERINC5;PSPH;SEPHS1;CTH;GGT1
prerank,cellular response to pH (GO:0071467),0.34681950791090316,0.8889553624333048,0.5920303605313093,0.87649399765169,1.0,2/17,10.19%,INSRR;PKD1L3
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.3321844051848576,0.888835626178276,0.6238859180035651,0.8761738905509382,1.0,4/21,12.74%,WNT3A;FZD2;GSK3B;DVL3
prerank,cellular senescence (GO:0090398),0.3231332386149318,0.8887600782239383,0.627177700348432,0.8757578359706792,1.0,8/27,15.23%,CDKN2B;MAPK14;NSMCE2;MAP2K1;OPA1;KAT6A;MAPKAPK5;PML
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.2951031770523295,-0.888362597582478,0.6295454545454545,0.9261570884796234,1.0,4/25,5.07%,SLIT2;LIMK2;TBC1D30;ARHGAP44
prerank,negative regulation of nuclear division (GO:0051784),0.387811683493006,0.8883520985607356,0.6,0.8760563360604889,1.0,5/11,22.84%,BMP7;NANOS2;TOM1L2;TOM1L1;NME6
prerank,cellular iron ion homeostasis (GO:0006879),0.27961289536293166,0.8880769656506812,0.6330578512396694,0.8760663691107144,1.0,2/55,0.43%,CP;BMP6
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.2632622609691874,0.887908838341068,0.6666666666666666,0.8758524013747954,1.0,21/73,20.54%,SUZ12;HDAC4;POLR1C;BAZ1B;EPC1;IGF2;POLR1G;JARID2;TASOR;POLR2F;ERCC6;MYO1C;KAT2B;DDX21;DNMT3A;PPHLN1;BMI1;POLR2K;MPHOSPH8;SPHK2;PHF1
prerank,mitochondrial translational termination (GO:0070126),-0.2242087029630455,-0.8878649219452914,0.7180232558139535,0.9264985543612672,1.0,40/88,37.55%,MRPL4;MRPS18A;MRPL1;MRPS30;MRPS23;MRPL57;MRPL28;AURKAIP1;MTRF1;MRPL35;MRPL47;MRPS5;MRPL34;MRPL23;MRPL9;MRPS31;MRPL52;MRPS2;MRPS12;MRPL11;MRPL49;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;MRPL54;MRPL32;MRPL43;MRPL2;ERAL1;MRPL24;MRPL37;MRPL30;MRPL45;MRPS24;MRPS15;MRPL12
prerank,DNA double-strand break processing (GO:0000729),-0.3184153815901991,-0.8878143674071277,0.6423982869379015,0.9257687474359091,1.0,6/18,16.87%,UBE2V2;MRE11;ATM;BARD1;EXD2;BRCA1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.29993656661608403,-0.887785492794813,0.6297169811320755,0.924183624975214,1.0,9/23,30.47%,MAPK8;YWHAH;PPP1R13B;YWHAQ;BAD;YWHAZ;PPP3CC;PMAIP1;TP53
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.29993656661608403,-0.887785492794813,0.6297169811320755,0.924183624975214,1.0,9/23,30.47%,MAPK8;YWHAH;PPP1R13B;YWHAQ;BAD;YWHAZ;PPP3CC;PMAIP1;TP53
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.28169447369901,-0.8876786721052115,0.6519721577726219,0.9235871670207154,1.0,5/30,6.47%,CSGALNACT1;CSPG4;HEXB;CHST9;NDNF
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.378044407030002,0.8876633777633551,0.6171875,0.8758176583086648,1.0,3/13,11.83%,GLI3;TGFBR2;IHH
prerank,positive regulation of isotype switching (GO:0045830),-0.3421718595343851,-0.8875925310237719,0.6252723311546841,0.9229788559990257,1.0,4/15,15.22%,TFRC;CD40;CLCF1;HMCES
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.31953161761836,-0.8873842468519735,0.6134831460674157,0.9226703724826307,1.0,2/19,0.89%,DLG2;LRRC7
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.3092442943678267,-0.8871327896537564,0.6379690949227373,0.9224324521397463,1.0,4/21,11.42%,RPL5;RPS7;RPL11;RPL23
prerank,nucleotide-excision repair (GO:0006289),0.251933764981723,0.8868079319771696,0.6791044776119403,0.8771175664970263,1.0,28/101,21.06%,POLR2D;SLX4;CUL4A;RFC1;RNF111;CCNH;MNAT1;CDK7;XRCC1;TCEA1;RPA3;POLR2C;OGG1;PRPF19;POLR2F;GTF2H4;ERCC6;ERCC5;ERCC1;USP45;FANCC;GTF2H2;UVSSA;XPC;USP7;POLR2K;ERCC8;POLD3
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.29584886123832665,-0.8865608520608232,0.6136363636363636,0.923035274926779,1.0,8/23,16.43%,SIX1;BMP4;VEGFA;PAX2;FGF2;PIK3CD;SIX4;EGF
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.37653808635661695,-0.8858862123723217,0.6175298804780877,0.9238319725360725,1.0,3/10,18.38%,IQSEC1;EPB41L4B;ARF6
prerank,negative regulation of protein secretion (GO:0050709),-0.2674076965079682,-0.8858644734284268,0.683291770573566,0.9230672075584178,1.0,8/38,14.85%,RAB11FIP1;CCN3;OPRM1;RAB11FIP3;KCNB1;RHBDF2;INHBB;RAB11FIP5
prerank,neuron apoptotic process (GO:0051402),-0.31622559921295423,-0.8857369880710695,0.6220302375809935,0.9225498102909242,1.0,4/19,8.98%,CIT;TRPC5;SCN2A;FAS
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.22645096130735132,-0.8855782996848935,0.7130177514792899,0.9221057853460191,1.0,28/86,25.07%,NAV3;PTK2B;NCKAP1;PAK1;RPS3;MET;LMOD1;STMN2;CDC42EP3;VASP;CDC42EP1;CDC42EP5;FES;EVL;RAC1;MAPT;PYCARD;ARF6;CDK5RAP2;PRKCE;PFN2;DCTN1;ARL2;OCLN;CARMIL1;PFN1;MAPRE1;EDN1
prerank,fatty acid transmembrane transport (GO:1902001),0.3450698774831645,0.8854482591617722,0.5763358778625954,0.8794129458208657,1.0,2/19,1.71%,PRKAG2;PRKAA2
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.3723702485667907,0.8853564025878495,0.6252319109461967,0.8790332841463578,1.0,2/14,11.97%,IL23R;CSF1
prerank,regulation of sodium ion transport (GO:0002028),0.3012646866648453,0.8851110610391216,0.6314907872696818,0.8790243290412516,1.0,8/34,9.89%,NKAIN4;NEDD4;SNTA1;ATP2B4;WNK4;SCN3B;DLG1;GPD1L
prerank,production of siRNA involved in RNA interference (GO:0030422),0.39358076527830405,0.8846443850547339,0.5906432748538012,0.8794313743627332,1.0,2/10,13.61%,TERT;TARBP2
prerank,positive regulation of interleukin-6 production (GO:0032755),0.26866319912468,0.8844567413825873,0.6462264150943396,0.8792880098417629,1.0,9/68,9.31%,IL16;IL17D;IL6;TLR4;NOS2;LGALS9;WNT5A;SETD4;TLR2
prerank,muscle cell development (GO:0055001),0.30498787454078014,0.8839175450038067,0.6342668863261944,0.8798649487538357,1.0,4/30,5.53%,CXADR;MYOF;EFEMP2;NEBL
prerank,regulation of extracellular matrix organization (GO:1903053),0.36791265025466136,0.8834043914153226,0.6204379562043796,0.8804291928259635,1.0,3/15,5.06%,DDR2;EFEMP2;AEBP1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.38101754270087107,-0.8833163497104175,0.6092184368737475,0.9265794461358973,1.0,4/10,18.94%,ELOVL5;ABCD2;MID1IP1;SLC45A3
prerank,positive regulation of axon extension (GO:0045773),-0.3003842550860183,-0.8832112675036463,0.6281179138321995,0.925995309709328,1.0,7/22,11.28%,MACF1;SEMA7A;SHTN1;VEGFA;L1CAM;ZFYVE27;DBNL
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.3281582237877987,-0.8830808048988301,0.6311111111111111,0.9254680045369826,1.0,4/16,16.87%,ERLIN1;CEACAM1;ACADVL;BRCA1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.22601661066725826,-0.8829966970830049,0.7168674698795181,0.9248356244387536,1.0,30/82,24.12%,PPP2R1A;CSNK1D;KCNH5;NPM1;DYNC1H1;PCNT;TUBA1A;TUBB4A;PRKAR2B;CEP43;ATAD5;HSP90AA1;DYNC1I2;NEK10;NDE1;TUBB4B;PLK4;CEP135;CDK2;CEP290;SSNA1;CDK5RAP2;DCTN1;TUBG1;CENPF;CEP41;HMMR;CEP70;KIF14;MAPRE1
prerank,establishment of protein localization to organelle (GO:0072594),0.2628346735856144,0.8828313157127041,0.668141592920354,0.8810750662796188,1.0,13/72,17.95%,PRICKLE1;TNPO1;LAMP2;APPL2;TPR;PHB2;APPL1;IPO7;EIF4ENIF1;POM121;RAN;RANBP17;HK1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.23749381209886472,0.8822454771568653,0.6970108695652174,0.8817596899946099,1.0,28/151,16.11%,PDGFRA;CCN2;NOTCH2;FPR2;MTURN;GLIPR2;NRP1;ROR1;ANGPT1;BMP2;PRKCZ;PTPN22;PDGFRB;CCL2;LGALS9;ACKR3;PHB2;DSTYK;MAP2K1;P2RY6;ARRB1;NTRK3;P2RY1;PRKD2;CCL25;ICAM1;PLA2G5;APP
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.2801094212433055,-0.8817067645748131,0.6461916461916462,0.9270357696804189,1.0,7/32,15.89%,RPS19;RPL39;RPL30;DEFA6;PGLYRP1;HMGN2;RNASE7
prerank,protein insertion into membrane (GO:0051205),-0.27271004414702055,-0.8815189787554711,0.6544117647058824,0.9266622020818063,1.0,14/32,27.91%,REEP1;SERP1;TRAM1;EGFR;CCDC47;MAIP1;WDR83OS;SEC61G;CYB5A;HMOX1;TRAM1L1;SEC61B;GET1;VAMP2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2620041587338921,0.8814978549788788,0.6697247706422018,0.8827222029510811,1.0,16/80,15.71%,COPZ2;PLPP3;ARFGAP3;KDELR3;ARF4;ERGIC1;TAPBP;ARF3;UVRAG;COPE;ARCN1;SCFD1;KLC1;COPZ1;TMED9;GBF1
prerank,regulation of necroptotic process (GO:0060544),0.32768091038875924,0.8812836187099589,0.6112084063047285,0.8826412786694233,1.0,5/23,15.00%,ZBP1;CFLAR;BIRC3;FLOT2;SLC25A4
prerank,negative regulation of hydrolase activity (GO:0051346),-0.2549058466804436,-0.8811427800958642,0.6863753213367609,0.9267213213608075,1.0,12/49,14.54%,CST3;LRCH1;CPEB2;DAB2IP;RCC2;CAMK2A;TMED2;NOS1;SLC39A14;F11R;HRAS;MAP2
prerank,negative regulation of cell aging (GO:0090344),-0.3240934951881541,-0.881126469493197,0.6331096196868009,0.9259443645159736,1.0,3/16,7.40%,CDK6;YBX1;RBL1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.33673965595966493,-0.8808438466041458,0.6355748373101953,0.9257410683233687,1.0,5/15,13.53%,SIX1;BMP4;VEGFA;PAX2;SIX4
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.32283072424212267,0.8806359666214202,0.6136752136752137,0.8834038429689476,1.0,3/22,11.18%,NR2F2;LATS2;IPO7
prerank,long-chain fatty acid transport (GO:0015909),0.30951529340919676,0.8805476174433179,0.6345811051693404,0.8830167803296203,1.0,4/30,8.92%,PRKAG2;PRKAA2;ACSL1;SLC27A2
prerank,snRNA metabolic process (GO:0016073),-0.3211866759496112,-0.880178247356776,0.6228448275862069,0.9264862590444487,1.0,9/17,31.04%,INTS7;INTS10;INTS12;ZCCHC8;INTS11;INTS1;INTS5;INTS2;RBM7
prerank,negative regulation of secretion (GO:0051048),0.39751390883240884,0.879973020155034,0.6064638783269962,0.8836134237086037,1.0,5/10,23.68%,NR1H3;TIFAB;ERBB3;PTGER3;NRG1
prerank,regulation of protein catabolic process (GO:0042176),-0.220016615800054,-0.8792260236103228,0.7235494880546075,0.927855006759973,1.0,14/99,11.30%,FMN2;FOXO1;WWP1;HECW1;NSF;SORL1;EEF1A1;DAB2IP;SNX3;OAZ1;OAZ2;NEDD4L;ZDHHC2;BARD1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.3520965132032087,-0.8790114229897604,0.628755364806867,0.9275262471347587,1.0,1/12,0.93%,TMEFF2
prerank,quinone biosynthetic process (GO:1901663),-0.3453125151471022,-0.878991521135516,0.6518046709129511,0.9267547165988246,1.0,6/14,23.87%,COQ9;FDXR;COQ8A;COQ10B;COQ3;COQ5
prerank,pharyngeal system development (GO:0060037),-0.33355656991779326,-0.8786818609092798,0.6252676659528907,0.9266639264759485,1.0,4/15,6.66%,TGFB2;BMPR2;TBX1;BMP4
prerank,cranial nerve development (GO:0021545),0.3836237623614959,0.878530147043317,0.6209523809523809,0.8861644508711963,1.0,2/11,7.95%,SALL1;TIFAB
prerank,regulation of mitotic cell cycle (GO:0007346),-0.2020774743070712,-0.8783412732589274,0.8171641791044776,0.9266384594461498,1.0,43/171,20.64%,BRINP3;MEIS2;BRINP1;NEK7;BRINP2;PSMC3;CDC26;LGMN;SDCBP;SIK1;PSMD3;PSMD14;TFAP4;TAL1;TTC28;CAV2;CCDC8;PSMD6;BORA;PSMD4;ANGEL2;PSMA6;PSMA4;UBE2E1;PSMB8;DYNLT3;PSMA8;CYLD;BUB1B;PSME1;UBE2D1;BTG1;ASNS;CDKN1C;L3MBTL1;MAEA;PSMD7;AFAP1L2;PSMC6;MKI67;PRMT5;USP2;PSMB5
prerank,regulation of myoblast fusion (GO:1901739),0.3878086011059857,0.8782332372479162,0.6131386861313869,0.8862592101156902,1.0,2/11,10.62%,CFLAR;MAPK14
prerank,carbohydrate catabolic process (GO:0016052),-0.26263927793311437,-0.8781241540134304,0.6478149100257069,0.9263408548755447,1.0,9/38,16.38%,PGK1;PKM;ALDOC;NEU1;TPI1;GPI;PGAM1;PGAM4;ENO1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.2848724590487539,-0.8781099963077237,0.6586538461538461,0.9255631265729308,1.0,3/27,5.77%,GPCPD1;GDPD1;ENPP6
prerank,cellular response to amino acid starvation (GO:0034198),-0.2309338552480633,-0.8778202108270657,0.7410714285714286,0.9254312708451858,1.0,21/71,21.57%,MAP3K5;MAPK8;ATP6V1B2;DAPL1;MAPK3;SESN3;ATP6V0C;RRAGB;FAS;ATP6V1D;ATF4;PRKD1;CDKN1A;RRAGC;ATP6V1G2;LAMTOR2;ATP6V0E2;MLST8;ATP6V1F;ATP6V0D2;DEPDC5
prerank,atrioventricular valve development (GO:0003171),-0.3431259365465351,-0.8777628711215567,0.6170212765957447,0.9247567088020703,1.0,6/14,13.82%,TGFB2;BMPR2;NOTCH1;ZFPM1;ACVR1;APLNR
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.29285238852298723,-0.8776352807333372,0.6591928251121076,0.9242482264705881,1.0,8/25,15.11%,DMD;ATP1B1;ANK3;TRPC6;CTSS;NDUFA4;STAC;GLRX
prerank,regulation of mitochondrial depolarization (GO:0051900),0.3904871428683463,0.8771989981117899,0.6082474226804123,0.8879214666344388,1.0,3/10,8.73%,DCN;BCL2;LRRK2
prerank,regulation of translation (GO:0006417),0.23081492773454276,0.8771656834680008,0.7451487710219923,0.8874228159370608,1.0,38/173,19.73%,PLD1;SAMD4A;EIF2AK2;IGFBP5;SHMT1;VIM;IGF2BP1;DAPK1;PKP3;IL6;NANOS2;IGF2BP2;CTIF;TRAP1;FOXO3;ILF3;ZCCHC4;RPS6KA3;EIF4ENIF1;DDX6;GEMIN5;EIF2AK3;GIGYF2;ALKBH1;MAPKAPK5;SOX4;CNOT9;APP;SHFL;CPEB3;UPF3A;FXR2;OGFOD1;PLXNB2;DHX36;EIF4H;NANOS1;ERBB2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.3253402654563813,-0.8768504792082428,0.6169724770642202,0.9252828701949308,1.0,4/16,11.64%,TPT1;RPS3;CCAR2;CXCL12
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.39334835132371276,0.8768060186047892,0.6166982922201139,0.887633324651609,1.0,4/10,19.01%,MIA3;TLR4;TICAM1;CD36
prerank,regulation of cell projection organization (GO:0031344),-0.34043112903329914,-0.8762938445139182,0.6511627906976745,0.925685139639196,1.0,7/13,19.14%,SEMA4D;MACF1;ERMN;MFSD2A;CCL19;NTNG2;NTNG1
prerank,protein K48-linked deubiquitination (GO:0071108),-0.2989048571198669,-0.8754467674117481,0.6565420560747663,0.9268533385673553,1.0,8/23,22.28%,OTUD7A;USP37;MINDY2;VCPIP1;YOD1;MINDY1;ATXN3;OTUB2
prerank,regulation of mRNA processing (GO:0050684),-0.2773053170042016,-0.8752398819129406,0.6919431279620853,0.9265441496208195,1.0,5/32,11.44%,QKI;KHDRBS2;KHDRBS3;HNRNPK;PTCD2
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.250495947855249,0.8751539096313158,0.7008426966292135,0.8905030397302104,1.0,18/85,16.64%,PRICKLE1;NUPR1;RNF217;ZYG11B;RNF19A;GSK3B;NUB1;PIAS1;LRRK2;SUMO1;KEAP1;HECTD1;TRIB1;DDA1;RCHY1;DAB2;RNF180;RNF185
prerank,smooth muscle contraction (GO:0006939),0.36583785598809904,0.8749929403857385,0.6293706293706294,0.8902692875314464,1.0,5/14,14.11%,ROCK2;PIK3C2A;BDKRB2;NMUR1;SMTN
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.30758376060292963,-0.8747142554238921,0.6447963800904978,0.9269290207921583,1.0,6/20,14.05%,HSP90AB1;AKT1;CCND1;TTBK1;EGFR;RGCC
prerank,Fc receptor signaling pathway (GO:0038093),0.24509365734907218,0.8745698374508691,0.7042857142857143,0.8905535923032856,1.0,16/110,12.92%,PDPK1;TEC;GAB2;FER;KIT;MAP3K1;PSMB10;PSMA7;PSMA3;PSME4;PSMA5;PPP3CB;FBXW11;MAP3K7;BTRC;MAPK9
prerank,mammary gland development (GO:0030879),0.3328176473076039,0.8744280218854892,0.6170212765957447,0.8902976899724551,1.0,1/21,0.45%,WNT4
prerank,modulation by symbiont of entry into host (GO:0052372),-0.32428659873076127,-0.8744200137132019,0.6252771618625277,0.9267610386849474,1.0,5/16,16.03%,HS3ST5;TRIM68;CAV1;TRIM62;FUCA2
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.29414111304884216,-0.8741870646366707,0.6426858513189448,0.9264688562949981,1.0,11/23,36.26%,SEL1L;LMAN1;TECPR2;PREB;HERPUD1;SEC61B;RANGRF;UFD1;SEC13;AUP1;DERL1
prerank,regulation of chromatin organization (GO:1902275),0.3710026739154625,0.8737379192108182,0.6197440585009141,0.8912094772513638,1.0,4/14,15.54%,MLLT3;IGF2;TLK2;SETD5
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.3142179626274509,-0.8736719410514923,0.6595238095238095,0.9268223665188947,1.0,6/20,21.92%,ENTPD1;HSP90AB1;PSTPIP1;P2RX7;PYCARD;CASP1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.3165459679963765,-0.873508813057544,0.6448202959830867,0.9263786449399346,1.0,2/19,0.77%,PRKCH;CLDN5
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.32727224388283105,0.8734375816783744,0.6419753086419753,0.8912382980441017,1.0,4/22,10.63%,DYNLL1;BMP7;CDKN2B;PLEK
prerank,genitalia development (GO:0048806),0.38058482622460854,0.8730630762152933,0.6135922330097088,0.8914964049874399,1.0,2/12,7.95%,WNT5A;TIFAB
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3300313960871716,-0.8729922996222375,0.6412371134020619,0.9267351943260339,1.0,4/15,13.64%,PRKCH;BMP4;SFRP4;ETV4
prerank,negative regulation by host of viral process (GO:0044793),0.39712217491580454,0.8728631916225185,0.6107784431137725,0.8913150831270891,1.0,2/10,7.70%,CRP;VAPA
prerank,antibacterial humoral response (GO:0019731),-0.3251393262305795,-0.87264135476922,0.6541850220264317,0.9267037704468514,1.0,3/16,15.89%,RPL39;DEFA6;RNASE7
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.23573712458906693,-0.8726232300325775,0.6976744186046512,0.9259438371763903,1.0,18/55,25.37%,PSMC3;PSMD3;PSMD14;PSMD6;PSMD4;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;SKP1;PSMD8;PSMD11
prerank,establishment of vesicle localization (GO:0051650),-0.312982320757247,-0.871848927904745,0.6179775280898876,0.926889670256269,1.0,9/18,26.09%,LIMK2;RAB27A;KIF5C;KIF5A;SNAPIN;TESK1;SYNJ1;CDK5;F8A1
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.26542978400831546,-0.871802252507529,0.681704260651629,0.9261967639343086,1.0,7/33,18.03%,SETX;CSTF2;CPSF2;SYMPK;SNRPB;CSTF2T;SNRPF
prerank,cellular response to leucine starvation (GO:1990253),-0.3678493976399544,-0.8717902205940169,0.614406779661017,0.9254401225316776,1.0,2/10,8.87%,SESN3;RRAGB
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.36826904057133086,-0.8714564212638367,0.6209677419354839,0.9253841776712491,1.0,4/10,18.84%,GALNT13;GALNT3;GALNT4;POGLUT3
prerank,iron ion homeostasis (GO:0055072),0.2716886791150268,0.8713752284793947,0.6736672051696284,0.8938445090227156,1.0,2/58,0.43%,CP;BMP6
prerank,response to glucocorticoid (GO:0051384),-0.2909889892995198,-0.8712955245275735,0.6651053864168618,0.9249367573988697,1.0,2/26,5.00%,SLIT2;FAM107A
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.2772109055693851,0.8709764199376401,0.6403785488958991,0.8941401693896593,1.0,8/52,8.93%,PDPK1;SPTBN1;EPHA3;SORBS1;ATP2B4;PTPN9;KIF5B;DLG1
prerank,positive regulation of phagocytosis (GO:0050766),0.2815641432458345,0.8709475009676231,0.6495327102803738,0.8936376503742208,1.0,7/47,8.16%,CAMK1D;FPR2;APOA2;APPL2;CD47;CCL2;C2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.35310211945186387,-0.8708825691433788,0.6423982869379015,0.9251332933611986,1.0,2/12,12.75%,ACSL3;MFSD2A
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.36473591279218814,0.8708636464211054,0.6011787819253438,0.8932441810828289,1.0,4/13,19.28%,VDAC2;BAX;RHOT1;RHOT2
prerank,C-terminal protein amino acid modification (GO:0018410),-0.35983537905541396,-0.8703941027277685,0.6549586776859504,0.9254713143626578,1.0,1/11,0.97%,AGBL4
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3569419717039335,0.8700529090417981,0.6290909090909091,0.8943166423037415,1.0,4/14,21.09%,MYO9A;PATJ;FSCN1;RAP2A
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.30871808322965616,0.8693381068211571,0.6519524617996605,0.8952175986287448,1.0,6/29,14.78%,IKBKE;TLR4;BIRC3;LY96;TICAM1;TBK1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.3454971663736822,-0.8692767841947747,0.6295546558704453,0.9271549145091673,1.0,2/12,2.16%,CTNNA3;RYR2
prerank,mitotic cell cycle phase transition (GO:0044772),0.22332025930302654,0.8692033969857396,0.7470664928292047,0.8949252821353356,1.0,37/203,15.36%,PHLDA1;NINL;DYNLL1;ALMS1;FBXL17;SDCCAG8;LATS2;CCND3;CLASP1;OPTN;CUL4A;CEP152;CDKN2B;HAUS8;FBXL3;CRLF3;CCNH;ANAPC1;UBE2C;MNAT1;CDK7;FBXL7;PPP1R12B;PPP1CB;NEDD1;NES;CUL3;CCDC57;FBXW11;BTRC;CDC27;MASTL;CHMP4B;KDM8;ACTR1A;FBXL12;CEP250
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.2296478618163718,-0.8691471536267289,0.7476038338658147,0.9266623820291826,1.0,27/76,25.07%,TEK;PTK2B;NCKAP1;LMOD1;CDC42EP3;DYNC1H1;VASP;CDC42EP1;CDC42EP5;PFDN2;FES;HRAS;EVL;PLK4;NTF3;P2RX7;PYCARD;ARF6;SPAG5;PRKCE;PFN2;HCLS1;NUP62;CARMIL1;PFN1;CDK5;EDN1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.23290383433699813,-0.8690413227826705,0.7568306010928961,0.9261114580503919,1.0,17/73,21.33%,PTPRJ;PLCG2;IL33;THBS1;HMGB1;ARHGEF2;HAVCR2;CD86;SYK;PTPRC;CCL19;NOD2;ADAM8;PYCARD;LPL;FZD5;MIF
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.2819165813782404,-0.8689266634247675,0.690176322418136,0.925545577018084,1.0,13/31,28.69%,DIS3L2;EXOSC2;DCP1A;HBS1L;EXOSC4;CNOT8;LSM4;EDC3;LSM2;EXOSC1;POLR2G;LSM3;DCPS
prerank,myeloid leukocyte differentiation (GO:0002573),0.26296728048502355,0.8688021064602525,0.6927899686520376,0.8951758825111795,1.0,14/65,16.62%,IL31RA;GAB2;KIT;PIR;TGFBR2;GLO1;LGALS9;MAPK14;CSF1;EPHA2;THOC5;RARA;PML;FARP2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.31414050577488223,0.8686788673031798,0.6278659611992945,0.8948617300670033,1.0,7/25,15.23%,QRICH2;SGTA;EPHA4;HFE;EFNA1;CSNK2A2;PML
prerank,response to amino acid starvation (GO:1990928),-0.22833581798599462,-0.868569539607173,0.7492537313432835,0.9255746544834729,1.0,21/72,21.57%,MAP3K5;MAPK8;ATP6V1B2;DAPL1;MAPK3;SESN3;ATP6V0C;RRAGB;FAS;ATP6V1D;ATF4;PRKD1;CDKN1A;RRAGC;ATP6V1G2;LAMTOR2;ATP6V0E2;MLST8;ATP6V1F;ATP6V0D2;DEPDC5
prerank,regulation of cardiac conduction (GO:1903779),0.27461597648708425,0.8678741297587389,0.6854838709677419,0.8959532367120393,1.0,9/54,12.58%,ATP1A2;ITPR1;TMEM65;CORIN;ATP2B4;NPPC;TRPC1;ATP1B2;ATP2B1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.3817257536229579,0.8677202495828381,0.6188524590163934,0.8957296548097936,1.0,3/10,11.48%,RC3H1;FOXP3;NFKBIZ
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.31894596476985915,0.8677072854552502,0.6362098138747885,0.8951852224534012,1.0,4/23,8.52%,GHR;KIT;IL6;CRLF3
prerank,regulation of protein kinase A signaling (GO:0010738),0.33249009454308565,0.8676495418861753,0.6418181818181818,0.894729562578119,1.0,4/20,8.73%,AKAP12;ADGRV1;PJA2;LRRK2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.3766312492743942,0.8675892276592175,0.6263940520446096,0.8942947914039212,1.0,3/12,9.42%,SORBS1;EPM2AIP1;IGF2
prerank,calcium ion import across plasma membrane (GO:0098703),-0.3313256696372383,-0.8674672462201098,0.6618257261410788,0.9271971787985596,1.0,2/14,5.51%,SLC24A2;SLC8A1
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.3061021431901866,0.8673950473770352,0.6160714285714286,0.8935849000684534,1.0,4/29,11.05%,ACOT11;ACOT9;ACOT1;ACAT1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.3061021431901866,0.8673950473770352,0.6160714285714286,0.8935849000684534,1.0,4/29,11.05%,ACOT11;ACOT9;ACOT1;ACAT1
prerank,regulation of DNA metabolic process (GO:0051052),0.2780427711849077,0.866920959757086,0.698019801980198,0.8940217150476203,1.0,12/44,20.88%,POLH;NUCKS1;STOX1;MPV17;UBE2V1;SMG5;SMG6;SMG1;IL7R;MPHOSPH8;TOM1L1;WDR70
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.30223788316182765,-0.8667094696668326,0.6334106728538283,0.9280829811428134,1.0,8/22,31.70%,MMS19;NDOR1;CIAO3;HSCB;IBA57;ISCU;GLRX5;NUBPL
prerank,aminoglycan biosynthetic process (GO:0006023),-0.249780115875686,-0.8666531543751574,0.7286821705426356,0.9274125886073417,1.0,7/49,5.53%,GPC5;HS3ST1;HS6ST2;HS3ST5;XYLT1;SDC3;EXT1
prerank,ear morphogenesis (GO:0042471),0.33477581765985337,0.8665145100653069,0.6072727272727273,0.8943216612905024,1.0,5/20,16.18%,OSR1;ZIC1;TIFAB;NOG;NIPBL
prerank,chromosome organization (GO:0051276),0.2456239305636219,0.8663403053929138,0.7363896848137536,0.8941124997950083,1.0,7/99,6.54%,TCF7L2;NUCKS1;BRWD1;CDAN1;CUL4A;TOP2B;TCF7L1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.29762365124973633,-0.8662257424001142,0.6833333333333333,0.9275886261573462,1.0,10/22,30.82%,NOL11;DDX11;SMARCB1;PWP1;ATF4;HEATR1;RASL11A;LYAR;WDR75;PIH1D1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.3267845362910391,-0.8659372795767433,0.6552511415525114,0.9274409500043811,1.0,4/16,24.77%,CELF4;TRA2A;RBM3;RBMXL1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.2621101813202801,0.8656379390871966,0.6707503828483921,0.8949909523440893,1.0,8/63,8.19%,IL6ST;IL23R;ANXA1;IL6;BCL2;VCAM1;IL18;CD274
prerank,nitrogen compound transport (GO:0071705),0.2358868131374393,0.8655283199553776,0.7330567081604425,0.8946376022426231,1.0,7/141,4.57%,SLC7A11;PDPN;SLC7A2;SLC6A13;SLC6A12;SLC7A14;MIA3
prerank,granulocyte chemotaxis (GO:0071621),0.2720802485347362,0.8653150922137837,0.6874003189792663,0.8945241882825923,1.0,5/55,7.35%,CXADR;CXCL10;ANXA1;CKLF;CCL2
prerank,regulation of neuron projection arborization (GO:0150011),-0.3221338915055535,-0.8652234200093194,0.6510638297872341,0.9282840151599142,1.0,7/15,19.14%,MACF1;GRIP1;DVL1;MFSD2A;FZD4;NTNG2;NTNG1
prerank,cellular response to radiation (GO:0071478),-0.2540995528979071,-0.8650912756917439,0.7241379310344828,0.9278061162758638,1.0,17/40,33.15%,NET1;INTS7;RHOB;KDM4D;CDKN1A;RAD51;RAD1;GPR88;ECT2;RHNO1;RAD51AP1;BLM;EEF1D;TP53;RRH;OPN1MW3;OPN1MW
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.255292046198664,-0.8649129100643846,0.6915422885572139,0.9273965277957442,1.0,12/40,19.70%,PTK2B;RPL5;RPS7;RPL11;RAD23A;RPL23;XPO1;GNA12;FOXF2;UBQLN4;CCDC22;UFL1
prerank,proteasomal protein catabolic process (GO:0010498),0.22267835131465827,0.8646593432984153,0.7810880829015544,0.8952495363914807,1.0,54/201,23.37%,SPSB1;SMURF2;TBL1XR1;FBXL17;NEDD4;NHLRC3;KLHL22;SIAH2;UBE2U;SPSB4;RNF216;CUL4A;PSMB10;PSMA7;PSMA3;PSME4;ERLEC1;UBXN2A;PSMA5;WWP2;SPOPL;HUWE1;IFI27;CUL3;FBXW11;BTRC;HECW2;ARRB1;BFAR;PRPF19;KCTD5;PML;SOCS6;TBL1X;RNF185;PPP2R5C;UBE4B;CLOCK;TRIM3;PCBP2;RCN3;SIRT2;UBE2K;PSMC2;ERCC8;RNF139;UBXN1;PELI1;FBXW7;RMND5B;RMND5A;SYVN1;PSME3;PSMD1
prerank,nucleus organization (GO:0006997),-0.24601125256857154,-0.8642373403890528,0.7222222222222222,0.9281052291248789,1.0,17/47,31.50%,SYNE1;RPS19;NUP93;CTDNEP1;CHMP1A;CHMP1B;CHMP2B;CHMP7;CHMP2A;CEP55;NUP54;CHMP6;CHMP4C;TOR1A;REEP4;NDC1;PITPNB
prerank,negative regulation of cell activation (GO:0050866),0.3621114743373134,0.8641396609287594,0.6666666666666666,0.8957249951013718,1.0,1/14,0.98%,PDGFRA
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.35256898779780527,0.864120287599985,0.6357012750455373,0.8952002760826822,1.0,2/15,8.42%,SMPD3;PLA2G6
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.3295959665422343,-0.8638400765511544,0.6687898089171974,0.9281677686326482,1.0,5/15,18.94%,ELOVL5;PPARD;NR4A3;MID1IP1;SLC45A3
prerank,snRNA processing (GO:0016180),-0.3210567128660675,-0.8631608151036589,0.6497890295358649,0.9289515600195071,1.0,9/16,29.93%,INTS7;INTS10;INTS6L;INTS12;TOE1;INTS11;INTS1;INTS5;INTS2
prerank,positive regulation of protein acetylation (GO:1901985),0.36288334632801067,0.8628960959885169,0.6224299065420561,0.8971378661535803,1.0,1/12,1.71%,PRKAA2
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.37264731647798305,-0.862480393286385,0.6473118279569893,0.9296807324692915,1.0,4/10,24.07%,SORL1;DNAJA4;SACS;HSPA2
prerank,regulation of secretion (GO:0051046),-0.33827890796855153,-0.8620306306183021,0.6528066528066528,0.9298954096262585,1.0,7/13,32.22%,ACSL3;KCNQ1;EGF;SGK1;FGF10;POFUT2;SCIN
prerank,respiratory electron transport chain (GO:0022904),-0.33958500544182124,-0.8619840002586153,0.6134969325153374,0.929220124889143,1.0,3/14,20.54%,GPD2;SLC25A13;SLC25A12
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.37962381242034193,0.8619683270290555,0.6448979591836734,0.8984514428731201,1.0,3/11,7.87%,STAT1;TGFBR2;WNT5A
prerank,regulation of gene silencing by miRNA (GO:0060964),0.26606526011362797,0.8619407458111646,0.6671899529042387,0.8979437009776464,1.0,15/62,20.93%,POU5F1;POLR2D;RANBP2;TPR;TNRC6A;POLR2C;POLR2F;POM121;NUP37;WTIP;PUM2;AJUBA;POLR2K;NUP85;ELAVL1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.29025957175060857,-0.8617751129760625,0.6651685393258427,0.9289111054898483,1.0,5/23,7.32%,PAK1;MAP3K5;RPS3;DAB2IP;MAP3K11
prerank,B cell differentiation (GO:0030183),-0.25050050082727376,-0.8615338101259424,0.7107231920199502,0.9286278574738577,1.0,11/46,17.05%,PTPRJ;PLCG2;TPD52;ITGA4;HDAC9;TCF3;HHEX;DCAF1;CLCF1;PTPRC;RABL3
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3113007636752214,0.8613386094510379,0.6620926243567753,0.8986300498739129,1.0,6/26,11.53%,STK39;NEDD4;ACTN2;DLG1;WWP2;ATP1B2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.3287964333657154,-0.8612407423984877,0.6645833333333333,0.9285347361478653,1.0,1/15,0.18%,PRKCH
prerank,autophagosome maturation (GO:0097352),-0.269136738803078,-0.8611239713810965,0.6882494004796164,0.9280080325332548,1.0,8/32,15.53%,CALM1;GABARAP;GABARAPL1;VPS33B;VMP1;TECPR1;ATP2A2;VIPAS39
prerank,vesicle transport along microtubule (GO:0047496),-0.291250982405697,-0.8606536855176694,0.6778846153846154,0.9282499564984117,1.0,9/23,23.94%,KIF1C;DYNC1H1;NDE1;KIF3B;BICDL1;KIF5A;HAP1;CLN3;HTT
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.2818697579005734,0.8598817102070045,0.6921824104234527,0.9010549418594545,1.0,6/42,10.37%,POLH;WRN;RFC1;PARP10;REV1;RPA3
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.32692940800483516,-0.8595516880373802,0.6547884187082406,0.929863393735198,1.0,2/15,3.07%,PIEZO2;SCN1A
prerank,macrophage migration (GO:1905517),0.3643141111265391,0.8594839998977953,0.6395348837209303,0.9013255405876923,1.0,3/13,16.85%,CKLF;CCL2;P2RX4
prerank,DNA catabolic process (GO:0006308),0.38314842703829904,0.8591236024084267,0.6461232604373758,0.9015020623714786,1.0,3/11,18.94%,FBH1;DNASE1L1;DFFB
prerank,sphingosine metabolic process (GO:0006670),-0.31102375520121006,-0.8587642059701494,0.6610169491525424,0.9307804989032155,1.0,2/17,2.15%,ACER3;ACER2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.26180128566546107,-0.8583196066098567,0.6958637469586375,0.9309995607974009,1.0,11/37,16.43%,SMAD7;CALM1;CALM2;INPP5K;CEMIP;CALM3;DDIT4;SPRED2;IRGM;SPRED3;EGF
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.2313420772115967,-0.8581227218349454,0.7209302325581395,0.9290924263729523,1.0,17/61,21.67%,GRIA1;NSF;CTSC;CSNK1D;TMED2;TRAPPC4;CNIH1;NAPA;LMAN1;ANKRD28;TRAPPC6B;RAB1B;SAR1B;COL7A1;TRAPPC3;SEC22B;PPP6C
prerank,COPII vesicle coating (GO:0048208),-0.2313420772115967,-0.8581227218349454,0.7209302325581395,0.9290924263729523,1.0,17/61,21.67%,GRIA1;NSF;CTSC;CSNK1D;TMED2;TRAPPC4;CNIH1;NAPA;LMAN1;ANKRD28;TRAPPC6B;RAB1B;SAR1B;COL7A1;TRAPPC3;SEC22B;PPP6C
prerank,vesicle coating (GO:0006901),-0.2313420772115967,-0.8581227218349454,0.7209302325581395,0.9290924263729523,1.0,17/61,21.67%,GRIA1;NSF;CTSC;CSNK1D;TMED2;TRAPPC4;CNIH1;NAPA;LMAN1;ANKRD28;TRAPPC6B;RAB1B;SAR1B;COL7A1;TRAPPC3;SEC22B;PPP6C
prerank,mesenchymal to epithelial transition (GO:0060231),-0.3723599962633778,-0.8576337330960561,0.6666666666666666,0.929433043309181,1.0,3/10,11.84%,BMP4;PAX2;BASP1
prerank,skeletal muscle tissue development (GO:0007519),0.2985030754871528,0.8574826743038764,0.6585365853658537,0.9041730940370776,1.0,7/32,12.21%,CSRP3;CFLAR;IGSF8;POPDC2;SKI;MSC;EGR2
prerank,stem cell development (GO:0048864),-0.3205740490116103,-0.8574667612978959,0.6614349775784754,0.9290104851689825,1.0,10/16,45.80%,CDH2;PTPRC;SOX11;KBTBD8;SOX8;CYP26C1;NOLC1;KLHL12;PDCD6;SNAI2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.24293873491619916,0.8573329176192915,0.7419804741980475,0.9039330076283938,1.0,22/100,16.54%,PRICKLE1;RNF217;ZYG11B;ARAF;RNF19A;FHIT;GSK3B;WAC;NUB1;PIAS1;LRRK2;TLK2;SUMO1;KEAP1;HECTD1;HFE;TRIB1;DDA1;RCHY1;DAB2;TAF9;RNF180
prerank,positive regulation of calcium ion import (GO:0090280),0.37137075064901554,0.857272609328417,0.635673624288425,0.9034896850032864,1.0,2/12,7.35%,PDGFRB;CCL2
prerank,heterocycle biosynthetic process (GO:0018130),-0.33032696556594837,-0.8571744738315159,0.6709129511677282,0.9288351522409914,1.0,8/14,37.39%,GPHN;GCH1;PYCR2;PYCR1;ALOX5;LIAS;MOCS2;MOCS3
prerank,response to UV-A (GO:0070141),-0.3286365205476798,-0.8567664344809608,0.6645962732919255,0.9289469035078834,1.0,4/14,16.62%,AKT1;CCND1;EGFR;MMP1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.275132367191224,0.856370676109397,0.6837060702875399,0.9047737578561804,1.0,10/49,14.39%,NUPR1;BCL2;GSDME;MCL1;BAX;DNM1L;BCL2L1;DAPK2;NDUFS3;EIF2AK3
prerank,negative regulation of lyase activity (GO:0051350),-0.31921028962249565,-0.8563065863309531,0.654945054945055,0.9291023547545799,1.0,2/16,3.37%,GRM3;GABBR2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.3448647000254538,-0.8561499642688324,0.6610526315789473,0.9286892189180049,1.0,1/11,1.59%,PLCG2
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.39389893350116084,0.8560199962774961,0.6354961832061069,0.9049579071567457,1.0,2/10,11.39%,APPL2;ANO6
prerank,response to UV (GO:0009411),-0.2144251508367849,-0.8557730435715306,0.7899686520376176,0.9287535629074336,1.0,27/95,24.60%,PTPRK;RPL26;MAPK8;AKT1;NPM1;MAP4K3;CCND1;YY1;CCAR2;ATF4;COPS9;EGFR;USF1;CASP9;BMF;MEN1;MFAP4;N4BP1;NOC2L;POLD1;BCL3;DCUN1D3;DTL;POLK;DDB2;ATR;RHNO1
prerank,regulation of protein localization (GO:0032880),0.2629121006174006,0.8553970982755917,0.7201907790143084,0.9057058129068096,1.0,11/58,12.74%,AFDN;TRIM17;AAK1;TPR;TRIM5;DLG1;USP8;SUMO1;TRIM21;ATCAY;DVL3
prerank,modulation by host of viral genome replication (GO:0044827),0.3614663748741579,0.8553671812527673,0.6400778210116731,0.9051970361637331,1.0,3/13,11.86%,NUCKS1;VAPA;IFI27
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.35099544787140025,-0.8553533933464428,0.6523517382413088,0.9288701603859906,1.0,3/11,20.24%,TERF1;CCT5;WRAP53
prerank,muscle tissue development (GO:0060537),0.3671935931286002,0.8550914559879139,0.6299810246679317,0.9051837336473257,1.0,2/13,4.87%,CSRP3;CSRP1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.30012145499895304,0.8548629673408019,0.670774647887324,0.9050651238568526,1.0,5/30,8.19%,IL6;TLR4;PRKCZ;LGALS9;CD274
prerank,vesicle organization (GO:0016050),-0.2420470850603461,-0.8545367047772068,0.7117794486215538,0.9298347859612169,1.0,16/46,24.60%,FNBP1L;CD34;ALS2CL;VPS33B;CAV2;PI4K2A;CAV1;ALS2;SORT1;CHMP2B;SAR1B;DNAJC13;VPS18;SNX33;LAPTM4B;PHETA2
prerank,cellular lipid catabolic process (GO:0044242),0.3058472162122743,0.8537201132372415,0.6694772344013491,0.9068467595688888,1.0,9/27,23.20%,APOA2;ENPP2;LPIN2;ACOX1;SIRT2;ANGPTL3;ACBD5;NUDT19;LPIN1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.3699552045465396,-0.8536578464521091,0.6646090534979424,0.9309889076402237,1.0,5/10,36.61%,SIRT7;ZNF692;DGKQ;GNMT;PDK2
prerank,regulation of response to oxidative stress (GO:1902882),-0.365508268438012,-0.8531677353585823,0.6588693957115009,0.9312163824882794,1.0,7/11,29.58%,MCTP1;PINK1;SELENON;GGT7;AIFM2;ACOX2;ALOX5
prerank,mitochondrial gene expression (GO:0140053),-0.2536013038746371,-0.8528232325556377,0.7336343115124153,0.93122018867676,1.0,14/42,24.14%,LARS2;MRPS18A;FASTKD2;TWNK;MRPL57;RARS2;MRPL47;HARS1;TFB2M;MRPL23;MRPS2;MRPS12;POLRMT;MRPS16
prerank,regulation of programmed cell death (GO:0043067),0.2273312206436459,0.8527113788220892,0.7628458498023716,0.9083704626794055,1.0,19/161,8.73%,IGFBP3;KANK2;CXCL10;STEAP3;FBXO11;DAPK1;WRN;PLK5;IFT57;HAX1;BIRC3;CREBBP;STAT1;ACTN2;ANP32E;BAX;TRIM24;CHM;LRRK2
prerank,homologous chromosome segregation (GO:0045143),-0.30743038531106043,-0.8524654529485808,0.6923076923076923,0.9312795514609087,1.0,4/20,19.05%,FMN2;PTTG1;MEI4;SIRT7
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3308162497626264,0.8522845408179395,0.6558558558558558,0.9087183478495834,1.0,6/19,19.19%,ENPP1;TPST1;ABHD14B;SULT1A1;PAPSS1;SULT6B1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.2380048956352894,0.8520905033675631,0.7320916905444126,0.9085537695185025,1.0,16/107,14.39%,RASGRF1;ITPR1;CREB3L2;CASP4;UBA5;CREB3L3;BCL2;GSK3B;BAX;QRICH1;ERLEC1;GORASP2;ERN2;TMEM33;NCK1;EIF2AK3
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.30078191761834294,0.8519600504681442,0.6745762711864407,0.9082397410873873,1.0,6/30,14.78%,IKBKE;TLR4;BIRC3;LY96;TICAM1;TBK1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.33173656219163716,-0.8514929535310407,0.6726057906458798,0.932632786942592,1.0,9/14,31.62%,PLCG2;SEMA7A;CD74;NR4A3;CAMK4;LILRB1;LAPTM5;GPRC5B;BCL10
prerank,microtubule nucleation (GO:0007020),0.3254828680285492,0.8513767291071598,0.6453900709219859,0.9088059768925847,1.0,7/19,16.86%,CLASP1;TUBGCP4;SLAIN2;CCDC57;TUBGCP2;TUBGCP5;GOLGA2
prerank,regulation of microtubule nucleation (GO:0010968),-0.35334198050110077,-0.8509212987998768,0.6421052631578947,0.9330834470314541,1.0,4/10,27.88%,PAK1;ARHGEF7;DCTN1;RANGRF
prerank,regulation of lysosomal lumen pH (GO:0035751),0.3674492584848757,0.850908023677796,0.6339113680154143,0.9091768435052643,1.0,5/12,20.79%,CLN5;LRRK2;TMEM165;TMEM9;VPS33A
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.3235825491902752,0.850660162133064,0.6547406082289803,0.9091093626541973,1.0,1/20,1.84%,FOXC1
prerank,negative regulation of binding (GO:0051100),0.2489073027955686,0.8504433343097545,0.7442218798151001,0.9089920026965053,1.0,11/81,9.57%,SP100;CFHR2;ARHGAP28;IFIT2;DACT1;CPNE1;EFHB;GSK3B;BAX;LRRK2;SUMO1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.36292772467952866,0.8496936418006775,0.6561922365988909,0.9099955380199816,1.0,2/12,4.62%,TERT;IL6
prerank,mitotic spindle assembly (GO:0090307),0.2786604158856012,0.8496796471365679,0.6823899371069182,0.9094617373669737,1.0,12/42,21.70%,MAP9;STAG1;CLASP1;MISP;TOGARAM1;TOGARAM2;SPICE1;GOLGA2;CCDC61;OFD1;CHEK2;STAG2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.24854729564537015,0.8491648134969086,0.7265745007680492,0.9099638478215735,1.0,11/85,10.43%,PRICKLE1;SMURF2;FZD2;PARD6A;CELSR1;WNT5A;PSMB10;PSMA7;PSMA3;PSME4;PSMA5
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.25267932544192406,-0.8490562517938741,0.7528868360277137,0.9362850074169822,1.0,9/41,13.61%,GRM5;NTRK2;GAS6;DOCK3;ACE;LRP8;SRCIN1;CSF1R;RELN
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.22499354888658918,0.8486724308239526,0.7754010695187166,0.9104383200422236,1.0,18/172,9.89%,PTPN13;PLEKHA2;PLD1;PLA2G4A;APOA2;AGPAT4;DGKD;PI4KA;CPNE1;MTMR3;PLEKHA4;PLA2G4C;PIK3C2A;ETNK2;STARD10;PIK3R5;ARF3;GPD1L
prerank,regulation of synapse organization (GO:0050807),-0.2806986647312183,-0.8485196065837223,0.7018779342723005,0.9366995317219451,1.0,3/26,3.89%,CTNNA2;MEF2C;IL1RAPL1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.29913034694333346,-0.848512209184804,0.6941964285714286,0.9359428517839112,1.0,6/21,23.34%,NOS1AP;CACNA1D;KCNQ1;KCNE4;GJA5;SCN1B
prerank,positive regulation of TOR signaling (GO:0032008),-0.24715863783271808,-0.8483452113032951,0.7533875338753387,0.9354995843864403,1.0,16/40,32.56%,GPR137C;GAS6;SMCR8;RRAGB;RRAGC;PIP4P1;LAMTOR2;MLST8;LAMTOR4;HTR6;TREM2;GOLPH3;MIOS;WDR24;PIH1D1;SEC13
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.3696787449992078,0.8481672215199427,0.65234375,0.9108449977770474,1.0,1/12,2.97%,IL23R
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3803306005392704,0.8479976408698489,0.6583969465648855,0.9106316465800675,1.0,7/11,26.80%,BCL2;TAF9;MUC1;KDM1A;CD44;TRIAP1;ING2
prerank,establishment of epithelial cell polarity (GO:0090162),-0.3070846748948888,-0.8478864811493128,0.6799116997792495,0.9357038097139674,1.0,2/19,2.85%,CYTH3;CYTH1
prerank,positive regulation of reproductive process (GO:2000243),0.2944346473897967,0.8478440285230416,0.6917808219178082,0.9103754023015774,1.0,4/31,8.24%,SMURF2;LHFPL2;FAM170B;SYDE1
prerank,proteolysis (GO:0006508),0.21623961676412157,0.847835272728047,0.8173913043478261,0.909836143347863,1.0,38/252,14.61%,DPP4;ADAMTS12;CPQ;ADGRV1;PRSS57;ANPEP;CASP4;BMP1;AEBP1;MMP14;CPNE1;DPP8;NPEPPS;LACTB;CTSH;SPPL3;PLAU;SUFU;CPB2;CTSW;ERAP1;CAPN15;ADAM19;NLN;SENP6;PLAT;DPP7;CLPX;ENDOU;ADAMTS7;CELA1;SENP1;CPXM2;FBXO3;RNPEP;LNPEP;SRGN;VHL
prerank,regulation of DNA damage checkpoint (GO:2000001),0.3833283101457596,0.8477441843943975,0.6590909090909091,0.9094621699612044,1.0,3/10,14.02%,CRY1;RFWD3;THOC5
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3363805199328312,0.8472921624561739,0.6512059369202227,0.9098364923389411,1.0,1/17,0.73%,AKAP13
prerank,phosphatidylcholine metabolic process (GO:0046470),0.2528598834296982,0.8466862536499912,0.739329268292683,0.9105517603023756,1.0,15/70,18.86%,PLA2G4A;APOA2;MBOAT2;NR1H3;PLA2G4C;PLA2G6;STARD10;ENPP2;CSNK2A2;PLA2G5;LPIN2;PCYT1A;ABHD3;PEMT;SLC44A2
prerank,sensory perception of taste (GO:0050909),0.38469746422294737,0.8464482432070105,0.6476578411405295,0.9104869629498391,1.0,10/10,61.55%,PKD1L3;CD36;ASIC2;TAS1R3;GNAT3;ASIC1;TAS1R2;PKD2L1;TAS1R1;ASIC3
prerank,macrophage differentiation (GO:0030225),0.36112308060450143,0.845730420942427,0.6421845574387948,0.9113866808007051,1.0,2/13,11.97%,IL31RA;CSF1
prerank,lipid biosynthetic process (GO:0008610),0.2470758324257767,0.8450592145789464,0.7155824508320726,0.9121092413096222,1.0,15/77,20.47%,PRKAA2;AGPAT4;HSD17B1;PAM;ACSL1;SCP2;SCD5;AGPAT3;ABCD3;STAR;PDSS1;MVK;PIP5K1A;SREBF1;XBP1
prerank,regulation of protein ubiquitination (GO:0031396),0.23670260906305068,0.8449853179678299,0.7674418604651163,0.9116994633533544,1.0,16/108,12.88%,SASH1;PRICKLE1;ANGPT1;CRY1;MYCBP2;TGFBR1;BIRC3;RIPK2;LRRK2;FBXO4;SPOPL;CENPX;HUWE1;CUL3;ARRB1;TBC1D7
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.20807300707725637,-0.844901653689202,0.8535031847133758,0.9404309006952802,1.0,20/104,14.52%,RPS6KA5;PLCG2;PAK1;PSMC3;PSMD3;PSMD14;MALT1;LYN;FCER1G;PSMD6;PSMD4;ICAM2;PAK3;PSMA6;PSMA4;SYK;PSMB8;KRAS;HRAS;PSMA8
prerank,cellular response to lectin (GO:1990858),-0.20807300707725637,-0.844901653689202,0.8535031847133758,0.9404309006952802,1.0,20/104,14.52%,RPS6KA5;PLCG2;PAK1;PSMC3;PSMD3;PSMD14;MALT1;LYN;FCER1G;PSMD6;PSMD4;ICAM2;PAK3;PSMA6;PSMA4;SYK;PSMB8;KRAS;HRAS;PSMA8
prerank,sphingoid metabolic process (GO:0046519),0.36890638539839776,0.844663768443276,0.6363636363636364,0.9117837407122047,1.0,2/12,8.45%,PLPP3;NAAA
prerank,positive regulation of cell cycle (GO:0045787),-0.230596852827219,-0.8446094526510189,0.7558139534883721,0.9402499128810052,1.0,15/62,18.30%,MEIS2;TGFB2;RPS15A;LGMN;AKT1;RAD23A;CCND1;LRP6;TAL1;CALR;EGFR;RGCC;CDK4;ASNS;CHEK1
prerank,snRNA 3'-end processing (GO:0034472),-0.3034821038063388,-0.8445408054879455,0.6887871853546911,0.9396253450563913,1.0,9/19,29.93%,INTS7;INTS6L;EXOSC2;INTS12;EXOSC4;TOE1;INTS1;INTS5;INTS2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3325445121813514,0.8442483697534647,0.6831501831501832,0.9120400779689821,1.0,6/18,14.96%,CAMK1D;ADCY1;OPRD1;CRTC1;CRTC3;PRKD2
prerank,Golgi to plasma membrane transport (GO:0006893),0.27142107787564873,0.8438897885571507,0.7152,0.9121865575730064,1.0,7/47,7.34%,SPTBN1;VAMP5;RAB10;ARL3;OPTN;EXOC2;VPS35L
prerank,spliceosomal complex assembly (GO:0000245),0.2669875921631961,0.8438233600258387,0.6950819672131148,0.9117557154429872,1.0,10/46,18.91%,CELF2;ZRSR2;DDX23;SRPK1;RBM5;PRPF19;SRSF5;TXNL4A;SCAF11;USP39
prerank,regulation of protein metabolic process (GO:0051246),-0.2443086518314223,-0.8432901224302322,0.7558441558441559,0.94148259736998,1.0,10/44,13.88%,KLF2;FKBP1A;MAPK8;HSP90AB1;ACE;NEDD4L;SPOP;ZDHHC2;KLF4;PLAUR
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.21429831805481503,0.843238216105982,0.8327183271832719,0.9123523257159457,1.0,73/259,22.41%,DCDC2;PARVA;CYS1;DYNLL1;ASAP1;FGD4;NRP1;ARL13B;RFX3;KIT;IFT88;NTN1;ARL3;VCL;TTC39C;HYLS1;ARF4;TMEM107;EXOC2;DYNC2I1;DNAAF1;ACTN2;PMP22;MTSS1;RAP2C;IFT81;NUDCD3;CC2D2A;ANO6;CDC14A;CDH13;CCDC57;IQCB1;RAB3IP;WDR19;CFAP221;IFT20;TRAPPC14;FBF1;CCDC66;NPHP3;RFX2;CPLANE1;CEP250;GBF1;AVIL;EXOC7;EXOC1;TTBK2;RAP2B;IFT52;RPGR;DMTN;WDR11;ARL6;B9D2;ARFIP2;CEP131;PIP5K1A;FSCN1;SSX2IP;RHOD;RAP2A;OFD1;DZIP1L;CFAP410;RP2;ACTR3;LZTFL1;MAP4K4;PKD1;CYFIP1;FGD1
prerank,negative regulation of biosynthetic process (GO:0009890),-0.3111033409036131,-0.8426456979416416,0.6896551724137931,0.9419904423094079,1.0,5/16,15.12%,ASXL3;EMILIN1;CEACAM1;ABCD2;PARK7
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.31765842426617885,-0.8422338735069267,0.6995708154506438,0.942053823793914,1.0,8/14,37.27%,ENTPD1;ADPRM;NUDT18;NUDT16;NUDT1;ENTPD2;NUDT15;ENTPD3
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.34732500057022553,-0.8422326018373042,0.6596194503171248,0.9412837566388937,1.0,4/11,22.24%,TIMM8B;TIMM22;NDUFA13;TIMM10
prerank,DNA-dependent DNA replication (GO:0006261),-0.20308343355096428,-0.8418556653115394,0.8436482084690554,0.9413003689840589,1.0,46/128,27.73%,REV3L;PSMC3;GINS3;UBB;PSMD3;PSMD14;MGME1;PSMD6;POLA1;PSMD4;PSMA6;PSMA4;PSMB8;UBA52;ORC6;TWNK;PSMA8;POLD2;PNKP;CDK2;CDC45;RAD51;PSME1;POLE;RFC4;SIRT7;PSMD7;POLD1;PSMC6;PSMB5;PSMC5;POLB;PSMB1;WRNIP1;PSMD8;MCM10;SRPK2;RFC5;POLE3;PSMD11;RFC2;RECQL;GINS4;BLM;CDC34;CDK2AP1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.35842412262944523,0.8415568905345028,0.6666666666666666,0.9151577058445236,1.0,7/12,26.75%,UBE2C;BTRC;GOLGA2;PTEN;UBE2S;GORASP1;FZR1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.20695474895477,-0.8414084676482549,0.861198738170347,0.9414248506930211,1.0,20/105,14.52%,RPS6KA5;PLCG2;PAK1;PSMC3;PSMD3;PSMD14;MALT1;LYN;FCER1G;PSMD6;PSMD4;ICAM2;PAK3;PSMA6;PSMA4;SYK;PSMB8;KRAS;HRAS;PSMA8
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.33210957217803394,0.8410804543777556,0.6943462897526502,0.9155353415742875,1.0,8/18,24.63%,TERT;IL6;MAP2K1;DDX5;RIPK1;ZC3H12A;TGFB1;ZC3H10
prerank,protein glycosylation (GO:0006486),0.22975169167054052,0.8406448198080675,0.7678571428571429,0.9158205187608464,1.0,22/125,14.21%,MAN1C1;GALNT18;GALNTL5;TRAK1;LARGE1;GALNT2;ALG9;MGAT3;NPC1;GALNT1;POMT2;B4GALT1;GCNT4;FUT4;C1GALT1C1;FUT10;TMEM165;ALG11;TET2;TUSC3;ALG1;MGAT4C
prerank,mononuclear cell differentiation (GO:1903131),0.30870752608023627,0.8397791659655495,0.6884328358208955,0.9169286948377913,1.0,3/24,5.34%,AXL;IL31RA;PIR
prerank,negative regulation of defense response to virus (GO:0050687),0.3755195299146319,0.8396249736856374,0.6850715746421268,0.9166791357072758,1.0,4/10,18.50%,PPM1B;TARBP2;MUL1;PCBP2
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.2870728688074079,-0.8394658729346488,0.6961451247165533,0.9444885933735716,1.0,10/23,38.40%,CALM1;PDE6A;SAG;NMT2;PDE6G;GUCA1B;PDE6B;GUCY2D;GUCY2F;FNTA
prerank,protein localization to organelle (GO:0033365),-0.20031023326915368,-0.8394528986506551,0.8832116788321168,0.94374093345214,1.0,39/133,21.64%,SCG3;SIX1;CSNK1D;SORL1;RPL11;CEP68;BMP4;YBX1;PAQR3;ARL1;CNTLN;GCC2;RAB35;HHEX;CALR;SERP1;TUB;DVL1;TRAM1;ATP6V1D;SIX4;TMEM30A;DCP1A;CCDC47;LAMP5;LAMP1;CTDNEP1;TOR1B;BBS2;WDR83OS;BBS1;TOLLIP;ARF6;SEC61G;MSX1;MTCH2;CYB5A;UBAC2;PPP1R15A
prerank,histone H2A monoubiquitination (GO:0035518),0.3282942724428991,0.8394096101083005,0.6666666666666666,0.9165335611493519,1.0,8/17,22.29%,BCOR;PCGF5;KDM2B;RNF2;RING1;BMI1;PCGF3;PCGF2
prerank,regulation of cell cycle (GO:0051726),0.21029606605559875,0.8393873012383248,0.8537794299876085,0.9160287520745146,1.0,49/271,15.91%,TCF7L2;SMAD3;NOTCH2;NUPR1;GATA6;FBXL17;SMIM22;PRDM11;BMP2;APBB1;BMP7;TGFBR1;PRCC;BTG4;BIRC3;CDKN2B;RNF20;FBXL3;MAP2K6;CRLF3;ANKRD17;CDK7;SND1;E4F1;NUPR2;GMNN;GRK5;RRP8;CDC14A;TRIM21;TSPYL2;MAP2K1;NR4A1;NUDT6;MASTL;THAP1;CSNK2A2;WDR6;PKD2;FBXL12;RARA;PML;IQGAP1;FIGNL1;LIN9;NF2;GBF1;KAT2B;WDR12
prerank,regulation of exosomal secretion (GO:1903541),0.32369947745603317,0.8389522706561571,0.6869244935543278,0.9162920561486426,1.0,1/19,1.26%,SMPD3
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.25392864067545734,-0.8388476235989281,0.751269035532995,0.9441725657744612,1.0,10/38,15.17%,GRM5;GAS6;ACE;LRP8;SH3BP5L;CAV1;SRCIN1;CSF1R;RELN;PTPRC
prerank,signal transduction by p53 class mediator (GO:0072331),-0.2733727396126778,-0.8382318865832492,0.7029702970297029,0.9446833137071075,1.0,14/30,33.52%,ACER2;HINT1;JMY;STK11;PPP1R13B;PYCARD;E2F7;BCL3;MYBBP1A;PMAIP1;TP53;POU4F1;PAXIP1;BOK
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3141231580366603,0.8379990929952913,0.6636029411764706,0.9175846581611902,1.0,3/22,13.27%,ROCK2;EPHA4;EFNA1
prerank,chromatin assembly (GO:0031497),-0.2568206191159909,-0.8378441320900409,0.7494199535962877,0.9447079924912721,1.0,8/38,15.36%,H3-3A;LIN54;NPM1;SART3;ASF1A;H1-0;ANP32B;SPTY2D1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.2724470223576345,0.8376534842386689,0.7215189873417721,0.9177048544710942,1.0,7/45,10.17%,IL6;TLR4;GBP5;LGALS9;WNT5A;RIPK2;PANX1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.3030357253617526,0.8374466711891237,0.7062818336162988,0.91756618809469,1.0,5/26,10.16%,OSBPL8;SORBS1;CREBL2;RHOQ;APPL1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2786853482329679,0.8374313345266216,0.7065026362038664,0.9170333538380924,1.0,4/39,4.57%,ARFGAP3;STEAP3;RAB10;MIA3
prerank,protein deacylation (GO:0035601),-0.2793909122586403,-0.8372853040115155,0.7116704805491991,0.9450857783922301,1.0,6/23,19.05%,HDAC7;HDAC6;SIRT5;HDAC1;ABHD17A;SIRT7
prerank,regulation of cellular response to stress (GO:0080135),-0.2041996152453125,-0.8372370619902142,0.8606271777003485,0.9444135890360618,1.0,40/115,26.55%,HSPA8;OPRM1;MAPK3;HSP90AB1;CHCHD2;PINK1;BAG1;CAMK2A;CAMK2D;NPM1;HSBP1;CCAR2;AAAS;MANF;ATM;NUP93;AKT1S1;ATF4;HSP90AA1;NPAS2;CASP9;ARMT1;MAPT;RAE1;ADCY8;FKBP4;VASH1;MLST8;NUP62;BAG4;SLC38A2;CLN3;ATR;NUP188;MBTPS2;NUP54;CAMK2G;NUP210;NUP42;AIFM2
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3411434068011906,0.8370909576414052,0.6935201401050788,0.9171459956851947,1.0,2/16,6.49%,PID1;PPARA
prerank,calcium ion import into cytosol (GO:1902656),-0.31483509940146825,-0.8369842140248173,0.7063655030800822,0.9442005857961236,1.0,2/15,5.51%,SLC24A2;SLC8A1
prerank,renal water homeostasis (GO:0003091),0.3143724292045992,0.8368228905177596,0.6900175131348512,0.9170981276558247,1.0,7/23,20.57%,ADCY7;ADCY5;ADCY1;ADCY6;MYO5B;RAB11FIP2;PRKAR1B
prerank,positive regulation of secretion by cell (GO:1903532),-0.22569954390158503,-0.8367914317030508,0.8080229226361032,0.9438406532644259,1.0,20/70,21.22%,SLC12A2;TGFB2;RAB27A;CADPS;FRMD4A;SNCA;RAB27B;TGFB3;KCNB1;RGCC;PPIA;CLASP2;MYO18A;MYOM1;EXPH5;ADAM8;ARF6;SYTL4;TTN;ATP6AP1
prerank,protein deubiquitination (GO:0016579),-0.1824416611472885,-0.8366934768854598,0.9457013574660633,0.9432563903667947,1.0,73/242,25.64%,USP29;IL33;SMAD7;ACTB;ESR1;PSMC3;OTUD7A;SNX3;USP31;CLSPN;NFRKB;UBB;RAD23A;MBD5;PSMD3;PSMD14;BABAM1;YY1;EIF3F;USP13;ZRANB1;SMAD1;PSMD6;PSMD4;ADRB2;BARD1;PSMA6;PSMA4;PSMB8;FOXO4;USP46;USP3;TFPT;UBA52;USP37;OTUD1;PSMA8;CYLD;TAF9B;MINDY2;COPS5;VCPIP1;SUDS3;YOD1;BRCA1;PSME1;UBE2D1;USP38;TOMM20;MINDY1;KAT2A;PSMD7;PSMC6;USP2;PSMB5;ATXN3;PSMC5;POLB;PSMB1;USP42;KDM1B;OTUB2;SHMT2;DDB2;ASXL1;PSMD8;MCRS1;USP22;USP11;INO80B;PSMD11;RAD23B;JOSD2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3003318444869574,0.8365072618984389,0.6790780141843972,0.917130455998852,1.0,4/26,9.33%,ADAMTS1;ANXA1;CCND3;ANKRD17
prerank,protein import (GO:0017038),0.24155056089004534,0.8360028724591905,0.7681159420289855,0.9175390524404091,1.0,13/84,14.67%,PRICKLE1;TNPO1;LAMP2;APPL2;TPR;PHB2;PXMP2;APPL1;IPO7;EIF4ENIF1;ABCD3;PEX2;POM121
prerank,hematopoietic stem cell differentiation (GO:0060218),0.37606782283076023,0.8359864672398919,0.6560636182902585,0.9170119582945867,1.0,1/10,1.73%,MLLT3
prerank,DNA repair (GO:0006281),0.20821333074758547,0.8359146044893139,0.870049504950495,0.916614312322592,1.0,68/284,21.49%,EYA1;PDS5B;POLH;PARP9;NUCKS1;WRN;APBB1;PARP3;SLX4;ASCC3;RAD50;UBE2U;DTX3L;FBH1;FTO;BAZ1B;USP47;MNAT1;PSME4;XRCC4;SUMO1;UVRAG;NABP1;RAD51B;XRCC1;RPA3;FANCM;DCLRE1A;UBE2V1;CENPX;HUWE1;RFWD3;RBBP8;ADPRS;FANCE;OGG1;INTS3;GTF2H4;RAD9A;ALKBH1;PDS5A;ERCC6;UIMC1;ERCC5;MGMT;ERCC1;USP45;KMT5C;FANCC;DNA2;PARP4;GTF2H2;SMARCAL1;TDP2;ACTR8;SETD2;XPC;BRCC3;INO80;WDR33;KMT5B;NSMCE3;ERCC8;NABP2;POLD3;CHEK2;UBXN1;EYA3
prerank,positive regulation of ERAD pathway (GO:1904294),-0.3277035569104024,-0.8355242073959898,0.6880530973451328,0.9448259857456476,1.0,6/13,27.47%,BAG6;USP13;CAV1;ATXN3;TMEM259;HERPUD1
prerank,RNA splicing (GO:0008380),0.23685632907389484,0.8351244813817975,0.7383309759547383,0.9176244277015693,1.0,27/95,19.23%,SNRPA1;ZRSR2;LSM1;NOVA1;HNRNPC;SF3B3;DDX23;SLU7;CDK12;RNPC3;SRSF4;DHX16;USB1;HNRNPH3;DHX8;MAGOHB;SRPK1;ZMAT5;FUS;PPP2CA;TXNL4A;SCAF11;WBP4;SNRNP40;PRPF3;USP39;KHSRP
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.2264364851183255,0.8350587604215088,0.8176943699731903,0.9171904675726378,1.0,27/149,15.29%,EIF2AK2;FER;TRAF5;ROR1;CFLAR;SLCO3A1;IL6;TLR4;MTDH;PRKCZ;TRIM5;EDA;LGALS9;WNT5A;IL18;RIPK2;TLR2;IRAK3;UBE2V1;TRIM21;MAP3K7;CRNN;FLOT2;MAP3K13;TICAM1;PRKD2;ALK
prerank,mitotic nuclear division (GO:0140014),0.24725690440955325,0.8350536126969886,0.7391952309985097,0.9166472351358107,1.0,22/71,23.05%,MAP9;STAG1;CLASP1;KLHL22;KLHDC8B;ESPL1;MISP;UBE2C;ZWINT;CHMP4B;TOGARAM1;TOGARAM2;SPICE1;GOLGA2;CCDC61;RAN;INO80;OFD1;CHEK2;STAG2;UBE2S;SPAST
prerank,monocyte differentiation (GO:0030224),0.37009762577307714,0.8350295645946052,0.6575052854122622,0.9161439690338468,1.0,2/10,5.34%,IL31RA;PIR
prerank,establishment of skin barrier (GO:0061436),-0.3194294116256068,-0.8349284637591953,0.7012448132780082,0.9444827745399685,1.0,7/15,30.37%,MET;LSR;HRNR;STMN1;FA2H;UGCG;TMEM79
prerank,regulation of water loss via skin (GO:0033561),-0.3194294116256068,-0.8349284637591953,0.7012448132780082,0.9444827745399685,1.0,7/15,30.37%,MET;LSR;HRNR;STMN1;FA2H;UGCG;TMEM79
prerank,neuron projection fasciculation (GO:0106030),-0.363049199322927,-0.8348916746186047,0.6770186335403726,0.9437982048301342,1.0,4/10,21.43%,CNTN4;NRCAM;EPHB3;AMIGO1
prerank,establishment of protein localization to membrane (GO:0090150),0.25406165984298174,0.8343508679184362,0.7420382165605095,0.9169249955080302,1.0,13/66,15.04%,SYNE3;AFDN;RAB10;ZDHHC3;NPC1;CHM;MICALL1;COX18;GRIN3B;GORASP2;RAB3IP;SEC63;MYO1C
prerank,spermatid development (GO:0007286),0.2906296400080794,0.8342218506413126,0.6938775510204082,0.9166214319757324,1.0,2/32,3.03%,GALNTL5;ZMYND15
prerank,activation of protein kinase A activity (GO:0034199),0.3344464197415377,0.8340718415332778,0.6499068901303539,0.9163873476784431,1.0,3/16,7.23%,ADCY7;ADCY5;ADCY1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.3186901713489838,-0.8337500596240036,0.7244444444444444,0.9453264879479505,1.0,6/15,21.13%,REEP1;ARL6IP1;ZFYVE27;RTN3;RAB18;ATL2
prerank,regulation of T cell cytokine production (GO:0002724),0.3236979569558635,0.833671597735005,0.6697247706422018,0.9166095497344783,1.0,4/15,13.14%,CD55;FOXP3;MAP3K7;HFE
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.31537385151059744,0.833053901950507,0.6844919786096256,0.9172585528185929,1.0,6/21,16.08%,ADCY7;ADCY5;ADCY1;NPPC;GUCY2C;ADCY6
prerank,regulation of phosphatase activity (GO:0010921),0.30326580275687515,0.832354689552103,0.6896551724137931,0.9180412544571129,1.0,7/24,22.56%,BMP2;PPP1R35;PPP6R3;URI1;SH2D4A;CDK5RAP3;PPP1R2
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.3005910549227261,0.8322189056383118,0.6835664335664335,0.917737346624066,1.0,3/26,6.10%,PRKAG2;PRKAA2;NR1H3
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3277878157570431,0.832136891487219,0.6923076923076923,0.9173456216834508,1.0,5/18,14.14%,FRS2;BMP2;HDAC4;BHLHE41;BDNF
prerank,embryonic axis specification (GO:0000578),0.3348748683175802,0.8321067409876564,0.6754716981132075,0.9168574825268108,1.0,4/15,18.49%,SMAD6;TASOR;SMAD2;PTCH1
prerank,glycoprotein catabolic process (GO:0006516),0.33670449658744195,0.8319361141026933,0.7070524412296564,0.9166265681788014,1.0,2/17,8.39%,ADAMTS12;MANBA
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.34689803581300876,0.8316440333387279,0.6546489563567363,0.9166413428148095,1.0,1/13,1.93%,GAB2
prerank,protein complex oligomerization (GO:0051259),0.24308872753563407,0.8314301869779765,0.7562043795620438,0.9165430787861948,1.0,27/85,24.80%,MCU;RNF213;MICU1;PRF1;CLDN1;DNM1L;CUTC;TIFA;OPA1;FUS;PKD2;ATL1;RNF135;SLC9A1;IKZF4;JMJD6;ELAVL1;NACC2;ZC3H12A;OXA1L;PNPT1;SPAST;PRMT1;STOML2;UGDH;GSDMD;TMEM120A
prerank,positive regulation of lipid localization (GO:1905954),0.36639610597934374,0.8312895508534567,0.6742857142857143,0.9162591985960954,1.0,5/11,27.31%,IKBKE;LRP1;ZC3H12A;HILPDA;NFKB1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3068429194414406,0.8311183268280993,0.7022375215146299,0.9160565389582142,1.0,1/25,0.36%,LEPROT
prerank,protein stabilization (GO:0050821),0.21727796947113717,0.8304706608558867,0.8147138964577657,0.9167398105023004,1.0,35/168,16.45%,PARVA;PLPP3;WNT10B;APOA2;LAMP2;AAK1;MORC3;CREBL2;USP9X;USP27X;CTNND1;PHB2;CCNH;STK3;EPHA4;NAA16;CDK7;SUMO1;ATF7IP;NAA15;ATP1B2;DVL3;FLOT2;EFNA1;RTN4;USP36;MDM4;VHL;STK4;SOX4;PER3;MUL1;TBL1X;TAF9;CCT6A
prerank,purine-containing compound salvage (GO:0043101),0.35702705110972416,0.8304641839064775,0.6635859519408502,0.9162139603994877,1.0,1/12,1.06%,AMPD3
prerank,glycolipid biosynthetic process (GO:0009247),-0.2533044825807964,-0.8304057957516551,0.7429245283018868,0.9511915240552837,1.0,13/38,21.54%,ST8SIA6;MPPE1;ST6GALNAC5;PIGU;PIGM;PIGQ;PIGH;DPM2;ST3GAL4;PIGO;ST8SIA5;B4GALT6;PIGB
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.3691868260633609,0.830350807086226,0.6620278330019881,0.9158920333823761,1.0,4/11,17.27%,AFDN;RAP2C;TJP1;RAP2B
prerank,estrogen metabolic process (GO:0008210),0.34257195938613183,0.8300064203641389,0.6704119850187266,0.9160157376058241,1.0,3/15,17.03%,HSD17B1;HSD17B14;SULT1A1
prerank,mucosal immune response (GO:0002385),0.3397930942304837,0.8298263827365855,0.6836158192090396,0.9158526947087073,1.0,3/15,10.99%,BPIFB1;NOS2;IFNLR1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.3165603786234694,-0.829749599615508,0.6788008565310493,0.9517453064294633,1.0,7/14,30.35%,PHACTR4;EMP2;PRKD1;LIMS2;TIMP1;BST1;SLC2A10
prerank,positive regulation of cellular protein localization (GO:1903829),0.24724892458117814,0.8297291205907393,0.7666666666666667,0.9154886482258029,1.0,18/69,17.63%,PRKAA2;PARP9;PARD6A;DTX3L;GSK3B;YAP1;NGFR;GPD1L;ENTR1;RTN4;EIF2AK3;CROCC;TM9SF4;CEP250;MEAK7;WWTR1;GAS8;ABCA7
prerank,epithelial cell differentiation (GO:0030855),0.24127788454254728,0.8295485037164982,0.7762962962962963,0.9153133626198103,1.0,9/88,7.96%,FSTL1;GATA6;MAF;ANXA1;RAB10;GLI1;ANXA4;GSTK1;ANXA7
prerank,icosanoid secretion (GO:0032309),0.3539976571565406,0.8292745433674743,0.6823956442831216,0.9152714849287146,1.0,3/12,7.14%,ANXA1;NOS2;BDKRB2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.3531979020074683,0.8292637417290417,0.7001795332136446,0.9147533138473465,1.0,3/13,6.74%,PID1;PPARA;NOS2
prerank,organelle assembly (GO:0070925),0.20282201445787656,0.8289706118558866,0.8959537572254336,0.9147702401589728,1.0,100/384,22.71%,DCDC2;TMOD3;PARVA;CYS1;DYNLL1;ASAP1;AMBRA1;SMIM22;ARL13B;SYNPO;RFX3;RC3H1;IFT88;ARL3;RAB43;TTC39C;HYLS1;ARF4;TMEM107;PLA2G4C;EXOC2;POGZ;DYNC2I1;DNAAF1;HAUS8;GOLGA8B;TUBGCP4;HPS1;IFT81;NUDCD3;UBXN2A;CC2D2A;CDC14A;CCDC57;GORASP2;IQCB1;UBAP2L;ATG12;RAB3IP;WDR19;EIF4ENIF1;CFAP221;IFT20;DDX6;TRAPPC14;TUBGCP2;WDR45B;CHMP3;FBF1;CCDC66;CHMP4A;CHMP4B;SH3PXD2B;NPHP3;RFX2;RBM14;CPLANE1;CEP250;ATG2A;TUBGCP5;GBF1;AVIL;FARP2;GOLGA2;EXOC7;EXOC1;TTBK2;CCDC61;CENPC;WIPI2;OGFOD1;IFT52;RPGR;PATL1;PRRC2C;MAPRE3;RAB19;WDR11;ARL6;B9D2;CEP131;INO80;CHMP5;NEK6;SSX2IP;IST1;CEP63;OFD1;CDS1;DZIP1L;CFAP410;RP2;ACTR3;LZTFL1;ATG7;PKD1;ATG13;MAPRE2;ATG3;YTHDF3
prerank,regulation of amyloid-beta formation (GO:1902003),0.282728864130353,0.8288563938586307,0.7152899824253075,0.9144246752426398,1.0,9/34,20.88%,ROCK2;RTN1;EPHA4;EFNA1;RTN4;ABCA7;CASP3;ROCK1;GGA3
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.29887606680281786,-0.8287781851018416,0.7177777777777777,0.9528913346423882,1.0,4/17,12.75%,PDE3B;SORL1;AKT1;MFSD2A
prerank,histone H2A acetylation (GO:0043968),0.33538369600802226,0.8285583412541764,0.6635160680529301,0.9144307982933508,1.0,9/16,30.13%,EPC1;ACTL6A;BRD8;SPHK2;NAA40;EP400;ING3;RUVBL1;MORF4L1
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.24099304691188433,-0.8285369813450856,0.7973333333333333,0.9526161220905016,1.0,14/45,30.47%,PIK3R1;LIN28B;SETX;BMP4;EGFR;HRAS;SIRT7;HNRNPLL;HEATR1;SLC38A2;RBM20;WDR75;RELA;TP53
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.33590100426316094,-0.8284272195223815,0.6851851851851852,0.9520800943552994,1.0,3/11,15.17%,SMAD7;CEACAM1;PTPRC
prerank,receptor metabolic process (GO:0043112),-0.23241560656556992,-0.8278507340326969,0.7619047619047619,0.9524474072519372,1.0,9/53,12.31%,DNM3;TFRC;SNCA;LGMN;RAMP2;LDLRAP1;FCER1G;CAV1;SYK
prerank,RNA stabilization (GO:0043489),0.28701554112198074,0.8274131629511776,0.7230273752012882,0.915976318674315,1.0,10/33,20.93%,TENT5A;NOCT;EIF4ENIF1;FUS;TENT2;AXIN2;GDNF;DHX36;PARN;ELAVL1
prerank,mitochondrial fusion (GO:0008053),-0.2947583481566616,-0.8272698078471336,0.701123595505618,0.952796741341724,1.0,4/18,11.16%,MFF;MFN2;GDAP1;MFN1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.23648885273226633,0.8265531814526194,0.7944606413994169,0.9170150691772767,1.0,19/94,17.29%,NINL;DYNLL1;ALMS1;SDCCAG8;CLASP1;CEP152;NPHP1;C2CD3;HAUS8;CC2D2A;NEDD1;IQCB1;RAB3IP;RPGRIP1L;FBF1;ACTR1A;CEP250;TTBK2;YWHAE
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.36170683225209427,-0.8264957952135872,0.7086776859504132,0.9535765874435111,1.0,5/10,34.37%,RPUSD2;RPUSD1;NOP10;RPUSD3;NHP2
prerank,rRNA catabolic process (GO:0016075),0.33822609425267386,0.8264860540207081,0.7,0.9165969029024906,1.0,6/16,16.77%,XRN1;DIS3L;ERN2;SLFN14;DIS3;EXOSC10
prerank,negative regulation of viral transcription (GO:0032897),-0.3298299834421677,-0.826393170124743,0.6944444444444444,0.9530009983204779,1.0,3/13,13.74%,MID2;TRIM62;IFITM3
prerank,cochlea morphogenesis (GO:0090103),-0.3594833315980841,-0.8261945790836543,0.7166666666666667,0.9526146746419154,1.0,2/10,11.17%,TBX1;PAX2
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.32417773457099386,-0.8260038814017903,0.7251082251082251,0.9521810954005716,1.0,5/14,21.83%,PTBP1;RNPS1;SRSF9;C1QBP;SRSF6
prerank,innate immune response in mucosa (GO:0002227),0.37201458227062767,0.8258393477299005,0.6679920477137177,0.9172173255810381,1.0,2/10,6.74%,BPIFB1;NOS2
prerank,heterochromatin assembly (GO:0031507),0.3186020611314158,0.8250852157058816,0.6904761904761905,0.9181319597940178,1.0,10/20,27.69%,MBD2;BAZ2A;RRP8;ZNFX1;SIRT2;SMCHD1;EZH1;SUV39H1;CENPV;HMGA2
prerank,regulation of presynapse assembly (GO:1905606),0.32696633651330054,0.8249807134704501,0.7088846880907372,0.9172479494011487,1.0,2/18,2.20%,GPC6;WNT3A
prerank,regulation of presynapse organization (GO:0099174),0.32696633651330054,0.8249807134704501,0.7088846880907372,0.9172479494011487,1.0,2/18,2.20%,GPC6;WNT3A
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.31118475682399044,0.8245729689631505,0.6982456140350877,0.9174547981825638,1.0,3/21,5.81%,CHST15;DCN;CHSY1
prerank,rRNA 3'-end processing (GO:0031125),-0.34813509063070625,-0.8245490339499716,0.6904276985743381,0.9542818366883647,1.0,3/10,18.47%,RPS21;EXOSC2;ERI1
prerank,glucose import (GO:0046323),-0.3258641873067602,-0.8241882257277444,0.7106382978723405,0.9541756061845597,1.0,4/13,18.99%,SLC2A1;SORT1;ZDHHC7;SLC2A4
prerank,leukocyte tethering or rolling (GO:0050901),0.3312184454070786,0.8240827542905214,0.6934865900383141,0.9178688724007753,1.0,2/17,6.59%,SELP;VCAM1
prerank,organelle fission (GO:0048285),-0.27430901141810526,-0.8239982520655765,0.7254464285714286,0.9537500536070416,1.0,6/24,21.20%,DNM3;MFF;GDAP1;PEX19;PEX11A;MTFR1L
prerank,heme biosynthetic process (GO:0006783),-0.2768266830639727,-0.8239360887069,0.7219730941704036,0.9531087898099739,1.0,1/22,0.17%,ABCG2
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.312722596102154,0.8238310879426779,0.7014134275618374,0.9178057348345864,1.0,8/22,23.07%,MAN1C1;AMFR;UGGT2;RNF185;EDEM2;RNF139;SYVN1;EDEM1
prerank,tRNA wobble uridine modification (GO:0002098),-0.3177550428328417,-0.8235743380314189,0.7222222222222222,0.9530070364215686,1.0,7/14,30.79%,ELP1;TRMT9B;DPH3;KTI12;CTU2;ELP3;ALKBH8
prerank,histone H2A ubiquitination (GO:0033522),0.3267546799308641,0.8231462687390422,0.6915887850467289,0.918518760592938,1.0,5/17,16.68%,BCOR;DTX3L;KDM2B;RNF2;RING1
prerank,protein targeting to lysosome (GO:0006622),-0.2898636796740705,-0.8229430175026801,0.713963963963964,0.9534615770379056,1.0,5/20,12.02%,HSPA8;SORL1;GCC2;M6PR;SCARB2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.24425280948621578,0.8227752608022023,0.7518573551263001,0.9186480767860499,1.0,12/80,13.61%,UACA;EPHA7;SH3RF1;DAPK1;SIAH2;PDCD5;NGFR;USP47;FNIP1;MAP2K5;RPS6KA3;ACVR1C
prerank,regulation of interleukin-13 production (GO:0032656),-0.3243710967412141,-0.8226711302624615,0.6997885835095138,0.9532062130945108,1.0,1/13,0.14%,LEF1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.19580571795529092,-0.8226171563309485,0.8888888888888888,0.9525575786864656,1.0,55/125,34.55%,RPS27;EFHC2;RCC2;KPNB1;DYNC1H1;PCNT;KIF18A;XPO1;DYNC1I2;NDE1;KIF3B;PPP1CC;CLASP2;DYNLL2;CENPU;SKA2;BUB1B;NEK9;ZWILCH;CENPT;STMN1;CENPL;CENPQ;TUBG1;MAD1L1;CENPF;NSL1;KIF4A;CENPN;DSN1;KNTC1;DCTN6;SPDL1;CENPA;MAPRE1;TUBG2;SGO1;BCCIP;STIL;ITGB3BP;BIRC5;CLIP1;TBCE;ZW10;DLGAP5;NUF2;AURKA;PLK1;SEC13;CDC20;BUB1;MIS12;BUB3;KNL1;NUDC
prerank,epithelial cell-cell adhesion (GO:0090136),0.36595498366766777,0.8223859442044021,0.6829745596868885,0.9188340036421107,1.0,3/11,10.90%,KIT;VCL;SERPINB8
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.3321312295343478,-0.8218338280954305,0.6892778993435449,0.9533432938710018,1.0,3/13,11.99%,RPS15;NPM1;XPO1
prerank,mesenchymal cell development (GO:0014031),-0.29698682029357604,-0.8214857924131362,0.7251585623678647,0.9532908895972261,1.0,2/18,2.33%,CDH2;NOTCH1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.34713743502373295,-0.821376444818057,0.6895833333333333,0.9527271884035822,1.0,6/11,36.59%,MFHAS1;LYN;TREM2;TLR6;TLR1;TIRAP
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.26014150314802154,0.8211656584890367,0.7332268370607029,0.9205353531366978,1.0,9/55,11.25%,NUPR1;WWOX;BCL2;GSDME;TGFBR1;TNFRSF12A;BAX;DNM1L;BCL2L1
prerank,cellular response to interferon-beta (GO:0035458),-0.31820334317964316,-0.8209553038359999,0.7078189300411523,0.9528216985658698,1.0,6/14,28.76%,AIM2;IFITM2;IRGM;NDUFA13;CDC34;UBE2G2
prerank,DNA duplex unwinding (GO:0032508),0.2590396945971782,0.8203330071497847,0.7323481116584565,0.9215583678717666,1.0,9/50,14.51%,ANXA1;WRN;ASCC3;RAD50;CUL4A;MCM4;SUPV3L1;MCM6;GTF2H4
prerank,bicellular tight junction assembly (GO:0070830),0.26493644634656766,0.8202292564333895,0.7357259380097879,0.921209406355045,1.0,6/46,8.93%,AFDN;CDH5;PARD6G;PARD6A;CLDN1;DLG1
prerank,atrial septum development (GO:0003283),-0.31623233838350107,-0.8199294325466362,0.6940928270042194,0.9540197077186221,1.0,3/13,8.95%,TGFB2;BMPR2;ZFPM1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.2967574629950241,0.8191649991353099,0.6948529411764706,0.92269988187845,1.0,11/26,26.28%,PPM1B;IRAK3;TRIM21;TRIB1;MUL1;PCBP2;SIRT2;NMI;CARD16;MAPKBP1;TYRO3
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.3265980884159905,-0.8190034615263534,0.7195652173913043,0.9550403240742746,1.0,6/12,28.13%,EPHB1;HSP90AB1;HSP90AA1;B4GALT6;EPHB6;SPTBN4
prerank,regulation of protein transport (GO:0051223),-0.26513848746988544,-0.8189919304435341,0.7582938388625592,0.9543065576278438,1.0,7/27,18.76%,HSPA8;STXBP5L;SNX3;RHBDF2;PPM1F;DISP1;LCP1
prerank,monosaccharide transmembrane transport (GO:0015749),-0.30271415261335916,-0.8189267159438433,0.6905829596412556,0.9536684876542094,1.0,8/16,32.09%,SLC2A9;SLC50A1;SLC45A3;SLC2A2;SLC23A1;SLC23A2;SLC2A10;SLC5A3
prerank,in utero embryonic development (GO:0001701),0.2914362003095152,0.8187391998296129,0.7058823529411765,0.9229400636743978,1.0,4/25,9.42%,ARNT2;BMP2;TGFBR1;IGF2
prerank,regulation of protein import into nucleus (GO:0042306),0.2761201160365644,0.818530626543513,0.7225042301184433,0.9227697379313422,1.0,4/36,9.37%,SMAD3;ZIC1;TPR;SUFU
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.31569183824270225,-0.8183752336381577,0.7052401746724891,0.9539214912500734,1.0,4/14,19.53%,TMSB4X;MDFI;NFKBIB;CCDC22
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.3126177946053363,-0.8182533448506584,0.7098121085594989,0.9534043439729121,1.0,4/16,12.73%,PIGM;PIGQ;PIGH;DPM2
prerank,receptor recycling (GO:0001881),-0.3383726230644867,-0.8177017017013561,0.6946236559139785,0.9536913050719882,1.0,3/10,24.60%,SORL1;NSG1;PHETA2
prerank,stem cell differentiation (GO:0048863),0.27559474788439775,0.8176906896561232,0.7591362126245847,0.9237604801325944,1.0,6/39,9.99%,OSR1;MLLT3;FBXL17;KIT;SOX21;JARID2
prerank,nuclear pore complex assembly (GO:0051292),0.3773037678274304,0.8176006889301287,0.6834264432029795,0.9233975553482391,1.0,3/10,14.10%,TPR;AHCTF1;RTN4
prerank,hematopoietic stem cell proliferation (GO:0071425),0.3566898423808857,0.8173339314197107,0.7058823529411765,0.9233721288160749,1.0,3/11,7.87%,WNT2B;WNT10B;WNT5A
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.30369879332825567,-0.8172107904030804,0.7006369426751592,0.9538884491933396,1.0,3/17,7.50%,PTPRJ;DGKZ;CEACAM1
prerank,T cell activation involved in immune response (GO:0002286),-0.33108309688388204,-0.8170568269222287,0.6898047722342733,0.9534074546929947,1.0,4/12,27.84%,CD74;FCER1G;LCP1;LILRB1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.2785864737203648,0.8170384623611943,0.7366548042704626,0.9233484419775911,1.0,6/36,8.93%,DACT1;DUSP10;TAOK3;PTPN22;ZMYND11;DLG1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.29007067652471785,0.8170353768794598,0.7159663865546219,0.9228149175888667,1.0,5/30,10.63%,MLLT3;FSTL3;KIT;SBDS;PLEK
prerank,regulation of DNA replication (GO:0006275),0.2642974804720453,0.8168290280890588,0.7413793103448276,0.9226526614793573,1.0,15/49,19.84%,ORC5;NUCKS1;GLI1;CDAN1;ANKRD17;GMNN;ESCO1;TSPYL2;PDS5A;ORC3;S100A11;PPP2CA;DNA2;DSCC1;CTC1
prerank,response to leucine (GO:0043201),0.36794306542098665,0.816727688211186,0.6851485148514852,0.9217810695069316,1.0,4/10,22.75%,KLHL22;SESN1;LARS1;RRAGD
prerank,cellular response to leucine (GO:0071233),0.36794306542098665,0.816727688211186,0.6851485148514852,0.9217810695069316,1.0,4/10,22.75%,KLHL22;SESN1;LARS1;RRAGD
prerank,microtubule polymerization (GO:0046785),0.2897415295859646,0.8165984256667217,0.7226027397260274,0.9214781766089493,1.0,8/28,16.86%,CLASP1;HDGFL3;TUBGCP4;SLAIN2;CCDC57;TUBGCP2;TUBGCP5;GOLGA2
prerank,peptide metabolic process (GO:0006518),0.24079177765139295,0.816445056940364,0.7912254160363086,0.921211989413005,1.0,13/75,14.33%,CPQ;ANPEP;AEBP1;MGAT3;NPEPPS;SPPL3;CLN5;GSTK1;ERAP1;NLN;GSTA3;CPXM2;LNPEP
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.3593375039626512,0.8162220604453087,0.7049808429118773,0.9210749785480293,1.0,4/12,14.25%,SGTA;SEC63;CHMP4A;CHMP4B
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.3451979710364501,0.8161435245668162,0.7031539888682746,0.92067430092399,1.0,3/13,9.42%,SORBS1;EPM2AIP1;IGF2
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.2862254350228893,0.8155417875172657,0.732463295269168,0.9212210419258976,1.0,4/28,8.91%,PTN;ADCY1;GSK3B;EPHA4
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2553522570626257,0.8155377632173819,0.7438423645320197,0.9206921011275592,1.0,15/52,22.46%,SHMT1;SLC19A1;MTHFD1;IDH1;ME2;MDH1B;D2HGDH;IDH2;PHYH;ADHFE1;ASS1;MTHFD2L;MTHFD1L;HOGA1;HAAO
prerank,cortical cytoskeleton organization (GO:0030865),0.2692929203921438,0.8152984353383753,0.7430894308943089,0.9205710012858292,1.0,9/41,13.68%,ROCK2;RHOBTB2;RHOF;FMNL2;RHOQ;DLG1;PLEK;RHOC;LLGL2
prerank,negative regulation of intracellular protein transport (GO:0090317),0.30049739398172826,0.815151096986371,0.7150259067357513,0.9203023018035144,1.0,3/22,9.37%,SP100;LRRK2;SUFU
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.3259710648555561,-0.8148420269517417,0.7170212765957447,0.9567241270404672,1.0,5/13,34.42%,CD74;PTTG1IP;MIF;YJU2;MDM2
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2661302646416372,0.8147868368006821,0.7658536585365854,0.9204531159980059,1.0,6/40,11.49%,POLH;CRY1;MCL1;NEK4;UBE2V1;RFWD3
prerank,glycogen catabolic process (GO:0005980),0.3326408214333953,0.8147824251908404,0.6921606118546845,0.919929235426571,1.0,5/15,19.43%,PYGB;PYGM;STBD1;PHKB;PHKA2
prerank,positive regulation of lymphocyte migration (GO:2000403),0.35768408050626804,0.8145212551351386,0.6976284584980237,0.9198766651391552,1.0,2/12,8.14%,CXCL10;TNFRSF14
prerank,mRNA 3'-end processing (GO:0031124),0.2401833871340861,0.8138761255417383,0.7888563049853372,0.9205108857017605,1.0,25/78,22.09%,POLR2D;PCF11;RPRD2;PAPOLG;CDC73;SLU7;SRSF4;MAGOHB;PAF1;DDX39A;THOC5;TENT2;PABPN1;LEO1;CSTF3;SRSF5;APP;PAPOLB;SLBP;GRSF1;RPRD1B;WDR33;TENT4B;SRSF3;SRSF11
prerank,regulation of macroautophagy (GO:0016241),-0.1983915697286508,-0.8136913172352351,0.9053627760252366,0.9580985051199216,1.0,27/105,21.18%,ATP6V0A1;KDR;MAPK8;SCOC;ATP6V1B2;EXOC4;SESN3;ATP6V0C;AKT1;PINK1;HDAC6;SMCR8;RRAGB;EPM2A;CAPN1;ATP6V1D;ULK1;CAPNS1;QSOX1;ATP6V0A2;RRAGC;ATP6V1G2;BNIP3L;LAMTOR2;ATP6V0E2;MLST8;ATP6V0D2
prerank,cell cycle G1/S phase transition (GO:0044843),-0.21997021641568504,-0.8136311738470247,0.8507853403141361,0.9574606555952179,1.0,13/61,15.51%,USP29;CDK6;MAX;MAP3K11;CAMK2A;CCND1;BCAT1;HINFP;ACVR1;USP37;CDK2;CDK4;CDKN1A
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.28197245103080804,-0.8135029839556849,0.7505518763796909,0.9569419532952145,1.0,11/22,35.52%,VPS37B;MVB12B;RNF126;VPS37A;VPS28;SNF8;PLAA;STAM;UBAP1L;PTPN23;VPS4B
prerank,regulation of cell-substrate adhesion (GO:0010810),0.26720429772090204,0.8128518398952226,0.7852459016393443,0.9218103884355652,1.0,2/42,1.83%,PDPN;ECM2
prerank,keratan sulfate catabolic process (GO:0042340),0.3489673976387438,0.8120622337577216,0.6906187624750499,0.9227028082986389,1.0,2/11,8.74%,OMD;PRELP
prerank,regulation of cholesterol transport (GO:0032374),0.30723511338372833,0.8119084860831999,0.7066189624329159,0.9224525684627686,1.0,2/20,6.10%,APOA2;NR1H3
prerank,B cell proliferation (GO:0042100),0.32154961438470303,0.8117944244486309,0.702247191011236,0.9221327501371649,1.0,2/17,4.68%,CTPS1;BCL2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.34628613426413285,0.8116929960166265,0.6871401151631478,0.9217890861666427,1.0,3/12,15.95%,HEYL;SMARCA4;DAB2
prerank,autophagy of mitochondrion (GO:0000422),0.2681884619792493,0.8115415470288322,0.7463414634146341,0.9215392417641483,1.0,11/38,22.69%,AMBRA1;SPATA18;PHB2;ATG12;WDR45B;ATG2A;FUNDC1;WIPI2;ATG7;ATG13;ATG3
prerank,regulation of cell death (GO:0010941),-0.20585926179239963,-0.8112493251133042,0.8920634920634921,0.9603004426618355,1.0,23/94,21.83%,ACER3;PDE8A;ACER2;DCC;SNCA;CCN3;EPHB1;CCN5;BMP4;UBB;TNFRSF1B;FGF2;NPAS2;PRKD1;PARK7;HTR2B;BNIP3L;PACRG;SRGAP2;CHRNA7;PRR7;SNCG;SRSF6
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.33552217005040075,0.8109678101317873,0.7260536398467433,0.9220147094455544,1.0,5/15,21.40%,TNRC6B;TNRC6A;EIF4ENIF1;CPEB3;TENT4B
prerank,protein-containing complex disassembly (GO:0032984),-0.22767570044973504,-0.8109487026694636,0.8052631578947368,0.9601132069910602,1.0,11/54,11.76%,HSPA8;CTNNB1;GABARAP;GABARAPL1;VPS33B;LRP6;DVL1;PPP1CA;RPL23;TECPR1;CAV1
prerank,histone lysine demethylation (GO:0070076),-0.2611621868780183,-0.8108256620312413,0.7605985037406484,0.9595750782960979,1.0,8/25,17.26%,JMJD1C;RIOX2;KDM4D;KDM4C;KDM4A;KDM5C;HR;PHF2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.3282638631442387,0.8102895512397078,0.702846975088968,0.9227229213586708,1.0,8/16,27.76%,FBH1;KLHL15;SHLD2;RIF1;SMCHD1;SHLD1;CGAS;FANCB
prerank,dendritic cell differentiation (GO:0097028),0.29996913002837033,0.8102251540013604,0.7284172661870504,0.9223117275300449,1.0,3/22,7.50%,AXL;TGFBR2;LGALS9
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.3375163037139427,0.8098969355758975,0.6788990825688074,0.9223872662433137,1.0,2/14,7.51%,OSR1;ZEB1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3155812346919551,0.809870683172848,0.7269230769230769,0.9219049062768865,1.0,19/19,68.48%,ZC3H12A;CARD16;CD33;FFAR1;GHRL;MEFV;GHSR;TNFAIP3;NLRP2B;IGF1;CX3CL1;PYDC1;FFAR4;APOA1;GSTP1;GIT1;CPTP;CX3CR1;NLRP3
prerank,monocyte chemotaxis (GO:0002548),0.27800044441748945,0.8097857089436362,0.7529215358931552,0.9215347103490289,1.0,4/32,7.35%,ANXA1;IL6;MSMP;CCL2
prerank,negative regulation of MAPK cascade (GO:0043409),0.23193337315212312,0.8096760370871983,0.794435857805255,0.9211946473378817,1.0,13/87,12.20%,TIMP3;FBLN1;DAG1;DUSP10;BMP7;TLR4;PTPN2;PPEF2;DLG1;IRAK3;SMAD4;SH2B3;PTPN1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.34966466803905194,0.809572119069572,0.7106227106227107,0.9208208010145332,1.0,1/12,4.78%,BMP7
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.22770392309676765,0.8093395155357361,0.8179190751445087,0.9206976552700271,1.0,15/109,12.92%,PDPK1;TEC;GAB2;FER;MAP3K1;PSMB10;PSMA7;PSMA3;PSME4;PSMA5;PPP3CB;FBXW11;MAP3K7;BTRC;MAPK9
prerank,positive regulation of hormone secretion (GO:0046887),-0.2966175641284515,-0.8092066151034171,0.7336244541484717,0.961781354010076,1.0,8/17,30.96%,C1QTNF3;SPP1;GRP;EDN1;RASL10B;SOX11;VAMP8;NMB
prerank,protein processing (GO:0016485),-0.19990288192006014,-0.809045460587579,0.8722741433021807,0.9613007994215461,1.0,23/102,23.08%,CPE;F3;PCSK2;LGMN;ECE1;MMP16;FAM111A;CPD;SPCS2;CTSS;SEC11C;SPCS1;CTSL;PCSK7;PHEX;PSENEN;ADAMTS3;GGT1;PCSK5;CPXM1;CASP1;CPZ;CLN3
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.3442440977474806,0.8089091070960582,0.7120921305182342,0.9209243835710923,1.0,2/13,6.10%,NUPR1;NR1H3
prerank,regulation of platelet aggregation (GO:0090330),0.3187456691520639,0.8088412463314711,0.7167630057803468,0.9205211338232493,1.0,1/17,0.30%,PDPN
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.34575638261094793,-0.8085143687773217,0.7045908183632734,0.9614774234449806,1.0,4/10,35.19%,PDE6A;SAG;PDE6G;PDE6B
prerank,regulation of epidermal cell differentiation (GO:0045604),0.3110047070817734,0.808501929214978,0.7116788321167883,0.9205817006758883,1.0,2/21,4.52%,ROCK2;ERRFI1
prerank,cardiac ventricle development (GO:0003231),0.312613407899945,0.8082742506348685,0.7163636363636363,0.9204589730361344,1.0,5/20,14.40%,TMEM65;SALL1;HEYL;HECTD1;MDM4
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.3354356659848126,0.8081394996424972,0.6654676258992805,0.9201728052550902,1.0,1/15,0.40%,TEC
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.2844123007705954,-0.8074269891587392,0.7433035714285714,0.9627040428043833,1.0,6/19,20.96%,MAF1;ZNF76;POLR3C;POLR3G;NAB2;ZC3H8
prerank,regulation of cell cycle phase transition (GO:1901987),-0.20338786788608554,-0.8067643254155342,0.8730650154798761,0.9632170525327555,1.0,38/91,34.74%,PSMC3;CDC26;PSMD3;PSMD14;TFAP4;PSMD6;PSMD4;PSMA6;PSMA4;UBE2E1;PSMB8;NEK10;PSMA8;CDKN1A;BUB1B;PSME1;UBE2D1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;SKP1;PSMD8;TCIM;PSMD11;ANAPC2;TP53;ANAPC15;CDK1;PSMD5;PLK1;NEK11;CDC20;BUB3;DBF4;PSMC1;PSMD2
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3264654344675004,0.8066913646907589,0.7075471698113207,0.9222081441049166,1.0,2/16,9.28%,AMPD3;PAICS
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.2174935061308068,-0.8065759058325243,0.8533333333333334,0.9628091965050974,1.0,15/69,21.33%,PTPRJ;PLCG2;IL33;THBS1;HMGB1;ARHGEF2;HAVCR2;SYK;PTPRC;CCL19;NOD2;PYCARD;LPL;FZD5;MIF
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.31465871289067515,0.8063075608638614,0.7181818181818181,0.9223780266151346,1.0,3/19,7.50%,TLR4;LY96;LGALS9
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.23426129415618868,-0.8056758695498203,0.820855614973262,0.9636585550098954,1.0,14/46,24.01%,PLCB1;PITPNA;RPLP0;TALDO1;PPIA;HNRNPF;SOD1;CFL1;AIP;LCP1;GSTO1;MIF;MTAP;IL12RB2
prerank,nucleocytoplasmic transport (GO:0006913),0.26878565018754036,0.805161577437594,0.7598116169544741,0.9238368421849719,1.0,2/40,2.18%,ATXN1;GEMIN4
prerank,negative regulation of DNA recombination (GO:0045910),0.266688537464718,0.8051210653364712,0.7596638655462185,0.9233694837733419,1.0,18/43,27.76%,POLR2D;PARP3;FBH1;KLHL15;POLR2C;POLR2F;SHLD2;RIF1;POLR2K;RTEL1;MSH2;ATRX;SMCHD1;ZRANB3;SHLD1;POLR2H;CGAS;FANCB
prerank,miRNA metabolic process (GO:0010586),0.3109420012069762,0.8049389075925362,0.726775956284153,0.9231453810122313,1.0,9/20,22.20%,TUT4;SND1;TARBP2;RAN;TUT7;KHSRP;PARN;TENT4B;XPO5
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.20263301990745033,-0.8048051845729458,0.8802588996763754,0.964477709712251,1.0,28/86,25.37%,KLF2;PSMC3;UBB;PSMD3;PSMD14;ELOB;VEGFA;PSMD6;PSMD4;PSMA6;PSMA4;PSMB8;ATF4;UBA52;PSMA8;PSME1;CHEK1;PSMD7;PSMC6;HIGD1A;PSMB5;HIF1AN;PSMC5;PSMB1;PSMD8;EPO;HMOX1;PSMD11
prerank,gastrulation (GO:0007369),0.34151778828103263,0.8047501547670868,0.7116104868913857,0.9229359994383903,1.0,6/15,24.50%,LMBRD1;TASOR;NPHP3;SMAD2;MEGF8;UGDH
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2684695156284523,0.8045761020547519,0.757328990228013,0.9227146224937304,1.0,4/41,7.46%,PRKAG2;RANBP2;TPR;JMJD8
prerank,cellular response to starvation (GO:0009267),0.21435409902643918,0.8031878414784103,0.8590425531914894,0.9246020334971832,1.0,24/147,14.48%,RNF152;PRKAG2;EIF2AK2;PRKAA2;GCGR;WRN;LAMP2;MTMR3;CARTPT;PPARA;LRRK2;STK24;NUPR2;FNIP1;RRP8;FOXO3;SESN1;SLC38A9;TCIRG1;WDR45B;ATP6V0B;NPRL3;EIF2AK3;NUAK2
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.2319493117875356,0.80315054309588,0.8135838150289018,0.9241350126008262,1.0,18/88,15.54%,FBXL17;CUL4A;FBXO9;FBXL3;PSMB10;PSMA7;PSMA3;FBXL20;PSME4;FBXL7;FBXO38;PSMA5;FBXO4;FBXW11;BTRC;FBXL4;FBXL12;FBXL13
prerank,regulation of myelination (GO:0031641),0.2940087542731918,0.8031083882062171,0.7410714285714286,0.9236729631029467,1.0,1/25,0.47%,PTN
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.29879402236229313,-0.8027183331865214,0.7422907488986784,0.9674713471694385,1.0,3/16,9.49%,ESR1;DDX54;DDX17
prerank,cellular response to heat (GO:0034605),0.27243203036712443,0.8018818167653312,0.7619834710743801,0.925279766880149,1.0,5/35,9.57%,FGF1;POLR2D;TPR;SLU7;SUMO1
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.3162855781343408,-0.801849716862972,0.7331975560081466,0.9682486200096461,1.0,2/13,4.88%,CSPG4;HEXB
prerank,dorsal/ventral pattern formation (GO:0009953),0.3173305530485139,0.8007641164931548,0.7225225225225225,0.9266513056516475,1.0,2/20,2.63%,BMPR1A;NBL1
prerank,cytoplasmic microtubule organization (GO:0031122),0.25106038611688636,0.8004454758501109,0.7832278481012658,0.9266934736408348,1.0,12/54,15.63%,CLASP1;CLIP4;KATNAL1;CCDC13;DLG1;TUBGCP4;FIGN;FSD1;SLAIN2;TUBGCP2;FIGNL1;TUBGCP5
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.2329342616988528,0.7990765117100594,0.8155487804878049,0.9284669796291772,1.0,13/87,10.43%,KANK2;DACT1;CDKN2B;CCL2;CDC73;PSMB10;PSMA7;DLG1;USP47;PSMA3;PSME4;FBXL7;PSMA5
prerank,pre-replicative complex assembly (GO:0036388),-0.21461937445991203,-0.797492718423275,0.8342391304347826,0.9751608194347716,1.0,18/64,21.90%,PSMC3;UBB;PSMD3;PSMD14;PSMD6;PSMD4;PSMA6;PSMA4;PSMB8;UBA52;ORC6;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.2997033941002257,-0.7971766888159834,0.7483443708609272,0.9749967433466897,1.0,7/15,29.69%,SCARB1;SIK1;MFSD2A;CTDNEP1;C3;NR1H2;LDLR
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.33771450515385043,-0.7961779116189578,0.7331975560081466,0.975975769865761,1.0,5/10,15.27%,GAS6;RAPGEF2;LYN;CXCL12;CCL19
prerank,hexose biosynthetic process (GO:0019319),-0.2361826866478474,-0.7959296066530661,0.8229426433915212,0.975615665847138,1.0,15/42,21.97%,PGK1;ALDOC;SLC39A14;TPI1;GPI;MDH1;ATF4;PGAM1;ENO1;PER2;SLC25A13;CRTC2;GAPDHS;SLC25A12;MDH2
prerank,exit from mitosis (GO:0010458),-0.32290133544708755,-0.7958300779140285,0.720164609053498,0.9750342863669366,1.0,6/12,22.95%,EPS8;CTDP1;CLASP2;CHMP7;SIRT7;CHMP2A
prerank,negative regulation of hippo signaling (GO:0035331),-0.32953015100090055,-0.7953431988904947,0.7640692640692641,0.975141114142216,1.0,3/12,7.24%,CIT;SHANK2;WWC1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.29327977461521565,0.7952107156100526,0.7317073170731707,0.9346048999105233,1.0,5/24,20.28%,PLA2G4A;PLA2G5;SERAC1;LPGAT1;SLC27A1
prerank,positive regulation of cell cycle process (GO:0090068),-0.19926125934102673,-0.7935214303473569,0.9143835616438356,0.9773965473485506,1.0,28/91,26.80%,INSR;CIT;RCC2;NSFL1C;DDX11;DYNC1H1;MAP3K20;RANBP1;LRP5;RGCC;PLK4;EGF;ECT2;GEN1;KIF23;SPAG5;PRKCE;WIZ;E2F7;NUP62;RACGAP1;KIF14;RAD21;RHNO1;UBXN2B;EDN1;CDC14B;NUDT16
prerank,midbody abscission (GO:0061952),-0.28141146184690147,-0.7934345338149775,0.7456896551724138,0.97679762506668,1.0,9/17,31.02%,CHMP1A;CHMP1B;CHMP2B;CHMP7;CHMP2A;CEP55;CHMP6;CHMP4C;KIF20A
prerank,regulation of monocyte differentiation (GO:0045655),0.3216592107334239,0.7933099368780038,0.713472485768501,0.9372925114305256,1.0,3/14,11.97%,IL34;ACIN1;CSF1
prerank,chromatin remodeling at centromere (GO:0031055),-0.2504310195121107,-0.7926360899848571,0.8023809523809524,0.9774079871565836,1.0,11/31,26.08%,NPM1;HELLS;CENPU;CENPT;CENPL;CENPQ;CENPN;MIS18BP1;CENPA;RBBP7;ITGB3BP
prerank,regulation of leukocyte migration (GO:0002685),0.31722734334747393,0.7925580174444407,0.7368421052631579,0.937992629835487,1.0,2/16,4.57%,ANXA1;MIA3
prerank,cellular response to misfolded protein (GO:0071218),0.30771045271997566,0.792354410561235,0.7313167259786477,0.9378110902535105,1.0,5/20,16.64%,POMT2;KLHL15;UGGT2;CUL3;RNF185
prerank,regulation of cellular biosynthetic process (GO:0031326),0.27998312769579575,0.7920751802483339,0.7864583333333334,0.9377678312057791,1.0,3/28,6.88%,PRKAG2;PRKAA2;CD47
prerank,negative regulation of phosphatase activity (GO:0010923),-0.2656232948836128,-0.7919242552763467,0.8051643192488263,0.9778735346477234,1.0,4/25,8.60%,TGFB2;FKBP1A;SEMA4D;PPP1R11
prerank,response to interleukin-6 (GO:0070741),0.3532329982820643,0.7896620300255276,0.6984126984126984,0.9413004106790754,1.0,1/10,1.32%,PID1
prerank,natural killer cell activation (GO:0030101),0.28961462714212316,0.7896031201900376,0.7717206132879046,0.9408624363972702,1.0,4/23,12.21%,AXL;ELF4;PBX1;SNX27
prerank,protein K63-linked deubiquitination (GO:0070536),-0.2470768328019393,-0.7896015159708256,0.7909738717339667,0.981049218405971,1.0,11/31,22.73%,OTUD7A;PSMD14;BABAM1;USP13;ZRANB1;OTUD1;CYLD;YOD1;ATXN3;OTUB2;SHMT2
prerank,adenine nucleotide transport (GO:0051503),-0.2866782011561675,-0.7892838064596349,0.755656108597285,0.9808191756206066,1.0,4/17,16.18%,ABCC4;LRRC8C;SLC25A42;ABCC5
prerank,NAD biosynthetic process (GO:0009435),0.301291656365712,0.7886889183114664,0.7586837294332724,0.9418871817097468,1.0,7/20,22.46%,PARP9;PARP10;PARP16;PTGS2;NADSYN1;QPRT;HAAO
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.3410647124140685,-0.7880868641893763,0.7448559670781894,0.9821065945206562,1.0,3/10,13.48%,DIS3L2;UBB;UBA52
prerank,plasma membrane repair (GO:0001778),0.3318410008715565,0.7875832741861692,0.7540983606557377,0.9431929125513466,1.0,1/13,1.47%,MYOF
prerank,regulation of hippo signaling (GO:0035330),0.31419076254002454,0.7874542027510798,0.7346570397111913,0.9428878928027787,1.0,8/17,19.92%,NEK8;WWC2;MAPK14;VGLL4;NF2;WTIP;DLG5;AJUBA
prerank,purine ribonucleotide transport (GO:0015868),-0.2907053011637003,-0.7872555484848552,0.7358916478555305,0.9826804222990752,1.0,4/16,16.18%,ABCC4;LRRC8C;SLC25A42;ABCC5
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.2700285616319994,-0.7864401149930693,0.7562076749435666,0.9832533692980949,1.0,5/21,16.57%,KDR;MAPK3;KARS1;EGF;HTR2B
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.3135779591840411,0.7858958239497101,0.7337057728119181,0.9449467875920695,1.0,4/15,13.14%,APOA2;FOXP3;IRAK3;HFE
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.30712471837944977,0.7855203592142629,0.7378277153558053,0.9450355644817876,1.0,2/18,6.59%,SELP;VCAM1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.25077934185543127,0.7854908414250779,0.8025276461295419,0.9445623289729534,1.0,7/52,14.31%,LEPROT;BCL2;NPEPPS;HUWE1;CSNK2A2;RHOU;USP36
prerank,glycogen biosynthetic process (GO:0005978),-0.31946286696437365,-0.7853207241160427,0.7768595041322314,0.9836763733580298,1.0,3/12,16.60%,PGM2L1;PPP1R3C;PER2
prerank,glucan biosynthetic process (GO:0009250),-0.31946286696437365,-0.7853207241160427,0.7768595041322314,0.9836763733580298,1.0,3/12,16.60%,PGM2L1;PPP1R3C;PER2
prerank,cytosolic transport (GO:0016482),-0.19195357774023025,-0.784359492400841,0.9322033898305084,0.9844850363417844,1.0,31/108,25.40%,MYO1D;EMP2;DOP1B;RAB6B;STX16;WDR81;ARL1;GCC2;CORO7;KLHL20;RGP1;WASHC1;EVI5;RNF126;SORT1;VPS51;KIF16B;LAMP1;VTI1A;UBE2O;TBC1D5;PIK3C3;DCTN1;SNF8;CLN3;YKT6;PHETA2;VPS13C;SNX32;TBC1D10B;AP2A1
prerank,phospholipid catabolic process (GO:0009395),0.2925364670687252,0.7842351800832051,0.7616487455197133,0.9460870852984063,1.0,4/24,10.98%,PLA2G4A;APOA2;PLA2G4C;ENPP2
prerank,regulation of endocytosis (GO:0030100),-0.2167557464357236,-0.7836811908468951,0.8756906077348067,0.9848677586987465,1.0,15/61,19.88%,HIP1;RIT2;MCTP1;SNCA;HIP1R;SCAMP5;NEDD4L;RAB5C;PRKD1;CCL19;CBLL1;LRSAM1;MTMR2;SNX17;DLL1
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.2739164687827527,-0.7836788423939124,0.7805907172995781,0.9841179569271395,1.0,7/21,26.87%,ABCA3;EEPD1;CAV1;RXRA;GPS2;TREM2;NR1H2
prerank,protein acetylation (GO:0006473),0.27619152323392054,0.7836377583523283,0.7651122625215889,0.9465336987645239,1.0,10/30,20.68%,CREBBP;NAA16;NAA15;ESCO1;KAT6A;KAT2B;NAA35;CLOCK;DSCC1;NAA40
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2608952130035005,0.7833054745772386,0.800332778702163,0.9465505783788802,1.0,7/40,11.49%,NUCKS1;WRN;TONSL;FBH1;FANCM;CENPX;RFWD3
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.35130513434948574,0.7826579799756962,0.7393822393822393,0.9470885923441231,1.0,5/11,23.33%,IL6;MAP2K1;DDX5;RIPK1;TGFB1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.19094460434817148,-0.7825087762682259,0.9391891891891891,0.985262569201633,1.0,20/104,17.77%,ACTB;CALM1;SNCA;CALM2;DAB2IP;SLC8A1;CALM3;AKT1;CCND1;LRP6;ADRB2;CNPPD1;CSF1R;LRP5;SERTAD1;CDKN1A;CCNF;IRGM;CCNG1;PYCARD
prerank,keratan sulfate metabolic process (GO:0042339),-0.24825104337463266,-0.782359470243686,0.8274231678486997,0.9847435909551614,1.0,13/31,30.82%,ST3GAL6;HEXB;B3GNT2;B4GALT4;ST3GAL4;B3GNT3;B4GALT6;LUM;CHST5;B4GAT1;B4GALT2;GALNS;ST3GAL2
prerank,positive regulation of coagulation (GO:0050820),-0.3300439048472217,-0.7822896777846168,0.7494736842105263,0.983363563450136,1.0,2/10,13.47%,THBS1;ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),-0.3300439048472217,-0.7822896777846168,0.7494736842105263,0.983363563450136,1.0,2/10,13.47%,THBS1;ST3GAL4
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.1825067295268018,-0.7818345408417902,0.975177304964539,0.9833391304628808,1.0,47/148,25.71%,RPS15;RPL5;RPL11;TAF15;MRE11;JMY;RPS20;AKT1;PHF20;STK11;TAF3;SSRP1;RFFL;PPP1R13B;HDAC1;ATM;BARD1;RPL23;TAF11;TAF9B;CDK2;RMI2;BRCA1;RAD1;RPL37;CCNG1;PIP4P1;RFC4;CHEK1;L3MBTL1;NOC2L;MLST8;PRMT5;USP2;ATRIP;PRR5;SGK1;ATR;EXO1;RBBP7;RHNO1;BRPF1;CDK5;HIPK2;RFC5;RFC2;CSNK2B
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3274545486682479,0.7818064111029286,0.7428571428571429,0.9479039781108409,1.0,4/14,17.72%,PPP2R2B;NCK1;PPP2CA;PPP2R2A
prerank,iron-sulfur cluster assembly (GO:0016226),-0.266650234458297,-0.7817666662727825,0.7850467289719626,0.9826928517081115,1.0,8/24,31.70%,MMS19;NDOR1;CIAO3;HSCB;IBA57;ISCU;GLRX5;NUBPL
prerank,intracellular cholesterol transport (GO:0032367),0.32307194378256177,0.7814027036414902,0.7437858508604207,0.9480252709897958,1.0,7/15,26.26%,NPC1;ABCA1;STAR;SERAC1;VPS4A;ABCG1;OSBPL2
prerank,UV protection (GO:0009650),0.357095477286574,0.7806479344912844,0.7269155206286837,0.9487291386628416,1.0,2/10,15.17%,SCARA3;ERCC5
prerank,steroid hormone biosynthetic process (GO:0120178),-0.2538365034790635,-0.7806164895195002,0.8095238095238095,0.9838246944522787,1.0,8/29,28.10%,STARD3NL;SRD5A3;FDXR;HSD17B7;DHCR7;HSD17B8;HSD17B11;TSPOAP1
prerank,regulation of telomere capping (GO:1904353),-0.27025790498886565,-0.7805566558889394,0.7802690582959642,0.9831837329890563,1.0,6/23,17.36%,PRKCQ;NEK7;MAPK3;ATM;PNKP;PKIB
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.3494225458197339,0.7801093210803736,0.739961759082218,0.9491240579474267,1.0,10/10,65.08%,MYO9A;RAP2A;SH3BP1;RHOA;CAMSAP3;OPHN1;CDC42;SYNE4;EZR;MSN
prerank,protein localization to chromatin (GO:0071168),-0.2781203203949726,-0.7797025456159573,0.7931769722814499,0.983796428881407,1.0,8/18,32.98%,ESR1;MCM9;CHMP7;SGF29;RAD21;PIH1D1;PLK1;RUVBL2
prerank,nucleotide biosynthetic process (GO:0009165),0.30612502168979894,0.7795785341936837,0.7615526802218114,0.949443589734427,1.0,4/18,11.62%,MTHFD1;RRM1;PRPSAP1;RRM2B
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.22324034586778618,0.7776860622452455,0.8887323943661972,0.9519781608059034,1.0,28/101,22.71%,PLD1;SAMD4A;VIM;DACT1;IL6;NR1H3;CSF1;ZCCHC4;FBXW11;VGLL4;BTRC;HDAC2;SOX4;CPEB3;UPF3A;ATG10;FXR2;CYFIP2;PLXNB2;ASPH;ERBB2;AGT;IST1;ELAVL1;VPS35;ATG7;METTL5;YTHDF3
prerank,positive regulation of telomere maintenance (GO:0032206),-0.24930475295207494,-0.7772339610558598,0.8024691358024691,0.9869022682583037,1.0,9/31,19.29%,PRKCQ;NEK7;MRE11;MAPK3;ATM;PNKP;PKIB;GNL3;PPP1R10
prerank,error-prone translesion synthesis (GO:0042276),0.29200913234779596,0.776653535954206,0.7335701598579041,0.9530705861509086,1.0,4/21,10.37%,POLH;RFC1;REV1;RPA3
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.2462153234287504,-0.776584023388941,0.819047619047619,0.9871599949858815,1.0,10/29,21.67%,MRE11;HSP90AB1;TERF1;HSP90AA1;PPIA;CDK2;ANKRD28;TINF2;WRAP53;PPP6C
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.30118692987315365,0.7764149776592406,0.7737226277372263,0.9529286278983359,1.0,7/19,21.40%,DCP2;HNRNPC;XRN1;EXOSC10;TEN1;CTC1;TENT4B
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.241889631172286,0.7763777067885662,0.8235294117647058,0.9524593327373468,1.0,15/55,21.91%,PID1;PDGFRB;ARF4;MPV17;TGFBR2;NOXO1;MAPK14;BCO2;SIRT2;SPHK2;XDH;DHRS4;AGT;RIPK1;ZC3H12A
prerank,fatty acid oxidation (GO:0019395),-0.21415066817652734,-0.7762062158566547,0.8703703703703703,0.987046053816432,1.0,4/57,5.07%,ADIPOR2;ACAD10;ABCD4;PPARD
prerank,myelin assembly (GO:0032288),-0.33635629304750425,-0.7758529972963271,0.7414529914529915,0.9868291872230038,1.0,7/10,37.05%,TENM4;NCMAP;TPPP;DICER1;CNTNAP1;CD9;ABCA2
prerank,regulation of TOR signaling (GO:0032006),0.23363724509275233,0.7757120579251586,0.8260869565217391,0.9529817732373391,1.0,12/67,16.69%,DEPTOR;PRKAA2;ARAF;FBXO9;FNIP1;TTI1;SLC38A9;TBC1D7;NPRL3;MAPKAPK5;RICTOR;LARS1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.19239228763434535,0.7755796162056955,0.9592814371257485,0.9526410978774909,1.0,59/314,18.50%,SPSB1;SMURF2;TBL1XR1;FBXL17;NEDD4;NHLRC3;KLHL22;SIAH2;UBE2U;SPSB4;RNF216;CUL4A;ANAPC11;FBXO9;KLHL15;FBXL3;PSMB10;SGTA;ANAPC1;PSMA7;AMFR;UBE2C;PSMA3;FBXL20;PSME4;FBXL7;UBXN2A;FBXO38;PSMA5;FBXO4;WWP2;SPOPL;HUWE1;UBXN4;IFI27;CUL3;FBXW11;BTRC;HECW2;ARRB1;CDC27;RNF103-CHMP3;BFAR;KCTD5;FBXL4;FBXL12;PML;FAF2;FBXL13;TBL1X;RNF185;AMN1;ECPAS;PPP2R5C;UBE4B;DNAJB2;CLOCK;TRIM3;PCBP2
prerank,cellular response to tumor necrosis factor (GO:0071356),0.2040443986642312,0.7755386444079209,0.9178807947019868,0.9521732926771315,1.0,17/175,9.38%,PID1;ADAMTS12;ZFAND6;GBP2;TRAF5;TNFSF15;GSDME;BIRC3;TNFRSF12A;EDA;STAT1;CCL2;PSMB10;TNFRSF14;PSMA7;PSMA3;PSME4
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.23250555713276902,0.7745252635971863,0.8616541353383459,0.9532499763458196,1.0,14/72,17.92%,ENPP1;RAD50;CUL4A;RFC1;FBH1;RPA3;SPO11;OGG1;GTF2H4;ERCC5;DNASE1L1;ERCC1;DNA2;GTF2H2
prerank,L-serine metabolic process (GO:0006563),0.34219379986573967,0.7740518271146086,0.7377690802348337,0.9534741661985574,1.0,2/10,4.27%,SHMT1;PHGDH
prerank,mRNA stabilization (GO:0048255),0.25782756672677004,0.7735185724360795,0.7981220657276995,0.9537976591329512,1.0,9/40,17.34%,TENT5A;IGF2BP1;HNRNPC;NOCT;MAPK14;EIF4ENIF1;FUS;AXIN2;GDNF
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.3337829514760302,0.7732738931270821,0.7467166979362101,0.9536249371888816,1.0,4/12,18.63%,ACSL1;SCP2;ELOVL1;ACOX1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.2751759593199509,0.7730312935542902,0.7764505119453925,0.9534833809781297,1.0,4/25,11.69%,ITPR1;LRRK2;PLEK;CDH13
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.23067504319774934,0.7729582200381098,0.8403100775193798,0.9530845542673959,1.0,23/69,23.38%,POLR2D;RPRD2;INTS9;CDK7;NABP1;INTS14;POLR2C;POU2F1;POLR2F;INTS3;SNAPC3;INTS8;TAF9;INTS13;SNAPC5;INTS6;RPRD1B;POLR2K;NABP2;SNAPC4;SRRT;SP1;ELL
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.24147050190847064,0.7727862488669696,0.8386581469648562,0.9528435810127995,1.0,7/48,11.04%,DOCK5;NRP1;S100A10;MYADM;CUX1;TRIOBP;CUX2
prerank,regulation of nervous system development (GO:0051960),0.26218375786571807,0.772522689773354,0.7873462214411248,0.9527260213065081,1.0,6/37,14.38%,PTN;YAP1;DOCK7;HEYL;BHLHE41;NPHP3
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3158807478967719,0.7714975752813802,0.7567049808429118,0.9538198510265099,1.0,4/14,13.96%,BAX;PTPN1;TMEM33;BFAR
prerank,glycine transport (GO:0015816),-0.3285466599446434,-0.7710348138313727,0.7678207739307535,0.9936203463470178,1.0,3/10,12.09%,SLC38A5;SLC36A1;SLC6A5
prerank,histone H3-K9 demethylation (GO:0033169),0.33741934289241454,0.770368708833879,0.7621722846441947,0.9550831641768261,1.0,2/11,5.55%,KDM7A;KDM3B
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.29554065683130626,-0.7702280023615172,0.7578288100208769,0.9941014960228997,1.0,7/15,28.10%,PPARD;AKT1;LDLRAP1;SLC45A3;PRKCE;IRS1;PMAIP1
prerank,mitotic sister chromatid segregation (GO:0000070),-0.191917911636342,-0.7698501603523601,0.9230769230769231,0.9939569401795734,1.0,36/98,27.14%,DIS3L2;MCPH1;KPNB1;KIF18A;NAA50;SMC2;CHMP1A;CHMP1B;SET;PRC1;NCAPH2;CHMP2B;CHMP7;KIF23;KNSTRN;NCAPH;SPAG5;TTN;TUBG1;TENT4A;NUP62;NSL1;REC8;KIF22;CHMP2A;DSN1;KIF14;SPDL1;CEP55;RAD21;TUBG2;SGO1;CSNK2B;CHMP6;CHMP4C;NCAPD2
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.2654000907002324,-0.7694896059954242,0.8104265402843602,0.9937401846368364,1.0,8/20,30.15%,HSP90AB1;HSPA4;HSP90AA1;TMEM35A;HOPX;BBS10;CLU;PSMG2
prerank,peptidyl-lysine acetylation (GO:0018394),0.35120130185113874,0.7692676449453497,0.7538167938931297,0.9562681714461205,1.0,3/10,15.86%,CREBBP;ESCO1;KAT2B
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.21354455007857917,0.7692103586837448,0.90633608815427,0.9558166224235451,1.0,25/122,18.16%,PLD1;SAMD4A;VIM;SLC6A9;IL6;GLI1;TLR4;SORBS1;PDGFRB;EPM2AIP1;CCL2;TLR2;IGF2;SLC25A37;ZCCHC4;SMOC2;PRKD2;SOX4;CPEB3;NOX1;UPF3A;HSPH1;DNA2;FXR2;PLXNB2
prerank,visual system development (GO:0150063),-0.23299583359219173,-0.7691810693496525,0.8411910669975186,0.993491853932982,1.0,14/37,27.69%,MEIS2;TGFB2;PBX3;FREM2;ATF6;BMPR1B;SIPA1L3;SMOC1;SOX2;RAB18;MAB21L2;HIPK2;C3;PBX4
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.23214281614774662,-0.7689243376942642,0.851581508515815,0.9931334905919015,1.0,9/40,20.27%,AKT1;MFF;PINK1;PRELID1;GHITM;PLAUR;BMF;PYCARD;BAD
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.26959638103781,-0.7684210016217774,0.7978494623655914,0.9931672386572366,1.0,10/18,43.93%,CEP135;CCT5;WRAP53;TREM2;CCT7;CHP1;CEP295;CCT8;CCT4;TNF
prerank,regulation of protein-containing complex assembly (GO:0043254),0.21425812420956258,0.7683680814701317,0.8945086705202312,0.9565790198752544,1.0,16/110,12.05%,SELP;EIF2AK2;CDH5;PRKCZ;FBLIM1;SPIDR;GSK3B;OPRD1;BAX;SLF2;SUMO1;ATF7IP;FNIP1;ABCA1;HJURP;RHOC
prerank,regulation of membrane depolarization (GO:0003254),0.3018207316474994,0.768012448429331,0.7663043478260869,0.9566100970351505,1.0,4/18,9.89%,PTPN3;SCN3B;LRRK2;GPD1L
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.32071345340267177,0.767560907166489,0.7711069418386491,0.9567567842851303,1.0,3/15,8.18%,FSTL3;DACT1;SKI
prerank,regulation of lamellipodium assembly (GO:0010591),-0.2347370750869705,-0.7672016837898036,0.8290816326530612,0.9942404597284711,1.0,5/34,9.41%,SLIT2;PIK3R1;NCKAP1;ARPC2;ABI3
prerank,autophagy of nucleus (GO:0044804),0.3107747245218164,0.7670338545786315,0.7689463955637708,0.9570340126958964,1.0,7/16,22.69%,ATG12;WDR45B;ATG2A;WIPI2;ATG7;ATG13;ATG3
prerank,phospholipid dephosphorylation (GO:0046839),0.25965448373864564,0.7664023295187933,0.8080133555926544,0.9574804314639455,1.0,5/37,8.96%,PLPP3;TPTE;MTMR3;MTMR11;PLPPR3
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.2792042809454684,-0.7662038243940505,0.8034557235421166,0.994987023632301,1.0,7/17,36.26%,SEL1L;HERPUD1;SEC61B;UFD1;HM13;AUP1;DERL1
prerank,primary alcohol metabolic process (GO:0034308),0.2810517395580615,0.7659337256887139,0.7545454545454545,0.9576668580316715,1.0,5/25,16.43%,RDH10;RBP4;NAAA;PECR;NAPEPLD
prerank,response to nutrient levels (GO:0031667),-0.27455977554886635,-0.7656981664768993,0.8080168776371308,0.9949789938494656,1.0,4/17,12.71%,FAM107A;KCNB1;ULK1;ATF4
prerank,"base-excision repair, gap-filling (GO:0006287)",0.26030787554994195,0.7656910638091798,0.7893835616438356,0.9575133814617314,1.0,7/35,12.98%,RFC1;POLG;NTHL1;XRCC1;RPA3;ADPRS;OGG1
prerank,neuromuscular process (GO:0050905),-0.28526793404227824,-0.7650242666167514,0.7801724137931034,0.9952668713615107,1.0,6/16,23.08%,NRXN1;GCH1;SHANK1;KCNA1;DCTN1;CLN3
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.29739829756119907,-0.7645105363894938,0.7902542372881356,0.995288056211448,1.0,9/14,40.57%,AKT1;MFSD2A;ABCD2;IRS1;LONP2;MTLN;TYSND1;PLIN5;ABCD1
prerank,nucleosome organization (GO:0034728),-0.21340222456264796,-0.7640650948830542,0.8923884514435696,0.995231092511176,1.0,12/55,16.43%,H3-3A;ZNHIT1;LIN54;NPM1;SART3;SMARCB1;ASF1A;H1-0;ANP32B;SPTY2D1;DMAP1;SET
prerank,negative regulation of ion transport (GO:0043271),-0.25818632017019455,-0.7636789098515768,0.8223234624145785,0.9950892001875996,1.0,5/24,10.16%,PTK2B;GPM6B;SNCA;INPP5K;NOS1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.3023024204343273,0.7633560504919054,0.7823741007194245,0.9605347640960696,1.0,3/18,9.42%,IL23R;IL18;IGF2
prerank,negative regulation of lymphocyte activation (GO:0051250),0.28925862004254815,0.7632592169518327,0.7801047120418848,0.9601439661453336,1.0,2/21,5.29%,TNFAIP8L2;PTPN22
prerank,regulation of double-strand break repair (GO:2000779),0.2528500947168314,0.7632416813523382,0.8325123152709359,0.9596421680875937,1.0,14/39,22.35%,TRIP12;SPIDR;PPP4R2;SLF2;PML;FIGNL1;MGMT;SHLD2;UBR5;KDM1A;SETD2;SPIRE1;PPP4C;RTEL1
prerank,nucleotide catabolic process (GO:0009166),0.3065719592532643,0.7628215971709176,0.7654784240150094,0.9597440375585694,1.0,5/16,20.46%,NT5C;DERA;ITPA;NT5C1A;XDH
prerank,T cell differentiation in thymus (GO:0033077),0.3194806833169762,0.7628039042583256,0.7702448210922788,0.9592457001136082,1.0,1/14,2.66%,GLI3
prerank,glycoprotein metabolic process (GO:0009100),0.23862335119212455,0.7627381295449992,0.8511326860841424,0.9588193879567398,1.0,4/53,4.44%,MAN1C1;PRKCSH;MAN2A1;LARGE1
prerank,protein lipidation (GO:0006497),-0.2099182350794059,-0.7627306654458698,0.8946015424164524,0.9957452810943391,1.0,18/59,25.03%,MPPE1;ZDHHC14;ZDHHC20;PIGU;PIGM;ZDHHC2;PIGQ;PIGH;DPM2;PIGO;ZDHHC7;PIK3C3;ZDHHC23;PIGB;WDR45;ZDHHC9;ZDHHC5;SELENOK
prerank,positive regulation of signaling receptor activity (GO:2000273),0.26118629380482977,0.7626857928892607,0.8,0.9583607794364101,1.0,8/36,15.96%,NRP1;NCOA3;TGFA;CCL2;HFE;ADRA2C;HDAC2;ADRA2A
prerank,histone deubiquitination (GO:0016578),0.3004404905025012,0.7626049131405267,0.7532956685499058,0.9579547474575537,1.0,6/18,19.89%,ATXN7;USP36;UIMC1;USP15;BRCC3;USP7
prerank,neutrophil chemotaxis (GO:0030593),0.24164607254941434,0.7625542950800989,0.8472668810289389,0.9575121399941845,1.0,4/53,7.35%,CXADR;CXCL10;CKLF;CCL2
prerank,negative regulation of bone remodeling (GO:0046851),0.33870653200660394,0.7624976385901947,0.7388781431334622,0.9570662644001878,1.0,2/11,6.43%,IL6;CARTPT
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.2975057985037421,-0.7624821066933734,0.7782258064516129,0.9953809673890229,1.0,7/14,32.25%,FASTKD2;C1QBP;RCC1L;TRMT10C;RPUSD3;MPV17L2;COA3
prerank,macrophage activation (GO:0042116),-0.23482653345375754,-0.7624780976934917,0.819371727748691,0.9946416621534221,1.0,4/34,5.73%,PLCG2;CD93;SNCA;DYSF
prerank,plasma membrane tubulation (GO:0097320),0.3280445531267393,0.762042380962654,0.7335907335907336,0.9572474039379383,1.0,4/13,14.25%,PACSIN2;SNX9;MICALL1;CHMP4A
prerank,regulation of brown fat cell differentiation (GO:0090335),0.30219886717631195,0.7619576538509714,0.7588028169014085,0.9568401936763887,1.0,4/16,20.03%,BMP7;FTO;NAPEPLD;PTGS2
prerank,regulation of tube diameter (GO:0035296),0.3172076423182867,0.7616643549629661,0.741635687732342,0.9562277619114964,1.0,1/13,0.67%,ROCK2
prerank,vascular process in circulatory system (GO:0003018),0.3172076423182867,0.7616643549629661,0.741635687732342,0.9562277619114964,1.0,1/13,0.67%,ROCK2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.24822844134080618,-0.761397534494927,0.8444976076555024,0.9954784560848708,1.0,6/24,18.37%,NOD1;UBB;UBA52;CYLD;NOD2;IRAK1
prerank,positive regulation of organelle assembly (GO:1902117),-0.21897624999210247,-0.760968102331509,0.8398876404494382,0.9953453782851716,1.0,15/44,27.44%,RAB3GAP1;CCDC88A;SDCBP;DYNC1H1;PLK4;CNOT2;LRSAM1;LCP1;SPAG5;NUP62;SDC4;HTT;SH3GLB1;STX18;PIP4K2A
prerank,regulation of cellular catabolic process (GO:0031329),0.2334919218744907,0.7605435302624225,0.8648648648648649,0.9573426858661083,1.0,8/62,12.99%,ITPR1;NUPR1;DAPK1;MTMR3;LRRK2;KEAP1;DAPK2;PIP4K2B
prerank,protein tetramerization (GO:0051262),0.2305532616459685,0.7604086352218219,0.8460342146189735,0.9570245041704278,1.0,4/67,6.74%,ALDH1A2;SHMT1;APPL2;GBP5
prerank,endoplasmic reticulum organization (GO:0007029),-0.20045998167774096,-0.7600537646853104,0.9085545722713865,0.9959657378808919,1.0,30/72,31.08%,REEP1;DOP1B;LMAN2L;REEP5;SHTN1;CAV2;SERP1;TRAM1;LMAN1;CCDC47;VCPIP1;TOR1B;WDR83OS;SEC61A1;SEC61G;RTN3;RAB18;ATL2;CYB5A;TOR1AIP2;HMOX1;TRAM1L1;STX18;SEC61B;GET1;VAMP2;SPTSSB;REEP4;TRDN;BNIP1
prerank,positive regulation of translation (GO:0045727),-0.18812187333362518,-0.7599881379143714,0.9466666666666667,0.9953181527738136,1.0,30/94,27.59%,THBS1;RPS9;RPL26;RPL5;PKM;RPS4X;EEF2;CNBP;NPM1;YTHDF2;EIF5A;EIF5AL1;FASTKD2;CDC123;PASK;EIF5A2;RBM3;POLDIP3;C1QBP;UHMK1;BCL3;PYM1;NIBAN1;EIF6;RCC1L;TRMT10C;POLR2G;HNRNPD;METTL14;BOLL
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.2608014073809822,-0.7597660444786181,0.8329571106094809,0.9948774231741665,1.0,5/21,14.13%,RPIA;PGM2L1;TKT;GPI;TALDO1
prerank,outer dynein arm assembly (GO:0036158),0.31732735757886127,0.7591325555428383,0.7727272727272727,0.9584091444822296,1.0,3/14,10.15%,ODAD4;DNAAF1;DNAL1
prerank,negative regulation of transport (GO:0051051),-0.21952016868619062,-0.7587913810455978,0.8835227272727273,0.9955335948037898,1.0,12/51,19.50%,MCTP1;SNCA;SCAMP5;SNX3;DYSF;RACK1;PRKD1;EGF;LRSAM1;PPM1F;YRDC;MTMR2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.27946728186570846,0.7587454570723335,0.79,0.9584254842057907,1.0,2/24,4.38%,RBPJ;CREB3L3
prerank,proton transmembrane transport (GO:1902600),0.25589518984711374,0.758682092361479,0.8213689482470785,0.9580037121262579,1.0,4/36,10.12%,ATP1A2;SLC4A11;NNT;OTOP1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.22869239568107186,0.7585729210669078,0.8784615384615385,0.9576479984917073,1.0,17/66,24.56%,IL6;TLR4;GBP5;LGALS9;WNT5A;RIPK2;PANX1;APP;TRIM16;CD36;ZC3H12A;TMEM106A;INAVA;CARD16;EGR1;JAK2;GSDMD
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.3132151356922436,0.7583540518880336,0.7757009345794392,0.957442453714059,1.0,4/14,16.42%,RPL7L1;ZNHIT3;WDR12;DDX18
prerank,establishment of mitotic spindle localization (GO:0040001),0.27344144247782143,0.7581265325022444,0.8017391304347826,0.9572696299693091,1.0,5/28,12.51%,GJA1;CLASP1;ESPL1;MISP;FBXW11
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.24027527692595804,-0.7573226144131505,0.8419753086419753,0.9968998998978894,1.0,13/30,31.33%,NOS3;ARHGEF2;RFFL;FAS;TMBIM1;PARK7;BRCA1;TNFRSF10B;BMP5;HMOX1;FADD;TRADD;TRAF2
prerank,response to organonitrogen compound (GO:0010243),-0.2284684306723111,-0.757225105683237,0.8782383419689119,0.9962895725287707,1.0,11/38,21.87%,GLRA3;SEL1L;BRSK2;CCDC47;RRAGC;KAT7;GLRA2;GLRA1;UBXN6;KYNU;TRPM2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.22446839612023908,0.7572047995782722,0.8637037037037038,0.958123553534336,1.0,10/76,12.85%,MTURN;TCEAL7;BMP7;ANXA4;FOXP3;PARP10;IRAK3;TRIM21;MAP2K5;ARRB1
prerank,organic cation transport (GO:0015695),-0.2674928172939609,-0.7571820483021758,0.8123569794050344,0.9956035544535038,1.0,4/20,16.59%,SLC47A1;SLC25A42;SLC22A5;SLC25A19
prerank,positive regulation of macroautophagy (GO:0016239),0.24266500762061194,0.7571260408626884,0.8613376835236541,0.9577217193298015,1.0,10/48,15.00%,PRKAA2;DCN;OPTN;WAC;UVRAG;SESN1;MAP3K7;PIP4K2B;TBK1;SLC25A4
prerank,regulation of urine volume (GO:0035809),0.33786723745614766,0.7559312794510473,0.7334558823529411,0.9589382656302559,1.0,4/10,20.90%,ADM;NPR3;ADCY6;HAS2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.22294429788875383,0.7555097320140153,0.8443465491923642,0.9590297307752454,1.0,13/76,15.96%,LPAR1;FPR2;F2RL3;C5AR2;PLCE1;ACTN2;OPRD1;NMUR1;P2RY6;GPR65;P2RY1;CCKBR;ADRA2A
prerank,snRNA transcription (GO:0009301),0.22564824499468022,0.7554588047649891,0.8873239436619719,0.9585892750669988,1.0,23/70,23.38%,POLR2D;RPRD2;INTS9;CDK7;NABP1;INTS14;POLR2C;POU2F1;POLR2F;INTS3;SNAPC3;INTS8;TAF9;INTS13;SNAPC5;INTS6;RPRD1B;POLR2K;NABP2;SNAPC4;SRRT;SP1;ELL
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.22808837469965815,-0.7553706888542563,0.8531645569620253,0.9975186209304315,1.0,15/38,29.53%,H3-3A;NPM1;ASF1A;CENPU;CENPT;CENPL;CENPQ;CENPN;MIS18BP1;IPO4;CENPA;RBBP7;ITGB3BP;ASF1B;OIP5
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.196719518893144,0.7551833442501087,0.9449664429530201,0.9584721468013497,1.0,27/184,12.97%,NINL;DYNLL1;ALMS1;SDCCAG8;PLK5;CLASP1;APPL2;ANAPC11;CEP152;HAUS8;KLHL18;PSMB10;ANAPC1;PSMA7;UBE2C;PSMA3;PSME4;PTPN6;APPL1;PSMA5;NEDD1;CDC14A;CUL3;BTRC;MAD2L1BP;HECW2;CDC27
prerank,regulation of centriole replication (GO:0046599),-0.2770742225933226,-0.7551292546584502,0.8206896551724138,0.9971057544014832,1.0,8/17,25.96%,NPM1;PLK4;TRIM37;BRCA1;KAT2A;CDK5RAP2;NUP62;STIL
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.3423666992564333,0.7549587804264581,0.7495327102803738,0.9582712930122127,1.0,1/10,1.71%,PRKAA2
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.2972007484625733,-0.7545109487785631,0.7938144329896907,0.9972047941046561,1.0,8/13,36.60%,FCER1G;SYK;LPL;ITGB2;CD81;LDLR;CD9;PPARG
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.29998977120252,0.754365105937029,0.7803030303030303,0.9586408644066414,1.0,3/16,13.74%,WRN;MCM4;MCM6
prerank,protein K11-linked ubiquitination (GO:0070979),0.2678187292989402,0.7543494477838255,0.8043478260869565,0.9581437900095823,1.0,5/27,13.39%,ANAPC11;ANAPC1;UBE2C;CDC27;UBE2E3
prerank,regulation of proteolysis (GO:0030162),-0.21516202997269132,-0.7543487320642256,0.8857938718662952,0.9966988358182702,1.0,17/48,28.38%,CST3;PERP;AKT1;HDAC6;BAG6;SPOP;CAV1;PLAUR;AURKAIP1;BAD;FGFR4;CLN3;CDK5;FADD;LTBP4;GSAP;NEDD8
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.2955008271033237,-0.7543247694093138,0.8064516129032258,0.9959913948553935,1.0,5/13,21.64%,RACK1;HSPA5;PPP1R15B;UFL1;PPP1R15A
prerank,regulation of cell aging (GO:0090342),0.3351975501081966,0.7543106694181002,0.7570093457943925,0.9576774559155824,1.0,5/11,26.80%,NEK4;NEK6;PNPT1;RSL1D1;ING2
prerank,smooth muscle tissue development (GO:0048745),-0.32492241848330616,-0.7535966140284368,0.7782515991471215,0.9963114219822514,1.0,2/10,8.42%,BMP4;MYLK
prerank,autophagosome assembly (GO:0000045),-0.2119746112182189,-0.7534234982227485,0.9131578947368421,0.9958034344825609,1.0,13/52,20.18%,GABARAP;GABARAPL1;NSFL1C;ATG16L1;ATG9A;MFN2;TP53INP2;VMP1;ULK1;ATP2A2;IRGM;RAB1B;PIK3C3
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.297670006042705,-0.753150491331825,0.7974413646055437,0.9954500090253487,1.0,5/14,28.10%,AKT1;NNMT;SLC45A3;IRS1;PMAIP1
prerank,mitochondrion transport along microtubule (GO:0047497),-0.29826528534684754,-0.7529621412316441,0.774617067833698,0.9949882982580691,1.0,3/13,15.58%,SYBU;UBB;MAPT
prerank,carboxylic acid metabolic process (GO:0019752),0.2594615142490493,0.7529110516705988,0.8113522537562604,0.9591334123021741,1.0,12/33,22.16%,PLA2G4A;DDO;LIPT1;SIRT4;PON3;HAO1;ST3GAL1;GRHPR;CARNMT1;AGXT;ST6GAL1;CYB5R3
prerank,global genome nucleotide-excision repair (GO:0070911),0.2767376258839796,0.7528236250842903,0.7979094076655052,0.9587358533291539,1.0,7/26,19.60%,CUL4A;RNF111;GTF2H4;ERCC1;USP45;GTF2H2;XPC
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.3289208899860207,-0.7527478953177521,0.8004073319755601,0.9945592016076804,1.0,4/10,17.99%,SNX3;TERF1;MAPT;PPM1F
prerank,positive regulation of organelle organization (GO:0010638),0.26171561084124717,0.7521595030178574,0.8105939004815409,0.9591851089141553,1.0,7/32,17.12%,ANXA2;ANXA1;GSK3B;UVRAG;TMED9;PLA2G5;KATNBL1
prerank,positive regulation of cytokinesis (GO:0032467),-0.23583119263038085,-0.7521076428585282,0.8475,0.9947256326116037,1.0,19/32,45.62%,CIT;ECT2;KIF23;PRKCE;RACGAP1;KIF14;CDC14B;KIF20B;CDC6;OPN1MW;DRD3;GIPC1;MAP10;AURKB;CXCR5;CDC42;TAS1R2;AURKC;RXFP3
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.27922962253966754,0.7520579943843303,0.7810344827586206,0.9587942964569403,1.0,3/23,6.53%,TPTE;MTMR3;MTMR11
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.32380483722240183,0.7515181311690726,0.7708333333333334,0.9590691851467278,1.0,2/11,11.48%,IL23R;NFKBIZ
prerank,positive regulation of cholesterol transport (GO:0032376),-0.2456839840944767,-0.7511871605814611,0.8656387665198237,0.9953139369766075,1.0,9/27,26.87%,ABCA3;EEPD1;CAV1;RXRA;ABCB4;ABCA13;GPS2;TREM2;NR1H2
prerank,Golgi organization (GO:0007030),-0.18273210628044395,-0.7510460164202859,0.9755244755244755,0.9947861646234081,1.0,41/112,31.18%,SYNE1;CSNK1D;ATP8B2;LMAN2L;STX16;ARL1;NSFL1C;GCC2;TMED2;ATP8B1;PI4K2A;VMP1;ARHGEF7;LMAN1;CLASP2;PRKD1;VPS51;MYO18A;VCPIP1;VTI1A;VRK1;TMED7;RAB30;PRMT5;SEC22B;ATL2;TMED5;YWHAZ;HTT;UBXN2B;HACE1;PI4K2B;ATP8B4;GOLPH3;PDCD10;DYM;SPTBN5;ZW10;RAB1A;CDK1;GOLPH3L
prerank,negative regulation of DNA binding (GO:0043392),-0.24250791812910133,-0.7509161250880527,0.866822429906542,0.9942311185093092,1.0,5/28,16.60%,LEF1;MDFI;TFAP4;HEY1;PER2
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.2824060293561228,0.7508825034339114,0.7992831541218638,0.9594235248772265,1.0,7/22,18.31%,SLC16A2;APPL2;LRRK2;NES;DISP3;KDM2B;KDM1A
prerank,receptor catabolic process (GO:0032801),-0.2560687241840479,-0.7507744578583617,0.8574766355140186,0.9936996134400005,1.0,10/24,26.71%,LGMN;VLDLR;KIF16B;AP2B1;SNX25;AP2A2;AP2A1;CLTA;AP2M1;SH3GLB1
prerank,regulation of neurogenesis (GO:0050767),0.2386432487059139,0.7506943657320102,0.8632619439868204,0.9591730963810509,1.0,7/55,10.49%,WNT3A;NUMB;IL6;APPL2;YAP1;DOCK7;HEYL
prerank,positive regulation of intracellular protein transport (GO:0090316),0.20356527367979516,0.7498416563828901,0.9236016371077762,0.9598751890315345,1.0,33/144,22.41%,TCF7L2;LEPROT;SMAD3;ZIC1;BCL2;TPR;NPEPPS;GSK3B;HUWE1;CSNK2A2;RHOU;USP36;MYO1C;TM9SF4;MIEF1;SAR1A;RAN;YWHAE;RAPGEF3;UBR5;SEC16A;TENM1;EFCAB7;EMD;ERBB2;CEP131;ZFAND1;BAG3;ZC3H12A;TCAF1;FBXW7;TFDP2;ATG13
prerank,centromere complex assembly (GO:0034508),-0.22819549366600392,-0.7496310550387271,0.882903981264637,0.9945322047881978,1.0,17/36,34.49%,NPM1;HELLS;CENPU;CENPT;CENPL;CENPQ;CENPF;CENPN;MIS18BP1;CENPA;RBBP7;ITGB3BP;OIP5;DLGAP5;CENPW;MIS12;KNL1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.34247190151364343,0.7492450736114141,0.7461538461538462,0.9596787306177462,1.0,4/10,21.14%,MYADM;MAP2K5;WNK1;MAPK7
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.34247190151364343,0.7492450736114141,0.7461538461538462,0.9596787306177462,1.0,4/10,21.14%,MYADM;MAP2K5;WNK1;MAPK7
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.2823609353730375,-0.7491050999408934,0.79957805907173,0.9945080614230861,1.0,8/15,43.29%,CCT5;NOP10;RUVBL2;NHP2;CCT7;SHQ1;CCT8;CCT4
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.29776618941558464,0.7489321474038314,0.7763636363636364,0.9596040987840463,1.0,2/17,3.96%,EIF2AK2;TAOK3
prerank,hyaluronan metabolic process (GO:0030212),-0.2548157526413553,-0.7484939977728042,0.8497854077253219,0.9946253008227371,1.0,10/23,28.28%,HEXB;CEMIP;FGF2;GUSB;ABCC5;HMMR;HAS1;HAS3;HYAL3;STAB2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.315967589864594,-0.747841928946499,0.8008130081300813,0.9947672939654733,1.0,2/10,5.06%,SEMA6A;DAB2IP
prerank,negative regulation of chemokine production (GO:0032682),0.31495166013368114,0.7467419258583491,0.7782178217821782,0.9622032671270078,1.0,4/14,15.88%,IL6;LGALS9;MAP2K5;MUL1
prerank,protein localization to mitochondrion (GO:0070585),-0.30652328227681425,-0.7466865750047385,0.8185567010309278,0.9955747799030378,1.0,5/11,25.85%,AKT1;PINK1;MAIP1;MTCH2;DNAJA1
prerank,positive regulation of lipid transport (GO:0032370),-0.2998260696407705,-0.7462040121184057,0.8134490238611713,0.9954556686676378,1.0,3/12,10.29%,ABCA3;PRELID1;SPP1
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.18186632511829626,-0.7459842737618317,0.9467455621301775,0.995027730898416,1.0,8/112,5.97%,PTPRJ;PLCG2;IL33;THBS1;CD34;GAS6;HMGB1;ARHGEF2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.2914633803571911,0.7458956960678159,0.7834179357021996,0.9628986826638244,1.0,2/18,3.71%,NELL1;DACT1
prerank,inner ear morphogenesis (GO:0042472),0.2815481000936173,0.7457026044337701,0.8007312614259597,0.9626525863787001,1.0,3/22,7.95%,ZIC1;TTC39C;TIFAB
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.2896400183766826,0.7450857136276307,0.8123861566484517,0.9629843642178143,1.0,2/18,5.39%,FPR2;C5AR2
prerank,cholesterol metabolic process (GO:0008203),0.22141633754242088,0.7450000089422326,0.9073783359497645,0.9625908784940694,1.0,9/68,13.00%,APOA2;APOF;CYP27A1;INSIG2;SOAT1;ABCA1;OSBPL5;CH25H;LBR
prerank,melanosome organization (GO:0032438),0.261097602361115,0.7448551967936987,0.803030303030303,0.9622702671875788,1.0,3/26,9.85%,SHROOM2;DTNBP1;HPS1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.23474409773733174,-0.744195581269959,0.8504672897196262,0.9967061127203375,1.0,7/31,18.32%,PEX26;PEX10;PEX16;DNLZ;GRPEL2;TOMM40L;TOMM20
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.2937014022165406,0.74337065950324,0.7989130434782609,0.9638432295420735,1.0,5/17,14.69%,NRP1;BAIAP2L1;HAX1;BAIAP2;NTRK3
prerank,electron transport chain (GO:0022900),0.30889983517623715,0.741809910413908,0.766260162601626,0.9654454466891501,1.0,2/15,11.89%,POR;ETFA
prerank,lipoprotein transport (GO:0042953),-0.3184115121004465,-0.7413342874062694,0.8,0.9997298818797398,1.0,2/10,10.62%,PRKCB;VMP1
prerank,protein insertion into ER membrane (GO:0045048),-0.2226488741196757,-0.7410776375418588,0.9064935064935065,0.9993366131030081,1.0,14/37,27.91%,BAG6;SERP1;TRAM1;CAMLG;CCDC47;EMC10;WDR83OS;SEC61G;CYB5A;HMOX1;TRAM1L1;SEC61B;GET1;VAMP2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.2481113075382647,0.7410465740255372,0.8387096774193549,0.9659588206019315,1.0,9/39,17.92%,CUL4A;RFC1;NTHL1;RPA3;OGG1;GTF2H4;ERCC5;ERCC1;GTF2H2
prerank,integrated stress response signaling (GO:0140467),0.3104722461026281,0.7407783432715298,0.7899461400359067,0.9658078789542667,1.0,3/14,14.39%,CCL2;QRICH1;EIF2AK3
prerank,mitotic metaphase plate congression (GO:0007080),-0.2053337830380993,-0.7407114782348984,0.9029649595687331,0.999041607534033,1.0,32/51,42.53%,KPNB1;KIF18A;CHMP1A;CHMP1B;CHMP2B;CHMP7;MAD1L1;NUP62;KIF22;CHMP2A;KIF14;SPDL1;CEP55;CHMP6;CHMP4C;ZW10;NUF2;MIS12;NUDC;VPS4B;RAB11A;KIF2C;CCNB1;CDC23;DCTN2;KIFC1;BOD1;RRS1;CENPE;CHAMP1;PINX1;CDT1
prerank,regulation of inclusion body assembly (GO:0090083),-0.3046600766123483,-0.7395554135628165,0.7983014861995754,0.9998388651189278,1.0,4/11,24.07%,DNAJA4;SACS;SNCAIP;HSPA2
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.3221969691396393,0.7394028555469971,0.7816764132553606,0.9671844599899604,1.0,3/11,17.63%,NECAB1;SOAT1;ABCA7
prerank,"DNA-templated transcription, termination (GO:0006353)",0.22626473945688522,0.7390538593602447,0.8765243902439024,0.9671497256313643,1.0,24/68,26.11%,PCF11;POLR1C;CCNH;MNAT1;CDK7;POLR1G;MTERF2;POLR2F;GTF2H4;PABPN1;CSTF3;SLBP;GTF2H2;CAVIN1;TTF1;POLR2K;WDR33;UBTF;CLP1;MAZ;PAPOLA;POLR1A;TAF1D;POLR2H
prerank,cellular component maintenance (GO:0043954),-0.29973656385688097,-0.7384850062490433,0.7937219730941704,1.0,1.0,5/12,30.01%,INSR;ITGA3;MTMR2;TREM2;PICK1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.24561295093638055,0.7381899361984449,0.8545454545454545,0.9678132954886901,1.0,4/38,7.53%,SP100;CFLAR;SERPINE1;GSK3B
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.2656551474597614,0.7379386335377421,0.8081967213114755,0.967613067703156,1.0,1/26,0.48%,ATP1A2
prerank,toll-like receptor signaling pathway (GO:0002224),0.2143839250549734,0.7374629547058338,0.9186046511627907,0.9677108717503725,1.0,13/84,14.18%,COLEC12;TLR4;MAP3K1;SCARA3;BIRC3;LY96;LGALS9;RIPK2;TLR2;IRAK3;RPS6KA3;MAP3K7;TICAM1
prerank,negative regulation of TORC1 signaling (GO:1904262),0.31397029343701793,0.7372713241754497,0.810379241516966,0.9674665248947083,1.0,1/13,1.01%,RNF152
prerank,protein methylation (GO:0006479),0.2454712932020623,0.7372480490772975,0.8588850174216028,0.9669781759699131,1.0,4/40,7.93%,NSD3;NSD1;ETFBKMT;METTL21C
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.2873377528244916,0.7371459517203139,0.8137432188065099,0.9666040681340151,1.0,2/20,9.28%,AMPD3;PAICS
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.2574436687218097,-0.7365560605945837,0.8451327433628318,1.0,1.0,3/22,7.50%,PTPRJ;DGKZ;CEACAM1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.2919160812314157,0.7363794107528335,0.8050541516245487,0.9670473504119191,1.0,3/17,11.96%,EMC2;SGTA;EMC9
prerank,microtubule bundle formation (GO:0001578),-0.21387403069615477,-0.7361184092843489,0.9060052219321149,1.0,1.0,19/42,33.69%,RP1;MTCL1;AAAS;CFAP46;CFAP74;NCKAP5;SPAG16;TPPP;NAV1;CDK5RAP2;GAS2L1;TTLL3;DCX;CLIP1;KIF20A;PLK1;CFAP206;FOXJ1;CCDC40
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.30221587613734335,0.7359568231976598,0.7938342967244701,0.9670738053532939,1.0,6/15,23.91%,NYNRIN;SLFN14;ZC3H12B;RNASEH1;ZC3H12A;KHNYN
prerank,DNA replication (GO:0006260),0.20630723878967316,0.7359317351335055,0.9171511627906976,0.9665924353457944,1.0,18/105,15.69%,RBMS1;ORC5;WRN;TOP1;RAD50;POLA2;RFC1;POLG;REV1;MCMBP;BAZ1A;RPA3;MCM4;RBBP8;MCM6;RAD9A;ORC3;ORC4
prerank,cellular response to estrogen stimulus (GO:0071391),0.3080537768846168,0.7359198992167486,0.795880149812734,0.9660959617834713,1.0,4/14,19.37%,SFR1;TRIM24;RARA;ARID5A
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.3160831201053229,-0.7348240075644089,0.7815126050420168,1.0,1.0,7/10,29.48%,NOTCH1;PHACTR4;LRP6;DLL4;BMP5;SOX11;TBX20
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.25554515827435814,0.7344651239155017,0.8585526315789473,0.9675244688899692,1.0,5/33,11.97%,IL34;IL23R;HAX1;ACIN1;CSF1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.19788247750425295,-0.7341965585348322,0.9307479224376731,1.0,1.0,20/62,28.61%,TPT1;ARHGEF2;AKT1;PINK1;CCAR2;CXCL12;PTTG1IP;PLAUR;PPIA;PARK7;ENO1;NOC2L;NDUFA13;EPO;DNAJA1;CREB3L1;HERPUD1;CLU;HSPB1;VNN1
prerank,cellular response to interleukin-12 (GO:0071349),-0.2108017950384419,-0.7339886434911197,0.9259259259259259,1.0,1.0,14/48,24.01%,PLCB1;PITPNA;RPLP0;TALDO1;PPIA;HNRNPF;SOD1;CFL1;AIP;LCP1;GSTO1;MIF;MTAP;IL12RB2
prerank,negative regulation of RNA metabolic process (GO:0051253),0.28597369169705655,0.7337073795535304,0.8190954773869347,0.9679920819557162,1.0,2/18,3.92%,PTBP3;TERT
prerank,detection of visible light (GO:0009584),0.29878777097062403,0.7332938680019866,0.7801556420233463,0.9680018533266015,1.0,1/16,2.04%,ABCA4
prerank,interstrand cross-link repair (GO:0036297),0.23035382584481498,0.7321187308102307,0.8571428571428571,0.969033859461116,1.0,8/53,12.02%,NUCKS1;SLX4;RPA3;FANCM;DCLRE1A;CENPX;RFWD3;FANCE
prerank,regulation of DNA recombination (GO:0000018),0.2541863931104481,0.7320852927706107,0.8472222222222222,0.9685607697371663,1.0,13/32,24.40%,RAD50;SPIDR;PPP4R2;FIGNL1;SHLD2;KDM1A;IL7R;SETD2;PPP4C;RTEL1;MSH2;ZCWPW1;ZRANB3
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.22501387919033367,-0.7314821537285643,0.8870192307692307,1.0,1.0,15/33,30.99%,MRE11;HSP90AB1;TERF1;HSP90AA1;CDK2;RAD51;ANKRD28;TINF2;WRAP53;PPP6C;ZBTB48;STN1;NOP10;DCLRE1B;PIF1
prerank,cell projection assembly (GO:0030031),0.2745146639902438,0.7313866405910081,0.8123953098827471,0.9689080159407167,1.0,2/22,2.16%,PARVA;QRICH2
prerank,negative regulation of cellular component organization (GO:0051129),0.21695030780098065,0.731029907892567,0.9086892488954345,0.968870606055692,1.0,6/74,7.85%,BMP6;APOA2;EPHA3;PRKCZ;GSK3B;OPRD1
prerank,regulation of TORC1 signaling (GO:1903432),-0.23150811857942288,-0.7303900770666323,0.8877551020408163,1.0,1.0,9/33,18.18%,GPR137C;SESN3;STK11;SMCR8;RRAGB;ATM;SPAAR;RRAGC;PIP4P1
prerank,regulation of ATP metabolic process (GO:1903578),0.22825289375092894,0.7293093108295231,0.8520249221183801,0.9706328840189301,1.0,15/54,25.60%,PRKAG2;RANBP2;TPR;JMJD8;POM121;NUP37;ATP5IF1;UQCC2;NUP85;SPHK2;HIF1A;COX7A2L;NUP107;NUP160;PRKAG1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2359049956188835,0.7292478484503189,0.8578125,0.970196213746461,1.0,8/48,15.23%,IKBKE;BCL2;MCL1;BAX;BCL2L1;EPHA2;HIC1;PML
prerank,positive regulation of immunoglobulin production (GO:0002639),0.2559789371876469,0.7289725417135868,0.8393162393162393,0.9700582489227447,1.0,8/31,20.47%,RBP4;IL6;PHB2;SHLD2;KMT5C;RIF1;KMT5B;XBP1
prerank,protein heterotetramerization (GO:0051290),-0.29346242117629695,-0.7289632095118292,0.8624229979466119,1.0,1.0,4/13,21.72%,GRIN2B;GRIN1;HSD17B8;FARSB
prerank,"phototransduction, visible light (GO:0007603)",0.30187838529329625,0.72889606919352,0.805607476635514,0.9696358004057821,1.0,1/14,2.04%,ABCA4
prerank,positive regulation of phospholipid transport (GO:2001140),-0.3102368769881915,-0.728267843780626,0.8255578093306288,1.0,1.0,4/10,18.22%,ABCA3;PRELID1;TMEM30A;ABCB4
prerank,negative regulation of type I interferon production (GO:0032480),0.240693660250124,0.7282607032287609,0.8631051752921536,0.969951893054708,1.0,11/40,23.50%,IKBKE;RNF216;PPM1B;NLRX1;TBK1;IFIH1;RNF135;PCBP2;REL;OTUD5;TAX1BP1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.26747415413406395,-0.7275810757451544,0.8466666666666667,1.0,1.0,3/18,9.96%,PIK3R1;BAG6;USP13
prerank,Rap protein signal transduction (GO:0032486),0.33007347354647487,0.7273693225627411,0.7946257197696737,0.9705421578545811,1.0,6/10,26.51%,RAP2C;RAP2B;RAPGEF3;RAP2A;RAPGEF1;RAP1B
prerank,synaptic vesicle transport (GO:0048489),0.3175622955980944,0.7270475549193324,0.7926356589147286,0.9704358198390045,1.0,3/11,11.94%,TMEM230;KIF5B;SPG11
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.18411290334196123,0.726712424180993,0.9828220858895705,0.9703626447412528,1.0,57/264,18.91%,GEMIN4;POLR2D;PCF11;PRCC;RBM41;SNRPA1;ZRSR2;SRRM2;NOVA1;SNIP1;HNRNPH1;HNRNPC;RBMX2;SF3B3;DDX23;SLU7;CWF19L1;RNPC3;PSPC1;SNRNP27;POLR2C;SRSF4;PRPF38A;DHX16;HNRNPH3;DHX8;MAGOHB;SF3B6;SRPK1;ZMAT5;STRAP;RBM6;RBM5;DDX39A;PRPF19;GEMIN5;POLR2F;FUS;RBM15;PABPN1;RBM14;CSTF3;CCAR1;SRSF5;TGS1;HNRNPR;HNRNPA2B1;CDK13;TXNL4A;CTNNBL1;CWC22;SCAF11;WBP4;PCBP2;SNRNP40;PRPF3;USP39
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.30213923449216834,-0.7263215180689825,0.8280922431865828,1.0,1.0,9/12,42.53%,KAT7;WRNIP1;BLM;WDR18;TICRR;NBN;METTL4;NUGGC;CDT1
prerank,regulation of protein localization to cell surface (GO:2000008),0.251004592066325,0.725884437299489,0.866779089376054,0.9708846591986549,1.0,8/33,17.63%,LEPROT;ACTN2;GPD1L;HFE;BDNF;TM9SF4;GBF1;ABCA7
prerank,protein palmitoylation (GO:0018345),-0.22730827354053124,-0.7255414878307027,0.893719806763285,1.0,1.0,13/30,32.40%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;ZDHHC5;SELENOK;ZDHHC4;GOLGA7B;ZDHHC13;GOLGA7
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.22816413525319004,0.7254253857890915,0.8822605965463108,0.970964537899836,1.0,5/54,6.40%,CFLAR;CASP4;BIRC3;CPNE1;PTPN2
prerank,RNA 3'-end processing (GO:0031123),-0.18967110883380792,-0.7253185137895551,0.954954954954955,1.0,1.0,20/69,23.52%,LIN28B;CSTF2;RPRD1A;CPSF2;SRSF2;SYMPK;SRSF1;ZC3H11A;THOC2;MTPAP;CSTF2T;RNPS1;POLDIP3;SRSF9;TENT4A;CHTOP;SRSF6;CDC40;CPSF3;U2AF1
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.2600626504603506,-0.7249369755540868,0.8680851063829788,1.0,1.0,7/19,23.94%,PINK1;HDAC6;VDAC1;PARK7;CAMKK2;FZD5;HTT
prerank,regulation of DNA binding (GO:0051101),0.2384585528752903,0.7247252436589315,0.8856152512998267,0.9713505975708917,1.0,6/44,11.50%,SP100;FOXC1;CPNE1;SKI;SUMO1;HJURP
prerank,cellular response to ionizing radiation (GO:0071479),0.23141608635947647,0.7247213466038345,0.8719512195121951,0.9708421592047819,1.0,12/47,18.31%,PRAP1;NUCKS1;WRN;SPIDR;YAP1;TLK2;MAPK14;RAD9A;FIGNL1;NIPBL;CLOCK;KDM1A
prerank,autophagosome organization (GO:1905037),-0.20503116670100882,-0.7244330014333307,0.9065656565656566,1.0,1.0,17/50,28.30%,GABARAP;GABARAPL1;NSFL1C;ATG16L1;ATG9A;TP53INP2;VMP1;ULK1;ATP2A2;IRGM;RAB1B;PIK3C3;WDR45;ULK3;UBXN2B;MAP1LC3B;STX12
prerank,glial cell development (GO:0021782),-0.24219907119870282,-0.7233446277277883,0.8716049382716049,1.0,1.0,10/25,31.95%,CDK6;EIF2B2;TPPP;DLL1;CSPG5;SOX11;PICK1;PRDM8;MT3;S100A9
prerank,DNA conformation change (GO:0071103),0.2895572122491992,0.7229516729085811,0.8121645796064401,0.9725587779530648,1.0,3/17,14.37%,TOP1;TOP2B;KAT6A
prerank,regulation of autophagosome maturation (GO:1901096),-0.29041669262931846,-0.7226875412808614,0.816414686825054,1.0,1.0,5/13,23.08%,SMCR8;ADRB2;IRGM;UBQLN4;CLN3
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.23205929480946272,-0.7215460813356357,0.8829268292682927,1.0,1.0,13/29,34.49%,NPM1;CENPU;CENPT;CENPL;CENPQ;CENPN;MIS18BP1;CENPA;RBBP7;ITGB3BP;OIP5;CENPW;KNL1
prerank,CENP-A containing chromatin organization (GO:0061641),-0.23205929480946272,-0.7215460813356357,0.8829268292682927,1.0,1.0,13/29,34.49%,NPM1;CENPU;CENPT;CENPL;CENPQ;CENPN;MIS18BP1;CENPA;RBBP7;ITGB3BP;OIP5;CENPW;KNL1
prerank,sensory perception of chemical stimulus (GO:0007606),0.29910899251539214,0.7207217907456287,0.7755102040816326,0.974827495828311,1.0,1/15,2.40%,BEST2
prerank,protein modification by small protein removal (GO:0070646),0.18265120532580004,0.72014756802806,0.9873577749683944,0.9749899837177665,1.0,55/252,19.89%,SMAD3;USP18;SMURF2;SENP7;INO80D;TGFBR1;SIAH2;BIRC3;USP9X;USP24;USP27X;STAMBP;PSMB10;PSMA7;USP47;PSMA3;PSME4;USP8;PSMA5;STAMBPL1;KEAP1;MYSM1;ATXN7;SMAD4;SENP6;ACTL6A;USP40;MAP3K7;SENP3;SENP1;USP34;USP36;MDM4;USP35;UIMC1;IFIH1;SMAD2;KAT2B;ASXL2;USP12;INO80E;USP45;USP15;INO80C;TNIP1;RHOT1;JOSD1;USP32;USP10;USP4;ACTR8;BRCC3;TAB1;INO80;USP7
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.3206202112561103,0.7201120065499306,0.7945205479452054,0.9745197831113191,1.0,2/10,10.63%,ACTN2;PLEK
prerank,response to acidic pH (GO:0010447),-0.2872686500667229,-0.7200423180591575,0.8117408906882592,1.0,1.0,3/13,14.85%,LGMN;CTSS;RAB11FIP5
prerank,sulfur compound catabolic process (GO:0044273),-0.21471150638621905,-0.7194653795240076,0.9049881235154394,1.0,1.0,12/38,24.73%,CSPG4;HEXB;GGT5;TXN2;GGT7;CTH;ADO;GGT1;MPST;LUM;CSPG5;IDS
prerank,ncRNA catabolic process (GO:0034661),0.25968787233274726,0.7194333663942386,0.8505942275042445,0.9748292577844532,1.0,10/28,21.40%,TUT4;SND1;XRN1;DIS3L;ERN2;SLFN14;DIS3;EXOSC10;PARN;TENT4B
prerank,regulation of dephosphorylation (GO:0035303),0.29697895312874995,0.7191289499151661,0.8248175182481752,0.9746930280482369,1.0,5/15,13.52%,MTMR3;PPP1R16A;SMG5;SMG6;SMG7
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.2923119908826328,0.7180883262315008,0.8229571984435797,0.9754703363197561,1.0,2/15,13.40%,ANXA1;NR3C1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.18930062598224776,-0.718003722104718,0.9628571428571429,1.0,1.0,18/65,23.73%,PSMC3;PSMD3;PSMD14;PSMD6;PSMD4;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;CHEK1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;SKP1;PSMD8
prerank,regulation of Golgi organization (GO:1903358),0.28282019326682284,0.7177503107108575,0.7979094076655052,0.9753765055398644,1.0,5/17,19.09%,ARMH3;MAP2K1;RAB33B;MYO5A;USP6NL
prerank,glutamine family amino acid catabolic process (GO:0009065),0.29872196349029395,0.7171714727079415,0.8,0.975546400168462,1.0,3/13,8.68%,NOS2;ALDH4A1;GLUL
prerank,regulation of store-operated calcium entry (GO:2001256),-0.3090171398560946,-0.7169066272122662,0.8645418326693227,1.0,1.0,5/10,24.85%,HOMER1;CD84;SLC8B1;CASQ1;HOMER2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.29112608956812835,-0.7166944070076139,0.8359683794466403,1.0,1.0,6/11,38.88%,NOTCH4;TNRC6C;EIF6;ZFP36;AGO4;TRIM71
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.29112608956812835,-0.7166944070076139,0.8359683794466403,1.0,1.0,6/11,38.88%,NOTCH4;TNRC6C;EIF6;ZFP36;AGO4;TRIM71
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.27368495587156666,-0.7165668962195948,0.8428874734607219,1.0,1.0,6/15,36.26%,SEL1L;HERPUD1;SEC61B;UFD1;AUP1;DERL1
prerank,alcohol catabolic process (GO:0046164),0.3189008867476719,0.7159357840620643,0.8111753371868978,0.9765286255721166,1.0,1/10,3.20%,CYP27A1
prerank,epithelial cell development (GO:0002064),-0.2556349739127577,-0.71581647600945,0.8473804100227791,1.0,1.0,5/20,16.25%,ACTA2;RILPL2;SLC4A7;SIPA1L3;EXPH5
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.2385090166576725,-0.7142603943234003,0.8919540229885058,1.0,1.0,5/25,16.60%,DOT1L;H1-0;HEY1;PARK7;PER2
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.2897732869653191,-0.7138827791579524,0.821656050955414,1.0,1.0,2/12,7.23%,MBTPS1;KPNB1
prerank,protein kinase A signaling (GO:0010737),0.3152807120766906,0.7137374013203515,0.826,0.9787046338920373,1.0,1/12,2.94%,TCP11X2
prerank,mRNA export from nucleus (GO:0006406),0.20302435110922668,0.7133534475043266,0.9478138222849083,0.9786497603467946,1.0,28/102,22.09%,NXF2;POLR2D;RANBP2;TPR;SLU7;IWS1;SRSF4;SMG5;SMG6;MAGOHB;SMG7;DDX39A;THOC5;POM121;PABPN1;SRSF5;NUP37;HNRNPA2B1;SMG1;DDX19B;SLBP;AGFG1;WDR33;UPF2;NUP85;DDX19A;SRSF3;SRSF11
prerank,lysosome organization (GO:0007040),0.23844210030071586,0.7131521770348676,0.9039735099337748,0.9783932876622673,1.0,6/36,12.46%,CLN5;LRRK2;HPS1;TMEM165;ABCA1;ARSB
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.3250945688678465,0.7128609911218317,0.8407258064516129,0.9782301856679253,1.0,2/10,7.03%,STAT1;TGFBR2
prerank,regulation of gene silencing by RNA (GO:0060966),0.2300268280823648,0.7127744342266491,0.8727569331158238,0.977314780618517,1.0,11/50,20.22%,POLR2D;RANBP2;TPR;TNRC6A;POLR2C;POLR2F;POM121;NUP37;PUM2;POLR2K;NUP85
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2300268280823648,0.7127744342266491,0.8727569331158238,0.977314780618517,1.0,11/50,20.22%,POLR2D;RANBP2;TPR;TNRC6A;POLR2C;POLR2F;POM121;NUP37;PUM2;POLR2K;NUP85
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.22964135354154944,-0.7126724400380287,0.8888888888888888,1.0,1.0,10/28,28.73%,CTSC;PSMC3;DAB2IP;TMTC3;CCDC22;PSMC6;PSMC5;TREM2;CLU;LAPTM5
prerank,negative regulation of histone methylation (GO:0031061),0.3215871550043612,0.7126471557287742,0.814,0.9769492195930565,1.0,4/10,20.54%,BCOR;JARID2;KDM1A;PHF1
prerank,protein acylation (GO:0043543),-0.2131437856896503,-0.7121317162559677,0.9125964010282777,1.0,1.0,12/38,25.03%,FOXO1;ZDHHC14;ZDHHC20;ZDHHC2;NAA10;ZDHHC7;KAT2A;ZDHHC23;ZDHHC9;ING4;ZDHHC5;SELENOK
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2518802918549186,-0.7115991783464541,0.8805309734513275,1.0,1.0,4/19,20.96%,SOD1;PARK7;MAOB;PRDX2
prerank,regulation of G0 to G1 transition (GO:0070316),0.23884315871255724,0.7113058670549971,0.8774834437086093,0.978006244422513,1.0,13/38,23.79%,SUZ12;UXT;MGA;CDKN2B;EPC1;RBBP8;RNF2;RING1;BMI1;PCGF2;APAF1;TFDP2;EHMT2
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.20055642789522812,-0.7112999513162476,0.944,1.0,1.0,11/51,18.34%,PRKCQ;NEK7;CTNNB1;MAPK3;TERF1;GNL3L;ATM;PNKP;CCT5;PKIB;TINF2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.2666502033866191,-0.7111342791323747,0.8733905579399142,1.0,1.0,5/17,23.34%,NOS1AP;KCNQ1;KCNE4;GJA5;SCN1B
prerank,negative regulation of T cell activation (GO:0050868),0.24204635109801717,0.7107428047311561,0.8697123519458545,0.9781871454369885,1.0,4/35,8.19%,TNFAIP8L2;PTPN22;FOXP3;CD274
prerank,melanosome localization (GO:0032400),-0.23955085040351892,-0.7103909805977533,0.868421052631579,1.0,1.0,5/21,17.09%,RAB27A;RAB27B;VPS33B;MLPH;BBS2
prerank,lymphocyte proliferation (GO:0046651),0.2655616090610264,0.7103810437594393,0.8315412186379928,0.9781082932434719,1.0,4/22,12.19%,CTPS1;BCL2;ELF4;PPP3CB
prerank,regulation of gluconeogenesis (GO:0006111),-0.23217942590104756,-0.7094616099953884,0.8905109489051095,1.0,1.0,8/27,28.70%,C1QTNF3;SIK1;PGP;NNMT;SIRT7;ZNF692;DGKQ;GNMT
prerank,defense response to fungus (GO:0050832),-0.2626043564083058,-0.7092607272149519,0.867237687366167,1.0,1.0,1/17,1.59%,PLCG2
prerank,neuron remodeling (GO:0016322),-0.2985080655320801,-0.7091195171010076,0.8533057851239669,1.0,1.0,1/10,0.83%,ADGRB3
prerank,regulation of mitochondrial translation (GO:0070129),-0.24666838013032075,-0.7090097226584754,0.8678038379530917,1.0,1.0,9/21,32.25%,FASTKD2;C1QBP;MALSU1;SHMT2;RCC1L;TRMT10C;RPUSD3;MPV17L2;COA3
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.25169222386517176,-0.7087325368508597,0.8689320388349514,1.0,1.0,7/18,28.40%,MAF1;ATF4;SIRT7;HEATR1;RASL11A;LYAR;WDR75
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.29574460705202965,0.7086058964550226,0.8326923076923077,0.9796763121994774,1.0,4/14,12.86%,IL34;PTK2;CSF1;RARRES2
prerank,ncRNA 3'-end processing (GO:0043628),-0.27965019277282077,-0.7080049673408948,0.8438133874239351,1.0,1.0,7/14,29.93%,INTS7;INTS6L;INTS12;ERI1;TOE1;INTS5;INTS2
prerank,cellular protein-containing complex assembly (GO:0034622),0.18643153201459214,0.706837165405694,0.9773635153129161,0.981217735450774,1.0,24/159,16.04%,TCF4;SMAD3;WNT3A;ANGPT1;PSMG1;TPR;PIK3C2A;POGZ;DNAAF1;SNX9;UVRAG;DNAI4;SMAD4;FCHO2;AHCTF1;DRC1;CHMP3;NCK1;RTN4;CHMP4A;CHMP4B;SMAD2;SRP19;TBCA
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.22751533475047314,-0.7059809619604905,0.8955223880597015,1.0,1.0,7/29,17.77%,THBS1;RET;CAV1;CYLD;DEDD2;LTBR;PYCARD
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.291695436570209,-0.7046535430430659,0.8351409978308026,1.0,1.0,11/11,70.86%,PRDX2;PRDX5;GPX1;GPX3;PRDX4;PXDNL;MPO;PRDX1;CAT;PRDX3;PXDN
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.260289994382355,-0.7046442501852183,0.873015873015873,1.0,1.0,2/16,8.87%,GPR137C;RRAGB
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.2990392890261084,0.7027703661912389,0.8254620123203286,0.9853486329502726,1.0,4/12,17.68%,PLA2G6;PPP3CB;BAIAP3;C2CD2L
prerank,positive regulation of ion transport (GO:0043270),0.22933196251523763,0.7025893875693765,0.9077429983525536,0.9850234773664774,1.0,17/48,24.67%,ACTN2;SCN3B;KIF5B;DLG1;GPD1L;STIM2;ANO6;ATP2B1;ADRA2A;P2RX4;GDNF;ANK2;VAMP7;CNKSR3;WNK3;SCN4B;SCN5A
prerank,acyl-CoA metabolic process (GO:0006637),-0.21625338677060202,-0.70224765462118,0.9423076923076923,1.0,1.0,8/35,20.52%,HMGCS1;HMGCS2;SUCLA2;ACACA;ACBD6;ACOT2;MCEE;ACSF2
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.2921252680784092,-0.7015907321110775,0.841541755888651,1.0,1.0,2/11,6.66%,TGFB2;BMP4
prerank,postreplication repair (GO:0006301),0.22806268014905579,0.7011501051275284,0.9218241042345277,0.9861100896228276,1.0,6/45,11.06%,POLH;RFC1;PARP10;REV1;RPA3;UBE2V1
prerank,negative regulation of B cell activation (GO:0050869),0.2641431231333957,0.7010691323371407,0.8511029411764706,0.9856826961334002,1.0,2/21,4.82%,RC3H1;PARP3
prerank,ureteric bud morphogenesis (GO:0060675),-0.2644119305695972,-0.7010082907787947,0.8599562363238512,1.0,1.0,4/16,11.79%,SIX1;BMP4;PAX2;FGF2
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.2872385172951533,-0.7009185515198743,0.864476386036961,1.0,1.0,6/12,32.99%,CTNNB1;DDX11;RAD21;CTCF;FEN1;BUB1
prerank,regulation of cholesterol storage (GO:0010885),0.28908163971884493,0.7004577735717488,0.8422053231939164,0.9858161751808519,1.0,3/15,11.23%,NR1H3;PPARA;ABCA1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.2342182494649199,-0.7002302260164461,0.8949771689497716,1.0,1.0,9/25,30.47%,MFF;PINK1;PLAUR;BMF;PYCARD;BAD;HRK;PMAIP1;TP53
prerank,positive regulation of catalytic activity (GO:0043085),0.234749014049834,0.6996110314173584,0.8905723905723906,0.9862201892477196,1.0,6/37,10.62%,NHEJ1;WRN;AZIN2;IGF2;XRCC4;MAPK14
prerank,cellular protein catabolic process (GO:0044257),0.21660442711823608,0.6992622340346175,0.9211309523809523,0.9860847477208116,1.0,9/59,12.85%,ADAMTS12;SPATA18;SIAH2;CTSH;AFG1L;CTSW;CLPX;ADAMTS7;TCIRG1
prerank,negative regulation of cell cycle process (GO:0010948),0.21485546068807237,0.6992016446162702,0.9315068493150684,0.9856435427491588,1.0,19/61,24.33%,SUZ12;BMP7;UXT;MGA;NANOS2;ESPL1;EPC1;RBBP8;TOM1L2;RNF2;RING1;BMI1;TOM1L1;PCGF2;APAF1;TFDP2;NME6;EHMT2;VPS4A
prerank,intestinal absorption (GO:0050892),-0.27444882462059894,-0.6983462708744798,0.8571428571428571,1.0,1.0,5/13,28.08%,KCNQ1;TJP2;F11R;UGCG;SLC2A2
prerank,regulation of T cell migration (GO:2000404),0.2780439488031259,0.6976214485693836,0.8696461824953445,0.9868390147872966,1.0,2/18,8.14%,CXCL10;TNFRSF14
prerank,mRNA processing (GO:0006397),0.17461620918886891,0.6971721635296749,0.992744860943168,0.9868321845931797,1.0,59/287,18.91%,POLR2D;PCF11;PRCC;RBM41;RPRD2;SNRPA1;ZRSR2;SRRM2;NOVA1;SNIP1;HNRNPH1;HNRNPC;RBMX2;CCNH;SF3B3;DDX23;SLU7;MNAT1;CDK7;CWF19L1;RNPC3;PSPC1;SNRNP27;POLR2C;SRSF4;PRPF38A;DHX16;HNRNPH3;DHX8;MAGOHB;SF3B6;ZMAT5;RBM6;RBM5;DDX39A;PRPF19;THOC5;GEMIN5;POLR2F;FUS;GTF2H4;RBM15;PABPN1;RBM14;CSTF3;CCAR1;SRSF5;HNRNPR;HNRNPA2B1;TXNL4A;CTNNBL1;CWC22;GTF2H2;SCAF11;WBP4;PCBP2;SNRNP40;PRPF3;USP39
prerank,regulation of telomere maintenance (GO:0032204),0.25135741155147573,0.6970893031475582,0.8836065573770492,0.9864074866379768,1.0,10/26,24.00%,RAD50;SMG5;SMG6;PML;ERCC1;SMG1;DHX36;USP7;RTEL1;ATRX
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.3008859455111616,0.6970575467040566,0.8261682242990654,0.9859320970387888,1.0,2/11,9.13%,NRP1;MST1R
prerank,purine nucleotide catabolic process (GO:0006195),-0.2736532210899791,-0.696842620711547,0.8568421052631578,1.0,1.0,3/13,15.04%,HINT1;PNP;NT5C2
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.26840056169088344,-0.6965270524631703,0.873589164785553,1.0,1.0,3/15,19.38%,CPEB2;GSTO2;GSTO1
prerank,regulation of cytoplasmic transport (GO:1903649),0.3035968146338073,0.6959314900203448,0.8448598130841122,0.9866381816538725,1.0,4/11,19.89%,LRRK2;MAP2K1;CHMP3;USP7
prerank,nuclear pore organization (GO:0006999),0.2920652972464957,0.6958116190892643,0.8440860215053764,0.9862572301422277,1.0,3/14,14.10%,TPR;AHCTF1;RTN4
prerank,positive regulation of cellular respiration (GO:1901857),0.3091652195612862,0.6958070466404804,0.8147410358565738,0.9857533385477331,1.0,2/11,10.99%,NUPR1;IFNLR1
prerank,sister chromatid segregation (GO:0000819),0.23853650499107154,0.6954675316201038,0.8758741258741258,0.9856051276823575,1.0,4/31,9.68%,KLHL22;TOP2B;ESPL1;ZWINT
prerank,cellular response to interleukin-15 (GO:0071350),-0.2794254165325886,-0.6950695662159733,0.8502202643171806,1.0,1.0,1/13,0.94%,PLCB1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.2794254165325886,-0.6950695662159733,0.8502202643171806,1.0,1.0,1/13,0.94%,PLCB1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.2768801542772359,0.6949157701056189,0.8493647912885662,0.985693384270972,1.0,6/18,22.24%,POR;GDNF;ABL2;SIRT3;AGT;PDP2
prerank,RNA transport (GO:0050658),0.20830975035464222,0.694654254870171,0.9332321699544764,0.9854802530892927,1.0,13/71,17.52%,SIDT1;NXF2;TPR;TGFBR2;SLU7;SRSF4;MAGOHB;DDX39A;THOC5;POM121;SRSF5;HNRNPA2B1;SLBP
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.31162180064541645,0.694286939888886,0.820040899795501,0.9853677222490258,1.0,2/11,11.08%,PPARA;TRAP1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.19280553867041125,0.6942230125992321,0.9696092619392185,0.98493264256274,1.0,16/113,12.05%,ASAP1;CDH5;TLR4;UNC13B;CUL4A;GBP5;SPIDR;GSK3B;BAX;SLF2;SUMO1;RPA3;PLEK;FNIP1;ABCA1;RHOC
prerank,regulation of mitotic spindle assembly (GO:1901673),0.2662599325491878,0.6941903001984832,0.8541666666666666,0.9844561873756867,1.0,5/19,20.14%,TPR;CHMP3;CHMP4B;EML3;CHMP5
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.17589199445716458,0.6941725248983659,0.9926108374384236,0.9839656174376114,1.0,51/241,18.91%,POLR2D;PCF11;PRCC;RBM41;SNRPA1;ZRSR2;SRRM2;NOVA1;SNIP1;HNRNPH1;HNRNPC;RBMX2;SF3B3;DDX23;SLU7;CWF19L1;RNPC3;PSPC1;SNRNP27;POLR2C;SRSF4;PRPF38A;DHX16;HNRNPH3;DHX8;MAGOHB;SF3B6;ZMAT5;RBM6;RBM5;DDX39A;PRPF19;GEMIN5;POLR2F;FUS;RBM15;PABPN1;RBM14;CSTF3;CCAR1;SRSF5;HNRNPR;HNRNPA2B1;TXNL4A;CTNNBL1;CWC22;WBP4;PCBP2;SNRNP40;PRPF3;USP39
prerank,regulation of cell cycle process (GO:0010564),-0.16970605353468182,-0.6940807617902951,0.9931972789115646,1.0,1.0,26/104,22.68%,CALM1;CALM2;CTNNB1;RAB11FIP3;CALM3;YTHDF2;DYNC1H1;CAV2;CCDC8;BORA;CEP85;PLK4;RMI2;PRC1;RAB11FIP4;ECT2;CHEK1;L3MBTL1;KNSTRN;SPAG5;PIK3C3;MKI67;PRMT5;MAD1L1;DCUN1D3;RACGAP1
prerank,endocytic recycling (GO:0032456),0.22193903845491703,0.6940205518068866,0.9246467817896389,0.9836255614809387,1.0,8/50,12.21%,TRARG1;SNX12;VPS35L;DENND1A;ACAP2;MICALL1;ENTR1;SNX27
prerank,cellular response to ATP (GO:0071318),0.2989571686876114,0.6939746547553143,0.8277153558052435,0.983171142822522,1.0,6/14,24.46%,SSH1;CIB2;P2RY1;P2RX4;TAF1;P2RX3
prerank,COPII-coated vesicle budding (GO:0090114),-0.18380068529657856,-0.6936116112140756,0.9457831325301205,1.0,1.0,17/68,21.67%,GRIA1;NSF;CTSC;CSNK1D;TMED2;TRAPPC4;CNIH1;NAPA;LMAN1;ANKRD28;TRAPPC6B;RAB1B;SAR1B;COL7A1;TRAPPC3;SEC22B;PPP6C
prerank,hexose metabolic process (GO:0019318),0.22800454034884174,0.6935609893445746,0.9041322314049587,0.9831104338350785,1.0,9/39,20.45%,CHST15;GALK2;FPGT;SLC37A4;KHK;HK1;PGM1;GALM;SORD
prerank,telomere maintenance via telomerase (GO:0007004),-0.22222120871381046,-0.6933816089450157,0.8990610328638498,1.0,1.0,9/28,21.67%,MRE11;HSP90AB1;TERF1;HSP90AA1;CDK2;ANKRD28;TINF2;WRAP53;PPP6C
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.20488473115530412,0.6932158148031904,0.9476831091180867,0.9829754011899672,1.0,6/80,7.52%,VPS54;DENND2A;SNX6;HEATR5A;SNX12;CLN5
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.23551195501601904,0.6931212637652073,0.8974358974358975,0.98258782507661,1.0,8/37,17.92%,CUL4A;RFC1;NTHL1;RPA3;GTF2H4;ERCC5;ERCC1;GTF2H2
prerank,protein maturation (GO:0051604),-0.17511416711959069,-0.6926097340425719,0.9835526315789473,1.0,1.0,23/95,23.08%,CPE;F3;PCSK2;SORL1;TSPAN14;ECE1;MMP16;CPD;CTSS;NAA50;TASP1;PCSK7;PHEX;NNAT;NAA10;MMS19;PSENEN;ADAMTS3;TSPAN33;PCSK5;CPXM1;CPZ;CLN3
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.29130548518139104,-0.6925912378738291,0.8497854077253219,1.0,1.0,2/10,20.53%,ASRGL1;KYNU
prerank,vitamin D metabolic process (GO:0042359),-0.2765286069734677,-0.6924018803162584,0.8433734939759037,1.0,1.0,8/13,46.89%,LGMN;CYP2R1;VDR;GC;CYP1A1;CYP24A1;FGF23;CYP27B1
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.25159737064651416,-0.6922686372652499,0.8778280542986425,1.0,1.0,9/17,40.31%,HDAC9;SORT1;LPL;PCSK5;NR1H2;LIPC;FURIN;APOH;PCSK6
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.2541845381054197,0.6922361684294017,0.8775510204081632,0.9829758777259752,1.0,3/21,9.68%,KLHL22;TPR;ZWINT
prerank,autophagy of peroxisome (GO:0030242),-0.2776528070924352,-0.691060950292847,0.8613445378151261,1.0,1.0,4/12,30.55%,ATM;PIK3C3;MAP1LC3B;SQSTM1
prerank,methylguanosine-cap decapping (GO:0110156),0.31396352253544524,0.6901979496000656,0.8120437956204379,0.9846100891932794,1.0,2/10,7.58%,DCP2;LSM1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.29065960347137637,-0.6896304849644104,0.8598326359832636,1.0,1.0,5/10,26.07%,ABCA3;MFSD2A;MTMR2;MTMR1;MTMR9
prerank,tRNA modification (GO:0006400),-0.1850019283763254,-0.6885866295656135,0.9536231884057971,1.0,1.0,23/62,34.43%,PUS7;TRMT13;THUMPD1;ELP5;QTRT2;PUS3;DTWD2;WDR4;TYW5;CDKAL1;TRMT9B;TRMT6;TRUB1;PUSL1;ADAT2;CTU2;TRMT61A;THUMPD2;ALKBH8;TRMT10A;BCDIN3D;TPRKB;THG1L
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.29628178987835085,-0.6883352980166735,0.8561946902654868,1.0,1.0,6/10,36.05%,WIZ;E2F7;E2F8;DBF4;SSBP1;CDC7
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.2553780646324474,0.6879034519448398,0.8805460750853242,0.9854671108567238,1.0,3/20,9.68%,KLHL22;TPR;ZWINT
prerank,spindle assembly checkpoint signaling (GO:0071173),0.2553780646324474,0.6879034519448398,0.8805460750853242,0.9854671108567238,1.0,3/20,9.68%,KLHL22;TPR;ZWINT
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.2553780646324474,0.6879034519448398,0.8805460750853242,0.9854671108567238,1.0,3/20,9.68%,KLHL22;TPR;ZWINT
prerank,nucleosome assembly (GO:0006334),-0.2187510375274928,-0.6874967716435718,0.9287356321839081,1.0,1.0,6/31,15.36%,H3-3A;NPM1;SART3;ASF1A;ANP32B;SPTY2D1
prerank,regulation of coagulation (GO:0050818),-0.2811509680955522,-0.6868489499327738,0.8622881355932204,1.0,1.0,2/11,11.76%,HS3ST5;CAV1
prerank,response to reactive oxygen species (GO:0000302),0.21188529671260886,0.6856351446520361,0.9355877616747182,0.9872063738596889,1.0,5/54,8.78%,PDGFRA;FER;TPM1;MPV17;STK24
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.19995847867874614,0.6853440990503785,0.9402985074626866,0.9869942140601489,1.0,20/78,23.32%,NR2F2;LATS2;CCND3;CDKN2B;CCNH;MNAT1;CDK7;IPO7;PSRC1;PKD2;CDKN3;MAPRE3;CCNY;CCNG2;PKMYT1;PTEN;CDK5RAP3;PKD1;HEXIM1;CEBPA
prerank,positive regulation of ATPase activity (GO:0032781),-0.2055559946625968,-0.6852961229128469,0.947103274559194,1.0,1.0,18/41,35.85%,ATP1B1;RYR2;MSH3;VMP1;DYNLL2;AHSA1;PFN2;CHTOP;TOR1AIP2;PFN1;UHRF1;FGF10;MYL4;DNAJB11;ATP1B3;GABARAPL2;SSBP1;ALDOB
prerank,regulation of endocytic recycling (GO:2001135),-0.2846923596936194,-0.6852951025898892,0.8731501057082452,1.0,1.0,2/11,11.17%,SORL1;ARHGAP1
prerank,negative regulation of histone modification (GO:0031057),0.27887546857096224,0.6847066856704332,0.8428030303030303,0.9871059614309114,1.0,3/14,9.99%,FOXP3;TAF7;JARID2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.27048447704803563,0.6846916981392343,0.8498168498168498,0.986611048651313,1.0,1/17,1.37%,FGF1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.23826504290335834,-0.6845468693685038,0.8797169811320755,1.0,1.0,13/21,39.19%,RCC2;NPM1;CCND1;ATAD5;CDK4;DTL;CDK1;DYRK3;VPS4B;CDC7;RAB11A;CCNB1;CDC25C
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.29935781741289147,0.6841803737234102,0.8397790055248618,0.9866134253646406,1.0,2/12,8.91%,MYCBP2;EPHA4
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.30192706044818296,0.6839652496132825,0.8258317025440313,0.9863210788616943,1.0,11/11,69.83%,PKD1L3;RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;PKD2L1;RTP3;LPO
prerank,RNA interference (GO:0016246),0.2662208136986445,0.6836542402539451,0.8599640933572711,0.9861428649095181,1.0,2/17,13.61%,TERT;TARBP2
prerank,regulation of T cell differentiation (GO:0045580),0.23365458388308719,0.6833049101798279,0.9111842105263158,0.9859997640755198,1.0,3/33,11.03%,ZMIZ1;FOXP3;TCF7
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.307600747905989,0.6830303355603411,0.8206106870229007,0.9857834912228457,1.0,3/10,11.91%,IRAK3;SH2B3;MAP2K5
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.2617619737686398,-0.6829452556652644,0.8726114649681529,1.0,1.0,9/14,36.59%,HNRNPA0;ANGEL2;MYD88;BOLL;ZFP36;YBX3;TARDBP;DAZL;TIRAP
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.25137448755673686,-0.6828888130484221,0.8823529411764706,1.0,1.0,3/18,14.73%,CCN3;KCNB1;INHBB
prerank,apoptotic mitochondrial changes (GO:0008637),0.2423162644875521,0.6828441109895418,0.9032258064516129,0.9854597612517081,1.0,5/32,11.25%,IFIT2;BCL2;BAX;DNM1L;BCL2L1
prerank,sensory organ development (GO:0007423),0.21779990900162455,0.6828313885935563,0.9238410596026491,0.9849699445266282,1.0,9/51,14.89%,FOXC1;SHROOM2;RBP4;MAB21L1;MAFB;PBX1;SH3PXD2B;SALL2;CHRDL1
prerank,macroautophagy (GO:0016236),0.18858562109987678,0.682448185238489,0.9770114942528736,0.9848386888015275,1.0,16/118,14.25%,PRKAG2;PRKAA2;DYNLL1;AMBRA1;LAMP2;MTMR3;UVRAG;SNX14;ATG12;TCIRG1;VPS16;PIP4K2B;CHMP3;CSNK2A2;CHMP4A;CHMP4B
prerank,regulation of response to stress (GO:0080134),-0.29996321230785195,-0.6816551766140144,0.8539094650205762,1.0,1.0,7/10,37.15%,OPRM1;MLC1;ADCY8;SLC38A2;EIF4G1;DYRK3;CRHBP
prerank,signal peptide processing (GO:0006465),-0.2844972277272671,-0.6813986507182039,0.8706365503080082,1.0,1.0,3/11,11.14%,SPCS2;SEC11C;SPCS1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.21009233028963797,0.6802813080344452,0.9375,0.98651836802308,1.0,17/58,20.43%,NHEJ1;RAD50;XRCC4;SUMO1;UVRAG;DCLRE1A;NSMCE2;KDM2A;PRPF19;ERCC6;UIMC1;ERCC1;SMARCAL1;RIF1;BRCC3;CYREN;ERCC8
prerank,mitotic cytokinetic process (GO:1902410),-0.23317421479100386,-0.67984198396207,0.9035874439461884,1.0,1.0,9/20,26.95%,CHMP1A;CHMP1B;CHMP2B;CHMP7;CNTROB;CHMP2A;CEP55;CHMP6;CHMP4C
prerank,cellular response to estradiol stimulus (GO:0071392),0.2692398871920007,0.6796552714672737,0.8628884826325411,0.9866043598507397,1.0,2/18,8.64%,NCOA3;FAM210B
prerank,sensory perception of pain (GO:0019233),-0.2333668793625081,-0.6784531281622055,0.9023861171366594,1.0,1.0,5/21,17.71%,OPRM1;SCN9A;KCNA2;CHRNA4;P2RX7
prerank,cellular response to amino acid stimulus (GO:0071230),-0.21054114820677897,-0.6783116895891954,0.9647887323943662,1.0,1.0,9/33,19.45%,SESN3;RRAGB;SPAAR;CPEB4;UBR1;RRAGC;GLRA2;GLRA1;LAMTOR2
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.2145529090726982,-0.6779600936440601,0.9336609336609336,1.0,1.0,6/31,15.01%,GPHN;FDXR;GCH1;DHRS11;PRLR;PYCR2
prerank,negative regulation of translational initiation (GO:0045947),0.2880930036297061,0.6770776433264012,0.8874045801526718,0.9885827596893734,1.0,1/13,5.97%,TPR
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.2504097139389251,0.676721554108784,0.9120287253141831,0.9884211089075984,1.0,9/24,23.89%,NR1H3;LRRK2;BCL2L1;OPA1;XBP1;UBXN1;SYVN1;TXNDC12;USP25
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.3023099682521652,0.6765970529156369,0.8522072936660269,0.9880306277139486,1.0,3/11,16.64%,POMT2;UGGT2;RNF185
prerank,positive regulation of DNA binding (GO:0043388),-0.21740867265754676,-0.6765401473543838,0.9295454545454546,1.0,1.0,7/31,17.68%,HMGB1;NGF;H1-0;PLAUR;PARK7;EGF;HES1
prerank,fatty acid beta-oxidation (GO:0006635),0.21297927829854943,0.6761319364582445,0.9443535188216039,0.9879538235501141,1.0,14/51,23.75%,ACOXL;AMACR;SCP2;SLC27A2;ACAT1;ETFA;ABCD3;PEX2;ACADS;ACOX1;HADHA;IVD;HADH;ECHS1
prerank,histone exchange (GO:0043486),-0.2015799325627048,-0.6760220519408324,0.9624060150375939,1.0,1.0,13/37,26.08%,ZNHIT1;NPM1;SPTY2D1;DMAP1;CENPU;CENPT;CENPL;CENPQ;CENPN;MIS18BP1;CENPA;RBBP7;ITGB3BP
prerank,transcription by RNA polymerase III (GO:0006383),-0.217837358863578,-0.6759543073104248,0.9196217494089834,1.0,1.0,6/27,22.81%,IVNS1ABP;RO60;GTF3C6;POLR3G;ZC3H8;SNAPC1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.30524132870632137,0.6752227580271191,0.8511904761904762,0.9883162612540763,1.0,3/10,17.66%,ZNHIT3;TAF9;NUFIP1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.26503411191490023,-0.6750045592524162,0.8708971553610503,1.0,1.0,6/13,28.76%,BRSK2;YOD1;UBAC2;UBE2J1;SVIP;UBE2G2
prerank,pseudouridine synthesis (GO:0001522),-0.2681123736758338,-0.6744223607290805,0.8921775898520085,1.0,1.0,7/13,34.37%,PUS7;PUS3;TRUB1;PUSL1;RPUSD2;NOP10;NHP2
prerank,ERAD pathway (GO:0036503),-0.17214560688875769,-0.6744109413349717,0.9900662251655629,1.0,1.0,28/83,31.02%,SEL1L;ERLIN1;BAG6;USP13;UBXN8;BRSK2;CCDC47;YOD1;HSPA5;TMUB2;STT3B;FAM8A1;UBXN6;PSMC6;ATXN3;SGTB;UBE2J1;TMUB1;FBXO6;RNF121;HERPUD1;SEC61B;RNF5;FBXO2;UBE2G2;TOR1A;UFD1;RHBDD2
prerank,hyaluronan catabolic process (GO:0030214),-0.24244144058123346,-0.6740053860325451,0.9150743099787686,1.0,1.0,4/18,11.87%,HEXB;CEMIP;FGF2;GUSB
prerank,positive regulation of transmembrane transport (GO:0034764),-0.267185544188784,-0.6737782723508032,0.8706140350877193,1.0,1.0,5/13,17.71%,CA2;ACSL5;C2CD5;NR4A3;P2RX7
prerank,regulation of T cell activation (GO:0050863),0.22246593072278484,0.6730470733348047,0.9238249594813615,0.9898438809515543,1.0,4/42,7.35%,TNFAIP8L2;PTPN22;CD47;CCL2
prerank,DNA alkylation (GO:0006305),-0.2347295224606025,-0.6722536014147859,0.8926174496644296,1.0,1.0,5/19,17.56%,HELLS;GATAD2A;MTRR;DMAP1;DNMT1
prerank,DNA methylation or demethylation (GO:0044728),-0.2347295224606025,-0.6722536014147859,0.8926174496644296,1.0,1.0,5/19,17.56%,HELLS;GATAD2A;MTRR;DMAP1;DNMT1
prerank,response to gamma radiation (GO:0010332),-0.22683563419263486,-0.672083117113003,0.925,1.0,1.0,11/24,31.09%,RPL26;MAP3K20;ATM;HRAS;MEN1;DCUN1D3;ATR;XRCC6;MYC;TP53;TMEM109
prerank,organelle fusion (GO:0048284),-0.2313559654916681,-0.672005225234353,0.9117647058823529,1.0,1.0,4/22,11.16%,MFF;MFN2;GDAP1;MFN1
prerank,response to fatty acid (GO:0070542),0.26572887192557104,0.6719857790618383,0.8595825426944972,0.9903095910454123,1.0,1/17,1.32%,PID1
prerank,mismatch repair (GO:0006298),-0.22078747196257886,-0.6717322423237694,0.9401913875598086,1.0,1.0,8/27,30.53%,MSH3;MCM9;PMS1;POLD2;POLD1;EXO1;PCNA;MSH5
prerank,chromatin organization (GO:0006325),0.1853256944190342,0.6716117461018657,0.9751724137931035,0.9901391335315621,1.0,31/132,21.04%,MYB;NUCKS1;BRWD1;TOP1;BAZ2A;CDAN1;FOXP3;TCF7L1;HDAC4;BAZ1B;BAZ1A;JARID2;SETD7;MYSM1;ACTL6A;KDM5B;BPTF;SUPV3L1;HDAC2;SMARCA4;SMARCC1;SETD5;KAT2B;LRWD1;INO80C;HCFC2;SETDB1;SETD2;INO80;PHF1;RSF1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.23221638494765545,0.6715245551248169,0.9098497495826378,0.9897187601680665,1.0,9/32,20.28%,APOA2;STARD10;CSNK2A2;LPIN2;PCYT1A;ABHD3;PEMT;SLC44A2;SLC27A1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.26061919621058743,-0.6715052749561692,0.8552631578947368,1.0,1.0,1/14,2.13%,TFRC
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.28110585626837115,-0.6714302842837719,0.8673684210526316,1.0,1.0,8/11,47.40%,CAMK4;ITGB2;TYROBP;STAP1;ITGAM;MAVS;F2RL1;CD177
prerank,lipoprotein catabolic process (GO:0042159),0.28990655512442387,0.6706387562346514,0.8546511627906976,0.9900091003459117,1.0,1/11,4.93%,ABHD10
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.28401351672450215,-0.6704281645409853,0.8760504201680672,1.0,1.0,6/11,30.47%,ATF6;ATF4;HSPA5;MBTPS2;CREB3L1;TP53
prerank,covalent chromatin modification (GO:0016569),-0.25442031673866383,-0.6700946907319415,0.9137931034482759,1.0,1.0,6/14,22.04%,HDAC1;HELLS;PARK7;SIRT7;UFL1;PARP2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.23167009092428434,0.6696060878317008,0.9109243697478991,0.9904544898726967,1.0,4/33,6.40%,RC3H1;UBASH3A;PTPN22;PTPN2
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.2187041411593466,-0.6695387942325258,0.9047619047619048,1.0,1.0,10/26,27.86%,ST3GAL6;B3GNT2;B4GALT4;ST3GAL4;B3GNT3;B4GALT6;LUM;CHST5;B4GAT1;B4GALT2
prerank,protein homotrimerization (GO:0070207),-0.2673805726294234,-0.6694022841359086,0.8725701943844493,1.0,1.0,7/14,31.19%,SLC1A2;SIGMAR1;SCARA5;DISP1;MIF;ALOX5AP;STEAP4
prerank,protein trimerization (GO:0070206),-0.2673805726294234,-0.6694022841359086,0.8725701943844493,1.0,1.0,7/14,31.19%,SLC1A2;SIGMAR1;SCARA5;DISP1;MIF;ALOX5AP;STEAP4
prerank,plasma membrane invagination (GO:0099024),-0.20894194058483317,-0.6691878926799912,0.9466019417475728,1.0,1.0,9/29,25.96%,ELMO1;DOCK1;SNX18;FCGR1A;ITGB2;SNX33;BIN2;AIF1;MSR1
prerank,sterol biosynthetic process (GO:0016126),-0.21158756826962938,-0.669095861235675,0.945273631840796,1.0,1.0,14/33,31.46%,HMGCS1;NSDHL;SQLE;INSIG1;ACLY;SC5D;HSD17B7;DHCR7;MVD;LSS;MSMO1;DHCR24;IDI1;PLPP6
prerank,negative regulation of RNA splicing (GO:0033119),-0.24466403119100658,-0.6687818682736854,0.9265402843601895,1.0,1.0,7/19,21.83%,PTBP1;RPS13;RPS26;RNPS1;SRSF9;C1QBP;SRSF6
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.2102647682057946,-0.6681124200447175,0.9569377990430622,1.0,1.0,11/31,30.47%,MAPK8;HIP1R;YWHAH;PPP1R13B;YWHAQ;BAD;CHCHD10;YWHAZ;PPP3CC;PMAIP1;TP53
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.20780274536336887,0.6674171428578349,0.9578606158833063,0.9919210108247154,1.0,5/53,7.85%,ANXA1;HRH3;MC2R;CCL2;OPRD1
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.2564591999358512,-0.6673121965403044,0.8822314049586777,1.0,1.0,6/16,24.34%,ACACA;ACLY;SCD;HSD17B8;GCDH;FASN
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.2670029033363148,-0.6663695450295036,0.8933901918976546,1.0,1.0,4/12,21.33%,RPL26;CD74;TAF9B;MIF
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.26168062768049133,-0.6653650465800621,0.8941684665226782,1.0,1.0,4/13,20.63%,SORL1;TMEM30A;SAR1B;CD81
prerank,synaptonemal complex organization (GO:0070193),-0.251052390307094,-0.6652743576811995,0.8881720430107527,1.0,1.0,5/15,24.55%,BAG6;TEX11;REC8;TRIP13;RAD21
prerank,synaptonemal complex assembly (GO:0007130),-0.251052390307094,-0.6652743576811995,0.8881720430107527,1.0,1.0,5/15,24.55%,BAG6;TEX11;REC8;TRIP13;RAD21
prerank,translesion synthesis (GO:0019985),0.21987896239216537,0.6646087131367946,0.9412724306688418,0.9939079488446712,1.0,7/42,15.19%,POLH;RFC1;PARP10;REV1;RPA3;POLDIP2;RCHY1
prerank,regulation of lipase activity (GO:0060191),0.27920805210944966,0.6645434389956029,0.8715083798882681,0.9934620344797679,1.0,2/13,12.05%,APOA2;RHOC
prerank,positive regulation of actin nucleation (GO:0051127),-0.27699179717947897,-0.6636110247012645,0.8702127659574468,1.0,1.0,1/11,3.05%,NCKAP1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.20620107249591213,-0.6628560576858196,0.9312796208530806,1.0,1.0,12/31,32.96%,RPS2;PINK1;DCUN1D2;DCUN1D5;DCUN1D1;DCUN1D3;SKP1;CDC14B;RAB1A;PLK1;UBE2L3;CDC20
prerank,regulation of vasculature development (GO:1901342),0.23900129379465912,0.6620423910253197,0.9061433447098977,0.9951899443502061,1.0,2/26,4.62%,SP100;IL6
prerank,protein catabolic process (GO:0030163),-0.1812975549691334,-0.6617150109937711,0.9941520467836257,1.0,1.0,10/59,17.75%,HSPA8;DAB2IP;CTSD;CEACAM1;BAG6;HSP90AA1;RAB12;PSMA8;LRSAM1;STT3B
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.2700917776538101,0.6613635910785347,0.888268156424581,0.9952555665486837,1.0,6/17,22.26%,CCND3;PSRC1;PKD2;MAPRE3;CCNY;PKD1
prerank,fatty acid metabolic process (GO:0006631),-0.16197450743954983,-0.6611245563333493,0.9968051118210862,1.0,1.0,37/115,30.49%,ADIPOR2;ACSL3;PPARD;ACSL5;GGT5;ACACA;ACLY;ACSBG1;ABCD2;CROT;AOAH;PER2;AASDH;LPL;LPIN3;ACOT2;GGT1;ACSF2;HPGD;HSD17B8;PNPLA3;MCAT;CPT1C;FA2H;FAAH;FASN;ACOT6;ALKBH7;ADIPOR1;LIPH;MSMO1;LIPC;ACOX2;SLC27A6;ALOX5;CPT1B;ALOX5AP
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.2321088055526749,-0.6611083526525717,0.8954545454545455,1.0,1.0,6/19,19.08%,GFPT2;PGM3;GFPT1;RENBP;GNPNAT1;PMM2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.29459717507216904,0.6604496789366351,0.8597194388777555,0.9955312367907706,1.0,1/10,3.21%,SH3RF1
prerank,tRNA 5'-leader removal (GO:0001682),-0.26959373547642557,-0.6600709272414342,0.8910256410256411,1.0,1.0,4/13,26.17%,PRORP;RPP30;RPP25L;POP7
prerank,catecholamine metabolic process (GO:0006584),0.27666806494013124,0.6597854711446839,0.8494208494208494,0.9955709858788807,1.0,3/14,19.68%,COMT;RNF180;LRTOMT
prerank,endosome organization (GO:0007032),0.21844191566946508,0.6594624202336473,0.9396411092985318,0.9953623596007917,1.0,12/41,19.36%,RAB22A;WASHC4;DNM1;USP8;TMCC1;EEA1;ANXA8;ANXA8L1;HOOK1;ARFGEF2;PLEKHF1;TMEM9
prerank,proteasome assembly (GO:0043248),-0.2667167766579977,-0.657274259073441,0.8866396761133604,1.0,1.0,5/11,31.01%,PSMD4;POMP;PSMD11;PSMG2;PSMD5
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.25063367120788554,-0.6570701944146498,0.9385593220338984,1.0,1.0,1/14,1.84%,ATP1B1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.23321910492964765,0.6567852544162242,0.9179487179487179,0.9970805273859576,1.0,5/28,12.71%,LACC1;MAP2K6;RIPK2;UBE2V1;MAP3K7
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.23744823299110412,0.6561531700598392,0.9050847457627119,0.9971302654404263,1.0,6/26,15.02%,MAP2K6;RIPK2;UBE2V1;MAP3K7;TIFA;IFIH1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.2787529164765419,0.6552620965097427,0.8747731397459165,0.9973437843812573,1.0,1/13,2.97%,IL23R
prerank,apoptotic nuclear changes (GO:0030262),-0.22226481745360951,-0.6549099429698066,0.9515011547344111,1.0,1.0,6/24,19.11%,HMGB1;KPNB1;H1-0;DEDD2;FOXL2;DICER1
prerank,regulation of isotype switching (GO:0045191),0.2738355337412494,0.654751130409999,0.8811700182815356,0.9972664717362889,1.0,5/14,20.29%,PARP3;SHLD2;KMT5C;RIF1;KMT5B
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.2541542261090451,0.653996959439949,0.8865248226950354,0.9973912392743942,1.0,3/18,9.96%,STOX1;BRD4;RAD51B
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.26983264196591994,0.6537832065569144,0.8819320214669052,0.9970816224745888,1.0,7/15,26.80%,BCL2;TAF9;MUC1;KDM1A;CD44;TRIAP1;ING2
prerank,negative regulation of ATPase activity (GO:0032780),0.2673318759819562,0.6529836036216311,0.898854961832061,0.9972201054232555,1.0,6/16,26.50%,IFIT1;ATP5IF1;PXK;OXA1L;THADA;TNNI3
prerank,axoneme assembly (GO:0035082),-0.2033298276085619,-0.6513636031341661,0.9432314410480349,1.0,1.0,14/30,33.69%,RP1;CFAP46;CFAP74;DNAAF3;SPAG16;SPAG1;SPAG17;TTLL3;DCX;CCDC65;DNAAF2;CFAP206;FOXJ1;CCDC40
prerank,histone acetylation (GO:0016573),0.19558320825907222,0.6511220213904825,0.967741935483871,0.9982319842128985,1.0,16/69,17.35%,APBB1;BRD1;CREBBP;KAT6B;EPC1;JADE2;ACTL6A;MAP3K7;BRD8;KAT6A;ZZZ3;KAT2B;PHF20L1;TAF9;TRIM16;ATF2
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.21106537740983713,0.6507067723404366,0.9507936507936507,0.9975606919577615,1.0,20/51,25.51%,SUMO1;AHCTF1;LBR;CHMP3;CHMP4A;CHMP4B;POM121;NUP37;PPP2CA;RAN;PPP2R2A;EMD;SIRT2;NUP85;IST1;SPAST;RANGAP1;VPS4A;NUP107;NUP160
prerank,mitotic nuclear membrane organization (GO:0101024),0.21106537740983713,0.6507067723404366,0.9507936507936507,0.9975606919577615,1.0,20/51,25.51%,SUMO1;AHCTF1;LBR;CHMP3;CHMP4A;CHMP4B;POM121;NUP37;PPP2CA;RAN;PPP2R2A;EMD;SIRT2;NUP85;IST1;SPAST;RANGAP1;VPS4A;NUP107;NUP160
prerank,tryptophan metabolic process (GO:0006568),-0.26753456139864434,-0.6504492563361548,0.8976034858387799,1.0,1.0,7/11,53.51%,KMO;KYNU;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.2437004623513684,-0.6504026902608177,0.8966244725738397,1.0,1.0,4/15,17.64%,AP3S2;AP3B2;SNAPIN;AP3D1
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.2437004623513684,-0.6504026902608177,0.8966244725738397,1.0,1.0,4/15,17.64%,AP3S2;AP3B2;SNAPIN;AP3D1
prerank,DNA strand elongation (GO:0022616),0.2568715366789894,0.6496681842521451,0.8893129770992366,0.997826550233594,1.0,3/18,10.58%,TERT;RAD50;MCM4
prerank,positive regulation of chromosome organization (GO:2001252),-0.2551628596505074,-0.6485766693879187,0.9183673469387755,1.0,1.0,6/15,24.55%,MRE11;DDX11;GNL3;PPP1R10;SHCBP1L;RAD21
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.2092559498325925,-0.6485739997727623,0.9361702127659575,1.0,1.0,5/24,14.82%,TPT1;CD74;CCAR2;CXCL12;TAF9B
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.24565998134781497,0.6485118780390228,0.8954128440366973,0.9982562138844219,1.0,2/22,6.24%,DUSP10;FOXP3
prerank,regulation of protein acetylation (GO:1901983),0.2726552709923227,0.6482629096838042,0.8974358974358975,0.9979580187010593,1.0,3/12,23.42%,GSK3B;RAPGEF3;FAM161A
prerank,histone H4 deacetylation (GO:0070933),0.28670009560284543,0.6480919475616688,0.869980879541109,0.9975999410376533,1.0,4/10,21.06%,HDAC4;HDAC2;SIRT2;RCOR1
prerank,coenzyme A metabolic process (GO:0015936),0.27189523670992827,0.6479588144628349,0.8747731397459165,0.9972065223352896,1.0,2/14,11.05%,PANK2;ACAT1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.23952336358461918,-0.6479311864005991,0.9128630705394191,1.0,1.0,7/17,27.52%,NTRK2;SORL1;RTN3;CHRNA7;HAP1;RTN2;CLU
prerank,positive regulation of cell development (GO:0010720),0.2245969216840485,0.647702101196693,0.924908424908425,0.9969073441427448,1.0,2/31,4.06%,NUMB;RFX3
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.21164127751836326,-0.6475879515413968,0.9476309226932669,1.0,1.0,11/29,28.69%,EXOSC2;DCP1A;HBS1L;EXOSC4;CNOT8;LSM4;EDC3;LSM2;EXOSC1;LSM3;DCPS
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.17343064930643176,-0.6474784926818179,0.99375,1.0,1.0,22/69,31.02%,SEL1L;ERLIN1;BAG6;UBXN8;YOD1;HSPA5;TMUB2;STT3B;FAM8A1;PSMC6;SGTB;UBE2J1;TMUB1;FBXO6;RNF121;HERPUD1;SEC61B;RNF5;FBXO2;UBE2G2;UFD1;RHBDD2
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.2191920428025684,0.6468788172629422,0.9155629139072847,0.9970232376985502,1.0,12/36,23.79%,SUZ12;UXT;MGA;EPC1;RBBP8;RNF2;RING1;BMI1;PCGF2;APAF1;TFDP2;EHMT2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.25404154201639123,0.6466960691671765,0.8790786948176583,0.9961668033881934,1.0,3/19,14.28%,POLR2D;POLR2C;POLR2F
prerank,regulation of DNA recombination at telomere (GO:0072695),0.25404154201639123,0.6466960691671765,0.8790786948176583,0.9961668033881934,1.0,3/19,14.28%,POLR2D;POLR2C;POLR2F
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.2042493051481004,0.6466729250604463,0.9521531100478469,0.9956906900512879,1.0,15/52,23.83%,KDELR3;SRPRA;CTDSP2;DNAJC3;TSPYL2;ERN2;PARP16;SEC31A;EXTL2;SHC1;XBP1;MYDGF;SYVN1;EDEM1;YIF1A
prerank,tRNA transport (GO:0051031),-0.19782904037546697,-0.6460289672634077,0.9614457831325302,1.0,1.0,15/35,33.20%,YBX1;AAAS;NUP93;RAE1;XPOT;TOMM20;NUP62;NUP188;NUP54;NUP210;NUP42;NUP153;NDC1;SEC13;NOL6
prerank,regulation of actin nucleation (GO:0051125),0.2824509499976987,0.6450679505336498,0.876425855513308,0.996438359784688,1.0,4/12,20.95%,ARPIN;ARF1;ARFIP2;CORO1B
prerank,regulation of exit from mitosis (GO:0007096),0.213995884858984,0.644648467884185,0.947107438016529,0.9962437722657501,1.0,7/38,12.97%,ANAPC11;PHB2;ANAPC1;UBE2C;CDC14A;MAD2L1BP;CDC27
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.2009634764969143,-0.6439137797345855,0.9493975903614458,1.0,1.0,8/33,20.30%,ALDH5A1;GCLC;SLC39A8;GLS;PYCR2;GGT1;MTHFS;GLS2
prerank,mitochondrial membrane organization (GO:0007006),0.22383888384516548,0.6437357752334558,0.9378238341968912,0.9964312510576364,1.0,8/32,20.98%,BCL2;MICOS10;BCL2L1;OPA1;SLC25A4;HSPA9;SLC25A31;MTX2
prerank,P-body assembly (GO:0033962),0.2756562180163217,0.6435920915530587,0.8838951310861424,0.9960547828902704,1.0,4/12,18.26%,RC3H1;EIF4ENIF1;DDX6;PATL1
prerank,inner dynein arm assembly (GO:0036159),0.29448730475872287,0.6434380137018443,0.8706563706563707,0.9956806358935354,1.0,3/10,22.96%,DNAAF1;CCDC39;DNAAF4
prerank,glycosphingolipid metabolic process (GO:0006687),0.20978356395808506,0.6425179004148391,0.958974358974359,0.9958793012022923,1.0,4/42,8.14%,SMPD3;A4GALT;LARGE1;ESYT1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.18247416038387715,-0.6422476312437638,0.9807692307692307,1.0,1.0,11/54,20.83%,CRADD;RPL26;PLAGL1;ATM;RGCC;CDKN1A;RBL2;E2F4;CNOT2;CNOT8;E2F7
prerank,regulation of execution phase of apoptosis (GO:1900117),0.2871446154340295,0.6420848093619617,0.8941176470588236,0.9956869338314273,1.0,2/11,11.25%,DLC1;BCL2L1
prerank,positive regulation of vacuole organization (GO:0044090),0.2896634854241809,0.6415464833776244,0.8823529411764706,0.9955768699983663,1.0,3/10,18.99%,ANXA2;PIP4K2B;PIP4K2C
prerank,protein hydroxylation (GO:0018126),-0.2417260690777721,-0.6414192593117706,0.9199134199134199,1.0,1.0,5/15,24.41%,VPS33B;VIPAS39;PLOD2;HIF1AN;JMJD7
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.23879695797038758,-0.6414078566540431,0.9027149321266968,1.0,1.0,4/17,18.64%,TGFB2;RET;SYK;RAC3
prerank,regulation of establishment of protein localization (GO:0070201),-0.2542376267699405,-0.6409313797870276,0.9175475687103594,1.0,1.0,5/13,26.73%,CTSD;CEP135;CEP290;DNAJA1;TREM2
prerank,establishment of melanosome localization (GO:0032401),-0.22284853374665153,-0.6408624703505476,0.9364705882352942,1.0,1.0,11/19,38.80%,RAB27A;RAB27B;MLPH;BBS2;BBS7;MREG;MKKS;RAB11A;GPR143;RAB17;BBS5
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.2917945569591372,0.6404912855517837,0.8755102040816326,0.9958631898722888,1.0,3/10,22.99%,ETFA;ACADS;IVD
prerank,Golgi inheritance (GO:0048313),0.2786884356251017,0.6403231704333057,0.8998211091234347,0.9954890960931657,1.0,3/11,16.86%,PLK5;GBF1;GOLGA2
prerank,lymphocyte migration (GO:0072676),0.21612662770535407,0.6397977930245564,0.9332191780821918,0.9953666804530211,1.0,3/32,7.35%,CKLF;MSMP;CCL2
prerank,lytic vacuole organization (GO:0080171),0.22186644456338586,0.639389246141264,0.9487179487179487,0.9951842577056945,1.0,5/32,12.46%,CLN5;LRRK2;HPS1;ABCA1;ARSB
prerank,axonemal dynein complex assembly (GO:0070286),0.22915161019820451,0.6391723170292336,0.9285714285714286,0.9948377136420511,1.0,5/27,13.04%,ODAD4;DNAAF1;DNAL1;DNAI4;DRC1
prerank,lipid droplet organization (GO:0034389),0.235828225799445,0.6389713972317493,0.9237749546279492,0.9944871531875927,1.0,3/22,10.04%,SMIM22;PLA2G4C;PPID
prerank,indolalkylamine catabolic process (GO:0046218),-0.2708754405514419,-0.6379463212640302,0.9004329004329005,1.0,1.0,7/10,53.51%,KMO;KYNU;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.20347349684457994,-0.6377929192446629,0.9598997493734336,1.0,1.0,9/29,25.88%,SMAD7;DAB2IP;IL17RD;SPRED2;SPRED3;SPRED1;BMP5;ADIPOR1;SDHAF2
prerank,DNA replication checkpoint signaling (GO:0000076),-0.24093861493116797,-0.6377778051563715,0.9284253578732107,1.0,1.0,10/16,45.52%,CLSPN;CDC45;HUS1B;TOPBP1;CDC6;TICRR;TIMELESS;CDT1;RAD17;HUS1
prerank,nuclear membrane reassembly (GO:0031468),0.20381796207070307,0.6377413215195021,0.9609984399375975,0.9948617681655314,1.0,21/54,25.51%,SUMO1;UBXN2A;AHCTF1;LBR;CHMP3;CHMP4A;CHMP4B;POM121;NUP37;PPP2CA;RAN;PPP2R2A;EMD;SIRT2;NUP85;IST1;SPAST;RANGAP1;VPS4A;NUP107;NUP160
prerank,response to estrogen (GO:0043627),-0.19721294440472628,-0.6375654810132265,0.9495192307692307,1.0,1.0,7/31,23.38%,SERPINB9;ESR1;CAV1;BRCA1;ASH2L;KRT19;RBBP5
prerank,negative regulation of cell division (GO:0051782),-0.2633166107986951,-0.6375172404388753,0.9056603773584906,1.0,1.0,6/11,32.95%,ORC6;E2F7;CHMP4C;BLM;MYC;E2F8
prerank,microglial cell activation (GO:0001774),-0.21677326283705856,-0.6372773297429442,0.9631336405529954,1.0,1.0,14/21,43.93%,SNCA;GRN;MAPT;ITGB2;AIF1;TREM2;CLU;TYROBP;C1QA;CX3CR1;IL4;C5AR1;ITGAM;TNF
prerank,amyloid precursor protein catabolic process (GO:0042987),0.25639835922334764,0.6367306714556153,0.907258064516129,0.9951058303712643,1.0,5/14,26.18%,ADAM19;ABCA7;PSEN1;NCSTN;ABCG1
prerank,cellular macromolecule catabolic process (GO:0044265),0.20386239409609774,0.6365727689880367,0.9716981132075472,0.9947372767241951,1.0,14/49,23.06%,SIAH2;MANBA;SND1;SUPV3L1;DNASE1L1;RNASEH1;DFFB;RNASE3;CHEK2;RIPK1;RNASEH2B;ADAMTS9;PNPT1;RNASEH2A
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.24151470051791943,-0.6363258749899328,0.9203539823008849,1.0,1.0,15/16,51.05%,CYRIB;CEACAM1;PTPRC;STX7;LILRB1;FADD;IL12A;IL12RB1;IL23A;KLRD1;IL12B;RIPK3;KLRC1;AGER;XCL1
prerank,ruffle organization (GO:0031529),0.2531595567685165,0.6351749147735415,0.9054290718038529,0.9952485173249905,1.0,7/16,22.31%,TPM1;LIMA1;PLEK;ARFIP2;PIP5K1A;CORO1B;CYFIP1
prerank,rRNA modification (GO:0000154),-0.22524853823872348,-0.6336712995274311,0.945823927765237,1.0,1.0,10/21,44.64%,FTSJ3;THUMPD1;TFB2M;TFB1M;NOP10;FBL;NHP2;FBLL1;TSR3;NAT10
prerank,phagosome-lysosome fusion (GO:0090385),-0.27003275282919453,-0.6336554856160644,0.9204081632653062,1.0,1.0,3/10,23.08%,SYT7;RAB39A;CLN3
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.21749828832700735,-0.633063772434761,0.9454976303317536,1.0,1.0,12/23,32.57%,NSFL1C;NDE1;INSC;CDK5RAP2;DCTN1;SPDL1;HTT;CENPA;UBXN2B;ZW10;PLK1;PKHD1
prerank,intestinal lipid absorption (GO:0098856),0.279497517579645,0.6326970352842302,0.9028571428571428,0.9964377071232057,1.0,2/11,19.01%,LIMA1;CD36
prerank,early endosome to late endosome transport (GO:0045022),-0.22595519703377184,-0.6324302692813898,0.9422632794457275,0.9997832645907422,1.0,5/20,22.29%,EMP2;WDR81;KIF16B;PIK3C3;SNF8
prerank,regulation of keratinocyte migration (GO:0051547),-0.2552540005478344,-0.6311651195820468,0.9309623430962343,0.9998898998111966,1.0,3/12,18.38%,IQSEC1;EPB41L4B;ARF6
prerank,positive regulation of protein deacetylation (GO:0090312),-0.24737780782264268,-0.6307164514540795,0.9168539325842696,0.9995198843457298,1.0,3/14,17.34%,CTBP1;APLNR;NNMT
prerank,male meiosis I (GO:0007141),0.2509732512872035,0.6304927738991463,0.9080675422138836,0.9974359063538045,1.0,16/16,74.93%,ZSCAN21;SLC25A31;FOXJ3;ING2;MYBL1;DDX4;BTBD18;MEIOC;DNMT3L;CCNA1;HSF2BP;BRDT;FOXJ2;MOV10L1;TDRD9;SYCP3
prerank,protein localization to microtubule organizing center (GO:1905508),-0.23634489178305634,-0.6293222481176822,0.9239130434782609,0.9996984569152174,1.0,2/15,7.08%,CSNK1D;CEP83
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.1741965385355856,-0.6285950587356093,0.9914040114613181,0.9994815804475475,1.0,13/63,20.83%,CRADD;RPL26;PLAGL1;CCND1;ATM;RGCC;CDK2;CDKN1A;RBL2;E2F4;CNOT2;CNOT8;E2F7
prerank,ketone body metabolic process (GO:1902224),0.2815378497422538,0.6282039982713273,0.8864059590316573,0.9984789811986204,1.0,3/10,17.64%,OXCT1;ACAT1;ACSS3
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.19278576376573908,-0.627590790506505,0.9660194174757282,0.9994289323185923,1.0,9/32,23.48%,PIK3R1;NCKAP1;ARPC2;ARHGEF7;RAC1;OCLN;BRK1;CARMIL1;AKIRIN1
prerank,mRNA transport (GO:0051028),-0.15488084568581675,-0.6266801534399036,0.9965870307167235,0.9992978203409432,1.0,33/101,28.85%,CPSF2;SRSF2;SYMPK;SRSF1;ZC3H11A;THOC2;HHEX;AAAS;NUP93;KIF5C;RAE1;RNPS1;POLDIP3;SRSF9;UPF1;RBM15B;NXT1;NUP62;CHTOP;SRSF6;ALKBH5;CDC40;CPSF3;U2AF1;NUP188;NUP54;NUP210;CPSF1;NUP42;MCM3AP;NUP153;ZFP36;UPF3B
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.22399256516569477,-0.6262441240196184,0.9616204690831557,0.9988935483887614,1.0,3/20,8.74%,MBTPS1;KPNB1;LDLRAP1
prerank,phosphate ion transmembrane transport (GO:0035435),-0.2544084971682383,-0.6262313148025859,0.9089108910891089,0.9982477550311473,1.0,5/12,28.12%,XPR1;SLC25A30;SLC20A2;SLC37A1;SLC37A2
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.28622287002333835,0.6260781242443259,0.9026217228464419,0.9994095655633332,1.0,4/10,21.03%,AMDHD2;ST3GAL1;NAGK;ST6GAL1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.25201989080185605,0.6250139246647464,0.9188118811881189,0.9996061719089321,1.0,3/14,12.22%,FASTKD5;FOXO3;MTERF2
prerank,regulation of B cell differentiation (GO:0045577),0.24383136243052042,0.6236900910295295,0.9342105263157895,0.9999635851867231,1.0,5/17,25.55%,MMP14;INHA;XBP1;ZFP36L2;ZFP36L1
prerank,regulation of histone methylation (GO:0031060),0.26130780626362454,0.6222000261565894,0.9076923076923077,1.0,1.0,3/13,13.54%,NSD1;JARID2;PAF1
prerank,regulation of calcium ion import (GO:0090279),-0.2170663433770436,-0.6212940207378753,0.9461883408071748,1.0,1.0,6/21,25.63%,CTNNB1;SLC30A1;CXCL12;EGF;STC1;PLN
prerank,regulation of translational initiation (GO:0006446),-0.16602899459593035,-0.6210735480324898,0.991044776119403,0.9998777486778133,1.0,19/63,28.20%,EIF2B2;NPM1;YTHDF2;EIF5B;EIF1B;ATF4;CDC123;PPP1R15B;EIF1;EIF4A2;UHMK1;PAIP2;PAIP1;EIF3H;CSDE1;POLR2G;EIF4G1;BOLL;HSPB1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.216481171229127,-0.6208152779153903,0.9660194174757282,0.9993560660628531,1.0,13/22,44.86%,RPS21;EXOSC2;FTSJ3;ERI1;ABT1;UTP20;EXOSC3;RRS1;ERI2;EXOSC8;EXOSC9;URB1;NOP14
prerank,positive regulation of macrophage migration (GO:1905523),0.24527665227478584,0.618743604131549,0.9364485981308411,1.0,1.0,5/19,16.85%,IL34;PTK2;CSF1;RARRES2;P2RX4
prerank,protein targeting to peroxisome (GO:0006625),0.220838116622468,0.6178536795205968,0.9571183533447685,1.0,1.0,5/29,13.54%,ZFAND6;PXMP2;HACL1;ABCD3;PEX2
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.22710044669917961,0.6175885674050656,0.9273049645390071,1.0,1.0,2/24,6.12%,AUTS2;PLCE1
prerank,response to light stimulus (GO:0009416),0.19552090939747788,0.6172002165963163,0.9806138933764136,1.0,1.0,12/55,20.43%,CRY2;CRY1;FECH;REV1;ERCC6;ERCC5;OPN3;UBE4B;GTF2H2;CLOCK;UVSSA;ERCC8
prerank,zymogen activation (GO:0031638),0.20277836459165613,0.6168545269376591,0.9690553745928339,1.0,1.0,10/39,20.25%,MMP14;CTSH;RIPK2;PLAU;PLAT;CYFIP2;KLK1;ASPH;HP;HPR
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.2535045202925436,-0.6165298756940163,0.9212253829321663,1.0,1.0,3/11,15.27%,SCARB1;MFSD2A;CTDNEP1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.2703473185105282,0.6161593232303213,0.9013035381750466,1.0,1.0,5/11,24.40%,FBH1;GMNN;SMARCAL1;TIPIN;ZRANB3
prerank,mitochondrial transport (GO:0006839),0.1942078112848059,0.6161024858239913,0.9777424483306836,1.0,1.0,17/53,25.21%,BCL2;TIMM17A;SLC25A24;BCL2L1;COX18;TMEM14A;TIMM9;SLC25A4;TOMM34;SLC25A31;MTX2;OXA1L;BCAP31;TMEM14C;TOMM40;TOMM7;TOMM70
prerank,regulation of cytokinesis (GO:0032465),0.18022295062407628,0.6156211193036811,0.9926470588235294,1.0,1.0,14/78,17.15%,MAP9;PLK5;KLHL21;UVRAG;KLHL13;BCL2L1;CDC14A;FSD1;CUL3;ENTR1;AHCTF1;BIRC6;PKN2;MYO19
prerank,UV-damage excision repair (GO:0070914),0.26301416281991,0.6154541586461825,0.8806509945750453,1.0,1.0,4/12,21.06%,ERCC1;XPC;INO80;POLD3
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.22362889837863975,-0.6152720355137227,0.9336188436830836,1.0,1.0,4/18,11.42%,ZC3H11A;THOC2;HHEX;NUP93
prerank,protein localization to chromosome (GO:0034502),-0.1893194351768144,-0.6133967140454571,0.9664268585131894,1.0,1.0,9/34,24.55%,ESR1;MCM9;SLF1;CHMP7;TINF2;IFFO1;ATR;CENPA;RAD21
prerank,linoleic acid metabolic process (GO:0043651),0.24429266475225017,0.6131472950880313,0.9197080291970803,1.0,1.0,2/17,8.66%,ACSL1;ALOXE3
prerank,pentose-phosphate shunt (GO:0006098),0.2694783617339632,0.6128190912922243,0.8840864440078585,1.0,1.0,2/11,10.29%,PGD;DERA
prerank,mitochondrion disassembly (GO:0061726),-0.18635332419692086,-0.6108534723937397,0.9848866498740554,1.0,1.0,5/34,11.91%,GABARAP;GABARAPL1;PINK1;ATG9A;ULK1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.2693476859463759,0.6106385197518812,0.883399209486166,1.0,1.0,9/10,50.62%,CEP250;TULP1;CNGB1;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.2693476859463759,0.6106385197518812,0.883399209486166,1.0,1.0,9/10,50.62%,CEP250;TULP1;CNGB1;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1
prerank,myelin maintenance (GO:0043217),-0.2531723756866741,-0.6103874291298244,0.9178947368421052,1.0,1.0,5/10,40.89%,ABCD2;SOD1;CLU;ABCD1;DEGS1
prerank,histone H3 deacetylation (GO:0070932),-0.23604069458313875,-0.6103155947938708,0.9511111111111111,1.0,1.0,4/15,19.05%,HDAC9;HDAC1;PER2;SIRT7
prerank,regulation of viral release from host cell (GO:1902186),0.23077360123466864,0.6099619912289209,0.9429097605893186,1.0,1.0,5/21,15.23%,TRIM5;TRIM21;TRIM26;CHMP3;PML
prerank,mitotic spindle organization (GO:0007052),-0.14206514739668297,-0.6088485295863099,1.0,1.0,1.0,45/153,26.64%,RPS27;EFHC2;RCC2;KPNB1;DYNC1H1;PCNT;KIF18A;AAAS;XPO1;DYNC1I2;NDE1;KIF3B;PPP1CC;CLASP2;DYNLL2;CENPU;SKA2;BUB1B;PRC1;NEK9;ZWILCH;CENPT;STMN1;CENPL;CENPQ;KIF23;TUBG1;MAD1L1;CENPF;NSL1;KIF4A;CENPN;DSN1;KNTC1;DCTN6;SPDL1;CENPA;MAPRE1;TUBG2;SGO1;BCCIP;STIL;ITGB3BP;BIRC5;CLIP1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.19141894270530183,0.6071907155385461,0.9856,1.0,1.0,6/50,9.38%,CCND3;STOX1;CDKN2B;CCNH;MNAT1;CDK7
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.24193368466201604,0.6066248309564337,0.9273422562141491,1.0,1.0,7/16,27.09%,KIF5B;PLEKHM2;VAMP7;ULBP1;KLRK1;CEBPG;ARL8B
prerank,positive regulation of sodium ion transport (GO:0010765),0.2594080713179635,0.6065834849967081,0.9252336448598131,1.0,1.0,6/12,24.67%,SCN3B;GPD1L;CNKSR3;WNK3;SCN4B;SCN5A
prerank,mitotic recombination (GO:0006312),0.2511686950068973,0.6058275300311643,0.933579335793358,1.0,1.0,5/15,21.63%,RAD50;NSMCE2;ERCC1;SMC6;TEP1
prerank,phasic smooth muscle contraction (GO:0014821),0.2717314475970851,0.6048071536796604,0.9154639175257732,1.0,1.0,3/10,21.38%,TIFAB;GDNF;PTGER3
prerank,regulation of pH (GO:0006885),0.263229143335548,0.6047871086679918,0.9105367793240556,1.0,1.0,3/11,18.96%,LACC1;SLC9A7;SLC9A1
prerank,axonal fasciculation (GO:0007413),0.26759324552501657,0.6046502225886574,0.9207547169811321,1.0,1.0,3/12,14.10%,EPHA3;EPHA4;RTN4
prerank,regulation of chromosome segregation (GO:0051983),-0.22350469633935865,-0.6041339570129363,0.9455782312925171,1.0,1.0,9/16,41.14%,RMI2;MKI67;SMC5;RAD18;CDC6;BUB1;IHO1;KIF2C;AURKB
prerank,membrane lipid catabolic process (GO:0046466),0.2689759747566132,0.6036252272182291,0.9037037037037037,1.0,1.0,2/10,17.85%,ENPP2;SGPL1
prerank,tryptophan catabolic process (GO:0006569),0.2718591993959197,0.6034827930268615,0.923217550274223,1.0,1.0,1/11,5.87%,AFMID
prerank,Golgi to lysosome transport (GO:0090160),-0.25277456955508304,-0.6034450843394952,0.9317180616740088,1.0,1.0,4/11,28.73%,SORT1;LAMP1;CLN3;LAPTM5
prerank,phospholipid homeostasis (GO:0055091),0.2677170296905407,0.6022533795665017,0.9195402298850575,1.0,1.0,11/11,73.25%,ABCA1;RCN3;ANGPTL3;ABCG1;LIPG;TLCD1;ABCB11;APOA1;HNF4A;TLCD2;FABP3
prerank,monocarboxylic acid catabolic process (GO:0072329),0.22936593075367986,0.6021634295688928,0.951304347826087,1.0,1.0,8/21,23.20%,HAO1;LPIN2;ACOX1;AGXT;HOGA1;ACBD5;NUDT19;LPIN1
prerank,regulation of mitotic nuclear division (GO:0007088),0.18564850583554388,0.6019121784229646,0.9785604900459418,0.9997436236780087,1.0,4/55,5.76%,PHIP;TGFA;BMP7;PDGFRB
prerank,DNA recombination (GO:0006310),0.19873614148740834,0.6015502627736891,0.976068376068376,0.9994627716772047,1.0,6/37,15.93%,WRN;RAD50;FBH1;RAD51B;SUPV3L1;ERCC1
prerank,protein localization to phagophore assembly site (GO:0034497),-0.2515190380881944,-0.6013504243446393,0.9290060851926978,1.0,1.0,2/11,9.94%,ATG9A;MFN2
prerank,cellular response to gamma radiation (GO:0071480),0.237453094493641,0.6012967267777014,0.941712204007286,0.9991056787000313,1.0,3/17,9.54%,WRN;YAP1;TLK2
prerank,lipoxygenase pathway (GO:0019372),0.2512014948803101,0.6012423189662861,0.9153846153846154,0.9986510803630909,1.0,3/14,20.03%,ALOXE3;PON3;PTGS2
prerank,regulation of cholesterol efflux (GO:0010874),-0.19254266106866244,-0.6010222313912837,0.9698375870069605,1.0,1.0,7/30,26.87%,ABCA3;EEPD1;CAV1;RXRA;GPS2;TREM2;NR1H2
prerank,purine nucleotide biosynthetic process (GO:0006164),0.25522586639471573,0.6007077983912691,0.922509225092251,0.9984495070350282,1.0,4/12,20.70%,MTHFD1;PRPSAP1;PRPSAP2;ADSL
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.2563860691762425,0.5998765335678129,0.9003831417624522,0.9984075783504435,1.0,3/13,13.69%,ALG9;ALG11;ALG1
prerank,alpha-amino acid metabolic process (GO:1901605),-0.17154242760470756,-0.5983863320375783,0.978891820580475,1.0,1.0,15/45,29.85%,MTHFR;GLS;MTRR;PYCR2;SLC25A13;KMO;ASNS;GLS2;SLC25A12;NOX4;RIMKLA;PYCR1;GNMT;GPT;GPT2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.2104819675142424,0.5983825581342253,0.9586330935251799,0.9987067265542033,1.0,7/31,19.38%,RC3H1;FOXP3;CD274;DLG5;VTCN1;BLK;CEBPB
prerank,tRNA wobble base modification (GO:0002097),-0.22880385160284678,-0.5960221423885523,0.9461206896551724,1.0,1.0,7/14,30.79%,TRMT9B;DPH3;KTI12;ADAT2;CTU2;ELP3;ALKBH8
prerank,lung epithelium development (GO:0060428),0.26293772947919747,0.5947210037988621,0.9205702647657841,1.0,1.0,1/10,4.52%,ERRFI1
prerank,regulation of histone deacetylation (GO:0031063),0.25289469423638966,0.5944419012252832,0.9122137404580153,0.9997363135464958,1.0,4/13,20.33%,FOXP3;SAP30BP;NIPBL;SPHK2
prerank,mRNA metabolic process (GO:0016071),-0.14861759274335842,-0.5938567530284666,1.0,1.0,1.0,28/90,32.29%,DIS3L2;PTBP1;DHX15;SRSF2;HNRNPA0;SRSF1;YTHDF2;SNRPB;NUDT16L1;AURKAIP1;SNRPF;RIDA;SRSF9;NONO;ALKBH5;CPSF3;U2AF1;LSM2;NUDT16;LSM3;TBRG4;ZFP36;RNH1;TP53;CPSF6;NUDT12;PRPF8;ZC3H12D
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.2329907636862307,-0.5929198539773208,0.9397849462365592,1.0,1.0,3/13,23.10%,RPS21;BMS1;ABT1
prerank,early endosome to Golgi transport (GO:0034498),-0.2469261447026339,-0.5922798360505496,0.9433551198257081,1.0,1.0,2/11,14.87%,LMAN1;SNX8
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.2484677990890691,0.5915597312090894,0.9337016574585635,1.0,1.0,4/14,24.00%,TERT;TNKS2;NABP2;ATRX
prerank,maturation of LSU-rRNA (GO:0000470),0.21550409434436574,0.5913797053157697,0.9570661896243292,1.0,1.0,6/26,16.52%,NSA2;RPL7L1;ZNHIT3;WDR12;DDX18;RPF1
prerank,protein localization to lysosome (GO:0061462),-0.1913961249060354,-0.5909062890785791,0.9740566037735849,1.0,1.0,5/28,12.02%,SORL1;GCC2;M6PR;GLMP;SCARB2
prerank,phagolysosome assembly (GO:0001845),-0.23918764498136902,-0.589981904591033,0.9560669456066946,1.0,1.0,2/12,11.89%,SYT7;RAB39A
prerank,glycerol metabolic process (GO:0006071),-0.25429650169045503,-0.5891290772256227,0.9347368421052632,1.0,1.0,4/10,25.37%,TPI1;PGP;COQ3;GK
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.1988049790286323,-0.5888716371844901,0.9787735849056604,1.0,1.0,6/25,19.82%,CCAR2;EAF2;EAF1;KAT7;CCNK;TCEA2
prerank,reticulophagy (GO:0061709),0.2543164355347236,0.5879317846146811,0.9178832116788321,1.0,1.0,2/12,15.61%,UBA5;ATG2A
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.20033001838043596,-0.5873771258660097,0.9566160520607375,1.0,1.0,9/23,33.82%,HMGB1;KPNB1;H1-0;FOXL2;DICER1;KPNA1;ENDOG;MUS81;DFFA
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.25268843990609724,-0.5870765793080313,0.9265658747300216,1.0,1.0,2/10,12.88%,GFPT2;GFPT1
prerank,cellular response to interleukin-2 (GO:0071352),0.25870542989936546,0.5868458236453411,0.9223484848484849,1.0,1.0,4/11,18.77%,STAT5B;JAK1;STAT5A;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.25870542989936546,0.5868458236453411,0.9223484848484849,1.0,1.0,4/11,18.77%,STAT5B;JAK1;STAT5A;SHC1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.22867783697734945,0.586496625681006,0.9408502772643254,1.0,1.0,4/18,20.80%,DCP2;CCT6A;EXOSC10;PARN
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.2500105980341205,-0.586072440155258,0.9555084745762712,1.0,1.0,5/10,43.29%,CCT5;WRAP53;CCT7;CCT8;CCT4
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.22943251393147907,-0.5859627676366027,0.96,1.0,1.0,6/14,33.57%,RFK;ADSS2;ADSS1;IMPDH1;LHPP;PFAS
prerank,B cell activation involved in immune response (GO:0002312),0.25180488417352,0.5858899161252931,0.9361702127659575,1.0,1.0,13/13,74.84%,MSH2;RNF8;GPR183;MSH6;CD40LG;CD180;GAPT;CD19;BATF;LIG4;FCGR2B;EXOSC3;RNF168
prerank,positive regulation of lymphocyte activation (GO:0051251),0.20685335236590746,0.5858383890184279,0.9668989547038328,1.0,1.0,3/28,7.35%,IL6;CD47;CCL2
prerank,protein prenylation (GO:0018342),-0.25155146868680484,-0.5858205275644458,0.948051948051948,1.0,1.0,5/10,30.72%,PGGT1B;CHML;RABGGTA;RABGGTB;PTAR1
prerank,cellular response to hydroxyurea (GO:0072711),0.26060307305359276,0.5849879190444961,0.9303675048355899,0.9999967304445727,1.0,4/10,25.82%,SPIDR;NSMCE3;ATRX;RTF2
prerank,natural killer cell mediated immunity (GO:0002228),-0.22129826869159916,-0.5844300353084741,0.9577167019027484,0.9999317132653792,1.0,3/15,15.59%,TUBB4B;RAET1E;LYST
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.15542745502386587,-0.5837890527062516,0.9971509971509972,0.9995463606343411,1.0,14/72,21.25%,CRADD;ACER2;RPL26;PLAGL1;TFAP4;ATM;RGCC;CDKN1A;RBL2;E2F4;CNOT2;CNOT8;E2F7;BCL3
prerank,spinal cord development (GO:0021510),0.2548779166991175,0.5814521211538345,0.9357277882797732,1.0,1.0,3/12,15.82%,LOXL3;PKD2;SOX4
prerank,cilium-dependent cell motility (GO:0060285),0.21380694678232567,0.5805934123950464,0.9575221238938053,1.0,1.0,5/22,19.72%,RFX3;RSPH9;DRC1;GAS8;CCDC39
prerank,kinetochore organization (GO:0051383),-0.23089169948880175,-0.5800285302661041,0.9617021276595744,1.0,1.0,9/13,42.53%,CENPT;CENPF;CENPA;DLGAP5;NUF2;CENPW;MIS12;CENPE;CDT1
prerank,protein alkylation (GO:0008213),0.20829885043778784,0.5799206896319823,0.9409660107334525,1.0,1.0,2/22,7.93%,ETFBKMT;METTL21C
prerank,RNA export from nucleus (GO:0006405),0.16678580018043407,0.5797788673315116,0.9985815602836879,1.0,1.0,26/100,22.20%,NXF2;RANBP2;TPR;SLU7;SRSF4;SMG5;SMG6;MAGOHB;SMG7;DDX39A;THOC5;POM121;SRSF5;NUP37;HNRNPA2B1;SMG1;DDX19B;RAN;SLBP;AGFG1;WDR33;UPF2;NUP85;SRSF3;SRSF11;XPO5
prerank,neuromuscular synaptic transmission (GO:0007274),-0.20804268948995044,-0.5792045230177566,0.9757709251101322,1.0,1.0,1/18,2.41%,KIF1B
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.21087644607590905,0.5791109908319938,0.9675213675213675,1.0,1.0,7/26,16.11%,TTL;KLHL18;CUL3;CCDC57;SMOC2;APP;PKN2
prerank,negative regulation of B cell proliferation (GO:0030889),-0.24110717383250213,-0.5787279987894844,0.954,0.9996288664501444,1.0,3/11,15.76%,LYN;ATM;TNFRSF21
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.21230060610158563,-0.5767699596631137,0.9672489082969432,0.9997156020454467,1.0,3/16,14.03%,SRSF1;WBP11;SART1
prerank,determination of left/right symmetry (GO:0007368),0.19954011383824513,0.5767039975103451,0.9778911564625851,1.0,1.0,12/36,23.22%,RFX3;ODAD4;DNAAF1;NPHP3;PKD2;ARL6;CCDC39;MEGF8;OFD1;CITED2;DNAAF4;DAND5
prerank,protein localization to vacuole (GO:0072665),-0.2251862934045743,-0.5760264464268989,0.9728601252609603,0.9993607044625701,1.0,6/13,32.99%,GLMP;CD81;LAMTOR4;SH3GLB1;KPTN;SZT2
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.18077167327555063,-0.5758164624476099,0.9927710843373494,0.998804136665385,1.0,6/32,20.73%,GRM5;ATXN2;PUM3;PGAM1;RBM3;NANOS3
prerank,placenta development (GO:0001890),0.247034850123675,0.575540433292345,0.9285714285714286,1.0,1.0,2/12,10.94%,ADAM19;PTK2
prerank,rRNA transcription (GO:0009303),-0.21085943602081328,-0.5742369578693696,0.9582417582417583,0.9987209236684448,1.0,8/17,38.11%,GTF3C6;SPIN1;SIRT7;POLR1E;TAF1B;NIFK;GTF3C4;GTF3C1
prerank,protein-DNA complex disassembly (GO:0032986),-0.21372059490797474,-0.5732086779405855,0.9563409563409564,0.9984669565109934,1.0,8/16,37.10%,SMARCB1;RPL23;SET;SMARCC2;MYC;GRWD1;NFE2;HMGA1
prerank,regulation of chromosome organization (GO:0033044),-0.19326101196725487,-0.57047801139252,0.9653579676674365,0.9987947916354148,1.0,14/22,45.94%,MAPT;RMI2;UPF1;SHCBP1L;HNRNPD;MYC;PIF1;BUB1;TERF2IP;HDAC8;CDT1;YLPM1;LIG4;SETMAR
prerank,epithelial cell morphogenesis (GO:0003382),-0.21468036598504445,-0.5703867689368475,0.9693654266958425,0.9981892753301566,1.0,8/17,39.56%,MET;RILPL2;SIPA1L3;STC1;PKHD1;POF1B;GRHL2;RAB25
prerank,neuron maturation (GO:0042551),0.22118926884354223,0.5695675696725747,0.9385171790235082,1.0,1.0,5/18,20.20%,EPHA8;CLN5;APP;FARP2;MTCH1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.24591985078779144,-0.5695302336581287,0.9359504132231405,0.997870290632112,1.0,6/10,43.28%,CEACAM1;PTPRC;LILRB1;CX3CR1;FCGR2B;KLRD1
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.20060224008895305,-0.569200039630615,0.954070981210856,0.997340491453259,1.0,6/19,31.16%,RIC3;CHRNA4;CHRFAM7A;CHRNA7;NQO1;ACHE
prerank,DNA methylation (GO:0006306),-0.190500291144419,-0.5689020017787193,0.9720930232558139,0.9968047916974562,1.0,8/23,30.01%,HELLS;GATAD2A;MTRR;DMAP1;DNMT1;N6AMT1;FOS;PICK1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.22345897373292958,-0.5681044024033906,0.9497991967871486,0.9964353817569593,1.0,6/13,43.87%,NELFCD;RNF168;NELFA;SUPT4H1;NELFB;LARP7
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.2058275757017214,0.5659175637821927,0.9711711711711711,1.0,1.0,6/27,16.16%,CREBBP;KAT6B;BRD8;KAT6A;KAT2B;PHF20L1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.22362151384603207,0.565833036137731,0.9638336347197106,1.0,1.0,4/18,15.95%,SNX12;MAP2K1;CHMP3;DAB2
prerank,negative regulation of interferon-beta production (GO:0032688),-0.24239958449846408,-0.5657000616240557,0.9611451942740287,0.9965885614443724,1.0,3/10,27.84%,YY1;PYCARD;LILRB1
prerank,carboxylic acid catabolic process (GO:0046395),-0.22991095495995098,-0.5655318873535835,0.9521829521829522,0.9960090751519864,1.0,3/12,18.23%,BCKDK;RENBP;NPL
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.16313712818248385,0.5641645152592457,0.9971550497866287,1.0,1.0,22/96,20.22%,NXF2;RANBP2;TPR;SLU7;SRSF4;SMG5;SMG6;MAGOHB;SMG7;DDX39A;THOC5;POM121;SRSF5;NUP37;HNRNPA2B1;SMG1;DDX19B;SLBP;AGFG1;WDR33;UPF2;NUP85
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.2001309036391421,-0.5632454579242893,0.9625550660792952,0.99610395431509,1.0,2/21,10.20%,SETX;MED30
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.20431036699209473,0.5631220261578602,0.9709401709401709,1.0,1.0,8/27,23.20%,ETNK2;PLA2G6;NAAA;NAPEPLD;LPIN2;SLC27A1;PLAAT5;LPIN1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.24349708647319332,0.5625996625540794,0.9603024574669187,1.0,1.0,3/11,21.05%,P4HTM;OGFOD1;EGLN1
prerank,positive regulation of viral transcription (GO:0050434),0.20295077193281705,0.5620684477981075,0.9637931034482758,1.0,1.0,8/25,26.41%,POLR2D;POLR2C;POLR2F;POLR2K;RSF1;DHX9;POLR2H;GTF2F1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.19371131837559613,-0.5615731873751186,0.9901477832512315,0.9960086173012591,1.0,13/23,45.53%,ACSBG1;HPGD;FADS1;ALOX5;CYP2E1;ACOT7;GSTM4;GPX4;LTC4S;GSTP1;CYP1A1;ALOX12;ELOVL6
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.2074124566059562,-0.5613670213316923,0.9730941704035875,0.9954423945577532,1.0,7/15,38.22%,CD53;ADGRB1;TREM2;TYROBP;SCGB3A1;IL4;ADAM9
prerank,adipose tissue development (GO:0060612),0.24412260262651164,0.5583940225125216,0.9602272727272727,1.0,1.0,4/11,20.47%,DGAT2;ARID5B;SH3PXD2B;XBP1
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.17768446150051495,-0.5582185248585736,0.9906976744186047,0.9957142136574616,1.0,7/29,24.55%,BAG6;MEI4;SIRT7;TEX11;REC8;TRIP13;RAD21
prerank,isotype switching (GO:0045190),0.25175746924428805,0.5572396768533096,0.9364754098360656,1.0,1.0,10/10,74.84%,MSH2;RNF8;MSH6;CD40LG;BATF;HSPD1;CCR6;LIG4;EXOSC3;RNF168
prerank,phosphate ion transport (GO:0006817),-0.21165727937391346,-0.5546806631273895,0.9849785407725322,0.9962323422164089,1.0,5/16,28.12%,XPR1;SLC25A30;SLC20A2;SLC37A1;SLC37A2
prerank,mitochondrial transcription (GO:0006390),-0.23930357309330166,-0.5541010242061972,0.9546313799621928,0.9957795147359563,1.0,4/10,23.62%,TWNK;TFB2M;TFB1M;POLRMT
prerank,ncRNA export from nucleus (GO:0097064),-0.16801067611535742,-0.5537157223254133,0.9926108374384236,0.9952684524376648,1.0,14/36,33.20%,NPM1;AAAS;NUP93;RAE1;XPOT;NUP62;NUP188;NUP54;NUP210;NUP42;NUP153;NDC1;SEC13;NOL6
prerank,RNA catabolic process (GO:0006401),0.17906119767797998,0.5535516850020417,0.9902439024390244,1.0,1.0,13/46,23.44%,NANOS2;DCP2;SND1;SLFN14;METTL16;SUPV3L1;DNA2;RNASEH1;RNASE3;RNASEH2B;PNPT1;RNASEH2A;ZFP36L2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.22801601617668554,0.5526522879921807,0.9596153846153846,1.0,1.0,2/14,12.71%,TNFSF15;MAP3K7
prerank,lysosome localization (GO:0032418),0.18581759281962085,0.551505725522685,0.9917491749174917,1.0,1.0,9/37,21.30%,KIT;MAP6;KIF5B;RAB34;PLEKHM2;BORCS5;VPS33A;KXD1;DEF8
prerank,regulation of spindle assembly (GO:0090169),0.19929703260668893,0.5508619072007368,0.966499162479062,1.0,1.0,5/25,15.98%,TPR;SENP6;CHMP3;CHMP4B;EML3
prerank,regulation of cellular protein metabolic process (GO:0032268),0.17675078288860635,0.5489869483221494,0.9935275080906149,1.0,1.0,8/47,16.11%,PKP3;NR1H3;SSH1;FOXO3;CSF1;GEMIN5;MAPKAPK5;APP
prerank,chromatin assembly or disassembly (GO:0006333),0.23395707748101227,0.5483193706477625,0.9578313253012049,1.0,1.0,1/11,6.01%,CDAN1
prerank,amyloid-beta metabolic process (GO:0050435),0.2150632134098411,0.5482619087631085,0.9674329501915708,1.0,1.0,5/16,25.91%,MGAT3;ABCA7;APEH;PSEN1;NCSTN
prerank,cytoplasmic translational initiation (GO:0002183),-0.19977495957138375,-0.548006086079414,0.9720930232558139,0.9963076366311343,1.0,5/17,27.25%,EIF4A1;EIF3A;EIF4A2;EIF3I;EIF4G1
prerank,nuclear membrane organization (GO:0071763),0.20876323467292734,0.5478565858867834,0.9743589743589743,1.0,1.0,7/19,24.33%,TOR1AIP1;UBXN2A;NEMP1;CHMP4B;EMD;SPAST;VPS4A
prerank,positive regulation of integrin activation (GO:0033625),-0.2304300701044947,-0.547259811360556,0.9813664596273292,0.9958712831776566,1.0,1/11,5.13%,RASIP1
prerank,regulation of oxidoreductase activity (GO:0051341),0.2285661541168027,0.5470555368074761,0.9548872180451128,1.0,1.0,4/13,22.03%,SIRT4;ABL2;HP;OXA1L
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.214708078450907,-0.5446669608243899,0.9615384615384616,0.995946144052979,1.0,8/13,49.48%,MMS19;YAE1;GLRX5;LTO1;CISD3;ISCA2;GLRX3;BOLA2
prerank,telomere capping (GO:0016233),-0.1996768492364503,-0.5442418377210161,0.9648760330578512,0.9954382231955935,1.0,9/16,38.77%,MRE11;TERF1;TINF2;DCLRE1C;STN1;DCLRE1B;PRKDC;TERF2IP;NBN
prerank,positive regulation of lipid storage (GO:0010884),0.2067950832553695,0.543563569598466,0.980701754385965,1.0,1.0,5/21,24.58%,IKBKE;PLIN3;ZC3H12A;OSBPL11;HILPDA
prerank,respiratory chain complex IV assembly (GO:0008535),-0.1892684058374525,-0.53937833333082,0.9770642201834863,0.9960617113188195,1.0,8/21,32.25%,COX20;COX19;PET100;TIMM21;BCS1L;COA5;SCO2;COA3
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.19520916150816375,-0.5364423250967286,0.9779735682819384,0.9961805751554407,1.0,8/18,32.25%,COX20;COX19;PET100;TIMM21;BCS1L;COA5;SCO2;COA3
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.22158695924343216,0.5362930387752161,0.9651376146788991,1.0,1.0,3/13,20.03%,BMP7;NAPEPLD;PTGS2
prerank,nuclear envelope organization (GO:0006998),0.2050934689629746,0.5350055747863256,0.9705340699815838,1.0,1.0,7/20,24.33%,TOR1AIP1;NEMP1;DMPK;EMD;SUN1;LEMD3;VPS4A
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.21301757610508457,0.5350048123465196,0.9635701275045537,1.0,1.0,8/18,27.10%,AMFR;UGGT2;RNF185;EDEM2;RNF139;SYVN1;OS9;UGGT1
prerank,transcription preinitiation complex assembly (GO:0070897),0.22730569460586167,0.5336247094506679,0.9653846153846154,1.0,1.0,4/12,24.06%,TAF7;BDP1;DR1;TAF1
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.2245669421222914,-0.5336116116226032,0.9599198396793587,0.996268063062103,1.0,2/11,10.86%,H3-3A;ASF1A
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.2117799654512646,-0.5330567137715347,0.9774127310061602,0.995780073404993,1.0,8/12,42.53%,MAD1L1;NUF2;MIS12;KIF2C;BOD1;CENPE;CHAMP1;CDT1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.24300780676367442,0.5315599660288984,0.9531568228105907,1.0,1.0,6/10,31.16%,DCLRE1A;RIF1;RTEL1;TFIP11;TERF2;ACD
prerank,regulation of B cell activation (GO:0050864),-0.17451262953022745,-0.5307258688876751,0.9865771812080537,0.9956994250351463,1.0,10/25,40.47%,SH3KBP1;NOD2;SAMSN1;LAPTM5;IKZF3;THEMIS2;FOXJ1;IL4;CD22;FCGR2B
prerank,regulation of mRNA metabolic process (GO:1903311),0.2330922199944262,0.5304850406698538,0.9615384615384616,1.0,1.0,2/11,13.35%,IWS1;SRPK1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.19202285995104879,-0.5296783904991834,0.9799554565701559,0.995306558014553,1.0,3/18,12.77%,CTSC;PTTG1IP;HSP90AA1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.22379432303254296,0.5291795479872037,0.956766917293233,1.0,1.0,1/13,5.97%,TPR
prerank,positive regulation of protein depolymerization (GO:1901881),0.22761623710984633,0.5264080779630256,0.9678030303030303,1.0,1.0,2/11,11.82%,PLEK;NES
prerank,erythrocyte development (GO:0048821),0.2383726598893242,0.5263456469404648,0.9647058823529412,1.0,1.0,3/10,19.05%,SH2B3;ALAS2;DMTN
prerank,regulation of microglial cell activation (GO:1903978),-0.20050347008146052,-0.5262621613623487,0.9778761061946902,0.9954586172049106,1.0,3/15,15.17%,TTBK1;GRN;PTPRC
prerank,DNA modification (GO:0006304),0.20033119075392009,0.5259285242625988,0.9748653500897666,1.0,1.0,3/22,12.98%,PARP3;NTHL1;OGG1
prerank,regulation of viral transcription (GO:0046782),0.1728341092206296,0.525362308638891,0.9950576606260296,1.0,1.0,13/39,26.41%,POLR2D;POLR2C;TRIM21;TARBP2;POLR2F;POLR2K;RSF1;HEXIM1;DHX9;TRIM32;UBP1;POLR2H;GTF2F1
prerank,protein localization to centrosome (GO:0071539),0.20952097000341174,0.5223732497471405,0.9743119266055046,1.0,1.0,3/17,11.45%,C2CD3;NUDCD3;NEDD1
prerank,extracellular transport (GO:0006858),0.22598870056497167,0.5204521564715567,0.9662698412698413,1.0,1.0,12/12,77.42%,WWP2;SPEF2;DNAAF4;ROPN1L;TSG101;SPA17;ARRDC1;CCDC40;DNAAF2;CABYR;SPAG17;ADCY10
prerank,double-strand break repair via break-induced replication (GO:0000727),0.21810232473264826,0.5198244584559207,0.9593810444874274,1.0,1.0,2/12,13.74%,MCM4;MCM6
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.2001752925320897,-0.5193777630183678,0.9747126436781609,0.99628622018905,1.0,5/14,35.09%,CSTF2;TSEN54;CPSF1;TSEN34;DDX1
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.18817659901407136,-0.5190138020218679,0.9772727272727273,0.9957420716872097,1.0,4/18,23.08%,LDLRAP1;PSENEN;NSG1;CLN3
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.17315360019676504,0.5164643831556972,0.9966666666666667,1.0,1.0,12/37,24.12%,ENTPD7;SND1;SUPV3L1;DNASE1L1;RNASEH1;DFFB;RNASE3;RNASEH2B;PNPT1;ENTPD6;RNASEH2A;ENTPD5
prerank,regulation of phosphate metabolic process (GO:0019220),0.2092428962417844,0.5159570923798676,0.9707602339181286,1.0,1.0,8/16,29.39%,SMG5;SMG6;SMG7;SIRT2;MCM7;PSEN1;IGBP1;GNB3
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.20061406983490337,0.5159013374009289,0.982725527831094,1.0,1.0,6/19,20.88%,RTN1;FLOT2;RTN4;ABCA7;ROCK1;GGA3
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.19040680420182246,-0.5136591512027119,0.9798657718120806,0.9961772566440998,1.0,3/16,15.27%,SCARB1;MFSD2A;CTDNEP1
prerank,positive regulation of protein maturation (GO:1903319),0.22416348179799336,0.5130664850262812,0.96415770609319,1.0,1.0,2/11,15.82%,CCBE1;SOX4
prerank,regulation of cilium movement (GO:0003352),0.22913109672472332,0.5122291118036447,0.9644268774703557,1.0,1.0,3/10,19.72%,DNAAF1;DRC1;CCDC39
prerank,positive regulation of mRNA processing (GO:0050685),0.19364305193036335,0.504753323128935,0.9778911564625851,1.0,1.0,11/21,28.99%,CDC73;PAF1;LEO1;DHX36;NCL;RBMX;DAZAP1;SF3B4;NUP98;THRAP3;TRA2B
prerank,regulation of B cell apoptotic process (GO:0002902),-0.20567722789089868,-0.5042797256855329,0.9821782178217822,0.9973174280637352,1.0,3/12,19.82%,LYN;ORMDL3;NOC2L
prerank,protein import into mitochondrial matrix (GO:0030150),-0.18272888747235225,-0.5031720429406785,0.9853249475890985,0.9968693935247744,1.0,4/18,18.32%,DNLZ;GRPEL2;TOMM40L;TOMM20
prerank,RNA methylation (GO:0001510),-0.13545440595642233,-0.5022730905598038,1.0,0.9964122234367472,1.0,18/60,33.36%,TRMT13;FTSJ3;VIRMA;CBLL1;ZC3H13;RBM15B;TRMT6;TFB2M;TFB1M;METTL8;TRMT10C;METTL14;TRMT61A;THUMPD2;ALKBH8;TRMT10A;BCDIN3D;FBL
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.19423455588188374,0.5010742165172982,0.9798534798534798,1.0,1.0,2/20,8.04%,BCL2;BAX
prerank,tRNA export from nucleus (GO:0006409),0.17748862011483826,0.49938710211049114,0.9947735191637631,1.0,1.0,6/32,17.26%,RANBP2;TPR;POM121;NUP37;SSB;RAN
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.17748862011483826,0.49938710211049114,0.9947735191637631,1.0,1.0,6/32,17.26%,RANBP2;TPR;POM121;NUP37;SSB;RAN
prerank,spliceosomal snRNP assembly (GO:0000387),0.16711692336632428,0.4959806226897124,0.9966996699669967,1.0,1.0,7/38,19.03%,GEMIN4;STRAP;PRPF19;GEMIN5;TGS1;PRPF3;USP4
prerank,eosinophil chemotaxis (GO:0048245),0.2037811466347897,0.49473167270037904,0.9836065573770492,1.0,1.0,1/14,7.35%,CCL2
prerank,eosinophil migration (GO:0072677),0.2037811466347897,0.49473167270037904,0.9836065573770492,1.0,1.0,1/14,7.35%,CCL2
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.18825564137494882,-0.49455493164687253,0.986046511627907,0.996977695320187,1.0,9/15,48.58%,CSTF2;TSEN54;CPSF1;TSEN34;DDX1;ERN1;RTCB;CPSF4;TSEN15
prerank,rRNA methylation (GO:0031167),0.18623671540822678,0.4935219183525736,0.9856887298747764,1.0,1.0,6/22,23.24%,ZCCHC4;METTL16;FDXACB1;METTL15;METTL5;MTERF4
prerank,mitochondrial protein processing (GO:0034982),0.21523411681512988,0.49343893737074573,0.9724950884086444,1.0,1.0,5/11,30.87%,PMPCB;AFG3L2;STOML2;PMPCA;YME1L1
prerank,cilium movement (GO:0003341),-0.1423177139876064,-0.49287844499185446,1.0,0.9965978628548917,1.0,21/47,37.49%,CFAP251;DNAH11;CFAP70;CFAP54;ODAD2;ADCY10;SPAG17;ODAD3;CABYR;DNAAF2;CFAP100;DNAH17;CFAP206;CFAP61;DNAH9;CCDC40;CCDC63;CFAP91;TEKT5;TTC29;DNAH1
prerank,positive regulation of cilium assembly (GO:0045724),0.19363731270278084,0.4819406936014166,0.9859894921190894,1.0,1.0,3/18,14.99%,TAPT1;ENTR1;CROCC
prerank,carbohydrate derivative catabolic process (GO:1901136),0.1911517005710518,0.48059384592678406,0.9872262773722628,1.0,1.0,2/18,10.29%,MANBA;DERA
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.19039577091850246,-0.4802855987482298,0.9799196787148594,0.9976819404331235,1.0,5/13,32.89%,SART3;LSM2;PRPF8;SRSF12;DDX20
prerank,ncRNA transcription (GO:0098781),0.20420940839415996,0.4788013526582572,0.9803921568627451,1.0,1.0,3/13,18.22%,POLR1G;SNAPC3;CAVIN1
prerank,positive regulation of translational initiation (GO:0045948),0.1842577670562484,0.4785118512465145,0.9870848708487084,1.0,1.0,1/18,3.58%,POLR2D
prerank,protein autoprocessing (GO:0016540),0.19142439774474457,0.47786001462634137,0.980701754385965,1.0,1.0,1/17,4.23%,CASP4
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.19075786012672197,-0.4681692297250539,0.9878296146044625,0.9984828633662756,1.0,5/12,43.87%,NELFCD;RNF168;NELFA;NELFB;LARP7
prerank,aromatic amino acid family catabolic process (GO:0009074),0.195097883450729,0.4650595385274497,0.9946140035906643,1.0,1.0,1/15,7.28%,HGD
prerank,glutathione derivative biosynthetic process (GO:1901687),0.1746404818288358,0.46306157903006084,0.9854014598540146,1.0,1.0,2/20,12.34%,GSTK1;GSTA3
prerank,glutathione derivative metabolic process (GO:1901685),0.1746404818288358,0.46306157903006084,0.9854014598540146,1.0,1.0,2/20,12.34%,GSTK1;GSTA3
prerank,positive regulation of cell division (GO:0051781),0.15333757060824146,0.46292456993923964,0.9983388704318937,1.0,1.0,1/38,1.37%,FGF1
prerank,nuclear body organization (GO:0030575),0.20238543628374148,0.45684456890527364,0.9905660377358491,1.0,1.0,12/12,79.78%,AFF2;PML;HABP4;ETS1;ZPR1;SERBP1;USP50;DYRK3;USPL1;HIPK2;SRPK2;WRAP53
prerank,regulation of centrosome duplication (GO:0010824),0.1599594532443797,0.4527607920345089,0.9950738916256158,1.0,1.0,6/29,20.14%,ALMS1;CHMP3;CHMP4B;SPICE1;CEP131;CHMP5
prerank,positive regulation of rRNA processing (GO:2000234),-0.19219532172492454,-0.4492155737312605,0.9896694214876033,0.9996127428628536,1.0,3/10,28.40%,SIRT7;HEATR1;WDR75
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.19453481091518948,0.4490848473511957,0.9921875,1.0,1.0,4/12,25.56%,PAICS;GMPS;ADSL;ATIC
prerank,fatty acid transport (GO:0015908),0.1771792028336427,0.4477108873041331,0.9942307692307693,1.0,1.0,4/17,20.28%,ACSL1;SLC27A3;CD36;SLC27A1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.18167071131865176,0.44637280541506963,0.9902912621359223,1.0,1.0,3/17,15.17%,NTHL1;OGG1;ERCC5
prerank,regulation of rRNA processing (GO:2000232),0.18147130018629798,0.44637115992944704,0.9944547134935305,1.0,1.0,3/16,15.86%,UTP15;USP36;KAT2B
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.1855174270516442,-0.44523464530450846,0.997907949790795,0.9986706523603807,1.0,5/11,43.87%,CCT5;CCT7;CCT8;CCT4;LARP7
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.1855174270516442,-0.44523464530450846,0.997907949790795,0.9986706523603807,1.0,5/11,43.87%,CCT5;CCT7;CCT8;CCT4;LARP7
prerank,cellular response to UV-A (GO:0071492),0.19680910796108148,0.4448160937970731,0.9841897233201581,1.0,1.0,2/11,16.99%,PPID;OPN3
prerank,chromatin disassembly (GO:0031498),0.1845963431470994,0.4445241837723208,0.9886363636363636,1.0,1.0,6/14,23.69%,SMARCA4;SMARCC1;SMARCD3;ARID2;SMARCD1;SMARCE1
prerank,nucleosome disassembly (GO:0006337),0.1845963431470994,0.4445241837723208,0.9886363636363636,1.0,1.0,6/14,23.69%,SMARCA4;SMARCC1;SMARCD3;ARID2;SMARCD1;SMARCE1
prerank,response to hydroxyurea (GO:0072710),0.19380099073086393,0.4444451624596449,0.990530303030303,1.0,1.0,4/11,25.82%,SPIDR;NSMCE3;ATRX;RTF2
prerank,regulation of amyloid-beta clearance (GO:1900221),0.17800396673611774,0.4440314497489783,1.0,0.999818909875521,1.0,5/16,24.61%,LRPAP1;LRP1;ABCA7;ROCK1;APOE
prerank,positive regulation of DNA recombination (GO:0045911),0.15617541238739036,0.43312336884737396,0.9964726631393298,1.0,1.0,11/27,27.76%,FUS;ERCC6;SHLD2;KMT5C;RIF1;KMT5B;ARID2;ZCWPW1;SHLD1;ERCC2;FANCB
prerank,tRNA metabolic process (GO:0006399),0.17244275461263353,0.43308545833277323,0.9964093357271095,0.9998514452824787,1.0,3/17,16.53%,TRPT1;DTD2;SSB
prerank,regulation of lymphocyte proliferation (GO:0050670),0.16964315120469609,0.42588983779614054,0.9927667269439421,0.999907493772438,1.0,1/16,5.29%,PTPN22
prerank,tRNA methylation (GO:0030488),0.14449102118859508,0.4249814496341125,0.9983333333333333,0.9994969827817979,1.0,11/34,24.92%,THUMPD3;WDR6;TYW3;METTL1;FTSJ1;METTL2B;METTL2A;DALRD3;THADA;METTL6;TARBP1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.1852705415820258,0.4200713931403459,0.9981343283582089,0.9993445403192326,1.0,1/12,6.49%,PPARA
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.158431553779406,-0.41471974495864544,1.0,0.9998002312669299,1.0,5/15,31.92%,MRE11;MDC1;HUS1B;MUS81;NEK11
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.16778607745904212,-0.39801636038082655,1.0,0.9997629312394942,1.0,11/11,83.24%,EXOSC2;EXOSC4;FBL;EXOSC3;FBLL1;LARP7;DKC1;EXOSC5;TENT4B;PARN;EXOSC10
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.166813159216474,0.397821577965082,0.9960707269155207,1.0,1.0,14/14,83.33%,FUS;ERCC6;ARID2;FANCB;WDR48;OOEP;PARP1;MRNIP;ACTR2;TIMELESS;WAS;RAD51AP1;WRAP53;MMS19
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.14777824329319186,0.3944609346091813,1.0,0.9996966393535633,1.0,4/22,19.60%,CUL4A;GTF2H4;GTF2H2;XPC
prerank,DNA packaging (GO:0006323),0.14830162255205934,0.36742309827640507,1.0,0.9999809117144495,1.0,2/16,14.37%,CDAN1;KAT6A
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.11873998147014134,-0.3397720844157661,1.0,0.9999306163643874,1.0,5/20,32.91%,MBTPS1;PSENEN;MBTPS2;RELA;HM13
prerank,meiosis I (GO:0007127),0.11807581913722426,0.3225914829938832,1.0,0.9999519151601973,1.0,22/23,75.00%,ZSCAN21;SLC25A31;FOXJ3;ZCWPW1;ING2;MEIOB;BCL2L11;MYBL1;DDX4;BTBD18;MEIOC;MEI1;DNMT3L;CCNA1;HSF2BP;BRDT;FOXJ2;MEIKIN;MOV10L1;TDRD9;SYCP3;SGO1
